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Abstract 
■  Chapter One 
Development of Simple Organic Molecules as Catalysts for Enantioselective 
Allyl Additions to N-Phosphinoylaldimines and Isatins 
 A new catalytic protocol for the enantioselective addition of organoborates to 
imines and carbonyls is described. This novel method, which does not require transition 
metals utilizes a modular and easily accessed aminophenol to dictate the stereochemistry 
of the products. Allyl-additions to N-phosphinoylaldimines and isatins, as well as allenyl-
additions to isatins are studied and literature relevant to these transformations is 
discussed. Additionally, two separate methods for obtaining "crotyl-type" addition 
products to aldimines; one requiring α-chiral allylboronates and the other requiring a 
zinc-alkoxide, are discussed.  Studies to elucidate the mechanism of this catalytic 
protocol are also contained in this chapter. 
  
 
■  Chapter Two 
Enantioselective Additions to Fluorinated Ketones: A Platform for Studying 
the Interaction Between Organofluorine and a Small Molecule 
 Utilizing the new protocol discussed in Chapter One, allyl- and allenyl-groups are 
added enantioselectively to ketones containing a fluorinated substituent.  Myriad tertiary 
alcohols are synthesized, demonstrating the value of this method. This study also allows 
for examining how organofluorine containing compounds bind to other organic 
molecules, which is a current topic of intense interest in the field of medicinal chemistry. 
Mechanistic studies support the idea that, in many cases, the fluorine of the substrate is 
electrostatically attracted to the ammonium-ion in the catalyst. 
■  Chapter Three 
Enantioselective Additions of Organoboronates to Ketones and 
Alphaketoesters Promoted by an Aminophenol Containing Catalyst 
 Modification of the aminophenol disclosed in Chapter One allows for increased 
enantioselectivity for the allyl-addition to both simple ketones (such as acetophenone) 
and alphaketoesters. For simple ketones, a critical component of the optimal catalyst is 
replacing the tert-butyl group ortho to the phenol with the sterically large triphenylsilyl 
group. For alphaketoesters, this tert-butyl group was replaced with the sterically smaller 
metyl group. Rationale for why these contradictory changes in the catalyst structure lead 
to higher enantioselectivity for reactions with these two classes of ketones is discussed. 
 
 
■  Chapter Four 
Ag-Catalyzed Enantioselective Vinylogous Mannich Reactions of γ-
Substituted Siloxyfurans with Aldimines 
 A previously disclosed Ag-catalyzed enantioselective vinylogous Mannich 
reaction (EVM) with α-, β-, and unsubstituted siloxyfurans is extended to include γ-
substituted siloxyfurans. This method, which generates a tertiary stereogenic center 
concurrent with an adjacent to a quaternary stereogenic center, requires a rarely used 2-
thiomethylaniline N-protecting group for the aldimines. 
 i 
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Chapter One 
 
Development of Simple Organic Molecules as 
Catalysts for Enantioselective Allyl Additions 
to N-Phosphinoylaldimines and Isatins 
 
1.1 Introduction 
 Enantiomerically pure compounds are prevalent throughout biology, from simple 
amino acids and sugars, to more complex proteins and nucleic acids.  It should, therefore, 
not come as a surprise that the presence of stereogenic centers are an extremely important 
structural aspect of biologically active molecules.  Examination of a large database of 
biologically tested molecules made in the pharmaceutical industry reveals that as a drug 
candidate progresses from the discovery phase to a finished drug, the likelihood of it  
 
containing a stereogenic center increases from a 46% chance to a 61% chance (Table 
1.1).1  While the increase between each stage is generally not statistically significant,  
(except between Phase II and Phase III) the overall change from 46% to 61% represents a 
                                                
(1) Lovering, F.; Bikker, J.; Humblet, C. J. Med. Chem. 2009, 52, 6752–6756. 
Percentage of molecules containing 
at least one stereogenic center
(Number of molecules)
Stage of Development
46%
(1.3 Million)
Discovery
49%
(249)
Phase I
52%
(369)
Phase II
62%
(120)
Phase III
61%
(1089)
Market
Table 1.1. Presence of Stereochemistry in Pharmaceuticals Versus their Development Stage
(1980–2008)
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significant 32% increase.2  Importantly this is not simply a matter of more complex 
compounds are more drug-like. The same study showed that another measure of 
molecular complexity, average molecular weight, decreased from 449 amu to 360 amu as 
a candidate moved from discovery to market.1 The fact that a drug on the market is more 
likely to be chiral than a molecule made in discovery raises two major questions: 1) Why 
don't medicinal chemists start with a larger percentage of chiral compounds in discovery 
considering these compounds are more likely to resemble the finished product? and 2) 
What is the reason that stereogenic centers are important in pharmaceuticals? 
 Regarding the first question, the likely answer is that it is still non-trivial to 
stereoselectively synthesize a desired compound in a reliable, simple, and cost-effective 
manner.1, 3 Supporting this statement are two separate analyses of the way a stereogenic 
center is incorporated into enantiopure molecules in the medicinal programs of 
GlaxoSmithKline, AstraZeneca, and Pfizer (Chart 1.1 and 1.2).3a,3b  Analysis by Carey et 
al. in 20063a of a selection of biologically-active compounds in the early stages of  
 
                                                
(2) It should be noted that the authors find a similar trend pertaining to the fraction of sp3 atoms in a 
molecule and clinical success.  That is, the fraction of sp3 carbons in a molecule (Fsp3) increases as it 
progresses from discovery to market.  Based on data analysis, it seems these trends are independent of each 
other and are individually significant. 
(3) (a) Carey, J. S.; Laffan, D.; Thomson, C.; Williams, M. T. Org. Biomol. Chem. 2006, 4, 2337–2347. (b) 
Roughley, S. D.; Jordan, A. M. J. Med. Chem. 2011, 54, 3451–3479. (c) Cooper, T. W. J.; Campbell, I. B.; 
Macdonald, S. J. F. Angew. Chem. Int. Ed. 2010, 49, 8082–8091. 
Stereoselective 
Synthesis 
Resolution 
Purchased 
55%
17%
28%
Chart 1.1. Source of Stereochemistry of Molecules Synthesized in Medicinal Chemistry
(Carey, et al., 2006)
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development shows that 55% of all stereogenic centers come from purchased 
enantiomerically pure compounds.  The second major source of stereogenic centers, 28%, 
are obtained through resolution (by a chiral salt complex, chromatographic separation of 
diastereomers, kinetic resolution, chromatography through a chiral stationary phase, etc.), 
and the last 17% of stereogenic centers are obtained by stereoselective synthesis, with 
enantioselective catalysis being favored over diastereoselective induction in a 3:2 ratio.   
 Five years later, using a much larger data set of molecules, Roughley and Jordan3b 
reported that 87% of all stereogenic centers in molecules made by medicinal chemists, 
where it is known how they were installed into a molecule, originated from a purchased 
 
enantiomerically pure starting material (Chart 1.2).  That leaves only 13% of the 
stereogenic centers being formed through either a resolution or a stereoselective (either 
enantio- or diastereoselective) transformation.  Regardless of the differences between the 
two reviews, it is obvious that the introduction of a stereogenic center is still not regarded 
as an easy task by medicinal chemists, as they overwhelmingly prefer to either purchase 
the source of chirality or set it through resolution instead of carrying out a stereoselective 
process.  Therefore, development of reliable and practical methods for the stereoselective 
synthesis of molecules is still a critical goal in organic chemistry, even though there have 
Chart 1.2. Source of Stereochemistry of Molecules Synthesized in Medicinal Chemistry (Roughly, et al., 2011)
Stereoselec)ve+
Synthesis+
Resolu)on+
Purchased+
7%
6%
87%
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been major advances made in the last four decades.4  Driving home the point that chiral 
molecules are still challenging compounds to work with in medicinal chemistry (from a 
manuscript published recently in 2010), Tony W. J. Cooper, Ian B. Campbell, and Simon 
J. F. Macdonald (all experienced medicinal chemists from GlaxoSmithKline) state3c "... 
the introduction of a stereogenic center (or a further stereogenic center) in a lead series is 
rarely undertaken lightly, particularly when the stereogenic center is not embedded in a 
commercially available molecule or cannot be introduced with good stereoselectivity […] 
In our experience, considerable nerve is required from the medicinal chemist to justify 
the 'time delays' that might result" (pg. 8090).   
 Concerning why the presence of stereochemistry is important in the success of a 
drug, Frank Lovering of Pfizer has compellingly hypothesized that as the number of 
stereogenic centers increases, a drug is less likely to have unacceptable levels of toxicity.5  
This reduction in toxicity is in large part due to a reduction in the "promiscuity"6 of a 
molecule i.e. increasing the amount of stereogenic centers reduces the amount of targets 
(and therefore off-target effects) of a molecule.  The importance of toxicity cannot be 
overstated, as it is currently the most likely reason for a drug to fail in clinical trials.7,8 
Decreasing promiscuity is especially important for amine (i.e. ionizable amines) 
containing compounds, which are about four times as promiscuous as molecules that do 
                                                
(4) Principles of Asymmetric Synthesis: 2nd Edition; Gawley, R. E., Aubé, J., Eds.; Elsevier: Oxford, 
United Kingdom, 2012. 
(5) Lovering, F. Med. Chem. Commun. 2013, 4, 515–519. 
(6) Lovering defines promiscuity as "the number of targets inhibited at greater than 50 percent at 10 µM 
divided by the number of targets tested" (page 515).  A possible flaw in this measurement is that a molecule 
with no biological activity would have a promiscuity of 0.  One assumes such molecules have been 
excluded from the study, but the fact that Lovering does not comment on this possible flaw is a bit 
worrisome. 
(7) Leeson, P. D.; Springthorpe, B. Nat. Rev. Drug Discovery 2007, 6, 881–890. 
(8) Specifically failure in phase I-II (where a drug is most likely to fail).  The cause of failure in phase III is 
not dominated by toxicity.  
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not contain an amine (average promiscuity of 0.25 vs. 0.06).5  As the number of 
stereogenic centers increase, the promiscuity of the molecule is reduced.  For molecules 
containing an amine, there is a 58% decrease in promiscuity (from 0.31 to 0.13, Table  
 
1.2) when moving from no stereogenic centers to >2 stereogenic centers.5,9 Bearing in 
mind that most targets of small molecules are enantiopure proteins, it is expected that 
chirality leads to a more discriminating pharmaceutical agent. Considering that toxicity is 
the leading cause of failure in Phase I and II (but not phase III)7,8 clinical trials, and that 
increasing the number of stereogenic centers in a molecule decreases its promiscuity (and 
likely its toxicity as well),5 one can draw a correlation with the data in Table 1.1, which 
shows a significant increase in the presence of stereochemistry when comparing 
compounds in Phase I and II versus those in Phase III and the market.  
 If low promiscuity is so important, and amine-containing compounds are so much 
more promiscuous than those without amines, why do chemists put amines in potential 
drugs?  The answer is that ionizable-amines readily act as hydrogen-bond acceptors 
and/or donors, making up a large amount of the interactions that are so critically 
important for molecular recognition.10 Another major reason for their presence is that 
ionizable-amines decrease the lipophilicity of the molecule of interest.3b Accordingly, 
nitrogen is contained in approximately 90% of potential active pharmaceutical 
                                                
(9) Analogous to the statement in footnote 2, a similar trend, that increasing Fsp3 of a molecule decreases 
its promiscuity, is observed.   
(10) Bissantz, C.; Kuhn, B.; Stahl, M. J. Med. Chem. 2010, 53, 5061–5084. 
Average promiscuity
Number of Stereogenic Centers
0.31
0
0.26
1
0.21
2
0.13
>2
Table 1.2. Average Promiscuity of an Amine-Containing Molecule Versus the 
Number of Stereogenic Centers
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ingredients;3a with aliphatic amines occurring in 43% of the molecules surveyed and 
amines bearing at least one aryl substituent existing in approximately 33% of all 
molecules surveyed.3b Amides are present in 54% the molecules surveyed.3b   
 Since nitrogen is nearly ubiquitous in compounds of interest to medicinal 
chemists, and chirality is an important property of successful drugs, stereogenic centers 
where one of the substituents is nitrogen are a common functional group in many active 
pharmaceutical ingredients.  Out of the top 25 small-molecule drugs in terms of revenue 
from 2012, 10 of them (40%) contain a nitrogen-bonded stereocenter.11 Scheme 1.1  
 
shows the structure of five of these compounds. All of these drugs besides Ritalin 
(Scheme 1.1) are sold as a single enantiomer. Notably, the enantiopure version of Ritalin 
(enantiomer depicted in Scheme 1.1, marketed as Focalin) has been shown to be more 
effective at treating ADHD than Ritalin and is also in the top 200 of revenue-producing 
drugs.11  
                                                
(11) Vitaku, E.; Ilardi, E. A.; Njardarson, J. T. "Top 200 Pharmaceutical Products by US Retail Sales in 
2012" Njardarson Group 25 Jun. 2014 <http://cbc.arizona.edu/njardarson/group/top-pharmaceuticals-
poster> 
N
S
O O
Cl
Me
Plavix
anti-coagulent
Januvia
treats type 2 diabetes
N
OH
OH
F O
FZetia
cholesterol regulator
F
F
F
NH2 O
N
N
N
N
CF3
OMeO
H
N
+ enantiomer
Ritalin
treats ADHD
NH2
O
N
H
Me
H2N
Vyvanse 
treats ADHD
Scheme 1.1. Representative Best-selling Drugs Containing a Nitrogen-Bonded 
Stereocenter
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 Discovery of such blockbuster drugs requires medicinal chemists to have made a 
lead compound containing important structural features present in the finished 
product.1,3,5 Since stereogenic carbons bound to nitrogen are important moieties in active 
pharmaceutical agents, the development of reliable and practical methods to install such 
functionality in a diverse array of molecules is a critical goal for the advancement of 
medicine.12   
 A desirable sub-class of enantiomerically enriched amines is homoallylamines.13 
Chiral homoallylamines are valuable synthetic intermediates in the synthesis of 
 
heterocycles, bicycles, amino aldehydes, and many other nitrogen containing functional 
groups (Scheme 1.2).14 Such versatility has lead to their employment in various syntheses 
of biologically active compounds, such as the anti- cancer agent aza-epothilone 15 
                                                
(12) Chiral Amine Synthesis; Nugent, T. C., Ed.; Wiley-VCH: Weinheim, Germany, 2010. 
(13) For reviews regarding homoallylamines, see: (a) Puentes, C. O.; Kouznetsov, V. J. Heterocyclic 
Chem., 2002, 39, 595–614. (b) Ding, H.; Friestad, G. K. Synthesis, 2005, 17, 2815–2829. 
(14) For representative functionalizations of homoallylamines, see: (a) Friestad, G. K.; Korapala, C. S.; 
Ding, H.  J. Org. Chem. 2006, 71, 281–289. (b) Yadav, J. S.; Reddy, B. V. S.; Chaya, D. N.; Kumar, G. G. 
K. S. N.; Aravind, S.; Kunwar, A. C.; Madavi, C. Tetrahedron Letters 2008, 49, 3330–3334. (c) 
Spangenberg, T.; Breit, B.; Mann, A. Org. Lett. 2009, 11, 261-264. (d) Lorthiois, E.; Marek, I.; Normant, J. 
F. J. Org. Chem. 1998, 63, 2442–2450. (e) Ferry, A.; Billard, T.; Langlois, B. R. Synlett 2005, 6, 1027-
1029. (f) Sunderhaus, J. D.; Dockendorff, C.; Martin, S. F. Tetrahedron 2009, 65, 6454–6469.  
(15) (a) Borzilleri, R. M. et al. J. Am. Chem. Soc., 2000, 122, 8890–8897.  It should be noted that the 
synthetic route involving a chiral homoallylamine was inefficient due to a ring-closing metathesis that was 
both afforded a 1:5 mixture of olefin isomers, with the undesired E isomer dominating.  Recent advances in 
olefin metathesis may make it possible to address such shortcomings, see: (b) Yu, M.; Wang, C.; Kyle, A. 
F.; Jakubec, P.; Dixon, D. J.; Schrock, R. R.; Hoveyda, A. H. Nature, 2011, 479, 88–93. (c) Wang, C.; Yu, 
Scheme 1.2  Utility of Chiral Homoallylamines in Organic Synthesis
R
HN
G
R=aryl,alkyl
G=Protecting Group
R
HN
G
O
H
R
HN
G
O
Me R
N
O
Me
G
R
N
O
N
H
G
H
N
R
G
R
N
G
Me
O
OMe
R
N
G
Cy
I
Me
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(Scheme 1.3), leuconicine A and B, both of which negate multidrug resistance in cancer 
cell lines,16 and the immunosuppressant FR235222.17 In addition to being a valuable 
building block, the homoallylamine moiety itself appears as a structural unit in a number 
of alkaloids, such as the antibiotic eponemycin18  and the analgesic augustifoline19 
(Scheme 1.4).  
 
 
1.2 Background 
 The substantial utility of enantiomerically enriched homoallylamines has led to 
the development of a number of methodologies for the stereoselective addition of an allyl 
                                                                                                                                            
M.; Kyle, A. F.; Jakubec, P.; Dixon, D. J.; Schrock, R. R.; Hoveyda, A. H. Chem. Eur. J. 2013, 19, 2726–
2740. 
(16) Sirasani, G.; Andrade, R. B. Org. Lett. 2011, 13, 4736–4737.   
(17) Xie, W.; Zou, B.; Pei, D.; Ma, D. Org. Lett. 2005, 7, 2775–2777. 
(18) Schmidt, U.; Schmidt, J. Synthesis 1994, 300–305. 
(19) Hassall, C. H.; Wilson, E. M.; J. Chem. Soc. 1964, 2657–2663. 
Scheme 1.3 Chiral Homoallylamines in the Synthesis of Biologically Active Targets
N
N
O
Et
H
CO2Me
N
H
N
I
Me
O H
Leuconicine B
reverses vincristine
drug resistance
Me
HN
O OH O
Me
OH
O
Me Me
Me
S
N
Me
Me
NH2
S
N
Me
Aza-epothilone A
anti-cancer activity
N
NH
O
H
angustifoline
O
HO
NH
O
O OH
O
4
Me
eponemycin
Scheme 1.4  Natural Products Bearing the Homoallylamine Motif
antibiotic analgesic
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unit to imines. These methods can be divided into two major classifications: 
stoichiometric methods,20 where stereoselectivity is controlled by at least one equivalent 
of an enantiomerically enriched reaction component and catalytic methods,21 where a 
catalytic enantioselective transformation dictates the stereochemistry of the desired 
product.  Both will be discussed below.  
1.2.1 Background-Stoichiometric Methods 
 For stoichiometric methods to access enantiomerically enriched homoallylamines 
(Scheme 1.5), the component that determines the stereochemical outcome of the 
transformation is almost invariably either a chiral allyl-containing reagent or an imine 
substrate containing a chiral auxiliary. A variety of allyl reagents, such as an allylboron,22 
allylsilane,23,24 or allylzinc25 have been reported. Chiral alcohols can also be used as the 
source of the allyl-group in Ti-mediated Kulinkovich-type reactions.26   
                                                
(20) Yus, M.; González-Gómez, J. C.; Foubelo, F. Chem. Rev. 2013, 113, 5595–5698. 
(21) Yus, M.; González-Gómez, J. C.; Foubelo, F. Chem. Rev. 2011, 111, 7774–7854. 
(22) For reviews addressing the use of a chiral allylboron, see: (a) Ramachandran, P. V.; Burghardt, T. E. 
Pure Appl. Chem. 2006, 78, 1397–1406. (b) Ramadhar, T. R., Batey, R. A. Synthesis 2011, 9, 1321–1346.  
For representative examples, see: (c) Itsuno, S.; Watanabe, K.; Ito, K.; El-Shehawy, A. A.; Sarhan, A. A. 
Angew. Chem. Int. Ed. Engl. 1997, 36, 109–110. (d) Chataigner, I.; Zammattio, F.; Lebreton, J.; Villiéras, J. 
Synlett 1998, 3, 275–276. (e) Sugiura, M.; Hirano, K.; Kobayashi, S. J. Am. Chem. Soc. 2004, 126, 7182–
7183. (f) Ramachandran, P. V.; Burghardt, T. E. Chem. Eur. J. 2005, 11, 4387–4395. (g) Hernandez, E.; 
Canales, E.; Gonzalez, E.; Soderquist, J. A. Pure Appl. Chem. 2006, 78, 1389–1396. (h) Ramachandran, P. 
V.; Biswas, D. Org. Lett. 2007, 7, 3025–3027. (i) Wu, T. R.; Chong, J. M. J. Am. Chem. Soc. 2006, 128, 
9646–9647. 
(23) For methods employing an isolated chiral allylsilane, see: (a) Panek, J. S.; Jain, N. F. J Org. Chem. 
1994, 59, 2674–2675. (b) Schaus, J. V.; Jain, N.; Panek, J. S. Tetrahedron 2000, 56, 10263–10274.  (c) 
Berger, R.; Rabbat, P. M. A.; Leighton, J. L. J. Am. Chem. Soc. 2003, 125, 9596–9597. (d) Rabbat, P. M. 
A.; Valdez, S. C.; Leighton, J. L. Org. Lett. 2006, 8, 6119–6121. (e) Perl, N. R.; Leighton, J. L. Org. Lett. 
2007, 9, 3699–3701. (f) Huber, J. D.; Perl, N. R.; Leighton, J. L. Angew. Chem. Int. Ed. 2008, 47, 3037–
3039. (g) Feske, M. I.; Santanilla, A. B.; Leighton, J. L. Org. Lett. 2010, 12, 688–691. 
(24) For representative examples of chiral allylsilanes generated in-situ from allyltrichlorosilanes and a 
stoichiometric amount of an enantiomerically-pure Lewis base, see: (a) Kobayashi, S.; Ogawa, C.; Konishi, 
H.; Sugiura, M. J. Am. Chem. Soc. 2003, 125, 6610–6611. (b) García-Flores, F.; Flores-Michel, L. S.; 
Juaristi, E. Tetrahedron Letters 2006, 47, 8235–8238. (c) Fernández, I. Valdivia, V.; Leal, M. P.; Khiar, N. 
Org. Lett. 2007, 9, 2215–2218. 
(25) Sklute, G.; Marek, I. J. Am. Chem. Soc. 2006, 128, 4642–4649. 
(26) (a) Takahashi, M. McLaughlin, M.; Micalizio, G. C. Angew. Chem. Int. Ed. 2009, 48, 3648–3652. (b) 
Lysenko, I. L.; Lee, H. G.; Cha, J. K. Org. Lett. 2009, 11, 3132–3134. (c) Chen, M. Z. et al. J. Org. Chem. 
2010, 75, 8048–8059. (d) Yang, D.; Micalizio, G. C. J. Am. Chem. Soc. 2011, 133, 9216–9219. 
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 Chiral auxiliaries for imines and hydrazones that have been shown to affect 
diastereoselective allyl-addition range from nitrogen-protecting groups derived from 
amino acids and amino alcohols,27 tert-butylsulfinamides (Ellman's Auxiliary),28 and 
other moieties29, to auxiliaries that are present elsewhere in the imine30.  When compared 
                                                
(27) For recent representative examples, see: (a) Yanada, R.; Kaieda, A.; Takemoto, Y. J. Org. Chem. 
2001, 66, 7516–7518. (b) Sugimoto, Y.; Imamura, H.; Sakoh, H.; Yamada, K.; Morishima, H. Synlett 2001, 
11, 1747–1750. c) Cook, G. R.; Maity, B. C.; Kargbo, R. Org. Lett. 2004, 6, 1741–1743. (d) Dalmolen, J. et 
al. Eur. J. Org. Chem. 2004, 1544–1557. (e) Vilaivan, T.; Winotapan, C.; Banphavichit, V.; Shinada, T.; 
Ohfune, Y. J. Org. Chem. 2005, 70, 3464–3471. (f) Friestad, G. K.; Korapala, C. S.; Ding, H. J. Org. 
Chem. 2006, 71, 281–289.  
(28) For a review of indium-promoted diastereoselective allyl-additions to tert-butyl N-sulfinyl imines, see:  
(a) Foubelo, F.; Yus, M. Eur. J. Org. Chem. 2014, 485–491.  For representative examples of 
diasteroselective allyl-additions to tert-butyl N-sulfinyl imines, see: (b) Cogan, D. A.; Liu, G.; Ellman, J. 
Tetrahedron 1999, 55, 8883–8904. (c) Foubelo, F.; Yus, M. Tetrahedron: Asymmetry 2004, 15, 3823–
3825. (d) Grigg, R.; McCaffrey, S.; Sridharan, V.; Fishwick, C. W. G.; Kilner, C.; Korn, S.; Bailey, K.; 
Blacker, J. Tetrahedron 2006, 62, 12159–12171. (e) Sun, X.-W.; Xu, M.-H; Lin, G.-Q. Org. Lett. 2006, 8, 
4979–4982. (f) Sun, X.-W.; Liu, M.; Xu, M.-H; Lin, G.-Q. Org. Lett. 2008, 10, 1259–1262. (g) González-
Gómez, J. C.; Medjahdi, M.; Foubelo, F.; Yus, M. J. Org. Chem. 2010, 75, 6308–6311. (h) Liu, M.; Shen, 
A.; Sun, X.-W.; Deng, F.; Xu, M.-H.; Lin, G.-Q. Chem. Commun. 2010, 46, 8460–8462. (i) Guo, T.; Song, 
R.; Yuan, B.-H., Chen, X.-Y., Sun, X.-W., Lin, G.-Q. Chem. Commun. 2013, 49, 5402–5404. 
(29) For additions to an imine derived from an aminosugar, see: (a) Laschat, S.; Kunz, H. J. Org. Chem. 
1991, 56, 5883–5889. For additions to an imine with a chiral N-phosphinoyl group, see: (c) Kattuboina, A.; 
Scheme 1.5  Representative Chiral Reagents and Imines in Stoichiometric Methods
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to methods where the enantioselectivity of the product is determined by a catalytic 
amount of an enantiomerically pure molecule (or molecules), all of the methods 
mentioned previously have fundamental disadvantages to them resulting from their use of 
a stoichiometric amount of a chiral molecule.31 Enantiomerically pure molecules capable 
of such control are precious, and even when considering a chiral catalyst that operates at 
a high 10 mol % catalyst loading, this catalytic transformation uses one-tenth of the 
amount of chiral molecules that a stoichiometric method does to access the same amount 
of desired product. A catalyst that is even more efficient further magnifies the economic 
advantage of enantioselective catalysis. Even if an auxiliary can be recycled in high yield 
(and many cannot), there is always cost associated with this process, and if the auxiliary 
is never going to be used again, recycling becomes pointless. Additionally, the 
purification of catalytic reactions is generally easier due to only needing to separate the 
product from a catalytic amount of the chiral molecule, rather than one (or more) 
equivalents.  
 A point worth mentioning is that the tert-butylsulfinamide chiral auxiliary 
(Ellman's auxiliary) is used often to promote diastereoselective additions to imines.32 
This protecting group has the desirable traits of being relatively inexpensive (though still 
more expensive than most achiral protecting groups) as either enantiomer, being easy to 
remove, and being simple to install.  Still, as it is a chiral auxiliary, one is limited to it as 
the protecting group on the resultant amine formed, rather than whatever protecting group 
                                                                                                                                            
Kaur, P.; Nguyen, T.; Li, G. Tetrahedron Lett. 2008, 49, 3722–3724. For additions to iminium ions derived 
from an enantiopure 1-(1-naphthyl)ethylamine, see: (d) Suh, Y-g. et al. Org. Lett. 2011, 13, 5920–5923. 
(30) Kulkarni, N. A.; Yao, C-f.; Chen, K. Tetrahedron 2007, 63, 7816–7822. 
(31) Mulzer, J. "Chapter 3: Basic Principles of Asymmetric Synthesis" in Comprehensive Asymmetric 
Catalysis, Volume I; Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.; Springer-Verlag: Heidelberg, 
Germany, 1999. 
(32) Robak, M. T.; Herbage, M. A.; Ellman, J. A. Chem. Rev. 2010, 110, 3600–3740. 
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is ideally desired.  Also, in catalytic reactions, in order to obtain an efficient and 
enantioselective transformation with a desired substrate, multiple catalyst structures are 
often examined.  Modifying the chiral-auxiliary structure while maintaining its desirable 
traits of being inexpensive, easy to install and remove, is far more difficult than 
modifying the catalyst structure/system.  As a catalyst is used sub-stoichiometrically, the 
bar for it being easy to access is much lower than that of a chiral-auxiliary.  A catalyst is 
also not intimately tied to the ease of imine formation and nitrogen protecting-group 
removal in the way an auxiliary is.  One advantage that a chiral-auxiliary based approach 
has is that it is often possible to separate the diastereomers of the product, allowing for, 
after removal of the auxiliary, isolation of enantiopure material.  Additionally, catalytic 
methods can have the drawbacks of both catalyst poisoning and having to compete with a 
background reaction. 
1.2.2 Background-Catalytic Methods 
 Due to the benefits discussed above, catalytic enantioselective protocols are an 
attractive strategy for the stereoselective synthesis of homoallylamines.21 Two pioneering 
reports in this field were published in 1998.  K. A. Jørgenson reported a Cu-catalyzed ene 
reaction to tosyl-protected α-imino esters (Scheme 1.6)33 and Y. Yamamoto reported the 
addition of tri-butyl allylstannane to a range of aldimines catalyzed by a bis-Pd-π-allyl 
complex.34  While undeniably important to the development of the field, these two initial 
methods have major drawbacks.  The method from the Jørgenson group is extremely 
limited, since it only works for highly activated α-imino esters and not with imines 
derived from aromatic and aliphatic imines.  It is additionally restricted to 2-substituted 
                                                
(33) Yao, S.; Fang, X.; Jørgensen, K. A. Chem. Commun. 1998, 2547–2548. 
(34) Nakamura, H.; Nakamura, K.; Yamamoto, Y. J. Am. Chem. Soc. 1998, 120, 4242–4243. 
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allyl groups; even reducing the size of this group to a methyl group results in a decrease 
in enantioselectivity (Scheme 1.6).   The method by Yamamoto, while applicable to 
imines that are not α-imino esters, employs tri-butyl allylstannane as the allyl source. The 
toxicity of allylstannanes35 makes them fundamentally unattractive. 
 
 In order to increase synthetic utility, Yamamoto developed a method using a 
similar catalytic system that employs an allylsilane36 as the nucleophile (Scheme 1.7).37 
All products are obtained in a synthetically useful yield of ≥76%, but a noticeable drop in 
the e.r. of the product is observed with non aryl-substituted imines, especially those with 
aliphatic substitution (Scheme 1.7). An additional drawback is that dimer 1.1 is difficult 
to access, being obtained in only 6% overall yield from the expensive ($17/mmol)36 
Pd(CF3COO)2.  This would be less of a problem if the catalytic system was more 
efficient, but 5 mol % catalyst loading of dimer 1.1 (10 mol % loading of catalyst) is 
                                                
(35) For an improvement of Yamamoto's original method that still uses allylstannane, see: (a) Fernandes, R. 
A.; Stimac, A.; Yamamoto, Y. J. Am. Chem. Soc. 2003, 125, 14133–14139.  For other methods employing 
allylstannane, see: (b) Fang, X.; Johannsen, M.; Yao, S.; Gathergood, N.; Hazell, R. G.; Jørgensen, K. A. J. 
Org. Chem. 1999, 64, 4844–4849. (c) Gastner, T.; Ishitani, H.; Akiyama, R.; Kobayashi, S. Angew. Chem., 
Int. Ed. 2001, 40, 1896–1898. (d) Aydin, J.; Kumar, K. S.; Sayah, M. J.; Wallner, O. A.; Szabó, K. J. J. Org. 
Chem. 2007, 72, 4689–4697. (e) Colombo, F.; Annunziata, R.; Benaglia, M. Tetrahedron Lett. 2007, 48, 
2687–2690. (f) Li, X.; Liu, X.; Fu, Y.; Wang, L.; Zhou, L.; Feng, X. Chem. Eur. J. 2008, 14, 4796–4798. 
(g) Fernandes, R. A.; Chaudhari, D. A. Eur. J. Org. Chem. 2012, 1945–1952. 
(36) Prices for all metals, metal salts and ligands are from the Strem catalog unless otherwise noted. Prices 
for all allylsilanes are from the Gelest catalog.  Prices for all other chemicals are from the Aldrich catalog 
unless otherwise noted. 
(37) Fernandes, R. A.; Yamamoto, Y. J. Org. Chem. 2004, 69, 735–738. 
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Scheme 1.6  Cu-Catalyzed Ene Reaction Reported by Jørgenson
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required to obtain full conversion in 14–32 hours, corresponding to a turnover frequency 
of 0.64 to 0.28/h. 
 
 Although allylsilanes are inexpensive and essentially harmless, catalytic 
enantioselective additions to imines that employ allylsilanes tend to suffer from such low 
reactivity.  Because of this, many of these methods are generally limited to the highly 
activated α-imino esters discussed previously.38 Those that are not limited in this way 
require high-catalyst loadings and long reaction times.39  
 An interesting strategy for the enantioselective allyl-addition to imines is to use an 
achiral homoallylamine as the imine protecting group and to use a chiral catalyst to affect 
an enantioselective aza-Cope rearrangement.40  The Wulff group described an impressive 
application of this strategy in 2011 (Scheme 1.8).40b,c  Following hydrolysis of the 
ketimine that is formed after the aza-Cope rearrangement, the homoallylamines are 
                                                
(38) (a) Lectka, T. et al. J. Am. Chem. Soc. 2001, 124, 67–77. (b) Hamada, T.; Manabe, K.; Kobayashi, S. 
Angew. Chem., Int. Ed. 2003, 42, 3927–3930. (c) Kiyohara, H.; Nakamura, Y.; Matsubara, R.; Kobayashi, 
S. Angew. Chem. Int. Ed. 2006, 45, 1615–1617.  For a similar example to (c) using an allylboronate, see: 
(d) Fujita, M.; Nagano, T.; Schneider, U.; Hamada, T.; Ogawa, C.; Kobayashi, S. J. Am. Chem. Soc. 2008, 
130, 2914–2915. For an example with highly-activated ketimines derived from isatins, see: (e) Nakamura, 
S.; Hyodo, K.; Nakamura, M.; Nakane, D.; Masuda, H. Chem. Eur. J. 2013, 19, 7304–7309. For a method 
that is limited in scope to imines derived from benzaldehyde which contain a difficult to remove protecting 
group, see: (f) Naodovic, M.; Wadamoto, M.; Yamamoto, H. Eur. J. Org. Chem. 2009, 5129–5131.  For a 
catalytic enantioselective allyl-addition to cyclic imines, see: Itoh, T. et al. J. Org. Chem. 2011, 76, 534–
542. 
(39) (a) Momiyama, N.; Nishimoto, H.; Terada, M. Org. Lett. 2011, 13, 2126–2129. (b) Gandhi, S.; List, B. 
Angew. Chem., Int. Ed. 2013, 52, 2573–2576. 
(40) (a) Rueping, M.; Antonchick, A. P. Angew. Chem. Int. Ed. 2008, 47, 10090–10093. (b) Ren, H.; Wulff, 
W. D. J. Am. Chem. Soc. 2011, 133, 5656–5659. (c) Desai, A. A.; Ren. H.; Mukherjee, M.; Wulff, W. D. 
Org. Process. Res. Dev. 2011, 15, 1108–1115. 
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formed analytically pure without the need for column chromatography in the yields and 
enantioselectivities shown in Scheme 1.8.  Importantly, alkyl-substituted 
homoallylamines are formed in >95:5 e.r., which contrasts with most other methods 
where such products are formed in low selectivities, if at all.  An additional advantage of 
this method is that it starts with the aldehyde, therefore eliminating an additional step 
normally required for imine addition.  The drawbacks of this technique are that it needs 
the achiral homoallylamine 1.2 (a four-step synthesis); requires relatively long reactions 
times, and uses the sensitive boronate complex 1.3, which must be generated before each 
reaction from BH3•SMe2, mesityl alcohol, and expensive VANOL ($260/mmol from 
Sigma-Aldrich).  Even with these flaws, this is one of the most impressive methods to 
date for the enantioselective synthesis of homoallylamines. 
 
 Allylindiums, generally generated in situ from a Barbier-type reaction between a 
super-stoichiometric (based on the imine) amount of indium metal and an allylhalide, 
have a low level of toxicity, favorable levels of reactivity as well as high 
chemoselectivity.  Unfortunately, indium is a rare metal whose value is likely to keep 
increasing due to the rising demand for the light-emitting diodes and high-definition 
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1.1 equiv.
R2
R2
+
R2 R2
H2N
1.0 equiv.
5 mol % 1.3, 
5 mol % BzOH,
5 Å MS,
m-xylene, 60 ºC,
18-30 h Ph
Ph
O
O
B
O B
O
BO
OAr
OAr
1.3R2=3,5-Me2C6H3
Scheme 1.8 Catalytic Enantioselective Aza-Cope Rearrangement
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displays it is used in.41 Regarding the catalytic synthesis of chiral homoallylamines, 
methods employing allylindium42 generally proceed with high levels of enantioselectivity 
for aryl hydrazone substrates, but proceed in lower levels of enantioselectivity for the 
corresponding alkyl substrates.  An illustrative report by Cook and Lloyd-Jones shows 
selectivities that range from 93.5:6.5 e.r. to >99:1 e.r. for aryl hydrazones to 85:15 e.r. for 
an alkyl-hydrazone (Scheme 1.9).42a This lower level of enantioselectivity is proposed to 
be from a more efficient uncatalyzed addition of allylindium to alkyl-substituted 
hydrazones vs. aryl-substituted ones42a  Additionally, removal of the hydrazone 
protecting group from the product without reducing the homoallylamine olefin requires 
super-stoichiometric amounts of rare and expensive SmI2.24a 
 
 In order to decrease the amount of precious indium used, a method for 
enantioselective allyl-additions to homoallylamines whereby the nucleophilic allylindium 
species is generated from a catalytic amount of indium was developed by the Kobayashi 
group (Scheme 1.10).43  Setting it apart from most other catalytic protocols, this method 
                                                
(41) Nakamura, E.; Sato, K. Nature Mater. 2011, 10, 158–161. 
(42)  (a) Kargbo, R.; Taakahashi, Y.; Bhor, S.; Cook, G. R.; Lloyd-Jones, G. C.; Shepperson, I. R. J. Am. 
Chem. Soc. 2007, 129, 3846–3847. (b) Tan, K. L.; Jacobsen, E. N. Angew. Chem. Int. Ed. 2007, 46, 1315–
1317. (c) Kim, S. J.; Jang, D. O. J. Am. Chem. Soc. 2010, 132, 12168–12169. 
(43) Chakrabarti, A.; Konishi, H.; Yamamguchi, M.; Schneider, U.; Kobayashi, S. Angew. Chem., Int. Ed. 
2010, 49, 1838–1841.  
R
N
N
O
O
H
Br 3.0 equiv.
In(0) 2.0 equiv.
10 mol % Diol
4Å MS, thf,
0 ºC to 23 ºC, 24 h R
HN
N
O
O
R=Ar, cinnamyl
R=hydrocinnamyl
82-98%, 93.5:6.5->99:1 e.r. 
93%, 85:15 e.r.
OH
OH
SO2CF3
SO2CF3
Diol
Scheme 1.9  Enantioselective Addition of Allylindium to Hydrazones Catalyzed
by a Chiral Diol
 
Page 16
   
can be used to generate products that contain an additional stereogenic center on the 
allylic carbon (crotyl–addition type products) in synthetically useful enantio- and  
 
diastereoselectivities (Scheme 1.10). Interestingly, this transformation is one of the rare 
examples in allyl-addition literature where the carbon α to the boron in the nucleophile 
ends up directly bound to the electrophile (α-addition) instead of the carbon γ to the 
boron in the nucleophile (γ-addition).44 In all examples shown in the manuscript, the ratio 
of α-addition to γ-addition is at least 49:1.  The authors propose this intriguing 
regioselectivity results from an initial γ-addition of the allylboronate (promoted by a 
Lewis base; the authors suggest the identity of the Lewis base is likely the hydrazone 
substrate) to the indium-ligand complex (Scheme 1.11) to form complex 1.5. This 
allylmetal species then adds to the hydrazone substrate in a γ-selective fashion via a six-
membered transition state to afford the net α-addition product. Overall, two γ-additions 
afford the product of a net α-addition. Unfortunately, even though the allylindium is 
                                                
(44) For examples that afford the α-addition product and are proposed to occur through a γ-addition of the 
starting allyl nucleophile to a catalyst to generate an allylmetal, followed by a second γ-addition of this 
allylmetal to the substrate (two γ-additions result in the product of net α-addition), see: Ref. 38d, (a) 
Kobayashi, S.; Konishi, H.; Schneider, U. Chem. Commun. 2008, 2313–2315. (b) Kobayashi, S.; Endo, T.; 
Schneider, U.; Ueno, M. Chem. Commun. 2010, 46, 1260–1262. (c) Fandrick, K. R. et al. Org. Lett. 2010, 
12, 3748–3751. (d) Kobayashi, S.; Endo, T.; Ueno, M. Angew. Chem., Int. Ed. 2011, 50, 12262–12265. (e) 
Cui, Y.; Yamashita, Y.; Kobayashi, S. Chem. Commun. 2012, 48, 10319–10321. (f) Kobayshi, S.; Endo, T.; 
Yoshino, T.; Schneider, U.; Ueno, M. Chem. Asian J. 2013, 8, 2033–2045.  For reports where the author 
explains the α-addition product by a γ-addition to the substrate followed by a Lewis acid catalyzed 
sigmatropic-rearrangement, see: (g) Ramachandran, P. V.; Pratihar, D.; Biswas, D. Chem. Commun. 2005, 
1988–1989. (h) Selander, N.; Szabó, K. J. J. Org. Chem. 2009, 74, 5695–5698. 
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generated catalytically, which should diminish advantageous background reactions; 
additions to alkyl-substituted hydrazones are much less selective than aryl-substituted  
 
ones (Scheme 1.10). This issue is partially addressed in a subsequent report, where the 
cyclohexyl-substituted homoallylamine is obtained in 98:2 e.r., but aliphatic 
homoallylamines not containing alpha-branching are obtained in 86:14 e.r (Scheme 
1.12).45 The newer method also suffers from the use of the Ag-salt of an expensive chiral 
phosphoric acid (1.7) as well as a nitrogen-protecting group that requires a two-step 
procedure of DIBAL-H followed by HCl in MeOH for removal.46,47 
 Importantly, even though the active allyl nucleophile in these two methods is a 
catalytically generated allylindium species, the stoichiometric sources of the allyl 
functionality are allylborons.  Allylborons are essentially non-toxic and the reactivity and 
stability of this class of reagents can be greatly varied by modifying the substituents of 
the boron.22a,b A particularly noteworthy allylboron is the allylboronate48 allylboronic49 
                                                
(45) Huang, Y.-Y.; Chakrabarti, A.; Morita, N.; Schneider, U.; Kobayashi, S. Angew. Chem., Int. Ed. 2011, 
50, 11121–11124. 
(46) Lou, S.; Moquist, P. N.; Schaus, S. E. J. Am. Chem. Soc. 2007, 129, 15398–15404. 
(47) For an alternative method for removal of acyl-protecting groups from imines, see: Spaggiari, A.; 
Blaszczak, L. C.; Prati, F. Org. Lett. 2004, 6, 3885–3888.  It should be noted that there are no examples of 
this method being applied to molecules containing an alkene. 
(48) For a review on the use of allylboronates as nucleophiles in catalytic, enantioselective additions to 
imines and carbonyls, see: Huo, H.-X.; Duvall, J. R.; Huang, M.-Y.; Hong, R. Org. Chem. Front. 2014, 1, 
303–320. 
O B
O
Me
Me
Me
Me Me
Lewis base
Lewis base-B(pin)
In
Me
1st γ-addition
1.5
Ph
N
NHBz
2nd γ-addition
Ph
HN
NHBz
Me
Net α-addition
Scheme 1.11  Proposed Mechanism for the Formation of α-Addition Products
In-Ligand
Ligand
 
Page 18
   
acid pinacol ester (1.6, Scheme 1.12), which has an optimal balance of being reactive 
enough to participate in a wide variety of transformations while still being stable enough 
to air and moisture to be convenient to use.  
 
 Replacing the pinacol group of 1.6 with two isopropoxy groups results in the 
more reactive allyldiisopropoxyborane 1.8 (Scheme 1.13).  This increased reactivity is 
required by the Schaus group to obtain noticeable reactivity (<2% conversion under all 
conditions when employing 1.6), but the cost of this reactivity is that boronate 1.8 is far 
less stable than 1.6 and requires the reaction to be rigorously anhydrous (Scheme 1.13).46  
Even though Schaus' method requires this reactive allylboronate, long reactions times, 
high catalyst loading (a turnover frequency of 0.16/h),50 and a difficult to remove 
protecting group,47 it is still a noteworthy method for several reasons.  First, because of 
the uniformly high levels of enantioselectivity and yields obtained for aryl-,heteroaryl-, 
cinnamyl- as well as the traditional troublesome alkyl-substituted aldimines. Secondly, it 
is the only catalytic method to enantioselectively add allylboronates to imines without 
                                                                                                                                            
(49) For a book on the subject of boronic acids and their derivatives, see: Boronic Acids: Preparation and 
Applications in Organic Synthesis, Medicine and Materials, 2nd Edition; Hall, D. G. Ed.; Wiley-VCH: 
Weinheim, Germany, 2011. 
(50) Using a very similar system, the catalyst efficiency and selectivity for the enantioselective allylation of 
ketones was enhanced by performing the reactions in tert-butanol.  A more stable allyldioxaborolane was 
used as the allylating agent. The authors propose that product release is the turnover limiting step and the 
facility of this step can be increased in the presence of excess alcohol.  This has not been applied to 
reactions with imines. See Barnett, D. S.; Moquist, P. N.; Schaus, S. E. Angew. Chem. Int. Ed. 2009, 48, 
8679–8682. 
R
HN
1.2 equiv.
5 mol %
6.5 mol % 1.7,
toluene/CPME (1:1), 
23 ºC, 18 h R
HN
R=Ar, heteroaryl
R=Cy
94-99%, 95:5-98:2 e.r.
96%, 98:2 e.r.
InCI,
+
R=n-heptyl 88%, 86:14 e.r.
Scheme 1.12  Improved Method for Homoallylamine Synthesis via  Catalytically Generated
Allylindium
OMe
O B
O
Me
Me
Me Me
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O
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going through the intermediacy of an allylmetal. Lastly, high levels of enantio- and 
diastereoselectivities obtained when crotylboronate E-1.10 is employed (Scheme 1.13). 
Interestingly, when Z-1.10 is used, the yield and selectivities obtained are lower; however 
the same major enantiomer is obtained as with E-1.10 (Scheme 1.13), rendering the syn-
croyl product unattainable.  The authors suggest this is due to a more favorable boat-like 
transition state occurring when Z-1.10 is used.46  
 
 All other protocols that use allylborons51 for the catalytic enantioselective allyl-
addition to imines proceed through an allylmetal52 intermediate. One example forms 
allylrhodiums from potassium allyltrifluoroborates (synthesized from the corresponding  
                                                
(51) An interesting strategy for the catalytic enantioselective synthesis of homoallylamines is to form a 
stoichiometric amount of an enantiomerically enriched allylboron through a catalytic enantioselective 
process and then add this allylboron to an imine.  See Sieber, J. D.; Morken, J. P J. Am. Chem. Soc. 2006, 
128, 74–75. 
(52) For a method proposed to go through an allyl-Pd species and uses allyl alcohol as the allyl source, see: 
Qiao, X.-C.; Zhu, S.-F.; Chen, W.-Q.; Zhou, Q.-L. Tetrahedron: Asymmetry 2010, 21, 1216–1220.   
OH
OH
Ph
Ph
1.9
R
N
15 mol % 1.9, 
3Å MS
+
R
HN
23 ºC, toluene,
 36 h
B(Oi-Pr)2
1.0 equiv.
R=Ar, heteroaryl, cinnamyl
R=alkyl
81-94% yield, 95:5-99:1 e.r. 
80-84% yield, 95.5:4.5-99.5:0.5 e.r.
85% yield, 99:1 e.r., 99:1 d.r.
O
Ph
O
Ph
Ph
N
15 mol % 1.9, 
3Å MS
+
Ph
HN
23 ºC, toluene,
 36 hB(Oi-Pr)2
1.0 equiv.
E-1.10
O
Ph
O
Ph
Me
1.8
Me
1.0 equiv.
Z-1.10
62% yield, 94:6 e.r., 98:2 d.r.
Same major diastereomer obtained
as with E-1.10.
Scheme 1.13 Enantioselective Addition of Allylboronates to Aldimines Catalyzed
by a Chiral Diol.
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allylboronic acid pinacol esters) and adds these nucleophiles to a limited class of cyclic 
imines.53 More attractive strategies utilize either a bis-phosphine–Cu54 or N-heterocyclic 
carbene–Cu 55  catalyst to achieve enantioselective allyl-additions to ketimines or 
aldimines respectively.  Both methods are proposed to operate through a nucleophilic 
allylcopper species, which is generated through transmetalation of a copper-alkoxide 
complex with allylboronate 1.6.  These protocols are among the most efficient catalytic  
methods for imine allylation, with turnover frequencies as high as 18/h.56 The second 
method (Scheme 1.14), developed in the Hoveyda laboratory, also has the advantage of 
being applicable to the enantioselective synthesis of alkyl-substituted homoallylamines.  
Two major shortcomings of this method (Scheme 1.15) are: a) use of crotylboronate E-
1.11 (Z-1.11 behaves similarly) affords products in ~3:2 diastereomeric ratio (Scheme 
1.15a) and b) notable sensitivity to oxygen and/or moisture.57  Performing the reaction 
outside of a glovebox with CuCl2•2H2O (Scheme 1.15b)58 led to slightly diminished 
                                                
(53) (a) Luo, Y.; Hepburn, H. B.; Chotsaeng, N.; Lam, H. W. Angew. Chem. Int. Ed. 2012, 51, 8309–8313.  
(b) Hepburn, H. B.; Chotsaeng, N.; Luo, Y.; Lam, H. W. Synthesis 2013, 45, 2649–2661. 
(54) Wada, R.; Shibuguchi, T.; Makino, S.; Oisaki, K.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2006, 
128, 7687–7691. 
(55) Vieira, E. M.; Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2011, 133, 3332–3335. 
(56) Efficiencies are especially impressive when excluding methods that require a highly activated α-imino 
ester, such as the one in reference 38c.   
(57) Vieira, E. M.; Haeffner, F.; Snapper, M. L.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2012, 51, 6618–
6621. 
(58) Use of CuCl2•2H2O worked well for the protocol developed for enantioselective propargyl-addition to 
imines (Ref. 57).  As that protocol is proposed to proceed with a very similar mechanism to the allyl-
addition protocol, the lower enantioselectivity is not believed to be due to a copper (II) salt, but rather 
R=Aryl, heteroaryl, alkenyl
R=Alkyl 88-98% yield, 96:4-98.5:1.5 e.r. 61-81% yield, 81:19-97:3 e.r.
NP(O)Ph2
R Mes
N
Ph Ph
i-Pr
NMe
BF4
+ B(pin)
5 mol %
5 mol % CuCl, 12 mol % NaOt-Bu, 
2.0 equiv. MeOH, thf, -50 ºC, 6 h
1.6
1.5 equiv.
NHP(O)Ph2
R
Scheme 1.14 Enantioselective Addition of Allylboronates to Aldimines Catalyzed by an
NHC–Cu Complex
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efficiency (92% vs. >98% conv.) as well as much lower enantioselectivity (84:16 e.r. vs. 
97:3 e.r.). 
 
 Collectively, these reports represent substantial progress in the development 
catalytic enantioselective methods for the enantioselective allyl-addition to imines. 
Nevertheless, they all have notable shortcomings.  It is rare to find the following desired 
attributes, and no method has all of them: the protecting group of the homoallylamine is 
easily removed (e.g. in one step and ≥ 85% yield of the free homoallylamine without 
resorting to exotic conditions such as super-stoichiometric samarium 
iodide),35e,38g,39b,40,51,55 short reaction times (e.g. less than eight hours),38e,38g,54,55 the 
ability to afford alkyl-substituted as well as aryl-substituted homoallylamines in high 
enantioselectivities (e.g. ≥ 90:10 e.r.),39b,40b–c,42c,45,46,51,55 and the ability to promote 
diastereoselective crotyl-type additions (e.g. ≥ 90:10 e.r and d.r.).35c,38a,38c,39a,43,46,53  
Beyond these attributes, these methods all have notable flaws, such as: narrow 
                                                                                                                                            
sensitivity to moisture and/or oxygen.  It is interesting to note that the propargylation protocol is far more 
robust than the allylation protocol, perhaps due to increased stability of the allenyl–Cu species. 
b) Usually highly sensitive to oxygen and/or moisture
a)The π-allylmetal intermediate usually leads to low dr or one diastereomer is inaccessible
>80% yield, 
85:15–90:10 e.r.,
~60:40 d.r.
NP(O)Ph2
Ph Mes
N
Ph Ph
i-Pr
NMe
BF4
+
B(pin)
5 mol %
5 mol % CuCl, 12 mol % NaOt-Bu, 
2.0 equiv. MeOH, thf, -50 ºC, 18 h
E-1.11
1.5 equiv.
NHP(O)Ph2
Ph
Me
Me
Scheme 1.15 Some Disadvantages of an Allylmetal Pathway
91%,
84:16 e.r.
NP(O)Ph2
Ph Mes
N
Ph Ph
Me
NMe
BF4
+
5 mol %
5 mol % CuCl2•2H2O, 12 mol % NaOt-Bu, 
2.0 equiv. MeOH, thf, -50 ºC, 6 h
NHP(O)Ph2
Ph
B(pin)
1.6
(performed outside glovebox)
(97:3 e.r. with CuCl inside glovebox)
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substrate/nucleophile scope38f–g,40a,51 (e.g. restricted to highly activated substrates like α-
imino esters33,35b,35e,38a–e or cyclic dioxobenzathiazenes53), high catalyst loading (e.g. ≥10 
mol %),33,34,35a,35c,35f,35g,37,38b–c,38e,39,40a,42,43,46,54 cryogenic temperatures (e.g.  -50º C or 
less),38a,38f,55 use of precious metals (either catalytically34,35a,35d–g,37,38f,43,45,51–53 or 
stoichiometrically38d,42) use of difficult-to-access or expensive ligands/catalysts (e.g. 
>$100/mmol),34,35a,35d,37,38f,39,40,45,52-55 or employing an undesirable allyl source (e.g. those 
that are toxic,34,35, sensitive,46 or difficult-to-access40b–c).   
 Considering the state-of-the-art, development of an efficient and selective 
catalytic method that utilizes components that are readily accessible and handled easily 
represents a significant advance in enantioselective catalysis.  The previous method 
developed in the Hoveyda laboratory55 (Scheme 1.14) suggested that relying on the 
intermediacy of an allylmetal lead to the shortcomings discussed previously (Scheme 
1.15). We therefore investigated whether it was possible to develop a transition metal-
free catalytic protocol that was not overly moisture/oxygen sensitive (can be performed 
outside of a glovebox) and could stereoselectively access crotyl-addition products (and 
ideally other substitutions besides methyl as well) without sacrificing the efficiency and 
enantioselectivity of the copper-based protocol.  
1.3 Discovery of New Catalysts by Dr. Tatiana Pilyugina 
 The initial proposal for a new catalytic manifold was to harness the 
nucleophilicity of N-heterocyclic carbenes (NHCs)59 by using these molecules to activate 
                                                
(59) For reviews of NHCs as catalysts for various transformations in organic chemistry, see: (a) Enders, D.; 
Niemeier, O.; Henseler, A. Chem. Rev. 2007, 107, 5606–5655. (b) Marion, N.; Díez-González, S.; Nolan, 
S. P. Angew. Chem. Int. Ed. 2007, 46, 2988–3000. 
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allylboronates60 for addition to imines; this process could be rendered enantioselective 
through the use of a chiral NHC.  Our group has utilized this mode of catalysis to 
promote additions of B2(pin)2 1.12 (Scheme 1.16) to enones in both racemic61 and 
enantioselective62 fashions. Mechanistic studies61,63 suggest that the catalyst operates by 
coordinating to the empty p-orbital of boron resulting in a weakening of the B-B bond 
(Scheme 1.16), which in turn raises the nucleophilicity of the sp2-hydridized boron in 
1.14.64 We were excited to see if this emerging catalytic manifold65 could be used to 
activate a C-B bond, namely the one in allylB(pin) 1.6, enough to promote its addition to 
an imine. 
 
  
 
                                                
(60) For relevant reviews, see: (a) Curran, D. P.; Solovyev, A.; Brahmi, M. M.; Fensterbank, L.; Malacria, 
M.; Lacôte, E. Angew. Chem. Int. Ed. 2011, 50, 10294–10317. (b) Cid, J.; Gulyás, H.; Carbó, J. J.; 
Fernández, E. Chem. Soc. Rev. 2012, 41, 3558–3570. 
(61) Lee, K.-s.; Zhugralin, A. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 7253–7255. 
(62) (a)Wu, H.; Radomkit, S.; O'Brien, J. M.; Hoveyda, A. H. J. Am. Chem. Soc. 2012, 134, 8277–8285. 
(b) Radomkit, S.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2014, 53, 3387–3391. 
(63) Kleeberg, C. et al. J. Org. Chem. 2012, 77, 785–789. 
(64) Denmark, S. E.; Beutner, G. L. Angew. Chem. Int. Ed. 2008, 47, 1560–1638. 
(65) For other representative examples, none of which activate a C-B bond, see: (a) O'Brien, J. M.; 
Hoveyda, A. H. J. Am. Chem. Soc. 2011, 133, 7712–7715. (b) Kleeberg, C.; Borner, C. Eur. J. Inorg. 
Chem. 2013, 2799–2806. (c) Wen, K.; Chen, J.; Gao, F.; Bhadury, P. S.; Fan, E.; Sun, Z. Org. Biomol. 
Chem. 2013, 11, 6350–6356. 
NCyCyN
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Scheme 1.16  Conjugate Addition of Boron to Enones through Activation 
of B2(pin)2 with an NHC Catalyst
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 Initial investigations by graduate student Erika Vieira were followed up by post-
doctoral researcher Dr. Tatiana Pilyugina.  Phosphinoylimines,66 such as 1.15a (Scheme 
1.17) were chosen as substrates for a variety of reasons.  The phosphinoyl protecting 
group is easily removed under acidic or reducing conditions67 to afford the free amine in 
high yield.  Moreover, even though this protecting group has a large molecular weight, it 
significantly eases purifications by increasing the tendency of both the starting imine and 
the homoallylamide (e.g. 1.17a) products to be crystalline. In many cases expensive and 
tedious column chromatography can be altogether avoided, which more than makes up 
for its otherwise low atom economy.  As an example, our group has shown that when the 
NHC–Cu-catalyzed allyl-addition is performed on a gram-scale, analytically pure product 
can be isolated in 75% following a simple filtration (no chromatography necessary).55 
                                                
(66) For a review of these compounds, see: Weinreb, S. M.; Orr, R. K. Synthesis, 2005, 8, 1205–1227. 
(67) Burgos, P. O.; Fernández, I.; Iglesias, M. J.; García-Granda, S.; Ortiz, F. L. Org. Lett. 2008, 10, 537–
540. 
N N
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Me
MeMe Me
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Scheme 1.17  NHC-Catalyzed Allyl-Additions to Phosphinoylimines and Important Control Reactions
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Phosphinoylimines also are suitably activated, having electrophilicities comparable to 
that of N-Boc aldimines.68  Allylboron 1.6 was chosen due to its aforementioned 
favorable balance of reactivity and stability, and methanol was determined to be critical 
for reactivity early on in the study, which was believed to be because it facilitates catalyst 
turnover. 
 The equation in the top of Scheme 1.17 is representative of optimized conditions. 
With 10 mol % catalyst loading of chiral imidazolinium salt 1.16 as the NHC precursor, 
the reaction proceeds in 58% conversion and affords desired product in nearly racemic 
(52:48 e.r.) form.  Other than the lack of enantioselectivity, reproducibility issues also 
mar this transformation, with conversions varying as much as +/- 30% from reaction to 
reaction.  Hoping to better understand the system, Dr. Pilyugina carried out a series of 
critically important control reactions (Scheme 1.17). Fitting in with the hypothesis of an 
NHC-catalyzed transformation, when the reaction is performed in the absence of NaOt-
Bu, <5% conversion to 1.17a is observed.  Omitting methanol also leads to <2% 
conversion.  Surprisingly, leaving out imidazolinium salt 1.16 results in a much more 
efficient transformation, implying that an alkoxide (presumably NaOMe due to the 
presence of MeOH) is a better catalyst for this transformation than an NHC.  
Additionally, this base-catalyzed protocol proved to be far more reliable than the NHC-
catalyzed one in terms of consistent conversions. It is, however, only capable of 
producing racemic homoallylamides. 
                                                
(68) Appel, R.; Mayr, H. J. Am. Chem. Soc. 2011, 133, 8240–8251. 
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 Dr. Pilyugina then decided to screen catalytic amounts of chiral alcohols69 to 
determine if these molecules are capable of engendering an enantioselective 
transformation. After screening various alcohols as promoters for the enantioselective 
allylation of aldimine 1.15a, what gave rise to the highest selectivity was chiral phenol 
1.18 (Scheme 1.18).70  Structural modifications of 1.18, such as changing the alcohol-
protecting group, the nature of the halide substituent, or the backbone (e.g. hydrogenated 
vs. non-hydrogenated) did not give rise to a more selective catalyst.  In order to obtain a 
more active and selective catalytic reaction, more substantial changes in the structure of 
1.18 were investigated.  Wanting to keep the phenol moiety intact, amino acid based 
1.19a, based on ligands previously developed in our group, was synthesized.71 Such  
 
amino acid based phenols not only afford higher enantioselectivity for the allyl-addition 
product 1.17a, they also allow for more rapid structure modification due to their facile 
                                                
(69) We initially felt that the identity of the active catalyst was a chiral phenoxide that operated in the same 
way the NHC in Scheme 1.16 is proposed to operate.  Mechanistic studies (to be discussed in a later 
section) suggest that this is not the case. 
(70) The choice of this phenol was inspired by other work in our group.  See: Malcolmson, S. J.; Meek, S. 
J.; Sattely, E. S.; Schrock, R. R.; Hoveyda, A. H. Nature 2008, 456, 933–937. 
(71) Cole, B. M.; Shimizu, K. D.; Kruger, C. A.; Harrity, J. P. A.; Snapper, M. L.; Hoveyda, A. H. Angew. 
Chem. Int. Ed. 1997, 35, 1668–1671. 
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Scheme 1.18  Enantioselective Allyl-Additions Promoted by Chiral Phenols
 
Page 27
   
modularity and ease of synthesis.71 Changing aminophenol 1.19a eventually led to a 
1.19b, which was both more efficient and more enantioselective than either 1.18 or 1.19a. 
It was at this point that I joined the project. With a promising reaction in hand, we turned 
our attention to optimization of the reaction through alterations to the structure of 1.19b 
and reaction conditions. 
1.4 Development of Enantioselective Allyl-Additions to N-Phosphinoylaldimines 
Promoted by a Chiral Aminophenol 
 We initially chose to examine the reaction solvent along with whether the linker 
between the aryl ring of the phenol and the nitrogen from the amino acid is an amide,  
 
Table 1.3  Screen of Solvent and General Phenol Structure
a Determined by 400 MHz 1H NMR analysis of unpurified reaction mixture.  bDetermined 
by HPLC analysis.
Catalyst Structures: Ar=2-OH-3,5-(tBu)C6H2
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9
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1.19b
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1.19e
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98 89:11
toluene >98 88:12
toluene 30
toluene 94 62:38
toluene 82 62:38
toluene 55 racemic
thf
CH2Cl2
thf
CH2Cl2
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11
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66:34
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85 racemic
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74:26
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imine, or amine (Table 1.3).  Toluene remained the optimal solvent, with reactions 
performed in more polar solvents furnishing products of low to negligible enantiopurity. 
 Notably, mono-amino acid containing 1.19c behaves the same as the previously 
optimal 1.19b (compare entries 1 and 2, Table 1.3).  Due to the greater facility with 
which aminophenols bearing a single amino acid can be synthesized, 1.19c has an 
inherent advantage over 1.19b.  Imine containing chiral phenol 1.19d produced 
homoallylamines with 74:26 er, but was less active than amine containing 1.19b and 
1.19c (Table 1.3, entries 1-3).  Chiral phenols 1.19e and 1.19f, which are analogous to 
1.19b and 1.19c only with an amide instead of amine functionality, show reasonable 
activity, but promote less enantioselective reactions (entries 1-2 vs. entries 4-5, Table 1). 
Changing the linker in these molecules results in multiple differences between the 
resultant compounds, making it difficult to extrapolate as to precisely why 1.19c 
promotes a more efficient and enantioselective transformation than 1.19d or 1.19f.  Imine 
containing 1.19d and amide containing 1.19f have significantly more acidic phenol 
protons than 1.19c, which has an amine linker. The linkers in 1.19d and 1.19f are also 
more rigid than the amine linker in 1.19c. Additionally, the Lewis basicity of the nitrogen 
is different between these functional groups as is the presence and acidity of any 
hydrogen on them.  
 From these preliminary investigations, we decided to carry out modifications to 
the structure of the chiral phenol, using 1.19c as a starting point and decreasing the 
reaction time for the screening reactions from 18 h to 8h.  The first site selected for 
modification was the N-terminus (Scheme 1.19). Removal of the tert-butyl group para to 
the phenol (1.19h) affords higher selectivities. Comparing 1.19h with 1.19i or 1.19j with 
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1.19m, it becomes clear that the tert-butyl group ortho to the phenol is important for both 
reactivity and enantioselectivity. The electron poor phenols 1.19k and 1.19l are less 
active than the more electron rich compounds 1.19j and 1.19m, although comparing the 
series of 1.19i-k suggests electron poor aminophenols are more enantioselective. With 
the further optimized structure represented by 1.19h in Scheme 1.19, we turned our 
attention to determining the ideal amino acid to incorporate into this aminophenol. 
 
 Reducing the reaction time further (from 8 h in Scheme 1.19, to 4 h in Table 1.4), 
we were pleased to see that the reaction featuring aminophenol 1.19h still proceeds to full 
conversion (entry 1, Table 1.4). Altering the amino acid moiety of the aminophenol 
shows that incorporation of amino acids lacking α-branching give rise to catalytic 
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Scheme 1.19  Modifications to Aminophenol N-Terminus
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reactions that are less efficient than when incorporating amino acids bearing α-branching 
(compare entries 1, 2, 4, and 9 with 3, 5, 6, and 8, Table 1.4).  The amino acids valine or 
tert-leucine emerged as the top two candidates, and we decided to continue using valine 
in synthesis of new aminophenols due to its substantially lower price when compared to 
tert-leucine (entries 1 and 4, Table 1.3). Next, we focused on modification of the C-
terminus of the chiral phenoxide precursors in the hopes of generating a more selective 
and efficient catalytic reaction. 
 
 We were curious to learn whether the proton located on the amide nitrogen of the 
aminophenol is critical to the catalysts' reactivity or selectivity (Scheme 1.20).  
Intriguingly, not only is this proton non-essential for reactivity or selectivity, reactions 
with tertiary amide containing 1.19o are more enantioselective than those from secondary 
amide containing 1.19h and 1.19n (Scheme 1.20). When the amide is changed to an ester, 
the efficiency and enantioselectivity of the catalytic reaction is greatly diminished 
(1.19p).  Such a decrease likely indicates the importance of the Lewis basicity of the  
 2.0 equiv. allylB(pin) 1.6,
2.0 equiv. MeOH, 
toluene, 22 ºC, 4 h
N
Ph
P
O
Ph
Ph
NHP(O)Ph2
Ph
1.15a
10 mol % NaOt-Bu
1.17a
Table 1.4  Modifications to Amino Acid Substituent
12 mol %
OH
N
H
R
O
NHBu
a Determined by 400 MHz 1H NMR analysis of unpurified reaction 
mixture.  bDetermined by HPLC analysis.
conv (%)aentry e.r.b
1
2
3
4
5
6
7
>98 92:8
>98
81:1983
>98 95:5
22 79:21
28 73:27
>98 61:39
R
t-Bu
Ile
Leu
Tle
Thr(Ot-Bu
89:11
8
9
42 72:28
93 58:42
Ser(Ot-Bu)
Phg
Cys(Bn)
Val (1.19h)
Phe
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carbonyl group on the catalyst.  To determine if the increase in selectivity between 1.19h 
and 1.19o could be simply from an increase in sterics (rather than an increase in Lewis 
basicity), the size of the amide group was further increased to diisobutylamide containing 
1.19q.  As 1.19q promotes a reaction that is essentially identical to that with smaller 
diethylamide containing 1.19o, it suggests that increasing the sterics of the amide does 
not increase the enantioselectivity of the transformation.  Changing the amide to a 
dimethylamide (1.19r) or a pyrrolidinyl amide (1.19s) should increase the Lewis basicity 
of the carbonyl due to an increased overlap of the nitrogen lone pair with the π-orbitals of 
>98% conv., 93:7 e.r.
N
H
NHPh
OH
i-Pr
O
t-Bu
N
H
NEt2
OH
i-Pr
O
t-Bu
N
H
NHMe
OH
i-Pr
O
t-Bu
N
H
N
OH
i-Pr
O
t-Bu
>98% conv, 96:4 e.r.
N
H
OEt
OH
i-Pr
O
t-Bu
N
H
NMe2
OH
i-Pr
O
t-Bu
47% conv, 80:20 e.r.
N
H
N(i-Bu)2
OH
i-Pr
O
t-Bu
N
H
N
OH
i-Pr
O
t-Bu
OMe
Me
 1.5 equiv. allylB(pin) 1.6,
2.5 equiv. MeOH, 
toluene, 22 ºC, 4 h
N
Ph
P
O
Ph
Ph
NHP(O)Ph2
Ph
1.15a
2.5 mol % NaOt-Bu
1.17a
3 mol % Chiral Alcohol
N
H
NHn-Bu
OH
i-Pr
O
t-Bu
>98% conv, 90:10 e.r. >98% conv, 88:12 e.r. >98% conv, 95:5 e.r.
>98% conv, 96.5:3.5 e.r.
>98% conv, 91:9 e.r.
>98% conv, 95:5 e.r.
1.19h 1.19n 1.19o
1.19p 1.19q 1.19r
1.19s 1.19t 1.19u
Scheme 1.20  Modifications to Aminophenol C-Terminus
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the carbonyl.72  Further supporting the idea that a stronger Lewis basic carbonyl results in 
a more selective catalyst, these two aminophenols afford products in the highest 
enantiomeric ratios observed thus far for this class of catalysts (Scheme 1.20).  Again 
examining size, to confirm that this increase in enantioselectivity was not due to 
decreasing the size of the substituents on the nitrogen of the amide, sterically smaller 
1.19t, derived from methylamine, was synthesized and employed in the transformation 
being studied.  It behaves the same to 1.19h, suggesting optimal aminophenols 1.19r and 
1.19s are not more selective than 1.19h simply because they are smaller in size.  
Spectroscopically, the carbonyl's Lewis basicity can be observed, since the IR stretching 
frequency correlates with bond strength. Weakening of the carbonyl bond leads to more 
single bond character (and a lower IR frequency), which leads to more anionic-like 
properties of the oxygen, and thus a stronger Lewis base. The carbonyl expected to have 
the highest Lewis basicity is that of pyrrolidine derived 1.19s,72 and the amide carbonyl 
in this compound has a stretching frequency of 1632 cm-1.  Moving through a 
representative list, dimethylamine derived 1.19r has a stretching frequency of 1638 cm-1, 
n-butylamine derived 1.19h has a stretching frequency of 1644 cm-1, aniline derived 
1.19n has a stretching frequency of 1655 cm-1, and ethyl ester containing 1.19p has a 
stretching frequency of 1728 cm-1. 
 Having developed a suitable aminophenol for use in the catalytic enantioselective 
synthesis of homoallylamide 1.17a, we subsequently focused on modifying the aldimine 
substrate to probe what structural features are tolerated by our newly established 
protocol.  Examining different aryl-substituted aldimines (Table 1.5) shows that the  
                                                
(72) (a) Hickmott, P. W. Tetrahedron 1982, 38, 1975–2050. (b) Spivey, A. C.; Arseniyadis, S. Angew. 
Chem. Int. Ed. 2004, 43, 5436–5441. 
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method tolerates a wide range of aryl-groups, including those that are ortho-substituted as 
in entries 1 to 4 (although increasing the size of this group to a methyl group results in a 
small reduction in enantioselectivity and reactivity, see entry 4), meta-substituted (entry 
5), electron poor (entries 6 to 8), electron rich (entries 9 to 11), as well as heterocycles 
containing oxygen (entry 12) and nitrogen (entries 13 and 14).  A general trend is that 
reactions with substrates that contain electron poor groups are more efficient and 
enantioselective than those with electron rich structures.   
 Alkenyl-substituted aldimines (Table 1.6) undergo allyl-addition to form nearly a 
single enantiomer in most cases (entries 1 to 3), although increasing the sterics of the 
olefin moiety does lead to lower enantioselectivities, and in some cases, reactivities, as 
exemplified by comparing aldimines 1.20a to 1.20c with 1.20d and then 1.20e (Table 
1.6).  Even the homoallylamide derived from the aldimine containing a sterically small 
 1.5 equiv. allylB(pin) 1.6,
2.5 equiv. MeOH, 
toluene, 22 ºC
N
Ar
P
O
Ph
Ph NHP(O)Ph2
Ar
1.15
2.5 mol % NaOt-Bu
1.17
3.0 mol % 1.19r
All data are the average of at least two trials. aConversion to the desired product 
as measured by analysis the 400 MHz 1H NMR specta of the unpurified reaction 
mixture versus an internal standard of 9-methylanthracene. bYield of isolated 
product.  cDetermined by HPLC analysis. See experimental section for details.
conv. (%)aentry e.r.c
1
2
3
4
5
6
8
>98 96.5:3.5
>98
Ar
98:2
time (h) yield (%)b
9
10
11
12
13
Ph; 1.15a
o-FC6H4; 1.15b
4.0 95
4.0 91
>98 97.5:2.5o-BrC6H4; 1.15c 4.0 86
o-MeC6H4; 1.15d 6.0 >98 91 93.5:6.5
m-BrC6H4; 1.15e 4.0 >98 95 98:2
p-BrC6H4; 1.15f 6.0 >98 91 97:3
7 p-CF3C6H4; 1.15g 4.0 >98 93 98:2
p-MeOC6H4; 1.15i 4.0 >98 98 96.5:3.5
p-(n-Bu)2C6H4; 1.15k 4.0 95 93 92:8
p-MeO2CC6H4; 1.15h 4.0 >98 98 98:2
2-furyl; 1.15l 6.0 >98 93 98:2
3-pyridyl; 1.15m 4.0 90 75 98:2
4-pyridyl; 1.15n 6.0 98 74 98:2
Table 1.5 Allyl-Additions to Aryl-Substituted Imines
14
p-MeC6H4; 1.15j 4.0 >98 98 96.5:3.5
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alkynylaldimine 1.20g is afforded in a synthetically useful enantiomeric ratio of 88:12 
(entry 7, Table 1.6).   Catalytic enantioselective allylation of aliphatic aldimines afforded  
 
highly enantiomerically enriched homoallylamides (>97:3 e.r.) but only in 50-71% 
isolated yield (Table 1.6).  Examining the 1H NMR spectra of the unpurified reaction 
mixture in entry 8 or 9 reveals no starting material present but approximately 20% of a 
 1.5 equiv. allylB(pin) 1.6,
2.5 equiv. MeOH,
toluene, 22 ºC, 4.0 h
N
G
P
O
Ph
Ph NHP(O)Ph2
G
1.20
2.5–8.5 mol % NaOt-Bu
1.21
3.0–6.0 mol % 1.19r
conv. (%)aentry e.r.cG yield (%)b
Table 1.6 Allyl-Additions to Alkenyl-, Alkynyl-, and Alkyl-Substituted Imines
1.19r (mol %);
 NaOt-Bu (mol %)
1 3.0; 2.5 >98 84 >99:1
2 3.0; 2.5 >98 95 >99:1
NO2
3 3.0; 2.5 >98 98 >99:1
MeO
4 3.0; 2.5 >98 96 98:2
Br
6 n-Pr 3.0; 2.5 >98 95 98:2
1.20a
1.20b
1.20c
1.20d
7 3.0; 2.5 >98 95 88:12
1.20f
1.20gPh
8 Ph 6.0; 5.0 66 50 >99:11.20h
9 i-Pr 6.0; 5.0 70 51 >99:11.20i
10 6.0; 8.5 90 71 97.5:2.5
1.20j
All data are the average of at least two trials. aConversion to the desired product as measured 
by analysis the 400 MHz 1H NMR specta of the unpurified reaction mixture versus an internal 
standard of 9-methylanthracene. bYield of isolated product.  cDetermined by HPLC analysis. 
dReaction time = 8.0 h. See experimental section for details.
5d 3.0; 2.5 85 76 93:7
Me 1.20e
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hemiaminal ether derived from addition of methanol to the starting imines.73  This 
suggests that the lower yields observed stem from decomposition of alkyl aldimines 
during the reaction. Extensive modifications to reaction conditions, such as increased 
reaction time and catalyst loading, decreased reaction temperature, other protic additives, 
slow addition of methanol or substrate, or increasing the amount of allylboronate 1.6 do 
not result in higher yields.  For α-branched imine 1.20j, a slight excess of NaOt-Bu led to 
a cleaner reaction, possibly by favoring collapse of the hemiaminal to the imine (entry 10, 
Table 1.6).  Applying this modification to γ- or β- branched aliphatic aldimines (entries 8 
and 9, Table 1.6) led to no improvement in yield, likely due to their decreased sterics not 
favoring the collapse of the hemiaminal ether intermediates to the starting imine. 
 In order to further challenge the method as well as demonstrate the synthesis of 
compounds that can serve as intermediates in the synthesis of biologically active 
compounds, we targeted the aldimine 1.20k as a substrate (Table 1.7). The resultant  
 
                                                
(73) The 1H NMR spectrum of the unpurified reaction mixture in entry 8 does not show this hemiaminal. 
Me
NP(O)Ph2
S
N
Me
Me
NHP(O)Ph2
S
N
Me
OH
N
H
O
R1
t-Bu
+ B(pin)
1.6
R2
mol % NaOt-Bu
3.0 mol %
1.20k 1.21k
2.5 equiv. MeOH, toluene,
22 ºC, 6.0 h
Table 1.7  Optimization of Enantioselective Allyl Addition to 1.20k
entry
5d
e.r.cconv. (%)a
>98
6
86
83>98
20
20
yield (%)b
95.5:4.5
96:4
2
1 92:891
>98
3
75
76
77>98
2.5
5.0
10
4 89>98 93.5:6.520
93.5:6.5
93.5:6.5
NaOt-Bu (mol%) R1 R2
1.5 equiv.
i-Pr; NMe2; 1.19r
i-Pr; NMe2; 1.19r
i-Pr; NMe2; 1.19r
i-Pr; NMe2; 1.19r
i-Pr; pyrrolidine; 1.19s
t-Bu; NMe2; 1.19v
 aConversion to the desired product as measured by analysis the 400 MHz 1H NMR specta of the unpurified 
reaction mixture versus an internal standard of 9-methylanthracene. bYield of isolated product.  cDetermined by 
HPLC analysis. dData are the average of two trials. See experimental section for details.
;
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homoallylamine can be used to synthesize the anti-cancer agent aza-epothilone A 
(Scheme 1.3). Performing this transformation under the conditions used for previous 
enantioselective allyl-additions to aldimines led to less than complete conversion as well 
as a less-than-ideal enantioselectivity (entry 1, Table 1.7).  This is likely due to the sterics 
of the alkenyl substituent, rather than the presence of the thiazole, since the aldimine 
1.20e (Table 1.6), which has a comparably sized aldimine substituent, behaves similarly. 
To improve the transformation, we first increased the amount of NaOt-Bu, which we had 
occasionally observed to improve the enantioselectivity and reactivity of the 
aminophenol-promoted enantioselective allyl addition. By making this change, the yield 
of 1.21k was increased along with its enantiopurity (Table 1.7, entries 1 to 4). 
Modifications to the aminophenol utilized led to an increase in the enantioselectivity of 
the transformation. The pyrrolidine containing aminophenol 1.19s was chosen as optimal 
because although it promotes reactions with similar efficiency and enantioselectivity as 
aminophenol 1.19v, pyrrolidine is cheap and readily available while tert-Leucine, needed 
for the synthesis of 1.19v, is not.   
 In the interest of further displaying reaction generality, the scope of the reaction 
was expanded to include 2-substituted allylboronates in addition to the previously studied  
 
entry
2
time (h)
6.0
1 4.0
e.r.c
97.5:2.5
97.5:2.5
conv. (%)a
>98
>98
2.5 mol % NaO-tBu
2.5 equiv. MeOH,
 toluene, 22 ºC
HN
PPh2
O
Ph
2.5 mol % 1.19r
1.15a
Table 1.8  Reactions with 2-Substituted Allylboronates
R
+ B(pin)
R
yield (%)b
96
98
R
1.5 equiv.
Me; 1.22a
Ph; 1.22b
All data are the average of at least two trials. aConversion to the desired 
product as measured by analysis the 400 MHz 1H NMR specta of the 
unpurified reaction mixture versus an internal standard of 9-methylanthracene. 
bYield of isolated product.  cDetermined by HPLC analysis.  See experimental 
section for details.
1.23a-b
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unsubstituted 1.6 (Table 1.8).  These reactions proceed efficiently to afford the desired 
products in both high yield and enantioselectivity (Table 1.8). 
 Favorable aspects regarding the practicality of the enantioselective allyl-addition 
to aldimines promoted by aminophenol 1.19r deserve special mention. The aminophenol 
 
a) Ease of Aminophenol Synthesis:
N
H
OH
i-Pr
O
Boc
EDC•HCl
HOBt•H2O
HNMe2 in H2O
CH2Cl2, 22 ºC
N
H
NMe2
i-Pr
O
Boc HCl in dioxane
0 to 22 ºC
NaBH4, HCl
MeOH, 0 to 22 ºC
N
H
NMe2
i-Pr
O
t-Bu
OH
MW: 306.4 g/mol
N
NMe2
OH
i-Pr
O
t-Bu
OH
t-Bu
O
,MgSO4, Et3N
CH2Cl2, 22 ºC
only step under nitrogen
H3N
NMe2
i-Pr
OCl
● 73% yield over four steps (~5 g scale).
● No silica gel chromatography required.
● Crystalline solid; Indefinitely stable at 22 ºC.
● All reagents commercially available for <$5/mmol
1.19r
Scheme 1.21  Practicality of Method
B
O
O
NP(O)Ph2
1.0 mol %
(10 mg)
NHP(O)Ph2
1.0 mol % NaOH (pellet)
1.5 equiv. MeOH, toluene, 22 °C, 2.0 h
N
H
NMe2
OH
i-Pr
O
t-Bu
>98% conv, 92% yield,
97:3 e.r.
1.0 gram 1.3 equiv
● Performed in a common fume hood. 
● Reaction vessel not flame dried.
● Commercial (as received) allyB(pin), NaOH, MeOH used.
● Workup: only solvent evaporation.
● Product purification: trituration (silica gel chromatography not needed).
b) Ease of Catalytic Reaction:
1.6
1.19r
1.15a 1.17a
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takes only four simple steps to synthesize and can be performed on approximately a 5g 
scale to afford 1.19r in 73% yield without the use of silica gel chromatography. Just one 
step is performed under a nitrogen atmosphere (all others can be performed in an open 
reaction vessel, Scheme 1.21a) with reagents that are all commercially available for less 
than $5/mmol.  The most expensive component is the 3-tert-butyl-salicylaldehyde 
($4.5/mmol from Aldrich); all other components are less than $0.20/mmol.  Importantly, 
the other enantiomer of 1.19r is easily accessible, as Boc-D-Valine is only $0.50/mmol 
(from Advanced Chemtech, where we purchase most of our amino acids; for comparison, 
Boc-L-Valine is $0.19/mmol).   
 Additionally, the allyl-addition can be performed on a gram scale outside of a 
glovebox with reagents that were used as received.74  Using only 1.0 mol% of the 
aminophenol and less reactive NaOH (instead of NaOt-Bu), the transformation proceeds 
to full conversion in two hours, affording homoallylamide 1.17a in 92% yield and 97:3 
e.r. The product is purified after the reaction by trituration (again, no silica gel 
chromatography is necessary), and 1.17a obtained in this manner passes elemental 
analysis after being put under vacuum (~1 Torr) overnight to remove solvent. 
1.5 Investigation of Reaction Mechanism 
 Following these studies to illustrate the efficiency, enantioselectivity, and utility 
of this new catalytic transformation, we turned our attention to elucidating a plausible 
reaction mechanism.  We began by ruling out the possibility that a small impurity of a 
transition metal in the NaOt-Bu used in the reaction was actually the active catalyst in 
                                                
(74) The methanol purchased does need to be of the anhydrous variety.  The toluene used was dispersed 
from a solvent purification system.  See the experimental section for details.  The reaction must be 
performed under a nitrogen atmosphere. 
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this transformation. 75   As shown in Eq. 1, freshly distilled amide base 1,8-
diazabicycloundec-7-ene (DBU) promotes a comparably efficient and enantioselective 
transformation to NaOt-Bu, suggesting that a transition metal impurity does not play a 
critical role in the catalytic cycle.  The drop in efficiency (Eq. 1) likely stems from the 
difference in pKa between NaOt-Bu and DBU.  This experiment also confirms that the 
 
structure of the base does not play a significant role in determining enantioselectivity, 
since the disparate structures of DBU and NaOt-Bu lead to essentially the same 
enantioselectivity.  Following this trend, the countercation of the metal alkoxide (Table 
1.9) also does not greatly affect the transformation (although Zn(Ot-Bu)2 does lead to a 
slightly more efficient transformation), which we discovered during initial optimization  
 
                                                
(75) For a representative example, see: Arvela, R. K.; Leadbeater, N. E.; Sangi, M. S.; Williams, V. A; 
Granados, P.; Singer, R. D. J. Org. Chem. 2005, 70, 161–168. 
2.5 equiv. MeOH, 
toluene, 22 ºC, 75 min
N
Ph
P
O
Ph
Ph NHP(O)Ph2
Ph
1.15a
2.5 mol % DBU
1.17a  83% conv., 96:4 e.r.
with NaOt-Bu: >98% conv., 96.5:3.5 e.r
+
B(pin)
1.6
1.5 equiv.
N
H
NMe2
OH
i-Pr
O
t-Bu
1.19r
3.0 mol %
(1)
Metal Alkoxide
2.0 equiv. 1.6, 2.0 equiv. MeOH
  toluene, 22 ºC, 30 min
12 mol %
a Determined by 400 MHz 1H NMR analysis of unpurified 
reaction mixture.  bDetermined by HPLC analysis.
conv (%)aentry e.r.b
1
2
3
88 93:7
93:779
>98 92:8
MOt-Bu
LiOt-Bu; 10 mol %
Zn(Ot-Bu)2; 5.0 mol %
Table 1.9  Initial Optimization of Metal Alkoxide
NaOt-Bu; 10 mol %
N
H
NHBu
OH
i-Pr
O
t-Bu
1.19hN
Ph
P
O
Ph
Ph
1.15a
NHP(O)Ph2
Ph
1.17a
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of the reaction (note the aminophenol in Table 1.9 is not the optimal aminophenol, but 
the one from preliminary studies). 
 A crucial observation for understanding the reaction mechanism, shown in Eq. 2, 
is that the enantioselective allyl-addition greatly favors the formation of α-addition 
products (that is, the carbon of the allyl group directly attached to the boron of the 
nucleophile becomes the carbon of the allyl group directly attached to the newly formed 
stereogenic carbon in the homoallylamide) versus the γ-addition product, which is far  
 
more common for transformations involving an allylboronate (see Scheme 1.11 and its 
discussion).44 This result is surprising because all other reported α-selective additions to 
carbonyls or imines involving allylborons as the nucleophile are proposed to obtain their 
selectivity through an allylmetal76 intermediate or a metal-catalyzed rearrangement.43-45,53 
The α-selectivity of the more commonly encountered/proposed allylmetal intermediates 
is therefore strongly dependent on the substitution of the allylboron, with nucleophiles 
bearing only deuterium substitution (such as d2-1.6 in Eq. 2) affording a 1:1 mixture of 
α- and γ-addition products due to the propensity of such allylmetals to readily 
isomerize.53,77,78  
                                                
(76) For a review on the reactivity and selectivity of allylmetals, see: Yamamoto, Y.; Asao, N. Chem. Rev. 
1993, 93, 2207–2293. 
(77) Schneider, U.; Dao, H. T.; Kobayashi, S. Org. Lett. 2010, 12, 2488–2491. 
(78) For an example of an α-selective conjugate addition of d2-1.6 that is proposed to go through an 
allylpalladium species, see: Sieber, J. D.; Morken, J. P. J. Am. Chem. Soc. 2008, 130, 4978–4983. 
2.5 mol % NaOt-Bu
2.5 equiv. MeOH,
toluene, 22 ºC, 6.0 h
(pin)B
D D
Me
NP(O)Ph2
S
N
Me 1.20k
+
d2-1.6
3.0 mol % 1.19s,
95% α
Me
NHP(O)Ph2
S
N
Me d2-1.21k-α
D D
(2)
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 Knowing that our newly developed reaction afforded products with α-selectivity, 
we sought to determine whether this selectivity arose from two γ-selective additions43-45,53 
leading to a net α-addition (such as the process shown in Scheme 1.11), or a single 
α-addition.79  If the catalyst operates through a single α-addition, then the terminal 
methyl group of trans-crotylboronate E-1.24 (Eq. 3) should not affect the transformation.  
As seen in Equation 3, use of E-1.24 leads to a far less efficient transformation (though  
notably still an α-selective one),80 suggesting that the catalyst operates through two γ-
selective additions (net α-addition).44c   
 
 These and other mechanistic and computational experiments (to be discussed in 
further detail below) led us to propose the catalytic cycle illustrated in Scheme 1.22.  
Reaction of aminophenol 1.19r with allylboronic acid pinacol ester 1.6 in the presence of 
NaOt-Bu and MeOH forms chiral allylboron i, which we propose is protonated by 1.26 (a 
Lewis acid activated by a Brønstead acid) to form ii.81 Although the presence of NaOt-Bu 
in solution makes it tempting to refer to the reaction conditions as overall basic, the 
                                                
(79) For a related transformation where aryl-, alkenyl-, and alknylboronates are added to imines through a 
single α-addition, see:  Bishop, J. A.; Lou, S.; Schaus, S. E. Angew. Chem. Int. Ed. 2009, 48, 4337–4340. 
(80) Increasing reaction time did not significantly increase conversion (~40% conv. after 48h). 
(81) For relevant reviews, see: (a) Yamamoto, H.; Futatsugi, K. Angew. Chem. Int. Ed. 2005, 44, 1924–
1942. (b) Yamamoto, H.; Futatsugi, K. "Chapter 1: Recent Advance of 'Combined Acid' Strategy for 
Asymmetric Catalysis" in Acid Catalysis in Modern Organic Synthesis; Yamamoto, H.; Ishihara, K. Eds.; 
Wiley-VCH: Weinheim, Germany, 2008. 
N
H
NMe2
OH
i-Pr
O
t-Bu
6 mol %
5 mol % NaOt-BuN
Ph
P
O
Ph
Ph +
2.5 equiv. MeOH,
toluene, 22 ºC, 18 h
NHP(O)Ph2
Ph
35% conv., 3:1 α:γ
(pin)B Me Me
1.25-α
NHP(O)Ph2
Ph
1.25-γ
+Me
If catalyst operates through a
single α−addition, then this distant
Me should not affect reactivity
1.15a
(3)
E-1.24
1.19r
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stoichiometric amount of MeOH and allylboronate 1.6 makes it more accurate to describe 
the reaction mixture as a buffered acidic solution.  This proton in ii82 we propose is key 
for a variety of reasons, including: 1) The Lewis acidity of ii is greatly increased, which 
 
promotes substrate binding (ii→iii), allyl-addition to the imine (iii→iv), and exchange of 
the allyl ligand from 1.6 onto the catalyst (v→vi→ii). 2) The intramolecular attraction83 
of the amide carbonyl to the proton locks the arm containing the stereogenic center into 
place, increasing structural rigidity, which allows for better discrimination of the 
                                                
(82) For a review of the such compounds, see: De Vries, T. S.; Prokofjevs, A.; Vedejs, E. Chem. Rev. 2012, 
112, 4246–4282. 
(83) We use the term 'intramolecular attraction' instead of hydrogen bond due to the relative rarity of five-
membered intramolecular hydrogen bonds.  See: Kuhn, B.; Mohr, P.; Stahl, M. J. Med. Chem. 2010, 53, 
2601–2611. 
Scheme 1.22 Catalytic Cycle Explaining α-Addition and Highlighting a Key Protonation
N
NMe2
O B O
i-Pr
NP
R
substrate binding
B
O
O
B
O
O
O
Me
N i-Pr
O B
H
O NMe2
H
3
1
MeOH
R
NHP
B
O
O
O
Me
H
N i-Pr
O B N
R
H
O NMe2
P
3 1
intramolecular protonation/
product release
N i-Pr
O B
H
O NMe2
N
RP
3
1
13
Net α-addition
N i-Pr
O B OMe
H
O NMe2
N i-Pr
O B
H
O NMe2
O
3
B
O
O
3
1
Me B
O
O
1
B
O
O
OMe
MeOH
Repeated removal of Boron obviated
Lewis acid activation 
of a Brønsted acid
Key Intramolecular Attraction:
1. Increase B Lewis acidity:
a. Facilitate substrate binding
b. Facilitate ligand exchange
2. Promote stereoselectivity
3. Promote product release
1st γ-addition
2nd γ-addition
NaOt-Bu
N
H
NMe2
OH
i-Pr
O
t-Bu 1.19r t-Bu
t-Bu
i
ii
iii
iv
v
vi
1.6
1.27
1.6
t-But-But-Bu
t-Bu
1.26
ligand exchange
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enantiotopic faces of the substrate. 3) The presence of the proton in iv allows for 
intramolecular protonation of the catalyst-homoallylamide N-B bond, facilitating product 
release and catalyst turnover (Scheme 1.22).   
 Another factor that facilitates catalyst turnover is that it is the same boron 
molecule bound to the aminophenol throughout catalytic turnover (from ii all the way 
back to ii), obviating removal of the aminophenol from boron after each catalytic cycle 
(as well as reformation of the active catalyst) and likely increasing catalytic efficiency.  It 
is this catalyst release step that plagues other metal-free allyl-additions to aldimines  
 
Remove B, regenerate catalyst
OH
OH
Ph
Ph
OH
O
Ph
Ph
B
Oi-Pr
i-PrO B
Oi-Pr
N
HR
Ph
O
OH
O
Ph
Ph
B
N
Oi-Pr
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O
R
i-PrOH
HN Ph
O
R
B(Oi-Pr)3
3 Å MS, toluene, 22 °C, 36 h
Reassembled 
after every cycle15 mol %
i-PrOH
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O
O
C6F5
C6F5
20 mol %
P
O
OH
Me3Si +
N
HR
Ar
O
Ar=2,6-(t-Bu)2C6H3 R
HN
O
Ar
O
O
C6F5
C6F5
P
O
O
O
O
C6F5
C6F5
P
O
OSiMe3
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O
O
P
O
OH
G
G
EtOAc, 30 ºC, 48 h
80 mol %
G=2,6-Me2C6H3
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O
O
P
O
OSiMe3
G
G
Me3Si
HN Ar
O
R
Scheme 1.23 Problematic Catalyst Release Steps in Previous Metal-Free Catalytic Methods for Imine Allylation
a) Method by Schaus
b) Method by Momiyama and Terada
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x xi
xiixiii
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(Scheme 1.23).  In a method by Schaus,46 the B-O bond in ix must be cleaved to afford 
free catalyst vii; this catalyst must then exchange onto the allylboronate to afford chiral 
allylboronate viii (Scheme 1.23a). 84   Mechanistic studies support this catalyst 
regeneration (ix to vii) is the turnover-limiting step.50  Avoiding this step (as well as the 
reformation step of vii to viii) is likely an important reason as to why our methodology is 
so much more efficient. 
 Catalyst turnover is also problematic in a method developed in the laboratories of 
Momiyama and Terada (Scheme 1.23b).39 Silylated catalyst xii is not effective at 
promoting the reaction and removal of this silyl group (xii→x) requires an equivalent of 
specially synthesized acid xiii, which is about as difficult to access as x itself.  All other 
acids examined by the authors lead to much lower levels of enantioselectivity.  Not 
having to release the catalyst from the residual heteroatom of the allyl group (in our case, 
boron; in Momiyama and Terada's case, silicon) precludes such a complication.  
 Scheme 1.22 also accounts for the observed α-selectivity. Starting from v, allyl 
transfer from 1.6 occurs through a γ-selective SE2' addition (vi) to form ii. Note the 
reversal of the 1 and 3 carbons of the allyl group, labeled in red, from 1.6. to ii.  A second 
γ-selective allylation (ii→iv; again, note the labeled 1 and 3 carbons) results in a 
homoallylamide that is the product of net α-addition (Scheme 1.22). 
 If initial chiral allylboron i (Scheme 1.22) is formed through simple exchange of 
aminophenol 1.19r with the pinacol of 1.6, the initial homoallylamides formed should be 
γ-selective since there would only be a single γ-selective allylation (ii→iv); subsequent 
                                                
(84) A later theoretical study strongly suggests that the identity of active catalyst is actually when both 
phenols of the catalyst exchange onto the allylboronate to form two covalent O-B bonds, rather than just 
one as shown in viii (Scheme 1.23).  Paton, R. S.; Goodman, J. M.; Pellegrinet, S. C. Org. Lett. 2009, 11, 
37–40.  
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catalyst turnovers would be α-selective.  It therefore stands to reason that increasing the 
catalyst loading would result in lower α-selectivity; however, as seen in entries 1 to 3 in 
Table 1.10, this is not the case.  No change in the α to γ selectivity suggests three  
 
possibilities: 1) Formation of i from 1.6 does not proceed through a simple ligand 
exchange. 2) The initial catalyst formed is v, which goes on to form ii. 3) Under catalytic 
conditions, only a small fraction of aminophenol 1.19r is initiated to form i, meaning 
most of the aminophenol added does not enter the catalytic cycle. We do not yet have 
definitive proof as to which of these scenarios is operative.  An extremely surprising 
result in Table 1.10 is that even without the aminophenol, the reaction is still noticeably 
α-selective (entry 4), indicating that the alkoxide catalyzed allyl-addition is more 
mechanistically interesting than originally proposed in Scheme 1.16 (Lewis base 
activation of allylboron. 85   To better understand factors contributing to the 
enantioselectivity of the catalytic protocol, we first investigated if there is an observable 
                                                
(85) Studying the reaction mechanism of such a transformation is a worthwhile endeavor; unfortunately, 
such studies are yet to be carried out. 
2.5 equiv. MeOH
  toluene, 22 ºC, 12 h
1.19r
N
Ph
P
O
Ph
Ph
1.15a
NHP(O)Ph2
Ph
d2-1.17a-α
NaOt-Bu
(pin)B
D D+
d2-1.6
D D
+
NHP(O)Ph2
Ph
d2-1.17a-γ
D
D
a Determined by 400 MHz 1H NMR analysis of unpurified reaction of purified compound.  These 
ratios are ≤2% different from those obtained through 76 MHz 2H NMR. b Average of two trials.
entry
1
2
3b
1.19r (mol %)
12 mol %
30 mol %
3.0 mol %
NaOt-Bu (mol %) d2-1.6 α:γa d2-1.17a α:γa
0 mol %
10 mol %
25 mol %
2.5 mol %
2.5 mol %
92:8
92:8
92:8
97:34
91:9
92:8
92:8
88:12
Table 1.10  Regioselectivity as a Function of Catalyst Loading
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non-linear effect.86  Plotting the ee of the aminophenol 1.19r vs. the ee of the product 
1.17a (conditions from entry 1 of Table 1.5) affords a straight line (Graph 1.1), which 
does not suggest that more than one molecule of aminophenol is present in the enantio-
determining step (although it does not rule it out).  Kinetic studies by Dr. Sebastian 
Torker indicate a buildup of negative charge on the aldimine in the turnover-limiting step 
(ρ value of +1.3, see experimental section for details), likely meaning this step is the 
allyl-addition to the aldimine. 
 
1.5.1 Investigation of Reaction Mechanism-Computational and Spectroscopic Studies 
 Computational studies (see experimental section for details) by Dr. Fredrik 
Haeffner to elucidate the stereochemical model were critical to this study, as it was these 
studies that led him to initially propose protonation of the aminophenol-allylboron 
complex (i→ii; Scheme 1.22). The aminophenol derived from L-tert-leucine 1.19v 
(Table 1.7) was modeled instead of 1.19r due to fewer possible conformers present in 
1.19v (Scheme 1.24).  The transition state leading to the major (R) enantiomer observed 
                                                
(86) Kagan, H. T.; Luukas, T. O. "Chapter 4: Non-Linear Effects and Autocatalysis" in Comprehensive 
Asymmetric Catalysis, Volume I; Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.; Springer-Verlag: 
Heidelberg, Germany, 1999. 
Graph 1.1 Investigation of Nonlinear Effects
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is shown in Scheme 1.24a. We propose the protonated amine of the catalyst plays yet 
another influential role by forming a six-membered hydrogen bond with the phosphinoyl  
 
O
N
B
O
NMe2N
P
Ph
O H
Ph
Ph
t-Bu
N
O
Bt-Bu
O
Me2N
N
Ph
PO
H
t-Bu
Ph
Ph
R-TS1.1
S-TS1.2
0.0 kcal/mol
+5.9  kcal/mol
N
O
B
NH
t-Bu
Ph
P
PhO
Ph
S-TS1.4
t-Bu
OMe2N
+10.8  kcal/mol
N
O
Bt-Bu
O
Me2N N
H
t-Bu
P
Ph
PhO
Ph
S-TS1.3
+7.5  kcal/mol
‡
a) Calculated Transition State Complex Which Leads to the R (Major) Enantiomer
Please Note: (a)  The energy of complex R-TS1.1 is used as a zero point 
reference. (b) The aminophenol derived from L-tert-leucine 1.19v (Table 1.7) was 
modeled instead of 1.19r due to fewer possible conformers present in 1.19v.
N
O
Bt-Bu
O
Me2N
N
PO
H
t-Bu
Ph
Ph
Ph
S-TS1.1
+2.4 kcal/mol
b) Calculated Transition State Complexes Which Lead to the S (Minor) Enantiomer
and their Energies Relative to R-TS-1.1
‡ ‡
‡‡
Scheme 1.24 Stereochemical Model Based on Calculations
Please Note: The energy of 
complex R-TS1.1 is used 
as a zero point reference.
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oxygen of the aldimine substrate (R-TS1.1, Scheme 1.24a).  Supporting this hypothesis, 
allyl addition to N-aryl aldimine 1.28, which does not containing a second point 
forhydrogen bonding, proceeds with nearly no enantioselectivity (Eq. 4). This proton also 
forms a five-membered intermolecular attraction83 with the dimethylamide, further 
rigidifying the catalyst structure. The increased energy of S-TS1.1 is from the higher 
energy of the cis-configureation of the phosphinoyl aldimine vs. its trans-configuration 
(as in R-TS1.1). Attributes of the catalyst we propose to discriminate against formation 
of the minor enantiomer (Scheme 1.24b) include the tert-butyl group of the amino acid 
moiety clashing with the allyl group in S-TS1.2, lack of the favorable hydrogen bond  
 
between the substrate and the catalyst in S-TS1.3 (again, see Eq. 4), and, in S-TS1.4, 
unfavorable steric interactions between the aldimine protecting group and the amide 
functionality of the catalyst, as well as between the aldimine and the tert-butyl group on 
the phenol ring. This second interaction is difficult to see from the perspective the 
transition states are drawn in Scheme 1.24, but is much easier to see Scheme 1.25.  
 
Ph
N
S
Me
N
H
NMe2
OH
i-Pr
O
t-Bu
3.0 mol %
2.5 mol % NaOt-Bu
1.5 equiv. 1.6, 2.5 equiv. MeOH,
toluene, 22 ºC, 75 min
1.19r
Ph
HN
S
Me
90% conv., 78% yield,
52:48 e.r.
(4)
1.28 1.29
N
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B
O
N
t-Bu
P O
H
Ph
Ph
R
B
O
N
t-Bu
N
H
R
Ph
P
OPh
Ph
R =
‡ ‡
R-TS1.1 S-TS1.4
Scheme 1.25 Alternate View of Relevant Transition States Which Illustrate the Clash Between the 
Substrate and the tert-Butyl Group on the Catalyst's Aryl Ring
t-Bu
O
Me2N
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 The idea of a protonated catalyst is further supported by NMR observations 
(Scheme 1.26).  Addition of five equivalents of methanol to a solution of deprotonated  
aminophenol 1.19r (formed by mixing the aminophenol with one equivalent of NaOt-Bu 
 
in toluene) leads to essentially no change in the 1H NMR spectrum.87  However, when 
two equivalents of allylB(pin) are added, complete protonation of the phenonoxide is  
observed in <5 minutes, supporting the proposal of the catalytic solution being overall 
acidic, but also that the acidity comes from Lewis acid (in our case, 1.6) activation of 
Brønsted acidic methanol.  
 Lending credence to the proton-amide interaction hypothesized in Scheme 1.24, 
the X-Ray crystal structures of 1.19r (Figure 1.1) and the HCl salt of 1.19r (Figure 1.2) 
both show this interaction. The bond length and bond angle from calculated transition 
state R-TS1.1 (Scheme 1.24) are 2.42 Å and 100º respectively,88 and fall almost exactly 
between the values for 1.19r and 1.19•HCl. 
 
 
                                                
(87) Addition of two equivalents of allylB(pin) to deprotonated 1.19r (without MeOH present) also leads to 
no protonation of the phenol moiety. 
(88) The upper distance for an intermolecular hydrogen bond is ~2.35 Å and the angle is from ~100º to 
~180º.  See reference 83. 
N
H
NMe2
OH O
i-Pr
t-Bu
1 equiv. NaOt-Bu NH
NMe2
O
O
i-Pr
t-Bu Na
5 equiv. MeOH NH
NMe2
O
O
i-Pr
t-Bu Na
no ArOH observedArOH disappearance observed by 1H NMR
2 equiv. allylB(pin)N
H
NMe2
OH O
i-Pr
t-Bu >98% ArOH observed by 1H NMR in <5 min
Scheme 1.26 NMR Study Showing an Overall Acidic Solution
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1.5.2 Investigation of Reaction Mechanism-Importance of Methanol 
 Congruent to methanol being important for more than just turnover,89 <5% 
conversion to product is observed even with stoichiometric amounts of NaOt-Bu and 
                                                
(89) Other than protonation of i (Scheme 1.22), methanol likely also assists in removing pinacol from 
allylboronic acid pinacol ester 1.6 to form a more sterically accessible dimethoxy- or monomethoxy, 
monopinacol boronate.  See Reference 62 for an example.  
N
i-Pr
OH
H
O NMe2
H
t-Bu
1.19r
H-O Bond Length: 2.82 Å
N-H-O Bond Angle: 86º
Figure 1.1 Insight about Proton-Amide Interaction through X-Ray Crystal Structure of 1.19r
N
H
i-Pr
OH
H
O NMe2
H
t-Bu
Cl
1.19r•HCl
H-O Bond Length: 2.13 Å
N-H-O Bond Angle: 111º
!
Figure 1.2 Insight about Proton-Amide Interaction through X-Ray Crystal Structure of 1.19r•HCl
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aminophenol (Eq. 5).  Related observations to this are: 1) Reactions with stoichiometric 
amounts of aminophenol and NaOt-Bu as well as 2.5 equivalents of methanol (Eq. 6) do 
 
afford enantiomerically enriched homoallylamides, although they are slower than those 
that use catalytic amounts, indicating that it is the absence of MeOH that accounts for the 
 
 lack of reactivity in equation 5. 2) In a catalytic reaction, use of only 0.5 equivalents of 
methanol leads to 39% conversion to the desired product (Eq. 7), showing that methanol 
 
is indeed needed for catalytic turnover. 3) As mixing 1.19r and NaOt-Bu in Equation 5 
affords an equivalent of tert-butanol, it stands to reason that tert-butanol is far less 
efficient at promoting this transformation than methanol.  Indeed, replacing methanol 
with tert-butanol (Eq. 8) results in a far more sluggish transformation than that with 
0 equiv. MeOH, 
toluene, 22 ºC, 24 h
N
Ph
P
O
Ph
Ph NHP(O)Ph2
Ph
1.15a
100 mol % NaOt-Bu
1.17a  <5% conv.
+
B(pin)
1.5 equiv.
N
H
NMe2
OH
i-Pr
O
t-Bu
1.19r
110 mol %
(5)1.6
2.5 equiv. MeOH, 
toluene, 22 ºC, 75 min
N
Ph
P
O
Ph
Ph NHP(O)Ph2
Ph
1.15a
100 mol % NaOt-Bu
1.17a 24% conv., 95:5 e.r.
After 16 h: >98% conv., 94:6 e.r.
+
B(pin)
1.5 equiv.
N
H
NMe2
OH
i-Pr
O
t-Bu
1.19r
110 mol %
(6)1.6
0.5 equiv. MeOH, 
toluene, 22 ºC, 75 min
N
Ph
P
O
Ph
Ph NHP(O)Ph2
Ph
1.15a
2.5 mol % NaOt-Bu
1.17a  39% conv.
+
B(pin)
1.5 equiv.
N
H
NMe2
OH
i-Pr
O
t-Bu
1.19r
3.0 mol %
(7)1.6
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methanol (>98% conv. in 75 minutes under otherwise the same conditions as in Equation 
8).  4) MeOD behaves identically to MeOH as a protic additive, consistent with proton 
transfer not being kinetically significant (no kinetic isotope effect).90  
1.5.3 Investigation of Reaction Mechanism-Structural Modifications of Aminophenol 
 To further gain insight into the reaction mechanism, we next undertook an 
investigation of modified amino alcohols to see how they behave in the reaction.  First we  
 
                                                
(90) The strength of hydrogen bonding interactions are nearly the same to deuterium bonding interactions. 
Scheiner, S.; Cuma, M. J. Am. Chem. Soc. 1996, 118, 1511–1521. 
2.5 equiv. t-BuOH, 
toluene, 22 ºC, 16 h
N
Ph
P
O
Ph
Ph NHP(O)Ph2
Ph
1.15a
2.5 mol % NaOt-Bu
1.17a  55% conv., 94:6 e.r.
+
B(pin)
1.5 equiv.
N
H
NMe2
OH
i-Pr
O
t-Bu
1.19r
3.0 mol %
(8)1.6
t-Bu
OH
N
H
i-Pr
O
NHBu
>98% conv., 91:9 e.r.
1.19h
N
H
OEt
OH
i-Pr
O
t-Bu
47% conv, 80:20 e.r.
1.19p
OH
N
H
i-Pr
O
NHBu
71% conv., 74.5:24.5 e.r.
1.19i
OH
N
i-Pr
O
NHBu
<2% conv.
1.19w
OH
N
H
i-Pr
O
NHBu
1.19x
<10% conv.
O
 1.5 equiv. allylB(pin) 1.6,
2.5 equiv. MeOH, 
toluene, 22 ºC, 4 h
N
Ph
P
O
Ph
Ph
NHP(O)Ph2
Ph
1.15a
2.5 mol % NaOt-Bu
1.17a
3 mol % Chiral Alcohol
All data are the average of at least two trials. Conversion is to the desired product as measured by 
analysis the 400 MHz 1H NMR specta of the unpurified reaction mixture versus an internal standard of 
9-methylanthracene. Enantiomeric ratios are determined by HPLC analysis. See experimental section 
for details.
Scheme 1.27 Revisitation of Key Data from Screening
N
H
NMe2
OH
i-Pr
O
t-Bu
>98% conv, 96.5:3.5 e.r.
1.19r
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revisited selected chiral alcohols from screening in order to compare them under the same 
conditions and to confirm key observations we learned from screening to be true (Scheme 
1.27).   The results in Scheme 1.27 are fully consistent with previous observations made 
about the importance of the amine linker versus an imine or amide linker (1.19i versus 
1.19w and 1.19x in Scheme 1.27 compared data in Table 1.3), the importance of the tert-
butyl group (1.19h vs. 1.19i; see Scheme 1.25 and Scheme 1.19), and the importance of a 
Lewis basic carbonyl (1.19r versus 1.19p and 1.19h; see Scheme 1.20 and the discussion 
surrounding it). 
 More systematic changes to the structure of aminophenol 1.19r are shown in 
Scheme 1.28, and these compounds are employed in the catalytic allyl-addition to 
phosphinoyl aldimine 1.15a.  To better compare efficiencies, the reaction time for these 
studies is 75-minutes.91  Removal of the tert-butyl group from 1.19r to afford 1.30a leads 
to a less selective and less active catalyst.  Interestingly, the drop in enantioselectivity is 
nearly the same when comparing 1.19i with 1.19h (Scheme 1.27); with ΔΔG‡=0.67 
kcal/mol for 1.19r versus 1.30a and 0.72 kcal/mol for 1.19i versus 1.19h. This suggests 
that the presence of the tert-butyl group and the amide in 1.19r do not have the same role 
in determining stereoselectivity.  The hypothesis for how a substituent ortho to the phenol 
influences enantioselectivity is, as previously shown in Scheme 1.25, by hampering S-
TS1.4 in Scheme 1.24. The result with 1.30b (Scheme 1.28) is consistent with this idea.  
The reason for the increase in efficiency between 1.30a and 1.19r (as well as 1.30b) may 
be due to sterically preventing inactive forms of the aminophenol, such as dimers or 
adducts with the aldimine substrate.   
                                                
(91) Subsequent kinetics studies show that under ideal conditions, the allyl-addition to 1.15a promoted by 
aminophenol 1.19r is complete in as little as 20-minutes.  Still, 75-minutes affords useful data, as many of 
the compounds in Scheme 1.28 do not reach full conversion. 
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 Replacing the hydrogen on the amine linker with a methyl group gives 1.30c, 
which causes a far less enantioselective and efficient transformation than 1.19r.  This 
result fits nicely with what we propose in Scheme 1.22, since 1.30c cannot form 
oxazaborolidine i and therefore should not be very active or selective.  That 1.30c does 
engender some enantioselectivity and reaction is not very surprising since the initial 
compounds examined by Dr. Pilyugina (1.18 in Scheme 1.18) did not have the ability to 
form anything resembling i either.  We propose those compounds (and probably 1.30c) 
act by exchanging with allylboronic acid pinacol ester to give a mono-phenoxy, mono-
1.30e
6% conv., 95:5 e.r.
2.5 mol % NaOt-Bu
1.5 equiv. allylB(pin) 1.6, 2.5 equiv. MeOH,
22 ºC, 75 min
>98% conv., 96.5:3.5 e.r.
76% conv., racemic
1.30d
70% conv., 61:39 e.r.
1.30f
>98% conv., 89:11 e.r.
1.30b
82% conv., 88.5:11.5 e.r.
1.30a
29% conv., 72:28 e.r.
1.30c
79% conv.
As above plus 3.0 mol % of the molecule shown
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Scheme 1.28 Structure-Activity Relationships for Aminophenol 1.19r
All data are the average of at least two trials. Conversion is to the desired product as measured by 
analysis the 400 MHz 1H NMR specta of the unpurified reaction mixture versus an internal standard of 
9-methylanthracene. Enantiomeric rations are determined by HPLC analysis. See experimental section 
for details.
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alkoxy allylboronate, which is sufficiently Lewis acidic enough to react with the 
substrate.92   
 Demonstrating the crucial nature of the phenol moiety of 1.19r, employing of des-
hydroxy 1.30 leads to a transformation that is not significantly different than when no 
chiral compound is added (that is to say, with just NaOt-Bu as a catalyst, top equation in 
Scheme 1.28).  Again, this is completely in line with what we have proposed for the 
reaction mechanism, although it does suggest that the phenol moiety is more important 
than the amine moiety.    
 An interesting point related to the result with 1.30d (Scheme 1.28) is if the NaOt-
Bu completely swamps any affect of 1.30d, why does NaOt-Bu not cause lower 
enantioselectivity with other aminophenols?  Based on the relative rates of the NaOt-Bu 
catalyzed reaction versus the transformation containing 1.19r, the aminophenol-based 
catalyst is not simply out competing NaOt-Bu.  In the presence of para-nitro containing 
1.30e, desired product is obtained in high 95:5 e.r., but the reaction only goes to 6% 
conversion, much less than the 79% conversion when just using NaOt-Bu.93  The mix of 
high enantioselectivity and low conversion suggest that the NaOt-Bu pathway is non-
operative94 when an aminophenol is present, especially combined with the multitude of 
examples where transformations in the presence of an aminophenol are slower than with 
just NaOt-Bu (1.30c in Scheme 1.28 and 1.19p are just two examples).  This fascinating 
observation is still not fully understood, and requires a better comprehension of the 
                                                
(92) This is reminiscent of the mechanism proposed by Professor S. E. Schaus.  See ref. 46 and Scheme 
1.13. 
(93) About 61% yield of aminophenol 1.30e is obtained from the reaction, indicating that 1.30e does not 
simply decompose under the reaction conditions. 
(94) For a recent mechanistic study on a transformation where the "background" reaction is not operative in 
the presence of the catalyst, see: Denmark, S. E.; Chi, H. M. J. Am. Chem. Soc. 2014, 136, 3655–3663. 
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mechanism of the NaOt-Bu catalyzed transformation in order to propose a reasonable 
hypothesis. 
 Why 1.30e affords lower selectivity may be due to a) The phenol oxygen is 
rendered much less nucleophilic by the electron-withdrawing nitro group and therefore 
has difficulties exchanging onto a molecule of boron to make i (Scheme 1.22) b) The pH 
of the reaction is changed so much by the much more acidic phenol proton that the 
reaction is inhibited.95   
 The importance of a Lewis basic carbonyl has been previously observed (Scheme 
1.20 and surrounding discussion) and is fully consistent to the mechanism proposed in 
Scheme 1.22.  The stronger the Lewis base the stronger the intramolecular interaction 
between that carbonyl and the key proton becomes.  This both rigidifies the catalyst as 
well as stabilizes protonated catalyst ii versus the unprotonated i (Scheme 1.22).  
Coinciding with these statements, the catalytic reaction using amide-lacking aminophenol 
1.30f is less efficient and almost completely racemic (Scheme 1.28).  Why this 
transformation is faster than when ester-containing 1.19p is used (Scheme 1.27) may be 
because 1.30f is smaller in size than 1.19p, leading to more efficient transformations 
through a non-protonated intermediate similar to i (Scheme 1.22).   
1.5.4 Investigation of Reaction Mechanism-Additional Kinetic Data 
 Additional kinetic experiments were carried out by Dr. Sebastian Torker, but 
these studies had issues with reproducibility, so the reader is cautioned about inferring 
too much from them.96  The data were obtained with para-dibutylamino aldimine 1.15k 
as the substrate in order to obtain slow enough reactivity to accurately measure.  Some 
                                                
(95) Additives that are too acidic completely shut down the reaction.  Addition of 3.0 mol % of acetic acid 
leads to <2% conversion regardless of the aminophenol (conditions otherwise as in Scheme 1.28). 
(96) Data are included here to compile some interesting observations that would otherwise go unreported. 
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interesting trends are a) An Eyring plot showed activation parameters of ΔS‡= -50.8 
cal/mol•k and ΔH‡= +6.4 kcal/mol.  The large value for ΔS‡, if true, is consistent with a 
highly ordered turnover-limiting step, likely due to non-polar toluene molecules from the 
solvent adopting conformations to better stabilize a charged transition state. Related to 
this, the selectivity does not increase upon cooling (or heating) the reaction, indicating 
the enantioselectivity is largely derived from entropic considerations. Thus the models in 
Scheme 1.24 should be considered working rather than actual models.   b) Overall 
reaction order is ~0.6 when using aminophenol 1.19r c) Reaction order in aldimine is ~0.  
d) Reaction order in allylB(pin) is 0.  e) Methanol slows down the reaction rate once its 
concentration exceeds that of the aldimine; the reaction is ~0 order in methanol when it is 
at a lower concentration than the aldimine. f) While there is a Hammett correlation when 
using aminophenol 1.19r, there is no such correlation when aminophenol 1.30f is used 
(Scheme 1.28), indicating a change in the turnover-limiting step. g) When aminophenol 
1.30f is used, the overall order increases to ~1.6, further confirming the change of the 
turnover-limiting step.  h) Generation of (pin)B-OMe 1.27 (Scheme 1.22) occurs at a rate 
identical to the rate of the reaction. 
1.6 Investigation of Mechanism of Allyl-Transfer as well as Obtaining Synthetically 
Useful "Crotyl-type" Addition Products by Studying the Reactivity and Selectivity of α-
Chiral Allylboronates. 
 Having obtained a much greater understanding of the reaction mechanism, we 
next wished to extend our method to the synthesis of homoallylamides with tertiary or 
quaternary stereogenic centers between the stereogenic center attached to nitrogen and 
the olefin of the allyl group as in 1.32 (Table 1.11).  As shown already in Equation 3, 
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crotylboronate 1.11 does not efficiently or selectively add to aldimines under the catalytic 
manifold, which we hypothesized to be due to an unfavorable first γ-addition in the 
catalytic cycle (see vi to ii in Scheme 1.22).  Keeping this in mind, we next attempted to 
utilize the unique α-selectivity of our system to catalyze the addition of enantiomerically 
enriched allylboronate 97  1.31 to imine 1.15a (Table 1.11).  Not only would this 
demonstrate the utility of this class of catalyst’s selective α−addition, but it would allow 
access to products that otherwise can be difficult to synthesize.98   Under typical 
conditions for enantioselective allyl addition to 1.15a we were pleased to find that the 
 
desired product was afforded as a single regioisomer (no γ-addition was detected) as well 
as in >90% ee and >4:1 d.r. (entry 1).  The only problem left to overcome was the low 
level of reactivity (24% conversion after 18 hours).  Increasing the temperature initially 
                                                
(97) Guzman-Martinez, A.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 10634–10637. 
(98) (a) Yin, L.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2009, 131, 9610–9611. (b) Kolodney, G.; 
Sklute, G.; Perrone, S.; Knochel, P.; Marek, I. Angew. Chem. Int. Ed. 2007, 46, 9291–9294. 
N
H
NMe2
OH
i-Pr
O
t-Bu
N
Ph
 mol %
P
O
Ph
Ph
 2.5 equiv MeOH, toluene
1.5 equiv.,
95:5 e.r.
NHP(O)Ph2
Ph
Me Cy
(pin)B
Cy Me+ mol % Base
1.15a 1.31
1.19r
α−addition
Table 1.11  Optimization of Reaction Conditions for Addition of Enantiomerically 
Enriched Allylboronate 1.31 to Imine 1.15a.a
entry 1.19r (mol %) e.r.dconv. (%)b yield (%)c
3* 6
2* 6 94:6
94.5:5.5
47
58
4 12 94:642
nd
nd
nd
1 6 95.5:4.524 nd
a >98:<2 α:γ ratio in all cases. bDetermined by 400 MHz 1H NMR analysis of unpurified reaction 
mixture.  cYield of isolated major diastereomer. d For major diastereomer. Determined by HPLC 
analysis. *Average of two experiments.
5 3 93:748
6 6 95:564
nd
nd
NaOt-Bu (5.0)
time (h)
18
18
48
NaOt-Bu (5.0)
NaOt-Bu (5.0)
NaOt-Bu (10.0)
NaOt-Bu (2.5)
LiOt-Bu (5.0) 18
18
18
Base  (mol %) temp (ºC)
8* 6
7 6 94:6
95:5
>98
>98
9 6 nd24
74
nd
7418
18
Zn(Ot-Bu)2 (2.5)
Zn(Ot-Bu)2 (2.5)
Zn(Ot-Bu)2 (2.5) 4
22
50
50
50
50
50
50
22
22
d.r.b
81:19
85:15
91:9
91:9
88:12
88:12
89:11
89:11
89:11
1.32
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doubled the conversion while barely decreasing the enantioselectivity; however the 
reaction seemed to die off as increasing the reaction time did not greatly increase 
conversion (entries 2 and 3).  Increasing or decreasing the catalyst loading showed little 
change in reactivity as well (entries 4 and 5). Since this transformation involves both an 
enantiomerically enriched catalyst and reagent, we worried there may be a matched 
mismatched interaction, but the antipode of aminophenol 1.19r under conditions in entry 
2 gave similar results although the opposite major diastereomer (40% conv., 21:79 dr).   
 Allylboronate 1.31 contains a quaternary stereogenic center directly next to the 
boron, so we hypothesized that the activation of boron may be what is slowing down the 
catalytic reaction.  To address this we first tried a sterically less hindered aminophenol 
(Me group containing 1.30b [Scheme 1.28] instead of t-Bu group containing in 1.19r), 
but we observed <2% conversion to desired product.  Another attempt to increase 
conversion was increasing the equivalents of methanol to 12.5 in hopes it would 
exchange with the pinacol group on 1.31 to make the boron less hindered, but this lead to 
no increase in conversion versus entry 2 of Table 1.11.  Taking into consideration past 
results suggesting Zn(Ot-Bu)2 to be superior to NaOt-Bu in terms of reactivity for this 
class of catalysts (Table 1.9), we examined it and LiOt-Bu as bases (entries 6-9, Table 
1.11).  By using Zn(Ot-Bu)2, the reaction went to full conversion in 18 hours at room 
temperature affording isolated major diastereomer in 74% yield and 95:5 e.r. (entry 8).  It 
is still unclear exactly what role the Zn salt plays, but one possibility is that since zinc 
posseses a +2 charge, it is better at sequestering free pinacol than +1 sodium.  This helps 
form a more sterically accessible dimethylborate which may help in catalyst initiation. 
We do not believe that a meaningful role of the Zn(Ot-Bu)2 is to cause the formation of 
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an allylzinc38d,44b–f species, since the enantioselectivity are the same when using Zn(Ot-
Bu)2 versus NaOt-Bu (cf. entry 1 and 8) that does not form an allylmetal species with 
allylboronate 1.6. 
 Investigations were then carried out into using an enantiomerically enriched 
allylboronate with a tertiary stereogenic center ((R)-1.33) as a nucleophile (Table 1.12).   
 
A brief optimization shows that NaOt-Bu as a base at room temperature leads to an 
optimal reaction in terms a d.r. and conversion (Table 1.12). Containing a tertiary 
stereogenic center rather than a quaternary one likely makes 1.33 far more reactive than 
1.31.  Employing (S)-1.33, the opposite enantiomer of the allylboronate shown in Table  
 
1.12, results in a very similar reaction to entry 1 of Table 1.12 in terms of yield, e.r., and 
d.r., but the opposite major diastereomer is afforded (Equation 9).  Therefore, by 
combining the correct enantiomer of the allylboronate coupled with the correct 
entry e.r.dconv. (%)b yield (%)c
 2.5 equiv. MeOH,
 toluene, 18 h
6 mol % 1.19r,
Table 1.12  Optimization of Reaction Conditions for Addition of 
Enantiomerically Enriched Allylboronate (R)-1.33 to Imine 1.15a.a
3
2 96:4
93:7
>98
>98 94
88
1* 96:4>98 93NaOt-Bu (5.0)
NaOt-Bu (5.0)
ZnOt-Bu (2.5)
Base  (mol %) temp. (ºC)
22
50
22
d.r.b
83:17
83:17
75:25
a >98:<2 α:γ ratio in all cases. bDetermined by 400 MHz 1H NMR analysis of unpurified 
reaction mixture.  cYield of isolated mixture of diastereomers. d Enantiomeric ratio of 
major diastereomer. Determined by HPLC analysis. *Average of two experiments.
mol % Base
NHP(O)Ph2
Ph
Ph
H
α−addition
1.34
N
Ph
P
O
Ph
Ph +
(pin)B
H
Ph
(R)-1.33
1.5 equiv.,
94:6 er
1.15a
5 mol % NaOt-BuN
Ph
P
O
Ph
Ph +
2.5 equiv. MeOH,
toluene, 22 ºC, 18 h
(pin)B
H
Ph
NHP(O)Ph2
Ph
Ph
H
(S)-1.33
94:6 e.r. 84% yield, 84:16 d.r.,
>98% α, 95:5 e.r. (major)
6 mol % Aminophenol 1.19r
1.15a 1.35
(9)
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enantiomer of the catalyst, all four possible stereoisomers of the product can be obtained 
selectively, making our method only the second example where this is possible in the 
literature of catalytic, enantioselective allyl-additions to imines.53  Notably, 
enantiomerically enriched allylboronates are required to obtain diastereoselectivity, as 
using Rac-1.33 affords the product in 1:1 d.r.,  though undiminished enantioselectivity 
(Equation 10). 
 
 In addition to affording synthetically useful products, these reactions with 
enantiomerically enriched borolanes give valuable insight into the reaction mechanism. 
Using X-ray crystallography, the absolute stereochemistry of each product was 
established to be what is shown in Table 1.11, Table 1.12, and Equation 9.  Importantly, 
this outcome requires the stereogenicity of the allylboronate to invert during the catalytic  
 
5 mol % NaOt-BuN
Ph
P
O
Ph
Ph +
2.5 equiv. MeOH,
toluene, 22 ºC, 18 h
(pin)B
NHP(O)Ph2
Ph
Rac-1.33
1:1 e.r.
86% yield, 52:48 d.r.,
>98% α, 94:6 e.r. (major)
95:5 e.r. (minor)
6 mol % Aminophenol 1.19r
Ph Ph
1.15a
(10)
MeOH
N
O
B
O
Me2N OMeH
t-Bu
N
O
B
O
Me2N
N
Ph
PO
H
t-Bu
Ph
Ph
MeO–B(pin)
(pin)B
H
N
O
B
O
Me2N
H
t-Bu
"synclinal"
NHP(O)Ph2
Ph
Ph
H
L3B OMe
Ph
Efficient and 
stereospecific
B–allyl bond
formation and
catalyst
regeneration
*(pin) group
omitted
for clarity
N
O
B
O
Me2N OH
B
*
t-Bu
Ph
PhHE
Ph
Ph
NP(O)Ph2
L3B OMe
L3B OMeL3B OMe
N
O
B
O
Me2N
N
Ph
PO
H
t-Bu
Ph
L3B OMe
PhPh Me
I
1.34
II
(R)-1.33
IIIIVV
1.15a
Scheme 1.29 Models and Mechanism of Allyl Transfer
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cycle.  A plausible reason for the formation of 1.34 is shown in Scheme 1.29.  Following 
release of product 1.34 leading to the start of a new catalytic cycle (I→II, Scheme 1.29), 
boronate II is formed. The hydrogen bonding between the amide oxygen and the N-H 
proton in II is critical for selective allyl transfer of 1.33 to the catalyst as this amide 
blocks 1.33 from approaching the boron from left side of II (Scheme 1.29).  If the allyl 
group reacted from the front of II, the opposite diastereomer of product would be 
obtained. We propose that the methoxy group on the catalyst in II assists in the allyl 
transfer which goes through synclinal-like transition state III and forms IV with high 
levels of selectivity for a single olefin isomer.   Allyl-addition through a six-membered 
transition state affords V, which constitutes a net inversion of stereochemistry from (R)-
1.33 to 1.34.   
 
 Also supporting the importance of the aminophenol in selective allyl transfer, 
reaction in the absence of the aminophenol affords no diastereoselectivity and low-
enantioselectivity, although still high levels of α-selectivity.99 Looking at this another  
 
                                                
(99) The α-selectivity as well as the small amount of enantioselectivity again suggests that studying the 
mechanism of the NaOt-Bu catalyzed reaction to be a worthwhile endeavor. See footnote 85.  
5 mol % NaOt-BuN
Ph
P
O
Ph
Ph +
2.5 equiv. MeOH,
toluene, 22 ºC, 18 h
(pin)B
H
Ph
NHP(O)Ph2
Ph
Ph
H
(R)-1.33
94:6 e.r. 80% conv., 70% yield, 50:50 d.r.,
>98% α, 73:27 e.r. (syn),
53:47 e.r. (anti)
1.15a
(11)
5 mol % NaOt-BuN
Ph
P
O
Ph
Ph +
2.5 equiv. MeOH,
toluene, 22 ºC, 18 h
(pin)B
H
Ph
NHP(O)Ph2
Ph
Ph
H
(R)-1.33
94:6 e.r. 59:41 Inversion: Retention
1.15a
(12)
Inversion
NHP(O)Ph2
Ph
Ph
H
Retention
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way (equation 12), the stereochemistry of the products show a ratio of those where 
allylboron 1.33 inverts to those where it does not of 59:41.  Compare this to when 
aminophenol is present in Equation 13, where the ratio is 89:11. With the establishment 
of α-substituted allylboronates as competent nucleophiles under the aminophenol 
promoted manifold, we next revisited looking at γ-substituted crotylboronic acid E-1.24 
(see Equation 3). 
 
 Based on our mechanistic understanding, the low reactivity we see with trans-
crotylboronic acid pinacol ester E-1.24 is likely due to increased sterics of the γ-addition 
to the catalyst, shown as II to VII in Scheme 1.30.  However, preceding data show that γ- 
 
addition of a similar allyl group to the substrate occurs readily (V→I, Scheme 1.29).  
This inspired us to introduce a third γ-addition to the catalytic cycle, allowing for net γ- 
addition of crotylboronates to aldimines (Scheme 1.31).  Studies by Kobayashi and 
Fandrick suggest the use of a zinc-alkoxide may accomplish this goal by transmetalating 
5 mol % NaOt-BuN
Ph
P
O
Ph
Ph +
2.5 equiv. MeOH,
toluene, 22 ºC, 18 h
(pin)B
H
Ph
NHP(O)Ph2
Ph
Ph
H
(R)-1.33
94:6 e.r.
6 mol % Aminophenol 1.19r
1.15a
(13)
NHP(O)Ph2
Ph
Ph
H
Inversion Retention
89:11 Inversion: Retention
N
O
B
O
Me2N OMeH
t-Bu
L3B OMe
II
(pin)B Me
N
O
B
O
Me2N OH
B*
t-Bu
H
L3B OMe
Me
Me
*(pin) group
omitted
for clarity
MeO–B(pin) N
O
B
O
Me2N
H
t-Bu
Me
Sterics likely disfavor
conversion of VI to VII
VI VII
L3B OMe
Scheme 1.30 Proposal for Poor Reactivity of E-1.24
E-1.24
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with allylboronate 100  in a γ-selective fashion to give VIII (Scheme 1.31).38d,44b–f  
Changing the base from NaOt-Bu to Zn(Ot-Bu)2 results in much more efficient 
transformation as well as switching the reaction to be γ-selective (Table 1.13, cf. entry 1 
and 2).  Lowering the reaction temperature decreases the reactivity without greatly 
affecting regio- or stereoselectivity (entry 3 and 4). 
 
 
 With my input, visiting scholar Dr. Hiroshi Miyamoto carried out further reaction 
optimization.   Use of the sterically smaller Zn(OMe)2 is crucial for high γ:α selectivity  
(Scheme 1.32), perhaps due to it being better able to promote the first transmetalation. 
                                                
(100) The study by Fandrick (ref 44c) shows that crotylboronate 1.24 is not compatible with their 
conditions (it gives <2% conversion), which brings of the interesting point of why exactly the 1.24 seems to 
transmetallate with zinc methoxide in our case.  Perhaps the aminophenol promotes transmetallation, or it 
could be something as subtle as a solvent effect (the Fandrick group uses THF while our chemistry uses 
toluene). 
M OR
RO–B(pin) Me
M
1st γ-addition
MeO–M
II
VIII
Stereochemical
Control?
2nd γ-addition
N
O
B
O
Me2N
H
t-Bu
MeIX
Ph
NP(O)Ph2
N
O
B
O
Me2N
N
Ph
PO
H
t-Bu
Ph
L3B OMe
Me
Ph
3rd γ-addition
L3B OMeE-1.24 1.15a
X
Scheme 1.31 A 3rd γ-Addition in Order to Affect an Efficient and Net γ-Selective Transformation
 2.5 equiv. MeOH,
toluene, 15 h
6 mol % 1.19r,
1.5 equiv.
entry
1
2*
γ:α ratiob
25:75
74:26
35
>98
conv. (%)a
n.d.=not determined a Determined by 400 MHz 1H NMR analysis of unpurified reaction mixture. b 
Determined by 400 MHz 1H NMR analysis of isolated product. c Yield of isolated product. d 
Determined by HPLC analysis. *Average of two experiments.
temp  (ºC)Base  (mol %)
NaOt-Bu (5.0)
Zn(Ot-Bu)2 (2.5)
22
22
3
4
70:30
-
59
<5
Zn(Ot-Bu)2 (2.5)
Zn(Ot-Bu)2 (2.5) -15
4
d.r. (γ)c e.r.(γ) (maj./min.)d
88:12 n.d.
- -
87:13
88:12
95:5/88:12
96:4/88:12
Table 1.13 Optimization of Addition of E-Crotylboronate to Aldimine 1.15a.
NHP(O)Ph2
Ph
Me
1.25-α
NHP(O)Ph2
Ph
1.25-γ
Me
(pin)B Me
E-1.24
mol % Base
yield (%)
n.d.
N
Ph
P
O
Ph
Ph
1.15a
83%
n.d.
n.d.
+
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The observation that both E- and Z-crotylboronates 1.24 afford the same major 
stereoisomer of product is consistent with a rapidly equilibrating allylzinc intermediate 
(XII→XIII, Scheme 1.33).101 
 
 A possible reaction mechanism is shown in Scheme 1.33.  Relay 1 proceeds 
through transition state XI to afford XII, which is in rapid equilibrium with XIII.  As 
                                                
(101) As this point we can not rule out the possibility that both (E)- and (Z)-XVI (Scheme 1.33) react with 
the aldimine to give the same stereochemical outcome due to (Z)-XVI reacting through a chair transition 
state and (E)-XVI reacting through a boat transition state.  For a related example, see ref 46. 
Me B O
O
Ph
NHP(O)Ph2
B O
O
Me
 >98% conv., 83% yield
95:5  γ/α
96:4 d.r.
96.5:3.5 e.r (maj)
E-1.24
Z-1.24
(1.5 equiv.)
MeOH (2.5 equiv.)
toluene (0.1 M)
22 ºC, 24 h
1.25-γ>98% conv., 87% yield 
>98 : 2 γ/α
96 : 4 d.r.
96:4 e.r. (maj)
Me
Both (E) and (Z)
afford same product
t-Bu
OH
N
H
N
i-Pr
O
2.0 mol %
5.0 mol % Zn(OMe)2
1.19s
Scheme 1.32 Optimized Conditions Comparing E-  and Z- Crotylboronates.
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t-Bu
Me
H
L3B OMe
Me
(pin)B Me
relay 1
B(pin)
O
ZnMe Me
(pin)B OMe
Me
Zn
‡
ZnMe
Zn(OMe)2
OMe
Zn = ZnOMe
Zn(OMe)2
relay 3
1.24 XI
XII
XIII
(E)-XVI
N
t-Bu
O
B
OMe
XIV
H
O N
i-Pr
L3B OMe
N
t-Bu
O
B
H
O N
i-Pr
L3B OMe
Me
cis or trans
XV
relay 2
N
O
B
O
N N
Ph
PO
H
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shown in Scheme 1.30, XII should be greatly preferred over XIII to react with 
oxazaborolidine XIV.  Reaction of XII through transition state XV is the second relay (γ-
addition) and produces (E)-XVI as well as regenerating Zn(OMe)2.  Aldimine binds to 
the allylboron and reacts to afford 1.25-γ through the third relay.  To explain the 
stereoconvergence with E- and Z-crotylboronates, we propose the reaction is in 
equilibrium until the final step (Scheme 1.33).  There are still many experiments to run to 
elucidate this mechanism. 
1.7 Additions to Isatins 
 In order to enhance the utility of this new catalytic method, we wished to extend 
the electrophile scope to include carbonyls as well as imines.  When deciding what type 
of carbonyl, we chose to focus on isatins for three main reasons: 1) The products of allyl-
addition to isatins are highly-useful. 2) Catalytic enantioselective methods to obtain these 
products are less than ideal. 3) Isatins, much like N-phosphinoylimines, posses the 
potential to have a second point of binding with the catalyst. 
 Much like homoallylamines discussed earlier, 3-allyl-3-hydroxy oxindoles 
(AHOs) are flexible chiral intermediates useful in the synthesis of molecules of biological 
significance. Arising biosynthetically from the oxidation of indoles, the 3-hydroxy 
oxindole pattern is found in a myriad of natural products capable of inducing a wide 
variety of effects in various organisms (Scheme 1.34).102 Examples include the urease  
                                                
(102) For reviews encompassing the synthesis and bioactivity of 3-hydroxy oxindoles, see: (a) Ruiz-
Sanchis, P.; Savina, S. A. S.; Albericio, F.; Álvarez, M. Chem. Eur. J. 2011, 17, 1388–1408.  (b) Ishikura, 
M.; Yamada, K. Nat. Prod. Rep. 2009, 26, 803–852.  (c) Peddibhotla, S. Curr. Bioact. Compd. 2009, 5, 20–
38. (d) Kumar, A.; Chimni, S. S. RSC Advances, 2012, 2, 9748–9762. 
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inhibitor103 3'-hydroxyglucoisatisin, rice growth regulator 5-hydroxy-dioxindole-3-acetic 
acid104, anti-leukemia maremycin B,105 neuron cell protector neuroprotectin B,106 and 
TMC-95 A-D,107 which are reversible inhibitors of the 20S proteasome, and have many 
applications in biology research.108 Utilizing the myriad transformations of the olefin 
present in AHOs, many alkaloids can be synthesized.  Such examples where AHOs can  
 
                                                
(103) Ahmad, I.; Fatima, I.; Afza, N.; Malik.; Lodhi, M.; Arid.; Iqbal, M. J. Enzyme Inhib. Med. Chem. 
2008, 33, 918–921. 
(104) Suzuki, Y.; Kinashi, H.; Takeuchi, S.; Kawarada, A. Phytochemistry 1977, 16, 635–637. 
(105) Tang, Y.-Q.; Sattler, I.; Thiericke, R.; Grabley, S.; Feng, X.-Z. Eur. J. Org. Chem. 2001, 261–267. 
(106) Kobayashi, H.; Shin-ya, K.; Furihata, K.; Nagai, K.; Suzuki, K.-I.; Hayakawa, Y.; Seto, H. J. 
Antibiot. 2001, 54, 1019–1024. 
(107) Kohno, J.; Koguchi, Y.; Nishio, M.; Nakao, K.; Kuroda, M.; Shimizu, R.; Ohnuki, T.; Komatsubara, 
S. J. Org. Chem. 2000, 65, 990–995. 
(108) (a) Groll, M.; Götz, M.; Kaiser, M.; Weyher, E.; Moroder, L. Chem. Biol. 2006, 13, 607–614. (b) 
Coste, A.; Couty, F.; Evano, G. C. R. Chemie 2008, 11, 1544–1573. 
Scheme 1.34 3-Hydroxy Oxindole Containing Biologically Active Compounds
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be employed as key intermediates are madindoline A and B,109 whose anti-osteoporosis 
activity is strongly dependent of the correct stereochemistry of the 3-hydroxy oxindole;110 
convolutamydine A,111 B, and E,112 of which A has the highest anticancer activity;113 and 
alkaloids CPC-1114 and alline.115 
 Catalytic, enantioselective methods that access 3-allyl-3-hydroxy oxindoles fall 
into two main categories; enantioselective oxidations and enantioselective allyl-additions.  
 
Strategically, the allyl-addition methods have an advantage versus oxidations since the 
allyl-addition can be performed directly on an isatin to afford the desired AHO 
(1.36→1.39, Scheme 1.36), whereas the oxidation must be performed on alpha-allyl-
oxindole 1.38, which requires two steps from isatin 1.36 to synthesize (Scheme 1.36).  As 
                                                
(109) Itoh, T.; Ishikawa, H.; Hayashi, Y. Org. Lett. 2009, 11, 3854–3857. 
(110) Yamamoto, D. et al. Bioorg. Med. Chem. Lett. 2006, 16, 2807–2811. 
(111) Cravotto, G. et al. Tetrahedron Asymmetry 2006, 17, 3070–3074. 
(112) Nakamura, T.; Shirokawa, S.-i.; Hosokawa, S.; Nakazaki, A.; Kobayashi, S. Org. Lett. 2006, 8, 677–
679. 
(113) Zhang, H.-P. et al. Tetrahedron 1995, 51, 5523–5528. 
(114) Kitajima, M.; Mori, I.; Arai, K.; Kogure, N.; Takayama, H. Tetrahedron Letters 2006, 47, 3199–
3202. 
(115) Kawasaki, T.; Takamiya, W.; Okamoto, N.; Nagaoka, M.; Hirayama, T. Tetrahedron Letters 2006, 
47, 5379–5382. 
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the representative example in Scheme 1.36 illustrates,116 low catalytic efficiencies are a 
general problem with this method.117    
 Out of all extant methods for catalytic enantioselective allyl-additions to isatins, 
the only one that can afford a wide range of products in greater than 95:5 enantiomeric  
ratio requires 5 mol % of precious iridium (2.5 mol % of [Ir(cod)Cl]2 which is $56/mmol  
 
from Strem) and an expensive phosphine ligand ($308/mmol from Strem) as well as 40 
hours at 100 ºC in a pressure vessel (Scheme 1.37).118  In addition to having less-than-
ideal enantioselectivities, the other protocols require use of toxic allylstannanes114,119 or 
mercury salts 120  and/or precious metals and difficult-to-access ligands. 121 We were 
hopeful our catalytic protocol would be as amenable to isatins as it is to N-
phosphinoylaldimines. 
 Based on the our proposed stereochemical model for the major enantiomer of the 
aldimine allyl-addition (R-TS1.1, Scheme 1.24), the amide carbonyl of an isatin may be  
                                                
(116) Yang, Y.; Moinodeen, F.; Chin, W.; Ma, T.; Jiang, Z.; Tan, C.-H. Org. Lett. 2012, 14, 4762–4765. 
(117) Low enantioselectivities are also common.  For representative examples, see: (a) Sano, D.; Nagata, 
K.; Itoh, T. Org. Lett. 2008, 10, 1593–1595. (b) Bui, T.; Candeias, N. R.; Barbas, C. F. J. Am. Chem. Soc. 
2010, 132, 5574–5575. 
(118) Itoh, J.; Han, S. B.; Krische, M. J. Angew. Chem. Int. Ed. 2009, 48, 6313–6316. 
(119) (a)Hanhan, N. V.; Sahin, A. H.; Chang, T. W.; Fettinger, J. C.; Franz, A. K. Angew. Chem. Int. Ed. 
2010, 49, 744–747. (b) Wang, T.; Hao, X.-Q.; Huang, J.-J. Wang, K.; Gong, J.-F.; Song, M.-P. 
Organometallics 2014, 33, 194–205. 
(120) Cao, Z.-Y.; Zhang, Y.; Ji, C.-B.; Zhou, J. Org. Lett. 2011, 13, 6398–6401. 
(121) (a) Qiao, X.-C.; Zhu, S.-F.; Zhou, Q.-L. Tetrahedron: Asymmetry 2009, 20, 1254–1261. (b) Hanhan, 
N. V.; Tang, Y. C.; Tran, N. T.; Franz, A. K. Org. Lett. 2012, 14, 2218–2221.  
OH
2.5 mol % [{Ir(cod)Cl}2], 
5 mol % CTH-(R)-P-Phos
4.0 equiv. i-PrOH,
20 mol % Cs2CO3,
10 mol % 4-CN-3-NO2-BzOH
thf, 100 ºC, 40–72 h
N
Bn
O
O
+ 2.0 equiv. N
Bn
O
HO
R1 R1
R2
R2 N
N
OMe
OMe
PPh2
PPh2
MeO
MeO
CTH-(R)-P-Phos
R2=H 65-89%, 95.5:4.5-98:2 e.r.
R2=Me 64-87%, 13:1-29:1 d.r.,90:10-96:4 e.r.
Scheme 1.37 Iridium-Catalyzed Enantioselective Allyl-Addition to Isatins Reported by Krische
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able to serve as the second point of binding to the catalyst that we propose to be critical to 
obtaining high enantioselectivity (Scheme 1.38).122 Under the same conditions used for 
the catalytic enantioselective allylation of imines, isatins with various N-substitutions 
were examined (Table 1.14).  While unprotected isatin 1.36a and N-Me isatin 1.36b are  
 
not efficient substrates under these conditions, reactions with N-Bn isatin 1.36c 
expediently give a high yield of AHO with 98:2 enantioselectivity  (Table 1.14).  The 
lack of conversion in entry 1 probably results from the acidity of the free proton in isatin 
1.36a. Consistent with this, addition of 10 mol % of 1.36a to the reaction with 1.36c in 
entry 3 completely shuts down the reaction (<2% conv.)  It is worth noting that the low 
reactivity in entry 2 is likely the result of 1.36b being insoluble under the reaction 
                                                
(122) This second point of binding forms a seven-membered-ring as opposed to the six-membered-ring 
proposed for the phosphinoylaldimines. 
N
R
O
O
allylB(pin) NR
HO
O
catalyst
N
O
B
O
Me2N O
O
H
t-Bu
N
R
Scheme 1.38 Proposed Two-Point Binding of Isatins with Catalyst Should Lead to High Enantioselectivity
efficiency?
 enantioselectivity?
entry
2
1
e.r.c
-
n.d.
conv. (%)a
5
30
5 mol % NaO-tBu
1.5 equiv. 1.16, 
2.5 equiv. MeOH,
 toluene, 22 ºC, 4 h
6 mol % 1.19r,
R
n.d. = not determined  a Conversion to desired as determined by 400 
MHz 1H NMR analysis of unpurified reaction mixture versus an internal 
standard of 9-methylanthracene. b Yield of isolated product. cDetermined 
by HPLC analysis.
yield (%)b
-
n.d.
N
R
O
O
N
R
O
HO
3
H;
>98 88 98:2
Me;
Bn;
1.36 1.39
1.36a
1.36b
1.36c
Table 1.14 Initial Examination of Allyl-Additions to Isatins
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conditions  (Table 1.14).  It may therefore be possible to modify the solvent in order to 
obtain higher conversion to product. 
 With the excellent lead result from entry 3 of Table 1.14 in hand, we investigated 
how far the catalyst loading and reaction time can be reduced for the enantioselective 
allyl addition to 1.36c.  Only 0.5 mol % of aminophenol and NaOt-Bu is needed for an 
efficient and selective reaction to proceed in two hours (Equation 14). This high  
 
selectivity is especially impressive considering when 1.19r and NaOt-Bu are omitted 
from the system, the background reaction is extremely efficient (66% conversion in 1 h) 
under otherwise identical conditions as in Equation 14. Based on the rate of this 
background reaction versus the rate of the catalytic reaction, again it seems the 
background reaction is somehow suppressed under catalytic conditions (See. 1.30d in 
Scheme 1.28 and related discussion).  
 Following this optimization, we examined how substituted isatins behaved as 
substrates (Table 1.15).  Electron rich substrates afford products in high yield and 
enantioselectivity (entries 2 and 3), but when the isatins are electron poor, the 
enantiomeric ratio drops to 91.5:8.5 (entries 4 and 10).  Attempts to raise these 
selectivities through lowering the reaction temperature, catalyst modification, or 
increasing catalyst loadings were unsuccessful. As a further demonstration of reaction 
generality, changing the allyl source to methallylboronic acid pinacol ester 1.22a results 
in a selective and efficient reaction when 1.16 is used as the electrophile (entry 5).  In  
0.5 mol % NaO-tBu
1.5 equiv. 1.16, 
2.5 equiv. MeOH,
 toluene, 22 ºC, 2 h
0.5 mol % 1.19r,
N
Bn
O
O
N
Bn
O
HO
1.36c 1.39
(14)
>98% conv., 93% yield, 97.5:2.5 e.r.
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support of the hypothesis that two points of binding between the substrate and the catalyst 
is needed to obtain products in high levels of enantioselectivity, allyl-addition to 
acetophenone affords the homoallyl alcohol in only 70:30 e.r (Equation 15).    
 
 We then focused on the synthesis of enantiomerically enriched AHOs that can be 
used for the synthesis of medicinally relevant compounds madindoline A and 
convulutamydine A (Scheme 1.35).  Accessing these compounds entails not only 
enantioselective allyl addition to the requisite N-protected isatins, but also practical and 
efficient removal of the protecting groups to produce the secondary amide-containing 
oxindole desired product.  Isatins with a PMB-protected nitrogen undergo aminophenol 
promoted allylation efficiently (≤1 h, ≤2 mol% catalyst loading) and with high levels of 
enantioselectivity (entries 6 and 7, Table 1.35), but this protecting group could not be 
entry X (mol %) e.r.byield (%)a
X mol % NaO-tBu
 2.5 equiv. MeOH,
 toluene, 22 ºC
 X mol % 1.19r,
Table 1.15  Scope of Catalytic Enantioselective Allyl Additions to Isatins
N
R1
O
O
N
R1
O
HO
3 0.5
2 0.5 98.5:1.5
97:3
4 2.0 91.5:8.5
92;
93;
91;
1 0.5 97.5:2.593;
All data are the average of at least two experiments. All conversions are >98% as 
determined by 400 MHz 1H NMR analysis of unpurified reaction mixtures a Yield of isolated 
product. bDetermined by HPLC analysis.
R2
G
4
5
6
7
R2
5 0.5 95:597;
H H
R2
B(pin)
1.5 equiv.
+
time (h)
2.0
2.0
4.0
H
H
H
5-Me
5-OMe
4,7-Cl2
H 1.0
4.0
G
4
5
6
7
G
Me
R1
Bn;
Bn;
Bn;
Bn;
Bn;
10 95; 91.5:8.5
7
6 99:1
8
98;
86;
96;
9 95; 98:2
93:7
98.5:1.5
H 0.5 1.0
4,6-Br2 2.0 0.25
H HTBS; 0.5 1.5
HTBS; 0.5 3.0
H 2.0 2.0
PMB;
PMB;
SEM;
H
H
5-OMe
4,6-Br2
1.36c
1.36d
1.36e
1.36f
1.36c
1.36g
1.36h
1.36i
1.36j
1.36k
1.39c
1.39d
1.39e
1.39f
1.40
1.39g
1.39h
1.39i
1.39j
1.39k
1.36 1.39–1.40
O
Me
2.5 mol % NaO-tBu
2.5 equiv. MeOH,
 toluene, 22 ºC, 4.0 h
2.5 mol % 1.19r,
Me
HO
77% yield, 70:30 e.r.;
lack of second point
of binding
(15)
1.41
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removed under various conditions.123 Examining TBS as a protecting group, which is 
rarely used for isatins,124 also leads to efficient and enantioselective transformations 
(entries 8 and 9, Table 1.15), but in this case, the silyl group of the AHO can be easily 
removed with p-TsOH in MeOH affording the desired compound in 94% yield over two 
steps (Equation 16).  Unfortunately, efforts toward enantioselective allyl addition to the 
 
TBS-protected 4,6-dibromoisatin, requisite for the synthesis of convulutamydine A, were 
unsuccessful. Likely due to the strong electron withdrawing nature of 4,6-dibromoisatin, 
the silyl group N-silyl 4,6-dibromoisatin is extremely labile and is cleaved under the 
reaction conditions. We investigated obtaining enantioselective allyl addition in the 
presence of an unprotected isatin N-H, but no changes that we pursued, such as using 
stoichiometric amounts of base, revealed any promising leads. 
 Following the difficulty with the silyl-protecting group on the isatin needed for 
convulutamydine A, we next examined SEM as the protecting group of 4,6-
dibromoisatin.  This substrate behaves similarly to the PMB protected isatin (cf. entries 
10 and 7) under the reaction conditions.   Pleasingly, the SEM group can be removed 
after addition of the allyl group (Equation 17).  By stirring the SEM protected 4,6- 
dibromo AHO with MgBr2•Et2O in dichloromethane at 22 ºC followed by stirring in 
                                                
(123) Dr. Erika Vieira studied the PMB protecting group removal.  She also was the main contributor 
ininvestigating the TBS protecting group and made key contributions to the SEM protecting group studies. 
(124) As far as we know, the only example is in the supporting information of a report by the Wood group, 
see: Reisman, S. E.; Ready, J. M.; Hasuoka, A.; Smith, C. J.; Wood, J. L. J. Am. Chem. Soc. 2006, 128, 
1448–1449. 
0.5 mol % NaO-tBu
1.5 equiv. 1.16, 
2.5 equiv. MeOH,
 toluene, 22 ºC, 1.5 h;
1.5 equiv. p-TsOH, 22 ºC, 5 h
0.5 mol % 1.19r,
N
TBS
O
O
N
H
O
HO
1.36i 1.39a
(16)
94% yield, 98.5:1.5 e.r
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aqueous saturated sodium bicarbonate (to collapse the resultant hemiaminal), the 
deprotected AHO was obtained in >98% yield.   
 
 These investigations of allyl-additions to aldimines led us probe whether it was 
possible to take advantage of the net α-addition of our catalytic protocol and perform 
additions of allenylboronic acid pinacol ester to obtain homoallenylalcohols.  These 
studies were carried out by Dr. Erika Vieira, but should be at least mentioned here 
(Equation 18).  With 0.25 mol % of aminophenol, a gram-scale reaction proceeds in only 
two minutes (corresponding to a TOF of >10,000/h); following deprotection of the amide 
nitrogen and trituration of the resultant product (no chromatography is needed), the 
homoallenyl alcohol is obtained in 90% yield, >98:2 α:γ selectivity, and >99:1 e.r. The 
 
high regioselectivity of the allenyl-addition product supports our proposed mechanism of 
net α-addition.  Fully consistent with our hypothesis of two γ-additions leading to a net 
α- addition, vinylB(pin), which is electronically similar to allenylB(pin) and lacks a γ-
substituent, is not added to isatins under the reaction conditions (Equation 19).125 If the 
                                                
(125) Under the conditions in Equation 18, allenylB(pin) is added to 1.36c efficiently (>98% conversion) 
and with 98:2 e.r. and complete regioselectivity (>98:2 α:γ) 
2.0 mol % NaO-tBu
1.5 equiv. 1.16, 
2.5 equiv. MeOH,
 toluene, 22 ºC, 2.0 h
2.0 mol % 1.19r,
N
SEM
O
O
N
H
O
HO
1.36k 1.39l
(17)
>98% yield, 91.5:8.5 e.r
Br
Br
Br
Br
1.39k
3) NaHCO3 (sat. aq.),
MeOH, 22 ºC, 5 h
2) 10 equiv. MgBr2•Et2O,
CH2Cl2, 38 ºC, 40 h
1)
N
TBS
O
O
0.25 mol % aminophenol 1.19r
0.4 mol % NaOt-Bu
•
B(pin)
1.05 equiv.
2.0 equiv. MeOH,
toluene, 22 ºC, 2 min! ;
aq. HCl, MeOH, 22 ºC
N
H
HO
O
•
90% yield, >99:1 er
>98:2 allene:propargyl
No Chromatography
(18)
1.36i
1.42
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reaction proceeds through a single α-addition, vinylB(pin) should add to 1.36c with 
efficiencies similar  to allenylB(pin).126 
1.8 Conclusion 
 We have developed a new class of catalysts for enantioselective allyl- and allenyl-
additions to unsaturated electrophiles. A wide range of substrates are tolerated, such as 
alkyl-, aryl-, heteroaryl-,alkenyl, and alkynyl-substituted aldimines, as well as a variety of 
isatins.  Additionally, the method is amenable to scale-up, does not require rigorously 
anhydrous reaction conditions, and proceeds efficiently at ambient conditions with low 
catalyst loadings of a simple-to-access aminophenol. These traits, of which no other 
catalytic method for the enantioselective allyl-addition to imines or isatins posseses, 
make this new methodology significantly impactful.  
 Perhaps even more notably, these catalysts operate in a mechanistically distinct 
fashion from any other reported catalyst for imine or ketone allylation, with α-addition 
products being obtained with a metal-free127 catalyst.  Even with the understanding of the 
mechanism we have obtained, there are still many questions to be answered, chief among 
them how does the catalyst initiate and how does the reaction promoted by NaOt-Bu 
occur (that is, without aminophenol)? One possibility is that a Lewis acidic boron species 
(maybe a trimethylborate-like species) is generated in situ which is then allylated by the 
                                                
(126) Similarly, BnB(pin) does not add to aldimines under the conditions in Table 1.5. 
(127) While there is sodium present in the reaction, it does not play a key role in catalysis as evidenced by 
DBU capably serving as a base for the aminophenol promoted enantioselective allyl-addition to imines.  
See Equation 1. 
2.5 mol % NaO-tBu
2.5 equiv. MeOH,
 toluene, 22 ºC, 4.0 h
2.5 mol % 1.19r,
N
Bn
O
HO
1.43
(19)
N
Bn
O
O
1.36c
(pin)B+
1.5 equiv.
<2% conversion!
H
HH
H
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stoichiometric allylB(pin) to make dimethoxyallylboron.  This reagent may be active 
enough to add to the aldimine. To test this hypothesis, one could synthesize 
dimethoxyallylboron and determine if it adds to the imine uncatalyzed. If it still requires 
NaOt-Bu, then synthesis of α-deuterated dimethoxyallylboronate would be interesting to 
see if it adds with γ-selectivity (as it would not require allyl-transfer before addition 
based on our hypothesis).  Answering these questions will likely lead to insight into how 
the catalyst loading can be lowered even further by modifying the reaction conditions to 
more greatly favor complete initiation of the aminophenol added to the reaction.  
 With regard to the crotyl-addition catalyzed by zinc-alkoxide, one interesting 
question is whether the reaction truely goes through three γ-additions (as shown in 
Scheme 1.33) or whether an aminophenol-bound zinc-alkoxide transmetallates with the 
allylboron, isomerizes, and then adds to the imine. This latter scenario may be disfavored 
by the steric interactions proposed in Scheme 1.30, but we do not have definitive 
evidence disproving this mechanistic pathway.  
1.9 General Experimental Section 
 ■  General. Infrared (IR) spectra were recorded on a Bruker alpha 
spectrophotometer, λmax in cm-1.  Bands are characterized as broad (br), strong (s), 
medium (m), and weak (w).  1H NMR spectra were recorded on a Varian Unity INOVA 
400 (400 MHz) spectrometer.  Chemical shifts are reported in ppm from 
tetramethylsilane with the solvent resonance as the internal standard (CDCl3: δ 7.26 ppm, 
CD3OD: δ 3.34 ppm).  Data are reported as follows: chemical shift, integration, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, sept = septet, br = broad, m = 
multiplet), and coupling constants (Hz). 13C NMR spectra were recorded on a Varian 
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Unity INOVA 400 (100 MHz) or a Varian Unity INOVA 500 (125 MHz) spectrometer 
with complete proton decoupling.  Chemical shifts are reported in ppm from 
tetramethylsilane with the solvent resonance as the internal standard (CDCl3: δ 77.16 
ppm). Data are reported as follows: chemical shift, multiplicity (singlet unless otherwise 
noted), and coupling constants (Hz). 2H NMR spectra were recorded on a Varian Unity 
INOVA 500 (76 MHz) tuned to the lock channel. High-resolution mass spectrometry was 
performed on a JEOL AccuTOF-DART (positive mode) at the Mass Spectrometry 
Facility, Boston College.  Enantiomer ratios (er) values were determined by HPLC 
analysis using either a Shimadzu LC-2010AHT or SCL-10AVP chromatograph (Chiral 
Technologies Chiralcel OD (4.6 x 250 mm), Chiral Technologies Chiralcel OD-H (4.6 x 
250 mm), Chiral Technologies Chiralcel OJ-H (4.6 x 250 mm), Chiral Technologies 
Chiralpak AD-H (4.6 x 250 mm), Chiral Technologies Chiralcel AZ-H (4.6 x 250 mm) 
columns), or GLPC (gas-liquid partition chromatography) with an Agilent chromatograph 
(Alltech Associated Chiraldex CD-BDM column (30 m x 0.25 mm) or a Hewlett Packard 
5890 Series II chromatograph (Alltech Associated Betadex 120 column (30 m x 0.25 m).  
Specific rotations were measured on a Rudolph Research Analytical Autopol IV 
Polarimeter. Melting points were determined using a Thomas Hoover Uni-melt capillary 
melting point apparatus.  Selected single crystals suitable for X-ray crystallographic 
analysis were used for structural determination. The X-ray intensity data were measured 
at 100(2) K (Oxford Cryostream 700) on a Bruker Kappa APEX Duo diffractometer 
system equipped with a sealed Mo-target X-ray tube (λ = 0.71073 Å) and a high 
brightness IµS copper source (λ = 1.54178 Å). The crystals were mounted on 
agoniometer head with paratone oil. The detector was placed at a distance of 5.000 or 
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6.000 cm from the crystal. For each experiment, data collection strategy was determined 
by APEX software package and all frames were collected with a scan width of 0.5° in ω 
and φ with an exposure time of 10 or 20s/frame. The frames were integrated with the 
Bruker SAINT Software package using a narrow-frame integration algorithm to a 
maximum 2θ angle of 56.54° (0.75 Å resolution) for Mo data and of 134° (0.84 Å 
resolution) for Cu data. The final cell constants are based upon the refinement of the 
XYZcentroids of several thousand reflections above 20 σ(I). Analysis of the data showed 
negligible decay during data collection. Data were corrected for absorption effects using 
the empirical method (SADABS). The structures were solved and refined by full-matrix 
least squares procedures on ⎟⎟F2⎟⎟ using the Bruker SHELXTL (version 6.12) software 
package. All hydrogen atoms were included in idealized positions for structure factor 
calculations except for those forming hydrogen bonds or on a chiral center. Anisotropic 
displacement parameters were assigned to all non-hydrogen atoms, except those 
disordered. 
■  Solvents: Unless otherwise noted, solvents were purged with Ar and purified under a 
positive pressure of dry Ar by a modified Innovative Technologies purification system.  
Toluene (Fisher, ACS Grade) was passed successively through activated copper and 
alumina columns.  Dichloromethane (Fisher, ACS Grade) and diethyl ether (Aldrich, 
Chromasolv®) were passed successively through two activated alumina columns. 
Tetrahydrofuran was purified by distillation from sodium benzophenone ketyl 
immediately prior to use. Dimethyl Sulfoxide (anhydrous, 99.9+%) was purchased from 
Alfa Aesar and used as received.  CDCl3 was purchased from Cambridge Isotope 
Laboratories and stored over activated 4Å molecular sieves prior to use.  CD3OD was 
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purchased from Cambridge Isotope Laboratories and used as received.  CD3C6D5 (d8–
toluene) was purchased from Cambridge Isotope Laboratories and distilled from sodium 
metal onto activated 4Å molecular sieves prior to use.  All work-up and purification 
procedures were carried out in air with reagent grade solvents (purchased from Fisher).   
■  Reagents: 
Allenylboronic Acid Pinacol Ester (19) was obtained from Frontier Scientific and used 
as received. 
Allylboronates: Allylboronic acid pinacol ester (1a) was purchased from Aldrich or 
obtained as a gift from Frontier Scientific, Inc and distilled prior to use. 1,1-Di-
deuterioallylboronic acid pinacol ester (d2-1a) was synthesized and purified in 
accordance with a procedure in the literature.128 (2-Methylallyl)boronic acid pinacol ester 
(1b) was synthesized and purified in accordance with a procedure in the literature.129 (2-
Phenylallyl)boronic acid pinacol ester (1c) was synthesized and purified in accordance 
with a procedure in the literature. 130  Enantiomerically enriched α-substituted 
allylboronates S-9, R-9, and 12 were synthesized and purified in accordance with a 
procedure in with the literature.131 
Benzyl Chloride was purchased from Aldrich and distilled from CaCl2 prior to use. 
Boc-Val-OH was purchased from Advanced ChemTech and used as received. 
tert-Butanol was purchased from Aldrich and distilled from sodium metal before use. 
n-Butylamine was purchased from Aldrich and used as received. 
                                                
(128) Sieber, J. D.; Morken, J. P.  J. Am. Chem. Soc. 2008, 130, 4978–4983. 
(129) Zhang, P.; Roundtree, I. A.; Morken, J. P. Org. Lett. 2012, 14, 1416–1419. 
(130) Corberan, R.; Mszar, N. W.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2011, 50, 7079–7082. 
(131) Guzman-Martinez, A.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 10634–10637. 
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tert-Butyldimethylsilyl Chloride was purchased from Strem and used as received. 
3-tert-Butyl-2-hydroxybenzaldehyde was purchased from Aldrich and used as received. 
1,8-Diazabicycloundec-7-ene (DBU) was purchased from Aldrich and distilled from 
CaH2 prior to use. 
Diethylzinc was purchased from Aldrich and used as received. 
Dimethylamine (40 wt % in H2O) was purchased from Aldrich and used as received. 
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Hydrochloride (EDCHCl) was 
purchased from Advanced ChemTech and used as received. 
Hydrochloric Acid (4.0 M in 1,4-dioxane) was purchased from Aldrich and used as 
received. 
Hydrochloric Acid (12 M, 36.5-38.0 wt %) was purchased from Alfa Aesar and used as 
received. 
1-Hydroxy-benzotriazole Hydrate (HOBtH2O) was purchased from Advanced 
ChemTech and used as received. 
Isatins. Isatin and 5-methylisatin were purchased from Aldrich and used as received. 5-
methoxyisatin was purchased from Oakwood and used as received.  4,6-Dibromoisatin 
was purchased from D-L Chiral Chemicals and was dissolved in methanol and copious 
purple solid impurities were removed by filtration. 
L-tert-Leucine was purchased from Chem-Impex and Boc protected prior to use. 
Magnesium Sulfate was purchased from Fisher and flame-dried under vacuum prior to 
use. 
Magnesium Bromide Diethyl Etherate (MgBr2Et2O) was purchased from Aldrich 
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and used as received. 
Methanol was purchased from Acros (99.8% anhydrous) and distilled at 1 atm from 
sodium metal prior to use or used as received. 
Potassium Carbonate was purchased from Fisher and dried at 80 ºC under vacuum for 
12 h prior to use. 
Pyrrolidine was purchased from Aldrich and used as received. 
Sodium Borohydride was purchased from Aldrich and used as received. 
Sodium tert-Butoxide was purchased from Strem and used as received. 
Sodium Hydride (60 wt% in oil) was purchased from Strem and used as received. 
Sodium Periodate was purchased from Acros and used as received. 
Titanium Tetrachloride (TiCl4) was purchased from Aldrich and used as received. 
Triethylamine was purchased from Aldrich and distilled from CaH2 prior to use. 
2-(Trimethylsilyl)ethoxymethyl Chloride, technical grade (SEM-Cl) was purchased 
from Aldrich and used as received. 
p-Toluenesulfonic Acid Monohydrate was purchased from Aldrich and used as 
received. 
L-Valine Ethyl Ester Hydrochloride was purchased from Aldrich and used as received. 
Zinc tert-Butoxide was prepared by reaction of tert-butanol with diethylzinc.  A flame-
dried round bottom flask is purged with nitrogen, sealed with a septum and electrical 
tape, and charged with toluene (100 mL) and tert-butanol (1.8 mL, 19 mmol) by syringe.  
The solution is cooled to –78 ºC and diethylzinc (Caution Pyrophoric! 1.5 mL, 15 
mmol) is added dropwise by syringe over 10 minutes.  The reaction is allowed to warm to 
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22 ºC and to stir for 18 h.  The toluene is removed by distillation under nitrogen at 1 atm. 
and the resulting solid is dried under vacuum for 12 h. The solid is removed from the 
flask in a nitrogen-filled glovebox to afford 1.5 g (7.1 mmol, 46% yield) of a white 
powder. 
 
EDCHCl (4.22 g, 22.0 mmol), reagent grade CH2Cl2 (80 mL), HOBtH2O (3.36 g, 22.0 
mmol), and Boc-Val-OH (4.34 g, 20.0 mmol) are added successively at 22 °C under air 
to a 250 mL round bottom flask equipped with a stir bar.  The light yellow solution is 
allowed to stir for five minutes and dimethylamine (40 wt % in H2O, 5.3 mL, 50 mmol) is 
added drop-wise over one minute.  The flask with the resulting light yellow solution is 
sealed with a rubber septum and allowed to stir for 12 h at 22 °C. An aqueous solution of 
citric acid (10 wt %, 80 mL) is then added and the mixture is allowed to stir for 0.5 h 
during which time a white precipitate is formed.  The precipitate is removed by filtration 
and the resulting two layers are separated.  The organic layer is washed sequentially with 
an aqueous solution of citric acid (10 wt %, 80 mL), a saturated aqueous solution of 
NaHCO3 (80 mL), and brine (80 mL) and is dried over Na2SO4 to give (S)-tert-butyl (1-
(dimethylamino)-3-methyl-1-oxobutan-2-yl)carbamate (S2) as pale yellow oil, which is 
employed without purification in the subsequent deprotection. 
In a 100 mL round bottom flask, (S)-tert-butyl (1-(dimethylamino)-3-methyl-1-oxobutan-
6.0 equiv. 4.0 M 
HCl/dioxane,BocHN
i-Pr
O
OH
1.1 equiv. HOBt•H2O,
1.1 equiv. EDC•HCl,
2.5 equiv. 40% HNMe2 in H2O, H2N
i-Pr
O
NMe2
ClCH2Cl2, 22 ºC, 12 h
BocHN
O
NMe2
0 ºC to 22 ºC, 1.5 h
CH2Cl2, 22 ºC, 12 h
1.0 equiv. 3-tert-butyl-2-
hydroxybenzaldehyde, 
3.0 equiv. MgSO4,
3.0 equiv. Et3N,
t-Bu
OH
N
i-Pr
O
NMe29.0 equiv. NaBH4,
cat. HCl,
i-Pr
MeOH,  0 ºC, 30 min;
22 ºC, 1.5 ht-Bu
OH
N
H2
i-Pr
O
NMe2
1.19r•HCl
1.43 1.44
1.45
Cl
Boc-Val-OH
Scheme 1.39. Representative Experimental Procedure for Synthesis of Aminophenol 1.19r
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2-yl)carbamate 1.43 (4.65 g, 19.3 mmol, 1.00 equiv.) is allowed to stir with a 4.0 M 
solution of hydrochloric acid in dioxane (28.9 mL, 116 mmol, 6.00 equiv.) for 1.5 h at 22 
°C under air, after which the solution is purged with nitrogen for 30 min (removal of HCl 
gas) and the solvent is removed under reduced pressure to yield (S)-2-amino-N,N,3-
trimethylbutanamide as HCl salt 1.44, which is used without purification in the 
subsequent condensation. 
To the same flask (purged with nitrogen) is added 3-(tert-butyl)-2-hydroxybenzaldehyde 
(3.43 g, 19.3 mmol, 1.00 equiv.) and MgSO4 (6.93 g, 57.8 mmol, 3.00 equiv.), followed 
by the addition of dichloromethane (70 mL) and triethylamine (8.11 mL, 57.8 mmol, 3.00 
equiv.) through a syringe. The mixture is allowed to stir overnight at 22 °C under 
nitrogen during which time the solution becomes bright yellow. The mixture is filtered 
through a small plug of silica gel to remove both MgSO4 and triethylamine hydrochloride 
(which inhibits the following reduction) and silica plug is eluted with hexanes:ethyl 
acetate (2:1) until the solution becomes colorless. After evaporation of the volatiles, the 
remaining yellow oil is washed several times with hexanes (to remove residual 
triethylamine hydrochloride salt) and the combined filtrates are concentrated to afford 
(S,E)-2-((3-(tert-butyl)-2-hydroxybenzylidene)amino)-N,N,3-trimethyl-butanamide (1.44) 
as yellow oil, which is utilized without purification in the follow-up reduction procedure. 
To a 500 mL round bottom flask containing a solution of imine 1.44 in 50 mL MeOH 
cooled to 0 ºC, NaBH4 is added (5.83 g, 154 mmol, 8.00 equiv.) followed by a drop of 12 
M aqueous hydrochloric acid. There is vigorous gas evolution upon addition of the acid 
and the yellow color of the solution disappears immediately. After the solution is allowed 
to stir for 30 min, the excess reducing agent is quenched through slow addition of a 2.0 M 
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solution of aqueous HCl until the pH is less than one. The aqueous phase is then washed 
with dichloromethane (4 x 50 mL) and the combined organic layers are dried over 
anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The white 
solid is purified by trituration from 10 mL dichloromethane and 80 mL hexanes to afford 
(S)-N-(3-(tert-butyl)-2-hydroxybenzyl)-1-(dimethylamino)-3-methyl-1-oxobutan-2-
aminium chloride 1.19rHCl as a white solid (5.30 g, 15.5 mmol, 77.5% yield based on 
Boc-Val-OH). Crystals suitable for X-ray crystallography were grown by vapor diffusion 
from a dichloromethane/toluene solvent system.   
(S)-N-(3-(tert-Butyl)-2-hydroxybenzyl)-1-(dimethylamino)-3-methyl-1-oxobutan-2-
aminium (1.19rHCl; see above): M.p. = 182−183 °C. IR (neat): 2952 (br, s), 2821 (m), 
2733 (m), 1664 (s), 1649 (s), 1548 (m), 1438 (s), 1396 (s), 1373 (m), 1360 (m), 1323 (m), 
1285 (m), 1209 (s), 1176 (s), 1139 (m), 1097 (m), 874 (m), 792 (m), 756 (s), 484 (m) cm-
1; 1H NMR (400 MHz, CDCl3): δ 10.62 (1H, br s), 8.24 (1H, br s), 7.61 (1H, br s), 7.30 
(1H, dd, J = 7.6, 1.6 Hz), 7.04 (1H, dd, J = 7.6, 1.6 Hz), 6.85 (1H, t, J = 7.6 Hz), 
4.44−4.38 (1H, m), 4.29−4.21 (2H, m), 2.95 (3H, s), 2.86 (3H, s), 2.50−2.44 (1H, m), 
1.40 (9H, s), 1.13 (6H, app d, J = 7.2 Hz); 13C NMR (100 MHz, CDCl3): δ 166.9, 155.3, 
141.3, 130.1, 129.1, 121.0, 119.9, 61.0, 47.9, 37.6, 36.2, 35.2, 30.3, 30.0, 18.7, 18.5. 
 
(S)-2-((3-(tert-Butyl)-2-hydroxybenzyl)amino)-N,N,3-trimethylbutanamide (1.19r, 
Scheme 1.27): The salt 1.19rHCl (5.30 g, 15.5 mmol) is dissolved in 100 mL 
dichloromethane and deprotonated with 200 mL of a saturated aqueous solution of 
t-Bu
OH
N
H2
i-Pr
O
NMe2
1.19r•HCl
Cl
NaHCO3 (aq.)
CH2Cl2
t-Bu
OH
N
H
i-Pr
O
NMe2
1.19r
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NaHCO3. The layers are separated and the aqueous phase is washed twice with 50 mL 
dichloromethane. The combined organic phases are dried over anhydrous sodium sulfate, 
filtered and concentrated under reduced pressure to afford 1.19r as white solid (4.45 g, 
14.5 mmol, 73% yield based on Boc-Val-NMe2 S1). Crystals suitable for X-ray 
crystallography were grown by slow evaporation of ethyl acetate. See Part D of the 
Supplementary Information for the X-ray crystal structure. M.p. = 97–99 ºC.  IR (neat): 
3310 (w), 2943 (w, br), 2872 (w, br), 1638 (s), 1589 (w), 1485 (m), 1459 (m), 1241 (m), 
1183 (m), 929 (m), 870 (w), 855 (w), 841(w), 753 (s), 648 (w) cm-1; 1H NMR (400 MHz, 
CDCl3): δ 11.03 (1H, br s), 7.19 (1H, dd, J = 7.0, 1.2 Hz), 6.80–6.75 (1H, m), 6.70 (1H, t, 
J = 7.6 Hz), 4.10 and 3.46 (2H, ABq, JAB = 13.6 Hz), 3.28 (1H, br s), 3.04 (3H, s), 2.89 
(3H, s), 2.65 (1H, br s), 1.90–1.84 (1H, m), 1.42 (9H, s), 0.97 (3H, d, J = 6.8 Hz), 0.94 
(3H, d, J = 6.9 Hz); 13C NMR (100 MHz, CDCl3): δ 173.6, 157.1, 137.1, 126.9, 126.2, 
122.9, 118.5, 61.2, 51.5, 37.1, 35.8, 34.8, 31.3, 29.6, 20.1, 18.0; HRMS Calcd for 
C18H31N2O2 [M + H]+: 307.23855; Found: 307.23736. [α]20D = –37 (c = 0.68, CHCl3). 
(S)-N-Butyl-2-((2-hydroxybenzyl)amino)-3-methylbutanamide (1.19i, Scheme 1.27): 
The title compound is prepared according to the representative synthesis of aminophenol 
1.19r except for the following changes: 1) For the amide formation (step 1), 2.5 equiv. of 
neat n-butylamine is used instead of dimethylamine.  2) For the imine formation (step 3) 
salicylaldehyde is utilized. 3) The product from the reduction is quenched with a 
saturated solution of aqueous NaHCO3 (formation of the HCl salt is omitted) and the 
aminophenol is then purified by silica gel chromatography (100% dichloromethane to 
98:2 dichloromethane:methanol) to afford 1.19i as an off-white solid. M.p. = 50–52 ºC. 
IR (neat): 3318 (w), 3294 (w, br), 3255 (w), 2958 (w), 2930 (w, br), 2872 (w), 1628 (s), 
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1560 (m), 1469 (m), 1387 (w), 1253 (s), 1101 (w), 970 (w), 750 (s), 682 (w, br) cm-1; 1H 
NMR (400 MHz, CDCl3): δ 10.58 (1H, br s), 7.18 (1H, dt, J = 7.9, 1.4 Hz), 6.93 (1H, d, J 
= 7.6 Hz), 6.85 (1H, d, J = 8.1 Hz), 6.77 (1H, t, J = 7.1 Hz), 5.46 (1H, br s), 4.10 and 
3.64 (2H, ABq, JAB = 13.9 Hz), 3.34 (2H, app. dd, J = 13.0, 7.1 Hz), 2.66 (1H, d, J = 7.0 
Hz), 2.41 (1H, br s), 1.94–1.85 (1H, m), 1.56–1.49 (2H, m), 1.42–1.33 (2H, m), 1.01 (3H, 
d, J = 6.8 Hz), 0.97–0.93 (6H, m); 13C NMR (100 MHz, CDCl3): δ 172.6, 158.1, 129.1, 
128.8, 122.4, 119.3, 116.5, 67.5, 51.0, 39.4, 31.9, 31.7, 20.2, 19.8, 19.2, 13.9; HRMS 
Calcd for C16H27N2O2 [M + H]+: 279.20725; Found: 279.20754. [α]20D = –33 (c = 0.55, 
CHCl3). 
(S,E)-N-Butyl-2-((2-hydroxybenzylidene)amino)-3-methylbutanamide (1.19w, 
Scheme 1.27): 
This material is synthesized in a manner analogous to aminophenol 2a except the final 
reduction step is not performed. The analytical data are fully consistent with those 
reported previously.132 
(S)-N-(1-(Butylamino)-3-methyl-1-oxobutan-2-yl)-2-hydroxybenzamide (1.19x, 
Scheme 1.27): 
The title compound is prepared according to the representative synthesis of aminophenol 
1.19i except after the second step; H2N-Val-NHn-Bu is treated with salicylic acid under 
the standard amide formation conditions outlined in the first step.  The resulting off-white 
solid is purified by silica gel chromatography (5:1 hexanes:ethyl acetate) to afford 2c as a 
white solid.  M.p. = 123–125 ºC. IR (neat): 3279 (w), 3090 (w, br), 2930 (m), 1620 (s), 
1605 (s), 1547 (s), 1530 (s), 1454 (s), 1371 (m, br), 1229 (m), 756 (s), 643 (m) cm-1; 1H 
                                                
(132) Wen, J.; Zhao, J.; Wang, X.; Dong, J.; You, T.  J. Mol. Cat. A: Chem, 2006, 245, 242–247. 
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NMR (400 MHz, CDCl3): δ 12.07 (1H, s), 7.51 (1H, d, J = 8.0 Hz), 7.40–7.36 (1H, m), 
7.29 (1H, br s), 6.97 (1H, dd, J = 8.4, 0.9 Hz), 6.85–6.81 (1H, m), 6.00 (1H, br s), 4.36 
(1H, t, J = 7.7 Hz), 3.39–3.30 (1H, m), 3.27–3.19 (1H, m), 2.25–2.17 (1H, m), 1.54–1.47 
(2H, m), 1.39–1.30 (2H, m), 1.03 (3H, d, J = 3.3 Hz), 1.01 (3H, d, J = 3.2 Hz), 0.91 (3H, 
t, J = 7.3 Hz); 13C NMR (100 MHz, CDCl3): δ 170.8, 169.8, 161.4, 134.5, 126.3, 119.0, 
118.5, 114.4, 58.9, 39.6, 31.7, 31.6, 20.2, 19.3, 18.7, 13.8; HRMS Calcd for C16H25N2O3 
[M + H]+: 293.18652; Found: 293.18532. [α]20D = –34 (c = 0.63, CHCl3). 
(S)-N-Butyl-2-((3-(tert-butyl)-2-hydroxybenzyl)amino)-3-methylbutanamide (1.19h, 
Scheme 1.27): The title compound is prepared according to the representative synthesis 
of aminophenol 1.19r except for the following changes: 1) For the first amide formation, 
2.5 equiv. of neat n-butylamine is used instead of dimethylamine. 2) The reduction is 
quenched with a saturated solution of aqueous NaHCO3 (formation of the HCl salt is 
omitted) and the desired product is purified by silica gel chromatography (100% 
dichloromethane to 98:2 dichloromethane:methanol) to afford 1.19h as a white solid. 
M.p. = 97–99 ºC. IR (neat): 3268 (w, br), 3084 (w, br), 2957 (m), 2871 (w), 1644 (s), 
1561 (m), 1435 (s), 1259 (s), 835 (m), 784 (m), 750 (s) cm-1; 1H NMR (400 MHz, 
CDCl3): δ 10.83 (1H, br s), 7.21 (1H, dd, J = 7.8, 1.6 Hz), 6.80 (1H, dd, J = 7.3, 1.6 Hz), 
6.71 (1H, t, J = 7.6 Hz), 5.52 (1H, br s), 4.13 and 3.59 (2H, ABq, JAB = 13.8 Hz), 3.37–
3.29 (2H, m), 2.59 (1H, d, J = 7.3 Hz), 1.90–1.81 (1H, m), 1.58–1.46 (2H, m), 1.43-1.33 
(11H, m), 1.00 (3H, d, J = 6.8 Hz), 0.95 (3H, t, J = 7.3 Hz), 0.91 (3H, d, J = 6.8 Hz); 13C 
NMR (100 MHz, CDCl3): δ 172.9, 157.1, 137.1, 127.0, 126.3, 122.6, 118.5, 67.0, 51.2, 
39.3, 34.8, 31.9, 31.7, 29.6, 20.2, 20.0, 19.1, 13.8; HRMS Calcd for C20H35N2O2 [M + 
H]+: 335.26985; Found: 335.27112. [α]20D = –68 (c = 0.63, CHCl3). 
 
Page 88
   
(S)-Ethyl 2-((3-(tert-butyl)-2-hydroxybenzyl)amino)-3-methylbutanoate (1.19p, 
Scheme 1.27): The title compound is prepared according to the representative synthesis 
of aminophenol 1.19r except for the following changes: 1) Initial amide formation 
carried out with L-Valine methyl ester hydrochloride instead of Boc-Val-OH. 2) The 
reduction is quenched with a saturated solution of aqueous NaHCO3  (formation of the 
HCl salt is omitted) and the desired product is purified by silica gel chromatography 
(100% hexanes to 30:1 hexanes:diethyl ether) to afford 1.19p as a yellow oil. IR (neat): 
2960 (m, br), 1728 (s), 1459 (s), 1237 (m), 1186 (s), 1140 (s), 1023 (m), 747 (s) cm-1; 1H 
NMR (400 MHz, CDCl3): δ 10.57 (1H, br s), 7.21 (1H, dd, J = 7.8, 1.7 Hz), 6.84–6.82  
(1H, m), 6.72 (1H, t, J = 7.6 Hz), 4.28–4.21 (2H, m), 4.08 and 3.66 (2H, ABq, JAB = 13.3 
Hz), 3.08 (1H, d, J = 4.9 Hz), 2.27 (1H, br s), 2.04–1.96 (1H, m), 1.41 (9H, s), 1.31 (3H, 
t, J = 7.1 Hz), 0.99 (6H, app dd, J = 10.5, 6.9 Hz); 13C NMR (100 MHz, CDCl3): δ 174.0, 
156.9, 137.1, 127.1, 126.4, 122.8, 118.6, 65.6, 61.0, 51.9, 34.8, 31.5, 29.7, 19.7, 18.3, 
14.5; HRMS Calcd for C18H30NO3 [M + H]+: 308.22257; Found: 308.22291. [α]20D = –42 
(c = 0.73, CHCl3). 
(S)-2-((3-(tert-Butyl)-2-hydroxybenzyl)amino)-3-methyl-1-(pyrrolidin-1-yl)butan-1-
one (1.19s, Scheme 1.20): The title compound is prepared according to the representative 
synthesis of aminophenol 1.19r except for the following changes:  1) For the first step, 
2.5 equiv. of neat pyrrolidine is used instead of dimethylamine.  2) For the reduction of 
the imine in the last step of the synthesis, 20.0 equiv. NaBH4 is used.  3) The reduction is 
quenched with a saturated solution of aqueous NaHCO3 (formation of the HCl salt is 
omitted) and the desired product is purified by silica gel chromatography (hexanes to 5:1 
hexanes:ethyl acetate to 3:1 hexanes:ethyl acetate) to afford 1.19s as a clear, colorless oil.  
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IR (neat): 3279 (w, br), 2956 (w, br), 2873 (w), 1632 (s), 1424 (s), 1356 (w), 1239 (m), 
1184 (w), 1141 (w), 1085 (w), 880 (m), 748 (s), 529 (w); 1H NMR (400 MHz, CDCl3): δ 
11.06 (1H, br s), 7.19 (1H, dd, J = 7.0, 1.2 Hz), 6.77 (1H, dd, J = 7.3, 1.5 Hz), 6.69 (1H, 
t, J = 7.5 Hz), 4.13 (1H, app d, J = 13.6 Hz), 3.66–3.60 (1H, m), 3.53–3.45 (2H, m), 
3.28–3.14 (2H, m), 3.05 (1H, d, J = 6.7 Hz), 2.60 (1H, br s), 1.91–1.81 (5H, m), 1.42 
(9H, s), 1.00 (3H, d, J = 6.7 Hz), 0.93 (3H, d, J = 6.8 Hz); 13C NMR (100 MHz, CDCl3): 
δ 172.1, 157.2, 137.1, 126.8, 126.2, 122.9, 118.4, 63.4, 51.3, 46.5, 45.8, 34.8, 31.4, 29.6, 
26.2, 24.3, 20.1, 18.5; HRMS Calcd for C20H33N2O2 [M + H]+: 333.25420; Found: 
333.25561. [α]20D = –58 (c = 0.58, CHCl3). 
(S)-2-((3-(tert-Butyl)-2-hydroxybenzyl)amino)-N,N,3,3-tetramethylbutanamide 
(1.19v, Table 1.7): The title compound is prepared according to the representative 
synthesis of aminophenol 1.19r except for the following changes: 1) Initial amide 
formation carried out with Boc-Tle-OH instead of Boc-Val-OH. 2) The product from the 
reduction process is quenched with a saturated solution of aqueous NaHCO3  (formation 
of the HCl salt is omitted) and the desired product is purified by silica gel 
chromatography (9:1 hexanes:ethyl acetate to 6:1 hexanes:ethyl acetate to 4:1 
hexanes:ethyl acetate) to afford 1.19v as a white solid. M.p. = 96–98 ºC. IR (neat): 2948 
(w, br), 1639 (s), 1460 (m), 1433 (m), 1352 (m), 1240 (m), 1135 (m), 878 (m), 782 (m), 
751 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 10.87 (1H, br s), 7.19 (1H, d, J = 7.3 Hz), 
6.77 (1H, d, J = 7.3 Hz), 6.70 (1H, t, J = 7.5), 4.09 and 3.40 (2H, ABq, JAB = 13.6 Hz), 
3.31 (1H, d, J = 11.3 Hz), 3.03 (3H, s), 2.89 (3H, s), 2.71 (1H, br s), 1.40 (9H, s), 0.96 
(9H, s); 13C NMR (100 MHz, CDCl3): δ 173.3, 157.0, 137.2, 126.9, 126.3, 122.9, 118.5, 
62.4, 51.3, 38.0, 35.8, 34.8, 34.7, 29.6, 27.0;  HRMS Calcd for C19H33N2O2 [M + H]+: 
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321.25420; Found: 321.25442. [α]20D = –33 (c = 0.93, CHCl3). 
(S)-2-((3-(tert-butyl)-2-hydroxybenzyl)amino)-3-methyl-N-phenylbutanamide (1.19n, 
Scheme 1.20): M.p. = 125–127 ºC. IR (neat): 3280 (w), 2958 (w, br), 2874 (w, br), 1655 
(m), 1637 (m), 1597 (m), 1437 (m), 1237 (m), 741 (s), 693 (m) cm-1; 1H NMR (400 MHz, 
CDCl3): δ 10.65 (1H, br s), 7.55–7.53 (2H, m), 7.38–7.34 (2H, m), 7.26–7.22 (1H, m), 
7.18–7.14 (2H, m), 6.83 (1H, dd, J = 7.3, 1.3 Hz), 6.74 (1H, t, J = 7.6 Hz), 4.21 (1H, d, J 
= 13.8 Hz), 3.69 (1H, d, J = 13.8 Hz), 2.81 (1H, d, J = 6.9 Hz), 2.55 (1H, br s), 1.85 (1H, 
dq, J = 13.6, 6.8 Hz), 1.43 (9H, s),  1.06 (3H, d, J = 6.8 Hz), 1.00  (3H, d, J = 6.8 Hz); 
13C NMR (100 MHz, CDCl3): δ 171.6, 157.0, 137.2, 137.2, 129.3, 127.2, 126.5, 125.0, 
122.5, 120.1, 118.7, 67.5, 51.2, 34.9, 31.9, 29.6, 20.0, 18.9; HRMS Calcd for C22H31N2O2 
[M + H]+: 355.23855; Found: 355.23950. [α]20D = -142 (c = 0.767, CHCl3). 
(S)-2-((2-Hydroxybenzyl)amino)-N,N,3-trimethylbutanamide (1.30a, Scheme 1.28): 
The title compound is synthesized analogously to 1.19r and purified by silica gel 
chromatography (slurry packed in 95:5 hexanes:triethylamine and eluted with 5:1 to 1:1 
hexanes:ethyl acetate) to afford 1.19i as an off-white solid.  M.p. = 70–72 ºC. IR (neat): 
2964 (w), 2928 (w), 2983 (w), 1637 (s), 1589 (m), 1467 (m), 1399 (m), 1353 (w), 1256 
(s), 1125 (m), 1105 (w), 1075 (m), 892 (m), 848 (m), 752 (s), 628 (m), 464 (m) cm-1; 1H 
NMR (400 MHz, CDCl3): δ 10.81 (1H, br s), 7.17 (1H, dt, J = 7.7, 1.7 Hz), 6.92 (1H, dd, 
J = 7.4, 1.7 Hz), 6.85 (1H, dd, J = 8.1, 1.2 Hz), 6.78–6.74 (1H, m), 4.05 and 3.53 (2H, 
ABq, JAB = 13.8 Hz), 3.34 (1H, d, J = 6.0 Hz), 3.04 (3H, s), 2.91 (3H, s), 1.94–1.81 (1H, 
m), 0.98 (6H, d, J = 6.8 Hz); 13C NMR (100 MHz, CDCl3): δ 173.4, 158.2, 129.0, 128.7, 
122.6, 119.3, 116.5, 61.7, 51.4, 37.1, 35.9, 31.4, 20.1, 18.0; HRMS Calcd for C14H23N2O2 
[M + H]+: 251.17595; Found: 251.17545. [α]25.1 D = –23 (c = 0.44, CHCl3). 
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(S)-2-((2-Hydroxy-3-methylbenzyl)amino)-N,N,3-trimethylbutanamide (1.30b): The 
title compound is synthesized analogously to 1.19r and purified by silica gel 
chromatography (5:1 to 2:1 hexanes:ethyl acetate) to afford 1.30b as a pale yellow oil. IR 
(neat): 3291 (w, br), 2960 (w, br), 2037 (w), 1637 (s), 1596 (w), 1467 (s), 1397 (s), 1262 
(m), 1230 (m), 1125 (m), 1078 (m), 831 (m), 764 (s), 739 (m) cm-1; 1H NMR (400 MHz, 
CDCl3): δ 10.89 (1H, s), 7.04 (1H, d, J = 7.5 Hz), 6.81–6.73 (1H, m), 6.67 (1H, t, J = 7.4 
Hz), 4.01 and 3.51 (2H, ABq, JAB = 13.6 Hz), 3.33 (1H, d, J = 6.0 Hz), 3.04 (3H, s), 2.93 
(3H, s), 2.24 (3H, s), 1.91–1.83 (1H, m), 0.98 (6H, d, J = 6.8 Hz); 13C NMR (100 MHz, 
CDCl3): δ 173.5, 156.3, 130.2, 126.3, 125.4, 121.9, 118.8, 61.8, 51.5, 37.2, 35.9, 
31.4, 20.1, 18.1, 15.9; HRMS Calcd for C15H25N2O2 [M + H]+: 265.19160; Found: 
265.19277. [α]25.1 D = –13 (c = 0.77, CHCl3). 
(S)-2-(Benzylamino)-N,N,3-trimethylbutanamide (1.30d, Scheme 1.28): The title 
compound is synthesized analogously to 1.19r. The analytical data are fully consistent 
with those reported previously for the racemic compound.133 [α]24.8 D = –31 (c = 0.64, 
CHCl3). 
(S)-2-((3-(tert-Butyl)-2-hydroxy-5-nitrobenzyl)amino)-N,N,3-trimethylbutanamide 
(1.30e, Scheme 1.28): The title compound is synthesized analogously to 1.19r and 
purified by silica gel chromatography (6:1 to 3:1 hexanes:ethyl acetate) to afford 1.30e as 
a yellow-orange solid. M.p. = 110–112 ºC. IR (neat): 3314 (w, br), 2959 (w, br), 2915 (w, 
br), 2873 (w, br), 1643 (s), 1588 (w), 1433 (m), 1410 (m), 1395 (m), 1334 (s), 1243 (s), 
1204 (m), 1171 (m), 1102 (m), 1066 (m), 932 (m), 901 (m), 711 (m), 668 (m) cm-1; 1H 
NMR (400 MHz, CDCl3): δ 12.60 (1H, s), 8.14 (1H, d, J = 2.7 Hz), 7.77–7.76 (1H, m), 
                                                
(133) Chen, J.; Cunico, R. F. Tetrahedron Lett. 2003, 44, 8025–8027. 
 
Page 92
   
4.16 and 3.53 (2H, ABq, JAB = 14.3 Hz), 3.27 (1H, d, J = 5.3 Hz), 3.05 (3H, s), 2.93 (3H, 
s), 1.92–1.84 (1H, m), 1.43 (9H, s), 0.98–0.94 (6H, m); 13C NMR (100 MHz, CDCl3): 
δ 172.6, 164.0, 139.6, 138.1, 122.9, 122.8, 122.6, 61.6, 51.3, 37.1, 36.0, 35.1, 31.1, 29.2, 
20.2, 17.7; HRMS Calcd for C18H30N3O4 [M + H]+: 352.22363; Found: 352.22264. [α]25.1 
D = –12 (c = 0.86, CHCl3). 
(R)-2-(tert-Butyl)-6-(((3-methylbutan-2-yl)amino)methyl)phenol (1.30f): The title 
compound is synthesized from 3-tert-butyl-2-hydroxybenzaldehyde and (R)-(-)-2-amino-
3-methylbutane (≥97% ee, Aldrich)  analogously to the last two steps to make 1.19r and 
purified by silica gel chromatography (slurry packed in 95:5 hexanes:triethylamine and 
eluted with hexanes to 30:1 hexanes:diethyl ether) to afford 1.30f as a clear colorless oil. 
IR (neat): 2958 (m), 22873 (m, br), 1591 (w), 1435 (s), 1388 (m), 1239 (s), 1184 (w), 
1140 (w), 1074 (w), 784 (m), 747 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ (phenol proton 
likely too broad to observe) 7.19 (1H, dd, J = 7.9, 1.7 Hz, 1H), 6.90–6.85 (1H, m), 6.73–
6.69 (1H, m), 4.03 and 3.88 (2H, ABq, JAB = 13.3 Hz), 2.58 (1H, dq, J = 6.5, 4.7 Hz), 
1.82–1.74 (1H, m), 1.42 (9H, s), 1.07 (3H, d, J = 6.5 Hz), 0.92 (6H, m); 13C NMR (100 
MHz, CDCl3): δ 157.5, 137.0, 126.5, 126.0, 123.7, 118.2, 57.5, 50.9, 34.8, 32.4, 29.6, 
19.0, 17.7, 15.7; HRMS Calcd for C16H28NO [M + H]+: 250.21709; Found: 250.21729. 
[α]25.0 D = –17.2 (c = 1.16, CHCl3). 
■  Preparation, Purification, and Analytical Data for Aldimine Substrates: Aryl-, 
heteroaryl-, alkenyl-, and alkynyl-substituted N-diphenylphosphinoyl imines were 
synthesized through a TiCl4-promoted reaction between P,P-diphenylphosphinic amide134 
                                                
(134) P,P-Diphenylphosphinic amide was routinely synthesized on deca-gram scale according to a 
previously reported procedure.  See: Desrosiers, J-N.; Côté, A.; Boezio, A. A.; Charette, A. B. Org. Syn. 
2006, 83, 8–9. 
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and the corresponding aldehyde.135 Alkyl-substituted aldimines as well as aldimines 
1.15e, 1.15g, 1.15h and 1.20f were synthesized through the intermediacy of the 
corresponding sulfinyl adducts according to previously disclosed methods.135b, 136 
Occasionally, for optimal results, aryl-, heteroaryl-, alkenyl-, and alkynyl-substituted 
aldimines should be purified by silica gel chromatography (5% triethylamine in the slurry 
packed bed of silica) shortly before to their use. 
General Procedure for Preparation of Aryl-, Heteroaryl-, Alkenyl-, and Alkynyl 
Aldimines (1.15, Table 1.5): Aldimine 1.15k was prepared following a modified 
reported procedure.135a A flame-dried 100 mL round-bottom flask, purged with nitrogen, 
is charged with 4-(dibutylamino) benzaldehyde137 (5.51 g, 23.6 mmol, 1.25 equiv.), P,P-
diphenylphosphinic amide (4.10 g, 18.9 mmol, 1.00 equiv.), triethylamine (10.6 mL, 75.6 
mmol, 4.00 equiv.), and dichloromethane (60 mL). The resulting mixture is allowed to 
cool to −78 °C, followed by the drop-wise addition of neat TiCl4 (1.14 mL, 10.4 mmol, 
0.55 equiv.). The solution is allowed to stir for 12 h at 22 °C and is then filtered through a 
plug of Celite. The resulting yellow solid is purified by silica gel column chromatography 
(ethyl acetate:hexanes 2:1 followed by 100% ethyl acetate as eluent) and  recrystallized 
from dichloromethane/hexanes to afford 1.15k as pale yellow solid (6.40 g, 14.8 mmol, 
78% yield). 
 (E)-N-(4-(dibutylamino)benzylidene)-P,P-diphenylphosphinic amide (1.15k, Table 
1.5): M.p. = 113–115 °C. IR (neat): 2951 (w), 2928 (w), 2869 (w), 1579 (m), 1525 (m), 
                                                
(135) (a) Jennings, W. B.; Lovely, C. J. Tetrahedron 1991, 47, 5561–5568. (b) Yamada, K-i.; Harwood, S. 
J.; Gröger, H.; Shibasaki, M. Angew. Chem., Int. Ed. 1999, 38, 3504–3506. 
(136) (a) Côté, A.; Boezio, A. A.; Charette, A. B. Proc. Natl. Acad. Sci. 2004, 101, 5405–5410. (b) 
Yamaguchi, A.; Matsunaga, S.; Shibasaki, M. Tetrahedron Lett. 2006, 47, 3985–3989. 
(137) Tian, L.; Hu, Z.; Shi, P.; Zhou, H.; Wu, J.; Tian, Y.; Zhou, Y.; Tao, X.; Jiang, M. J. Lumin. 2007, 
127, 423–430  
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1435 (m), 1364 (m), 1203 (m), 1173 (m), 1104 (m), 831 (s), 807 (m), 725 (m), 695 (s), 
580 (m), 545 (s), 522 (s), 510 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 9.08 (1H, d, J = 
32.0 Hz), 7.95−7.89 (4H, m), 7.85 (2H, d, J = 8.8 Hz), 7.48−7.38 (6H, m), 6.65 (2H, d, J 
= 9.2 Hz), 3.34 (4H, dd, J = 7.6, 7.2 Hz), 1.63−1.56 (4H, m), 1.37 (4H, app sextet, J = 7.6 
Hz), 0.97 (6H, t, J = 7.2 Hz); 13C NMR (100 MHz, CDCl3): δ 172.1 (d, J = 6.9 Hz), 
152.3, 134.4 (d, J = 126.0 Hz), 132.7 (br peak as the result of hindered rotation around 
the (Ar)−(C=NR) bond), 131.7 (d, J = 9.1 Hz), 131.4 (d, J = 2.7 Hz), 128.4 (d, J = 12.3 
Hz), 123.5 (d, J = 26.2 Hz), 111.0, 51.0, 29.4, 20.4, 14.1; HRMS Calcd for C27H34N2OP 
[M + H]+: 433.24087; Found: 433.23945. 
(E)-P,P-Diphenyl-N-(pyridin-4-ylmethylene)phosphinic amide (1.15n, Table 1.5): 
The title compound is purified by trituration with pentanes and washing of the resultant 
solid with diethyl ether to afford a light orange solid. M.p. = 97–99 ºC. IR (neat): 3055 
(br, w), 1621 (m), 1593 (w), 1557 (m), 1437 (m), 1411 (w), 1320 (w), 1197 (m), 1123 
(m), 1107 (m), 822 (s), 724 (s), 692 (s), 551 (s), 520 (s), 500 (s); 1H NMR (400 MHz, 
CDCl3): δ 9.32 (1H, d, J = 31.2 Hz), 8.84–8.82 (2H, m), 7.97–7.90 (4H, m), 7.83–7.82 
(2H, m), 7.55–7.42 (6H, m); 13C NMR (100 MHz, CDCl3): 172.2 (d, J = 7.7 Hz), 151.1, 
142.0 (d, J = 25.2 Hz), 132.3 (d, J = 2.8 Hz), 132.1 (d, J = 127.3 Hz), 131.7 (d, J = 9.4 
Hz), 128.8 (d, J = 12.6 Hz), 123.0; HRMS Calcd for C18H16N2O1P1 [M + H]+: 307.10002; 
Found: 307.09978. 
(E)-N-((E)-3-(2-Nitrophenyl)allylidene)-P,P-diphenylphosphinic amide (1.20b, Table 
1.6): White solid. M.p. = 148−149 °C. IR (neat): 3076 (w), 3041 (w), 2856 (w), 1625 
(m), 1608 (m), 1591 (m), 1520 (m), 1437 (w), 1344 (m), 1205 (s), 1157 (w), 1124 (m), 
1108 (m), 966 (w), 874 (m), 845 (m), 798 (s), 784 (m), 752 (w), 741 (w), 725 (s), 693 (s), 
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676 (m), 577 (w), 547 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 9.09 (1H, dd, J = 31.6, 8.8 
Hz), 8.06 (1H, d, J = 8.4 Hz), 7.94−7.86 (5H, m), 7.70 (1H, t, J = 8.0 Hz), 7.67 (1H, t, J = 
7.6 Hz), 7.58−7.42 (7H, m), 7.02 (1H, ddd, J = 15.6, 8.8, 1.6 Hz); 13C NMR (100 MHz, 
CDCl3): δ 174.1 (d, J = 7.9 Hz), 148.1, 145.0, 133.8, 133.0 (d, J = 28.6 Hz), 132.5 (d, J = 
126.0 Hz), 132.1 (d, J = 2.8 Hz), 131.7 (d, J = 9.3 Hz), 130.8, 130.7 (d, J = 1.4 Hz), 
129.0, 128.7 (d, J = 12.6 Hz), 125.3; HRMS Calcd for C21H18N2O3P [M + H]+: 
377.10550; Found: 377.10545. 
(E)-N-((E)-3-(4-Methoxyphenyl)allylidene)-P,P-diphenylphosphinic amide (1.20c, 
1.6): Pale yellow solid. M.p. = 150−151 °C. IR (neat): 3064 (w), 3053 (w), 3014 (w), 
2939 (w), 2844 (w), 1619 (m), 1586 (s), 1568 (s), 1513 (m), 1436 (m), 1311 (m), 1258 
(s), 1203 (s), 1180 (m), 1160 (m), 1123 (m), 1106 (m), 1023 (m), 875 (m), 818 (s), 753 
(m), 723 (m), 696 (s), 595 (m), 546 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 9.01 (1H, 
dd, J = 31.6, 8.8 Hz), 7.91−7.86 (4H, m), 7.53−7.42 (8H, m), 7.33 (1H, d, J = 15.6 Hz), 
7.00 (1H, ddd, J = 15.6, 9.2, 2.0 Hz), 6.93 (2H, d, J = 8.4 Hz), 3.85 (3H, s); 13C NMR 
(100 MHz, CDCl3): δ 175.1 (d, J = 7.7 Hz), 162.0, 150.7, 133.3 (d, J = 126.0 Hz), 131.8 
(d, J = 2.8 Hz), 131.7 (d, J = 9.1 Hz), 130.2, 128.6 (d, J = 12.5 Hz), 127.6 (d, J = 1.2 Hz), 
126.7 (d, J = 28.5 Hz), 114.6, 55.6; HRMS Calcd for C22H21NO2P [M + H]+: 362.13099; 
Found: 362.12964. 
(E)-N-((Z)-2-Bromo-3-phenylallylidene)-P,P-diphenylphosphinic amide (1.20d, 
Table 1.6): White solid. M.p. = 144−145 °C. IR (neat): 3074 (w), 3061 (w), 3025 (w), 
3012 (w), 2958 (w), 1620 (m), 1593 (s), 1569 (m), 1438 (m), 1199 (s), 1160 (w), 1134 
(m), 1122 (s), 1106 (m), 1070 (w), 877 (s), 808 (m), 752 (m), 726 (s), 702 (s), 684 (s), 
659 (m), 587 (m), 550 (s), 517 (m), 501 (s), 468 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 
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8.86 (1H, d, J = 29.2 Hz), 7.99−7.93 (6H, m), 7.78 (1H, s), 7.53−7.43 (9H, m); 13C NMR 
(100 MHz, CDCl3): δ 171.3 (d, J = 5.2 Hz), 148.2, 133.8, 132.9 (d, J = 127.0 Hz), 132.0 
(d, J = 2.8 Hz), 131.7 (d, J = 9.3 Hz), 131.1, 130.9, 128.7, 128.7 (d, J = 11.5 Hz), 124.1 
(d, J = 31.6 Hz); HRMS Calcd for C21H18BrNOP [M + H]+: 410.03094; Found: 
410.02999. 
(E)-P,P-Diphenyl-N-(1-tosylhex-2-en-1-yl)phosphinic amide (not shown in 
dissertation; precursor to 1.20f, Table 1.6): The title compound is synthesized 
following a previously reported procedure135 from P,P-diphenylphosphinic amide (2.17 
g, 10.0 mmol, 1.00 equiv.), (E)-hex-2-enal (2.31 mL, 20.0 mmol, 2.00 equiv.), and p-
toluenesulfinic acid138 (2.34 g, 15.0 mmol, 1.50 equiv.) to obtain the tile compound as 
white solid (3.22 g, 7.10 mmol, 71% yield). M.p. = 138−139 °C. IR (neat): 3177 (w, br), 
2959 (w), 2933 (w), 2870 (w), 1661 (m), 1596 (w), 1437 (m), 1300 (m), 1281 (m), 1214 
(m), 1185 (s), 1170 (m), 1138 (m), 1125 (s), 1106 (m), 1083 (m), 955 (m), 894 (m), 752 
(m), 726 (s), 693 (s), 662 (m), 583 (s), 568 (m), 536 (s) cm-1; 1H NMR (400 MHz, 
CDCl3): δ 7.79−7.71 (4H, m), 7.59 (2H, d, J = 8.4 Hz), 7.59−7.54 (2H, m), 7.50−7.43 
(4H, m), 7.23 (2H, d, J = 8.0 Hz), 5.90 (1H, ddd, J = 13.6, 11.6, 9.6 Hz), 5.31 (1H, t, J = 
10.0 Hz), 4.73 (1H, dd, J = 14.0, 10.4 Hz), 3.28 (1H, app td, J = 10.8, 3.6 Hz), 2.42 (3H, 
s), 1.97−1.88 (1H, m), 1.52−1.32 (2H, m), 1.20−1.10 (1H, m), 0.82 (3H, t, J = 7.2 Hz); 
13C NMR (100 MHz, CDCl3): δ 144.3, 134.7, 132.8, 132.6 (d, J = 2.9 Hz), 132.5 (d, J = 
2.9 Hz), 132.2 (d, J = 10.1 Hz), 131.9 (d, J = 10.1 Hz), 131.4 (d, J = 128.0 Hz), 131.1 (d, 
J = 128.0 Hz), 129.6, 129.2, 128.9 (d, J = 12.9 Hz), 128.9 (d, J = 13.0 Hz), 101.9 (d, J = 
9.9 Hz), 67.6, 29.7, 21.8, 20.0, 13.7. 
                                                
(138) Sisko, J.; Mellinger, M.; Sheldrake, P. W.; Baine, N. H. Org. Syn. 2000, 77, 198–205. 
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(E)-N-((E)-Hex-2-en-1-ylidene)-P,P-diphenylphosphinic amide (1.20f, Table 1.6): 
Following a modification to a previously reported procedure,7b 6 is synthesized through 
vigorous stirring of a suspension of the requisite sulfinic adduct (see above, 150 mg, 
0.330 mmol) in 5 mL of diethyl ether and 5 mL of an aqueous saturated solution of 
Na2CO3 until the white solid dissolves completely (~8 h). The layers are separated and 
the aqueous phase is washed with diethyl ether. The combined organic phases are dried 
with anhydrous sodium sulfate and the filtrate is concentrated to dryness. The residue is 
dissolved again in dichloromethane, filtered, and the solvent is evaporated to afford 6 as 
colorless viscous oil (97.7 mg, 0.328 mmol, 99% yield). IR (neat): 3056 (w), 2959 (w), 
2930 (w), 2871 (w), 1637 (m), 1596 (s), 1203 (s), 1122 (m), 1106 (m), 826 (s), 724 (s), 
693 (s), 571 (m), 544 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 8.86 (1H, dd, J = 32.4, 8.8 
Hz), 7.89−7.83 (4H, m), 7.50−7.41 (6H, m), 6.73 (1H, dt, J = 15.6, 6.8 Hz), 6.50−6.42 
(1H, m), 2.30 (2H, app quartet, J = 7.2 Hz), 1.53 (2H, app sextet, J = 7.2 Hz), 0.95 (3H, t, 
J = 7.2 Hz); 13C NMR (100 MHz, CDCl3): δ 175.5 (d, J = 8.0 Hz), 156.7, 133.1 (d, J = 
126.0 Hz), 132.3 (d, J = 26.8 Hz), 131.8 (d, J = 2.8 Hz), 131.6 (d, J = 9.1 Hz), 128.5 (d, J 
= 12.4 Hz), 35.2, 21.4, 13.8; HRMS Calcd for C18H21NOP [M + H]+: 298.13608; Found: 
298.13599. 
■   Preparation, Purification, and Analytical Data for Isatin Substrates  
General Procedure for Preparation of N-tert-Butyldimethylsilyl Isatins:  In a 250 mL 
flame dried round bottom flask equipped with a stir bar, tert-butyldimethylsilyl chloride 
(4.5 g, 30 mmol) is dissolved in 150 mL dichloromethane.  To this solution, in a single 
portion, isatin (2.2 g, 15 mmol) and 4-dimethylaminopyridine (0.18 g, 1.5 mmol) are 
added.  The flask is sealed with a rubber septum and purged with nitrogen.  
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Triethylamine (6.3 mL, 45 mmol) is added in one portion through a syringe and mixture 
is allowed to stir for 24 h at 22 ºC.  The volatiles are removed in vacuo and the resultant 
dark orange solid is purified by silica gel chromatography (hexanes to 1:1 
hexanes:dichloromethane to dichloromethane) to afford an orange solid, which is 
recrystallized from hot EtOH (details below) to afford 1.36i (2.6 g, 9.9 mmol, 67% yield) 
as an orange crystalline solid.  Please note that for long-term storage, N-tert-
butyldimethylsilyl protected isatins should be kept under an inert atmosphere at –15 ºC.  
1-(tert-Butyldimethylsilyl)indoline-2,3-dione (1.36i, Table 1.15):  M.p. = 123–124 °C. 
IR (neat): 2929  (w), 2853 (w), 1731 (s), 1603 (m), 1589 (m), 1463 (m), 1325 (m), 1252 
(m), 1170 (m), 1139 (m), 927 (m), 835 (s), 796 (m), 752 (s), 686 (m), 466 (m), 424 (m) 
cm-1; 1H NMR (400 MHz, CDCl3): δ 7.63–7.61 (1H, m), 7.53–7.49 (1H, m), 7.10–7.03 
(2H, m), 1.02 (9H, s), 0.56 (6H, s); 13C NMR (100 MHz, CDCl3): δ 184.2, 164.9, 155.4, 
138.3, 125.6, 123.4, 120.0, 115.1, 26.4, 19.7, –3.3; HRMS Calcd for C14H20NO2Si [M + 
H]+: 262.12633; Found: 262.12608. 
1-(tert-Butyldimethylsilyl)-5-methoxyindoline-2,3-dione (1.36j, Table 1.15): Crimson 
crystalline solid. M.p. = 169–171 °C. IR (neat): 2929 (w, br), 2859 (w), 1731 (s), 1625 
(w), 1589 (w), 1492 (m), 1310 (m), 1270 (m), 1142 (m), 942 (w), 847 (m) cm-1; 1H NMR 
(400 MHz, CDCl3): δ 7.12–7.07 (2H, m), 6.96 (1H, d, J = 9.0 Hz), 3.79 (3H, s), 1.01 (9H, 
s), 0.54 (6H, s); 13C NMR (100 MHz, CDCl3): δ 184.7, 165.3, 156.0, 149.5, 125.6, 120.4, 
116.0, 108.8, 56.0, 26.5, 19.8, –3.3; HRMS Calcd for C15H22NO3Si [M + H]+: 292.13689; 
Found: 292.13766. 
4,6-Dibromo-1-((2-(trimethylsilyl)ethoxy)methyl)indoline-2,3-dione (1.36k, Table 
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1.15):  Amide protection performed in accordance to a previously disclosed procedure.139 
Yellow crystalline solid, M.p. = 142–143 °C. IR (neat): 3077 (w), 2896 (w), 1742 (m), 
1595 (s), 1562 (m), 1419 (w), 1244 (m), 1073 (s), 1024 (m), 839 (s), 733 (m), 456 (m) 
cm-1; 1H NMR (400 MHz, CDCl3): δ 7.51 (1H, d, J = 1.6 Hz), 7.28 (1H, d, J = 1.2 Hz), 
5.16 (2H, s), 3.85 (2H, m), 0.94 (2H, m), –0.01 (9H, s); 13C NMR (100 MHz, CDCl3): 
δ 179.5, 157.2, 152.2, 133.5, 131.5, 122.1, 115.3, 114.3, 70.0, 67.1, 17.9, –1.3; HRMS 
Calcd for C14H21Br2N2O3Si [M + NH4]+: 450.96882; Found: 450.96873. 
 
Synthesis of N-Bn Isatins: Synthesized in accordance to a published procedure140 with the 
following modification:  After isolation of the unpurified N-protected isatin, a small 
portion (~10 mg) of the solid is passed through a small plug of silica gel using 
dichloromethane as the elutant.  If a dark (usually maroon) residue remains on the silica 
gel after the N-protected isatin is eluted, then the entire unpurified N-Bn isatin is 
dissolved in dichloromethane and passed through a short plug of silica gel using 
dichloromethane as an elutant.  After concentration in vacuo, the isatin is purified as 
described below.  
Purification of N-Bn, N-SEM, and N-TBS isatins: With hot EtOH as the solvent, ~95 % of 
the resulting solid is dissolved and filtered while hot through a fritted glass funnel (this 
initial filtration is critical to obtain N-protected isatins of sufficient purity).  The filtered 
solids are discarded.  The filtrate is allowed to cool to room temperature during which 
time the desired product crystallizes from solution. The desired product is collected by 
                                                
(139) Trost, B. M.; Frederiksen, M. U. Angew. Chem., Int. Ed. 2005, 44, 308–310. 
(140) Karimi, A. R.; Sedaghatpour, F. Synthesis 2010, 10, 1731–1735. 
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filtration through a fritted glass funnel.  Concentrating the mother liquor in vacuo and 
recrystallization of the resultant solids from hot EtOH yields additional product. The 
products are then dried azeotropically with anhydrous benzene prior to use. 
1-Benzyl-4,7-dichloroindoline-2,3-dione (1.36f, Table 1.15): Orange solid. M.p. = 
204–206 °C. IR (neat): 2934 (w), 2857 (w), 1667 (w), 1449 (w), 1424 (w), 1367 (w), 
1265 (w), 1061 (m), 1024 (m), 925 (w), 733 (s), 703 (m) cm-1; 1H NMR (400 MHz, 
CDCl3): δ 7.39–7.25 (6H, m), 7.03 (1H, d, J = 8.7 Hz), 5.40 (2H, s); 13C NMR (100 
MHz, CDCl3): δ 179.4, 158.2, 147.3, 140.8, 135.9, 133.2, 129.0, 128.0, 126.7, 126.7, 
117.2, 115.8, 45.3; HRMS Calcd for C15H10Cl2N1O2 [M + H]+: 306.00886; Found: 
306.00974. 
■  Procedure for Gram-Scale Catalytic Enantioselective Allyl Addition to Aldimine 
1.15a to Afford Homoallylamide 1.17a (Scheme 1.21): 
Preparation of the catalyst suspension: Aminophenol 1.19r (15.0 mg, 0.0490 mmol) is 
weighed out in air into a 4 mL vial to which is added 263 µL of a solution of sodium 
hydroxide (1.95 mg, 0.0490 mmol) in reagent-grade methanol [111 mg NaOH pellet 
(Fisher) is dissolved in 15 ml methanol]). After removal of the solvent in vacuo, the 
resultant white oil is azeotropically dried with reagent grade toluene. The obtained white 
solid is allowed to dry at 0.5 Torr for 30 min and the vial is sealed with a cap containing a 
teflon septum. Toluene (1.0 mL) is added to yield a suspension after sonication (2 min). 
A round bottom flask (50 mL, equipped with a magnetic stirring bar) is charged with 
imine 1.15a (1.00 g, 3.28 mmol) and dried at 0.5 Torr for 30 min, purged with nitrogen 
and sealed with a rubber septum. Toluene (30 mL) is added, followed by allylboronic 
acid pinacol ester 1.6 (800 µl, 4.26 mmol) from a septum-sealed bottle (Frontier 
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Scientific, Inc., as received) and methanol (200 µL, 4.92 mmol) from a septum-sealed 
bottle (Acros, grade: 99.9% ExtraDry, as received). A suspension of the catalyst 
containing aminophenol 1.19r (10.1 mg, 33 µmol, 0.0100 equiv.) and sodium hydroxide 
(1.31 mg, 33 µmol, 0.0100 equiv.) in 0.67 mL toluene is added with a syringe to the 
mixture (see below). After two h, the solvent is evaporated and the residue is taken up in 
30 mL hexanes. The suspension is allowed to sonicate for two min, filtered and washed 
with hexanes (4 x 3 mL). The desired product, dried under vacuum, is obtained in 
97.5:2.5 er (1.04 g, 3.01 mmol, 92% yield). Elemental analysis for C22H22NOP: Calcd: C, 
76.06; H, 6.38; N, 4.03. Found: C, 75.77; H, 6.43; N 3.98.   
(R)-P,P-Diphenyl-N-(1-phenylbut-3-en-1-yl)phosphinic amide (1.17a, Table 1.5): The 
analytical data are fully consistent with those reported previously.141 1H NMR (400 MHz, 
CDCl3): δ 7.89–7.84 (2H, m), 7.79–7.74 (2H, m), 7.51–7.47 (1H, m), 7.45–7.41 (3H, m), 
7.34–7.18 (7H, m), 5.61 (1H, dddd, J = 17.2, 10.0, 7.2, 7.2 Hz), 5.11–5.03 (2H, m), 4.47 
(1H, dddd, J = 10.4, 10.4, 6.4, 6.4 Hz), 3.35 (1H, br dd, J = 9.6, 6.0 Hz), 2.74–2.60 (2H, 
m); HRMS Calcd for C22H23NOP [M + H]+: 348.15173; Found: 348.15251; [α]20D	  = +52 
(c = 0.40, CHCl3) for a 96:4 er sample.	    The enantiomeric purity was determined by 
HPLC analysis in comparison with authentic racemic material (Chiracel OD, 92:8 
hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR of 4a: 16 min (major) and 21 min (minor).  
                                                
(141) Vieira, E. M.; Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2011, 133, 3332–3335. 
 
Page 102
   
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 16.5 min 50.660 1 15.5 min 96.036 
2 22.8 min 49.340 2 20.9 min 3.964 
 
■  Representative Procedure for Small Scale Catalytic Enantioselective Allyl 
Additions to Aryl-, Heteroaryl-, Alkenyl-, and Alkynyl N-Diphenylphosphinoyl 
Imines (Table 1.5): In a nitrogen-filled glovebox (not needed for gram scale; only used 
when reactions are performed at mg scale to achieve highly reproducible data), 
aminophenol 1.19r (6.9 mg, 0.023 mmol) is added to an oven-dried two dram vial 
equipped with a stir bar followed by 1.5 mL of a stock solution of NaOt-Bu in toluene 
(9.6 mg, 0.10 mmol/8.0 mL) and the solution is allowed to stir at 22 ºC for ~10 minutes.  
A separate vial equipped with a stir bar is charged sequentially with aldimine 1.15b (32.3 
mg, 0.100 mmol), 800. µL of toluene, MeOH (10. µL, 0.25 mmol), and allylboronic acid 
pinacol ester 1.6 (28 µL, 0.15 mmol) under nitrogen. To this mixture is added 200. µL of 
the 1.19r/NaOt-Bu solution and a cap is attached to the vial and sealed (electrical tape). 
The clear and colorless solution is allowed to stir at 22 ºC for four hours during which 
time the solution becomes cloudy and white. The cap is removed and 3 mL of a solution 
of saturated aqueous NaIO4 is added and the biphasic mixture is allowed to stir for 20 
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minutes. The aqueous layer is washed with ethyl acetate (4 x 4 mL), dried over Na2SO4, 
and concentrated in vacuo to yield a pale yellow solid. The homoallylamide product is 
purified by silica gel chromatography (10 mm diameter column slurry packed with 2.5 g 
of silica gel in 95:5 hexanes:triethylamine and eluted with 10 mL hexanes, 10 mL 3:1 
hexanes:ethyl acetate, 10 mL 1:1 hexanes:ethyl acetate, 10 mL 1:3 hexanes:ethyl acetate, 
and 15 mL ethyl acetate) to afford 1.17b (35.2 mg, 0.0960 mmol, 96% yield) as a white 
solid. 
(R)-N-(1-(2-Fluorophenyl)but-3-en-1-yl)-P,P-diphenylphosphinic amide (1.17b, 
Table 1.15): The analytical data are fully consistent with those reported previously.141 1H 
NMR (400 MHz, CDCl3): δ 7.87–7.82 (2H, m), 7.78–7.72 (2H, m), 7.51–7.47 (1H, m), 
7.44–7.39 (3H, m), 7.34–7.29 (2H, m), 7.23–7.18 (1H, m), 7.15 (1H, ddd, J = 7.6, 7.6, 
1.6 Hz), 7.05 (1H, ddd, J = 7.6, 7.6, 1.2 Hz), 6.97 (1H, ddd, J = 10.8, 8.0, 0.8 Hz), 5.61 
(1H, dddd, J = 17.2, 10.0, 7.2, 7.2 Hz), 5.09–5.01 (2H, m), 4.47 (1H, dddd, J = 10.4, 
10.4, 6.4, 6.4 Hz), 3.56 (1H, br dd, J =10.4, 6.8 Hz), 2.78–2.60 (2H, m); HRMS Calcd 
for C22H21FNOP [M + H]+: 366.14230; Found: 366.14250. [α]20D = +34 (c =0.39, CHCl3) 
for a 98.5:1.5 er sample.  The enantiomeric purity was determined by HPLC analysis in 
comparison to authentic racemic material (Chiracel OD, 92:8 hexanes:i-PrOH, 0.5 
mL/min, 220 nm) tR: 17 min (major) and 21 min (minor). 
 
Page 104
   
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 17.9 49.348 1 17.4 98.321 
2 20.8 50.652 2 21.0 1.679 
 
(R)-N-(1-(2-Bromophenyl)but-3-en-1-yl)-P,P-diphenylphosphinic amide (1.17c, 
Table 1.5): The title compound is purified in a manner identical to 1.17b affording 1.17c 
(38.0 mg, 0.0891 mmol, 89% yield) as a white solid. The analytical data are fully 
consistent with those reported previously.141 1H NMR (400 MHz, CDCl3): δ 7.87–7.82 
(2H, m), 7.75–7.70 (2H, m), 7.51–7.47 (1H, m), 7.44–7.39 (4H, m), 7.35–7.27 (4H, m), 
7.07 (1H, ddd, J = 8.8, 8.0, 2.0 Hz), 5.64 (1H, dddd, J = 17.4, 10.4, 7.2, 7.2 Hz), 5.14–
5.10 (2H, m), 4.71 (1H, dddd, J = 10.4, 10.4, 6.0, 6.0 Hz), 3.56 (1H, br dd, J = 9.6, 6.0 
Hz), 2.64 (2H, app t, J = 6.4 Hz); HRMS Calcd for C22H22BrNOP [M + H]+: 426.06224; 
Found: 426.06229. [α]20D	   =	   +2.30 (c =1.00, CHCl3) for a 98.0:2.0 er sample.  The 
enantiomeric purity was determined by HPLC analysis in comparison to authentic 
racemic material (Chiracel AD-H, 87:13 hexanes:i-PrOH, 0.5 mL/min, 220 nm) tR: 26 
min (minor) and 45 min (major). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 25.0 49.745 1 25.9 1.985 
2 43.0 50.255 2 45.1 98.015 
 
(R)-P,P-Diphenyl-N-(1-(o-tolyl)but-3-en-1-yl)phosphinic amide (1.17d, Table 1.5): 
The title compound is synthesized and purified analogously to 1.17b (six h reaction time) 
affording 1.17d (34.3 mg, 0.0949 mmol, 95% yield) as a white solid. The analytical data 
are fully consistent with those reported previously.141 1H NMR (400 MHz, CDCl3): δ 
7.88–7.83 (2H, m), 7.72–7.67 (2H, m), 7.50–7.46 (1H, m), 7.44–7.38 (3H, m), 7.33 (1H, 
d, J = 7.7 Hz), 7.29–7.21 (3H, m), 7.12 (1H, ddd, J = 8.4, 7.6, 1.6 Hz), 7.00 (1H, d, J = 
7.5 Hz), 5.61 (1H, dddd, J = 17.2, 10.0, 7.2, 7.2 Hz), 5.11–5.03 (2H, m), 4.54 (1H, dddd, 
J = 10.0, 10.0, 6.4, 6.4 Hz), 3.43 (1H, br dd, J = 9.6, 6.4 Hz), 2.65–2.52 (2H, m), 1.91 
(3H, s); HRMS Calcd for C23H25NOP [M + H]+: 362.16738; Found: 362.16744. [α]20D	  =	  
+7.20 (c =1.00, CHCl3) for a 94:6 er sample.  The enantiomeric purity was determined by 
HPLC analysis in comparison to authentic racemic material (Chiracel AD-H, 87:13 
hexanes:i-PrOH, 0.5 mL/min, 220 nm) tR: 25 min (major) and 31 min (minor). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 23.8 49.425 1 24.9 93.155 
2 28.7 50.575 2 30.9 6.845 
 
(R)-N-(1-(3-Bromophenyl)but-3-en-1-yl)-P,P-diphenylphosphinic amide (1.17e, 
Table 1.5): The title compound is purified identically to 1.17b affording 1.17e (39.5 mg, 
0.0927 mmol, 93% yield) as a white solid. The analytical data are fully consistent with 
those reported previously.141 1H NMR (400 MHz, CDCl3): δ 7.87–7.82 (2H, m), 7.77–
7.71 (2H, m), 7.53–7.47 (1H, m), 7.45–7.40 (3H, m), 7.35–7.30 (4H, m), 7.13–7.11 (2H, 
m), 5.58 (1H, dddd, J = 17.2, 10.0, 7.2, 7.2 Hz), 5.13–5.07 (2H, m), 4.31 (1H, dddd, J = 
10.0, 10.0, 6.4, 6.4 Hz), 3.42 (1H, br dd, J = 9.4, 6.0 Hz), 2.67–2.58 (2H, m); HRMS 
Calcd for C22H22BrNOP [M + H]+: 426.06224; Found: 426.06326. [α]20D	   = +59 (c = 
0.57, CHCl3) for a 97.5:2.5 er sample.	   The enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material (Chiracel OD, 92:8 hexanes:i-
PrOH, 0.5 mL/min, 220 nm): tR: 17 min (major) and 20 min (minor). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 16.8 49.640 1 16.6 97.673 
2 20.1 50.360 2 20.4 2.327 
 
(R)-N-(1-(4-Bromophenyl)but-3-en-1-yl)-P,P-diphenylphosphinic amide (1.17f, 
Table 1.5): The title compound is purified identically to 1.17b affording 1.17f (39.2 mg, 
0.0920 mmol, 92% yield) as a white solid. The analytical data are fully consistent with 
those reported previously.141 1H NMR (400 MHz, CDCl3): δ 7.87–7.82 (2H, m) 7.78–
7.72 (2H, m), 7.51–7.47 (1H, m), 7.45–7.37 (5H, m), 7.35–7.30 (2H, m), 7.08–7.05 (2H, 
m), 5.57 (1H, dddd, J = 16.8, 10.0, 7.2, 7.2 Hz), 5.13–5.06 (2H, m), 4.31 (1H, dddd, J = 
10.0, 10.0, 6.4, 6.4 Hz), 3.30 (1H, br dd, J = 9.6, 5.6 Hz), 2.69–2.55 (2H, m); HRMS 
Calcd for C22H22BrNOP [M + H]+: 426.0622; HRMS Calcd for C22H22BrNOP [M + H]+: 
426.06224; Found: 426.06197. [α]20D	  = +73  (c = 1.0, CHCl3) for a 97:3 er sample.	   The 
enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiracel AD-H, 97:3 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 36 
min (minor) and 44 min (major). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 35.5 49.744 1 35.6 2.763 
2 44.3 50.256 2 44.4 97.237 
 
(R)-P,P-Diphenyl-N-(1-(4-(trifluoromethyl)phenyl)but-3-en-1-yl)phosphinic amide 
(1.17g, Table 1.5): The title compound is purified identically to 1.17b affording 1.17g 
(38.8 mg, 0.0934 mmol, 93% yield) as a white solid. The analytical data are fully 
consistent with those reported previously.141 1H NMR (400 MHz, CDCl3): δ 7.88–7.83 
(2H, m) 7.75–7.70 (2H, m), 7.52–7.48 (3H, m), 7.45–7.40 (3H, m), 7.32–7.28 (4H, m), 
5.58 (1H, dddd, J = 17.2, 10.0, 7.2, 7.2 Hz), 5.14–5.08 (2H, m), 4.41 (1H, dddd, J = 9.6, 
9.6, 6.4, 6.4 Hz), 3.49 (1H, br dd, J = 8.8, 6.2 Hz), 2.71–2.58 (2H, m); HRMS Calcd for 
C23H22F3NOP [M + H]+: 416.13911; Found: 416.13996. [α]20D	  = +57 (c = 0.45, CHCl3) 
for a 98:2 er sample.	    The enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (Chiracel OD, 92:8 hexanes:i-PrOH, 0.5 
mL/min, 220 nm): tR: 17 min (major) and 19 min (minor). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 17.9 48.582 1 16.6 98.108 
2 20.4 51.418 2 19.3 1.892 
 
(R)-Methyl-4-(1-((diphenylphosphoryl)amino)but-3-en-1-yl)benzoate (1.17h, Table 
1.5): The title compound is synthesized and purified analogously to 4b except for the 
following changes: 1) 2.5 mol % aminophenol 1.19r (instead of 3 mol % 1.19r)  2) 1.5 
equiv. MeOH (instead of 2.5 equiv.). Homoallylamide 1.17h (74.4 mg, 0.183 mmol, 92% 
yield) is obtained as a white solid. M.p. = 128 °C. IR (neat): 3144 (w, br), 3055 (w), 3006 
(w), 2948 (w), 2872 (w), 1720 (s), 1610 (w), 1435 (m), 1277 (s), 1193 (s), 1181 (s), 1106 
(s), 1067 (m), 926 (m), 907 (m), 721 (s), 694 (s), 561 (m), 527 (s) cm-1; 1H NMR (400 
MHz, CDCl3): δ 7.93 (2H, d, J = 8.4 Hz), 7.86−7.80 (2H, m), 7.74−7.68 (2H, m), 
7.47−7.37 (4H, m), 7.30−7.25 (2H, m), 7.25 (2H, d, J = 8.0 Hz), 5.55 (1H, dddd, J = 
17.2, 10.0, 7.6, 6.8 Hz), 5.09−5.03 (2H, m), 4.38 (1H, app tt, J = 10.1, 6.2 Hz), 3.88 (3H, 
s), 3.52 (1H, br dd, J = 9.9, 5.9 Hz), 2.70−2.56 (2H, m); 13C NMR (100 MHz, CDCl3): δ 
166.9, 148.4 (d, J = 5.0 Hz), 133.2, 132.9 (d, J = 127.0 Hz), 132.5 (d, J = 9.7 Hz), 132.0 
(d, J = 2.7 Hz), 131.9 (d, J = 130.0 Hz), 131.9 (d, J = 3.9 Hz, one peak is overlapping 
with the other d at 131.9), 131.9 (d, J = 9.5 Hz), 129.8, 129.0, 128.6 (d, J = 12.5 Hz), 
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128.4 (d, J = 12.6 Hz), 126.6, 119.4, 54.3, 52.2, 43.6 (d, J = 4.2 Hz); HRMS Calcd for 
C24H25NO3P [M + H]+: 406.15720; Found: 406.15720. [α]20D = +75.5 (c = 2.40, CHCl3) 
for a 98:2 er sample. The enantiomeric purity of this compound was determined by HPLC 
analysis in comparison with authentic racemic material (Chiracel AD−H, 80:20 
hexanes:i-PrOH, 0.8 mL/min, 220 nm): tR: 30 min (major) and 38 min (minor). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 29.9 50.019 1 30.0 98.190 
2 38.2 49.981 2 38.5 1.810 
 
(R)-N-(1-(4-Methoxyphenyl)but-3-en-1-yl)-P,P-diphenylphosphinic amide (1.17i, 
Table 1.5): The title compound is synthesized and purified analogously to 1.17b except 
for the following changes: 1) 2.5 mol % aminophenol 1.19r (instead of 3 mol % 1.19r)  
2) 1.5 equiv. MeOH (instead of 2.5 equiv.). Homoallylamide 1.17i (74.1 mg, 0.196 
mmol, 98% yield) is afforded as a white solid. The analytical data are fully consistent 
with those reported previously.141 M.p. = 116−117 °C. 1H NMR (400 MHz, CDCl3): δ 
7.88–7.83 (2H, m), 7.80–7.75 (2H, m), 7.49–7.38 (3H, m), 7.35–7.30 (2H, m), 7.14–7.10 
(2H, m), 6.83–6.79 (2H, m), 5.56 (1H, dddd, J = 17.2, 10.4, 6.8, 6.8 Hz), 5.10–5.02 (2H, 
m), 4.30 (1H, dddd, J = 9.6, 9.6, 6.4, 6.4 Hz), 3.79 (3H, s), 3.28 (1H, br dd, J = 9.6, 6.0 
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Hz), 2.72–2.57 (2H, m); HRMS Calcd for C23H25NO2P [M + H]+: 378.16229; Found: 
378.16236. [α]20D = +54.7 (c = 1.99, CHCl3) for a 96.5:3.5 er sample. The enantiomeric 
purity of this compound was determined by HPLC analysis in comparison with authentic 
racemic material (Chiracel OJ−H, 92:8 hexanes:i-PrOH, 0.8 mL/min, 220 nm): tR: 12 min 
(minor) and 19 min (major). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 11.7 50.058 1 11.7 3.416 
2 17.9 49.942 2 19.2 96.584 
 
(R)-P,P-Diphenyl-N-(1-(p-4-methylphenyl)but-3-en-1-yl)phosphinic amide (1.17j, 
Table 1.5): This compound is not listed in Table 2 of the publication, but has been used 
for determination of the absolute stereochemistry through X-ray analysis. It was 
synthesized and purified analogously to 1.15b except for the following changes: 1) 2.5 
mol % aminophenol 1.19r (instead of 3 mol % 1.19r) 2) 1.5 equiv. MeOH (instead of 2.5 
equiv.). Homoallylamide 1.17j  (70.8 mg, 0.196 mmol, 98% yield) is obtained as a white 
solid. Crystals suitable for X-ray crystallography were obtained by slow evaporation of 
dichloromethane  M.p. = 130−131 °C. IR (neat): 3178 (w, br), 3076 (w), 3052 (w), 3007 
(w), 2977 (w), 2919 (w), 2882 (w), 1454 (m), 1435 (m), 1181 (s), 1123 (m), 1108 (m), 
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1078 (s), 917 (m), 899 (m), 748 (m), 723 (s), 694 (s), 561 (m), 535 (s), 497 (m) cm-1; 1H 
NMR (400 MHz, CDCl3): δ 7.88−7.75 (4H, m), 7.49−7.29 (6H, m), 7.09 (4H, app s), 
5.58 (1H, app ddt, J = 17.2 10.0, 7.2 Hz), 5.10−5.00 (2H, m), 4.33−4.26 (1H, m), 3.40 
(1H, br dd, J = 10.0, 6.4 Hz), 2.74−2.58 (2H, m), 2.31 (3H, s); 13C NMR (100 MHz, 
CDCl3): δ 140.1 (d, J = 5.7 Hz), 136.6, 133.9, 133.3 (d, J = 127.0 Hz, 1 peak hidden 
under 133.9), 132.6 (d, J = 9.6 Hz), 132.2 (d, J = 130.0 Hz), 131.9 (d, J = 9.6 Hz), 131.8 
(d, J = 3 Hz, 1 peak hidden under 131.9), 131.7 (d, J = 2.7 Hz), 129.1, 128.5 (d, J = 12.5 
Hz), 128.3 (d, J = 12.6 Hz), 126.4, 118.6, 54.5, 43.7 (d, J = 3.8 Hz), 21.1; HRMS Calcd 
for C23H25NOP [M + H]+: 362.16738; Found: 362.16709. [α]20D = +50.8 (c = 2.11, 
CHCl3) for a 96.5:3.5 er sample. The enantiomeric purity of this compound was 
determined by HPLC analysis in comparison with authentic racemic material (Chiracel 
OD−H, 92:8 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 16 min (major) and 18 min 
(minor). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 15.8 49.997 1 15.8 96.568 
2 17.9 50.003 2 18.3 3.432 
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(R)-N-(1-(4-(Dibutylamino)phenyl)but-3-en-1-yl)-P,P-diphenylphosphinic amide 
(1.17k, Table 1.5): The title compound is synthesized analogously to 1.17b except for 
the following changes: 1) 2.5 mol % aminophenol 1.19r (instead of 3 mol % 1.19r)  2) 
1.5 equiv. MeOH (instead of 2.5 equiv.). 3) Reaction time is six h. 4) After NaIO4 
workup (see representative procedure above), the unpurified mixture is treated for 12 h 
while allowing it to stir with ~ 1 g basic aluminum oxide in 4 mL 
dichloromethane:diethyl ether (1:1) to hydrolyze unreacted 1.15k, after which the 
aluminum oxide is filtered off and washed with dichloromethane and ethyl acetate (20 
mL). The product is purified as described for 1.15b, affording 1.15k (44.2 mg, 0.0931 
mmol, 93% yield) as a white solid. M.p. = 83–84 °C. IR (neat): 3154 (w, br), 3071 (w), 
2955 (m), 2930 (m), 2870 (m), 1614 (m), 1519 (m), 1455 (m), 1436 (m), 1368 (w), 1283 
(w), 1181 (s), 1107 (s), 1066 (m), 925 (m), 900 (m), 752 (w), 722 (s), 693 (s), 553 (s), 
521 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.89−7.79 (4H, m), 7.49−7.32 (6H, m), 7.03 
(2H, d, J = 8.8 Hz), 6.54 (2H, d, J = 8.8 Hz), 5.63 (1H, app ddt, J = 17.2, 10.0, 7.2 Hz), 
5.10–4.99 (2H, m), 4.26−4.19 (1H, m), 3.23 (4H, app dd, J = 7.8, 7.2 Hz), 3.26−3.21 (1H, 
m, overlapping with the dd at 3.23), 2.75−2.58 (2H, m), 1.59−1.52 (4H, m), 1.40−1.30 
(4H, app sextet, J = 7.6 Hz), 0.96 (6H, t, J = 7.6 Hz); 13C NMR (100 MHz, CDCl3): δ 
147.3, 134.6, 133.6 (d, J = 127.0 Hz), 132.6 (d, J = 9.5 Hz), 132.4 (d, J = 130.0 Hz), 
131.9 (d, J = 9.3 Hz), 131.7 (d, J = 2.7 Hz), 131.6 (d, J = 2.7 Hz), 129.2 (d, J = 6.3 Hz), 
128.4 (d, J = 12.3 Hz), 128.3 (d, J = 12.4 Hz), 127.6, 118.1, 111.5, 54.3, 50.9, 43.5 (d, J 
= 3.7 Hz), 29.5, 20.4, 14.1; HRMS Calcd for C30H40N2OP [M + H]+: 475.28782; Found: 
475.28783. [α]20D = +61.6 (c = 1.33, CHCl3) for a 92:8 er sample. The enantiomeric 
purity of this compound was determined by HPLC analysis in comparison with authentic 
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racemic material (Chiracel OD−H, 92:8 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 12 
min (major) and 14 min (minor). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 12.6 50.161 1 12.1 91.817 
2 14.7 49.839 2 13.9 8.183 
 
(R)-N-(1-(Furan-2-yl)but-3-en-1-yl)-P,P-diphenylphosphinic amide (1.17l, Table 
1.5): The title compound is synthesized and purified analogously to 1.15b (only with a 
six h reaction time) affording 1.17l (32.2 mg, 0.0955 mmol, 96% yield) as a light tan 
solid. The analytical data are fully consistent with those reported previously.141 1H NMR 
(400 MHz, CDCl3): δ 7.89–7.82 (4H, m), 7.50–7.37 (6H, m), 7.32–7.31 (1H, m), 6.25–
6.24 (1H, m), 6.12–6.11 (1H, m), 5.63 (1H, dddd, J = 17.6, 10.0, 7.6, 7.6 Hz), 5.14–5.05 
(2H, m), 4.37 (1H, dddd, J = 10.0, 10.0, 6.4, 6.4 Hz), 3.34 (1H, br dd, J = 10.4, 7.2 Hz), 
2.79–2.61 (2H, m); HRMS Calcd for C20H21NO2P [M + H]+: 338.13099; Found: 
338.13157. [α]20D	   = +53.3 (c = 1.00, CHCl3) for a 98:2 er sample.	    The enantiomeric 
purity was determined by HPLC analysis in comparison with authentic racemic material 
(Chiracel OD-H, 92:8 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 16 min (major) and 19 
min (minor). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 16.5 49.828 1 15.9 98.374 
2 19.0 50.372 2 18.5 1.626 
 
(R)-P,P-Diphenyl-N-(1-(pyridin-3-yl)but-3-en-1-yl)phosphinic amide (1.17m, Table 
1.5):  The title compound is synthesized analogously to 4b and purified analogously to 4o 
(see below).   M.p. = 133-134 °C. IR (neat): 3169 (w, br), 1438 (m), 1184 (s), 1123 (m), 
1109 (m), 1071 (m), 921 (w), 754 (w), 725 (m), 698 (m), 533 (m) cm-1; 1H NMR (400 
MHz, CDCl3): δ 8.39 (2H, br dd, J = 4.8, 1.6 Hz), 8.36 (1H, br d, J = 2.4 Hz), 7.82–7.77 
(2H, m), 7.70–7.65 (2H, m), 7.419–7.42 (2H, m), 7.40–7.34 (3H, m), 7.28–7.23 (2H, m), 
7.15–7.11 (1H, m), 5.53 (1H, dddd, J = 16.8, 10.4, 7.2, 7.2 Hz), 5.08–5.03 (2H, m), 4.35 
(1H, dddd, J = 9.6, 9.6, 6.4, 6.4 Hz), 3.33 (1H, br dd, J = 8.0, 5.6 Hz), 2.65–2.55 (2H, 
m); 13C NMR (125 MHz, CDCl3): δ 148.6 (d, J = 15.6 Hz), 138.5 (d, J = 4.5 Hz), 134.4, 
132.9, 132.7 (d, J = 127 Hz, peak overlaps with doublet at 132.06), 132.5 (d, J = 9.7 Hz), 
132.2 (d, J = 2.2 Hz), 132.1 (d, J = 2.9 Hz), 131.9 (d, J = 8.9 Hz), 131.8 (d, J = 127 Hz, 
peak overlaps with doublet at 132.5), 128.7 (d, J = 12.6 Hz), 128.5 (d, J = 12.7 Hz), 
123.4, 119.9, 52.5, 43.4 (d, J = 4.5 Hz); HRMS Calcd for C21H22N2OP [M + H]+: 
349.14697; Found: 349.14651. [α]25D = +45.2 (c = 1.00, CHCl3) for a 98:2 er sample. 
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The enantiomeric purity of this compound was determined by HPLC analysis in 
comparison with authentic racemic material (Chiralpak AD-H, 86:14 hexanes:i-PrOH, 
0.6 mL/min, 220 nm): tR of 4l: 38 min (major) and 43 min (minor).  
  
 
 
 
(R)-P,P-Diphenyl-N-(1-(pyridin-4-yl)but-3-en-1-yl)phosphinic amide (1.17n, Table 
1.5): The title compound is synthesized analagously to 1.15b and purified by silica gel 
chromatography (10 mm diameter column slurry packed with 2.5 g of silica gel in 95:5 
hexanes:triethylamine and eluted with 50 1:1 mL hexanes:diethyl ether, 20 mL diethyl 
ether, 5 mL dichloromethane, 20 mL 98:2 dichloromethane:triethylamine, and 40 mL 
96:4 dichloromethane:triethylamine) to afford 1.17n (26.1 mg, 0.0749 mmol, 75% yield) 
as a white solid. M.p. = 84 ºC (decomp). IR(neat): 3142 (w, br), 3073 (w, br), 3056 (w, 
br), 2919 (w, br), 1596 (w), 1458 (w), 1438 (m), 1412 (w), 1180 (m), 1121 (m), 1107 
(m), 1068 (m), 993 (m), 905 (m), 817 (m), 751 (m), 723 (s), 693 (s), 601 (m), 545 (s), 
521 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 8.53 (2H, br s), 7.90–7.84 (2H, m), 7.79–
7.73 (2H, m), 7.55–7.50 (1H, m), 7.48–7.42 (3H, m); 7.36–7.31 (2H, m), 7.17–7.15 (2H, 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 36.2 min 49.809 1 39.1 min 98.360 
2 40.8 min 50.191 2 43.1 min 1.640 
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m); 5.61–5.51 (1H, m), 5.17–5.11 (2H, m), 4.36 (1H, m), 3.42 (1H, br dd, J = 9.9, 5.7 
Hz), 2.70–2.59 (2H, m); 13C NMR (100 MHz, CDCl3): δ 152.1 (d, J = 4.7 Hz), 149.9, 
132.6 (d, J ~ 128 Hz, more upfield peak is overlapping with the peak at 131.9), 132.5 (d, 
J = 8.6 Hz), 132.4, 132.3 (d, J = 2.8 Hz), 132.2 (d, J = 2.9 Hz), 131.97 (d, J = 9.5 Hz), 
131.9 (d, J = 130.5 Hz), 128.8 (d, J = 12.5 Hz), 128.6 (d, J = 12.7 Hz), 121.9, 120.2, 
53.5, 43.1 (d, J = 4.5 Hz);  HRMS Calcd for C21H22N2OP [M + H]+: 349.14697; Found: 
349.14696. [α]25D = + 43 (c = 0.47, CHCl3) for a 98.5:1.5 er sample. The enantiomeric 
purity of this compound was determined by HPLC analysis in comparison with authentic 
racemic material (Chiracel AD-H, 9:1 hexanes:i-PrOH, 0.8 mL/min, 220 nm): tR: 44.3 
min (major) and 59.3 min (minor). 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1  45.2 49.342 1  44.3 98.682 
2  59.8 50.658 2  59.3 1.318 
 
(R)-N-(3-Methyl-1-phenylbut-3-en-1-yl)-P,P-diphenylphosphinic amide (1.23a, 
Table 1.8): The title compound is synthesized and purified analogously to 1.15b [except 
allylboronic acid pinacol ester 1.22a (32 µL, 0.15 mmol) is used as the nucleophile 
instead of 1.6], affording 1.23a (34.4 mg, 0.0952 mmol, 95% yield) as a white solid. The 
analytical data are fully consistent with those reported previously.141 1H NMR (400 MHz, 
CDCl3): δ 7.86–7.80 (2H, m), 7.76–7.70 (2H, m), 7.50–7.46 (1H, m), 7.44–7.38 (3H, m), 
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7.29–7.17 (7H, m), 4.78 (1H, s), 4.69 (1H, s), 4.40 (1H, dddd, J = 16.4, 16.4, 8.4, 8.4 
Hz), 3.32 (1H, br dd, J = 8.0, 6.0 Hz), 2.62 (1H, dd, J = 13.6, 7.2 Hz), 2.53 (1H, dd, J = 
14.0, 7.2 Hz), 1.58 (3H, s); HRMS Calcd for C23H25NOP [M + H]+: 362.16738; Found: 
362.16649. [α]20D	   = +39 (c = 1.2, CHCl3) for a 97.5:2.5 er sample.	    The enantiomeric 
purity was determined by HPLC analysis in comparison with authentic racemic material 
(Chiracel OD-H, 92:8 hexanes:i-PrOH, 0.8 mL/min, 220 nm): tR: 11 min (major) and 14 
min (minor). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 9.90 49.583 1 10.8 98.206 
2 12.1 50.417 2 14.1 1.792 
 
(R)-N-(1,3-Diphenylbut-3-en-1-yl)-P,P-diphenylphosphinic amide (1.23b, Table 1.8): 
The title compound is synthesized and purified analogously to 1.15b [except allylboronic 
acid pinacol ester 1.22b (37 µL, 0.15 mmol) is used as the nucleophile instead of 1.6 and 
the reaction time is 6 h] affording 4n (42.1 mg, 0.0994 mmol, >98% yield) as a white 
foam. The analytical data are fully consistent with those reported previously.141 1H NMR 
(400 MHz, CDCl3): δ 7.76–7.70 (4H, m), 7.47–7.40 (2H, m), 7.37–7.30 (4H, m), 7.27–
7.16 (8H, m), 7.07–7.00 (2H, m), 5.21 (1H, d, J = 1.2 Hz), 4.87 (1H, d, J = 1.2 Hz), 4.27 
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(1H, dddd, J = 8.4, 8.4, 6.4, 6.4 Hz), 3.29 (1H, br dd, J = 8.8, 5.6 Hz), 3.25 (1H, dd, J = 
14.0, 6.0 Hz), 2.99 (1H, dd, J = 14.0, 8.0 Hz); HRMS Calcd for C28H27NOP [M + H]+: 
424.18303; Found: 424.18255. [α]20D	  = +26 (c = 1.7, CHCl3) for a 98:2 er sample.	   The 
enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiracel OD-H, 92:8 hexanes:i-PrOH, 0.8 mL/min, 220 nm): tR: 15 
min (minor) and 16 min (major). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 13.3 50.107 1 14.5 3.286 
2 15.5 49.893 2 16.4 96.714 
 
(R,E)-P,P-Diphenyl-N-(1-phenylhexa-1,5-dien-3-yl)phosphinic amide (1.21a, Table 
1.6): The title compound is synthesized and purified analogously to 1.15b afford 1.21a 
(31.3 mg, 0.0838 mmol, 84% yield) as a white solid. The analytical data are fully 
consistent with those reported previously.141 1H NMR (400 MHz, CDCl3): δ 7.96–7.87 
(4H, m), 7.51–7.39 (6H, m), 7.31–7.26 (4H, m), 7.24–7.21 (1H, m), 6.46–6.42 (1H, m), 
6.15 (1H, ddd, J = 15.9, 6.3, 2.4 Hz), 5.78 (1H, dddd, J = 14.4, 7.6, 6.8, 6.8 Hz), 5.20–
5.12 (2H, m), 4.01–3.92 (1H, m), 3.09 (1H, br dd, J = 9.6, 6.0 Hz), 2.59–2.45 (2H, m); 
HRMS Calcd for C24H25NOP [M + H]+: 374.16738; Found: 374.16756. [α]20D	  = +89 (c = 
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0.65, CHCl3) for a 99:1 er sample.	    The enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material (Chiracel OD, 92:8 hexanes:i-
PrOH, 0.6 mL/min, 220 nm): tR: 17 min (major) and 21 min (minor). 
      
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 16.3 49.181 1 16.8 99.084 
2 19.5 50.819 2 20.7 0.916 
 
(R,E)-N-(1-(2-Nitrophenyl)hexa-1,5-dien-3-yl)-P,P-diphenylphosphinic amide 
(1.21b, Table 1.6): The title compound is purified identically to 1.15b affording 1.21b 
(39.6 mg, 0.095 mmol, 95% yield) as a white solid. M.p. = 135 °C. IR (neat): 3149 (m, 
br), 3067 (w), 2857 (w), 1641 (w), 1605 (w), 1571 (w), 1520 (s), 1436 (m), 1350 (m), 
1178 (s), 1123 (m), 1106 (m), 1067 (m), 952 (m), 918 (m), 745 (m), 724 (s), 691 (s), 541 
(s) cm-1; 1H NMR (400 MHz, CDCl3): δ 8.00−7.88 (5H, m), 7.55−7.35 (9H, m), 7.01 
(1H, dd, J = 16.0, 1.6 Hz), 6.17 (1H, dd, J = 15.6, 5.6 Hz), 5.80 (1H, dddd, J = 16.8, 10.0, 
7.6, 6.4 Hz), 5.22−5.14 (2H, m), 4.02−3.96 (1H, m), 3.16 (1H, br dd, J = 9.6, 5.6 Hz), 
2.62−2.49 (2H, m); 13C NMR (100 MHz, CDCl3): δ 147.7, 137.0 (d, J = 6.0 Hz), 133.3, 
133.3, 132.9, 132.9 (d, J = 128.0 Hz), 132.5 (d, J = 9.4 Hz), 132.4 (d, J = 130.0 Hz), 
132.0 (2 d peaks exactly overlapping, J = 3 Hz), 132.0 (d, J = 9.3 Hz), 129.2, 128.7 (2 d 
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peaks exactly overlapping, J = 12.6 Hz), 128.2, 125.9, 124.6, 119.5, 52.5, 42.0 (d, J = 4.2 
Hz); HRMS Calcd for C24H24N2O3P [M + H]+: 419.15245; Found: 419.15207. [α]20D = 
+94.4 (c = 1.00, CHCl3) for a 99.5:0.5 er sample. The enantiomeric purity of this 
compound was determined by HPLC analysis in comparison with authentic racemic 
material (Chiracel OD−H, 92:8 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR :30 min 
(minor) and 32 min (major). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 29.6 49.698 1 30.0 0.321 
2 32.7 50.302 2 32.2 99.679 
  
(R,E)-N-(1-(4-Methoxyphenyl)hexa-1,5-dien-3-yl)-P,P-diphenylphosphinic amide 
(1.21c, Table 1.6): The title compound is purified identically to 1.15b affording 1.21c 
(39.4 mg, 0.098 mmol, 98% yield) as a white solid. M.p. = 134 °C. IR (neat): 3180 (w, 
br), 3059 (w), 2929 (w), 2837 (w), 1607 (w), 1509 (m), 1433 (m), 1248 (m), 1185 (s), 
1124 (m), 1108 (m), 1069 (m), 1031 (m), 976 (m), 912 (w), 811 (m), 745 (m), 725 (s), 
693 (s), 541 (s), 516 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.96−7.86 (4H, m), 
7.51−7.37 (6H, m), 7.22 (2H, d, J = 8.8 Hz), 6.82 (2H, d, J = 8.4 Hz), 6.37 (1H, d, J = 
15.6 Hz), 6.01 (1H, dd, J = 16.0, 6.4 Hz), 5.79 (1H, dddd, J = 17.2, 10.4, 7.6, 7.2 Hz), 
5.19−5.10 (2H, m), 3.94 (1H, m), 3.80 (3H, s), 3.08 (1H, br dd, J = 9.6, 6.0 Hz), 
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2.58−2.43 (2H, m); 13C NMR (100 MHz, CDCl3): δ 159.3, 133.9, 133.3 (d, J = 127.0 
Hz), 132.7 (d, J = 130.0 Hz), 132.6 (d, J = 9.4 Hz), 132.0 (d, J = 9.5 Hz), 131.9 (d, J = 
2.8 Hz), 131.8 (d, J = 2.8 Hz), 129.9, 129.6, 129.3 (d, J = 5.7 Hz), 128.6 (d, J = 12.4 Hz), 
128.5 (d, J = 12.6 Hz), 127.7, 119.0, 114.0, 55.4, 52.9, 42.4 (d, J = 4.5 Hz); HRMS Calcd 
for C25H27NO2P [M + H]+: 404.17794; Found: 404.17730. [α]20D = +128.2 (c = 1.00, 
CHCl3) for a 99:1 er sample. The enantiomeric purity of this compound was determined 
by HPLC analysis in comparison with authentic racemic material (Chiracel OD−H, 95:5 
hexanes:i-PrOH, 0.2 mL/min, 220 nm): tR: 98 min (major) and 108 min (minor). 
 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 98.4 48.621 1 98.0 99.431 
2 105.9 51.379 2 108.1 0.569 
 
(R,Z)-N-(2-Bromo-1-phenylhexa-1,5-dien-3-yl)-P,P-diphenylphosphinic amide 
(1.21d, Table 1.6): The title compound is purified identically to 1.15b affording 1.21d 
(43.4 mg, 0.096 mmol, 96% yield) as a white solid. M.p. = 123 °C. IR (neat): 3133 (m, 
br), 3077 (w), 3056 (w), 2910 (w), 2861 (w), 1643 (w), 1591 (w), 1458 (w), 1434 (m), 
1182 (s), 1123 (m), 1105 (m), 1088 (m), 984 (m), 952 (m), 916 (m), 865 (m), 746 (m), 
723 (s), 691 (s), 594 (m), 568 (m), 536 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 
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7.95−7.85 (4H, m), 7.54−7.28 (11H, m), 6.56 (1H, s), 5.74 (1H, ddt, J = 17.2, 10.0, 7.2 
Hz), 5.19−5.08 (2H, m), 4.04−3.95 (1H, m), 3.40 (1H, br dd, J = 9.6, 8.4 Hz), 2.68−2.51 
(2H, m); 13C NMR (100 MHz, CDCl3): δ 135.1, 133.3, 133.0 (d, J = 127.0 Hz), 132.8 (d, 
J = 9.8 Hz), 132.2 (d, J = 2.7 Hz), 132.1 (d, J = 2.9 Hz), 131.9 (d, J = 130.0 Hz), 131.8 
(d, J = 9.6 Hz), 129.7 (d, J = 5.4 Hz), 129.4, 129.1, 128.7 (d, J = 12.5 Hz), 128.5 (d, J = 
12.8 Hz), 128.2, 128.1, 118.6, 58.8, 41.3 (d, J = 4.3 Hz); HRMS Calcd for C24H24BrNOP 
[M + H]+: 452.07789; Found: 452.07908. [α]20D = +7.5 (c = 1.00, CHCl3) for a 98:2 er 
sample. The enantiomeric purity of this compound was determined by HPLC analysis in 
comparison with authentic racemic material (Chiracel OD−H, 92:8 hexanes:i-PrOH, 0.5 
mL/min, 220 nm): tR: 14 min (major) and 19 min (minor). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 13.8 49.618 1 13.9 98.297 
2 19.1 50.382 2 19.5 1.703 
 
(R,E)-N-(2-Methyl-1-phenylhexa-1,5-dien-3-yl)-P,P-diphenylphosphinic amide 
(1.21e): Following the NaIO4 workup (see general procedure above), the crude product is 
treated overnight under stirring with ~ 1 g basic aluminum oxide in 4 ml 
dichloromethane:ether (1:1) to hydrolyze unreacted 1.20e, after which the aluminum 
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oxide id filtered off and washed with dichloromethane and 20 ml ethyl acetate.  After 
removal of the solvent in vacuo, the title compound is purified identically to 1.15b, 
affording 1.21e (30.2 mg, 0.0779 mmol, 78% yield) as a white solid. M.p. = 116–117 ºC. 
IR (neat): 3172 (m, br), 3055 (w), 2925 (w), 2907 (w), 2882 (w), 2856 (w), 1457 (w), 
1447 (w), 1434 (m), 1181 (s), 1122 (m), 1106 (s), 1085 (m), 988 (m), 918 (m), 747 (m), 
722 (s), 694 (s), 635 (m), 566 (m), 540 (s), 522 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 
7.95–7.86 (4H, m), 7.52–7.38 (6H, m), 7.31 (2H, m), 7.20 (1H, m), 7.13 (2H, m), 6.22 
(1H, s), 5.75 (1H, dddd, J = 17.2, 10.4, 7.6, 7.6 Hz), 5.17–5.09 (2H, m), 3.85 (1H, m), 
3.14 (1H, br dd, J = 9.2, 5.6 Hz), 2.61–2.42 (2H, m), 1.80 (3H, d, J = 1.2 Hz); 13C NMR 
(100 MHz, CDCl3): δ 138.1 (d, J = 4.4 Hz), 137.7, 134.1, 133.3 (d, J ~ 126 Hz, 2 peaks 
overlapping), 132.7 (d, J = 9.6 Hz), 132.5 (d, J ~ 130 Hz, 2 peaks overlapping), 132.0 (d, 
J ~ 2.7 Hz, two peaks overlapping), 131.9 (d, J = 9.3 Hz), 131.9 (d, J ~ 3.2 Hz, two peaks 
overlapping), 129.0, 128.6 (d, J = 12.5 Hz), 128.45 (d, J = 12.6 Hz), 128.12, 127.09, 
126.49, 118.36, 58.10, 40.51 (d, J = 4.8 Hz), 14.22; HRMS Calcd for C25H27NOP [M + 
H]+: 388.18303; Found: 388.18165. [α]25D = + 31.5 (c = 1.00, CHCl3) for a 92.5:7.5 er 
sample. The enantiomeric purity of this compound was determined by HPLC analysis in 
comparison with authentic racemic material (Chiracel OD-H, 92:8 hexanes:i-PrOH, 0.5 
mL/min, 220 nm): tR: 15.5 min (major) and 22.8 min (minor).  
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 15.6 49.087 1 15.5 92.524 
2 22.5 50.913 2 22.8 7.476 
 
(R,E)-N-(Nona-1,5-dien-4-yl)-P,P-diphenylphosphinic amide (1.21f, Table 1.6): The 
title compound is purified identically to 1.15b affording 1.21f from freshly prepared 
1.20f (except 2.5 mol % aminophenol 1.19r used in the reaction instead of 3.0 mol %) 
affording 1.21f (32.7 mg, 0.096 mmol, 96% yield) as a white solid. Crystals suitable for 
x-ray crystallography were obtained by vapor diffusion from a dichloromethane/hexane 
solvent system at 22 ºC. M.p. = 87 °C. IR (neat): 3121 (m, br), 3057 (w), 2953 (w), 2928 
(w), 2868 (w), 1639 (w), 1590 (w), 1458 (m), 1436 (m), 1198 (m), 1182 (m), 1107 (m), 
1065 (m), 966 (m), 909 (m), 753 (w), 719 (s), 691 (s), 565 (m), 524 (s) cm-1; 1H NMR 
(400 MHz, CDCl3): δ 7.94−7.83 (4H, m), 7.50−7.38 (6H, m), 5.74 (1H, dddd, J = 17.2, 
10.4, 8.0, 6.8 Hz), 5.50 (1H, dtd, J = 15.2, 6.4, 0.8 Hz), 5.39 (1H, ddt, J = 15.6, 6.0, 1.0 
Hz), 5.15−5.07 (2H, m), 3.78−3.68 (1H, m), 2.93 (1H, br dd, J = 9.6, 6.0 Hz), 2.47−2.31 
(2H, m), 1.94 (2H, quartet, J = 6.8 Hz), 1.33 (2H, app sextet, J = 7.2 Hz), 0.86 (3H, t, J = 
7.2 Hz); 13C NMR (100 MHz, CDCl3): δ 134.1, 133.4 (d, J = 127.0 Hz), 132.9 (d, J = 
130.0 Hz), 132.6 (d, J = 9.4 Hz), 132.0 (d, J = 9.5 Hz), 131.8 (2 d exactly overlapping, J 
= 2.5 Hz), 131.7 (d, J = 5.7 Hz), 131.5, 128.5 (d, J = 12.5 Hz), 128.5 (d, J = 12.5 Hz), 
118.4, 52.6, 42.7 (d, J = 4.5 Hz), 34.4, 22.4, 13.8; HRMS Calcd for C21H27NOP [M + 
H]+: 340.18303; Found: 340.18359. [α]20D = +7.40 (c = 1.00, CHCl3) for a 98:2 er 
sample. The enantiomeric purity of this compound was determined by HPLC analysis in 
comparison with authentic racemic material (Chiracel OD−H, 98.5:1.5 hexanes:i-PrOH, 
0.15 mL/min, 220 nm): tR: 175 min (major) and 193 min (minor). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 170.6 49.503 1 175.0 98.210 
2 181.4 50.497 2 193.4 1.790 
 
(R)-P,P-Diphenyl-N-(1-phenylhex-5-en-1-yn-3-yl)phosphinic amide (1.21g, Table 
1.6): The title compound is purified identically to 1.15b affording 1.21g (33.9 mg, 0.0913 
mmol, 91% yield) as a yellow solid. M.p. = 105–107 ºC.  IR (neat): 3132 (m, br), 3076 
(w), 3055 (w), 2913 (w), 2857 (w), 1641 (w), 1591 (w), 1488 (m), 1312 (m), 1181 (s), 
1125 (s), 1107 (s), 1070 (m), 945 (m), 747 (s), 725 (s), 690 (s), 530 (s) cm-1; 1H NMR 
(400 MHz, CDCl3): δ 8.04–7.99 (2H, m), 7.89–7.84 (2H, m), 7.52–7.40 (6H, m), 7.35–
7.32 (2H, m), 7.32–7.24 (3H, m) 5.97 (1H, dddd, J = 17.0, 10.0, 7.6, 6.9 Hz), 5.29–5.19 
(2H, m), 4.31–4.23 (1H, m), 3.37 (1H, dd, J = 10.1, 8.3 Hz), 2.70–2.53 (2H, m); 13C 
NMR (100 MHz, CDCl3): δ 133.2, 133.0 (d, J = 127.6 Hz), 132.9 (d, J = 9.8 Hz), 132.1 
(d, J = 2.7 Hz), 132.0 (d, J = 130.4 Hz), 131.8 (d, J = 9.8 Hz, only the peak at 131.9 is 
visible, the other is overlapping), 131.8, 128.8 (d, J = 12.6 Hz), 128.8 (d, J = 12.9 Hz), 
128.4 (d, J = 5.5 Hz, only the peak at 128.4 is visible, the other is overlapping), 122.9, 
119.7, 89.7 (d, J = 8.0 Hz), 84.1, 43.4, 42.9 (d, J = 3.5 Hz); HRMS Calcd for C24H23NOP 
[M + H]+: 372.15173; Found: 372.15177. [α]20D	  = -100 (c = 0.85, CHCl3) for a 88:12 er 
sample.	    The enantiomeric purity was determined by HPLC analysis in comparison with 
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authentic racemic material (Chiracel OD, 97:3 hexanes:i-PrOH, 0.8 mL/min, 220 nm): tR: 
27 min (minor) and 30 min (major). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 26.5 48.389 1 27.0 11.961 
2 30.1 51.611 2 29.5 88.039 
 
Representative Procedure for Enantioselective Allyl Additions to Alkyl-Substituted 
N-Diphenylphosphinoyl Imines: 136 
 
 
 
Preparation of the alkyl-substituted aldimine: A six-dram vial equipped with an 11 x 4 
mm stir bar is charged with sulfinyl adduct (eq. 1, 0.4 mmol) to which is added CH2Cl2 
(8.0 mL) and a saturated aqueous solution of NaHCO3 (8.0 mL) consecutively.  The 
biphasic mixture is allowed to stir vigorously enough for the solution to be homogeneous 
for 3 h at 22 °C.  The organic layer is separated and the aqueous phase is washed with 
CH2Cl2 (3 x 5 mL). The combined organic layers are dried over MgSO4.  The volatiles 
Me
S
O
O
NHPOPh2
sat. aq. NaHCO3
CH2Cl2, 3h, 22 ºC
NPOPh2
(19)Ph Ph
1.20h
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are removed under reduced pressure and the unpurified imine is azeotropically dried 
under vacuum with anhydrous benzene to afford aldimine 1.20h as light yellow oil 
(>98% conversion and yield are assumed). The vessel containing 1.20h is sealed with a 
rubber septum and anhydrous toluene (2 mL) is added to prepare a stock solution of 0.1 
mmol 1.20h/500. µL toluene.  
Preparation of catalyst solution (small scale): In a nitrogen-filled glovebox (not needed 
for gram scale; only used when reactions are performed at mg scale to achieve highly 
reproducible data), aminophenol 1.19r (6.9 mg, 0.023 mmol) is added to an oven-dried 
two-dram vial equipped with a stir bar followed by 1.5 mL of a stock solution of NaOt-
Bu in toluene (9.6 mg, 0.10 mmol/8.0 mL). The vial is sealed with a cap (phenolic open 
top cap with a red PFTE/white silicone septa) and electrical tape and allowed to stir under 
nitrogen at 22 ºC for ~10 minutes.  
An oven-dried two-dram vial equipped with a stir bar and sealed with a cap (phenolic 
open top cap with a red PFTE/white silicone septa) and electrical tape is charged with 
toluene (100. µL), methanol (10. µL, 0.25 mmol), and allylboronic acid pinacol ester (28 
µL, 0.15 mmol).  To this mixture is added 500. µL of the stock solution of aldimine 
1.20h (described above), followed by 400. µL of the catalyst solution (described above) 
of [1.19r (1.82 mg, 6.00 µmol) and NaOt-Bu (0.48 mg, 5.0 µmol)]. The clear and 
colorless solution is allowed to stir at 22 ºC for four h during which time no visible 
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change occurs. The cap is removed and 3 mL of saturated aqueous NaIO4 is added and 
the biphasic mixture is allowed to stir for 20 minutes. The aqueous layer is washed with 
ethyl acetate (4 x 4 mL), and the combined organic layers are dried over Na2SO4 and 
concentrated in vacuo. The resulting yellow oil was purified by silica gel chromatography 
(10 mm diameter column slurry packed with 2.5 g of silica gel in 95:5 
hexanes:triethylamine and eluted with 10 mL hexanes, 10 mL 3:1 hexanes:ethyl acetate, 
10 mL 2:1 hexanes:ethyl acetate, 10 mL 1:1 hexanes:ethyl acetate, and 10 mL ethyl 
acetate) to afford 1.21h (19.2 mg, 0.0511 mmol, 51% yield) as a white solid. 
(S)-P,P-Diphenyl-N-(1-phenylhex-5-en-3-yl)phosphinic amide (1.21h, Table 1.6): The 
analytical data are fully consistent with those reported previously.141 1H NMR (400 MHz, 
CDCl3): δ 7.91–7.84 (4H, m), 7.49–7.39 (6H, m), 7.24–7.19 (2H, m), 7.15–7.10 (3H, m), 
5.78 (1H, dddd, J = 17.2, 10.4, 7.6, 7.6 Hz), 5.14–5.09 (2H, m), 3.25–3.16 (1H, m), 2.82 
(1H, br dd, J = 10.8, 6.4 Hz), 2.73–2.57 (2H, m), 2.39–2.35 (2H, m), 1.86–1.80 (2H, m); 
HRMS Calcd for C24H27NOP [M + H]+: 376.18303; Found: 376.18135. [α]20D = –2.6 (c 
= 0.43, CHCl3) for a >99:1 er sample.	  The enantiomeric purity of this compound was 
determined by HPLC analysis in comparison with authentic racemic material (Chiracel 
OD-H, 95:5 hexanes:i-PrOH, 0.6 mL/min, 220 nm): tR: 22 min (major) and 28 min 
(minor). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 22.9 50.002 1 22.3 99.421 
2 27.8 49.998 2 28.1 0.579 
 
(S)-N-(6-Methylhept-1-en-4-yl)-P,P-diphenylphosphinic amide (1.21i, Table 1.6): 
The title compound is purified identically to 1.21h affording 1.21i (17.7 mg, 0.0540 
mmol, 54% yield) as a white solid. The analytical data are fully consistent with those 
reported previously.141 1H NMR (400 MHz, CDCl3): δ 7.93–7.87 (4H, m), 7.51–7.41 
(6H, m), 5.79 (1H, dddd, J = 17.6, 10.4, 7.6, 7.6 Hz), 5.14–5.10 (2H, m), 3.25–3.14 (1H, 
m), 2.75 (1H, br dd, J = 10.8, 6.0 Hz), 2.39–2.28 (2H, m), 1.84–1.70 (1H, m), 1.42–1.29 
(2H, m), 0.80 (3H, d, J = 6.6 Hz), 0.76 (3H, d, J = 6.5 Hz); HRMS Calcd for C20H27NOP 
[M + H]+: 328.18303; Found: 328.18398. [α]20D = –38 (c = 0.73, CHCl3) for a 98.5:1.5 er 
sample.	   The enantiomeric purity of this compound was determined by HPLC analysis in 
comparison with authentic racemic material (Chiracel OD-H, 95:5 hexanes:i-PrOH, 0.6 
mL/min, 220 nm): tR of S15: 13 min (minor) and 14 min (major). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 12.7 48.675 1 13.3 0.875 
2 13.4 51.325 2 14.1 99.125 
 
(R)-N-(1-Cyclohexylbut-3-en-1-yl)-P,P-diphenylphosphinic amide (1.21j, Table 1.6): 
The title compound is synthesized and purified identically to 1.21g (except 8.5 mol % of 
NaOt-Bu is used in the reaction instead of 5 mol %) affording 1.21j (27.2 mg, 0.0769 
mmol, 77% yield) as a white solid. M.p. = 120–122 °C. IR (neat): 3207 (w, br), 3075 (w), 
3057 (w), 2921 (m), 2850 (m), 1639 (w), 1436 (s), 1187 (s), 1123 (s), 1108 (s), 1067 (m), 
994 (w), 909 (m), 722 (s), 694 (s), 533 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.93–
7.87 (4H, m), 7.50–7.42 (6H, m), 5.77 (1H, dddd, J = 17.3, 10.1, 7.3, 7.3 Hz), 5.12–5.06 
(2H, m), 3.02–2.87 (1H, m), 2.77 (1H, br dd, J = 10.7, 6.1 Hz), 2.09 (2H, app t, J = 6.5 
Hz), 1.82–1.61 (5H, m), 1.46–1.41 (1H, m), 1.24–1.15 (4H, m), 0.98-0.92 (1H, m); 13C 
NMR (100 MHz, CDCl3): δ 135.1, 133.3 (d, J = 128.7 Hz), 133.2 (d, J = 129.8 Hz, only 
peak at 132.8 is visible, the other is overlapping), 132.5 (d, J = 9.3 Hz), 132.3 (d, J = 9.3 
Hz), 131.80 (d, J = 1.4 Hz), 131.78 (d, J = 1.4 Hz), 127.50 (d, J = 12.5 Hz), 127.48 (d, J 
= 12.5 Hz), 117.8, 55.9 (d, J = 2.2 Hz), 42.1 (d, J = 5.1 Hz), 38.5 (d, J = 4.2 Hz), 29.5, 
28.8, 26.6, 26.5, 26.4; HRMS Calcd for C22H29NOP [M + H]+: 354.19868; Found: 
354.19835. [α]20D	  = –21 (c = 0.78, CHCl3) for a 97.5:2.5 er sample.	    The enantiomeric 
purity of this compound was determined by HPLC analysis in comparison with authentic 
racemic material (Chiracel OD-H, 95:5 hexanes:i-PrOH, 0.6 mL/min, 220 nm): tR of S16: 
11 min (minor) and 14 min (major). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 11.3 50.004 1 10.8 2.631 
2 15.5 49.996 2 14.3 97.369 
 
(R,E)-N-(2-Methyl-1-(2-methylthiazol-4-yl)hexa-1,5-dien-3-yl)-P,P-
diphenylphosphinic amide (1.21k, Table 1.7): The title compound is synthesized 
analogously to 1.21k except for the following changes: 1) The aminophenol catalyst 
1.19s is employed as a catalyst instead of 1.19r. 2) 20 mol % of NaOt-Bu is used in the 
reaction instead of 3 mol %. 3) Reaction time is six h. The product is purified by silica 
gel chromatography (10 mm diameter column slurry packed with 2.5 g of silica gel in 
95:5 hexanes:triethylamine and eluted with 10 mL hexanes, 10 mL 1:1 hexanes:ethyl 
acetate, 15 mL diethyl ether, 6 mL ethyl acetate and 16 mL 5:1 ethyl acetate:MeOH) to 
afford 1.21k (37.7 mg, 0.0923 mmol, 92% yield) as a pale yellow oil. IR (neat): 3357 (w, 
br), 3193 (w, br), 3076 (w), 3058 (w), 2966 (w), 2926 (w), 2871 (w), 1574 (w), 1437 (m), 
1184 (s), 1121(m), 1108 (m), 952 (m), 910 (m), 723 (s), 694 (s), 525 (s) cm-1; 1H NMR 
(400 MHz, CDCl3): δ 7.92–7.84 (4H, m), 7.40–7.37 (6H, m), 6.83 (1H, s), 6.30 (1H, s), 
5.70 (1H, dddd, J = 17.1, 9.9, 7.2, 7.2 Hz), 5.14–5.06 (2H, m), 3.81 (1H, dddd, J = 9.4, 
9.4, 6.6, 6.6 Hz), 3.16 (1H, dd, J = 9.5, 5.6 Hz), 2.69 (3H, s), 2.60–2.53 (1H, m), 2.50–
2.43 (1H, m), 2.00 (3H, s); 13C NMR (100 MHz, CDCl3): δ 164.5, 152.9, 139.9 (d, J = 
5.0 Hz), 133.9, 133.1 (d, J = 127.6 Hz), 132.6 (d, J = 9.5 Hz), 132.4 (d, J = 131.1 Hz), 
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131.9 (d, J = 9.5 Hz), 131.9 (d, J = 2.8 Hz), 131.8 (d, J = 2.8 Hz), 128.6 (d, J = 12.6 Hz), 
128.5 (d, J = 12.7 Hz), 120.2, 118.6, 115.7, 58.0, 40.4 (d, J = 4.3 Hz), 19.3, 15.5; HRMS 
Calcd for C24H26N2OPS1 [M + H]+: 409.15034; Found: 409.15018. [α]20D	   = +94 (c = 
0.45, CHCl3) for a 95:5 er sample.	    The enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material (Chiracel AD, 86:14 hexanes:i-
PrOH, 0.5 mL/min, 220 nm): tR: 25 min (minor) and 35 min (major). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 25.4 49.688 1 25.3 4.741 
2 35.7 50.312 2 35.3 95.259 
 
(R,E)-N-(4,4-Dideuterio-2-methyl-1-(2-methylthiazol-4-yl)hexa-1,5-dien-3-yl)-P,P-
diphenylphosphinic amide (d2–1.21k, Equation 2): The title compound is synthesized 
and purified analogously to 4o, except 1,1-dideuterioallylboronic acid pinacol ester (d2-
1a) is used as the nucleophile (contaminated with ~50% vinylboronic acid pinacol ester). 
The reaction proceeded to 85% conversion (based on 400 MHz 1H NMR analysis and 
affords d2-4o (24.5 mg, 0.0597 mmol, 60% yield) in 95:5 α:γ addition products (see 
above; determined by 2H NMR) as yellow oil. The following analytical data is for α 
addition product α−d2-4o, unless otherwise noted. IR (neat): 3357 (w, br), 3193 (w, br), 
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3076 (w), 3058 (w), 2966 (w), 2926 (w), 2871 (w), 1574 (w), 1437 (m), 1184 (s), 
1121(m) 1108 (m), 910 (m), 723 (s), 694 (s), 525 (s) cm-1; 1H NMR (400 MHz, CDCl3): 
δ 7.95–7.85 (4H, m), 7.51–7.36 (6H, m), 6.84 (1H, s), 6.31 (1H, s), 5.70 (1H, dd, J = 
17.1, 10.1 Hz), 5.15–5.07 (2H, m), 3.79 (1H, app t, J = 9.6 Hz), 3.16 (1H, dd, J = 9.8, 5.6 
Hz), 2.70 (3H, s), 2.60–2.53 (1H, m), 2.50–2.43 (γ-addition product; 0.17 H, m), 2.00 
(3H, s); 13C NMR (100 MHz, CDCl3): δ 164.6, 152.9, 139.9 (d, J = 5.1 Hz), 133.8, 133.0 
(d, J = 127.7 Hz), 132.6 (d, J = 9.5 Hz), 132.4 (d, J = 131.1 Hz), 132.0 (d, J = 9.5 Hz), 
132.0 (d, J = 2.9 Hz), 131.9 (d, J = 2.6 Hz), 128.6 (d, J = 12.6 Hz), 128.5 (d, J = 12.7 
Hz), 120.2, 118.7, 115.7, 57.9, 40.4–39.2 (m), 19.4, 15.5; 2H NMR (76 MHz, 9:1 
CHCl3:CDCl3): δ 5.22–5.08 (γ-addition product; 0.09H, m), 2.51 (α-addition product; 
2H, d, J = 6.1 Hz); HRMS Calcd for C24H24D2N2OPS [M + H]+: 411.16290; Found: 
411.16232. [α]20D	  = +47 (c = 0.73, CHCl3) for a 95:5 er sample.	   The enantiomeric purity 
was determined by HPLC analysis in comparison with authentic racemic material 
(Chiracel AD-H, 86:14 hexanes:i-PrOH, 0.5 mL/min, 254 nm): tR: 25 min (minor) and 35 
min (major). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 24.6 49.354 1 24.2 4.425 
2 34.5 50.646 2 33.7 95.575 
 
■  Representative Procedure for Enantioselective Allyl Additions with 
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Enantiomerically Enriched Allylboronates (Table 1.11, Table 1.12):  Preparation of 
catalyst solution and allylboronate solution: Under an atmosphere of nitrogen, 
aminophenol 1.19r (6.1 mg, 0.02 mmol) is added to an oven-dried two-dram vial 
equipped with a stir bar followed by 1.0 mL of a stock solution of NaOt-Bu in toluene 
(9.6 mg, 0.010 mmol/6.0 mL) and the solution is allowed to stir at 22 ºC for ~10 minutes.  
In a separate oven-dried two-dram vial, allylboronate S-1.33 (70.8 mg, 0.260. mmol) and 
MeOH (17.5 µL, 0.690. mmol) are dissolved in 700. µL of toluene to make a stock 
solution of S-1.33 and MeOH. 
An oven-dried one-dram vial equipped with a stir bar is charged with phenyl-substituted 
aldimine 1.15a (15.3 mg, 50.0 µmol), 150. µL of toluene, and 200. µL of the prenominate 
stock solution of S-1.33 (20 mg, 74 µmol) and MeOH (4.0 mg, 13 µmol).  To this 
mixture is added 150. µL of the catalyst solution (described above) of 1.19r (0.92 mg, 3.0 
µmol) and NaOt-Bu (0.24 mg, 2.5 µmol) and a cap is attached to the vial and sealed with 
electrical tape. The clear and colorless solution is allowed to stir at 22 ºC for 18 hours 
during which time it becomes cloudy and white. The cap is removed and 3 mL of a 
saturated aqueous solution of NaIO4 is added and the biphasic mixture is allowed to stir 
for 20 minutes. The aqueous layer is washed with ethyl acetate (4 x 4 mL), dried over 
Na2SO4, and concentrated in vacuo to provide a yellow solid. The homoallylamide 
product was purified by silica gel chromatography (10 mm diameter column slurry 
packed with 2.5 g of silica gel in 95:5 hexanes:triethylamine and eluted with 10 mL 
hexanes, 10 mL 1:1 hexanes:diethyl ether, 30 mL 1:3 hexanes:diethyl ether, 35 mL 
diethyl ether, 30 mL 4:1 diethyl ether:ethyl acetate) to afford 1.35 (19.3 mg, 0.0427 
mmol, 85% yield of a 85:15 ratio of diastereomers) as an off white solid, which is re-
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crystallized from CH2Cl2/hexanes (vapor diffusion, 22 ºC) to give 6.4 mg (0.014 mmol, 
28% yield) of 1.35 as clear, colorless, needles suitable for X-ray crystallography in >20:1 
dr and >99:1 e.r.  This diastereo- and enantiomerically enriched product was used to 
obtain the data given below (excluding the HPLC chromatographs). The HPLC 
chromatograph of the authentic racemic material was obtained from a 60:40 ratio of 
anti:syn diastereomers (enriched by silica gel chromatography). The excess of the anti 
diastereomer allowed assignment of which peak corresponds to which diastereomer.  The 
identity and absolute stereochemistry of the major enantiomer of the major diastereomer 
is determined by X-Ray crystallography. 
N-((1R,2R)-2-Phenethyl-1-phenylbut-3-en-1-yl)-P,P-diphenylphosphinic amide 
(1.35, Equation 9): M.p. = 156–158 °C. IR (neat): 3228 (w, br), 3059 (w), 3027 (w), 
2916 (w), 2857 (w), 1437 (w), 1187 (m), 1125 (m), 1109 (m), 1069 (m), 917 (m), 745 
(m), 723 (m), 692 (s), 534 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.82–7.77 (2H, m), 
7.64–7.59 (2H, m),  7.50–7.46 (1H, m), 7.40–7.33 (3H, m), 7.21–7.12 (8H, m), 7.04–7.02 
(4H, m), 5.73 (1H, ddd, J = 17.5, 10.1, 9.1 Hz), 5.28 (1H, d, J = 10.3 Hz), 5.11 (1H, d, J 
= 17.1 Hz), 4.17 (1H, dd, J = 18.2, 8.0 Hz), 3.37 (1H, app t, J = 7.1 Hz), 2.62 (1H, ddd, J 
= 14.2, 9.4, 5.3 Hz), 2.50–2.43 (1H, m), 2.40–2.33 (1H, m), 1.76-1.68 (1H, m), 1.63–
1.53 (1H, m); 13C NMR (100 MHz, CDCl3): δ 142.6 (d, J = 3.1 Hz), 142.0, 138.8, 133.5 
(d, J = 127.2 Hz), 132.7 (d, J = 9.7 Hz, only peak at 132.6 is visible, the other is 
overlapping), 132.1 (d, J = 130.7 Hz, only peak at 131.4 is visible, the other is 
overlapping), 131.9 (d, J = 2.6 Hz), 131.8 (d, J = 9.6 Hz), 131.6 (d, J = 2.8 Hz), 128.6 
(d, J = 12.5 Hz), 128.6, 128.4, 128.2, 128.1 (d, J = 12.8 Hz), 127.4, 127.1, 125.8, 118.8, 
58.1, 51.1 (d, J = 5.5 Hz), 33.3, 32.1; HRMS Calcd for C30H31NOP [M + H]+: 452.21433; 
 
Page 137
   
Found: 452.21249. [α]20D	  = +12 (c = 0.43, CHCl3) for a >20:1 dr, >99:1 er sample.	   The 
enantiomeric purity of this compound was determined by HPLC analysis in comparison 
with authentic racemic material (Chiracel AZ-H, 90:10 hexanes:i-PrOH, 0.8 mL/min, 220 
nm): tR of 1.35 (anti diastereomer): 37 min (major) and 41 min (minor); tR of 1.35 (syn 
diastereomer): 26 min (major) and 45 min (minor). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 (syn) 25.9 18.157 1 (syn) 25.8 7.653 
2 (anti) 36.9 30.657 2 (anti) 36.6 87.094 
3 (anti) 41.3 31.716 3 (anti) 41.0 4.572 
4 (syn) 45.4 19.470 4 (syn) 45.0 0.681 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 (anti) 36.6 95.012 1 (syn) 25.8 91.828 
2 (anti) 41.0 4.988 2 (syn) 45.0 8.172 
 
To measure the enantiomeric purity of S-1.33, allylboronate S-1.33 was oxidized by 
hydrogen peroxide to the corresponding alcohol.  The enantiomeric purity of 
allylboronate S-1.33 was determined by GLPC analysis in comparison with authentic 
racemic material (Betadex 120 column, 110 ºC, 15 psi). 
 
 
N-((1R,2S)-2-Phenethyl-1-phenylbut-3-en-1-yl)-P,P-diphenylphosphinic amide (1.34, 
Table 1.12): The title compound is purified analogously to 1.35 affording 1.34 (22.5 mg, 
0.0498 mmol, >98 % yield of a 85:15 ratio of diastereomers) as a white solid.  Th e 
resulting solid was recrystallized from CH2Cl2/hexanes (vapor diffusion, 22 ºC) to give 
7.4 mg (0.016 mmol, 32% yield) of 1.34 as clear, colorless needles suitable for x-ray 
crystallography in >20:1 dr and >99:1 er.  This diastereo- and enantiomerically enriched 
product was used to obtain the data given below (excluding the HPLC chromatographs). 
The identity (and absolute stereochemistry of the major enantiomer) of the major 
diastereomer is determined by X-Ray crystallography (see Part D of the Supplementary 
Information). M.p. = 161–163 °C. IR (neat): 3215 (w, br), 3056 (w), 3027 (w), 2912 (w), 
2855 (w), 1494 (m), 1184 (m), 1122 (m), 1106 (m), 1083 (m), 912 (m), 749 (m), 691 (s), 
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531 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.84–7.79 (2H, m), 7.67–7.62 (2H, m), 
7.51–7.47 (1H, m), 7.42–7.36 (3H, m), 7.26–7.20 (7H, m), 7.15–7.12 (1H, m), 7.07–7.00 
(4H, m), 5.49 (1H, ddd, J = 17.3, 10.0, 10.0 Hz), 5.30–5.26 (2H, m), 4.22 (1H, ddd, J = 
11.1, 11.1, 4.7 Hz), 3.67 (1H, dd, J = 10.7, 6.4 Hz), 2.68–2.61 (1H, m), 2.58–2.42 (2H, 
m), 1.76 (1H, dddd, J = 13.5, 9.9, 6.3, 3.6 Hz), 1.29–1.19 (1H, m); 13C NMR (100 MHz, 
CDCl3): δ 142.3, 140.9 (d, J = 5.4 Hz), 137.6, 133.5 (d, J = 127.5 Hz, only peak at 134.1 
is visible, the other is overlapping), 132.8 (d, J = 9.8 Hz, only peak at 132.7 is visible, the 
other is overlapping), 132.0 (d, J = 2.7 Hz), 131.9 (d, J = 131.7 Hz), 131.77 (d, J = 9.6 
Hz), 131.78 (d, J = 2.8 Hz), 128.6 (d, J = 12.5 Hz), 128.5, 128.4, 128.3 (d, J = 12.8 Hz), 
128.0, 127.8, 127.2, 125.9, 120.0, 58.0, 52.1 (d, J = 3.1 Hz), 34.2, 33.9; HRMS Calcd for 
C30H31NOP [M + H]+: 452.21433; Found: 452.21376. [α]20D	  = –16 (c = 0.20) for a >20:1 
dr and >99:1 er sample.	    The enantiomeric purity of this compound was determined by 
HPLC analysis in comparison with authentic racemic material; see explanation of peak 
assignment in the analytical data for compound 1.35 (Chiracel AZ-H, 90:10 hexanes:i-
PrOH, 0.8 mL/min, 220 nm): tR of 1.34 (major diastereomer): 25 min (major) and 42 min 
(minor); tR of 1.34 (minor diastereomer): 35 min (major) and 38 min (minor). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 (syn) 25.9 18.157 1 (syn) 24.5 87.752 
2 (anti) 36.9 30.657 2 (anti) 34.9 8.135 
3 (anti) 41.3 31.716 3 (anti) 38.3 0.574 
4 (syn) 45.4 19.470 4 (syn) 41.7 3.539 
 
 
 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 (syn) 24.5 96.123 1 (anti) 34.9 93.411 
2 (syn) 41.7 3.877 2 (anti) 38.3 6.589 
To measure the enantiomeric purity of R-1.33, allylboronate R-1.33 was oxidized by 
hydrogen peroxide to the corresponding alcohol.  The enantiomeric purity of 
allylboronate R-1.33 was determined by GLPC analysis in comparison with authentic 
racemic material (Betadex 120 column, 110 ºC, 15 psi). 
 
 
N-((1S,2R)-2-Cyclohexyl-2-methyl-1-phenylbut-3-en-1-yl)-P,P-diphenylphosphinic 
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amide (1.32, Table 1.11): The title compound is synthesized in the manner identical to 
that used for the preparation of 1.35 (except utilizing Zn(Ot-Bu)2 instead of NaOt-Bu). 
The homoallylamide 1.32 is purified by silica gel chromatography (10 mm diameter 
column slurry packed with 2.5 g of silica gel in 95:5 hexanes:triethylamine and eluted 
with 10 mL hexanes, 10 mL 1:1 hexanes:diethyl ether, 30 mL 1:3 hexanes:diethyl ether, 
60 mL diethyl ether) to afford 1.32 (17.0 mg, 0.038 mmol, 76 % yield of isolated major 
diastereomer) as a white solid.  Crystals suitable for X-ray crystallography were obtained 
by vapor diffusion from a diethyl ether/hexane solvent system at 22 ºC. The identity (and 
absolute stereochemistry of the major enantiomer) of the major diastereomer is 
determined by X-ray crystallography. M.p. = 137–139 °C. IR (neat): 3221 (w, br), 3058 
(w), 2924 (s), 2851 (m), 1452 (m), 1184 (s), 1123 (s), 1108 (s), 1064 (m), 912 (m), 723 
(s), 698 (s), 530 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.79–7.74 (2H, m), 7.51–7.45 
(3H, m), 7.41–7.38 (2H, m), 7.34–7.30 (1H, m), 7.23–7.20 (3H, m), 7.15 (2H, ddd, J = 
7.7, 7.7, 3.2 Hz), 7.00–6.98 (2H, m), 5.70 (1H, dd, J = 17.7, 11.0 Hz), 5.27 (1H, dd, J = 
10.9, 1.4 Hz), 5.13 (1H, dd, J = 17.7, 1.4 Hz), 4.17 (1H, app t, J = 11.2 Hz), 3.56 (1H, 
app t, J = 9.8 Hz), 1.81 (1H, d, J = 12.9 Hz), 1.67 (1H, d, J = 10.8 Hz), 1.60–1.53 (2H, 
m), 1.36 (1H, d, J = 6.9 Hz), 1.22 (3H, s), 1.10–0.67 (6H, m); 13C NMR (100 MHz, 
CDCl3): δ 143.0, 141.9 (d, J = 3.3 Hz) 133.7 (d, J = 128.3 Hz), 132.8 (d, J = 9.9 Hz), 
132.0 (d, J = 131.8 Hz), 131.83 (d, J = 3.1 Hz, only peak at 131.81 is visible, the other is 
overlapping), 131.79 (d, J = 9.4 Hz, only peak at 131.74 is visible, the other is 
overlapping), 131.5 (d, J = 2.8 Hz), 128.6 (d, J = 12.4 Hz), 128.4, 128.0 (d, J = 12.8 Hz), 
127.7, 126.9, 115.9, 59.4, 48.5 (d, J = 3.8 Hz), 42.8, 29.1, 27.9, 27.1, 26.9, 26.6, 15.8; 
HRMS Calcd for C29H35NOP [M + H]+: 444.24563; Found: 444.24499. [α]20D	  = +8.9 (c 
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= 0.87, CHCl3) for a 95:5 er sample.	    The enantiomeric purity of this compound was 
determined by HPLC analysis in comparison with authentic racemic material (Chiracel 
AD-H, 90:10 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR of 1.32: 7.0 min (major) and 20 
min (minor). 
 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1  7.0 50.073 1  6.9 94.953 
2  19.9 49.927 2  19.5 5.047 
 
To measure the enantiomeric purity of 1.31, allylboronate 1.31 was oxidized by hydrogen 
peroxide to the corresponding alcohol.  The enantiomeric purity of allylboronate 1.32 was 
determined by GLPC analysis in comparison with authentic racemic material (Chiral dex 
CD-BDM column, 140 ºC, 15 psi). 
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■  Representative Procedure for Small Scale Catalytic Enantioselective Allyl 
Additions to Isatins (Figure 5a): Under an atmosphere of N2, aminophenol 1.19r (6.1 
mg, 0.020 mmol) is added to an oven-dried two dram vial equipped with a stir bar 
followed by 2.0 mL of a stock solution of NaOt-Bu in toluene (7.7 mg, 0.080 mmol/8.0 
mL). The vial is sealed with a cap (phenolic open top cap with a red PFTE/white silicone 
septa) and electrical tape, removed from the glovebox and allowed to stir under nitrogen 
at 22 ºC for ~10 minutes.   
A separate vial equipped with a stir bar is charged with N-TBS-isatin 1.36i (26.2 mg, 
0.100 mmol), sealed with a cap (phenolic open top cap with a red PFTE/white silicone 
septa) and electrical tape and purged with N2. To this sealed vial under nitrogen is added 
toluene (0.95 mL), 50. uL of a catalyst solution [described above; 1.19r (0.16 mg, 0.50 
mmol) and NaOt-Bu (0.048 mg, 0.50 mmol)], MeOH (10 µL, 0.25 mmol) and 
allylboronic acid pinacol ester 1.6 (28 µL, 0.15 mmol) by syringe in the stated order.  The 
clear yellow solution is allowed to stir at 22 ºC for 1.5 h during which time it becomes 
colorless, which signifies complete consumption of the highly pigmented starting 
material 1.36i. 
Removal of the TBS group: The cap is removed and the mixture is concentrated in vacuo. 
The resultant pale yellow oil is then dissolved in a solution of p-toluenesulfonic acid 
monohydrate (22.8 mg, 0.120 mmol) in methanol (0.5 mL, Fisher ACS grade).  The 
mixture is allowed to stir at 22 ºC for 3 h after which time 1 mL of a saturated solution of 
aqueous NaHCO3 is added drop-wise over one minute. Ethyl acetate (1 mL) is 
subsequently added, the organic and the aqueous layers are separated, which are then 
washed with ethyl acetate (3 x 1 mL).  The combined organic layers are dried over 
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Na2SO4 and concentrated in vacuo to provide a white solid that is purified by silica gel 
chromatography (10 mm diameter column slurry packed with 2.5 g of silica gel in 
hexanes. The off-white solid residue is dry loaded on silica gel and eluted with 10 mL 4:1 
hexanes:ethyl acetate, 20 mL 2:1 hexanes:ethyl acetate, 20 mL 1:1 hexanes:ethyl acetate) 
to afford 1.39a (17.5 mg, 0.0925 mmol, 98% yield) as a white solid.  Crystals suitable for 
X-ray crystallography  were grown by slow evaporation from methanol at 22 ºC. 
(R)-3-Allyl-3-hydroxyindolin-2-one (1.39a, Equation 15): The analytical data are fully 
consistent with those reported previously.142 1H NMR (400 MHz, CD3OD): δ 7.36 (1H, d, 
J = 7.2 Hz), 7.26 (1H, t, J = 8.5 Hz), 7.07 (1H, t, J = 7.4 Hz), 6.89 (1H, d, J = 7.7 Hz) 
5.54 (1H, app dq, J = 16.7, 8.1 Hz), 5.05–4.98 (2H, m), 2.76–2.59 (2H, m); HRMS Calcd 
for C11H12N1O2 [M + H]+: 190.08680; Found: 190.08650. [α]20D = +11 (c = 1.3, CHCl3) 
for a 98:2 er sample.	    The enantiomeric purity of this compound was determined by 
HPLC analysis in comparison with authentic racemic material (Chiracel OD-H, 90:10 
hexanes:i-PrOH, 0.8 mL/min, 220 nm): tR: 12 min (minor) and 15 min (major). 
 
 
 
                                                
(142) Sano, D.; Nagata, K.; Itoh, T. Org. Lett. 2008, 10, 1593–1595. 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1  12.3 47.660 1  12.0 1.303 
2  16.0 52.340 2  15.1 98.697 
 
(R)-3-Allyl-1-(tert-butyldimethylsilyl)-3-hydroxyindolin-2-one (1.36i, Table 1.15): To 
obtain the N-TBS protected hydroxyl-oxindole, after concentration in vacuo, the resultant 
pale yellow oil can be purified by silica gel chromatography (10 mm diameter column 
slurry packed with 2.5 g of silica gel in dichloromethane and eluted with 10 mL 
dichloromethane followed by 30 mL 20:1 dichloromethane:diethyl ether) to afford 1.39i 
(30.4 mg, 0.100 mmol, >98% yield) as pale yellow oil.  IR (neat): 3401 (w, br), 2953 (w), 
2929 (w), 2858 (w), 1701 (s), 1613 (m), 1465 (s), 1255 (s), 1171 (s), 1105 (m), 945 (m), 
824 (s), 732 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.36 (1H, dd, J = 7.4, 1.4 Hz), 7.22 
(1H, td, J = 7.8, 1.5 Hz),  7.05 (1H, td, J = 7.5, 0.8 Hz), 6.99 (1H, d, J = 8.0 Hz), 5.54 
(1H, dddd, J = 16.9, 10.1, 8.5, 6.2 Hz), 5.10–5.04 (2H, m), 2.96 (1H, s), 2.72–2.57 (2H, 
m), 0.99 (9H, s), 0.51 (3H, s), 0.50 (3H, s); 13C NMR (100 MHz, CDCl3): δ 185.3, 145.8, 
131.6, 130.9, 129.4, 124.4, 122.7, 120.3, 113.2, 76.3, 43.9, 26.6, 19.8, –3.1, –3.3; HRMS 
Calcd for C17H26NO2Si [M + H]+: 304.17328; Found: 304.17280. [α]20D = +24.2 (c = 1.5, 
CHCl3) for a 94:6 er sample.	   The enantiomeric purity of this compound was determined 
by HPLC analysis in comparison with authentic racemic material (Chiracel AD-H, 90:10 
hexanes:i-PrOH, 0.8 mL/min, 220 nm): tR: 7 min (major) and 9 min (minor). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1  7.2 50.070 1  7.2 98.043 
2  9.1 49.930 2  9.1 1.957 
 
(R)-3-Allyl-4,6-dibromo-3-hydroxyindolin-2-one (1.39l, Equation 16): The 
enantioselective allyl addition to SEM-isatin 1.36k is carried out following the 
representative procedure for aminophenol catalyzed enantioselective allyl additions to 
isatins.  The procedure for removal of SEM group is as follows.  After 2.0 h, the mixture 
of the enantioselective allyl addition turns from yellow to colorless (signifying complete 
consumption of highly pigmented 1.36k), the cap is removed and the reaction mixture is 
concentrated in vacuo. The resultant pale yellow oil is transferred to a two-dram vial, 
sealed with a septum and purged with nitrogen.  A separate oven dried one-dram vial 
equipped with a stir bar is charged with MgBr2Et2O (96.8 mg, 0.375 mmol), sealed with 
a cap (phenolic open top cap with a red PFTE/white silicone septa) and electrical tape, 
and removed from the glovebox.  The unpurified 3-allyl-3-hydroxy oxindole 1.39l is 
transferred through a syringe to the vial containing MgBr2Et2O using 3 x 300 uL of 
dichloromethane. The mixture is allowed to stir under nitrogen at 22 ºC for 60 h during 
which time it becomes a tan slurry.  The cap is removed and the tan slurry is dissolved in 
methanol and passed through a short plug of Celite®; the plug is washed with methanol 
(15 mL) and the combined solution is concentrated in vacuo to afford a tan solid.  The 
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resulting solid is dissolved in 1 mL of methanol and 2 mL of a solution of saturated 
aqueous NaHCO3, and the cloudy light pink solution is allowed to stir open to the air at 
22 ºC for five h.  Ethyl acetate (2 mL) is added and the layers separate.  The aqueous 
layer is extracted with 3 x 2 mL of ethyl acetate and the combined organic layers are 
dried over Na2SO4 and concentrated in vacuo to afford a light tan solid.  The 
hydroxyoxindole product is purified by silica gel chromatography (10 mm diameter 
column slurry packed with 2.5 g of silica gel in dichloromethane and eluted with 15 mL 
dichloromethane followed by 10 mL 9:1 dichloromethane:diethyl ether, 10 mL 8:1 
dichloromethane:diethyl ether, and 30 mL 4:1 dichloromethane:diethyl ether), affording 
1.39l (14.9 mg, 0.0429 mmol, 86% yield) as a white solid. The analytical data are fully 
consistent with those reported previously.143  IR (neat): 3368 (m, br), 3169 (w, br), 2923 
(w, br), 1703 (s), 1605 (s), 1572 (s), 1429 (m), 1364 (m), 1334 (m), 1300 (m), 1175 (m), 
1086 (m), 1074 (m), 944 (m), 928 (m), 840 (s), 785 (m), 738 (m), 673 (s) cm-1; 1H NMR 
(400 MHz, CD3OD): δ 7.38 (1H, s), 7.02 (1H, s), 5.39–5.28 (1H, m),  5.09–5.05 (1H, m), 
4.97–4.94 (1H, m), 3.26–3.21 (1H, m), 2.72–2.67 (1H, m), 3.24–3.19 (1H, m),  2.92 (1H, 
br s), 2.84–2.79 (1H, m), 0.91 (2H, t, J = 8.0 Hz),  –0.02 (9H, s); HRMS Calcd for 
C11H10NO2Br2 [M + H]+: 347.90578; Found: 347.90587. [α]20D = –10 (c = 0.64, CH3OH) 
for a 91.5:8.5 er sample.	    The enantiomeric purity of this compound was determined by 
HPLC analysis in comparison with authentic racemic material (Chiracel AD-H, 86:14 
hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 16 min (minor) and 21 min (major). 
 
                                                
(143) Cao, Z.-Y.; Zhang, Y.; Ji, C.-B.; Zhou, J. Org. Lett. 2011, 13, 6398–6401.  
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1  16.3 49.912 1  16.1 8.704 
2  21.7 50.088 2  21.2 91.296 
 
(R)-3-Allyl-4,6-dibromo-3-hydroxy-1-((2-(trimethylsilyl)ethoxy)methyl)indolin-2-
one (1.39k, able 1.15): If one wishes to obtain the N-SEM-protected hydroxyl-oxindole, 
then after concentration in vacuo, purify the resultant yellow oil by silica gel 
chromatography (10 mm diameter column slurry packed with 2.5 g of silica gel in 
dichloromethane and eluted with 40 mL dichloromethane) to afford 1.39k (23.0 mg, 
0.0481 mmol, 96% yield) as a clear, colorless oil. IR (neat): 3400 (w, br), 3082 (w), 2953 
(w), 2923 (w), 2895 (w), 1723 (m), 1597 (s), 1571 (m), 1249 (m), 1077 (s, br), 1010 (m), 
922 (m), 857 (m), 831 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.41 (1H, s), 7.16 (1H, s), 
5.34 (1H, dddd, J = 17.0, 17.0, 8.4, 8.4 Hz), 5.16–5.10 (2H, m), 5.00–4.97 (2H, m), 3.56–
3.46 (2H, m), 3.24–3.19 (1H, m), 2.92 (1H, br s), 2.84–2.79 (1H, m), 0.91 (2H, t, J = 8.0 
Hz),  –0.02 (9H, s); 13C NMR (100 MHz, CDCl3): δ 176.6, 145.0, 129.9, 129.6, 126.2, 
124.2, 121.0, 120.0, 112.9, 78.1, 70.0, 66.6, 40.1, 17.9, –1.3; HRMS Calcd for 
C18H24NO3NaSiBr2 [M + Na]+: 497.97062; Found: 497.97090. [α]20D = +5.6 (c = 1.1, 
CHCl3) for a 91.5:8.5 er sample.	    The enantiomeric purity of this compound was 
determined by HPLC analysis in comparison with authentic racemic material (Chiracel 
OJ-H, 95:5 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 9 min (major) and 20 min (minor). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1  9.1 49.485 1  9.1 91.606 
2  19.6 50.515 2  19.2 8.394 
 
(R)-3-Allyl-1-benzyl-3-hydroxyindolin-2-one (1.39c, Table 1.15): 1.39c is purified by 
silica gel chromatography (10 mm diamter column slurry packed with 2.5 g of silica gel 
in hexanes and eluted successively with 10 mL hexanes, 10 mL 6:1 hexanes:ethyl acetate, 
and 20 mL 4:1 hexanes:ethyl acetate) to afford 1.39c (25.1 mg, 0.090 mmol, 90% yield) 
as a white solid. The analytical data are fully consistent with those reported previously.144 
1H NMR (400 MHz, CDCl3): δ 7.38 (1H, d, J = 7.3 Hz), 7.30–7.21 (5H, m), 7.19–7.15 
(1H, m), 7.03 (1H, app t, J = 7.5 Hz), 5.60 (1H, dddd, J = 16.5, 10.1, 8.5, 6.3 Hz), 5.14–
5.06 (2H, m), 4.98 (1H, d, J = 15.7 Hz), 4.69 (1H, d, J = 15.7 Hz), 3.27 (1H, br s), 2.82–
2.77 (1H, m), 2.71–2.66 (1H, m); HRMS Calcd for C18H18NO2 [M + H]+: 280.13375; 
Found: 280.13317. [α]20D = +15.0 (c = 1.26, CHCl3) for a 97.5:2.5 er sample.	    The 
enantiomeric purity of this compound was determined by HPLC analysis in comparison 
with authentic racemic material (Chiracel OD-H, 97.5:2.5 hexanes:i-PrOH, 0.5 mL/min, 
220 nm): tR: 49 min (major) and 57 min (minor). 
 
                                                
(144) Itoh, J.; Han, S. B.; Krische, M. J. Angew. Chem. Int. Ed. 2009, 48, 6313–6316. 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1  48.1 49.804 1  49.1 97.590 
2  55.5 50.196 2  57.2 2.410 
 
(R)-3-Allyl-1-benzyl-3-hydroxy-5-methylindolin-2-one (1.39d, Table 1.15): 1.39d is 
purified by silica gel chromatography (10 mm diameter column slurry packed with 2.5 g 
of silica gel in hexanes and eluted successively with 10 mL hexanes, 10 mL 6:1 
hexanes:ethyl acetate, and 20 mL 4:1 hexanes:ethyl acetate) to afford 1.39d (24.5 mg, 
0.084 mmol, 84% yield) as an off-white solid.  The analytical data are fully consistent 
with those reported previously.144 1H NMR (400 MHz, CDCl3): δ 7.31–7.22 (6H, m), 
6.99 (1H, d, J = 7.9 Hz), 6.57 (1H, d, J = 8.0 Hz), 5.69–5.58 (1H, m), 5.18–5.09 (2H, m), 
4.99 (1H, d, J = 15.7 Hz), 4.70 (1H, d, J = 15.7 Hz), 3.18 (1H, br s), 2.83–2.78 (1H, m), 
2.73–2.68 (1H, m), 2.31 (3H, s); HRMS Calcd for C19H20NO2 [M + H]+: 294.14940; 
Found: 294.14905. [α]20D = +5.1 (c = 0.95, CHCl3) for a 98.5:1.5 er sample.	    The 
enantiomeric purity of this compound was determined by HPLC analysis in comparison 
with authentic racemic material (Chiracel OJ-H, 90:10 hexanes:i-PrOH, 0.8 mL/min, 220 
nm): tR: 13 min (major) and 16 min (minor). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1  13.4 49.524 1  13.3 98.654 
2  16.2 50.476 2  16.1 1.346 
 
(R)-3-Allyl-1-benzyl-3-hydroxy-5-methoxyindolin-2-one (1.39e, Table 1.15): 1.39e is 
purified by silica gel chromatography (10 mm diamter column slurry packed with 2.5 g 
of silica gel in dichloromethane and eluted successively with 10 mL dichloromethane 
followed by 30 mL 4:1 dichloromethane:ethyl acetate) to afford 1.39e (29.5 mg, 0.095 
mmol, 95% yield) as an clear, yellow oil.  The analytical data are fully consistent with 
those reported previously.144 1H NMR (400 MHz, CDCl3): δ 7.31–7.22 (5H, m), 7.01 
(1H, d, J = 2.5 Hz), 6.71 (1H, dd, J = 8.5, 2.6 Hz), 6.57 (1H, d, J = 8.5 Hz), 5.62 (1H, 
dddd, J = 16.8, 9.9, 8.5, 6.3 Hz), 5.17–5.08 (2H, m), 4.97 (1H, d, J = 15.7), 4.68 (1H, d, J 
= 15.7), 3.75 (3H, s), 3.39 (1H, br s), 2.83–2.78 (1H, m), 2.73–2.67 (1H, m); HRMS 
Calcd for C19H20NO3 [M + H]+: 310.14432; Found: 310.14467. [α]20D = +5.87 (c = 1.17, 
CHCl3) for a 97:3 er sample.	   The enantiomeric purity of this compound was determined 
by HPLC analysis in comparison with authentic racemic material (Chiracel OJ-H, 90:10 
hexanes:i-PrOH, 0.8 mL/min, 220 nm): tR: 16 min (major) and 24 min (minor). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1  16.8 49.341 1  16.7 96.527 
2  24.4 50.659 2  24.3 3.473 
 
(R)-3-Allyl-1-benzyl-4,7-dichloro-3-hydroxyindolin-2-one (1.39f, Table 1.15): 1.39f is 
purified by silica gel chromatography (10 mm diamter column slurry packed with 2.5 g 
of silica gel in hexanes and eluted successively with 10 mL hexanes, 20 mL 9:1 
hexanes:ethyl acetate, and 15 mL 5:1 hexanes:ethyl acetate) to afford 1.39f (31.3 mg, 
0.090 mmol, 90% yield) as a white solid.  mp = 107-109 ºC. IR (neat): 3068(w, br), 2949 
(m, br), 2866 (w), 1615 (w), 1451 (w), 1247 (w), 1247 (m), 1112 (m), 990 (w), 816 (s), 
780 (m), 727 (s), 697 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.31–7.13 (5H, m), 7.13 
(1H, d, J = 8.8 Hz), 6.96 (1H, d, J = 8.8 Hz), 5.45–5.29 (1H, m), 5.29–5.11 (3H, m), 5.02 
(1H, d, J = 10.1 Hz), 3.27–3.22 (3H, m), 2.96–2.91 (2H, m); 13C NMR (100 MHz, 
CDCl3): δ 177.5, 140.5, 136.8, 133.3, 130.5, 129.7, 128.7, 128.4, 127.4, 126.6, 125.2, 
121.1, 114.5, 76.8 (overlaps with CDCl3), 45.1, 40.4; HRMS Calcd for C18H16Cl2N1O2 
[M + H]+: 348.05581; Found: 348.05632. [α]20D = +13 (c = 0.76, CHCl3) for a 91:9 er 
sample.	   The enantiomeric purity of this compound was determined by HPLC analysis in 
comparison with authentic racemic material (Chiracel OJ-H, 90:10 hexanes:i-PrOH, 0.8 
mL/min, 220 nm): tR: 11 min (major) and 30 min (minor).  
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1  10.6 50.394 1  10.7 90.957 
2  29.8 49.606 2  30.4 9.043 
 
(R)-1-Benzyl-3-hydroxy-3-(2-methylallyl)indolin-2-one (1.40, Table 1.15): The title 
compound is synthesized in the same manner as described for 1.39c except for the 
following changes: 1) Reaction time is one h. 2) Allylboronate 1.22a is employed as the 
nucleophile instead of allylboronate 1.6 3) The catalytic enantioselective allyl addition 
process is quenched with 3 mL of a solution of saturated aqueous NaIO4 (to remove 
excess pinacol) and allowed to stir for 14 h at 22 ºC.  The aqueous layer is washed with 
ethyl acetate (4 x 4 mL), dried over Na2SO4, and concentrated in vacuo to provide yellow 
oil. The product is purified by silica gel chromatography (10 mm diameter column slurry 
packed with 2.5 g of silica gel in dichloromethane and eluted with 34 mL 
dichloromethane followed by 26 mL 9:1 dichloromethane:ethyl acetate), affording 1.40 
(28.7 mg, 0.0976 mmol, 98% yield) as a white solid. M.p. = 52–54 ºC. IR (neat): 3399 
(w, br), 3366 (w, br), 1692 (s), 1614 (m), 1466 (m), 1350 (m), 1196 (m), 991 (m), 756 
(s), 727 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.41 (1H, d, J = 7.3 Hz), 7.31–7.22 (5H, 
m), 7.20 (1H, t, J = 7.7 Hz), 7.06 (1H, t, J = 7.5 Hz), 6.69 (1H, d, J = 7.7 Hz), 5.02 and 
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4.72 (2H, ABq, JAB = 15.7 Hz), 4.79 (1H, s), 4.68 (1H, s), 2.93 (1H, s), 2.77 (2H, s), 1.50 
(3H, s); 13C NMR (100 MHz, CDCl3): δ 178.0, 142.9, 139.1, 135.5, 129.9, 129.8, 128.9, 
127.8, 127.4, 124.6, 123.1, 116.5, 109.6, 76.5, 46.3, 44.0, 24.1; HRMS Calcd for 
C19H20NO2 [M + H]+: 294.14940; Found: 294.14930. [α]20D = +22 (c = 1.3, CHCl3) for a 
96:4 er sample.	    The enantiomeric purity of this compound was determined by HPLC 
analysis in comparison with authentic racemic material (Chiracel OJ-H, 90:10 hexanes:i-
PrOH, 0.8 mL/min, 220 nm): tR: 15 min (major) and 34 min (minor). 
 
 
 
(R)-3-Allyl-3-hydroxy-1-(4-methoxybenzyl)indolin-2-one (1.39g, Table 1.15): The 
title compound is purified by silica gel chromatography (10 mm diameter column slurry 
packed with 2.5 g of silica gel in dichloromethane and eluted successively with 15 mL 
dichloromethane, 10 mL 8:1 dichloromethane:diethyl ether, and 10 mL 6:1 
dichloromethane:diethyl ether) to afford 1.39g (30.7 mg, 0.099 mmol, >98% yield) as a 
clear, colorless oil. The spectroscopic data match those reported previously.144 1H NMR 
(400 MHz, CDCl3): δ 7.39 (1H, d, J = 7.3 Hz), 7.22–7.18 (3H, m), 7.05 (1H, t, J = 7.5 
Hz), 6.82 (2H, d, J = 8.5 Hz), 6.72 (1H, d, J = 7.8 Hz), 5.67–5.57 (1H, m), 5.16–5.07 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1  16.4 50.578 1  15.4 95.755 
2  31.3 49.422 2  33.6 4.245 
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(2H, m), 4.93 (1H, d, J = 15.5 Hz), 4.66 (1H, d, J = 15.5 Hz), 3.76 (3H, s), 3.21 (br, s), 
2.83–2.78 (1H, m), 2.72–2.67 (1H, m); HRMS Calcd for C19H20N1O3 [M + H]+: 
310.14432; Found: 310.14458. [α]20D = +15.5 (c = 1.46, CHCl3) for a 99:1 er sample.	   
The enantiomeric purity of this compound was determined by HPLC analysis in 
comparison with authentic racemic material (Chiracel OJ-H, 90:10 hexanes:i-PrOH, 0.8 
mL/min, 220 nm): tR: 22 min (minor) and 25 min (major). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1  21.6 50.895 1  21.8 0.905 
2  24.5 49.105 2  24.6 99.095 
 
(R)-3-Allyl-4,6-dibromo-3-hydroxy-1-(4-methoxybenzyl)indolin-2-one (1.39h, Table 
1.15): The titular compound is purified by silica gel chromatography (10 mm diameter 
column slurry packed with 2.5 g of silica gel in dichloromethane and eluted successively 
with 15 mL dichloromethane, 10 mL 3:1 hexanes:diethyl ether, and 30 mL 2:1 
hexanes:diethyl ether) to afford 1.39h (20.1 mg, 0.043 mmol, 86% yield) as a white solid.  
mp = 102–104 ºC. IR (neat): 3349 (w, br), 2919 (w), 1707 (s), 1600 (m), 1574 (w), 1511 
(m), 1440 (m), 1418 (m), 1352 (m), 1282 (m), 1175 (m), 1087 (m), 1044 (m), 991 (m), 
832 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.34 (1H, s), 7.17 (2H, d, J = 8.5 Hz), 6.85 
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(2H, d, J = 8.6 Hz), 6.78 (1H, s), 5.41–5.30 (1H, m), 5.14 (1H, d, J = 16.9 Hz), 4.99 (1H, 
d, J = 10.0 Hz), 4.90 (1H, d, J = 15.5 Hz), 4.61 (1H, d, J = 15.5 Hz) 3.79 (3H, s), 3.23 
(1H, dd, J = 12.0, 6.6 Hz), 2.91–2.84 (2H, m); 13C NMR (100 MHz, CDCl3): δ 176.5, 
159.5, 145.8, 129.7, 129.4, 128.8, 126.6, 126.5, 123.9, 121.1, 120.0, 114.5, 112.1, 77.6, 
55.4, 43.7, 40.3; HRMS Calcd for C19H18Br2N1O3 [M + H]+: 465.96534; Found: 
465.96445. [α]20D = -11 (c = 0.67, CHCl3) for a 93:7 er sample.	   The enantiomeric purity 
of this compound was determined by HPLC analysis in comparison with authentic 
racemic material (Chiracel OJ-H, 90:10 hexanes:i-PrOH, 0.8 mL/min, 220 nm): tR: 15.1 
min (major) and 25.0 min (minor). 
 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1  16.0 50.089 1  15.1 92.781 
2  24.2 49.911 2  25.0 7.219 
 
(R)-3-Allyl-1-(tert-butyldimethylsilyl)-3-hydroxy-5-methoxyindolin-2-one (1.39j, 
Table 1.15): The title compound is purified by silica gel chromatography (10 mm 
diameter column slurry packed with 2.5 g of silica gel in dichloromethane and eluted 
with 10 mL dichloromethane, 15 mL 30:1 dichloromethane:diethyl ether, 30 mL 20:1 
 
Page 157
   
dichloromethane:diethyl ether), affording 1.39j (31.2 mg, 0.0932 mmol, 93% yield) as a 
pale orange oil. IR (neat): 3400 (w, br), 2953 (w), 2930 (w), 2858 (w), 1699 (s), 1594 
(m), 1482 (s), 1255 (s), 1197 (s), 1120 (w), 1081 (m), 911 (m), 840 (s), 790 (m), 730 (s) 
cm-1; 1H NMR (400 MHz, CDCl3): δ 6.96 (1H, d, J = 2.8 Hz), 6.89 (1H, d, J = 8.7 Hz), 
6.75 (1H, dd, J = 8.7, 2.7 Hz), 5.54 (1H, dddd, J = 16.9, 10.1, 9.0, 6.1 Hz),  5.11–5.07 
(2H, m), 3.79 (3H, s), 2.99 (1H, s), 2.70–2.56 (2H, m), 0.98 (9H, s), 0.50 (3H, s), 0.48 
(3H, s); 13C NMR (100 MHz, CDCl3): δ 185.2, 155.8, 138.9, 132.8, 130.8, 120.3, 114.5, 
113.7, 110.7, 76.7, 55.9, 44.0, 26.6, 19.8, –3.2, –3.4; HRMS Calcd for C18H28NO3Si [M + 
H]+: 334.18384; Found: 334.18318. [α]20D = +11 (c = 1.3, CHCl3) for a 98:2 er sample.	   
The enantiomeric purity of this compound was determined by HPLC analysis in 
comparison with authentic racemic material (Chiracel AD-H, 90:10 hexanes:i-PrOH, 0.8 
mL/min, 254 nm): tR: 9 min (major) and 12 min (minor). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1  8.7 49.828 1  8.9 97.966 
2  12.0 50.172 2  12.0 2.034 
 
■ Aminophenol-Catalyzed Enantioselective Allyl Additions to o-Thiomethylaniline-
derived Aldimines: 2-(methylthio)-N-(1-phenylbut-3-en-1-yl)aniline (1.29) is 
synthesized analogously to 1.15b and purified by column chromatography (10 mm 
diameter column slurry packed with 2.5 g of silica gel in 95:5 hexanes:triethylamine and 
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eluted with 50 mL hexanes and 20 mL 50:1 hexanes:diethyl ether) to afford 21 mg (0.078 
mmol, 78% yield) of 1.29 as a yellow oil.  The analytical data are fully consistent with 
those reported previously.141 The enantiomeric purity of this compound was determined 
by HPLC analysis in comparison with authentic racemic material (Chiracel OD, 98:2 
hexanes:i-PrOH, 0.5 mL/min, 220 nm):  11 min (minor) and 13 min (major).	  
	  	  
 
■  Representative Example of Utilization of DBU as the Base Instead of NaOt-Bu for 
the Enantioselective Allyl Addition to Aldimine 1.15a:  The reaction is performed 
following the representative procedure for small scale catalytic enantioselective allyl 
additions to aryl-, heteroaryl-, alkenyl-, and alkynyl N-diphenylphosphinoyl imines 
except for the following changes: 1) 2.5 mol % DBU is used (instead of 2.5 mol % NaOt-
Bu) 2) Reaction time is 75 min.  The conversion to desired product is 83% (judged by 
400 MHz 1H NMR spectra of unpurified reaction mixture vs. an internal standard of 9-
methylanthracene) which is lower than the >98% conversion obtained when using the 
same amount of NaOt-Bu.  The enantiomeric purity was determined by HPLC analysis in 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 10.8 min 50.097 1 10.6 min 47.756 
2 13.5 min 49.903 2 13.4 min 52.244 
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comparison with authentic racemic material (Chiracel OD, 92:8 hexanes:i-PrOH, 0.5 
mL/min, 220 nm): tR of 1.17a: 15 min (major) and 21 min (minor). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 16.5 min 50.660 1 15.4 min 95.561 
2 22.8 min 49.340 2 20.5 min 4.439 	  
■■  PROOF of ABSOLUTE STEREOCHEMISTRY of PRODUCTS 
Absolute configuration of homoallylamide 1.17j: Please see X-ray crystallographic 
data. 
Absolute configuration of homoallylamide 1.20f: Please see Part D X-ray 
crystallographic data.  For the catalytic enantioselective allyl additions to aldimines, it 
should be noted that the absolute stereochemical identities of the major product 
enantiomers are inferred from the obtained X-ray crystal structures of homoallylic amides 
1.17j and 1.20f. 
Absolute configuration of homoallylamide 1.35: Please see X-ray crystallographic 
data.  The absolute stereochemistry of the obtained crystal was further verified by HPLC 
analysis in comparison with authentic racemic material  
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 (syn) 25.9 18.157 1 (syn) 26.8 1.029 
2 (anti) 36.9 30.657 2 (anti) 37.8 98.971 
3 (anti) 41.3 31.716 3 (anti) - - 
4 (syn) 45.4 19.470 4 (syn) - - 
 
Absolute configuration of homoallylamide 1.34: Please see X-ray crystallographic 
data.  The absolute stereochemistry of the obtained crystal was further verified by HPLC 
analysis in comparison with authentic racemic material. 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 (syn) 25.9 18.157 1 (syn) 26.5 96.864 
2 (anti) 36.9 30.657 2 (anti) 38.0 2.910 
3 (anti) 41.3 31.716 3 (anti) - - 
4 (syn) 45.4 19.470 4 (syn) 47.6 0.226 
 
 
 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 (syn) 26.5 99.830 1 (anti) 38.0 100.000 
2 (syn) 41.7 0.170 2 (anti) - - 
 
Absolute configuration of homoallylamide 1.32: Please see X-ray crystallographic 
data.  The absolute stereochemistry the obtained crystal was further verified by HPLC 
analysis in comparison with authentic racemic material. 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1  7.0 50.073 1  7.1 97.460 
2  19.9 49.927 2  19.6 2.540 
Absolute configuration of homoallylic alcohol 1.39a: For the aminophenol catalyzed 
enantioselective allyl additions to isatin, please note that the absolute stereochemistries of 
the major product enantiomers are inferred from the obtained X-ray crystal structure of 
homoallylic alcohol 1.39a. The absolute stereochemistry of the obtained crystal was also 
verified by HPLC analysis in comparison with authentic racemic material (Chiracel OD-
H, 90:10 hexanes:i-PrOH, 0.8 mL/min, 220 nm): tR of: 12 min (minor) and 16 min 
(major). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1  12.3 47.660 1  12.2 0.088 
2  16.0 52.340 2  16.2 99.912 
 
■   Investigation of the Level of Brønsted Acidity of the Complex Derived from 
Allylboron Reagent (1.6) and MeOH 
General Information Specific to the Following Study (for further information; see 
above).  All vials, stir bars, and NMR tubes were oven-dried (135 ºC) overnight prior to 
use. The 1H NMR spectra were recorded on a Varian Unity INOVA 400 (400 MHz) 
spectrometer.  Chemical shifts are reported in ppm from tetramethylsilane with the 
solvent resonance as the internal standard (d8-toluene: δ 7.09 ppm). 
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Preparation of samples for NMR spectroscopy:  In a nitrogen-filled glovebox, 
aminophenol 1.19r (7.7 mg, 25 µmol) is weighed into a one-dram vial and dissolved in 
700. µL of d8-toluene.  The solution is transferred to an NMR tube and sealed with a cap 
and Teflon tape; it is then used to obtain Spectrum 1.   
A separate one-dram vial equipped with a stir bar is charged with 1.19r (30.8 mg, 0.101 
mmol) and 2.8 mL of a stock solution of NaOt-Bu in d8-toluene (9.6 mg, 0.10 mmol 
NaOt-Bu/2.8 mL d8-toluene) to afford a translucent solution. A 700. µL aliquot of this 
solution (containing NaOt-Bu [2.4 mg, 25 µmol] and aminophenol [7.7 mg, 25 µmol]) is 
added to an NMR tube and sealed with a cap and Teflon tape; it is then used to obtain 
Spectrum 2.   
A second 700. µL aliquot is transferred to a one-dram vial containing allylboronic acid 
pinacol ester (10. µL, 53 µmol) and this mixture is then used to obtain Spectrum 3. 
Methanol (10. µL, 250 µmol) is added to the remaining 1.4 mL of NaOt-Bu and 1.19r 
mixture and a 700. µL aliquot (containing NaOt-Bu [2.4 mg, 25 µmol], aminophenol 
1.19r [7.7 mg, 25 µmol], and methanol [5.0 µL, 130 µmol)] of the resultant solution is 
added to an NMR tube and sealed with a cap and Teflon tape; it is then used to obtain 
Spectrum 4. 
Allylboronic acid pinacol ester  (10. µL, 53 µmol) is added to the remaining solution 
(containing NaOt-Bu [2.4 mg, 25 µmol], aminophenol 1.19r [7.7 mg, 25 µmol], and 
methanol [5.0 µL, 130 µmol]), which results in formation of a white precipitate, causing 
the toluene solution to become cloudy.  The latter solution is added to an NMR tube and 
sealed with a cap and Teflon tape; it is then used to obtain Spectrum 5. 
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■  Generation of a Hammett Plot for the Aminophenol Catalyzed Enantioselective 
Allyl Addition to a Series of Aryl-Substituted Aldimines 
The electronic effect of the aryl substituent on the reaction rate of the aminophenol 
catalyzed enantioselective allyl addition to aryl-substituted aldimines was determined by 
React-IR measurements of conversion of imine [%] as a function of time [min] (Scheme 
S1).  
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General Procedure (for further information; see above): The preparation of stock 
solutions of reagents (allylboronate 1.6, MeOH, aminophenol 1.19r, and NaOt-Bu) and 
weighing of imines were performed in a nitrogen-filled glovebox. All vials and stir bars 
were oven-dried (135 ºC) overnight prior to use.  Rubber septa and caps were oven-dried 
(60 ºC) overnight prior to use. An 8 mL vial equipped with a stir bar is charged with the 
desired aldimine (0.200 mmol) and the vial is sealed with a cap. To prepare the stock 
solution of allylboronate 1.6, a 4 mL vial is charged with 1.6 (0.450 mL, 2.40 mmol) and 
toluene (3.55 mL) and sealed with a cap containing a teflon septum. To prepare the stock 
solution of MeOH, a 4 mL vial is charged with MeOH (0.120 mL, 3.00 mmol) and 
toluene (3.88 mL) and sealed with a cap containing a teflon septum. To prepare the stock 
solution of aminophenol 1.19r, 4 mL vial is charged with aminophenol 1.19r (15.3 mg, 
0.0499 mmol) and toluene (4.00 mL) and sealed with a cap containing a Teflon septum. 
To prepare the stock solution of NaOt-Bu, a 4 mL vial is charged with NaOt-Bu (19.2 
mg, 0.200 mmol) and toluene (4.00 mL). The NaOt-Bu solution is diluted further by 
charging a 4 mL vial with toluene (3.00 mL) and 1.00 mL of the original stock solution. 
NPOPh2
B O
O t-Bu
OH
N
H
i-Pr
O
NMe2
NHPOPh2
1.5 equiv. MeOH,
toluene, 22 °C
2.5 mol %
1a, 1.5 equiv.
1.0 equiv.
conc. = 0.1 M
R R
R = Br
Hammett σp-constant
2g
2.5 mol % NaOt-Bu,
Scheme S1: Reaction Conditions for the Enantioselective Allylation of Imines 
Applied in React-IR Measurements to Generate the Hammett Plot
*The σp-constant for -N(n-Pr)2 has been used for -N(n-Bu)2.
R = N(n-Bu)2
R = OMe
R = Me
R = H
R = N(n-Pr)2     -0.93*
R = OMe           -0.27
R = Me              -0.17
R = H                 0.00
R = Br                0.23
Increasing rate 
of reaction
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The vial was sealed with a cap containing a teflon septum. The prepared solutions and 
vials containing the imines were taken out of the glovebox and stored in a desiccator for 
the duration of React-IR measurements. 
React-IR measurements: Measurements were performed on a ReactIR iC10 instrument 
equipped with a 6.3 mm AgX DiComp Fiber probe. Spectra were recorded from 2000 
cm-1 to 650 cm-1 at standard resolution (8 cm-1) in 15 s intervals. The vial containing 
imine is equipped with a 14/20 rubber septum with a 4 mm diameter hole and attached to 
the probe, which had been dried with a heat gun (Tmax = 200 °C). The rubber septum is 
further sealed with electrical tape. Toluene (0.3 mL) is added with a syringe, followed by 
the addition of the stock solutions of allylboronate 1.6 (0.50 mL) and MeOH (0.40 mL). 
After 3 min, the reaction is started by the simultaneous addition of the solutions of 
aminophenol 1.19r (0.4 mL) and NaOt-Bu (0.4 mL). 
Data processing: The decrease in concentration of imine was monitored as a function of 
time [min] (Figures 1a and 1b). The following IR absorption frequencies characteristic of 
the imines in this study were used: 834–822 cm-1 for R = Br, 836–824 cm-1 for R = H, 
842–830 cm-1 for R = Me, 835–823 cm-1 for R = OMe, and 1592–1580 cm-1 for R = N(n-
Bu)2. The intensities were calibrated as following: the difference between the intensities 
at the start of the reaction and the intensities at the end of the reaction (i.e. when no 
further change was observed in the concentration of imine) was set to the conversion [%] 
determined by 400 MHz 1H NMR (100% except for 95% in the case of R = N(n-Bu)2). 
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The curves in Figures S1a and S1b were fitted with a 6th-order polynomial function 
through the use of Microsoft Excel (Figure S1c). In order to obtain a reasonable fit, the 
curves were truncated after a maximum time (8 min for R = Br, 20 min for R = H, 20 min 
for R = Me, 40 min for R = OMe, and 180 min for R = N(n-Bu)2). The relative rates kX 
(for time → 0 min) can be read directly from the equations of the polynomials (values in 
red), which are used for the generation of the Hammett plot in Graph S1 (plot of 
 
Page 170
   
log(kX/kH) vs σp-constant). Linear regression results in a ρ-value of 1.3 (slope), indicating 
a faster reaction with more electron deficient aryl substituted aldimines. 
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■  DFT Calculations:  All geometry and frequency calculations of the transition states 
shown in Scheme S2 were carried out employing the hybrid functional B3LYP145 and the 
split-valence 6-31G** basis set. The calculations were carried out in toluene, which was 
simulated by the polarizable dielectric continuum solvation model PCM.146 Frequency 
calculations were carried out on the fully optimized geometries. All computed 
frequencies are real except for the transition state structures, which have one imaginary 
frequency. Free energies were computed at 298.15 K and 1.0 atm. with harmonic, 
unscaled frequencies. All quantum chemical calculations were carried out with the 
Gaussian 09 computer program.147 
                                                
(145) (a) Becke, A. D.  J. Chem. Phys. 1993, 98, 5648-5652; Lee, C.; Yang, W.; Parr, R. G. Phys. Rev. B. 
1988, 37, 785–789. (b) Vosko, S. H.; Wilk, L.; Nusair, M. Can. J. Phys. 1980, 58, 1200–1211. (c) 
Stephens, P. J.; Devlin, F. J.; Chabalowski, C. F.; Frisch, M. J. J. Phys. Chem. 1994, 98, 11623–11627. 
(146) Tomasi, J.; Mennucci, B.; Cammi, R. Chem. Rev. 2005, 105, 2999−3093. 
(147) Gaussian 09, Revision A.02, M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, 
J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato, X. Li, 
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Transition State Energy for Complex R-TS1.1 (Scheme 1.24) 
  
  
 
 
 
 
----------------------------------- 
Cartesian coordinates (Angstroms): 
----------------------------------- 
H  -1.997   5.662  -2.432 
H   2.845   3.498  -3.033 
C  -1.530   4.983  -1.725 
H  -2.465   3.254  -2.572 
H   5.208   3.571  -2.438 
H  -0.497   6.545  -0.652 
H  -1.613   1.457  -3.522 
C  -1.786   3.619  -1.808 
C  -0.689   5.479  -0.724 
C   2.573   3.276  -1.995 
H   2.401   4.227  -1.484 
H   4.283   1.440  -3.143 
                                                                                                                                            
H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. 
Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. 
Montgomery, Jr., J. E. Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. N. 
Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, 
M. Cossi, N. Rega, J. M. Millam, M. Klene, J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. 
Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, 
K. Morokuma, V. G. Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, 
O. Farkas, J. B. Foresman, J. V. Ortiz, J. Cioslowski, and D. J. Fox, Gaussian, Inc., Wallingford CT, 2009. 
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C   4.982   3.358  -1.389 
H   1.634   2.723  -1.994 
H   4.852   4.319  -0.882 
H   0.707   0.874  -3.068 
C  -1.391   0.596  -2.902 
H  -5.918  -1.106  -2.868 
C   3.713   2.484  -1.315 
C   4.005   1.190  -2.114 
C  -0.079   0.199  -2.737 
H   5.856   2.856  -0.960 
C  -1.189   2.716  -0.908 
H  -2.184  -0.140  -2.815 
C  -0.116   4.598   0.192 
H  -5.159  -3.355  -3.599 
H   3.135   0.532  -2.147 
C  -5.062  -1.574  -2.391 
H   4.839   0.639  -1.667 
C  -4.636  -2.840  -2.799 
C  -1.614   1.287  -0.936 
C  -0.361   3.228   0.101 
H   0.524   4.972   0.985 
H  -4.759   0.058  -1.029 
H  -2.692   1.219  -1.082 
C  -4.398  -0.911  -1.359 
C   3.350   2.117   0.142 
C   0.298  -0.915  -1.906 
H  -2.085   2.015   1.781 
H   4.935   3.270   1.022 
O   1.420   0.816  -0.501 
H   1.301  -1.278  -2.131 
C  -3.548  -3.449  -2.171 
H  -0.423  -1.730  -1.893 
H  -3.599   3.312   3.221 
C   4.114   2.594   1.219 
H   0.076   2.562   0.832 
H  -3.226  -4.439  -2.477 
C   2.276   1.256   0.479 
 
Page 174
   
N  -1.101   0.313  -0.104 
C  -3.293  -1.514  -0.733 
B   0.412  -0.198  -0.346 
C  -3.060   1.611   2.023 
C  -2.876  -2.795  -1.139 
C  -3.918   2.348   2.839 
P  -2.343  -0.731   0.604 
H  -2.035  -3.269  -0.642 
C   3.872   2.228   2.544 
C  -3.464   0.367   1.515 
C   2.067   0.822   1.796 
H   2.858  -1.505   0.475 
H   4.490   2.633   3.339 
N   0.828  -1.158   0.907 
C  -5.179   1.847   3.164 
H   0.004   0.282   2.178 
C   2.862   1.319   2.831 
C   0.982  -0.187   2.060 
H  -5.845   2.422   3.800 
H  -0.019  -1.726   1.131 
O  -1.674  -1.763   1.479 
C   1.999  -2.122   0.728 
H   4.078  -2.097  -0.846 
O   0.453  -3.555  -0.377 
C  -4.733  -0.137   1.856 
C   1.592  -3.076  -0.411 
H   2.128  -3.964  -3.385 
H   4.232  -1.923   2.414 
C  -5.584   0.603   2.674 
H   2.686   0.991   3.852 
N   2.486  -3.397  -1.388 
H   1.101  -4.757  -2.160 
H   2.911  -1.394   3.453 
H   1.172  -0.740   2.975 
C   2.104  -4.401  -2.382 
C   3.849  -2.897  -1.544 
H  -5.056  -1.105   1.487 
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C   3.340  -2.260   2.952 
H   4.042  -4.031   0.993 
H   3.980  -2.510  -2.560 
C   2.366  -3.004   2.009 
H  -6.562   0.207   2.930 
H   4.571  -3.708  -1.392 
C   3.130  -4.273   1.547 
H   3.671  -2.949   3.736 
H   2.808  -5.240  -2.352 
H   2.511  -4.935   0.939 
H   0.546  -2.673   3.237 
C   1.109  -3.481   2.765 
H   3.433  -4.834   2.435 
H   0.429  -4.015   2.098 
H   1.413  -4.166   3.563 
----------------------------------- 
 
 SCF Done:  E(RB3LYP) =  -2349.81121449     A.U. after    1 cycles 
 
                     1                      2                      3 
                     A                      A                      A 
 Frequencies --  -309.7171                15.8257                27.8170 
 Red. masses --     8.1218                 5.5670                 3.9897 
 
 Zero-point correction=                                           0.861950 (Hartree/Particle) 
 Thermal correction to Energy=                              0.909242 
 Thermal correction to Enthalpy=                           0.910186 
 Thermal correction to Gibbs Free Energy=           0.782800 
 Sum of electronic and zero-point Energies=        -2348.949264 
 Sum of electronic and thermal Energies=            -2348.901973 
 Sum of electronic and thermal Enthalpies=         -2348.901028 
 Sum of electronic and thermal Free Energies=    -2349.028414 
 
 Item                           Value          Threshold     Converged? 
 Maximum Force        0.000000     0.000450     YES 
 RMS     Force            0.000000     0.000300     YES 
 
Transition State Energy for Complex S-TS1.1 (Scheme 1.24) 
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----------------------------------- 
Cartesian coordinates (Angstroms): 
----------------------------------- 
H   3.751   2.814  -3.386 
H   1.600   4.186  -3.258 
H   3.742   5.158  -2.730 
C   3.627   2.506  -2.342 
H   4.626   2.381  -1.911 
C   1.458   3.814  -2.238 
H   3.123   1.538  -2.327 
C   3.618   4.902  -1.674 
H   0.874   2.895  -2.297 
H   0.874   4.561  -1.689 
H   4.618   4.824  -1.236 
C   2.830   3.581  -1.563 
H   3.096   5.737  -1.195 
H   2.587  -4.468  -1.957 
O   1.682  -3.320  -0.246 
H   3.273  -3.522  -3.306 
C   3.431  -3.861  -2.276 
H   4.349  -4.459  -2.244 
O   1.449   1.133  -0.699 
C   2.650   3.137  -0.094 
H   3.638   4.856   0.738 
H   1.839  -1.100  -2.200 
N
O
Bt-Bu
O
Me2N N
PO
H
t-Bu
Ph
Ph
Ph
‡
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C   2.645  -2.557  -0.383 
C   2.006   1.929   0.274 
H  -1.628   0.879  -3.621 
B   0.744  -0.105  -0.450 
C  -1.216   0.149  -2.933 
N   3.558  -2.710  -1.382 
C   3.149   3.916   0.961 
H   3.444  -0.616   0.298 
C   0.790  -0.944  -1.951 
C   2.813  -1.429   0.653 
H   1.687  -2.174   3.275 
C   0.155  -0.027  -2.868 
H   3.597  -0.206   3.217 
N   1.422  -0.830   0.837 
H   0.273  -1.895  -1.838 
C   1.949   1.506   1.609 
H   4.733  -0.973  -1.039 
C   4.706  -1.856  -1.672 
C   3.055   3.531   2.299 
H   4.661  -1.527  -2.715 
C   2.456  -2.812   2.833 
H   0.784   0.715  -3.355 
C   4.233  -0.973   2.778 
H   1.952  -3.587   2.253 
C   3.480  -2.051   1.964 
H   3.456   4.172   3.077 
H   4.978  -0.464   2.158 
C   1.301   0.191   1.946 
C   2.470   2.314   2.622 
H   5.639  -2.412  -1.531 
H   2.983  -3.295   3.662 
H   0.231   0.304   2.121 
H   4.767  -1.457   3.602 
H   1.712  -0.222   2.862 
H   2.412   1.985   3.656 
C   4.563  -3.080   1.545 
H   5.336  -2.637   0.910 
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H   4.140  -3.947   1.034 
H   5.060  -3.444   2.448 
H  -1.867  -0.684  -2.686 
H   0.768  -1.597   1.104 
H  -3.176   2.810   3.452 
H  -5.140   1.636   4.419 
C  -3.423   1.804   3.128 
C  -4.525   1.143   3.672 
C  -2.633   1.174   2.168 
H  -1.775   1.696   1.758 
C  -4.831  -0.156   3.263 
H  -5.679  -0.679   3.693 
H  -1.790   3.507  -0.374 
C  -2.945  -0.124   1.736 
C  -4.043  -0.792   2.306 
H  -0.558   1.797  -1.282 
H  -3.908   4.769  -0.355 
C  -2.705   3.024  -0.706 
C  -1.313   1.041  -1.102 
O  -0.852  -1.903   1.512 
H  -4.278  -1.811   2.017 
C  -3.901   3.739  -0.697 
P  -1.806  -1.069   0.689 
C  -2.671   1.683  -1.129 
N  -0.830   0.110  -0.202 
C  -5.078   3.138  -1.145 
H  -0.955  -3.432  -0.608 
C  -2.716  -2.183  -0.429 
C  -3.852   1.102  -1.607 
H  -6.008   3.696  -1.151 
C  -1.990  -3.291  -0.906 
C  -5.046   1.823  -1.609 
H  -3.843   0.099  -2.011 
H  -4.663  -1.241  -0.357 
C  -4.077  -2.064  -0.749 
C  -2.610  -4.233  -1.726 
H  -2.042  -5.083  -2.090 
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H  -5.950   1.357  -1.989 
C  -4.694  -3.018  -1.559 
C  -3.960  -4.096  -2.056 
H  -5.750  -2.923  -1.793 
H  -4.443  -4.836  -2.687 
----------------------------------- 
 
 SCF Done:  E(RB3LYP) =  -2349.80692498     A.U. after    1 cycles 
 
                     1                      2                      3 
                     A                      A                      A 
 Frequencies --  -344.5655                12.7728                18.2767 
 Red. masses --     9.0648                 5.1910                 4.1843 
 
 Zero-point correction=                           0.862291 (Hartree/Particle) 
 Thermal correction to Energy=                    0.909628 
 Thermal correction to Enthalpy=                  0.910572 
 Thermal correction to Gibbs Free Energy=         0.782402 
 Sum of electronic and zero-point Energies=          -2348.944634 
 Sum of electronic and thermal Energies=             -2348.897297 
 Sum of electronic and thermal Enthalpies=           -2348.896353 
 Sum of electronic and thermal Free Energies=        -2349.024523 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000001     0.000450     YES 
 RMS     Force            0.000000     0.000300     YES 
 
Transition State Energy for Complex (S)-TS1.2 (Scheme 1.24) 
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----------------------------------- 
Cartesian coordinates (Angstroms): 
----------------------------------- 
H  -0.181   3.850   2.912 
H  -3.556   3.322  -2.949 
C   0.467   3.883   2.042 
H   0.240   1.790   1.642 
H  -4.343   5.027  -1.425 
H   0.893   5.988   2.223 
H   2.342   2.756  -2.636 
C   0.693   2.714   1.313 
C   1.070   5.079   1.658 
C  -3.425   2.604  -2.133 
H  -4.351   2.024  -2.048 
H  -1.941   4.884  -1.814 
C  -4.278   4.343  -0.574 
H  -2.618   1.923  -2.406 
H  -5.244   3.835  -0.485 
H  -0.031   2.235  -2.882 
C   2.005   1.735  -2.495 
H   3.305   0.613   4.518 
C  -3.119   3.353  -0.814 
C  -1.829   4.189  -0.974 
C   0.680   1.422  -2.758 
H  -4.123   4.951   0.323 
C   1.527   2.721   0.186 
H   2.761   0.974  -2.660 
O
N
B
O
NMe2N
P
Ph
O H
Ph
Ph
t-Bu ‡
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C   1.920   5.096   0.548 
H   3.407  -1.655   5.523 
H  -0.957   3.562  -1.159 
C   3.125  -0.263   3.903 
H  -1.631   4.779  -0.074 
C   3.180  -1.540   4.468 
C   1.920   1.442  -0.488 
C   2.154   3.928  -0.172 
H   2.409   6.017   0.249 
H   2.775   0.891   2.132 
H   3.004   1.335  -0.489 
C   2.833  -0.109   2.548 
C  -2.979   2.336   0.343 
C   0.161   0.095  -2.581 
H   4.917   0.061   0.693 
H  -4.553   3.194   1.527 
O  -1.128   1.179  -0.692 
H  -0.764  -0.070  -3.127 
C   2.938  -2.666   3.679 
H   0.886  -0.692  -2.785 
H   7.024   0.246  -0.574 
C  -3.823   2.397   1.463 
H   2.841   3.960  -1.011 
H   2.971  -3.658   4.119 
C  -2.034   1.281   0.337 
N   1.252   0.249  -0.277 
C   2.598  -1.240   1.749 
B  -0.233   0.078  -0.895 
C   4.968  -0.328  -0.318 
C   2.648  -2.521   2.323 
C   6.164  -0.234  -1.030 
P   2.265  -1.174  -0.035 
H   2.444  -3.391   1.708 
C  -3.778   1.469   2.503 
C   3.851  -0.950  -0.900 
C  -2.010   0.311   1.353 
H  -2.997  -1.148  -0.495 
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H  -4.455   1.566   3.346 
N  -0.910  -1.264  -0.227 
C   6.257  -0.768  -2.316 
H  -1.379  -1.695   1.823 
C  -2.885   0.407   2.436 
C  -1.049  -0.843   1.233 
H   7.192  -0.699  -2.865 
H  -0.193  -2.019  -0.260 
O   1.538  -2.398  -0.532 
C  -2.246  -1.920  -0.643 
H  -4.649  -1.587   0.296 
O  -1.433  -3.843   0.502 
C   3.959  -1.508  -2.187 
C  -2.404  -3.096   0.352 
H  -4.024  -4.150   2.877 
H  -4.040  -1.215  -2.801 
C   5.158  -1.411  -2.891 
H  -2.859  -0.351   3.216 
N  -3.579  -3.276   1.015 
H  -2.764  -4.975   1.917 
H  -2.500  -0.394  -2.892 
H  -0.051  -0.588   1.588 
C  -3.718  -4.456   1.871 
C  -4.794  -2.474   0.905 
H   3.116  -2.041  -2.614 
C  -2.978  -1.364  -3.022 
H  -4.409  -3.312  -1.719 
H  -5.111  -2.152   1.902 
C  -2.397  -2.474  -2.116 
H   5.238  -1.847  -3.881 
H  -5.602  -3.070   0.466 
C  -3.446  -3.617  -2.139 
H  -2.897  -1.648  -4.076 
H  -4.483  -5.128   1.465 
H  -3.097  -4.510  -1.614 
H  -0.275  -2.366  -2.746 
C  -1.088  -3.083  -2.653 
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H  -3.624  -3.897  -3.182 
H  -0.743  -3.884  -1.994 
H  -1.270  -3.509  -3.644 
----------------------------------- 
 
 SCF Done:  E(RB3LYP) =  -2349.80034463     A.U. after    1 cycles 
 
                     1                      2                      3 
                     A                      A                      A 
 Frequencies --  -335.3640                16.4052                22.4182 
 Red. masses --     8.2371                 5.2097                 4.3949 
 
 Zero-point correction=                           0.861454 (Hartree/Particle) 
 Thermal correction to Energy=                    0.908946 
 Thermal correction to Enthalpy=                  0.909890 
 Thermal correction to Gibbs Free Energy=         0.781405 
 Sum of electronic and zero-point Energies=          -2348.938890 
 Sum of electronic and thermal Energies=             -2348.891398 
 Sum of electronic and thermal Enthalpies=           -2348.890454 
 Sum of electronic and thermal Free Energies=        -2349.018940 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000000     0.000450     YES 
 RMS     Force            0.000000     0.000300     YES 
 
Transition State Energy for Complex (S)-TS1.3 (Scheme 1.24) 
  
 
 
----------------------------------- 
N
O
Bt-Bu
O
Me2N N
H
t-Bu
P Ph
PhO
Ph
‡
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Cartesian coordinates (Angstroms): 
----------------------------------- 
C  -0.273  -3.861   2.824 
C  -0.769  -2.924   1.919 
C   0.422  -4.980   2.362 
C  -0.573  -3.082   0.532 
C   0.608  -5.154   0.991 
C   0.110  -4.219   0.083 
C   4.390  -1.903  -3.060 
O   2.822  -2.546  -0.908 
N   3.992  -0.944  -2.028 
C   3.245  -1.383  -0.983 
C   5.356  -1.119   0.771 
C   4.166   0.318   2.380 
C   4.497   0.410  -2.243 
C   3.958  -0.849   1.388 
C   2.946  -0.462   0.210 
C   3.532  -2.133   2.129 
B   0.358  -0.146  -0.643 
N   1.453  -0.646   0.514 
C   0.985   0.068   1.766 
O   0.409   1.279  -0.682 
C   1.056   1.562   1.598 
C   0.807   2.111   0.332 
C   1.369   2.396   2.673 
C  -0.523   3.952  -1.935 
C   0.982   3.494   0.076 
C   0.897   4.102  -1.343 
C   1.457   3.767   2.474 
C   1.924   3.404  -2.267 
C   1.288   4.289   1.190 
C   1.239   5.607  -1.339 
C  -2.803   2.146   2.914 
C  -3.265   3.407   2.533 
C  -2.513   1.186   1.945 
C  -3.439   3.708   1.181 
C  -2.678   1.485   0.585 
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C  -3.149   2.752   0.208 
O  -2.312   0.865  -2.119 
P  -2.483   0.276  -0.751 
C  -3.964  -0.797  -0.691 
C  -4.577  -1.076  -1.923 
C  -4.554  -1.265   0.496 
C  -5.749  -1.832  -1.968 
C  -5.724  -2.021   0.444 
C  -6.320  -2.308  -0.788 
N  -1.092  -0.756  -0.265 
C   0.562  -0.676  -2.232 
C   0.267  -2.092  -2.396 
C  -1.302  -2.094  -0.341 
C  -1.008  -2.590  -2.474 
H  -0.440  -3.719   3.887 
H  -1.342  -2.079   2.287 
H   0.809  -5.711   3.064 
H   1.145  -6.021   0.620 
H   0.269  -4.381  -0.974 
H   3.913  -1.653  -4.014 
H   4.091  -2.903  -2.755 
H   5.476  -1.867  -3.193 
H   6.062  -1.308   1.584 
H   5.733  -0.258   0.210 
H   5.366  -1.996   0.121 
H   3.302   0.536   3.004 
H   4.439   1.241   1.859 
H   4.989   0.064   3.054 
H   4.271   0.715  -3.270 
H   5.584   0.443  -2.107 
H   4.036   1.132  -1.575 
H   3.069   0.594  -0.018 
H   2.600  -2.025   2.690 
H   4.306  -2.397   2.856 
H   3.417  -2.970   1.437 
H  -0.037  -0.273   1.926 
H   1.571  -0.263   2.618 
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H   1.541   1.968   3.657 
H  -1.252   4.482  -1.315 
H  -0.833   2.910  -2.017 
H  -0.551   4.398  -2.935 
H   1.686   4.429   3.302 
H   2.943   3.534  -1.885 
H   1.885   3.847  -3.268 
H   1.717   2.337  -2.362 
H   1.409   5.356   1.057 
H   2.247   5.804  -0.960 
H   0.527   6.191  -0.747 
H   1.194   5.984  -2.366 
H  -2.668   1.910   3.965 
H  -3.491   4.152   3.289 
H  -2.163   0.208   2.257 
H  -3.801   4.687   0.883 
H  -3.280   2.981  -0.844 
H  -4.141  -0.678  -2.833 
H  -4.119  -1.030   1.462 
H  -6.220  -2.039  -2.924 
H  -6.175  -2.379   1.364 
H  -7.234  -2.892  -0.823 
H   1.573  -0.421  -2.549 
H  -0.156  -0.035  -2.749 
H   1.094  -2.787  -2.284 
H  -2.332  -2.394  -0.516 
H  -1.832  -1.944  -2.757 
H  -1.186  -3.657  -2.565 
H   1.332  -1.656   0.648 
----------------------------------- 
 
 SCF Done:  E(RB3LYP) =  -2349.80118264     A.U. after    1 cycles 
 
                     1                      2                      3 
                     A                      A                      A 
 Frequencies --  -220.1960                21.2213                23.3750 
 Red. masses --     6.5227                 5.3294                 4.2832 
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 Zero-point correction=                           0.862703 (Hartree/Particle) 
 Thermal correction to Energy=                    0.909800 
 Thermal correction to Enthalpy=                  0.910744 
 Thermal correction to Gibbs Free Energy=         0.784683 
 Sum of electronic and zero-point Energies=          -2348.938480 
 Sum of electronic and thermal Energies=             -2348.891383 
 Sum of electronic and thermal Enthalpies=           -2348.890439 
 Sum of electronic and thermal Free Energies=        -2349.016500 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000001     0.000450     YES 
 RMS     Force            0.000000     0.000300     YES 
 
Transition State Energy for Complex (S)-TS1.4 (Scheme 1.24) 
 
 
  
 
 
----------------------------------- 
Cartesian coordinates (Angstroms): 
----------------------------------- 
H   1.303  -1.944   3.939 
H   3.208  -3.984   0.832 
C   0.753  -2.507   3.192 
H   0.359  -0.776   1.967 
H   5.522  -3.454   1.165 
H   0.956  -4.387   4.226 
H  -1.023  -3.966  -1.454 
N
O
B
NH
t-Bu
Ph
P PhO
Ph
t-Bu
OMe2N
‡
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C   0.240  -1.846   2.074 
C   0.555  -3.877   3.356 
C   3.104  -3.231   0.044 
H   3.304  -3.723  -0.915 
H   3.873  -2.143   2.448 
C   5.511  -2.720   0.353 
H   2.075  -2.879   0.054 
H   5.774  -3.248  -0.569 
H   1.063  -2.851  -2.012 
C  -1.043  -2.925  -1.754 
H  -5.318   3.294   2.053 
C   4.108  -2.080   0.280 
C   3.848  -1.399   1.644 
C   0.126  -2.325  -2.182 
H   6.294  -1.986   0.568 
C  -0.484  -2.553   1.103 
H  -1.993  -2.568  -2.138 
C  -0.181  -4.587   2.402 
H  -5.146   1.938   4.129 
H   2.878  -0.903   1.670 
C  -4.688   2.410   2.077 
H   4.627  -0.656   1.850 
C  -4.589   1.649   3.242 
C  -1.197  -1.825   0.014 
C  -0.705  -3.930   1.294 
H  -0.356  -5.650   2.529 
H  -4.049   2.635   0.033 
H  -2.257  -2.072   0.014 
C  -3.976   2.039   0.937 
C   4.007  -1.021  -0.840 
C   0.207  -0.946  -2.562 
H  -4.543  -1.429   0.263 
H   6.052  -1.254  -1.447 
O   1.656  -0.573  -0.415 
H   1.106  -0.749  -3.142 
C  -3.769   0.520   3.271 
H  -0.684  -0.548  -3.048 
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H  -6.177  -2.752  -1.026 
C   5.131  -0.714  -1.619 
H  -1.300  -4.492   0.582 
H  -3.682  -0.068   4.179 
C   2.818  -0.293  -1.120 
N  -0.935  -0.514  -0.311 
C  -3.153   0.903   0.962 
B   0.418  -0.114  -0.986 
C  -4.531  -1.384  -0.822 
C  -3.049   0.146   2.136 
C  -5.465  -2.122  -1.549 
P  -2.376   0.473  -0.618 
H  -2.392  -0.715   2.187 
C   5.126   0.264  -2.614 
C  -3.603  -0.566  -1.489 
C   2.814   0.726  -2.102 
H   2.303   2.214  -0.211 
H   6.025   0.459  -3.190 
N   0.634   1.499  -1.224 
C  -5.496  -2.035  -2.943 
H   1.057   1.282  -3.283 
C   3.971   0.994  -2.841 
C   1.590   1.578  -2.378 
H  -6.229  -2.604  -3.505 
H  -0.300   1.870  -1.484 
O  -2.021   1.655  -1.488 
C   1.235   2.374  -0.108 
H   3.510   2.089   1.232 
O  -0.408   1.611   1.439 
C  -3.658  -0.464  -2.890 
C   0.777   1.910   1.271 
H   1.719   0.880   4.138 
H   3.067   4.476   0.090 
C  -4.598  -1.199  -3.611 
H   3.952   1.781  -3.590 
N   1.679   1.900   2.295 
H   0.118   1.481   3.621 
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H   2.723   4.259  -1.629 
H   1.889   2.614  -2.522 
C   1.181   1.705   3.659 
C   3.092   2.266   2.221 
H  -2.984   0.213  -3.404 
C   2.310   4.629  -0.685 
H   1.186   4.522   1.813 
H   3.648   1.642   2.925 
C   0.970   3.954  -0.311 
H  -4.637  -1.111  -4.692 
H   3.251   3.315   2.497 
C   0.465   4.612   0.996 
H   2.166   5.708  -0.794 
H   1.342   2.613   4.251 
H  -0.485   4.184   1.323 
H   0.213   3.937  -2.398 
C  -0.081   4.267  -1.397 
H   0.314   5.680   0.816 
H  -1.056   3.832  -1.163 
H  -0.205   5.352  -1.452 
----------------------------------- 
 
 SCF Done:  E(RB3LYP) =  -2349.79523369     A.U. after    1 cycles 
 
                     1                      2                      3 
                     A                      A                      A 
 Frequencies --  -335.9124                12.6240                29.5812 
 Red. masses --     8.2872                 3.9844                 5.0315 
 
 Zero-point correction=                           0.862399 (Hartree/Particle) 
 Thermal correction to Energy=                    0.909414 
 Thermal correction to Enthalpy=                  0.910359 
 Thermal correction to Gibbs Free Energy=         0.783996 
 Sum of electronic and zero-point Energies=          -2348.932835 
 Sum of electronic and thermal Energies=             -2348.885819 
 Sum of electronic and thermal Enthalpies=           -2348.884875 
 Sum of electronic and thermal Free Energies=        -2349.011238 
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         Item               Value     Threshold  Converged? 
 Maximum Force            0.000011     0.000450     YES 
 RMS     Force            0.000002     0.000300     YES 
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Page 260
X-ray Crystal Structure of 1.19HCl  
 
Table 1. Crystal data and structure refinement for C18H31N2O2Cl (2gHCl) 
Identification code  C18H31N2O2Cl 
Empirical formula  C18H31N2O2Cl 
Formula weight  342.90 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P 21 
Unit cell dimensions a = 8.1015(4) Å α= 90° 
 b = 21.8686(12) Å β= 91.738(3)° 
 c = 16.8521(9) Å γ = 90° 
Volume 2984.3(3) Å3 
Z 6 
Density (calculated) 1.145 Mg/m3 
Absorption coefficient 1.776 mm-1 
F(000) 1116 
Crystal size 0.15 x 0.09 x 0.03 mm3 
Theta range for data collection 2.62 to 67.29° 
Index ranges -6<=h<=9, -25<=k<=26, -20<=l<=20 
Reflections collected 25872 
Independent reflections 9770 [R(int) = 0.0418] 
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Completeness to theta = 67.29° 98.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9487 and 0.7765 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9770 / 10 / 655 
Goodness-of-fit on F2 1.024 
Final R indices [I>2sigma(I)] R1 = 0.0379, wR2 = 0.0921 
R indices (all data) R1 = 0.0440, wR2 = 0.0956 
Absolute structure parameter 0.012(9) 
Extinction coefficient na 
Largest diff. peak and hole 0.280 and -0.175 e.Å-3 
 
 
 
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2 x 103) for 
C18H31N2O2Cl. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
Cl(1) 5873(1) 4279(1) 5833(1) 26(1) 
O(1) 4388(2) 5077(1) 7714(1) 26(1) 
O(2) 7895(2) 4751(1) 7289(1) 24(1) 
N(1) 3799(3) 5997(1) 8272(1) 31(1) 
N(2) 4854(3) 5570(1) 6282(1) 22(1) 
C(1) 4023(3) 5617(1) 7649(1) 24(1) 
C(2) 3712(3) 5890(1) 6820(1) 22(1) 
C(3) 6638(3) 5780(1) 6310(1) 23(1) 
C(4) 7424(3) 5837(1) 7132(1) 23(1) 
C(5) 7982(3) 5329(1) 7574(2) 23(1) 
C(6) 8680(3) 5404(1) 8351(2) 26(1) 
C(7) 8891(3) 6001(1) 8622(2) 32(1) 
C(8) 8415(3) 6508(1) 8179(2) 33(1) 
C(9) 7665(3) 6425(1) 7438(2) 29(1) 
C(10) 4175(4) 5763(2) 9066(2) 43(1) 
C(11) 3392(4) 6643(1) 8206(2) 41(1) 
C(12) 1882(3) 5784(1) 6565(1) 25(1) 
C(13) 1519(3) 5118(1) 6347(2) 29(1) 
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C(14) 1342(3) 6214(1) 5893(2) 31(1) 
C(15) 9156(3) 4852(1) 8865(1) 27(1) 
C(16) 10572(3) 4495(1) 8491(2) 29(1) 
C(17) 9771(4) 5044(1) 9704(2) 38(1) 
C(18) 7638(3) 4443(1) 8984(2) 30(1) 
Cl(2) 5017(1) 2369(1) 3817(1) 29(1) 
O(3) 3822(2) 1891(1) 6973(1) 30(1) 
O(4) 7517(2) 1357(1) 7073(1) 28(1) 
N(3) 3668(3) 2844(1) 7484(1) 29(1) 
N(4) 5179(3) 2204(1) 5653(1) 23(1) 
C(19) 3894(3) 2444(1) 6886(2) 26(1) 
C(20) 4168(3) 2690(1) 6045(1) 23(1) 
C(21) 7028(3) 2253(1) 5787(1) 24(1) 
C(22) 7548(3) 2410(1) 6627(1) 23(1) 
C(23) 7721(3) 1966(1) 7228(2) 24(1) 
C(24) 8175(3) 2141(1) 8009(2) 28(1) 
C(25) 8439(4) 2760(1) 8151(2) 33(1) 
C(26) 8292(4) 3195(1) 7560(2) 34(1) 
C(27) 7851(3) 3019(1) 6800(2) 28(1) 
C(28) 3285(4) 2597(1) 8261(2) 40(1) 
C(29) 3913(4) 3504(1) 7467(2) 33(1) 
C(30) 2535(3) 2771(1) 5562(2) 30(1) 
C(31) 1605(4) 3334(1) 5836(2) 37(1) 
C(32) 1460(4) 2199(2) 5555(2) 40(1) 
C(33) 8339(4) 1666(1) 8684(2) 34(1) 
C(34) 6708(4) 1328(1) 8784(2) 39(1) 
C(35) 8804(5) 1966(2) 9481(2) 50(1) 
C(36) 9749(4) 1218(1) 8496(2) 34(1) 
Cl(3) 4499(1) 5738(1) 4422(1) 26(1) 
O(5) 8331(3) 3526(1) 4414(1) 41(1) 
O(6) 5415(2) 3236(1) 2436(1) 30(1) 
N(5) 9467(3) 3444(1) 3206(2) 38(1) 
N(6) 6261(3) 4407(1) 4024(1) 26(1) 
C(37) 8504(4) 3720(1) 3741(2) 32(1) 
C(38) 7667(3) 4322(1) 3490(2) 29(1) 
C(39) 4789(3) 4001(1) 3827(1) 23(1) 
C(40) 4129(3) 4130(1) 2995(1) 24(1) 
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C(41) 4489(3) 3754(1) 2345(2) 24(1) 
C(42) 3970(3) 3922(1) 1566(1) 25(1) 
C(43) 3100(3) 4465(1) 1478(2) 30(1) 
C(44) 2711(4) 4832(1) 2115(2) 34(1) 
C(45) 3234(3) 4661(1) 2870(2) 28(1) 
C(46) 10336(5) 2882(2) 3432(2) 53(1) 
C(47) 9623(4) 3616(2) 2381(2) 39(1) 
C(48) 8878(4) 4867(1) 3540(2) 39(1) 
C(49) 9494(5) 4992(2) 4386(2) 61(1) 
C(50) 8131(5) 5432(2) 3151(2) 57(1) 
C(51) 4327(4) 3517(1) 846(2) 30(1) 
C(52) 6180(4) 3407(2) 764(2) 41(1) 
C(53) 3426(4) 2900(1) 933(2) 40(1) 
C(54) 3689(4) 3812(2) 66(2) 42(1) 
 
 
Table 3. Bond lengths [Å] and angles [°] for C18H31N2O2Cl  
_____________________________________________________  
O(1)-C(1)  1.221(3) 
O(2)-C(5)  1.354(3) 
O(2)-H(2O)  0.857(18) 
N(1)-C(1)  1.354(3) 
N(1)-C(11)  1.454(4) 
N(1)-C(10)  1.456(4) 
N(2)-C(2)  1.491(3) 
N(2)-C(3)  1.517(3) 
N(2)-H(1N)  0.937(17) 
N(2)-H(2N)  0.915(17) 
C(1)-C(2)  1.533(3) 
C(2)-C(12)  1.548(3) 
C(2)-H(2B)  1.0000 
C(3)-C(4)  1.512(3) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-C(9)  1.398(4) 
C(4)-C(5)  1.405(3) 
C(5)-C(6)  1.420(3) 
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C(6)-C(7)  1.390(4) 
C(6)-C(15)  1.528(3) 
C(7)-C(8)  1.386(4) 
C(7)-H(7A)  0.9500 
C(8)-C(9)  1.383(4) 
C(8)-H(8A)  0.9500 
C(9)-H(9A)  0.9500 
C(10)-H(10A)  0.9800 
C(10)-H(10B)  0.9800 
C(10)-H(10C)  0.9800 
C(11)-H(11A)  0.9800 
C(11)-H(11B)  0.9800 
C(11)-H(11C)  0.9800 
C(12)-C(14)  1.526(3) 
C(12)-C(13)  1.528(3) 
C(12)-H(12A)  1.0000 
C(13)-H(13A)  0.9800 
C(13)-H(13B)  0.9800 
C(13)-H(13C)  0.9800 
C(14)-H(14A)  0.9800 
C(14)-H(14B)  0.9800 
C(14)-H(14C)  0.9800 
C(15)-C(16)  1.539(4) 
C(15)-C(18)  1.540(4) 
C(15)-C(17)  1.542(3) 
C(16)-H(16A)  0.9800 
C(16)-H(16B)  0.9800 
C(16)-H(16C)  0.9800 
C(17)-H(17A)  0.9800 
C(17)-H(17B)  0.9800 
C(17)-H(17C)  0.9800 
C(18)-H(18A)  0.9800 
C(18)-H(18B)  0.9800 
C(18)-H(18C)  0.9800 
O(3)-C(19)  1.222(3) 
O(4)-C(23)  1.367(3) 
O(4)-H(4O)  0.855(18) 
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N(3)-C(19)  1.350(3) 
N(3)-C(29)  1.457(3) 
N(3)-C(28)  1.458(3) 
N(4)-C(20)  1.507(3) 
N(4)-C(21)  1.512(3) 
N(4)-H(3N)  0.914(17) 
N(4)-H(4N)  0.914(17) 
C(19)-C(20)  1.538(3) 
C(20)-C(30)  1.542(3) 
C(20)-H(20A)  1.0000 
C(21)-C(22)  1.505(3) 
C(21)-H(21A)  0.9900 
C(21)-H(21B)  0.9900 
C(22)-C(27)  1.383(4) 
C(22)-C(23)  1.407(3) 
C(23)-C(24)  1.409(4) 
C(24)-C(25)  1.389(4) 
C(24)-C(33)  1.543(4) 
C(25)-C(26)  1.379(4) 
C(25)-H(25A)  0.9500 
C(26)-C(27)  1.375(4) 
C(26)-H(26A)  0.9500 
C(27)-H(27A)  0.9500 
C(28)-H(28A)  0.9800 
C(28)-H(28B)  0.9800 
C(28)-H(28C)  0.9800 
C(29)-H(29A)  0.9800 
C(29)-H(29B)  0.9800 
C(29)-H(29C)  0.9800 
C(30)-C(31)  1.524(4) 
C(30)-C(32)  1.524(4) 
C(30)-H(30A)  1.0000 
C(31)-H(31A)  0.9800 
C(31)-H(31B)  0.9800 
C(31)-H(31C)  0.9800 
C(32)-H(32A)  0.9800 
C(32)-H(32B)  0.9800 
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C(32)-H(32C)  0.9800 
C(33)-C(34)  1.528(4) 
C(33)-C(35)  1.531(4) 
C(33)-C(36)  1.545(4) 
C(34)-H(34A)  0.9800 
C(34)-H(34B)  0.9800 
C(34)-H(34C)  0.9800 
C(35)-H(35A)  0.9800 
C(35)-H(35B)  0.9800 
C(35)-H(35C)  0.9800 
C(36)-H(36A)  0.9800 
C(36)-H(36B)  0.9800 
C(36)-H(36C)  0.9800 
O(5)-C(37)  1.223(4) 
O(6)-C(41)  1.363(3) 
O(6)-H(6O)  0.851(18) 
N(5)-C(37)  1.353(4) 
N(5)-C(47)  1.449(4) 
N(5)-C(46)  1.460(4) 
N(6)-C(38)  1.485(4) 
N(6)-C(39)  1.516(3) 
N(6)-H(5N)  0.909(17) 
N(6)-H(6N)  0.925(17) 
C(37)-C(38)  1.533(4) 
C(38)-C(48)  1.544(4) 
C(38)-H(38A)  1.0000 
C(39)-C(40)  1.512(3) 
C(39)-H(39A)  0.9900 
C(39)-H(39B)  0.9900 
C(40)-C(45)  1.380(3) 
C(40)-C(41)  1.408(4) 
C(41)-C(42)  1.416(3) 
C(42)-C(43)  1.386(4) 
C(42)-C(51)  1.536(3) 
C(43)-C(44)  1.384(4) 
C(43)-H(43A)  0.9500 
C(44)-C(45)  1.381(4) 
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C(44)-H(44A)  0.9500 
C(45)-H(45A)  0.9500 
C(46)-H(46A)  0.9800 
C(46)-H(46B)  0.9800 
C(46)-H(46C)  0.9800 
C(47)-H(47A)  0.9800 
C(47)-H(47B)  0.9800 
C(47)-H(47C)  0.9800 
C(48)-C(50)  1.518(5) 
C(48)-C(49)  1.521(4) 
C(48)-H(48A)  1.0000 
C(49)-H(49A)  0.9800 
C(49)-H(49B)  0.9800 
C(49)-H(49C)  0.9800 
C(50)-H(50A)  0.9800 
C(50)-H(50B)  0.9800 
C(50)-H(50C)  0.9800 
C(51)-C(52)  1.530(4) 
C(51)-C(54)  1.538(4) 
C(51)-C(53)  1.545(4) 
C(52)-H(52A)  0.9800 
C(52)-H(52B)  0.9800 
C(52)-H(52C)  0.9800 
C(53)-H(53A)  0.9800 
C(53)-H(53B)  0.9800 
C(53)-H(53C)  0.9800 
C(54)-H(54A)  0.9800 
C(54)-H(54B)  0.9800 
C(54)-H(54C)  0.9800 
 
C(5)-O(2)-H(2O) 116(2) 
C(1)-N(1)-C(11) 124.9(2) 
C(1)-N(1)-C(10) 117.9(2) 
C(11)-N(1)-C(10) 116.9(2) 
C(2)-N(2)-C(3) 116.52(19) 
C(2)-N(2)-H(1N) 111.0(18) 
C(3)-N(2)-H(1N) 106.0(18) 
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C(2)-N(2)-H(2N) 113.3(18) 
C(3)-N(2)-H(2N) 104.4(19) 
H(1N)-N(2)-H(2N) 105(2) 
O(1)-C(1)-N(1) 124.1(2) 
O(1)-C(1)-C(2) 119.4(2) 
N(1)-C(1)-C(2) 116.4(2) 
N(2)-C(2)-C(1) 106.47(19) 
N(2)-C(2)-C(12) 111.52(19) 
C(1)-C(2)-C(12) 108.9(2) 
N(2)-C(2)-H(2B) 110.0 
C(1)-C(2)-H(2B) 110.0 
C(12)-C(2)-H(2B) 110.0 
C(4)-C(3)-N(2) 115.37(19) 
C(4)-C(3)-H(3A) 108.4 
N(2)-C(3)-H(3A) 108.4 
C(4)-C(3)-H(3B) 108.4 
N(2)-C(3)-H(3B) 108.4 
H(3A)-C(3)-H(3B) 107.5 
C(9)-C(4)-C(5) 119.5(2) 
C(9)-C(4)-C(3) 117.6(2) 
C(5)-C(4)-C(3) 122.7(2) 
O(2)-C(5)-C(4) 122.5(2) 
O(2)-C(5)-C(6) 116.8(2) 
C(4)-C(5)-C(6) 120.6(2) 
C(7)-C(6)-C(5) 117.0(2) 
C(7)-C(6)-C(15) 121.9(2) 
C(5)-C(6)-C(15) 121.1(2) 
C(8)-C(7)-C(6) 123.0(2) 
C(8)-C(7)-H(7A) 118.5 
C(6)-C(7)-H(7A) 118.5 
C(9)-C(8)-C(7) 119.2(2) 
C(9)-C(8)-H(8A) 120.4 
C(7)-C(8)-H(8A) 120.4 
C(8)-C(9)-C(4) 120.5(2) 
C(8)-C(9)-H(9A) 119.8 
C(4)-C(9)-H(9A) 119.8 
N(1)-C(10)-H(10A) 109.5 
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N(1)-C(10)-H(10B) 109.5 
H(10A)-C(10)-H(10B) 109.5 
N(1)-C(10)-H(10C) 109.5 
H(10A)-C(10)-H(10C) 109.5 
H(10B)-C(10)-H(10C) 109.5 
N(1)-C(11)-H(11A) 109.5 
N(1)-C(11)-H(11B) 109.5 
H(11A)-C(11)-H(11B) 109.5 
N(1)-C(11)-H(11C) 109.5 
H(11A)-C(11)-H(11C) 109.5 
H(11B)-C(11)-H(11C) 109.5 
C(14)-C(12)-C(13) 111.1(2) 
C(14)-C(12)-C(2) 111.4(2) 
C(13)-C(12)-C(2) 112.7(2) 
C(14)-C(12)-H(12A) 107.1 
C(13)-C(12)-H(12A) 107.1 
C(2)-C(12)-H(12A) 107.1 
C(12)-C(13)-H(13A) 109.5 
C(12)-C(13)-H(13B) 109.5 
H(13A)-C(13)-H(13B) 109.5 
C(12)-C(13)-H(13C) 109.5 
H(13A)-C(13)-H(13C) 109.5 
H(13B)-C(13)-H(13C) 109.5 
C(12)-C(14)-H(14A) 109.5 
C(12)-C(14)-H(14B) 109.5 
H(14A)-C(14)-H(14B) 109.5 
C(12)-C(14)-H(14C) 109.5 
H(14A)-C(14)-H(14C) 109.5 
H(14B)-C(14)-H(14C) 109.5 
C(6)-C(15)-C(16) 110.3(2) 
C(6)-C(15)-C(18) 110.2(2) 
C(16)-C(15)-C(18) 111.4(2) 
C(6)-C(15)-C(17) 111.9(2) 
C(16)-C(15)-C(17) 106.8(2) 
C(18)-C(15)-C(17) 106.1(2) 
C(15)-C(16)-H(16A) 109.5 
C(15)-C(16)-H(16B) 109.5 
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H(16A)-C(16)-H(16B) 109.5 
C(15)-C(16)-H(16C) 109.5 
H(16A)-C(16)-H(16C) 109.5 
H(16B)-C(16)-H(16C) 109.5 
C(15)-C(17)-H(17A) 109.5 
C(15)-C(17)-H(17B) 109.5 
H(17A)-C(17)-H(17B) 109.5 
C(15)-C(17)-H(17C) 109.5 
H(17A)-C(17)-H(17C) 109.5 
H(17B)-C(17)-H(17C) 109.5 
C(15)-C(18)-H(18A) 109.5 
C(15)-C(18)-H(18B) 109.5 
H(18A)-C(18)-H(18B) 109.5 
C(15)-C(18)-H(18C) 109.5 
H(18A)-C(18)-H(18C) 109.5 
H(18B)-C(18)-H(18C) 109.5 
C(23)-O(4)-H(4O) 113(2) 
C(19)-N(3)-C(29) 127.2(2) 
C(19)-N(3)-C(28) 117.9(2) 
C(29)-N(3)-C(28) 114.7(2) 
C(20)-N(4)-C(21) 115.74(18) 
C(20)-N(4)-H(3N) 107.2(18) 
C(21)-N(4)-H(3N) 111.7(19) 
C(20)-N(4)-H(4N) 112.2(18) 
C(21)-N(4)-H(4N) 102.1(19) 
H(3N)-N(4)-H(4N) 108(2) 
O(3)-C(19)-N(3) 122.9(2) 
O(3)-C(19)-C(20) 117.8(2) 
N(3)-C(19)-C(20) 119.3(2) 
N(4)-C(20)-C(19) 104.64(19) 
N(4)-C(20)-C(30) 108.55(19) 
C(19)-C(20)-C(30) 112.4(2) 
N(4)-C(20)-H(20A) 110.4 
C(19)-C(20)-H(20A) 110.4 
C(30)-C(20)-H(20A) 110.4 
C(22)-C(21)-N(4) 113.9(2) 
C(22)-C(21)-H(21A) 108.8 
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N(4)-C(21)-H(21A) 108.8 
C(22)-C(21)-H(21B) 108.8 
N(4)-C(21)-H(21B) 108.8 
H(21A)-C(21)-H(21B) 107.7 
C(27)-C(22)-C(23) 119.9(2) 
C(27)-C(22)-C(21) 117.5(2) 
C(23)-C(22)-C(21) 122.6(2) 
O(4)-C(23)-C(22) 121.7(2) 
O(4)-C(23)-C(24) 118.0(2) 
C(22)-C(23)-C(24) 120.2(2) 
C(25)-C(24)-C(23) 117.3(2) 
C(25)-C(24)-C(33) 121.3(2) 
C(23)-C(24)-C(33) 121.3(2) 
C(26)-C(25)-C(24) 122.6(2) 
C(26)-C(25)-H(25A) 118.7 
C(24)-C(25)-H(25A) 118.7 
C(27)-C(26)-C(25) 119.6(3) 
C(27)-C(26)-H(26A) 120.2 
C(25)-C(26)-H(26A) 120.2 
C(26)-C(27)-C(22) 120.3(2) 
C(26)-C(27)-H(27A) 119.8 
C(22)-C(27)-H(27A) 119.8 
N(3)-C(28)-H(28A) 109.5 
N(3)-C(28)-H(28B) 109.5 
H(28A)-C(28)-H(28B) 109.5 
N(3)-C(28)-H(28C) 109.5 
H(28A)-C(28)-H(28C) 109.5 
H(28B)-C(28)-H(28C) 109.5 
N(3)-C(29)-H(29A) 109.5 
N(3)-C(29)-H(29B) 109.5 
H(29A)-C(29)-H(29B) 109.5 
N(3)-C(29)-H(29C) 109.5 
H(29A)-C(29)-H(29C) 109.5 
H(29B)-C(29)-H(29C) 109.5 
C(31)-C(30)-C(32) 112.2(2) 
C(31)-C(30)-C(20) 110.9(2) 
C(32)-C(30)-C(20) 113.0(2) 
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C(31)-C(30)-H(30A) 106.8 
C(32)-C(30)-H(30A) 106.8 
C(20)-C(30)-H(30A) 106.8 
C(30)-C(31)-H(31A) 109.5 
C(30)-C(31)-H(31B) 109.5 
H(31A)-C(31)-H(31B) 109.5 
C(30)-C(31)-H(31C) 109.5 
H(31A)-C(31)-H(31C) 109.5 
H(31B)-C(31)-H(31C) 109.5 
C(30)-C(32)-H(32A) 109.5 
C(30)-C(32)-H(32B) 109.5 
H(32A)-C(32)-H(32B) 109.5 
C(30)-C(32)-H(32C) 109.5 
H(32A)-C(32)-H(32C) 109.5 
H(32B)-C(32)-H(32C) 109.5 
C(34)-C(33)-C(35) 107.6(3) 
C(34)-C(33)-C(24) 110.6(2) 
C(35)-C(33)-C(24) 111.8(2) 
C(34)-C(33)-C(36) 111.2(2) 
C(35)-C(33)-C(36) 106.7(2) 
C(24)-C(33)-C(36) 108.9(2) 
C(33)-C(34)-H(34A) 109.5 
C(33)-C(34)-H(34B) 109.5 
H(34A)-C(34)-H(34B) 109.5 
C(33)-C(34)-H(34C) 109.5 
H(34A)-C(34)-H(34C) 109.5 
H(34B)-C(34)-H(34C) 109.5 
C(33)-C(35)-H(35A) 109.5 
C(33)-C(35)-H(35B) 109.5 
H(35A)-C(35)-H(35B) 109.5 
C(33)-C(35)-H(35C) 109.5 
H(35A)-C(35)-H(35C) 109.5 
H(35B)-C(35)-H(35C) 109.5 
C(33)-C(36)-H(36A) 109.5 
C(33)-C(36)-H(36B) 109.5 
H(36A)-C(36)-H(36B) 109.5 
C(33)-C(36)-H(36C) 109.5 
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H(36A)-C(36)-H(36C) 109.5 
H(36B)-C(36)-H(36C) 109.5 
C(41)-O(6)-H(6O) 110(2) 
C(37)-N(5)-C(47) 126.3(2) 
C(37)-N(5)-C(46) 119.0(3) 
C(47)-N(5)-C(46) 114.5(3) 
C(38)-N(6)-C(39) 113.96(19) 
C(38)-N(6)-H(5N) 112.0(19) 
C(39)-N(6)-H(5N) 102.8(19) 
C(38)-N(6)-H(6N) 110.3(19) 
C(39)-N(6)-H(6N) 104.8(19) 
H(5N)-N(6)-H(6N) 113(3) 
O(5)-C(37)-N(5) 123.2(3) 
O(5)-C(37)-C(38) 119.4(3) 
N(5)-C(37)-C(38) 117.3(2) 
N(6)-C(38)-C(37) 106.3(2) 
N(6)-C(38)-C(48) 111.6(2) 
C(37)-C(38)-C(48) 111.8(2) 
N(6)-C(38)-H(38A) 109.0 
C(37)-C(38)-H(38A) 109.0 
C(48)-C(38)-H(38A) 109.0 
C(40)-C(39)-N(6) 110.31(19) 
C(40)-C(39)-H(39A) 109.6 
N(6)-C(39)-H(39A) 109.6 
C(40)-C(39)-H(39B) 109.6 
N(6)-C(39)-H(39B) 109.6 
H(39A)-C(39)-H(39B) 108.1 
C(45)-C(40)-C(41) 119.6(2) 
C(45)-C(40)-C(39) 117.9(2) 
C(41)-C(40)-C(39) 122.3(2) 
O(6)-C(41)-C(40) 121.7(2) 
O(6)-C(41)-C(42) 117.8(2) 
C(40)-C(41)-C(42) 120.4(2) 
C(43)-C(42)-C(41) 117.2(2) 
C(43)-C(42)-C(51) 121.1(2) 
C(41)-C(42)-C(51) 121.7(2) 
C(44)-C(43)-C(42) 122.8(2) 
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C(44)-C(43)-H(43A) 118.6 
C(42)-C(43)-H(43A) 118.6 
C(45)-C(44)-C(43) 119.1(2) 
C(45)-C(44)-H(44A) 120.4 
C(43)-C(44)-H(44A) 120.4 
C(40)-C(45)-C(44) 120.9(2) 
C(40)-C(45)-H(45A) 119.6 
C(44)-C(45)-H(45A) 119.6 
N(5)-C(46)-H(46A) 109.5 
N(5)-C(46)-H(46B) 109.5 
H(46A)-C(46)-H(46B) 109.5 
N(5)-C(46)-H(46C) 109.5 
H(46A)-C(46)-H(46C) 109.5 
H(46B)-C(46)-H(46C) 109.5 
N(5)-C(47)-H(47A) 109.5 
N(5)-C(47)-H(47B) 109.5 
H(47A)-C(47)-H(47B) 109.5 
N(5)-C(47)-H(47C) 109.5 
H(47A)-C(47)-H(47C) 109.5 
H(47B)-C(47)-H(47C) 109.5 
C(50)-C(48)-C(49) 111.8(3) 
C(50)-C(48)-C(38) 111.2(3) 
C(49)-C(48)-C(38) 112.3(3) 
C(50)-C(48)-H(48A) 107.0 
C(49)-C(48)-H(48A) 107.0 
C(38)-C(48)-H(48A) 107.0 
C(48)-C(49)-H(49A) 109.5 
C(48)-C(49)-H(49B) 109.5 
H(49A)-C(49)-H(49B) 109.5 
C(48)-C(49)-H(49C) 109.5 
H(49A)-C(49)-H(49C) 109.5 
H(49B)-C(49)-H(49C) 109.5 
C(48)-C(50)-H(50A) 109.5 
C(48)-C(50)-H(50B) 109.5 
H(50A)-C(50)-H(50B) 109.5 
C(48)-C(50)-H(50C) 109.5 
H(50A)-C(50)-H(50C) 109.5 
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H(50B)-C(50)-H(50C) 109.5 
C(52)-C(51)-C(42) 111.8(2) 
C(52)-C(51)-C(54) 107.1(2) 
C(42)-C(51)-C(54) 111.5(2) 
C(52)-C(51)-C(53) 109.8(2) 
C(42)-C(51)-C(53) 109.1(2) 
C(54)-C(51)-C(53) 107.5(2) 
C(51)-C(52)-H(52A) 109.5 
C(51)-C(52)-H(52B) 109.5 
H(52A)-C(52)-H(52B) 109.5 
C(51)-C(52)-H(52C) 109.5 
H(52A)-C(52)-H(52C) 109.5 
H(52B)-C(52)-H(52C) 109.5 
C(51)-C(53)-H(53A) 109.5 
C(51)-C(53)-H(53B) 109.5 
H(53A)-C(53)-H(53B) 109.5 
C(51)-C(53)-H(53C) 109.5 
H(53A)-C(53)-H(53C) 109.5 
H(53B)-C(53)-H(53C) 109.5 
C(51)-C(54)-H(54A) 109.5 
C(51)-C(54)-H(54B) 109.5 
H(54A)-C(54)-H(54B) 109.5 
C(51)-C(54)-H(54C) 109.5 
H(54A)-C(54)-H(54C) 109.5 
H(54B)-C(54)-H(54C) 109.5 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 
 
Table 4. Anisotropic displacement parameters (Å2 x 103) for C18H31N2O2Cl  The anisotropic 
displacement factor exponent takes the form: -2p2[ h2 a*2U11 +  ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
Cl(1) 34(1)  25(1) 21(1)  0(1) -3(1)  2(1) 
O(1) 23(1)  31(1) 24(1)  4(1) -1(1)  -1(1) 
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O(2) 26(1)  24(1) 21(1)  -2(1) -5(1)  0(1) 
N(1) 25(1)  44(1) 25(1)  -8(1) 1(1)  -3(1) 
N(2) 20(1)  23(1) 22(1)  -1(1) 1(1)  0(1) 
C(1) 13(1)  36(1) 23(1)  -2(1) 0(1)  -5(1) 
C(2) 17(1)  24(1) 25(1)  -4(1) 4(1)  1(1) 
C(3) 16(1)  28(1) 26(1)  4(1) 3(1)  0(1) 
C(4) 15(1)  28(1) 27(1)  -1(1) 2(1)  -3(1) 
C(5) 13(1)  28(1) 28(1)  -3(1) 2(1)  -1(1) 
C(6) 18(1)  30(1) 29(1)  -3(1) -1(1)  -1(1) 
C(7) 24(2)  36(1) 37(2)  -8(1) -6(1)  -3(1) 
C(8) 29(2)  27(1) 42(2)  -9(1) -5(1)  -2(1) 
C(9) 21(1)  27(1) 38(1)  -2(1) 0(1)  -3(1) 
C(10) 35(2)  72(2) 22(1)  -9(1) 0(1)  -5(2) 
C(11) 39(2)  45(2) 40(2)  -14(1) 6(1)  -4(1) 
C(12) 18(1)  34(1) 22(1)  -1(1) 2(1)  1(1) 
C(13) 18(1)  38(2) 31(1)  1(1) -2(1)  -2(1) 
C(14) 23(2)  38(1) 32(1)  3(1) -3(1)  3(1) 
C(15) 25(2)  34(1) 22(1)  -3(1) -5(1)  -1(1) 
C(16) 22(1)  36(1) 28(1)  0(1) -5(1)  1(1) 
C(17) 40(2)  46(2) 27(2)  -6(1) -12(1)  3(1) 
C(18) 28(2)  37(2) 26(1)  4(1) -1(1)  -1(1) 
Cl(2) 40(1)  24(1) 24(1)  0(1) -2(1)  2(1) 
O(3) 32(1)  31(1) 29(1)  1(1) 2(1)  -4(1) 
O(4) 32(1)  25(1) 26(1)  -1(1) -6(1)  -1(1) 
N(3) 27(1)  33(1) 27(1)  -2(1) 2(1)  -2(1) 
N(4) 20(1)  25(1) 24(1)  0(1) -1(1)  0(1) 
C(19) 16(1)  33(1) 29(1)  0(1) -2(1)  -3(1) 
C(20) 20(1)  25(1) 25(1)  -3(1) 0(1)  2(1) 
C(21) 19(1)  27(1) 26(1)  1(1) 0(1)  2(1) 
C(22) 17(1)  28(1) 24(1)  2(1) -1(1)  2(1) 
C(23) 19(1)  25(1) 30(1)  -1(1) 1(1)  1(1) 
C(24) 24(2)  31(1) 29(1)  -1(1) -4(1)  4(1) 
C(25) 33(2)  34(1) 31(1)  -7(1) -10(1)  4(1) 
C(26) 34(2)  25(1) 42(2)  -5(1) -8(1)  -2(1) 
C(27) 23(2)  27(1) 34(1)  4(1) -3(1)  1(1) 
C(28) 48(2)  43(2) 28(2)  -2(1) 10(1)  -1(1) 
C(29) 33(2)  34(1) 31(1)  -4(1) 4(1)  4(1) 
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C(30) 21(2)  42(2) 27(1)  -2(1) -2(1)  1(1) 
C(31) 26(2)  48(2) 37(1)  2(1) -4(1)  9(1) 
C(32) 25(2)  52(2) 41(2)  -7(1) -6(1)  -2(1) 
C(33) 38(2)  34(1) 29(1)  -2(1) -7(1)  6(1) 
C(34) 46(2)  41(2) 30(1)  7(1) 6(1)  7(1) 
C(35) 77(3)  42(2) 31(2)  -3(1) -17(2)  14(2) 
C(36) 39(2)  31(1) 32(1)  4(1) -10(1)  3(1) 
Cl(3) 32(1)  25(1) 21(1)  0(1) -1(1)  1(1) 
O(5) 39(1)  48(1) 36(1)  3(1) -6(1)  10(1) 
O(6) 37(1)  32(1) 22(1)  3(1) 2(1)  11(1) 
N(5) 29(1)  43(1) 43(1)  -9(1) -4(1)  9(1) 
N(6) 26(1)  32(1) 21(1)  -3(1) 0(1)  0(1) 
C(37) 27(2)  39(2) 31(2)  -5(1) -7(1)  1(1) 
C(38) 25(2)  37(1) 25(1)  -1(1) -1(1)  2(1) 
C(39) 23(1)  24(1) 23(1)  -2(1) 2(1)  -2(1) 
C(40) 18(1)  28(1) 26(1)  -2(1) -1(1)  -4(1) 
C(41) 18(1)  25(1) 28(1)  1(1) 0(1)  0(1) 
C(42) 22(2)  29(1) 26(1)  -1(1) 0(1)  -5(1) 
C(43) 27(2)  32(1) 30(1)  6(1) -8(1)  -1(1) 
C(44) 34(2)  28(1) 38(2)  1(1) -8(1)  6(1) 
C(45) 24(2)  24(1) 35(1)  -6(1) -3(1)  0(1) 
C(46) 54(2)  50(2) 56(2)  0(2) 2(2)  20(2) 
C(47) 31(2)  49(2) 38(2)  -11(1) 2(1)  1(1) 
C(48) 34(2)  42(2) 41(2)  -9(1) 12(1)  -4(1) 
C(49) 64(3)  71(2) 48(2)  -23(2) 3(2)  -30(2) 
C(50) 60(3)  39(2) 75(3)  6(2) 32(2)  -2(2) 
C(51) 35(2)  33(1) 23(1)  0(1) -3(1)  0(1) 
C(52) 44(2)  55(2) 25(1)  0(1) 5(1)  4(2) 
C(53) 47(2)  34(2) 36(2)  -7(1) -8(1)  -1(1) 
C(54) 56(2)  46(2) 25(1)  -1(1) -4(1)  7(2) 
______________________________________________________________________________  
 
 
Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2 x 10 3) 
for C18H31N2O2Cl  
______________________________________________________________________________ 
 x  y  z  U(eq) 
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______________________________________________________________________________ 
H(2O) 7320(30) 4705(14) 6859(13) 36 
H(1N) 4490(30) 5606(12) 5751(11) 26 
H(2N) 4910(40) 5157(8) 6370(16) 26 
H(2B) 3960 6338 6829 26 
H(3A) 7297 5488 6001 28 
H(3B) 6699 6183 6044 28 
H(7A) 9384 6063 9134 39 
H(8A) 8602 6909 8381 39 
H(9A) 7312 6770 7136 34 
H(10A) 4262 5317 9047 65 
H(10B) 3292 5880 9421 65 
H(10C) 5224 5936 9264 65 
H(11A) 4405 6880 8139 62 
H(11B) 2851 6777 8688 62 
H(11C) 2645 6707 7745 62 
H(12A) 1201 5886 7032 30 
H(13A) 348 5075 6194 43 
H(13B) 1777 4856 6805 43 
H(13C) 2197 4997 5902 43 
H(14A) 180 6139 5748 47 
H(14B) 2023 6141 5432 47 
H(14C) 1477 6639 6069 47 
H(16A) 11517 4767 8423 43 
H(16B) 10200 4335 7973 43 
H(16C) 10900 4154 8840 43 
H(17A) 10743 5308 9662 57 
H(17B) 10068 4679 10013 57 
H(17C) 8895 5268 9968 57 
H(18A) 7195 4307 8466 45 
H(18B) 6791 4675 9257 45 
H(18C) 7962 4086 9304 45 
H(4O) 6910(40) 1290(15) 6658(14) 42 
H(3N) 4790(40) 1834(9) 5814(16) 28 
H(4N) 5070(40) 2218(13) 5112(10) 28 
H(20A) 4790 3085 6071 28 
H(21A) 7539 1858 5643 29 
 
Page 279
	  	  
H(21B) 7456 2569 5427 29 
H(25A) 8732 2888 8675 39 
H(26A) 8494 3613 7678 40 
H(27A) 7753 3317 6391 34 
H(28A) 3041 2159 8211 59 
H(28B) 2323 2810 8465 59 
H(28C) 4234 2655 8627 59 
H(29A) 4293 3625 6944 49 
H(29B) 4743 3620 7875 49 
H(29C) 2868 3710 7571 49 
H(30A) 2838 2848 4999 36 
H(31A) 570 3375 5523 55 
H(31B) 2286 3699 5761 55 
H(31C) 1359 3292 6399 55 
H(32A) 440 2277 5244 60 
H(32B) 1188 2092 6100 60 
H(32C) 2061 1859 5316 60 
H(34A) 5839 1622 8905 58 
H(34B) 6830 1033 9219 58 
H(34C) 6409 1111 8291 58 
H(35A) 7940 2256 9623 76 
H(35B) 9855 2184 9438 76 
H(35C) 8915 1651 9892 76 
H(36A) 9865 915 8923 51 
H(36B) 10785 1445 8454 51 
H(36C) 9490 1009 7993 51 
H(6O) 5220(40) 3068(14) 2878(13) 45 
H(5N) 6530(40) 4301(14) 4533(11) 32 
H(6N) 5860(40) 4802(9) 3982(17) 32 
H(38A) 7230 4281 2931 35 
H(39A) 5124 3566 3869 28 
H(39B) 3912 4075 4212 28 
H(43A) 2757 4591 959 36 
H(44A) 2093 5197 2033 41 
H(45A) 2974 4911 3310 33 
H(46A) 10179 2800 3997 80 
H(46B) 11516 2930 3338 80 
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H(46C) 9894 2541 3115 80 
H(47A) 8932 3975 2265 59 
H(47B) 9264 3276 2039 59 
H(47C) 10778 3714 2281 59 
H(48A) 9863 4752 3229 47 
H(49A) 10255 5341 4388 91 
H(49B) 10070 4630 4597 91 
H(49C) 8553 5087 4717 91 
H(50A) 8924 5770 3191 86 
H(50B) 7121 5546 3422 86 
H(50C) 7865 5347 2591 86 
H(52A) 6360 3147 301 61 
H(52B) 6624 3204 1243 61 
H(52C) 6742 3800 695 61 
H(53A) 3646 2640 474 59 
H(53B) 2236 2971 962 59 
H(53C) 3826 2695 1420 59 
H(54A) 3927 3542 -380 63 
H(54B) 4239 4206 -6 63 
H(54C) 2494 3876 89 63 
 
 
Table 6. Torsion angles [°] for C18H31N2O2Cl  
________________________________________________________________  
C(11)-N(1)-C(1)-O(1) 178.9(3) 
C(10)-N(1)-C(1)-O(1) 6.3(4) 
C(11)-N(1)-C(1)-C(2) -3.9(4) 
C(10)-N(1)-C(1)-C(2) -176.6(2) 
C(3)-N(2)-C(2)-C(1) -78.7(2) 
C(3)-N(2)-C(2)-C(12) 162.57(19) 
O(1)-C(1)-C(2)-N(2) -34.0(3) 
N(1)-C(1)-C(2)-N(2) 148.7(2) 
O(1)-C(1)-C(2)-C(12) 86.4(3) 
N(1)-C(1)-C(2)-C(12) -90.9(3) 
C(2)-N(2)-C(3)-C(4) 48.5(3) 
N(2)-C(3)-C(4)-C(9) -105.6(3) 
N(2)-C(3)-C(4)-C(5) 77.6(3) 
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C(9)-C(4)-C(5)-O(2) -175.1(2) 
C(3)-C(4)-C(5)-O(2) 1.7(4) 
C(9)-C(4)-C(5)-C(6) 4.5(4) 
C(3)-C(4)-C(5)-C(6) -178.7(2) 
O(2)-C(5)-C(6)-C(7) 175.1(2) 
C(4)-C(5)-C(6)-C(7) -4.6(4) 
O(2)-C(5)-C(6)-C(15) -5.6(4) 
C(4)-C(5)-C(6)-C(15) 174.7(2) 
C(5)-C(6)-C(7)-C(8) 1.7(4) 
C(15)-C(6)-C(7)-C(8) -177.6(3) 
C(6)-C(7)-C(8)-C(9) 1.3(5) 
C(7)-C(8)-C(9)-C(4) -1.5(4) 
C(5)-C(4)-C(9)-C(8) -1.4(4) 
C(3)-C(4)-C(9)-C(8) -178.4(2) 
N(2)-C(2)-C(12)-C(14) -81.6(3) 
C(1)-C(2)-C(12)-C(14) 161.2(2) 
N(2)-C(2)-C(12)-C(13) 44.0(3) 
C(1)-C(2)-C(12)-C(13) -73.2(2) 
C(7)-C(6)-C(15)-C(16) -115.4(3) 
C(5)-C(6)-C(15)-C(16) 65.3(3) 
C(7)-C(6)-C(15)-C(18) 121.1(3) 
C(5)-C(6)-C(15)-C(18) -58.2(3) 
C(7)-C(6)-C(15)-C(17) 3.4(4) 
C(5)-C(6)-C(15)-C(17) -175.9(3) 
C(29)-N(3)-C(19)-O(3) 172.3(3) 
C(28)-N(3)-C(19)-O(3) -1.5(4) 
C(29)-N(3)-C(19)-C(20) -10.9(4) 
C(28)-N(3)-C(19)-C(20) 175.4(2) 
C(21)-N(4)-C(20)-C(19) -86.5(2) 
C(21)-N(4)-C(20)-C(30) 153.2(2) 
O(3)-C(19)-C(20)-N(4) -30.7(3) 
N(3)-C(19)-C(20)-N(4) 152.3(2) 
O(3)-C(19)-C(20)-C(30) 86.9(3) 
N(3)-C(19)-C(20)-C(30) -90.1(3) 
C(20)-N(4)-C(21)-C(22) 42.3(3) 
N(4)-C(21)-C(22)-C(27) -95.7(3) 
N(4)-C(21)-C(22)-C(23) 83.8(3) 
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C(27)-C(22)-C(23)-O(4) -176.5(2) 
C(21)-C(22)-C(23)-O(4) 3.9(4) 
C(27)-C(22)-C(23)-C(24) 1.0(4) 
C(21)-C(22)-C(23)-C(24) -178.5(2) 
O(4)-C(23)-C(24)-C(25) 177.6(3) 
C(22)-C(23)-C(24)-C(25) -0.1(4) 
O(4)-C(23)-C(24)-C(33) -3.6(4) 
C(22)-C(23)-C(24)-C(33) 178.7(3) 
C(23)-C(24)-C(25)-C(26) -0.8(5) 
C(33)-C(24)-C(25)-C(26) -179.6(3) 
C(24)-C(25)-C(26)-C(27) 0.7(5) 
C(25)-C(26)-C(27)-C(22) 0.3(4) 
C(23)-C(22)-C(27)-C(26) -1.2(4) 
C(21)-C(22)-C(27)-C(26) 178.4(3) 
N(4)-C(20)-C(30)-C(31) -169.4(2) 
C(19)-C(20)-C(30)-C(31) 75.3(3) 
N(4)-C(20)-C(30)-C(32) 63.5(3) 
C(19)-C(20)-C(30)-C(32) -51.7(3) 
C(25)-C(24)-C(33)-C(34) 120.0(3) 
C(23)-C(24)-C(33)-C(34) -58.8(4) 
C(25)-C(24)-C(33)-C(35) 0.1(4) 
C(23)-C(24)-C(33)-C(35) -178.6(3) 
C(25)-C(24)-C(33)-C(36) -117.6(3) 
C(23)-C(24)-C(33)-C(36) 63.7(3) 
C(47)-N(5)-C(37)-O(5) 174.4(3) 
C(46)-N(5)-C(37)-O(5) 0.6(4) 
C(47)-N(5)-C(37)-C(38) -8.5(4) 
C(46)-N(5)-C(37)-C(38) 177.7(3) 
C(39)-N(6)-C(38)-C(37) -75.6(2) 
C(39)-N(6)-C(38)-C(48) 162.2(2) 
O(5)-C(37)-C(38)-N(6) -23.1(3) 
N(5)-C(37)-C(38)-N(6) 159.7(2) 
O(5)-C(37)-C(38)-C(48) 98.9(3) 
N(5)-C(37)-C(38)-C(48) -78.3(3) 
C(38)-N(6)-C(39)-C(40) -60.4(3) 
N(6)-C(39)-C(40)-C(45) -74.9(3) 
N(6)-C(39)-C(40)-C(41) 100.7(3) 
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C(45)-C(40)-C(41)-O(6) 177.8(2) 
C(39)-C(40)-C(41)-O(6) 2.2(4) 
C(45)-C(40)-C(41)-C(42) 1.3(4) 
C(39)-C(40)-C(41)-C(42) -174.3(2) 
O(6)-C(41)-C(42)-C(43) -176.9(2) 
C(40)-C(41)-C(42)-C(43) -0.2(4) 
O(6)-C(41)-C(42)-C(51) 4.1(4) 
C(40)-C(41)-C(42)-C(51) -179.3(2) 
C(41)-C(42)-C(43)-C(44) -1.1(4) 
C(51)-C(42)-C(43)-C(44) 178.0(3) 
C(42)-C(43)-C(44)-C(45) 1.3(4) 
C(41)-C(40)-C(45)-C(44) -1.1(4) 
C(39)-C(40)-C(45)-C(44) 174.6(2) 
C(43)-C(44)-C(45)-C(40) -0.2(4) 
N(6)-C(38)-C(48)-C(50) -71.3(3) 
C(37)-C(38)-C(48)-C(50) 169.7(2) 
N(6)-C(38)-C(48)-C(49) 54.9(3) 
C(37)-C(38)-C(48)-C(49) -64.1(3) 
C(43)-C(42)-C(51)-C(52) 122.7(3) 
C(41)-C(42)-C(51)-C(52) -58.2(3) 
C(43)-C(42)-C(51)-C(54) 2.9(4) 
C(41)-C(42)-C(51)-C(54) -178.0(3) 
C(43)-C(42)-C(51)-C(53) -115.6(3) 
C(41)-C(42)-C(51)-C(53) 63.4(3) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 
 
Table 7. Hydrogen bonds for C18H31N2O2Cl [Å and °] 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
 O(2)-H(2O)...Cl(1) 0.857(18) 2.26(2) 3.0861(17) 162(3) 
 N(2)-H(2N)...Cl(1) 0.915(17) 2.27(2) 3.042(2) 142(2) 
 N(2)-H(1N)...Cl(3) 0.937(17) 2.259(19) 3.161(2) 161(2) 
 O(4)-H(4O)...Cl(3)#1 0.855(18) 2.44(2) 3.2538(18) 160(3) 
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 N(4)-H(3N)...O(3) 0.914(17) 2.13(3) 2.603(3) 111(2) 
 N(4)-H(3N)...Cl(3)#1 0.914(17) 2.50(2) 3.218(2) 136(2) 
 N(4)-H(4N)...Cl(2) 0.914(17) 2.205(18) 3.113(2) 172(3) 
 O(6)-H(6O)...Cl(2) 0.851(18) 2.21(2) 3.0290(19) 161(3) 
 N(6)-H(5N)...Cl(1) 0.909(17) 2.27(2) 3.087(2) 149(3) 
 N(6)-H(6N)...Cl(3) 0.925(17) 2.45(2) 3.320(2) 157(2) 
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,y-1/2,-z+1  
 
X-ray Crystal Structure of 1.19r 
 
Table 1. Crystal data and structure refinement for C18H30N2O2  
Identification code  C18H30N2O2 
Empirical formula  C18H30N2O2 
Formula weight  306.44 
Temperature  143(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 7.4590(6) Å α= 90° 
 b = 14.9795(12) Å β= 90° 
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 c = 16.2770(13) Å γ = 90° 
Volume 1818.7(3) Å3 
Z 4 
Density (calculated) 1.119 Mg/m3 
Absorption coefficient 0.570 mm-1 
F(000) 672 
Crystal size 0.17 x 0.10 x 0.05 mm3 
Theta range for data collection 4.01 to 67.94° 
Index ranges -8<=h<=3, -18<=k<=17, -19<=l<=19 
Reflections collected 13923 
Independent reflections 3190 [R(int) = 0.0179] 
Completeness to theta = 67.94° 99.2 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9721 and 0.9093 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3190 / 3 / 210 
Goodness-of-fit on F2 1.064 
Final R indices [I>2sigma(I)] R1 = 0.0292, wR2 = 0.0780 
R indices (all data) R1 = 0.0293, wR2 = 0.0781 
Absolute structure parameter 0.09(19) 
Extinction coefficient na 
Largest diff. peak and hole 0.144 and -0.103 e.Å-3 
 
 
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2 x 103) for 
C18H30N2O2. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
O(1) -318(1) 6477(1) 2399(1) 34(1) 
O(2) 4304(1) 8137(1) 390(1) 39(1) 
N(1) 1412(2) 7118(1) 1121(1) 33(1) 
N(2) 5199(2) 8362(1) 1699(1) 36(1) 
C(1) -51(2) 7283(1) 2771(1) 28(1) 
C(2) -223(2) 7349(1) 3633(1) 28(1) 
C(3) 18(2) 8194(1) 3976(1) 33(1) 
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C(4) 456(2) 8934(1) 3510(1) 37(1) 
C(5) 650(2) 8851(1) 2667(1) 36(1) 
C(6) 380(2) 8032(1) 2291(1) 31(1) 
C(7) 503(2) 7944(1) 1367(1) 36(1) 
C(8) 3309(2) 7046(1) 1351(1) 29(1) 
C(9) 4330(2) 7894(1) 1115(1) 31(1) 
C(10) 5325(2) 8115(1) 2566(1) 44(1) 
C(11) 6055(2) 9200(1) 1471(1) 48(1) 
C(12) -610(2) 6519(1) 4160(1) 31(1) 
C(13) 882(2) 5825(1) 4040(1) 40(1) 
C(14) -2426(2) 6110(1) 3925(1) 40(1) 
C(15) -673(2) 6747(1) 5081(1) 38(1) 
C(16) 4143(2) 6228(1) 933(1) 35(1) 
C(17) 6119(2) 6137(1) 1134(1) 54(1) 
C(18) 3107(3) 5387(1) 1155(1) 56(1) 
 
 
Table 3. Bond lengths [Å] and angles [°] for C18H30N2O2  
_____________________________________________________  
O(1)-C(1)  1.3656(15) 
O(1)-H(1O)  0.839(13) 
O(2)-C(9)  1.2351(15) 
N(1)-C(7)  1.4659(19) 
N(1)-C(8)  1.4678(17) 
N(1)-H(1N)  0.898(13) 
N(2)-C(9)  1.3472(17) 
N(2)-C(11)  1.4563(18) 
N(2)-C(10)  1.4629(18) 
C(1)-C(6)  1.4043(17) 
C(1)-C(2)  1.4111(17) 
C(2)-C(3)  1.3956(18) 
C(2)-C(12)  1.5382(17) 
C(3)-C(4)  1.382(2) 
C(3)-H(3)  0.9500 
C(4)-C(5)  1.385(2) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.3858(19) 
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C(5)-H(5)  0.9500 
C(6)-C(7)  1.5127(17) 
C(7)-H(7A)  0.9900 
C(7)-H(7B)  0.9900 
C(8)-C(9)  1.5297(17) 
C(8)-C(16)  1.5332(19) 
C(8)-H(8)  0.991(12) 
C(10)-H(10A)  0.9800 
C(10)-H(10B)  0.9800 
C(10)-H(10C)  0.9800 
C(11)-H(11A)  0.9800 
C(11)-H(11B)  0.9800 
C(11)-H(11C)  0.9800 
C(12)-C(14)  1.535(2) 
C(12)-C(13)  1.5355(19) 
C(12)-C(15)  1.5385(17) 
C(13)-H(13A)  0.9800 
C(13)-H(13B)  0.9800 
C(13)-H(13C)  0.9800 
C(14)-H(14A)  0.9800 
C(14)-H(14B)  0.9800 
C(14)-H(14C)  0.9800 
C(15)-H(15A)  0.9800 
C(15)-H(15B)  0.9800 
C(15)-H(15C)  0.9800 
C(16)-C(17)  1.516(2) 
C(16)-C(18)  1.522(2) 
C(16)-H(16)  1.0000 
C(17)-H(17A)  0.9800 
C(17)-H(17B)  0.9800 
C(17)-H(17C)  0.9800 
C(18)-H(18A)  0.9800 
C(18)-H(18B)  0.9800 
C(18)-H(18C)  0.9800 
C(1)-O(1)-H(1O) 106.8(11) 
C(7)-N(1)-C(8) 115.97(11) 
C(7)-N(1)-H(1N) 109.7(10) 
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C(8)-N(1)-H(1N) 110.8(11) 
C(9)-N(2)-C(11) 118.70(12) 
C(9)-N(2)-C(10) 125.46(11) 
C(11)-N(2)-C(10) 115.81(12) 
O(1)-C(1)-C(6) 119.55(11) 
O(1)-C(1)-C(2) 119.25(11) 
C(6)-C(1)-C(2) 121.20(11) 
C(3)-C(2)-C(1) 116.73(11) 
C(3)-C(2)-C(12) 122.22(11) 
C(1)-C(2)-C(12) 121.03(11) 
C(4)-C(3)-C(2) 122.53(12) 
C(4)-C(3)-H(3) 118.7 
C(2)-C(3)-H(3) 118.7 
C(3)-C(4)-C(5) 119.78(12) 
C(3)-C(4)-H(4) 120.1 
C(5)-C(4)-H(4) 120.1 
C(4)-C(5)-C(6) 120.08(12) 
C(4)-C(5)-H(5) 120.0 
C(6)-C(5)-H(5) 120.0 
C(5)-C(6)-C(1) 119.65(12) 
C(5)-C(6)-C(7) 120.53(12) 
C(1)-C(6)-C(7) 119.80(12) 
N(1)-C(7)-C(6) 111.95(10) 
N(1)-C(7)-H(7A) 109.2 
C(6)-C(7)-H(7A) 109.2 
N(1)-C(7)-H(7B) 109.2 
C(6)-C(7)-H(7B) 109.2 
H(7A)-C(7)-H(7B) 107.9 
N(1)-C(8)-C(9) 110.81(10) 
N(1)-C(8)-C(16) 109.65(11) 
C(9)-C(8)-C(16) 110.53(10) 
N(1)-C(8)-H(8) 107.6(9) 
C(9)-C(8)-H(8) 110.4(9) 
C(16)-C(8)-H(8) 107.7(9) 
O(2)-C(9)-N(2) 121.89(12) 
O(2)-C(9)-C(8) 118.46(11) 
N(2)-C(9)-C(8) 119.64(11) 
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N(2)-C(10)-H(10A) 109.5 
N(2)-C(10)-H(10B) 109.5 
H(10A)-C(10)-H(10B) 109.5 
N(2)-C(10)-H(10C) 109.5 
H(10A)-C(10)-H(10C) 109.5 
H(10B)-C(10)-H(10C) 109.5 
N(2)-C(11)-H(11A) 109.5 
N(2)-C(11)-H(11B) 109.5 
H(11A)-C(11)-H(11B) 109.5 
N(2)-C(11)-H(11C) 109.5 
H(11A)-C(11)-H(11C) 109.5 
H(11B)-C(11)-H(11C) 109.5 
C(14)-C(12)-C(13) 109.77(11) 
C(14)-C(12)-C(2) 110.44(11) 
C(13)-C(12)-C(2) 109.86(11) 
C(14)-C(12)-C(15) 107.73(11) 
C(13)-C(12)-C(15) 107.23(11) 
C(2)-C(12)-C(15) 111.73(11) 
C(12)-C(13)-H(13A) 109.5 
C(12)-C(13)-H(13B) 109.5 
H(13A)-C(13)-H(13B) 109.5 
C(12)-C(13)-H(13C) 109.5 
H(13A)-C(13)-H(13C) 109.5 
H(13B)-C(13)-H(13C) 109.5 
C(12)-C(14)-H(14A) 109.5 
C(12)-C(14)-H(14B) 109.5 
H(14A)-C(14)-H(14B) 109.5 
C(12)-C(14)-H(14C) 109.5 
H(14A)-C(14)-H(14C) 109.5 
H(14B)-C(14)-H(14C) 109.5 
C(12)-C(15)-H(15A) 109.5 
C(12)-C(15)-H(15B) 109.5 
H(15A)-C(15)-H(15B) 109.5 
C(12)-C(15)-H(15C) 109.5 
H(15A)-C(15)-H(15C) 109.5 
H(15B)-C(15)-H(15C) 109.5 
C(17)-C(16)-C(18) 111.58(14) 
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C(17)-C(16)-C(8) 111.74(12) 
C(18)-C(16)-C(8) 110.55(11) 
C(17)-C(16)-H(16) 107.6 
C(18)-C(16)-H(16) 107.6 
C(8)-C(16)-H(16) 107.6 
C(16)-C(17)-H(17A) 109.5 
C(16)-C(17)-H(17B) 109.5 
H(17A)-C(17)-H(17B) 109.5 
C(16)-C(17)-H(17C) 109.5 
H(17A)-C(17)-H(17C) 109.5 
H(17B)-C(17)-H(17C) 109.5 
C(16)-C(18)-H(18A) 109.5 
C(16)-C(18)-H(18B) 109.5 
H(18A)-C(18)-H(18B) 109.5 
C(16)-C(18)-H(18C) 109.5 
H(18A)-C(18)-H(18C) 109.5 
H(18B)-C(18)-H(18C) 109.5 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 
Table 4. Anisotropic displacement parameters (Å2 x 103) for C18H30N2O2. The anisotropic 
displacement factor exponent takes the form: -2p2[ h2 a*2U11 +  ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
O(1) 36(1)  38(1) 26(1)  -3(1) 4(1)  -7(1) 
O(2) 41(1)  46(1) 31(1)  8(1) 8(1)  -2(1) 
N(1) 28(1)  46(1) 23(1)  2(1) -2(1)  -3(1) 
N(2) 32(1)  36(1) 40(1)  0(1) 0(1)  -4(1) 
C(1) 20(1)  33(1) 30(1)  -1(1) -1(1)  1(1) 
C(2) 20(1)  34(1) 31(1)  0(1) -1(1)  4(1) 
C(3) 27(1)  38(1) 34(1)  -6(1) -2(1)  8(1) 
C(4) 33(1)  31(1) 48(1)  -6(1) -4(1)  6(1) 
C(5) 27(1)  33(1) 48(1)  8(1) -1(1)  4(1) 
C(6) 19(1)  38(1) 34(1)  5(1) 0(1)  4(1) 
C(7) 28(1)  47(1) 32(1)  11(1) -1(1)  1(1) 
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C(8) 27(1)  38(1) 22(1)  2(1) 0(1)  -3(1) 
C(9) 25(1)  35(1) 31(1)  2(1) 5(1)  2(1) 
C(10) 39(1)  54(1) 40(1)  -3(1) -11(1)  -4(1) 
C(11) 41(1)  36(1) 68(1)  1(1) -3(1)  -6(1) 
C(12) 31(1)  35(1) 28(1)  1(1) 3(1)  2(1) 
C(13) 47(1)  38(1) 36(1)  4(1) 4(1)  10(1) 
C(14) 39(1)  46(1) 35(1)  2(1) 4(1)  -9(1) 
C(15) 39(1)  46(1) 29(1)  1(1) 3(1)  3(1) 
C(16) 35(1)  38(1) 32(1)  -1(1) 4(1)  -3(1) 
C(17) 41(1)  48(1) 73(1)  -7(1) 0(1)  10(1) 
C(18) 64(1)  38(1) 65(1)  -4(1) 22(1)  -8(1) 
______________________________________________________________________________  
 
 
Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2 x 10 3) for 
C18H30N2O2  
______________________________________________________________________________ 
 x  y  z  U(eq) 
______________________________________________________________________________ 
H(1O) 120(20) 6516(10) 1925(9) 40 
H(1N) 1270(20) 7029(10) 580(8) 39 
H(3) -124 8263 4553 40 
H(4) 624 9497 3768 45 
H(5) 968 9357 2347 43 
H(7A) -720 7951 1131 43 
H(7B) 1166 8461 1142 43 
H(8) 3360(20) 6950(10) 1952(8) 35 
H(10A) 4172 8227 2836 67 
H(10B) 6260 8473 2832 67 
H(10C) 5627 7481 2612 67 
H(11A) 6098 9250 871 72 
H(11B) 7277 9215 1692 72 
H(11C) 5365 9700 1697 72 
H(13A) 2038 6088 4194 60 
H(13B) 919 5640 3463 60 
H(13C) 642 5304 4388 60 
H(14A) -2422 5956 3340 60 
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H(14B) -3382 6543 4034 60 
H(14C) -2634 5570 4252 60 
H(15A) 476 7006 5249 57 
H(15B) -899 6202 5398 57 
H(15C) -1637 7178 5183 57 
H(16) 4036 6315 326 42 
H(17A) 6744 6690 987 81 
H(17B) 6628 5639 821 81 
H(17C) 6263 6024 1723 81 
H(18A) 1839 5468 1017 84 
H(18B) 3226 5271 1745 84 
H(18C) 3590 4880 845 84 
 
 
Table 6. Torsion angles [°] for C18H30N2O2  
________________________________________________________________  
O(1)-C(1)-C(2)-C(3) -178.35(11) 
C(6)-C(1)-C(2)-C(3) 1.33(17) 
O(1)-C(1)-C(2)-C(12) 3.12(18) 
C(6)-C(1)-C(2)-C(12) -177.20(11) 
C(1)-C(2)-C(3)-C(4) -1.86(19) 
C(12)-C(2)-C(3)-C(4) 176.65(12) 
C(2)-C(3)-C(4)-C(5) 0.8(2) 
C(3)-C(4)-C(5)-C(6) 0.9(2) 
C(4)-C(5)-C(6)-C(1) -1.42(19) 
C(4)-C(5)-C(6)-C(7) 177.15(12) 
O(1)-C(1)-C(6)-C(5) 179.94(11) 
C(2)-C(1)-C(6)-C(5) 0.27(18) 
O(1)-C(1)-C(6)-C(7) 1.36(17) 
C(2)-C(1)-C(6)-C(7) -178.31(12) 
C(8)-N(1)-C(7)-C(6) -65.06(14) 
C(5)-C(6)-C(7)-N(1) 139.83(12) 
C(1)-C(6)-C(7)-N(1) -41.61(16) 
C(7)-N(1)-C(8)-C(9) -48.44(13) 
C(7)-N(1)-C(8)-C(16) -170.73(10) 
C(11)-N(2)-C(9)-O(2) 3.13(19) 
C(10)-N(2)-C(9)-O(2) -178.84(13) 
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C(11)-N(2)-C(9)-C(8) -175.71(12) 
C(10)-N(2)-C(9)-C(8) 2.32(19) 
N(1)-C(8)-C(9)-O(2) -56.90(15) 
C(16)-C(8)-C(9)-O(2) 64.87(15) 
N(1)-C(8)-C(9)-N(2) 121.98(12) 
C(16)-C(8)-C(9)-N(2) -116.25(13) 
C(3)-C(2)-C(12)-C(14) 119.40(13) 
C(1)-C(2)-C(12)-C(14) -62.15(15) 
C(3)-C(2)-C(12)-C(13) -119.37(13) 
C(1)-C(2)-C(12)-C(13) 59.08(16) 
C(3)-C(2)-C(12)-C(15) -0.49(17) 
C(1)-C(2)-C(12)-C(15) 177.96(12) 
N(1)-C(8)-C(16)-C(17) 178.59(12) 
C(9)-C(8)-C(16)-C(17) 56.14(15) 
N(1)-C(8)-C(16)-C(18) -56.50(15) 
C(9)-C(8)-C(16)-C(18) -178.95(13) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 
 
Table 7. Hydrogen bonds for C18H30N2O2 [Å and °] 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
 O(1)-H(1O)...N(1) 0.839(13) 1.860(14) 2.6297(14) 151.9(15) 
 N(1)-H(1N)...O(2)#1 0.898(13) 2.167(14) 2.9439(14) 144.4(14) 
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 x-1/2,-y+3/2,-z  
 
 
 
X-ray Crystal Structure of 1.17j 
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Table 1. Crystal data and structure refinement for C23H24NOP  
Identification code  C23H24NOP 
Empirical formula  C23H24NOP 
Formula weight  361.40 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 2(1) 
Unit cell dimensions a = 9.9115(7) Å α= 90° 
 b = 19.7080(12) Å β= 101.997(4)° 
 c = 10.2367(7) Å γ = 90° 
Volume 1955.9(2) Å3 
Z 4 
Density (calculated) 1.227 Mg/m3 
Absorption coefficient 0.152 mm-1 
F(000) 768 
Crystal size 0.14 x 0.08 x 0.05 mm3 
Theta range for data collection 2.03 to 28.43° 
Index ranges -12<=h<=13, -26<=k<=26, -13<=l<=13 
Reflections collected 42680 
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Independent reflections 9807 [R(int) = 0.0707] 
Completeness to theta = 28.43° 99.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9925 and 0.9791 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9807 / 5 / 483 
Goodness-of-fit on F2 1.019 
Final R indices [I>2sigma(I)] R1 = 0.0419, wR2 = 0.0796 
R indices (all data) R1 = 0.0613, wR2 = 0.0867 
Absolute structure parameter 0.04(6) 
Extinction coefficient na 
Largest diff. peak and hole 0.360 and -0.247 e.Å-3 
 
 
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2 x 103) 
for. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________  
P(1) 9053(1) 7653(1) 1992(1) 17(1) 
O(1) 8854(2) 7958(1) 634(1) 23(1) 
N(1) 8318(2) 8098(1) 2991(2) 20(1) 
C(1) 9941(3) 10334(1) 4205(3) 45(1) 
C(2) 8899(3) 9939(1) 4126(2) 32(1) 
C(3) 8960(2) 9179(1) 4177(2) 25(1) 
C(4) 8168(2) 8840(1) 2881(2) 19(1) 
C(5) 6664(2) 9044(1) 2560(2) 20(1) 
C(6) 5698(2) 8734(1) 3176(2) 23(1) 
C(7) 4332(2) 8937(1) 2895(2) 26(1) 
C(8) 3876(2) 9459(1) 1984(2) 29(1) 
C(9) 4839(3) 9758(1) 1368(2) 30(1) 
C(10) 6201(2) 9557(1) 1641(2) 25(1) 
C(11) 2404(3) 9694(1) 1729(3) 45(1) 
C(12) 10858(2) 7526(1) 2686(2) 19(1) 
C(13) 11354(2) 7499(1) 4063(2) 24(1) 
C(14) 12722(2) 7348(1) 4577(2) 28(1) 
C(15) 13616(2) 7227(1) 3721(2) 27(1) 
 
Page 296
	  	  
C(16) 13136(2) 7261(1) 2359(2) 26(1) 
C(17) 11762(2) 7410(1) 1837(2) 22(1) 
C(18) 8271(2) 6825(1) 2005(2) 18(1) 
C(19) 9019(2) 6240(1) 2433(2) 23(1) 
C(20) 8367(2) 5614(1) 2356(2) 26(1) 
C(21) 6966(2) 5564(1) 1842(2) 27(1) 
C(22) 6217(2) 6140(1) 1423(2) 31(1) 
C(23) 6856(2) 6769(1) 1504(2) 26(1) 
P(2) 1823(1) 2359(1) 3130(1) 15(1) 
O(2) 1432(1) 2673(1) 4319(1) 22(1) 
N(2) 2302(2) 2892(1) 2097(2) 18(1) 
C(24) 2526(3) 5298(1) 2712(2) 34(1) 
C(25) 3013(2) 4794(1) 2109(2) 24(1) 
C(26) 2293(2) 4125(1) 1794(2) 22(1) 
C(27) 3094(2) 3516(1) 2530(2) 16(1) 
C(28) 4549(2) 3499(1) 2299(2) 17(1) 
C(29) 4824(2) 3329(1) 1062(2) 22(1) 
C(30) 6148(2) 3380(1) 828(2) 28(1) 
C(31) 7240(2) 3607(1) 1811(2) 27(1) 
C(32) 6966(2) 3764(1) 3047(2) 28(1) 
C(33) 5642(2) 3713(1) 3291(2) 24(1) 
C(34) 8661(3) 3702(1) 1536(3) 40(1) 
C(35) 409(2) 1896(1) 2116(2) 18(1) 
C(36) -925(2) 2044(1) 2252(2) 21(1) 
C(37) -2044(2) 1693(1) 1503(2) 25(1) 
C(38) -1821(2) 1187(1) 644(2) 25(1) 
C(39) -496(2) 1032(1) 503(2) 24(1) 
C(40) 622(2) 1388(1) 1234(2) 21(1) 
C(41) 3159(2) 1734(1) 3632(2) 18(1) 
C(42) 3063(2) 1295(1) 4685(2) 21(1) 
C(43) 3994(2) 766(1) 5009(2) 24(1) 
C(44) 5029(2) 671(1) 4313(2) 24(1) 
C(45) 5157(2) 1112(1) 3295(2) 24(1) 
C(46) 4218(2) 1640(1) 2943(2) 20(1) 
 
 
Table 3. Bond lengths [Å] and angles [°] for C23H24NOP  
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_____________________________________________________  
P(1)-O(1)  1.4889(14) 
P(1)-N(1)  1.6299(18) 
P(1)-C(12)  1.800(2) 
P(1)-C(18)  1.806(2) 
N(1)-C(4)  1.472(2) 
N(1)-H(1N)  0.855(15) 
C(1)-C(2)  1.283(3) 
C(1)-H(1A)  0.9500 
C(1)-H(1B)  0.9500 
C(2)-C(3)  1.499(3) 
C(2)-H(2)  0.9500 
C(3)-C(4)  1.546(3) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-C(5)  1.512(3) 
C(4)-H(4)  0.987(16) 
C(5)-C(6)  1.393(3) 
C(5)-C(10)  1.393(3) 
C(6)-C(7)  1.384(3) 
C(6)-H(6)  0.9500 
C(7)-C(8)  1.398(3) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.381(4) 
C(8)-C(11)  1.501(3) 
C(9)-C(10)  1.378(3) 
C(9)-H(9)  0.9500 
C(10)-H(10)  0.9500 
C(11)-H(11A)  0.9800 
C(11)-H(11B)  0.9800 
C(11)-H(11C)  0.9800 
C(12)-C(17)  1.391(3) 
C(12)-C(13)  1.393(3) 
C(13)-C(14)  1.382(3) 
C(13)-H(13)  0.9500 
C(14)-C(15)  1.390(3) 
C(14)-H(14)  0.9500 
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C(15)-C(16)  1.378(3) 
C(15)-H(15)  0.9500 
C(16)-C(17)  1.386(3) 
C(16)-H(16)  0.9500 
C(17)-H(17)  0.9500 
C(18)-C(19)  1.393(3) 
C(18)-C(23)  1.393(3) 
C(19)-C(20)  1.386(3) 
C(19)-H(19)  0.9500 
C(20)-C(21)  1.383(3) 
C(20)-H(20)  0.9500 
C(21)-C(22)  1.377(3) 
C(21)-H(21)  0.9500 
C(22)-C(23)  1.387(3) 
C(22)-H(22)  0.9500 
C(23)-H(23)  0.9500 
P(2)-O(2)  1.4868(14) 
P(2)-N(2)  1.6297(18) 
P(2)-C(41)  1.803(2) 
P(2)-C(35)  1.807(2) 
N(2)-C(27)  1.476(2) 
N(2)-H(2N)  0.841(15) 
C(24)-C(25)  1.313(3) 
C(24)-H(24A)  0.9500 
C(24)-H(24B)  0.9500 
C(25)-C(26)  1.501(3) 
C(25)-H(25)  0.9500 
C(26)-C(27)  1.546(3) 
C(26)-H(26A)  0.9900 
C(26)-H(26B)  0.9900 
C(27)-C(28)  1.509(3) 
C(27)-H(27)  1.005(15) 
C(28)-C(33)  1.388(3) 
C(28)-C(29)  1.390(3) 
C(29)-C(30)  1.385(3) 
C(29)-H(29)  0.9500 
C(30)-C(31)  1.390(3) 
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C(30)-H(30)  0.9500 
C(31)-C(32)  1.383(3) 
C(31)-C(34)  1.503(3) 
C(32)-C(33)  1.390(3) 
C(32)-H(32)  0.9500 
C(33)-H(33)  0.9500 
C(34)-H(34A)  0.9800 
C(34)-H(34B)  0.9800 
C(34)-H(34C)  0.9800 
C(35)-C(36)  1.389(3) 
C(35)-C(40)  1.393(3) 
C(36)-C(37)  1.394(3) 
C(36)-H(36)  0.9500 
C(37)-C(38)  1.378(3) 
C(37)-H(37)  0.9500 
C(38)-C(39)  1.385(3) 
C(38)-H(38)  0.9500 
C(39)-C(40)  1.390(3) 
C(39)-H(39)  0.9500 
C(40)-H(40)  0.9500 
C(41)-C(46)  1.393(3) 
C(41)-C(42)  1.401(3) 
C(42)-C(43)  1.387(3) 
C(42)-H(42)  0.9500 
C(43)-C(44)  1.378(3) 
C(43)-H(43)  0.9500 
C(44)-C(45)  1.381(3) 
C(44)-H(44)  0.9500 
C(45)-C(46)  1.393(3) 
C(45)-H(45)  0.9500 
C(46)-H(46)  0.9500 
O(1)-P(1)-N(1) 112.21(9) 
O(1)-P(1)-C(12) 110.65(9) 
N(1)-P(1)-C(12) 111.32(9) 
O(1)-P(1)-C(18) 113.47(9) 
N(1)-P(1)-C(18) 103.48(9) 
C(12)-P(1)-C(18) 105.33(9) 
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C(4)-N(1)-P(1) 122.62(15) 
C(4)-N(1)-H(1N) 116.6(15) 
P(1)-N(1)-H(1N) 116.4(15) 
C(2)-C(1)-H(1A) 120.0 
C(2)-C(1)-H(1B) 120.0 
H(1A)-C(1)-H(1B) 120.0 
C(1)-C(2)-C(3) 125.4(2) 
C(1)-C(2)-H(2) 117.3 
C(3)-C(2)-H(2) 117.3 
C(2)-C(3)-C(4) 113.09(17) 
C(2)-C(3)-H(3A) 109.0 
C(4)-C(3)-H(3A) 109.0 
C(2)-C(3)-H(3B) 109.0 
C(4)-C(3)-H(3B) 109.0 
H(3A)-C(3)-H(3B) 107.8 
N(1)-C(4)-C(5) 111.13(17) 
N(1)-C(4)-C(3) 109.79(16) 
C(5)-C(4)-C(3) 111.93(17) 
N(1)-C(4)-H(4) 107.0(13) 
C(5)-C(4)-H(4) 110.2(13) 
C(3)-C(4)-H(4) 106.6(13) 
C(6)-C(5)-C(10) 117.6(2) 
C(6)-C(5)-C(4) 121.63(18) 
C(10)-C(5)-C(4) 120.8(2) 
C(7)-C(6)-C(5) 121.0(2) 
C(7)-C(6)-H(6) 119.5 
C(5)-C(6)-H(6) 119.5 
C(6)-C(7)-C(8) 121.2(2) 
C(6)-C(7)-H(7) 119.4 
C(8)-C(7)-H(7) 119.4 
C(9)-C(8)-C(7) 117.5(2) 
C(9)-C(8)-C(11) 121.8(2) 
C(7)-C(8)-C(11) 120.7(2) 
C(10)-C(9)-C(8) 121.6(2) 
C(10)-C(9)-H(9) 119.2 
C(8)-C(9)-H(9) 119.2 
C(9)-C(10)-C(5) 121.2(2) 
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C(9)-C(10)-H(10) 119.4 
C(5)-C(10)-H(10) 119.4 
C(8)-C(11)-H(11A) 109.5 
C(8)-C(11)-H(11B) 109.5 
H(11A)-C(11)-H(11B) 109.5 
C(8)-C(11)-H(11C) 109.5 
H(11A)-C(11)-H(11C) 109.5 
H(11B)-C(11)-H(11C) 109.5 
C(17)-C(12)-C(13) 119.24(18) 
C(17)-C(12)-P(1) 119.50(15) 
C(13)-C(12)-P(1) 121.14(16) 
C(14)-C(13)-C(12) 120.3(2) 
C(14)-C(13)-H(13) 119.8 
C(12)-C(13)-H(13) 119.8 
C(13)-C(14)-C(15) 120.0(2) 
C(13)-C(14)-H(14) 120.0 
C(15)-C(14)-H(14) 120.0 
C(16)-C(15)-C(14) 119.9(2) 
C(16)-C(15)-H(15) 120.0 
C(14)-C(15)-H(15) 120.0 
C(15)-C(16)-C(17) 120.3(2) 
C(15)-C(16)-H(16) 119.8 
C(17)-C(16)-H(16) 119.8 
C(16)-C(17)-C(12) 120.15(19) 
C(16)-C(17)-H(17) 119.9 
C(12)-C(17)-H(17) 119.9 
C(19)-C(18)-C(23) 118.62(19) 
C(19)-C(18)-P(1) 123.33(16) 
C(23)-C(18)-P(1) 117.98(15) 
C(20)-C(19)-C(18) 120.6(2) 
C(20)-C(19)-H(19) 119.7 
C(18)-C(19)-H(19) 119.7 
C(21)-C(20)-C(19) 120.3(2) 
C(21)-C(20)-H(20) 119.8 
C(19)-C(20)-H(20) 119.8 
C(22)-C(21)-C(20) 119.6(2) 
C(22)-C(21)-H(21) 120.2 
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C(20)-C(21)-H(21) 120.2 
C(21)-C(22)-C(23) 120.6(2) 
C(21)-C(22)-H(22) 119.7 
C(23)-C(22)-H(22) 119.7 
C(22)-C(23)-C(18) 120.3(2) 
C(22)-C(23)-H(23) 119.8 
C(18)-C(23)-H(23) 119.8 
O(2)-P(2)-N(2) 115.09(9) 
O(2)-P(2)-C(41) 110.59(9) 
N(2)-P(2)-C(41) 109.20(10) 
O(2)-P(2)-C(35) 112.16(9) 
N(2)-P(2)-C(35) 104.38(9) 
C(41)-P(2)-C(35) 104.77(9) 
C(27)-N(2)-P(2) 123.38(13) 
C(27)-N(2)-H(2N) 117.9(15) 
P(2)-N(2)-H(2N) 117.0(15) 
C(25)-C(24)-H(24A) 120.0 
C(25)-C(24)-H(24B) 120.0 
H(24A)-C(24)-H(24B) 120.0 
C(24)-C(25)-C(26) 124.1(2) 
C(24)-C(25)-H(25) 117.9 
C(26)-C(25)-H(25) 117.9 
C(25)-C(26)-C(27) 113.86(16) 
C(25)-C(26)-H(26A) 108.8 
C(27)-C(26)-H(26A) 108.8 
C(25)-C(26)-H(26B) 108.8 
C(27)-C(26)-H(26B) 108.8 
H(26A)-C(26)-H(26B) 107.7 
N(2)-C(27)-C(28) 113.55(16) 
N(2)-C(27)-C(26) 108.28(15) 
C(28)-C(27)-C(26) 110.55(16) 
N(2)-C(27)-H(27) 104.8(12) 
C(28)-C(27)-H(27) 112.6(12) 
C(26)-C(27)-H(27) 106.6(12) 
C(33)-C(28)-C(29) 117.90(19) 
C(33)-C(28)-C(27) 120.33(18) 
C(29)-C(28)-C(27) 121.52(18) 
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C(30)-C(29)-C(28) 120.8(2) 
C(30)-C(29)-H(29) 119.6 
C(28)-C(29)-H(29) 119.6 
C(29)-C(30)-C(31) 121.5(2) 
C(29)-C(30)-H(30) 119.3 
C(31)-C(30)-H(30) 119.3 
C(32)-C(31)-C(30) 117.5(2) 
C(32)-C(31)-C(34) 120.9(2) 
C(30)-C(31)-C(34) 121.6(2) 
C(31)-C(32)-C(33) 121.4(2) 
C(31)-C(32)-H(32) 119.3 
C(33)-C(32)-H(32) 119.3 
C(28)-C(33)-C(32) 120.9(2) 
C(28)-C(33)-H(33) 119.5 
C(32)-C(33)-H(33) 119.5 
C(31)-C(34)-H(34A) 109.5 
C(31)-C(34)-H(34B) 109.5 
H(34A)-C(34)-H(34B) 109.5 
C(31)-C(34)-H(34C) 109.5 
H(34A)-C(34)-H(34C) 109.5 
H(34B)-C(34)-H(34C) 109.5 
C(36)-C(35)-C(40) 119.42(19) 
C(36)-C(35)-P(2) 118.47(15) 
C(40)-C(35)-P(2) 122.09(16) 
C(35)-C(36)-C(37) 120.3(2) 
C(35)-C(36)-H(36) 119.8 
C(37)-C(36)-H(36) 119.8 
C(38)-C(37)-C(36) 119.7(2) 
C(38)-C(37)-H(37) 120.1 
C(36)-C(37)-H(37) 120.1 
C(37)-C(38)-C(39) 120.5(2) 
C(37)-C(38)-H(38) 119.8 
C(39)-C(38)-H(38) 119.8 
C(38)-C(39)-C(40) 120.0(2) 
C(38)-C(39)-H(39) 120.0 
C(40)-C(39)-H(39) 120.0 
C(39)-C(40)-C(35) 120.0(2) 
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C(39)-C(40)-H(40) 120.0 
C(35)-C(40)-H(40) 120.0 
C(46)-C(41)-C(42) 119.07(19) 
C(46)-C(41)-P(2) 122.18(15) 
C(42)-C(41)-P(2) 118.55(16) 
C(43)-C(42)-C(41) 120.0(2) 
C(43)-C(42)-H(42) 120.0 
C(41)-C(42)-H(42) 120.0 
C(44)-C(43)-C(42) 120.5(2) 
C(44)-C(43)-H(43) 119.8 
C(42)-C(43)-H(43) 119.8 
C(43)-C(44)-C(45) 120.0(2) 
C(43)-C(44)-H(44) 120.0 
C(45)-C(44)-H(44) 120.0 
C(44)-C(45)-C(46) 120.3(2) 
C(44)-C(45)-H(45) 119.9 
C(46)-C(45)-H(45) 119.9 
C(41)-C(46)-C(45) 120.1(2) 
C(41)-C(46)-H(46) 120.0 
C(45)-C(46)-H(46) 120.0 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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Table 4. Anisotropic displacement parameters (Å2 x 103) for C23H24NOP. The anisotropic 
displacement factor exponent takes the form: -2p2[ h2 a*2U11 +  ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
P(1) 19(1)  17(1) 12(1)  1(1) 1(1)  4(1) 
O(1) 28(1)  26(1) 14(1)  2(1) 2(1)  3(1) 
N(1) 28(1)  16(1) 15(1)  4(1) 5(1)  5(1) 
C(1) 51(2)  38(1) 42(2)  5(1) 4(1)  -8(1) 
C(2) 35(1)  25(1) 32(1)  -2(1) -5(1)  1(1) 
C(3) 28(1)  20(1) 23(1)  1(1) 0(1)  2(1) 
C(4) 27(1)  15(1) 16(1)  2(1) 5(1)  3(1) 
C(5) 29(1)  15(1) 13(1)  -4(1) 0(1)  2(1) 
C(6) 30(1)  18(1) 20(1)  2(1) 2(1)  3(1) 
C(7) 29(1)  24(1) 26(1)  -5(1) 4(1)  0(1) 
C(8) 30(1)  27(1) 26(1)  -4(1) -3(1)  9(1) 
C(9) 41(1)  22(1) 24(1)  1(1) -1(1)  11(1) 
C(10) 36(1)  19(1) 18(1)  0(1) 3(1)  4(1) 
C(11) 32(2)  49(2) 49(2)  -3(1) -2(1)  18(1) 
C(12) 22(1)  14(1) 20(1)  -1(1) 2(1)  1(1) 
C(13) 25(1)  24(1) 22(1)  0(1) 1(1)  3(1) 
C(14) 28(1)  25(1) 26(1)  3(1) -4(1)  3(1) 
C(15) 17(1)  19(1) 42(1)  1(1) -2(1)  2(1) 
C(16) 23(1)  22(1) 36(1)  0(1) 11(1)  0(1) 
C(17) 26(1)  18(1) 21(1)  -1(1) 3(1)  -1(1) 
C(18) 24(1)  18(1) 13(1)  -2(1) 5(1)  3(1) 
C(19) 23(1)  22(1) 23(1)  0(1) 3(1)  3(1) 
C(20) 30(1)  20(1) 26(1)  0(1) 4(1)  4(1) 
C(21) 34(1)  21(1) 25(1)  -5(1) 6(1)  -7(1) 
C(22) 22(1)  30(1) 37(1)  -1(1) -2(1)  -4(1) 
C(23) 24(1)  21(1) 30(1)  1(1) -1(1)  4(1) 
P(2) 18(1)  15(1) 13(1)  0(1) 2(1)  -1(1) 
O(2) 28(1)  22(1) 16(1)  -2(1) 7(1)  0(1) 
N(2) 23(1)  16(1) 13(1)  -1(1) 0(1)  -5(1) 
C(24) 39(1)  21(1) 38(1)  -3(1) -2(1)  1(1) 
C(25) 20(1)  20(1) 31(1)  1(1) 0(1)  -2(1) 
C(26) 18(1)  21(1) 26(1)  -1(1) -1(1)  -1(1) 
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C(27) 18(1)  17(1) 14(1)  -2(1) 2(1)  -4(1) 
C(28) 18(1)  14(1) 20(1)  3(1) 3(1)  1(1) 
C(29) 27(1)  17(1) 23(1)  -1(1) 5(1)  -1(1) 
C(30) 36(1)  22(1) 31(1)  -1(1) 17(1)  0(1) 
C(31) 23(1)  16(1) 44(1)  8(1) 12(1)  3(1) 
C(32) 20(1)  28(1) 34(1)  8(1) -4(1)  -4(1) 
C(33) 23(1)  27(1) 20(1)  4(1) 1(1)  0(1) 
C(34) 29(1)  26(1) 68(2)  7(1) 21(1)  -1(1) 
C(35) 23(1)  15(1) 16(1)  3(1) 3(1)  -2(1) 
C(36) 23(1)  19(1) 21(1)  5(1) 8(1)  0(1) 
C(37) 16(1)  29(1) 30(1)  9(1) 4(1)  -2(1) 
C(38) 23(1)  24(1) 26(1)  7(1) -3(1)  -9(1) 
C(39) 28(1)  20(1) 22(1)  -1(1) 0(1)  -3(1) 
C(40) 20(1)  20(1) 22(1)  1(1) 4(1)  0(1) 
C(41) 17(1)  18(1) 15(1)  -2(1) -2(1)  -2(1) 
C(42) 22(1)  23(1) 19(1)  1(1) 4(1)  -1(1) 
C(43) 29(1)  24(1) 19(1)  6(1) 3(1)  0(1) 
C(44) 24(1)  18(1) 27(1)  0(1) 0(1)  2(1) 
C(45) 19(1)  23(1) 31(1)  -4(1) 7(1)  0(1) 
C(46) 24(1)  20(1) 18(1)  0(1) 5(1)  -3(1) 
______________________________________________________________________________  
 
 
Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2 x 10 3) for 
C23H24NOP  
______________________________________________________________________________ 
 x  y  z  U(eq) 
______________________________________________________________________________ 
H(1N) 8320(20) 7925(11) 3756(17) 24 
H(1A) 10842 10150 4305 54 
H(1B) 9812 10812 4164 54 
H(2) 8017 10144 4027 39 
H(3A) 8569 9020 4937 30 
H(3B) 9937 9034 4341 30 
H(4) 8630(20) 8986(11) 2160(19) 23 
H(6) 5981 8378 3798 28 
H(7) 3691 8718 3329 32 
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H(9) 4556 10112 740 36 
H(10) 6834 9772 1194 30 
H(11A) 2303 10045 2381 67 
H(11B) 1802 9310 1815 67 
H(11C) 2147 9882 825 67 
H(13) 10747 7586 4651 29 
H(14) 13053 7327 5516 33 
H(15) 14556 7122 4074 33 
H(16) 13749 7181 1775 32 
H(17) 11438 7433 897 26 
H(19) 9983 6269 2780 28 
H(20) 8886 5218 2659 31 
H(21) 6524 5134 1779 32 
H(22) 5253 6107 1074 37 
H(23) 6327 7164 1216 31 
H(2N) 1920(20) 2858(11) 1287(16) 22 
H(24A) 1668 5252 2977 41 
H(24B) 3033 5709 2882 41 
H(25) 3874 4856 1857 29 
H(26A) 2142 4045 820 27 
H(26B) 1377 4150 2035 27 
H(27) 3060(20) 3566(10) 3500(16) 20 
H(29) 4096 3176 369 27 
H(30) 6312 3256 -22 34 
H(32) 7698 3910 3743 34 
H(33) 5484 3825 4148 29 
H(34A) 8775 4174 1278 60 
H(34B) 8781 3399 808 60 
H(34C) 9352 3593 2342 60 
H(36) -1076 2387 2858 25 
H(37) -2956 1802 1584 30 
H(38) -2582 942 146 30 
H(39) -350 683 -92 29 
H(40) 1530 1285 1131 25 
H(42) 2358 1359 5176 26 
H(43) 3918 466 5717 29 
H(44) 5655 304 4532 29 
 
Page 308
	  	  
H(45) 5887 1053 2834 29 
H(46) 4301 1937 2233 25 
 
 
Table 6. Torsion angles [°] for C23H24NOP 
________________________________________________________________  
O(1)-P(1)-N(1)-C(4) -31.06(19) 
C(12)-P(1)-N(1)-C(4) 93.57(17) 
C(18)-P(1)-N(1)-C(4) -153.76(16) 
C(1)-C(2)-C(3)-C(4) -117.7(3) 
P(1)-N(1)-C(4)-C(5) 117.35(18) 
P(1)-N(1)-C(4)-C(3) -118.27(18) 
C(2)-C(3)-C(4)-N(1) 177.94(19) 
C(2)-C(3)-C(4)-C(5) -58.2(3) 
N(1)-C(4)-C(5)-C(6) 41.9(3) 
C(3)-C(4)-C(5)-C(6) -81.2(2) 
N(1)-C(4)-C(5)-C(10) -138.74(19) 
C(3)-C(4)-C(5)-C(10) 98.1(2) 
C(10)-C(5)-C(6)-C(7) -0.9(3) 
C(4)-C(5)-C(6)-C(7) 178.47(19) 
C(5)-C(6)-C(7)-C(8) 0.1(3) 
C(6)-C(7)-C(8)-C(9) 0.6(3) 
C(6)-C(7)-C(8)-C(11) -177.5(2) 
C(7)-C(8)-C(9)-C(10) -0.4(3) 
C(11)-C(8)-C(9)-C(10) 177.6(2) 
C(8)-C(9)-C(10)-C(5) -0.4(3) 
C(6)-C(5)-C(10)-C(9) 1.1(3) 
C(4)-C(5)-C(10)-C(9) -178.31(19) 
O(1)-P(1)-C(12)-C(17) -28.89(18) 
N(1)-P(1)-C(12)-C(17) -154.39(15) 
C(18)-P(1)-C(12)-C(17) 94.11(17) 
O(1)-P(1)-C(12)-C(13) 155.11(15) 
N(1)-P(1)-C(12)-C(13) 29.61(19) 
C(18)-P(1)-C(12)-C(13) -81.89(17) 
C(17)-C(12)-C(13)-C(14) -1.1(3) 
P(1)-C(12)-C(13)-C(14) 174.89(16) 
C(12)-C(13)-C(14)-C(15) 0.5(3) 
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C(13)-C(14)-C(15)-C(16) 0.2(3) 
C(14)-C(15)-C(16)-C(17) -0.4(3) 
C(15)-C(16)-C(17)-C(12) -0.2(3) 
C(13)-C(12)-C(17)-C(16) 0.9(3) 
P(1)-C(12)-C(17)-C(16) -175.13(15) 
O(1)-P(1)-C(18)-C(19) 118.70(18) 
N(1)-P(1)-C(18)-C(19) -119.45(18) 
C(12)-P(1)-C(18)-C(19) -2.5(2) 
O(1)-P(1)-C(18)-C(23) -58.24(19) 
N(1)-P(1)-C(18)-C(23) 63.61(18) 
C(12)-P(1)-C(18)-C(23) -179.42(16) 
C(23)-C(18)-C(19)-C(20) 0.2(3) 
P(1)-C(18)-C(19)-C(20) -176.75(17) 
C(18)-C(19)-C(20)-C(21) 0.6(3) 
C(19)-C(20)-C(21)-C(22) -0.9(3) 
C(20)-C(21)-C(22)-C(23) 0.4(4) 
C(21)-C(22)-C(23)-C(18) 0.4(4) 
C(19)-C(18)-C(23)-C(22) -0.7(3) 
P(1)-C(18)-C(23)-C(22) 176.43(18) 
O(2)-P(2)-N(2)-C(27) 35.84(19) 
C(41)-P(2)-N(2)-C(27) -89.21(17) 
C(35)-P(2)-N(2)-C(27) 159.20(16) 
C(24)-C(25)-C(26)-C(27) -116.1(2) 
P(2)-N(2)-C(27)-C(28) 111.83(18) 
P(2)-N(2)-C(27)-C(26) -124.99(17) 
C(25)-C(26)-C(27)-N(2) -177.98(18) 
C(25)-C(26)-C(27)-C(28) -53.0(2) 
N(2)-C(27)-C(28)-C(33) -134.69(19) 
C(26)-C(27)-C(28)-C(33) 103.4(2) 
N(2)-C(27)-C(28)-C(29) 51.1(2) 
C(26)-C(27)-C(28)-C(29) -70.9(2) 
C(33)-C(28)-C(29)-C(30) -0.7(3) 
C(27)-C(28)-C(29)-C(30) 173.62(19) 
C(28)-C(29)-C(30)-C(31) -0.6(3) 
C(29)-C(30)-C(31)-C(32) 1.7(3) 
C(29)-C(30)-C(31)-C(34) -176.4(2) 
C(30)-C(31)-C(32)-C(33) -1.6(3) 
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C(34)-C(31)-C(32)-C(33) 176.6(2) 
C(29)-C(28)-C(33)-C(32) 0.9(3) 
C(27)-C(28)-C(33)-C(32) -173.51(19) 
C(31)-C(32)-C(33)-C(28) 0.2(3) 
O(2)-P(2)-C(35)-C(36) 20.04(18) 
N(2)-P(2)-C(35)-C(36) -105.21(16) 
C(41)-P(2)-C(35)-C(36) 140.04(16) 
O(2)-P(2)-C(35)-C(40) -158.36(15) 
N(2)-P(2)-C(35)-C(40) 76.39(18) 
C(41)-P(2)-C(35)-C(40) -38.36(19) 
C(40)-C(35)-C(36)-C(37) -0.7(3) 
P(2)-C(35)-C(36)-C(37) -179.10(15) 
C(35)-C(36)-C(37)-C(38) 1.4(3) 
C(36)-C(37)-C(38)-C(39) -1.1(3) 
C(37)-C(38)-C(39)-C(40) 0.2(3) 
C(38)-C(39)-C(40)-C(35) 0.5(3) 
C(36)-C(35)-C(40)-C(39) -0.3(3) 
P(2)-C(35)-C(40)-C(39) 178.10(16) 
O(2)-P(2)-C(41)-C(46) -143.20(16) 
N(2)-P(2)-C(41)-C(46) -15.57(19) 
C(35)-P(2)-C(41)-C(46) 95.76(18) 
O(2)-P(2)-C(41)-C(42) 41.95(18) 
N(2)-P(2)-C(41)-C(42) 169.58(15) 
C(35)-P(2)-C(41)-C(42) -79.09(17) 
C(46)-C(41)-C(42)-C(43) -1.5(3) 
P(2)-C(41)-C(42)-C(43) 173.55(16) 
C(41)-C(42)-C(43)-C(44) 0.7(3) 
C(42)-C(43)-C(44)-C(45) 0.9(3) 
C(43)-C(44)-C(45)-C(46) -1.8(3) 
C(42)-C(41)-C(46)-C(45) 0.6(3) 
P(2)-C(41)-C(46)-C(45) -174.26(15) 
C(44)-C(45)-C(46)-C(41) 1.1(3) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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Table 7. Hydrogen bonds for C23H24NOP  [Å and °] 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
 N(1)-H(1N)...O(2)#1 0.855(15) 1.998(16) 2.840(2) 169(2) 
 N(2)-H(2N)...O(1)#2 0.841(15) 1.966(16) 2.796(2) 169(2) 
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,y+1/2,-z+1    #2 -x+1,y-1/2,-z  
 
X-ray Crystal Structure of 1.21f 
 
Table 1. Crystal data and structure refinement for C21H26NOP 
Identification code  C21H26NOP 
Empirical formula  C21H26NOP 
Formula weight  339.40 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 2(1) 
Unit cell dimensions a = 5.3475(3) Å α= 90° 
 b = 8.4812(4) Å β= 91.983(2)° 
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 c = 21.2781(10) Å γ = 90° 
Volume 964.45(8) Å3 
Z 2 
Density (calculated) 1.169 Mg/m3 
Absorption coefficient 0.149 mm-1 
F(000) 364 
Crystal size 0.30 x 0.24 x 0.08 mm3 
Theta range for data collection 1.92 to 28.48° 
Index ranges -7<=h<=7, -11<=k<=11, -28<=l<=28 
Reflections collected 39105 
Independent reflections 4895 [R(int) = 0.0215] 
Completeness to theta = 28.48° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9882 and 0.9566 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4895 / 77 / 253 
Goodness-of-fit on F2 1.069 
Final R indices [I>2sigma(I)] R1 = 0.0273, wR2 = 0.0718 
R indices (all data) R1 = 0.0278, wR2 = 0.0722 
Absolute structure parameter 0.00(5) 
Extinction coefficient na 
Largest diff. peak and hole 0.404 and -0.262 e.Å-3 
 
 
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2 x 103) for 
C21H26NOP. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
P(1) 520(1) -860(1) 8324(1) 13(1) 
O(1) -1929(1) -1644(1) 8175(1) 17(1) 
N(1) 2774(2) -1603(1) 7910(1) 16(1) 
C(1) 5612(4) -3552(4) 5942(1) 62(1) 
C(2) 3843(3) -3594(2) 6350(1) 36(1) 
C(3) 4157(2) -3166(2) 7029(1) 25(1) 
C(4) 2418(2) -1834(1) 7224(1) 17(1) 
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C(5) 2527(10) -366(5) 6853(2) 25(1) 
C(6) 698(7) 310(4) 6539(1) 29(1) 
C(7) 855(8) 1837(4) 6190(2) 40(1) 
C(8) -89(8) 1743(5) 5514(2) 46(1) 
C(9) 17(11) 3306(5) 5178(2) 63(1) 
C(5X) 3096(9) -323(6) 6874(3) 20(1) 
C(6X) 1493(8) 673(5) 6602(2) 36(1) 
C(7X) 2153(8) 2236(5) 6320(2) 46(1) 
C(8X) 1431(9) 2386(6) 5634(2) 60(1) 
C(9X) -1310(11) 2407(8) 5500(3) 80(2) 
C(10) 1615(2) -1035(1) 9129(1) 15(1) 
C(11) 3681(2) -1934(1) 9332(1) 19(1) 
C(12) 4308(2) -2036(2) 9972(1) 22(1) 
C(13) 2892(2) -1251(1) 10408(1) 22(1) 
C(14) 841(2) -353(2) 10210(1) 23(1) 
C(15) 211(2) -247(2) 9573(1) 20(1) 
C(16) 159(2) 1236(1) 8196(1) 15(1) 
C(17) 1976(2) 2315(1) 8408(1) 19(1) 
C(18) 1664(2) 3917(1) 8290(1) 23(1) 
C(19) -454(3) 4460(1) 7960(1) 25(1) 
C(20) -2246(2) 3391(2) 7741(1) 26(1) 
C(21) -1952(2) 1790(2) 7864(1) 21(1) 
 
 
 
Table 3. Bond lengths [Å] and angles [°] for C21H26NOP  
_____________________________________________________  
P(1)-O(1)  1.4931(8) 
P(1)-N(1)  1.6428(9) 
P(1)-C(10)  1.7978(11) 
P(1)-C(16)  1.8083(12) 
N(1)-C(4)  1.4767(14) 
N(1)-H(1N)  0.885(13) 
C(1)-C(2)  1.307(3) 
C(1)-H(1A)  0.993(17) 
C(1)-H(1B)  0.986(16) 
C(2)-C(3)  1.4923(19) 
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C(2)-H(2)  0.980(15) 
C(3)-C(4)  1.5302(16) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-C(5)  1.477(5) 
C(4)-H(4)  0.989(12) 
C(5)-C(6)  1.298(5) 
C(5)-H(5)  0.9500 
C(6)-C(7)  1.497(5) 
C(6)-H(6)  0.9500 
C(7)-C(8)  1.509(5) 
C(7)-H(7A)  0.9900 
C(7)-H(7B)  0.9900 
C(8)-C(9)  1.509(5) 
C(8)-H(8A)  0.9900 
C(8)-H(8B)  0.9900 
C(9)-H(9A)  0.9800 
C(9)-H(9B)  0.9800 
C(9)-H(9C)  0.9800 
C(10)-C(15)  1.3976(15) 
C(10)-C(11)  1.3991(15) 
C(11)-C(12)  1.3924(17) 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.3886(17) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.3889(17) 
C(13)-H(13)  0.9500 
C(14)-C(15)  1.3867(17) 
C(14)-H(14)  0.9500 
C(15)-H(15)  0.9500 
C(16)-C(21)  1.3922(15) 
C(16)-C(17)  1.3979(16) 
C(17)-C(18)  1.3900(17) 
C(17)-H(17)  0.9500 
C(18)-C(19)  1.3914(18) 
C(18)-H(18)  0.9500 
C(19)-C(20)  1.388(2) 
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C(19)-H(19)  0.9500 
C(20)-C(21)  1.3902(18) 
C(20)-H(20)  0.9500 
C(21)-H(21)  0.9500 
 
O(1)-P(1)-N(1) 111.71(5) 
O(1)-P(1)-C(10) 114.84(5) 
N(1)-P(1)-C(10) 105.01(5) 
O(1)-P(1)-C(16) 108.53(5) 
N(1)-P(1)-C(16) 111.89(5) 
C(10)-P(1)-C(16) 104.70(5) 
C(4)-N(1)-P(1) 120.56(7) 
C(4)-N(1)-H(1N) 115.7(10) 
P(1)-N(1)-H(1N) 118.5(10) 
C(2)-C(1)-H(1A) 119.6(17) 
C(2)-C(1)-H(1B) 122.8(16) 
H(1A)-C(1)-H(1B) 118(2) 
C(1)-C(2)-C(3) 125.23(16) 
C(1)-C(2)-H(2) 117.9(12) 
C(3)-C(2)-H(2) 116.9(12) 
C(2)-C(3)-C(4) 113.21(11) 
C(2)-C(3)-H(3A) 108.9 
C(4)-C(3)-H(3A) 108.9 
C(2)-C(3)-H(3B) 108.9 
C(4)-C(3)-H(3B) 108.9 
H(3A)-C(3)-H(3B) 107.7 
C(5)-C(4)-N(1) 114.2(2) 
C(5)-C(4)-C(3) 116.2(2) 
N(1)-C(4)-C(3) 107.93(9) 
C(5)-C(4)-H(4) 99.3(10) 
N(1)-C(4)-H(4) 107.5(9) 
C(3)-C(4)-H(4) 111.2(10) 
C(6)-C(5)-C(4) 127.2(4) 
C(6)-C(5)-H(5) 116.4 
C(4)-C(5)-H(5) 116.4 
C(5)-C(6)-C(7) 125.7(4) 
C(5)-C(6)-H(6) 117.2 
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C(7)-C(6)-H(6) 117.2 
C(6)-C(7)-C(8) 113.9(3) 
C(6)-C(7)-H(7A) 108.8 
C(8)-C(7)-H(7A) 108.8 
C(6)-C(7)-H(7B) 108.8 
C(8)-C(7)-H(7B) 108.8 
H(7A)-C(7)-H(7B) 107.7 
C(7)-C(8)-C(9) 112.9(3) 
C(7)-C(8)-H(8A) 109.0 
C(9)-C(8)-H(8A) 109.0 
C(7)-C(8)-H(8B) 109.0 
C(9)-C(8)-H(8B) 109.0 
H(8A)-C(8)-H(8B) 107.8 
C(8)-C(9)-H(9A) 109.5 
C(8)-C(9)-H(9B) 109.5 
H(9A)-C(9)-H(9B) 109.5 
C(8)-C(9)-H(9C) 109.5 
H(9A)-C(9)-H(9C) 109.5 
H(9B)-C(9)-H(9C) 109.5 
C(15)-C(10)-C(11) 119.24(10) 
C(15)-C(10)-P(1) 116.15(8) 
C(11)-C(10)-P(1) 124.57(8) 
C(12)-C(11)-C(10) 119.79(11) 
C(12)-C(11)-H(11) 120.1 
C(10)-C(11)-H(11) 120.1 
C(13)-C(12)-C(11) 120.37(11) 
C(13)-C(12)-H(12) 119.8 
C(11)-C(12)-H(12) 119.8 
C(12)-C(13)-C(14) 120.16(11) 
C(12)-C(13)-H(13) 119.9 
C(14)-C(13)-H(13) 119.9 
C(15)-C(14)-C(13) 119.70(11) 
C(15)-C(14)-H(14) 120.2 
C(13)-C(14)-H(14) 120.2 
C(14)-C(15)-C(10) 120.75(11) 
C(14)-C(15)-H(15) 119.6 
C(10)-C(15)-H(15) 119.6 
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C(21)-C(16)-C(17) 119.01(11) 
C(21)-C(16)-P(1) 119.24(9) 
C(17)-C(16)-P(1) 121.73(9) 
C(18)-C(17)-C(16) 120.27(11) 
C(18)-C(17)-H(17) 119.9 
C(16)-C(17)-H(17) 119.9 
C(17)-C(18)-C(19) 120.32(11) 
C(17)-C(18)-H(18) 119.8 
C(19)-C(18)-H(18) 119.8 
C(20)-C(19)-C(18) 119.57(11) 
C(20)-C(19)-H(19) 120.2 
C(18)-C(19)-H(19) 120.2 
C(19)-C(20)-C(21) 120.21(12) 
C(19)-C(20)-H(20) 119.9 
C(21)-C(20)-H(20) 119.9 
C(20)-C(21)-C(16) 120.60(12) 
C(20)-C(21)-H(21) 119.7 
C(16)-C(21)-H(21) 119.7 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 
Table 4. Anisotropic displacement parameters (Å2 x 103) for C21H26NOP. The anisotropic 
displacement factor exponent takes the form: -2p2[ h2 a*2U11 +  ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
P(1) 9(1)  12(1) 18(1)  0(1) 0(1)  0(1) 
O(1) 10(1)  16(1) 26(1)  -3(1) -1(1)  -1(1) 
N(1) 11(1)  18(1) 18(1)  -2(1) 0(1)  2(1) 
C(1) 57(1)  95(2) 33(1)  -19(1) 9(1)  12(1) 
C(2) 36(1)  40(1) 31(1)  -15(1) 0(1)  8(1) 
C(3) 26(1)  26(1) 24(1)  -2(1) 3(1)  9(1) 
C(4) 14(1)  18(1) 18(1)  -1(1) 0(1)  2(1) 
C(5) 24(2)  27(2) 26(2)  3(1) 2(2)  -1(2) 
C(6) 30(2)  31(2) 24(1)  10(1) 2(1)  8(2) 
C(7) 55(2)  34(2) 30(1)  9(1) -1(1)  15(2) 
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C(8) 54(2)  53(2) 32(2)  9(2) 2(1)  20(2) 
C(9) 116(4)  41(2) 31(2)  9(2) -6(2)  15(2) 
C(10) 13(1)  12(1) 18(1)  2(1) 1(1)  -1(1) 
C(11) 15(1)  19(1) 22(1)  1(1) 2(1)  3(1) 
C(12) 18(1)  26(1) 24(1)  5(1) -1(1)  3(1) 
C(13) 23(1)  24(1) 19(1)  5(1) 0(1)  -1(1) 
C(14) 25(1)  23(1) 20(1)  1(1) 6(1)  4(1) 
C(15) 18(1)  20(1) 22(1)  2(1) 3(1)  4(1) 
C(16) 15(1)  13(1) 17(1)  1(1) 2(1)  2(1) 
C(17) 18(1)  17(1) 21(1)  1(1) 0(1)  -1(1) 
C(18) 28(1)  14(1) 26(1)  0(1) 4(1)  -3(1) 
C(19) 30(1)  15(1) 30(1)  4(1) 9(1)  4(1) 
C(20) 22(1)  22(1) 33(1)  7(1) 1(1)  7(1) 
C(21) 16(1)  20(1) 28(1)  1(1) -2(1)  2(1) 
______________________________________________________________________________  
 
 
 
Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2 x 10 3) 
for C21H26NOP  
______________________________________________________________________________ 
 x  y  z  U(eq) 
______________________________________________________________________________ 
  
H(1N) 4340(20) -1474(19) 8048(7) 19 
H(1A) 7340(40) -3260(30) 6082(13) 74 
H(1B) 5330(50) -3860(30) 5497(8) 74 
H(2) 2180(30) -3950(20) 6204(10) 43 
H(3A) 5913 -2841 7116 30 
H(3B) 3830 -4109 7287 30 
H(4) 640(20) -2114(19) 7140(7) 20 
H(5) 4110 140 6843 31 
H(6) -877 -210 6531 34 
H(7A) 2620 2190 6199 48 
H(7B) -128 2642 6410 48 
H(8A) -1840 1362 5503 56 
H(8B) 928 965 5289 56 
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H(9A) -656 3184 4746 94 
H(9B) 1757 3666 5169 94 
H(9C) -983 4084 5399 94 
H(5X) 4825 -80 6850 24 
H(6X) -220 375 6584 43 
H(7XA) 1313 3082 6554 55 
H(7XB) 3981 2399 6374 55 
H(8XA) 2162 3370 5471 72 
H(8XB) 2167 1493 5404 72 
H(9XA) -1640 2485 5045 120 
H(9XB) -2048 3317 5709 120 
H(9XC) -2053 1434 5658 120 
H(11) 4654 -2474 9035 23 
H(12) 5711 -2647 10110 27 
H(13) 3327 -1328 10844 27 
H(14) -125 186 10508 27 
H(15) -1191 368 9438 24 
H(17) 3429 1952 8633 23 
H(18) 2904 4644 8437 27 
H(19) -672 5556 7883 30 
H(20) -3677 3753 7507 31 
H(21) -3204 1068 7721 26 
 
 
Table 6. Torsion angles [°] for C21H26NOP  
________________________________________________________________  
O(1)-P(1)-N(1)-C(4) 47.67(10) 
C(10)-P(1)-N(1)-C(4) 172.76(9) 
C(16)-P(1)-N(1)-C(4) -74.24(10) 
C(1)-C(2)-C(3)-C(4) 121.7(2) 
P(1)-N(1)-C(4)-C(5) 75.1(2) 
P(1)-N(1)-C(4)-C(3) -154.04(9) 
C(2)-C(3)-C(4)-C(5) -54.4(3) 
C(2)-C(3)-C(4)-N(1) 175.89(12) 
N(1)-C(4)-C(5)-C(6) -111.9(5) 
C(3)-C(4)-C(5)-C(6) 121.5(5) 
C(4)-C(5)-C(6)-C(7) 177.3(4) 
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C(5)-C(6)-C(7)-C(8) 127.5(5) 
C(6)-C(7)-C(8)-C(9) 178.3(4) 
O(1)-P(1)-C(10)-C(15) -67.14(10) 
N(1)-P(1)-C(10)-C(15) 169.76(9) 
C(16)-P(1)-C(10)-C(15) 51.77(10) 
O(1)-P(1)-C(10)-C(11) 110.54(10) 
N(1)-P(1)-C(10)-C(11) -12.56(11) 
C(16)-P(1)-C(10)-C(11) -130.55(10) 
C(15)-C(10)-C(11)-C(12) 0.16(17) 
P(1)-C(10)-C(11)-C(12) -177.45(9) 
C(10)-C(11)-C(12)-C(13) 0.03(18) 
C(11)-C(12)-C(13)-C(14) -0.18(19) 
C(12)-C(13)-C(14)-C(15) 0.13(19) 
C(13)-C(14)-C(15)-C(10) 0.06(19) 
C(11)-C(10)-C(15)-C(14) -0.20(18) 
P(1)-C(10)-C(15)-C(14) 177.61(10) 
O(1)-P(1)-C(16)-C(21) -14.04(11) 
N(1)-P(1)-C(16)-C(21) 109.67(10) 
C(10)-P(1)-C(16)-C(21) -137.13(9) 
O(1)-P(1)-C(16)-C(17) 167.59(9) 
N(1)-P(1)-C(16)-C(17) -68.70(10) 
C(10)-P(1)-C(16)-C(17) 44.50(10) 
C(21)-C(16)-C(17)-C(18) 0.30(18) 
P(1)-C(16)-C(17)-C(18) 178.68(9) 
C(16)-C(17)-C(18)-C(19) -0.20(19) 
C(17)-C(18)-C(19)-C(20) -0.64(19) 
C(18)-C(19)-C(20)-C(21) 1.37(19) 
C(19)-C(20)-C(21)-C(16) -1.3(2) 
C(17)-C(16)-C(21)-C(20) 0.43(18) 
P(1)-C(16)-C(21)-C(20) -177.98(10) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 
Table 7. Hydrogen bonds for C21H26NOP  [Å and °] 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
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____________________________________________________________________________  
 N(1)-H(1N)...O(1)#1 0.885(13) 2.009(13) 2.8692(12) 163.7(14) 
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 x+1,y,z  
 
 
 
 
 
 
 
 
 
 
X-ray Crystal Structure of 1.35 
 
Table 1. Crystal data and structure refinement for C30H30NOP 1.35 
Identification code  C30H30NOP 
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Empirical formula  C30H30NOP 
Formula weight  451.52 
Temperature  213(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 5.4229(2) Å α= 90° 
 b = 16.7050(6) Å β= 90° 
 c = 27.7408(11) Å γ = 90° 
Volume 2513.03(16) Å3 
Z 4 
Density (calculated) 1.193 Mg/m3 
Absorption coefficient 0.131 mm-1 
F(000) 960 
Crystal size 0.20 x 0.08 x 0.04 mm3 
Theta range for data collection 1.42 to 28.37° 
Index ranges -6<=h<=7, -22<=k<=22, -37<=l<=37 
Reflections collected 65893 
Independent reflections 6293 [R(int) = 0.0763] 
Completeness to theta = 28.37° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9948 and 0.9742 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6293 / 0 / 313 
Goodness-of-fit on F2 1.016 
Final R indices [I>2sigma(I)] R1 = 0.0422, wR2 = 0.0906 
R indices (all data) R1 = 0.0607, wR2 = 0.0990 
Absolute structure parameter 0.01(8) 
Extinction coefficient na 
Largest diff. peak and hole 0.227 and -0.202 e.Å-3 
 
 
 
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2 x 103) for 
C30H30NOP. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
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 x y z U(eq) 
______________________________________________________________________________ 
P(1) 10237(1) 1920(1) 1447(1) 25(1) 
O(1) 12782(2) 1714(1) 1299(1) 34(1) 
N(1) 8159(3) 1429(1) 1140(1) 28(1) 
C(1) 9453(3) 2960(1) 1370(1) 29(1) 
C(2) 7484(4) 3226(1) 1103(1) 47(1) 
C(3) 7029(5) 4042(1) 1060(1) 54(1) 
C(4) 8565(5) 4584(1) 1272(1) 51(1) 
C(5) 10554(6) 4327(1) 1528(1) 81(1) 
C(6) 10993(5) 3517(1) 1580(1) 64(1) 
C(7) 9832(3) 1752(1) 2088(1) 28(1) 
C(8) 7816(4) 2046(2) 2329(1) 56(1) 
C(9) 7515(5) 1903(2) 2818(1) 55(1) 
C(10) 9196(5) 1470(1) 3065(1) 48(1) 
C(11) 11243(6) 1201(2) 2836(1) 75(1) 
C(12) 11557(5) 1340(2) 2344(1) 58(1) 
C(13) 8636(4) 611(1) 964(1) 29(1) 
C(14) 8128(4) -26(1) 1339(1) 34(1) 
C(15) 6030(5) -6(1) 1619(1) 49(1) 
C(16) 5611(6) -590(2) 1964(1) 64(1) 
C(17) 7274(7) -1203(2) 2026(1) 69(1) 
C(18) 9355(6) -1231(2) 1748(1) 67(1) 
C(19) 9771(5) -646(1) 1408(1) 50(1) 
C(20) 7174(4) 486(1) 490(1) 33(1) 
C(21) 7710(5) 1155(1) 147(1) 49(1) 
C(22) 6103(8) 1636(2) -48(1) 79(1) 
C(23) 7847(4) -325(1) 262(1) 38(1) 
C(24) 6369(5) -520(1) -191(1) 51(1) 
C(25) 7255(4) -1271(1) -441(1) 37(1) 
C(26) 5986(4) -1981(1) -406(1) 48(1) 
C(27) 6824(5) -2660(1) -638(1) 58(1) 
C(28) 8930(5) -2649(1) -903(1) 53(1) 
C(29) 10220(4) -1956(2) -938(1) 54(1) 
C(30) 9382(4) -1268(1) -711(1) 49(1) 
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Table 3. Bond lengths [Å] and angles [°] for C30H30NOP 
_____________________________________________________  
P(1)-O(1)  1.4815(13) 
P(1)-N(1)  1.6343(16) 
P(1)-C(1)  1.8003(17) 
P(1)-C(7)  1.8131(17) 
N(1)-C(13)  1.473(2) 
N(1)-H(1N)  0.78(2) 
C(1)-C(2)  1.373(3) 
C(1)-C(6)  1.380(3) 
C(2)-C(3)  1.391(3) 
C(2)-H(2)  0.9400 
C(3)-C(4)  1.363(3) 
C(3)-H(3)  0.9400 
C(4)-C(5)  1.361(4) 
C(4)-H(4)  0.9400 
C(5)-C(6)  1.381(3) 
C(5)-H(5)  0.9400 
C(6)-H(6)  0.9400 
C(7)-C(12)  1.361(3) 
C(7)-C(8)  1.371(3) 
C(8)-C(9)  1.388(3) 
C(8)-H(8)  0.9400 
C(9)-C(10)  1.349(3) 
C(9)-H(9)  0.9400 
C(10)-C(11)  1.355(3) 
C(10)-H(10)  0.9400 
C(11)-C(12)  1.396(3) 
C(11)-H(11)  0.9400 
C(12)-H(12)  0.9400 
C(13)-C(14)  1.514(3) 
C(13)-C(20)  1.549(3) 
C(13)-H(13)  0.97(2) 
C(14)-C(15)  1.378(3) 
C(14)-C(19)  1.380(3) 
C(15)-C(16)  1.384(3) 
C(15)-H(15)  0.9400 
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C(16)-C(17)  1.377(4) 
C(16)-H(16)  0.9400 
C(17)-C(18)  1.368(4) 
C(17)-H(17)  0.9400 
C(18)-C(19)  1.377(3) 
C(18)-H(18)  0.9400 
C(19)-H(19)  0.9400 
C(20)-C(21)  1.498(3) 
C(20)-C(23)  1.539(3) 
C(20)-H(20)  0.98(2) 
C(21)-C(22)  1.301(4) 
C(21)-H(21)  0.9400 
C(22)-H(22A)  1.01(3) 
C(22)-H(22B)  0.93(3) 
C(23)-C(24)  1.527(3) 
C(23)-H(23)  0.9800 
C(23)-H(7B)  0.9800 
C(24)-C(25)  1.512(3) 
C(24)-H(24A)  0.9800 
C(24)-H(24B)  0.9800 
C(25)-C(30)  1.374(3) 
C(25)-C(26)  1.375(3) 
C(26)-C(27)  1.381(3) 
C(26)-H(26)  0.9400 
C(27)-C(28)  1.359(4) 
C(27)-H(27)  0.9400 
C(28)-C(29)  1.357(3) 
C(28)-H(28)  0.9400 
C(29)-C(30)  1.387(3) 
C(29)-H(29)  0.9400 
C(30)-H(30)  0.9400 
O(1)-P(1)-N(1) 112.31(8) 
O(1)-P(1)-C(1) 114.32(8) 
N(1)-P(1)-C(1) 105.06(8) 
O(1)-P(1)-C(7) 110.45(8) 
N(1)-P(1)-C(7) 110.49(8) 
C(1)-P(1)-C(7) 103.78(7) 
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C(13)-N(1)-P(1) 121.21(13) 
C(13)-N(1)-H(1N) 115.8(16) 
P(1)-N(1)-H(1N) 117.8(16) 
C(2)-C(1)-C(6) 118.66(18) 
C(2)-C(1)-P(1) 124.10(14) 
C(6)-C(1)-P(1) 117.20(15) 
C(1)-C(2)-C(3) 120.1(2) 
C(1)-C(2)-H(2) 119.9 
C(3)-C(2)-H(2) 119.9 
C(4)-C(3)-C(2) 120.3(2) 
C(4)-C(3)-H(3) 119.8 
C(2)-C(3)-H(3) 119.8 
C(5)-C(4)-C(3) 120.0(2) 
C(5)-C(4)-H(4) 120.0 
C(3)-C(4)-H(4) 120.0 
C(4)-C(5)-C(6) 120.0(2) 
C(4)-C(5)-H(5) 120.0 
C(6)-C(5)-H(5) 120.0 
C(1)-C(6)-C(5) 120.8(2) 
C(1)-C(6)-H(6) 119.6 
C(5)-C(6)-H(6) 119.6 
C(12)-C(7)-C(8) 118.34(18) 
C(12)-C(7)-P(1) 120.43(15) 
C(8)-C(7)-P(1) 121.22(14) 
C(7)-C(8)-C(9) 120.6(2) 
C(7)-C(8)-H(8) 119.7 
C(9)-C(8)-H(8) 119.7 
C(10)-C(9)-C(8) 120.6(2) 
C(10)-C(9)-H(9) 119.7 
C(8)-C(9)-H(9) 119.7 
C(9)-C(10)-C(11) 119.6(2) 
C(9)-C(10)-H(10) 120.2 
C(11)-C(10)-H(10) 120.2 
C(10)-C(11)-C(12) 120.1(2) 
C(10)-C(11)-H(11) 119.9 
C(12)-C(11)-H(11) 119.9 
C(7)-C(12)-C(11) 120.7(2) 
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C(7)-C(12)-H(12) 119.6 
C(11)-C(12)-H(12) 119.6 
N(1)-C(13)-C(14) 113.10(15) 
N(1)-C(13)-C(20) 108.47(15) 
C(14)-C(13)-C(20) 113.26(15) 
N(1)-C(13)-H(13) 105.7(12) 
C(14)-C(13)-H(13) 110.4(12) 
C(20)-C(13)-H(13) 105.4(11) 
C(15)-C(14)-C(19) 118.22(19) 
C(15)-C(14)-C(13) 121.40(17) 
C(19)-C(14)-C(13) 120.37(19) 
C(14)-C(15)-C(16) 120.6(2) 
C(14)-C(15)-H(15) 119.7 
C(16)-C(15)-H(15) 119.7 
C(17)-C(16)-C(15) 120.2(3) 
C(17)-C(16)-H(16) 119.9 
C(15)-C(16)-H(16) 119.9 
C(18)-C(17)-C(16) 119.7(2) 
C(18)-C(17)-H(17) 120.2 
C(16)-C(17)-H(17) 120.2 
C(17)-C(18)-C(19) 119.8(2) 
C(17)-C(18)-H(18) 120.1 
C(19)-C(18)-H(18) 120.1 
C(18)-C(19)-C(14) 121.5(2) 
C(18)-C(19)-H(19) 119.3 
C(14)-C(19)-H(19) 119.3 
C(21)-C(20)-C(23) 110.45(16) 
C(21)-C(20)-C(13) 109.87(16) 
C(23)-C(20)-C(13) 110.28(15) 
C(21)-C(20)-H(20) 107.7(12) 
C(23)-C(20)-H(20) 109.2(12) 
C(13)-C(20)-H(20) 109.3(12) 
C(22)-C(21)-C(20) 126.4(3) 
C(22)-C(21)-H(21) 116.8 
C(20)-C(21)-H(21) 116.8 
C(21)-C(22)-H(22A) 115.1(19) 
C(21)-C(22)-H(22B) 118(2) 
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H(22A)-C(22)-H(22B) 126(3) 
C(24)-C(23)-C(20) 113.68(17) 
C(24)-C(23)-H(23) 108.8 
C(20)-C(23)-H(23) 108.8 
C(24)-C(23)-H(7B) 108.8 
C(20)-C(23)-H(7B) 108.8 
H(23)-C(23)-H(7B) 107.7 
C(25)-C(24)-C(23) 112.82(18) 
C(25)-C(24)-H(24A) 109.0 
C(23)-C(24)-H(24A) 109.0 
C(25)-C(24)-H(24B) 109.0 
C(23)-C(24)-H(24B) 109.0 
H(24A)-C(24)-H(24B) 107.8 
C(30)-C(25)-C(26) 117.51(19) 
C(30)-C(25)-C(24) 120.9(2) 
C(26)-C(25)-C(24) 121.6(2) 
C(25)-C(26)-C(27) 120.7(2) 
C(25)-C(26)-H(26) 119.6 
C(27)-C(26)-H(26) 119.6 
C(28)-C(27)-C(26) 121.2(2) 
C(28)-C(27)-H(27) 119.4 
C(26)-C(27)-H(27) 119.4 
C(29)-C(28)-C(27) 118.9(2) 
C(29)-C(28)-H(28) 120.5 
C(27)-C(28)-H(28) 120.5 
C(28)-C(29)-C(30) 120.4(2) 
C(28)-C(29)-H(29) 119.8 
C(30)-C(29)-H(29) 119.8 
C(25)-C(30)-C(29) 121.3(2) 
C(25)-C(30)-H(30) 119.3 
C(29)-C(30)-H(30) 119.3 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 
 
Table 4. Anisotropic displacement parameters (Å2 x 103) for C30H30NOP. The anisotropic 
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displacement factor exponent takes the form: -2p2[ h2 a*2U11 +  ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
P(1) 23(1)  25(1) 27(1)  -1(1) -1(1)  2(1) 
O(1) 26(1)  38(1) 40(1)  -2(1) 2(1)  3(1) 
N(1) 23(1)  26(1) 36(1)  -8(1) -4(1)  5(1) 
C(1) 33(1)  28(1) 27(1)  0(1) 1(1)  2(1) 
C(2) 53(1)  33(1) 56(1)  1(1) -21(1)  2(1) 
C(3) 66(2)  34(1) 63(2)  3(1) -21(1)  11(1) 
C(4) 73(2)  28(1) 53(1)  1(1) -9(1)  6(1) 
C(5) 99(2)  30(1) 114(2)  -7(1) -49(2)  -5(1) 
C(6) 64(2)  36(1) 90(2)  -1(1) -40(1)  1(1) 
C(7) 30(1)  26(1) 29(1)  -2(1) -3(1)  -1(1) 
C(8) 49(1)  80(2) 37(1)  11(1) 6(1)  27(1) 
C(9) 55(1)  70(2) 39(1)  4(1) 16(1)  16(1) 
C(10) 63(2)  54(1) 29(1)  8(1) 2(1)  -2(1) 
C(11) 76(2)  107(2) 43(1)  29(2) 6(1)  44(2) 
C(12) 54(2)  80(2) 41(1)  15(1) 9(1)  31(1) 
C(13) 27(1)  27(1) 32(1)  -8(1) -3(1)  6(1) 
C(14) 38(1)  28(1) 35(1)  -7(1) -10(1)  1(1) 
C(15) 54(1)  43(1) 52(1)  8(1) 2(1)  3(1) 
C(16) 73(2)  64(2) 54(1)  14(1) 6(1)  -12(2) 
C(17) 102(3)  47(1) 58(2)  19(1) -23(2)  -14(2) 
C(18) 85(2)  44(1) 72(2)  15(1) -16(2)  14(1) 
C(19) 57(1)  38(1) 53(1)  -1(1) -9(1)  17(1) 
C(20) 35(1)  32(1) 32(1)  -6(1) -7(1)  4(1) 
C(21) 68(2)  42(1) 36(1)  -5(1) -6(1)  0(1) 
C(22) 118(3)  52(2) 68(2)  13(1) -35(2)  2(2) 
C(23) 42(1)  36(1) 35(1)  -9(1) -7(1)  5(1) 
C(24) 56(1)  51(1) 47(1)  -17(1) -19(1)  10(1) 
C(25) 43(1)  39(1) 28(1)  -6(1) -10(1)  -2(1) 
C(26) 47(1)  57(1) 41(1)  -9(1) 1(1)  -16(1) 
C(27) 83(2)  39(1) 54(1)  -9(1) -4(1)  -22(1) 
C(28) 66(2)  51(1) 41(1)  -14(1) -9(1)  12(1) 
C(29) 44(1)  78(2) 39(1)  -10(1) 4(1)  -2(2) 
C(30) 53(2)  51(1) 44(1)  -3(1) 0(1)  -18(1) 
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______________________________________________________________________________  
 
 
Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2 x 10 3) for 
C30H30NOP 
______________________________________________________________________________ 
 x  y  z  U(eq) 
______________________________________________________________________________ 
H(1N) 6780(40) 1537(12) 1182(8) 34 
H(2) 6441 2856 950 57 
H(3) 5656 4222 884 65 
H(4) 8251 5135 1241 62 
H(5) 11628 4701 1670 97 
H(6) 12359 3344 1761 76 
H(8) 6629 2346 2161 67 
H(9) 6128 2109 2979 66 
H(10) 8949 1357 3393 58 
H(11) 12454 919 3010 90 
H(12) 12976 1148 2187 70 
H(13) 10360(40) 603(11) 871(7) 35 
H(15) 4874 406 1576 59 
H(16) 4185 -566 2157 77 
H(17) 6983 -1601 2259 83 
H(18) 10498 -1649 1788 80 
H(19) 11207 -669 1219 60 
H(20) 5410(40) 495(12) 561(7) 39 
H(21) 9371 1236 63 58 
H(22A) 4370(70) 1590(20) 86(12) 95 
H(22B) 6680(60) 2030(20) -255(12) 95 
H(23) 9606 -324 182 45 
H(7B) 7572 -749 501 45 
H(24A) 4629 -585 -104 62 
H(24B) 6488 -69 -416 62 
H(26) 4532 -2005 -222 58 
H(27) 5922 -3139 -611 70 
H(28) 9484 -3114 -1060 63 
H(29) 11689 -1941 -1118 64 
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H(30) 10287 -791 -741 59 
 
 
Table 6. Torsion angles [°] for C30H30NOP  
________________________________________________________________  
O(1)-P(1)-N(1)-C(13) 32.32(17) 
C(1)-P(1)-N(1)-C(13) 157.18(14) 
C(7)-P(1)-N(1)-C(13) -91.49(16) 
O(1)-P(1)-C(1)-C(2) 123.78(17) 
N(1)-P(1)-C(1)-C(2) 0.20(19) 
C(7)-P(1)-C(1)-C(2) -115.85(18) 
O(1)-P(1)-C(1)-C(6) -53.9(2) 
N(1)-P(1)-C(1)-C(6) -177.49(19) 
C(7)-P(1)-C(1)-C(6) 66.5(2) 
C(6)-C(1)-C(2)-C(3) -1.8(3) 
P(1)-C(1)-C(2)-C(3) -179.48(19) 
C(1)-C(2)-C(3)-C(4) 1.6(4) 
C(2)-C(3)-C(4)-C(5) -0.1(4) 
C(3)-C(4)-C(5)-C(6) -1.1(5) 
C(2)-C(1)-C(6)-C(5) 0.7(4) 
P(1)-C(1)-C(6)-C(5) 178.5(3) 
C(4)-C(5)-C(6)-C(1) 0.8(5) 
O(1)-P(1)-C(7)-C(12) -12.0(2) 
N(1)-P(1)-C(7)-C(12) 112.92(19) 
C(1)-P(1)-C(7)-C(12) -134.92(18) 
O(1)-P(1)-C(7)-C(8) 166.88(17) 
N(1)-P(1)-C(7)-C(8) -68.24(19) 
C(1)-P(1)-C(7)-C(8) 43.91(19) 
C(12)-C(7)-C(8)-C(9) -2.0(4) 
P(1)-C(7)-C(8)-C(9) 179.1(2) 
C(7)-C(8)-C(9)-C(10) -0.2(4) 
C(8)-C(9)-C(10)-C(11) 2.6(4) 
C(9)-C(10)-C(11)-C(12) -2.7(5) 
C(8)-C(7)-C(12)-C(11) 1.9(4) 
P(1)-C(7)-C(12)-C(11) -179.3(2) 
C(10)-C(11)-C(12)-C(7) 0.5(5) 
P(1)-N(1)-C(13)-C(14) 84.0(2) 
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P(1)-N(1)-C(13)-C(20) -149.53(14) 
N(1)-C(13)-C(14)-C(15) 44.7(2) 
C(20)-C(13)-C(14)-C(15) -79.2(2) 
N(1)-C(13)-C(14)-C(19) -135.40(18) 
C(20)-C(13)-C(14)-C(19) 100.7(2) 
C(19)-C(14)-C(15)-C(16) 0.8(3) 
C(13)-C(14)-C(15)-C(16) -179.3(2) 
C(14)-C(15)-C(16)-C(17) -0.9(4) 
C(15)-C(16)-C(17)-C(18) 0.5(4) 
C(16)-C(17)-C(18)-C(19) 0.0(4) 
C(17)-C(18)-C(19)-C(14) -0.1(4) 
C(15)-C(14)-C(19)-C(18) -0.3(3) 
C(13)-C(14)-C(19)-C(18) 179.8(2) 
N(1)-C(13)-C(20)-C(21) 51.5(2) 
C(14)-C(13)-C(20)-C(21) 177.98(17) 
N(1)-C(13)-C(20)-C(23) 173.53(17) 
C(14)-C(13)-C(20)-C(23) -60.0(2) 
C(23)-C(20)-C(21)-C(22) 115.4(3) 
C(13)-C(20)-C(21)-C(22) -122.7(3) 
C(21)-C(20)-C(23)-C(24) -61.9(3) 
C(13)-C(20)-C(23)-C(24) 176.50(19) 
C(20)-C(23)-C(24)-C(25) 173.42(19) 
C(23)-C(24)-C(25)-C(30) -75.9(3) 
C(23)-C(24)-C(25)-C(26) 103.5(2) 
C(30)-C(25)-C(26)-C(27) -0.6(3) 
C(24)-C(25)-C(26)-C(27) 179.9(2) 
C(25)-C(26)-C(27)-C(28) 0.6(4) 
C(26)-C(27)-C(28)-C(29) 0.1(4) 
C(27)-C(28)-C(29)-C(30) -0.7(3) 
C(26)-C(25)-C(30)-C(29) 0.0(3) 
C(24)-C(25)-C(30)-C(29) 179.5(2) 
C(28)-C(29)-C(30)-C(25) 0.7(3) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 
Table 7. Hydrogen bonds for C30H30NOP  [Å and °] 
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____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
 N(1)-H(1N)...O(1)#1 0.78(2) 2.21(2) 2.987(2) 174(2) 
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 x-1,y,z  
 
X-ray Crystal Structure of 1.34  
 
Table 1. Crystal data and structure refinement for C30H30NOP 
Identification code  C30H30NOP 
Empirical formula  C30H30NOP 
Formula weight  451.52 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1) 
Unit cell dimensions a = 10.7855(5) Å α= 90° 
 b = 10.0513(5) Å β= 93.331(3)° 
 c = 11.6042(6) Å γ = 90° 
Volume 1255.87(11) Å3 
Z 2 
Density (calculated) 1.194 Mg/m3 
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Absorption coefficient 0.132 mm-1 
F(000) 480 
Crystal size 0.25 x 0.08 x 0.05 mm3 
Theta range for data collection 1.76 to 28.33° 
Index ranges -14<=h<=14, -12<=k<=13, -15<=l<=15 
Reflections collected 20929 
Independent reflections 6086 [R(int) = 0.0557] 
Completeness to theta = 28.33° 99.5 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9935 and 0.9679 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6086 / 6 / 313 
Goodness-of-fit on F2 1.028 
Final R indices [I>2sigma(I)] R1 = 0.0402, wR2 = 0.0759 
R indices (all data) R1 = 0.0599, wR2 = 0.0827 
Absolute structure parameter -0.09(7) 
Extinction coefficient na 
Largest diff. peak and hole 0.289 and -0.247 e.Å-3 
 
 
 
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2 x 103) for 
C30H30NOP (11). U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
P(1) -133(1) 612(1) 4531(1) 16(1) 
O(1) 102(1) 2053(1) 4761(1) 22(1) 
N(1) -146(1) -242(2) 5733(1) 16(1) 
C(1) 1070(2) -166(2) 3747(2) 18(1) 
C(2) 2273(2) -174(2) 4250(2) 25(1) 
C(3) 3254(2) -654(2) 3642(2) 28(1) 
C(4) 3037(2) -1123(2) 2532(2) 26(1) 
C(5) 1845(2) -1124(2) 2025(2) 27(1) 
C(6) 869(2) -636(2) 2627(2) 24(1) 
C(7) -1556(2) 397(2) 3651(2) 18(1) 
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C(8) -2129(2) 1510(2) 3138(2) 23(1) 
C(9) -3203(2) 1356(2) 2431(2) 27(1) 
C(10) -3700(2) 100(2) 2233(2) 26(1) 
C(11) -3145(2) -1009(2) 2750(2) 26(1) 
C(12) -2074(2) -865(2) 3464(2) 22(1) 
C(13) -906(2) 226(2) 6671(2) 17(1) 
C(14) -2240(2) -265(2) 6510(2) 18(1) 
C(15) -3162(2) 610(2) 6114(2) 23(1) 
C(16) -4386(2) 180(2) 5924(2) 29(1) 
C(17) -4689(2) -1129(2) 6137(2) 30(1) 
C(18) -3771(2) -2013(2) 6529(2) 27(1) 
C(19) -2556(2) -1583(2) 6709(2) 23(1) 
C(20) -265(2) -147(2) 7849(2) 19(1) 
C(21) -1071(2) 234(2) 8814(2) 30(1) 
C(22) -1255(2) -473(3) 9747(2) 46(1) 
C(23) 1008(2) 542(2) 8016(2) 21(1) 
C(24) 1794(2) -29(2) 9043(2) 28(1) 
C(25) 3003(2) 696(2) 9289(2) 22(1) 
C(26) 4026(2) 438(2) 8655(2) 26(1) 
C(27) 5127(2) 1131(2) 8865(2) 31(1) 
C(28) 5209(2) 2115(2) 9700(2) 32(1) 
C(29) 4202(2) 2380(2) 10329(2) 33(1) 
C(30) 3110(2) 1666(2) 10136(2) 28(1) 
 
 
Table 3. Bond lengths [Å] and angles [°] for C30H30NOP 
_____________________________________________________  
P(1)-O(1)  1.4922(13) 
P(1)-N(1)  1.6385(16) 
P(1)-C(1)  1.8060(19) 
P(1)-C(7)  1.8061(17) 
N(1)-C(13)  1.477(2) 
N(1)-H(1N)  0.854(15) 
C(1)-C(6)  1.388(3) 
C(1)-C(2)  1.391(3) 
C(2)-C(3)  1.391(3) 
C(2)-H(2)  0.9500 
 
Page 336
	  	  
C(3)-C(4)  1.378(3) 
C(3)-H(3)  0.9500 
C(4)-C(5)  1.383(3) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.386(3) 
C(5)-H(5)  0.9500 
C(6)-H(6)  0.9500 
C(7)-C(8)  1.395(3) 
C(7)-C(12)  1.398(3) 
C(8)-C(9)  1.389(3) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.385(3) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.386(3) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.389(3) 
C(11)-H(11)  0.9500 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.522(2) 
C(13)-C(20)  1.541(3) 
C(13)-H(13)  0.976(15) 
C(14)-C(15)  1.387(3) 
C(14)-C(19)  1.390(3) 
C(15)-C(16)  1.394(3) 
C(15)-H(15)  0.9500 
C(16)-C(17)  1.382(3) 
C(16)-H(16)  0.9500 
C(17)-C(18)  1.387(3) 
C(17)-H(17)  0.9500 
C(18)-C(19)  1.385(3) 
C(18)-H(18)  0.9500 
C(19)-H(19)  0.9500 
C(20)-C(21)  1.507(3) 
C(20)-C(23)  1.541(2) 
C(20)-H(20)  1.029(15) 
C(21)-C(22)  1.318(3) 
C(21)-H(21)  0.9500 
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C(22)-H(22A)  1.036(17) 
C(22)-H(22B)  0.995(16) 
C(23)-C(24)  1.534(3) 
C(23)-H(23A)  0.9900 
C(23)-H(23B)  0.9900 
C(24)-C(25)  1.506(3) 
C(24)-H(24A)  0.9900 
C(24)-H(24B)  0.9900 
C(25)-C(30)  1.385(3) 
C(25)-C(26)  1.386(3) 
C(26)-C(27)  1.385(3) 
C(26)-H(26)  0.9500 
C(27)-C(28)  1.385(3) 
C(27)-H(27)  0.9500 
C(28)-C(29)  1.370(3) 
C(28)-H(28)  0.9500 
C(29)-C(30)  1.386(3) 
C(29)-H(29)  0.9500 
C(30)-H(30)  0.9500 
O(1)-P(1)-N(1) 111.48(8) 
O(1)-P(1)-C(1) 113.01(8) 
N(1)-P(1)-C(1) 104.15(8) 
O(1)-P(1)-C(7) 110.32(8) 
N(1)-P(1)-C(7) 111.69(8) 
C(1)-P(1)-C(7) 105.95(8) 
C(13)-N(1)-P(1) 119.56(12) 
C(13)-N(1)-H(1N) 113.2(13) 
P(1)-N(1)-H(1N) 115.6(14) 
C(6)-C(1)-C(2) 118.85(17) 
C(6)-C(1)-P(1) 122.79(14) 
C(2)-C(1)-P(1) 118.06(14) 
C(3)-C(2)-C(1) 120.43(18) 
C(3)-C(2)-H(2) 119.8 
C(1)-C(2)-H(2) 119.8 
C(4)-C(3)-C(2) 120.01(18) 
C(4)-C(3)-H(3) 120.0 
C(2)-C(3)-H(3) 120.0 
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C(3)-C(4)-C(5) 120.02(18) 
C(3)-C(4)-H(4) 120.0 
C(5)-C(4)-H(4) 120.0 
C(4)-C(5)-C(6) 120.01(19) 
C(4)-C(5)-H(5) 120.0 
C(6)-C(5)-H(5) 120.0 
C(5)-C(6)-C(1) 120.67(18) 
C(5)-C(6)-H(6) 119.7 
C(1)-C(6)-H(6) 119.7 
C(8)-C(7)-C(12) 119.88(17) 
C(8)-C(7)-P(1) 119.11(14) 
C(12)-C(7)-P(1) 121.01(14) 
C(9)-C(8)-C(7) 119.77(19) 
C(9)-C(8)-H(8) 120.1 
C(7)-C(8)-H(8) 120.1 
C(10)-C(9)-C(8) 120.09(19) 
C(10)-C(9)-H(9) 120.0 
C(8)-C(9)-H(9) 120.0 
C(9)-C(10)-C(11) 120.54(18) 
C(9)-C(10)-H(10) 119.7 
C(11)-C(10)-H(10) 119.7 
C(10)-C(11)-C(12) 119.84(19) 
C(10)-C(11)-H(11) 120.1 
C(12)-C(11)-H(11) 120.1 
C(11)-C(12)-C(7) 119.87(18) 
C(11)-C(12)-H(12) 120.1 
C(7)-C(12)-H(12) 120.1 
N(1)-C(13)-C(14) 111.56(15) 
N(1)-C(13)-C(20) 109.66(14) 
C(14)-C(13)-C(20) 113.69(15) 
N(1)-C(13)-H(13) 105.6(12) 
C(14)-C(13)-H(13) 109.4(11) 
C(20)-C(13)-H(13) 106.5(12) 
C(15)-C(14)-C(19) 118.80(17) 
C(15)-C(14)-C(13) 119.30(17) 
C(19)-C(14)-C(13) 121.86(17) 
C(14)-C(15)-C(16) 120.7(2) 
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C(14)-C(15)-H(15) 119.7 
C(16)-C(15)-H(15) 119.7 
C(17)-C(16)-C(15) 119.9(2) 
C(17)-C(16)-H(16) 120.0 
C(15)-C(16)-H(16) 120.0 
C(16)-C(17)-C(18) 119.80(19) 
C(16)-C(17)-H(17) 120.1 
C(18)-C(17)-H(17) 120.1 
C(19)-C(18)-C(17) 120.0(2) 
C(19)-C(18)-H(18) 120.0 
C(17)-C(18)-H(18) 120.0 
C(18)-C(19)-C(14) 120.79(18) 
C(18)-C(19)-H(19) 119.6 
C(14)-C(19)-H(19) 119.6 
C(21)-C(20)-C(23) 109.95(15) 
C(21)-C(20)-C(13) 110.43(15) 
C(23)-C(20)-C(13) 110.68(15) 
C(21)-C(20)-H(20) 106.6(11) 
C(23)-C(20)-H(20) 108.1(11) 
C(13)-C(20)-H(20) 111.0(12) 
C(22)-C(21)-C(20) 126.5(2) 
C(22)-C(21)-H(21) 116.8 
C(20)-C(21)-H(21) 116.8 
C(21)-C(22)-H(22A) 117.9(15) 
C(21)-C(22)-H(22B) 121.8(16) 
H(22A)-C(22)-H(22B) 120(2) 
C(24)-C(23)-C(20) 112.22(16) 
C(24)-C(23)-H(23A) 109.2 
C(20)-C(23)-H(23A) 109.2 
C(24)-C(23)-H(23B) 109.2 
C(20)-C(23)-H(23B) 109.2 
H(23A)-C(23)-H(23B) 107.9 
C(25)-C(24)-C(23) 113.51(17) 
C(25)-C(24)-H(24A) 108.9 
C(23)-C(24)-H(24A) 108.9 
C(25)-C(24)-H(24B) 108.9 
C(23)-C(24)-H(24B) 108.9 
 
Page 340
	  	  
H(24A)-C(24)-H(24B) 107.7 
C(30)-C(25)-C(26) 118.15(18) 
C(30)-C(25)-C(24) 120.71(18) 
C(26)-C(25)-C(24) 121.11(19) 
C(27)-C(26)-C(25) 120.9(2) 
C(27)-C(26)-H(26) 119.5 
C(25)-C(26)-H(26) 119.5 
C(28)-C(27)-C(26) 120.1(2) 
C(28)-C(27)-H(27) 119.9 
C(26)-C(27)-H(27) 119.9 
C(29)-C(28)-C(27) 119.4(2) 
C(29)-C(28)-H(28) 120.3 
C(27)-C(28)-H(28) 120.3 
C(28)-C(29)-C(30) 120.4(2) 
C(28)-C(29)-H(29) 119.8 
C(30)-C(29)-H(29) 119.8 
C(25)-C(30)-C(29) 120.96(19) 
C(25)-C(30)-H(30) 119.5 
C(29)-C(30)-H(30) 119.5 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 
Table 4. Anisotropic displacement parameters (Å2 x 103) for C30H30NOP. The anisotropic 
displacement factor exponent takes the form: -2p2[ h2 a*2U11 +  ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
P(1) 17(1)  11(1) 19(1)  0(1) 0(1)  -1(1) 
O(1) 26(1)  12(1) 28(1)  -1(1) 1(1)  -2(1) 
N(1) 19(1)  8(1) 21(1)  -1(1) 2(1)  1(1) 
C(1) 20(1)  13(1) 21(1)  3(1) 3(1)  -1(1) 
C(2) 24(1)  26(1) 26(1)  -5(1) 0(1)  -1(1) 
C(3) 20(1)  29(1) 35(1)  -5(1) 2(1)  0(1) 
C(4) 27(1)  20(1) 31(1)  3(1) 12(1)  2(1) 
C(5) 34(1)  28(1) 19(1)  0(1) 6(1)  2(1) 
C(6) 26(1)  26(1) 21(1)  3(1) -1(1)  0(1) 
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C(7) 16(1)  18(1) 19(1)  1(1) 2(1)  1(1) 
C(8) 23(1)  19(1) 26(1)  2(1) 0(1)  1(1) 
C(9) 24(1)  28(1) 28(1)  5(1) -2(1)  6(1) 
C(10) 17(1)  39(1) 23(1)  -1(1) -2(1)  -1(1) 
C(11) 23(1)  28(1) 29(1)  -2(1) -2(1)  -8(1) 
C(12) 21(1)  19(1) 26(1)  2(1) -1(1)  -1(1) 
C(13) 18(1)  12(1) 22(1)  -2(1) 2(1)  2(1) 
C(14) 20(1)  20(1) 16(1)  -4(1) 3(1)  1(1) 
C(15) 22(1)  23(1) 24(1)  -3(1) 0(1)  2(1) 
C(16) 20(1)  37(1) 29(1)  -2(1) -2(1)  7(1) 
C(17) 18(1)  40(1) 30(1)  -9(1) 3(1)  -4(1) 
C(18) 28(1)  25(1) 29(1)  -2(1) 5(1)  -7(1) 
C(19) 21(1)  20(1) 28(1)  0(1) 2(1)  2(1) 
C(20) 21(1)  18(1) 18(1)  -1(1) 1(1)  -1(1) 
C(21) 25(1)  40(1) 27(1)  -6(1) 2(1)  -1(1) 
C(22) 37(1)  74(2) 29(1)  -4(1) 6(1)  -15(1) 
C(23) 22(1)  22(1) 21(1)  0(1) 1(1)  -4(1) 
C(24) 24(1)  29(1) 29(1)  6(1) -3(1)  -2(1) 
C(25) 22(1)  23(1) 21(1)  7(1) -3(1)  0(1) 
C(26) 27(1)  25(1) 26(1)  2(1) 1(1)  4(1) 
C(27) 24(1)  41(1) 28(1)  7(1) 3(1)  3(1) 
C(28) 29(1)  42(1) 25(1)  9(1) -8(1)  -12(1) 
C(29) 40(1)  34(1) 25(1)  -3(1) -6(1)  -5(1) 
C(30) 25(1)  35(1) 24(1)  1(1) 2(1)  4(1) 
______________________________________________________________________________  
 
 
 
 
 
 
 
 
Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2 x 10 3) for 
C30H30NOP  
______________________________________________________________________________ 
 x  y  z  U(eq) 
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______________________________________________________________________________ 
  
H(1N) -151(17) -1087(16) 5655(18) 19 
H(2) 2426 151 5014 30 
H(3) 4072 -658 3992 34 
H(4) 3708 -1446 2116 31 
H(5) 1695 -1459 1264 32 
H(6) 54 -624 2269 29 
H(8) -1786 2371 3273 27 
H(9) -3597 2112 2083 32 
H(10) -4427 -1 1738 32 
H(11) -3495 -1866 2616 32 
H(12) -1696 -1623 3826 26 
H(13) -895(17) 1196(15) 6627(17) 21 
H(15) -2958 1512 5970 27 
H(16) -5011 787 5649 34 
H(17) -5524 -1423 6015 35 
H(18) -3977 -2915 6673 33 
H(19) -1930 -2195 6971 28 
H(20) -127(17) -1158(16) 7911(18) 23 
H(21) -1489 1065 8744 37 
H(22A) -790(20) -1370(20) 9850(20) 56 
H(22B) -1780(20) -140(30) 10363(18) 56 
H(23A) 1464 435 7305 26 
H(23B) 881 1506 8140 26 
H(24A) 1306 8 9739 33 
H(24B) 1974 -976 8888 33 
H(26) 3973 -222 8069 31 
H(27) 5826 930 8435 37 
H(28) 5958 2602 9837 39 
H(29) 4252 3058 10901 40 
H(30) 2426 1844 10593 33 
 
 
Table 6. Torsion angles [°] for C30H30NOP  
________________________________________________________________  
O(1)-P(1)-N(1)-C(13) 49.52(15) 
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C(1)-P(1)-N(1)-C(13) 171.68(13) 
C(7)-P(1)-N(1)-C(13) -74.41(15) 
O(1)-P(1)-C(1)-C(6) -112.97(16) 
N(1)-P(1)-C(1)-C(6) 125.88(16) 
C(7)-P(1)-C(1)-C(6) 7.95(18) 
O(1)-P(1)-C(1)-C(2) 60.64(17) 
N(1)-P(1)-C(1)-C(2) -60.51(17) 
C(7)-P(1)-C(1)-C(2) -178.45(15) 
C(6)-C(1)-C(2)-C(3) -0.5(3) 
P(1)-C(1)-C(2)-C(3) -174.31(16) 
C(1)-C(2)-C(3)-C(4) 0.2(3) 
C(2)-C(3)-C(4)-C(5) -0.4(3) 
C(3)-C(4)-C(5)-C(6) 0.9(3) 
C(4)-C(5)-C(6)-C(1) -1.2(3) 
C(2)-C(1)-C(6)-C(5) 1.0(3) 
P(1)-C(1)-C(6)-C(5) 174.51(16) 
O(1)-P(1)-C(7)-C(8) 10.78(17) 
N(1)-P(1)-C(7)-C(8) 135.36(14) 
C(1)-P(1)-C(7)-C(8) -111.86(15) 
O(1)-P(1)-C(7)-C(12) -170.18(14) 
N(1)-P(1)-C(7)-C(12) -45.60(17) 
C(1)-P(1)-C(7)-C(12) 67.18(16) 
C(12)-C(7)-C(8)-C(9) -1.0(3) 
P(1)-C(7)-C(8)-C(9) 178.07(14) 
C(7)-C(8)-C(9)-C(10) -0.2(3) 
C(8)-C(9)-C(10)-C(11) 1.0(3) 
C(9)-C(10)-C(11)-C(12) -0.6(3) 
C(10)-C(11)-C(12)-C(7) -0.6(3) 
C(8)-C(7)-C(12)-C(11) 1.4(3) 
P(1)-C(7)-C(12)-C(11) -177.65(15) 
P(1)-N(1)-C(13)-C(14) 85.70(17) 
P(1)-N(1)-C(13)-C(20) -147.44(13) 
N(1)-C(13)-C(14)-C(15) -103.98(19) 
C(20)-C(13)-C(14)-C(15) 131.38(17) 
N(1)-C(13)-C(14)-C(19) 73.6(2) 
C(20)-C(13)-C(14)-C(19) -51.1(2) 
C(19)-C(14)-C(15)-C(16) 0.4(3) 
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C(13)-C(14)-C(15)-C(16) 178.03(17) 
C(14)-C(15)-C(16)-C(17) 0.3(3) 
C(15)-C(16)-C(17)-C(18) -0.6(3) 
C(16)-C(17)-C(18)-C(19) 0.2(3) 
C(17)-C(18)-C(19)-C(14) 0.5(3) 
C(15)-C(14)-C(19)-C(18) -0.8(3) 
C(13)-C(14)-C(19)-C(18) -178.38(18) 
N(1)-C(13)-C(20)-C(21) -175.90(16) 
C(14)-C(13)-C(20)-C(21) -50.2(2) 
N(1)-C(13)-C(20)-C(23) 62.1(2) 
C(14)-C(13)-C(20)-C(23) -172.23(16) 
C(23)-C(20)-C(21)-C(22) -98.5(2) 
C(13)-C(20)-C(21)-C(22) 139.1(2) 
C(21)-C(20)-C(23)-C(24) 70.2(2) 
C(13)-C(20)-C(23)-C(24) -167.56(16) 
C(20)-C(23)-C(24)-C(25) -175.36(17) 
C(23)-C(24)-C(25)-C(30) 97.6(2) 
C(23)-C(24)-C(25)-C(26) -80.7(2) 
C(30)-C(25)-C(26)-C(27) 0.1(3) 
C(24)-C(25)-C(26)-C(27) 178.41(19) 
C(25)-C(26)-C(27)-C(28) -1.4(3) 
C(26)-C(27)-C(28)-C(29) 1.1(3) 
C(27)-C(28)-C(29)-C(30) 0.3(3) 
C(26)-C(25)-C(30)-C(29) 1.4(3) 
C(24)-C(25)-C(30)-C(29) -176.93(19) 
C(28)-C(29)-C(30)-C(25) -1.6(3) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
Table 7. Hydrogen bonds for C30H30NOP [Å and °] 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
 N(1)-H(1N)...O(1)#1 0.854(15) 1.932(16) 2.779(2) 171(2) 
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x,y-1/2,-z+1  
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X-ray Crystal Structure of 1.32  
 
Table 1. Crystal data and structure refinement for C29H34NOP  
Identification code  C29H34NOP 
Empirical formula  C29H34NOP 
Formula weight  443.54 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1) 
Unit cell dimensions a = 22.5726(15) Å α= 90° 
 b = 20.6585(13) Å β= 119.094(4)° 
 c = 23.0355(15) Å γ = 90° 
Volume 9386.5(11) Å3 
Z 12 
Density (calculated) 0.942 Mg/m3 
Absorption coefficient 0.104 mm-1 
F(000) 2856 
Crystal size 0.15 x 0.06 x 0.05 mm3 
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Theta range for data collection 1.41 to 28.81° 
Index ranges -30<=h<=26, -27<=k<=27, 0<=l<=31 
Reflections collected 48686 
Independent reflections 48686 [R(int) = 0.0000] 
Completeness to theta = 28.81° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9948 and 0.9845 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 48686 / 1 / 1729 
Goodness-of-fit on F2 0.998 
Final R indices [I>2sigma(I)] R1 = 0.0492, wR2 = 0.1165 
R indices (all data) R1 = 0.0702, wR2 = 0.1245 
Absolute structure parameter -0.04(3) 
Extinction coefficient na 
Largest diff. peak and hole 0.458 and -0.341 e.Å-3 
 
 
 
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2 x 103) for 
C29H34NOP. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
P(1) 20(1) 2748(1) 29(1) 18(1) 
O(1) -106(1) 3419(1) 180(1) 22(1) 
N(1) 24(1) 2228(1) 570(1) 20(1) 
C(1) 809(1) 2687(1) 20(1) 21(1) 
C(2) 1116(1) 3246(1) -40(1) 27(1) 
C(3) 1714(1) 3207(1) -69(1) 34(1) 
C(4) 2002(1) 2616(1) -46(1) 34(1) 
C(5) 1701(1) 2052(1) 14(1) 32(1) 
C(6) 1104(1) 2086(1) 47(1) 26(1) 
C(7) -622(1) 2507(1) -790(1) 20(1) 
C(8) -493(1) 2454(1) -1323(1) 26(1) 
C(9) -1020(1) 2356(1) -1965(1) 30(1) 
C(10) -1675(1) 2312(1) -2080(1) 31(1) 
C(11) -1813(1) 2358(1) -1554(1) 29(1) 
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C(12) -1293(1) 2457(1) -918(1) 24(1) 
C(13) -22(1) 2444(1) 1156(1) 21(1) 
C(14) -751(1) 2391(1) 1025(1) 22(1) 
C(15) -1164(1) 1865(1) 695(1) 29(1) 
C(16) -1833(1) 1850(1) 558(1) 35(1) 
C(17) -2102(1) 2353(1) 749(1) 35(1) 
C(18) -1697(1) 2878(1) 1078(1) 33(1) 
C(19) -1027(1) 2898(1) 1213(1) 26(1) 
C(20) 514(1) 2112(1) 1819(1) 23(1) 
C(21) 337(1) 1400(1) 1832(1) 28(1) 
C(22) 507(1) 2493(1) 2378(1) 28(1) 
C(23) 402(1) 2263(1) 2857(1) 42(1) 
C(24) 1232(1) 2165(1) 1867(1) 29(1) 
C(25) 1800(1) 1867(1) 2513(1) 43(1) 
C(26) 2485(1) 1890(1) 2533(2) 54(1) 
C(27) 2683(1) 2570(1) 2452(1) 49(1) 
C(28) 2129(1) 2874(1) 1813(1) 40(1) 
C(29) 1442(1) 2860(1) 1801(1) 30(1) 
P(2) 10484(1) 10148(1) 10524(1) 20(1) 
O(2) 10410(1) 10866(1) 10490(1) 27(1) 
N(2) 10115(1) 9825(1) 9779(1) 22(1) 
C(30) 11363(1) 9912(1) 10986(1) 26(1) 
C(31) 11572(1) 9279(1) 11010(1) 30(1) 
C(32) 12242(1) 9111(1) 11377(1) 43(1) 
C(33) 12717(1) 9580(2) 11735(2) 64(1) 
C(34) 12524(1) 10212(2) 11709(2) 73(1) 
C(35) 11848(1) 10390(1) 11340(2) 49(1) 
C(36) 10058(1) 9765(1) 10924(1) 20(1) 
C(37) 10326(1) 9285(1) 11403(1) 29(1) 
C(38) 9943(1) 9022(1) 11667(1) 35(1) 
C(39) 9293(1) 9239(1) 11455(1) 33(1) 
C(40) 9022(1) 9722(1) 10986(1) 27(1) 
C(41) 9402(1) 9985(1) 10720(1) 25(1) 
C(42) 10108(1) 10178(1) 9223(1) 21(1) 
C(43) 10784(1) 10117(1) 9224(1) 24(1) 
C(44) 11049(1) 10648(1) 9058(1) 32(1) 
C(45) 11674(1) 10618(1) 9087(1) 41(1) 
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C(46) 12052(1) 10059(1) 9295(1) 43(1) 
C(47) 11796(1) 9523(1) 9461(1) 36(1) 
C(48) 11163(1) 9552(1) 9421(1) 27(1) 
C(49) 9471(1) 9993(1) 8551(1) 21(1) 
C(50) 9561(1) 9310(1) 8351(1) 24(1) 
C(51) 9402(1) 10486(1) 8040(1) 27(1) 
C(52) 9368(1) 10367(1) 7458(1) 38(1) 
C(53) 8820(1) 10020(1) 8632(1) 25(1) 
C(54) 8171(1) 9881(1) 7977(1) 34(1) 
C(55) 7543(1) 9874(1) 8067(1) 42(1) 
C(56) 7465(1) 10507(1) 8360(1) 42(1) 
C(57) 8108(1) 10650(1) 9014(1) 35(1) 
C(58) 8733(1) 10662(1) 8922(1) 27(1) 
P(3) 4815(1) 1138(1) 9976(1) 18(1) 
O(3) 4684(1) 486(1) 9662(1) 23(1) 
N(3) 4800(1) 1703(1) 9466(1) 19(1) 
C(59) 5631(1) 1203(1) 10714(1) 20(1) 
C(60) 6209(1) 1363(1) 10680(1) 27(1) 
C(61) 6840(1) 1353(1) 11252(1) 33(1) 
C(62) 6895(1) 1182(1) 11853(1) 31(1) 
C(63) 6325(1) 1019(1) 11889(1) 36(1) 
C(64) 5696(1) 1025(1) 11327(1) 29(1) 
C(65) 4229(1) 1314(1) 10278(1) 21(1) 
C(66) 3818(1) 827(1) 10301(1) 26(1) 
C(67) 3402(1) 943(1) 10577(1) 30(1) 
C(68) 3399(1) 1544(1) 10839(1) 31(1) 
C(69) 3807(1) 2037(1) 10811(1) 30(1) 
C(70) 4219(1) 1924(1) 10536(1) 27(1) 
C(71) 4388(1) 1600(1) 8743(1) 23(1) 
C(72) 3627(1) 1583(1) 8509(1) 25(1) 
C(73) 3332(1) 2005(1) 8769(1) 28(1) 
C(74) 2641(1) 1998(1) 8536(1) 34(1) 
C(75) 2224(1) 1565(1) 8042(1) 35(1) 
C(76) 2518(1) 1136(1) 7802(1) 37(1) 
C(77) 3218(1) 1142(1) 8044(1) 32(1) 
C(78) 4570(1) 2095(1) 8338(1) 25(1) 
C(79) 4282(1) 2759(1) 8329(1) 24(1) 
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C(80) 4282(1) 1821(1) 7644(1) 32(1) 
C(81) 3886(1) 2103(1) 7080(1) 47(1) 
C(82) 5367(1) 2144(1) 8656(1) 26(1) 
C(83) 5595(1) 2600(1) 8277(1) 34(1) 
C(84) 6361(1) 2670(1) 8629(1) 41(1) 
C(85) 6716(1) 2021(1) 8740(1) 42(1) 
C(86) 6491(1) 1568(1) 9114(1) 38(1) 
C(87) 5720(1) 1494(1) 8748(1) 33(1) 
P(4) 4568(1) 8661(1) 9798(1) 20(1) 
O(4) 4827(1) 7984(1) 9934(1) 24(1) 
N(4) 5108(1) 9158(1) 9741(1) 21(1) 
C(88) 4446(1) 9027(1) 10443(1) 23(1) 
C(89) 4998(1) 9302(1) 10996(1) 28(1) 
C(90) 4917(1) 9544(1) 11516(1) 34(1) 
C(91) 4294(1) 9514(1) 11486(1) 37(1) 
C(92) 3741(1) 9247(1) 10936(1) 35(1) 
C(93) 3819(1) 9007(1) 10422(1) 28(1) 
C(94) 3755(1) 8693(1) 9056(1) 21(1) 
C(95) 3413(1) 9279(1) 8830(1) 28(1) 
C(96) 2798(1) 9301(1) 8256(1) 34(1) 
C(97) 2519(1) 8744(1) 7893(1) 39(1) 
C(98) 2858(1) 8158(1) 8112(1) 41(1) 
C(99) 3472(1) 8131(1) 8687(1) 29(1) 
C(100) 5451(1) 8937(1) 9372(1) 21(1) 
C(101) 4997(1) 8986(1) 8622(1) 27(1) 
C(102) 4581(1) 9519(1) 8330(1) 30(1) 
C(103) 4187(1) 9564(1) 7644(1) 44(1) 
C(104) 4191(1) 9069(2) 7244(1) 55(1) 
C(105) 4593(1) 8535(2) 7526(1) 55(1) 
C(106) 4989(1) 8486(1) 8214(1) 40(1) 
C(107) 6147(1) 9296(1) 9618(1) 21(1) 
C(108) 6027(1) 9982(1) 9352(1) 27(1) 
C(109) 6539(1) 8902(1) 9364(1) 24(1) 
C(110) 6687(1) 9044(1) 8897(1) 41(1) 
C(111) 6541(1) 9322(1) 10396(1) 20(1) 
C(112) 7243(1) 9636(1) 10657(1) 24(1) 
C(113) 7614(1) 9695(1) 11416(1) 28(1) 
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C(114) 7689(1) 9037(1) 11741(1) 29(1) 
C(115) 6995(1) 8733(1) 11495(1) 28(1) 
C(116) 6618(1) 8668(1) 10735(1) 24(1) 
P(5) 9858(1) 1825(1) 4923(1) 19(1) 
O(5) 9798(1) 1153(1) 5125(1) 23(1) 
N(5) 9598(1) 2369(1) 5267(1) 20(1) 
C(117) 9393(1) 1912(1) 4033(1) 22(1) 
C(118) 9191(1) 1356(1) 3637(1) 30(1) 
C(119) 8839(1) 1414(1) 2952(1) 34(1) 
C(120) 8685(1) 2014(1) 2656(1) 35(1) 
C(121) 8884(1) 2565(1) 3046(1) 33(1) 
C(122) 9234(1) 2517(1) 3732(1) 25(1) 
C(123) 10723(1) 2028(1) 5154(1) 24(1) 
C(124) 10965(1) 1995(1) 4703(1) 38(1) 
C(125) 11641(1) 2093(2) 4909(2) 52(1) 
C(126) 12088(1) 2225(1) 5570(2) 49(1) 
C(127) 11858(1) 2251(1) 6025(1) 45(1) 
C(128) 11182(1) 2160(1) 5823(1) 35(1) 
C(129) 9313(1) 2191(1) 5696(1) 22(1) 
C(130) 9818(1) 2313(1) 6423(1) 22(1) 
C(131) 10225(1) 2861(1) 6633(1) 27(1) 
C(132) 10673(1) 2958(1) 7305(1) 32(1) 
C(133) 10720(1) 2515(1) 7771(1) 33(1) 
C(134) 10330(1) 1962(1) 7567(1) 38(1) 
C(135) 9883(1) 1862(1) 6896(1) 31(1) 
C(136) 8602(1) 2510(1) 5474(1) 24(1) 
C(137) 8687(1) 3235(1) 5649(1) 32(1) 
C(138) 8288(1) 2147(1) 5828(1) 34(1) 
C(139) 8046(1) 2394(2) 6199(1) 55(1) 
C(140) 8138(1) 2433(1) 4701(1) 27(1) 
C(141) 7435(1) 2738(1) 4444(1) 42(1) 
C(142) 7014(1) 2696(1) 3693(1) 53(1) 
C(143) 6932(1) 1999(1) 3445(1) 46(1) 
C(144) 7630(1) 1692(1) 3701(1) 36(1) 
C(145) 8044(1) 1731(1) 4458(1) 27(1) 
P(6) 10247(1) 9399(1) 4945(1) 22(1) 
O(6) 10179(1) 8682(1) 4925(1) 29(1) 
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N(6) 9641(1) 9746(1) 5041(1) 22(1) 
C(146) 10146(1) 9732(1) 4177(1) 23(1) 
C(147) 9535(1) 9616(1) 3602(1) 28(1) 
C(148) 9441(1) 9818(1) 2992(1) 31(1) 
C(149) 9949(1) 10144(1) 2943(1) 36(1) 
C(150) 10554(1) 10274(1) 3507(1) 42(1) 
C(151) 10656(1) 10060(1) 4123(1) 36(1) 
C(152) 11079(1) 9646(1) 5571(1) 25(1) 
C(153) 11582(1) 9185(1) 5907(1) 36(1) 
C(154) 12230(1) 9383(1) 6365(1) 52(1) 
C(155) 12377(1) 10026(2) 6487(2) 57(1) 
C(156) 11882(1) 10489(1) 6163(1) 44(1) 
C(157) 11230(1) 10301(1) 5709(1) 31(1) 
C(158) 9414(1) 9418(1) 5466(1) 24(1) 
C(159) 9920(1) 9494(1) 6208(1) 26(1) 
C(160) 10271(1) 10067(1) 6469(1) 28(1) 
C(161) 10730(1) 10111(1) 7145(1) 37(1) 
C(162) 10846(1) 9586(2) 7556(1) 45(1) 
C(163) 10504(1) 9018(1) 7298(1) 42(1) 
C(164) 10048(1) 8969(1) 6629(1) 35(1) 
C(165) 8677(1) 9610(1) 5285(1) 26(1) 
C(166) 8676(1) 10292(1) 5541(1) 27(1) 
C(167) 8441(1) 9118(1) 5615(1) 37(1) 
C(168) 8250(2) 9221(2) 6059(1) 54(1) 
C(169) 8204(1) 9591(1) 4514(1) 32(1) 
C(170) 7464(1) 9752(2) 4306(1) 48(1) 
C(171) 7007(1) 9763(2) 3548(1) 58(1) 
C(172) 7051(2) 9122(2) 3243(1) 62(1) 
C(173) 7784(2) 8976(2) 3440(1) 51(1) 
C(174) 8227(1) 8956(1) 4188(1) 41(1) 
 
 
Table 3. Bond lengths [Å] and angles [°] for C29H34NOP 
_____________________________________________________  
P(1)-O(1)  1.4897(13) 
P(1)-N(1)  1.6401(16) 
P(1)-C(1)  1.7961(19) 
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P(1)-C(7)  1.8040(19) 
N(1)-C(13)  1.472(2) 
N(1)-H(1N)  0.8800 
C(1)-C(2)  1.386(3) 
C(1)-C(6)  1.397(3) 
C(2)-C(3)  1.386(3) 
C(2)-H(2A)  0.9500 
C(3)-C(4)  1.372(3) 
C(3)-H(3A)  0.9500 
C(4)-C(5)  1.391(3) 
C(4)-H(4A)  0.9500 
C(5)-C(6)  1.387(3) 
C(5)-H(5A)  0.9500 
C(6)-H(6A)  0.9500 
C(7)-C(8)  1.394(3) 
C(7)-C(12)  1.400(3) 
C(8)-C(9)  1.390(3) 
C(8)-H(8A)  0.9500 
C(9)-C(10)  1.374(3) 
C(9)-H(9A)  0.9500 
C(10)-C(11)  1.392(3) 
C(10)-H(10A)  0.9500 
C(11)-C(12)  1.377(3) 
C(11)-H(11A)  0.9500 
C(12)-H(12A)  0.9500 
C(13)-C(14)  1.526(3) 
C(13)-C(20)  1.571(3) 
C(13)-H(13A)  1.0000 
C(14)-C(15)  1.392(3) 
C(14)-C(19)  1.392(3) 
C(15)-C(16)  1.384(3) 
C(15)-H(15A)  0.9500 
C(16)-C(17)  1.379(3) 
C(16)-H(16A)  0.9500 
C(17)-C(18)  1.382(3) 
C(17)-H(17A)  0.9500 
C(18)-C(19)  1.390(3) 
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C(18)-H(18A)  0.9500 
C(19)-H(19A)  0.9500 
C(20)-C(22)  1.516(3) 
C(20)-C(21)  1.529(3) 
C(20)-C(24)  1.572(3) 
C(21)-H(21A)  0.9800 
C(21)-H(21B)  0.9800 
C(21)-H(21C)  0.9800 
C(22)-C(23)  1.325(3) 
C(22)-H(22A)  0.9500 
C(23)-H(23A)  0.9500 
C(23)-H(23B)  0.9500 
C(24)-C(29)  1.541(3) 
C(24)-C(25)  1.542(3) 
C(24)-H(24A)  1.0000 
C(25)-C(26)  1.524(4) 
C(25)-H(25A)  0.9900 
C(25)-H(25B)  0.9900 
C(26)-C(27)  1.515(4) 
C(26)-H(26A)  0.9900 
C(26)-H(26B)  0.9900 
C(27)-C(28)  1.527(4) 
C(27)-H(27A)  0.9900 
C(27)-H(27B)  0.9900 
C(28)-C(29)  1.537(3) 
C(28)-H(28A)  0.9900 
C(28)-H(28B)  0.9900 
C(29)-H(29A)  0.9900 
C(29)-H(29B)  0.9900 
P(2)-O(2)  1.4899(14) 
P(2)-N(2)  1.6415(17) 
P(2)-C(30)  1.804(2) 
P(2)-C(36)  1.8048(19) 
N(2)-C(42)  1.467(2) 
N(2)-H(2N)  0.8800 
C(30)-C(31)  1.382(3) 
C(30)-C(35)  1.404(3) 
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C(31)-C(32)  1.372(3) 
C(31)-H(31A)  0.9500 
C(32)-C(33)  1.381(4) 
C(32)-H(32A)  0.9500 
C(33)-C(34)  1.368(5) 
C(33)-H(33A)  0.9500 
C(34)-C(35)  1.387(4) 
C(34)-H(34A)  0.9500 
C(35)-H(35A)  0.9500 
C(36)-C(37)  1.386(3) 
C(36)-C(41)  1.393(3) 
C(37)-C(38)  1.387(3) 
C(37)-H(37A)  0.9500 
C(38)-C(39)  1.376(3) 
C(38)-H(38A)  0.9500 
C(39)-C(40)  1.377(3) 
C(39)-H(39A)  0.9500 
C(40)-C(41)  1.385(3) 
C(40)-H(40A)  0.9500 
C(41)-H(41A)  0.9500 
C(42)-C(43)  1.529(3) 
C(42)-C(49)  1.564(3) 
C(42)-H(42A)  1.0000 
C(43)-C(48)  1.387(3) 
C(43)-C(44)  1.389(3) 
C(44)-C(45)  1.383(3) 
C(44)-H(44A)  0.9500 
C(45)-C(46)  1.377(4) 
C(45)-H(45A)  0.9500 
C(46)-C(47)  1.386(4) 
C(46)-H(46A)  0.9500 
C(47)-C(48)  1.388(3) 
C(47)-H(47A)  0.9500 
C(48)-H(48A)  0.9500 
C(49)-C(51)  1.505(3) 
C(49)-C(50)  1.529(3) 
C(49)-C(53)  1.570(3) 
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C(50)-H(50A)  0.9800 
C(50)-H(50B)  0.9800 
C(50)-H(50C)  0.9800 
C(51)-C(52)  1.328(3) 
C(51)-H(51A)  0.9500 
C(52)-H(52A)  0.9500 
C(52)-H(52B)  0.9500 
C(53)-C(54)  1.535(3) 
C(53)-C(58)  1.540(3) 
C(53)-H(53A)  1.0000 
C(54)-C(55)  1.528(3) 
C(54)-H(54A)  0.9900 
C(54)-H(54B)  0.9900 
C(55)-C(56)  1.522(3) 
C(55)-H(55A)  0.9900 
C(55)-H(55B)  0.9900 
C(56)-C(57)  1.530(3) 
C(56)-H(56A)  0.9900 
C(56)-H(56B)  0.9900 
C(57)-C(58)  1.525(3) 
C(57)-H(57A)  0.9900 
C(57)-H(57B)  0.9900 
C(58)-H(58A)  0.9900 
C(58)-H(58B)  0.9900 
P(3)-O(3)  1.4903(14) 
P(3)-N(3)  1.6441(16) 
P(3)-C(59)  1.8039(19) 
P(3)-C(65)  1.807(2) 
N(3)-C(71)  1.476(2) 
N(3)-H(3N)  0.8800 
C(59)-C(60)  1.385(3) 
C(59)-C(64)  1.397(3) 
C(60)-C(61)  1.393(3) 
C(60)-H(60A)  0.9500 
C(61)-C(62)  1.376(3) 
C(61)-H(61A)  0.9500 
C(62)-C(63)  1.370(3) 
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C(62)-H(62A)  0.9500 
C(63)-C(64)  1.380(3) 
C(63)-H(63A)  0.9500 
C(64)-H(64A)  0.9500 
C(65)-C(66)  1.385(3) 
C(65)-C(70)  1.400(3) 
C(66)-C(67)  1.388(3) 
C(66)-H(66A)  0.9500 
C(67)-C(68)  1.381(3) 
C(67)-H(67A)  0.9500 
C(68)-C(69)  1.394(3) 
C(68)-H(68A)  0.9500 
C(69)-C(70)  1.376(3) 
C(69)-H(69A)  0.9500 
C(70)-H(70A)  0.9500 
C(71)-C(72)  1.531(3) 
C(71)-C(78)  1.569(3) 
C(71)-H(71A)  1.0000 
C(72)-C(77)  1.368(3) 
C(72)-C(73)  1.395(3) 
C(73)-C(74)  1.381(3) 
C(73)-H(73A)  0.9500 
C(74)-C(75)  1.394(3) 
C(74)-H(74A)  0.9500 
C(75)-C(76)  1.373(3) 
C(75)-H(75A)  0.9500 
C(76)-C(77)  1.398(3) 
C(76)-H(76A)  0.9500 
C(77)-H(77A)  0.9500 
C(78)-C(80)  1.513(3) 
C(78)-C(79)  1.514(3) 
C(78)-C(82)  1.580(3) 
C(79)-H(79A)  0.9800 
C(79)-H(79B)  0.9800 
C(79)-H(79C)  0.9800 
C(80)-C(81)  1.303(3) 
C(80)-H(80A)  0.9500 
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C(81)-H(81A)  0.9500 
C(81)-H(81B)  0.9500 
C(82)-C(87)  1.525(3) 
C(82)-C(83)  1.536(3) 
C(82)-H(82A)  1.0000 
C(83)-C(84)  1.517(3) 
C(83)-H(83A)  0.9900 
C(83)-H(83B)  0.9900 
C(84)-C(85)  1.518(3) 
C(84)-H(84A)  0.9900 
C(84)-H(84B)  0.9900 
C(85)-C(86)  1.517(3) 
C(85)-H(85A)  0.9900 
C(85)-H(85B)  0.9900 
C(86)-C(87)  1.527(3) 
C(86)-H(86A)  0.9900 
C(86)-H(86B)  0.9900 
C(87)-H(87A)  0.9900 
C(87)-H(87B)  0.9900 
P(4)-O(4)  1.4894(14) 
P(4)-N(4)  1.6464(16) 
P(4)-C(94)  1.8016(19) 
P(4)-C(88)  1.804(2) 
N(4)-C(100)  1.474(2) 
N(4)-H(4N)  0.8800 
C(88)-C(93)  1.391(3) 
C(88)-C(89)  1.398(3) 
C(89)-C(90)  1.389(3) 
C(89)-H(89A)  0.9500 
C(90)-C(91)  1.376(3) 
C(90)-H(90A)  0.9500 
C(91)-C(92)  1.389(3) 
C(91)-H(91A)  0.9500 
C(92)-C(93)  1.374(3) 
C(92)-H(92A)  0.9500 
C(93)-H(93A)  0.9500 
C(94)-C(95)  1.391(3) 
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C(94)-C(99)  1.398(3) 
C(95)-C(96)  1.376(3) 
C(95)-H(95A)  0.9500 
C(96)-C(97)  1.381(4) 
C(96)-H(96A)  0.9500 
C(97)-C(98)  1.389(4) 
C(97)-H(97A)  0.9500 
C(98)-C(99)  1.376(3) 
C(98)-H(98A)  0.9500 
C(99)-H(99A)  0.9500 
C(100)-C(101)  1.523(3) 
C(100)-C(107)  1.573(3) 
C(100)-H(10B)  1.0000 
C(101)-C(102)  1.389(3) 
C(101)-C(106)  1.391(3) 
C(102)-C(103)  1.388(3) 
C(102)-H(10C)  0.9500 
C(103)-C(104)  1.378(4) 
C(103)-H(10D)  0.9500 
C(104)-C(105)  1.375(4) 
C(104)-H(10E)  0.9500 
C(105)-C(106)  1.394(3) 
C(105)-H(10F)  0.9500 
C(106)-H(10G)  0.9500 
C(107)-C(109)  1.513(3) 
C(107)-C(108)  1.514(3) 
C(107)-C(111)  1.568(3) 
C(108)-H(10H)  0.9800 
C(108)-H(10I)  0.9800 
C(108)-H(10J)  0.9800 
C(109)-C(110)  1.305(3) 
C(109)-H(10K)  0.9500 
C(110)-H(11B)  0.9500 
C(110)-H(11C)  0.9500 
C(111)-C(116)  1.528(3) 
C(111)-C(112)  1.539(3) 
C(111)-H(11E)  1.0000 
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C(112)-C(113)  1.532(3) 
C(112)-H(11F)  0.9900 
C(112)-H(11G)  0.9900 
C(113)-C(114)  1.522(3) 
C(113)-H(11H)  0.9900 
C(113)-H(11I)  0.9900 
C(114)-C(115)  1.519(3) 
C(114)-H(11J)  0.9900 
C(114)-H(11K)  0.9900 
C(115)-C(116)  1.536(3) 
C(115)-H(11L)  0.9900 
C(115)-H(11M)  0.9900 
C(116)-H(11N)  0.9900 
C(116)-H(11O)  0.9900 
P(5)-O(5)  1.4915(14) 
P(5)-N(5)  1.6398(16) 
P(5)-C(117)  1.8002(19) 
P(5)-C(123)  1.805(2) 
N(5)-C(129)  1.463(2) 
N(5)-H(5N)  0.8800 
C(117)-C(122)  1.389(3) 
C(117)-C(118)  1.398(3) 
C(118)-C(119)  1.384(3) 
C(118)-H(11P)  0.9500 
C(119)-C(120)  1.376(3) 
C(119)-H(11Q)  0.9500 
C(120)-C(121)  1.382(3) 
C(120)-H(12B)  0.9500 
C(121)-C(122)  1.383(3) 
C(121)-H(12C)  0.9500 
C(122)-H(12D)  0.9500 
C(123)-C(124)  1.391(3) 
C(123)-C(128)  1.403(3) 
C(124)-C(125)  1.375(3) 
C(124)-H(12E)  0.9500 
C(125)-C(126)  1.385(4) 
C(125)-H(12F)  0.9500 
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C(126)-C(127)  1.379(4) 
C(126)-H(12G)  0.9500 
C(127)-C(128)  1.374(3) 
C(127)-H(12H)  0.9500 
C(128)-H(12I)  0.9500 
C(129)-C(130)  1.521(3) 
C(129)-C(136)  1.574(3) 
C(129)-H(12J)  1.0000 
C(130)-C(135)  1.386(3) 
C(130)-C(131)  1.390(3) 
C(131)-C(132)  1.391(3) 
C(131)-H(13B)  0.9500 
C(132)-C(133)  1.375(3) 
C(132)-H(13C)  0.9500 
C(133)-C(134)  1.378(4) 
C(133)-H(13D)  0.9500 
C(134)-C(135)  1.391(3) 
C(134)-H(13E)  0.9500 
C(135)-H(13F)  0.9500 
C(136)-C(138)  1.515(3) 
C(136)-C(137)  1.538(3) 
C(136)-C(140)  1.575(3) 
C(137)-H(13G)  0.9800 
C(137)-H(13H)  0.9800 
C(137)-H(13I)  0.9800 
C(138)-C(139)  1.321(4) 
C(138)-H(13J)  0.9500 
C(139)-H(13K)  0.9500 
C(139)-H(13L)  0.9500 
C(140)-C(145)  1.532(3) 
C(140)-C(141)  1.534(3) 
C(140)-H(14A)  1.0000 
C(141)-C(142)  1.519(3) 
C(141)-H(14B)  0.9900 
C(141)-H(14C)  0.9900 
C(142)-C(143)  1.528(4) 
C(142)-H(14D)  0.9900 
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C(142)-H(14E)  0.9900 
C(143)-C(144)  1.526(3) 
C(143)-H(14F)  0.9900 
C(143)-H(14G)  0.9900 
C(144)-C(145)  1.529(3) 
C(144)-H(14H)  0.9900 
C(144)-H(14I)  0.9900 
C(145)-H(14J)  0.9900 
C(145)-H(14K)  0.9900 
P(6)-O(6)  1.4880(15) 
P(6)-N(6)  1.6515(17) 
P(6)-C(152)  1.798(2) 
P(6)-C(146)  1.806(2) 
N(6)-C(158)  1.472(2) 
N(6)-H(6N)  0.8800 
C(146)-C(151)  1.392(3) 
C(146)-C(147)  1.393(3) 
C(147)-C(148)  1.380(3) 
C(147)-H(14L)  0.9500 
C(148)-C(149)  1.381(3) 
C(148)-H(14M)  0.9500 
C(149)-C(150)  1.378(3) 
C(149)-H(14N)  0.9500 
C(150)-C(151)  1.396(3) 
C(150)-H(15B)  0.9500 
C(151)-H(15C)  0.9500 
C(152)-C(153)  1.392(3) 
C(152)-C(157)  1.395(3) 
C(153)-C(154)  1.386(4) 
C(153)-H(15D)  0.9500 
C(154)-C(155)  1.366(4) 
C(154)-H(15E)  0.9500 
C(155)-C(156)  1.382(4) 
C(155)-H(15F)  0.9500 
C(156)-C(157)  1.383(3) 
C(156)-H(15G)  0.9500 
C(157)-H(15H)  0.9500 
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C(158)-C(159)  1.534(3) 
C(158)-C(165)  1.558(3) 
C(158)-H(15I)  1.0000 
C(159)-C(164)  1.388(3) 
C(159)-C(160)  1.389(3) 
C(160)-C(161)  1.392(3) 
C(160)-H(16B)  0.9500 
C(161)-C(162)  1.380(4) 
C(161)-H(16C)  0.9500 
C(162)-C(163)  1.371(4) 
C(162)-H(16D)  0.9500 
C(163)-C(164)  1.379(3) 
C(163)-H(16E)  0.9500 
C(164)-H(16F)  0.9500 
C(165)-C(167)  1.512(3) 
C(165)-C(166)  1.526(3) 
C(165)-C(169)  1.567(3) 
C(166)-H(16G)  0.9800 
C(166)-H(16H)  0.9800 
C(166)-H(16I)  0.9800 
C(167)-C(168)  1.306(4) 
C(167)-H(16J)  0.9500 
C(168)-H(16K)  0.9500 
C(168)-H(16L)  0.9500 
C(169)-C(174)  1.526(3) 
C(169)-C(170)  1.534(3) 
C(169)-H(16N)  1.0000 
C(170)-C(171)  1.536(4) 
C(170)-H(17B)  0.9900 
C(170)-H(17C)  0.9900 
C(171)-C(172)  1.526(5) 
C(171)-H(17D)  0.9900 
C(171)-H(17E)  0.9900 
C(172)-C(173)  1.517(4) 
C(172)-H(17F)  0.9900 
C(172)-H(17G)  0.9900 
C(173)-C(174)  1.514(3) 
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C(173)-H(17H)  0.9900 
C(173)-H(17I)  0.9900 
C(174)-H(17J)  0.9900 
C(174)-H(17K)  0.9900 
O(1)-P(1)-N(1) 111.29(8) 
O(1)-P(1)-C(1) 111.77(9) 
N(1)-P(1)-C(1) 108.90(9) 
O(1)-P(1)-C(7) 110.71(8) 
N(1)-P(1)-C(7) 108.61(8) 
C(1)-P(1)-C(7) 105.33(9) 
C(13)-N(1)-P(1) 121.44(13) 
C(13)-N(1)-H(1N) 119.3 
P(1)-N(1)-H(1N) 119.3 
C(2)-C(1)-C(6) 119.69(18) 
C(2)-C(1)-P(1) 119.25(16) 
C(6)-C(1)-P(1) 121.02(15) 
C(3)-C(2)-C(1) 120.0(2) 
C(3)-C(2)-H(2A) 120.0 
C(1)-C(2)-H(2A) 120.0 
C(4)-C(3)-C(2) 120.4(2) 
C(4)-C(3)-H(3A) 119.8 
C(2)-C(3)-H(3A) 119.8 
C(3)-C(4)-C(5) 120.2(2) 
C(3)-C(4)-H(4A) 119.9 
C(5)-C(4)-H(4A) 119.9 
C(6)-C(5)-C(4) 119.9(2) 
C(6)-C(5)-H(5A) 120.1 
C(4)-C(5)-H(5A) 120.1 
C(5)-C(6)-C(1) 119.80(19) 
C(5)-C(6)-H(6A) 120.1 
C(1)-C(6)-H(6A) 120.1 
C(8)-C(7)-C(12) 118.51(18) 
C(8)-C(7)-P(1) 122.49(15) 
C(12)-C(7)-P(1) 118.41(15) 
C(9)-C(8)-C(7) 120.74(19) 
C(9)-C(8)-H(8A) 119.6 
C(7)-C(8)-H(8A) 119.6 
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C(10)-C(9)-C(8) 119.85(19) 
C(10)-C(9)-H(9A) 120.1 
C(8)-C(9)-H(9A) 120.1 
C(9)-C(10)-C(11) 120.2(2) 
C(9)-C(10)-H(10A) 119.9 
C(11)-C(10)-H(10A) 119.9 
C(12)-C(11)-C(10) 120.10(19) 
C(12)-C(11)-H(11A) 119.9 
C(10)-C(11)-H(11A) 119.9 
C(11)-C(12)-C(7) 120.58(18) 
C(11)-C(12)-H(12A) 119.7 
C(7)-C(12)-H(12A) 119.7 
N(1)-C(13)-C(14) 110.40(15) 
N(1)-C(13)-C(20) 113.24(15) 
C(14)-C(13)-C(20) 114.06(15) 
N(1)-C(13)-H(13A) 106.2 
C(14)-C(13)-H(13A) 106.2 
C(20)-C(13)-H(13A) 106.2 
C(15)-C(14)-C(19) 118.30(19) 
C(15)-C(14)-C(13) 122.41(18) 
C(19)-C(14)-C(13) 119.21(17) 
C(16)-C(15)-C(14) 120.7(2) 
C(16)-C(15)-H(15A) 119.7 
C(14)-C(15)-H(15A) 119.7 
C(17)-C(16)-C(15) 120.6(2) 
C(17)-C(16)-H(16A) 119.7 
C(15)-C(16)-H(16A) 119.7 
C(16)-C(17)-C(18) 119.4(2) 
C(16)-C(17)-H(17A) 120.3 
C(18)-C(17)-H(17A) 120.3 
C(17)-C(18)-C(19) 120.1(2) 
C(17)-C(18)-H(18A) 119.9 
C(19)-C(18)-H(18A) 119.9 
C(18)-C(19)-C(14) 120.8(2) 
C(18)-C(19)-H(19A) 119.6 
C(14)-C(19)-H(19A) 119.6 
C(22)-C(20)-C(21) 111.77(17) 
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C(22)-C(20)-C(13) 106.16(16) 
C(21)-C(20)-C(13) 110.65(16) 
C(22)-C(20)-C(24) 109.85(16) 
C(21)-C(20)-C(24) 109.70(16) 
C(13)-C(20)-C(24) 108.63(16) 
C(20)-C(21)-H(21A) 109.5 
C(20)-C(21)-H(21B) 109.5 
H(21A)-C(21)-H(21B) 109.5 
C(20)-C(21)-H(21C) 109.5 
H(21A)-C(21)-H(21C) 109.5 
H(21B)-C(21)-H(21C) 109.5 
C(23)-C(22)-C(20) 127.0(2) 
C(23)-C(22)-H(22A) 116.5 
C(20)-C(22)-H(22A) 116.5 
C(22)-C(23)-H(23A) 120.0 
C(22)-C(23)-H(23B) 120.0 
H(23A)-C(23)-H(23B) 120.0 
C(29)-C(24)-C(25) 108.45(18) 
C(29)-C(24)-C(20) 114.43(17) 
C(25)-C(24)-C(20) 112.66(18) 
C(29)-C(24)-H(24A) 107.0 
C(25)-C(24)-H(24A) 107.0 
C(20)-C(24)-H(24A) 107.0 
C(26)-C(25)-C(24) 111.9(2) 
C(26)-C(25)-H(25A) 109.2 
C(24)-C(25)-H(25A) 109.2 
C(26)-C(25)-H(25B) 109.2 
C(24)-C(25)-H(25B) 109.2 
H(25A)-C(25)-H(25B) 107.9 
C(27)-C(26)-C(25) 112.4(2) 
C(27)-C(26)-H(26A) 109.1 
C(25)-C(26)-H(26A) 109.1 
C(27)-C(26)-H(26B) 109.1 
C(25)-C(26)-H(26B) 109.1 
H(26A)-C(26)-H(26B) 107.9 
C(26)-C(27)-C(28) 110.3(2) 
C(26)-C(27)-H(27A) 109.6 
 
Page 366
	  	  
C(28)-C(27)-H(27A) 109.6 
C(26)-C(27)-H(27B) 109.6 
C(28)-C(27)-H(27B) 109.6 
H(27A)-C(27)-H(27B) 108.1 
C(27)-C(28)-C(29) 110.9(2) 
C(27)-C(28)-H(28A) 109.5 
C(29)-C(28)-H(28A) 109.5 
C(27)-C(28)-H(28B) 109.5 
C(29)-C(28)-H(28B) 109.5 
H(28A)-C(28)-H(28B) 108.0 
C(28)-C(29)-C(24) 111.82(18) 
C(28)-C(29)-H(29A) 109.3 
C(24)-C(29)-H(29A) 109.3 
C(28)-C(29)-H(29B) 109.3 
C(24)-C(29)-H(29B) 109.3 
H(29A)-C(29)-H(29B) 107.9 
O(2)-P(2)-N(2) 111.27(8) 
O(2)-P(2)-C(30) 111.24(9) 
N(2)-P(2)-C(30) 111.14(9) 
O(2)-P(2)-C(36) 112.89(8) 
N(2)-P(2)-C(36) 103.32(9) 
C(30)-P(2)-C(36) 106.65(9) 
C(42)-N(2)-P(2) 119.67(13) 
C(42)-N(2)-H(2N) 120.2 
P(2)-N(2)-H(2N) 120.2 
C(31)-C(30)-C(35) 119.2(2) 
C(31)-C(30)-P(2) 122.37(16) 
C(35)-C(30)-P(2) 118.43(18) 
C(32)-C(31)-C(30) 121.1(2) 
C(32)-C(31)-H(31A) 119.4 
C(30)-C(31)-H(31A) 119.4 
C(31)-C(32)-C(33) 119.6(3) 
C(31)-C(32)-H(32A) 120.2 
C(33)-C(32)-H(32A) 120.2 
C(34)-C(33)-C(32) 120.3(3) 
C(34)-C(33)-H(33A) 119.9 
C(32)-C(33)-H(33A) 119.9 
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C(33)-C(34)-C(35) 120.9(3) 
C(33)-C(34)-H(34A) 119.6 
C(35)-C(34)-H(34A) 119.6 
C(34)-C(35)-C(30) 118.9(3) 
C(34)-C(35)-H(35A) 120.6 
C(30)-C(35)-H(35A) 120.6 
C(37)-C(36)-C(41) 118.90(18) 
C(37)-C(36)-P(2) 125.82(15) 
C(41)-C(36)-P(2) 115.28(15) 
C(36)-C(37)-C(38) 120.3(2) 
C(36)-C(37)-H(37A) 119.8 
C(38)-C(37)-H(37A) 119.8 
C(39)-C(38)-C(37) 120.2(2) 
C(39)-C(38)-H(38A) 119.9 
C(37)-C(38)-H(38A) 119.9 
C(38)-C(39)-C(40) 120.21(19) 
C(38)-C(39)-H(39A) 119.9 
C(40)-C(39)-H(39A) 119.9 
C(39)-C(40)-C(41) 119.8(2) 
C(39)-C(40)-H(40A) 120.1 
C(41)-C(40)-H(40A) 120.1 
C(40)-C(41)-C(36) 120.5(2) 
C(40)-C(41)-H(41A) 119.7 
C(36)-C(41)-H(41A) 119.7 
N(2)-C(42)-C(43) 111.80(16) 
N(2)-C(42)-C(49) 110.85(15) 
C(43)-C(42)-C(49) 114.71(15) 
N(2)-C(42)-H(42A) 106.3 
C(43)-C(42)-H(42A) 106.3 
C(49)-C(42)-H(42A) 106.3 
C(48)-C(43)-C(44) 118.4(2) 
C(48)-C(43)-C(42) 121.72(18) 
C(44)-C(43)-C(42) 119.75(19) 
C(45)-C(44)-C(43) 121.2(2) 
C(45)-C(44)-H(44A) 119.4 
C(43)-C(44)-H(44A) 119.4 
C(46)-C(45)-C(44) 120.0(2) 
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C(46)-C(45)-H(45A) 120.0 
C(44)-C(45)-H(45A) 120.0 
C(45)-C(46)-C(47) 119.7(2) 
C(45)-C(46)-H(46A) 120.2 
C(47)-C(46)-H(46A) 120.2 
C(46)-C(47)-C(48) 120.2(2) 
C(46)-C(47)-H(47A) 119.9 
C(48)-C(47)-H(47A) 119.9 
C(43)-C(48)-C(47) 120.6(2) 
C(43)-C(48)-H(48A) 119.7 
C(47)-C(48)-H(48A) 119.7 
C(51)-C(49)-C(50) 111.47(16) 
C(51)-C(49)-C(42) 107.72(16) 
C(50)-C(49)-C(42) 109.28(15) 
C(51)-C(49)-C(53) 108.81(16) 
C(50)-C(49)-C(53) 109.77(15) 
C(42)-C(49)-C(53) 109.75(15) 
C(49)-C(50)-H(50A) 109.5 
C(49)-C(50)-H(50B) 109.5 
H(50A)-C(50)-H(50B) 109.5 
C(49)-C(50)-H(50C) 109.5 
H(50A)-C(50)-H(50C) 109.5 
H(50B)-C(50)-H(50C) 109.5 
C(52)-C(51)-C(49) 126.7(2) 
C(52)-C(51)-H(51A) 116.7 
C(49)-C(51)-H(51A) 116.7 
C(51)-C(52)-H(52A) 120.0 
C(51)-C(52)-H(52B) 120.0 
H(52A)-C(52)-H(52B) 120.0 
C(54)-C(53)-C(58) 109.03(17) 
C(54)-C(53)-C(49) 112.18(16) 
C(58)-C(53)-C(49) 113.92(16) 
C(54)-C(53)-H(53A) 107.1 
C(58)-C(53)-H(53A) 107.1 
C(49)-C(53)-H(53A) 107.1 
C(55)-C(54)-C(53) 111.85(19) 
C(55)-C(54)-H(54A) 109.2 
 
Page 369
	  	  
C(53)-C(54)-H(54A) 109.2 
C(55)-C(54)-H(54B) 109.2 
C(53)-C(54)-H(54B) 109.2 
H(54A)-C(54)-H(54B) 107.9 
C(56)-C(55)-C(54) 111.6(2) 
C(56)-C(55)-H(55A) 109.3 
C(54)-C(55)-H(55A) 109.3 
C(56)-C(55)-H(55B) 109.3 
C(54)-C(55)-H(55B) 109.3 
H(55A)-C(55)-H(55B) 108.0 
C(55)-C(56)-C(57) 110.1(2) 
C(55)-C(56)-H(56A) 109.6 
C(57)-C(56)-H(56A) 109.6 
C(55)-C(56)-H(56B) 109.6 
C(57)-C(56)-H(56B) 109.6 
H(56A)-C(56)-H(56B) 108.2 
C(58)-C(57)-C(56) 111.45(19) 
C(58)-C(57)-H(57A) 109.3 
C(56)-C(57)-H(57A) 109.3 
C(58)-C(57)-H(57B) 109.3 
C(56)-C(57)-H(57B) 109.3 
H(57A)-C(57)-H(57B) 108.0 
C(57)-C(58)-C(53) 111.63(17) 
C(57)-C(58)-H(58A) 109.3 
C(53)-C(58)-H(58A) 109.3 
C(57)-C(58)-H(58B) 109.3 
C(53)-C(58)-H(58B) 109.3 
H(58A)-C(58)-H(58B) 108.0 
O(3)-P(3)-N(3) 111.43(8) 
O(3)-P(3)-C(59) 113.29(8) 
N(3)-P(3)-C(59) 106.09(8) 
O(3)-P(3)-C(65) 111.00(8) 
N(3)-P(3)-C(65) 111.62(8) 
C(59)-P(3)-C(65) 103.05(9) 
C(71)-N(3)-P(3) 119.08(12) 
C(71)-N(3)-H(3N) 120.5 
P(3)-N(3)-H(3N) 120.5 
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C(60)-C(59)-C(64) 118.76(18) 
C(60)-C(59)-P(3) 121.52(15) 
C(64)-C(59)-P(3) 119.40(15) 
C(59)-C(60)-C(61) 120.0(2) 
C(59)-C(60)-H(60A) 120.0 
C(61)-C(60)-H(60A) 120.0 
C(62)-C(61)-C(60) 120.4(2) 
C(62)-C(61)-H(61A) 119.8 
C(60)-C(61)-H(61A) 119.8 
C(63)-C(62)-C(61) 119.9(2) 
C(63)-C(62)-H(62A) 120.1 
C(61)-C(62)-H(62A) 120.1 
C(62)-C(63)-C(64) 120.5(2) 
C(62)-C(63)-H(63A) 119.7 
C(64)-C(63)-H(63A) 119.7 
C(63)-C(64)-C(59) 120.4(2) 
C(63)-C(64)-H(64A) 119.8 
C(59)-C(64)-H(64A) 119.8 
C(66)-C(65)-C(70) 119.26(18) 
C(66)-C(65)-P(3) 119.92(15) 
C(70)-C(65)-P(3) 120.64(15) 
C(65)-C(66)-C(67) 120.52(19) 
C(65)-C(66)-H(66A) 119.7 
C(67)-C(66)-H(66A) 119.7 
C(68)-C(67)-C(66) 120.12(19) 
C(68)-C(67)-H(67A) 119.9 
C(66)-C(67)-H(67A) 119.9 
C(67)-C(68)-C(69) 119.6(2) 
C(67)-C(68)-H(68A) 120.2 
C(69)-C(68)-H(68A) 120.2 
C(70)-C(69)-C(68) 120.5(2) 
C(70)-C(69)-H(69A) 119.8 
C(68)-C(69)-H(69A) 119.8 
C(69)-C(70)-C(65) 120.06(19) 
C(69)-C(70)-H(70A) 120.0 
C(65)-C(70)-H(70A) 120.0 
N(3)-C(71)-C(72) 112.62(16) 
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N(3)-C(71)-C(78) 111.92(15) 
C(72)-C(71)-C(78) 112.36(16) 
N(3)-C(71)-H(71A) 106.5 
C(72)-C(71)-H(71A) 106.5 
C(78)-C(71)-H(71A) 106.5 
C(77)-C(72)-C(73) 118.25(19) 
C(77)-C(72)-C(71) 120.26(18) 
C(73)-C(72)-C(71) 121.47(18) 
C(74)-C(73)-C(72) 120.7(2) 
C(74)-C(73)-H(73A) 119.6 
C(72)-C(73)-H(73A) 119.6 
C(73)-C(74)-C(75) 120.7(2) 
C(73)-C(74)-H(74A) 119.6 
C(75)-C(74)-H(74A) 119.6 
C(76)-C(75)-C(74) 118.4(2) 
C(76)-C(75)-H(75A) 120.8 
C(74)-C(75)-H(75A) 120.8 
C(75)-C(76)-C(77) 120.6(2) 
C(75)-C(76)-H(76A) 119.7 
C(77)-C(76)-H(76A) 119.7 
C(72)-C(77)-C(76) 121.2(2) 
C(72)-C(77)-H(77A) 119.4 
C(76)-C(77)-H(77A) 119.4 
C(80)-C(78)-C(79) 111.29(17) 
C(80)-C(78)-C(71) 106.44(16) 
C(79)-C(78)-C(71) 111.24(16) 
C(80)-C(78)-C(82) 108.84(17) 
C(79)-C(78)-C(82) 109.41(16) 
C(71)-C(78)-C(82) 109.55(16) 
C(78)-C(79)-H(79A) 109.5 
C(78)-C(79)-H(79B) 109.5 
H(79A)-C(79)-H(79B) 109.5 
C(78)-C(79)-H(79C) 109.5 
H(79A)-C(79)-H(79C) 109.5 
H(79B)-C(79)-H(79C) 109.5 
C(81)-C(80)-C(78) 128.4(2) 
C(81)-C(80)-H(80A) 115.8 
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C(78)-C(80)-H(80A) 115.8 
C(80)-C(81)-H(81A) 120.0 
C(80)-C(81)-H(81B) 120.0 
H(81A)-C(81)-H(81B) 120.0 
C(87)-C(82)-C(83) 108.74(17) 
C(87)-C(82)-C(78) 114.06(17) 
C(83)-C(82)-C(78) 113.34(17) 
C(87)-C(82)-H(82A) 106.7 
C(83)-C(82)-H(82A) 106.7 
C(78)-C(82)-H(82A) 106.7 
C(84)-C(83)-C(82) 111.31(19) 
C(84)-C(83)-H(83A) 109.4 
C(82)-C(83)-H(83A) 109.4 
C(84)-C(83)-H(83B) 109.4 
C(82)-C(83)-H(83B) 109.4 
H(83A)-C(83)-H(83B) 108.0 
C(83)-C(84)-C(85) 112.2(2) 
C(83)-C(84)-H(84A) 109.2 
C(85)-C(84)-H(84A) 109.2 
C(83)-C(84)-H(84B) 109.2 
C(85)-C(84)-H(84B) 109.2 
H(84A)-C(84)-H(84B) 107.9 
C(86)-C(85)-C(84) 110.18(19) 
C(86)-C(85)-H(85A) 109.6 
C(84)-C(85)-H(85A) 109.6 
C(86)-C(85)-H(85B) 109.6 
C(84)-C(85)-H(85B) 109.6 
H(85A)-C(85)-H(85B) 108.1 
C(85)-C(86)-C(87) 110.8(2) 
C(85)-C(86)-H(86A) 109.5 
C(87)-C(86)-H(86A) 109.5 
C(85)-C(86)-H(86B) 109.5 
C(87)-C(86)-H(86B) 109.5 
H(86A)-C(86)-H(86B) 108.1 
C(82)-C(87)-C(86) 111.50(18) 
C(82)-C(87)-H(87A) 109.3 
C(86)-C(87)-H(87A) 109.3 
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C(82)-C(87)-H(87B) 109.3 
C(86)-C(87)-H(87B) 109.3 
H(87A)-C(87)-H(87B) 108.0 
O(4)-P(4)-N(4) 111.86(8) 
O(4)-P(4)-C(94) 110.46(9) 
N(4)-P(4)-C(94) 110.72(8) 
O(4)-P(4)-C(88) 114.94(9) 
N(4)-P(4)-C(88) 102.72(9) 
C(94)-P(4)-C(88) 105.77(9) 
C(100)-N(4)-P(4) 118.03(13) 
C(100)-N(4)-H(4N) 121.0 
P(4)-N(4)-H(4N) 121.0 
C(93)-C(88)-C(89) 118.96(19) 
C(93)-C(88)-P(4) 121.25(16) 
C(89)-C(88)-P(4) 119.68(15) 
C(90)-C(89)-C(88) 119.9(2) 
C(90)-C(89)-H(89A) 120.0 
C(88)-C(89)-H(89A) 120.0 
C(91)-C(90)-C(89) 120.1(2) 
C(91)-C(90)-H(90A) 120.0 
C(89)-C(90)-H(90A) 120.0 
C(90)-C(91)-C(92) 120.5(2) 
C(90)-C(91)-H(91A) 119.8 
C(92)-C(91)-H(91A) 119.8 
C(93)-C(92)-C(91) 119.6(2) 
C(93)-C(92)-H(92A) 120.2 
C(91)-C(92)-H(92A) 120.2 
C(92)-C(93)-C(88) 121.0(2) 
C(92)-C(93)-H(93A) 119.5 
C(88)-C(93)-H(93A) 119.5 
C(95)-C(94)-C(99) 119.27(18) 
C(95)-C(94)-P(4) 120.71(15) 
C(99)-C(94)-P(4) 119.98(15) 
C(96)-C(95)-C(94) 120.3(2) 
C(96)-C(95)-H(95A) 119.8 
C(94)-C(95)-H(95A) 119.8 
C(95)-C(96)-C(97) 120.3(2) 
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C(95)-C(96)-H(96A) 119.8 
C(97)-C(96)-H(96A) 119.8 
C(96)-C(97)-C(98) 119.8(2) 
C(96)-C(97)-H(97A) 120.1 
C(98)-C(97)-H(97A) 120.1 
C(99)-C(98)-C(97) 120.3(2) 
C(99)-C(98)-H(98A) 119.8 
C(97)-C(98)-H(98A) 119.8 
C(98)-C(99)-C(94) 120.0(2) 
C(98)-C(99)-H(99A) 120.0 
C(94)-C(99)-H(99A) 120.0 
N(4)-C(100)-C(101) 112.40(15) 
N(4)-C(100)-C(107) 111.05(15) 
C(101)-C(100)-C(107) 112.38(16) 
N(4)-C(100)-H(10B) 106.9 
C(101)-C(100)-H(10B) 106.9 
C(107)-C(100)-H(10B) 106.9 
C(102)-C(101)-C(106) 118.4(2) 
C(102)-C(101)-C(100) 121.74(19) 
C(106)-C(101)-C(100) 119.83(19) 
C(103)-C(102)-C(101) 120.9(2) 
C(103)-C(102)-H(10C) 119.6 
C(101)-C(102)-H(10C) 119.6 
C(104)-C(103)-C(102) 120.1(2) 
C(104)-C(103)-H(10D) 120.0 
C(102)-C(103)-H(10D) 120.0 
C(105)-C(104)-C(103) 119.9(2) 
C(105)-C(104)-H(10E) 120.1 
C(103)-C(104)-H(10E) 120.1 
C(104)-C(105)-C(106) 120.3(2) 
C(104)-C(105)-H(10F) 119.9 
C(106)-C(105)-H(10F) 119.9 
C(101)-C(106)-C(105) 120.4(2) 
C(101)-C(106)-H(10G) 119.8 
C(105)-C(106)-H(10G) 119.8 
C(109)-C(107)-C(108) 111.77(17) 
C(109)-C(107)-C(111) 110.35(15) 
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C(108)-C(107)-C(111) 108.70(16) 
C(109)-C(107)-C(100) 106.05(15) 
C(108)-C(107)-C(100) 110.12(15) 
C(111)-C(107)-C(100) 109.83(15) 
C(107)-C(108)-H(10H) 109.5 
C(107)-C(108)-H(10I) 109.5 
H(10H)-C(108)-H(10I) 109.5 
C(107)-C(108)-H(10J) 109.5 
H(10H)-C(108)-H(10J) 109.5 
H(10I)-C(108)-H(10J) 109.5 
C(110)-C(109)-C(107) 129.0(2) 
C(110)-C(109)-H(10K) 115.5 
C(107)-C(109)-H(10K) 115.5 
C(109)-C(110)-H(11B) 120.0 
C(109)-C(110)-H(11C) 120.0 
H(11B)-C(110)-H(11C) 120.0 
C(116)-C(111)-C(112) 109.50(15) 
C(116)-C(111)-C(107) 114.51(15) 
C(112)-C(111)-C(107) 111.32(15) 
C(116)-C(111)-H(11E) 107.0 
C(112)-C(111)-H(11E) 107.0 
C(107)-C(111)-H(11E) 107.0 
C(113)-C(112)-C(111) 111.52(16) 
C(113)-C(112)-H(11F) 109.3 
C(111)-C(112)-H(11F) 109.3 
C(113)-C(112)-H(11G) 109.3 
C(111)-C(112)-H(11G) 109.3 
H(11F)-C(112)-H(11G) 108.0 
C(114)-C(113)-C(112) 111.05(17) 
C(114)-C(113)-H(11H) 109.4 
C(112)-C(113)-H(11H) 109.4 
C(114)-C(113)-H(11I) 109.4 
C(112)-C(113)-H(11I) 109.4 
H(11H)-C(113)-H(11I) 108.0 
C(115)-C(114)-C(113) 109.77(17) 
C(115)-C(114)-H(11J) 109.7 
C(113)-C(114)-H(11J) 109.7 
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C(115)-C(114)-H(11K) 109.7 
C(113)-C(114)-H(11K) 109.7 
H(11J)-C(114)-H(11K) 108.2 
C(114)-C(115)-C(116) 111.12(17) 
C(114)-C(115)-H(11L) 109.4 
C(116)-C(115)-H(11L) 109.4 
C(114)-C(115)-H(11M) 109.4 
C(116)-C(115)-H(11M) 109.4 
H(11L)-C(115)-H(11M) 108.0 
C(111)-C(116)-C(115) 111.53(17) 
C(111)-C(116)-H(11N) 109.3 
C(115)-C(116)-H(11N) 109.3 
C(111)-C(116)-H(11O) 109.3 
C(115)-C(116)-H(11O) 109.3 
H(11N)-C(116)-H(11O) 108.0 
O(5)-P(5)-N(5) 112.21(8) 
O(5)-P(5)-C(117) 110.88(9) 
N(5)-P(5)-C(117) 109.54(8) 
O(5)-P(5)-C(123) 111.93(8) 
N(5)-P(5)-C(123) 106.79(9) 
C(117)-P(5)-C(123) 105.16(9) 
C(129)-N(5)-P(5) 122.21(12) 
C(129)-N(5)-H(5N) 118.9 
P(5)-N(5)-H(5N) 118.9 
C(122)-C(117)-C(118) 119.31(18) 
C(122)-C(117)-P(5) 121.60(15) 
C(118)-C(117)-P(5) 119.09(15) 
C(119)-C(118)-C(117) 119.8(2) 
C(119)-C(118)-H(11P) 120.1 
C(117)-C(118)-H(11P) 120.1 
C(120)-C(119)-C(118) 120.6(2) 
C(120)-C(119)-H(11Q) 119.7 
C(118)-C(119)-H(11Q) 119.7 
C(119)-C(120)-C(121) 119.7(2) 
C(119)-C(120)-H(12B) 120.2 
C(121)-C(120)-H(12B) 120.2 
C(120)-C(121)-C(122) 120.6(2) 
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C(120)-C(121)-H(12C) 119.7 
C(122)-C(121)-H(12C) 119.7 
C(121)-C(122)-C(117) 120.0(2) 
C(121)-C(122)-H(12D) 120.0 
C(117)-C(122)-H(12D) 120.0 
C(124)-C(123)-C(128) 118.8(2) 
C(124)-C(123)-P(5) 121.90(17) 
C(128)-C(123)-P(5) 119.00(16) 
C(125)-C(124)-C(123) 120.5(2) 
C(125)-C(124)-H(12E) 119.8 
C(123)-C(124)-H(12E) 119.8 
C(124)-C(125)-C(126) 120.1(2) 
C(124)-C(125)-H(12F) 119.9 
C(126)-C(125)-H(12F) 119.9 
C(127)-C(126)-C(125) 120.1(2) 
C(127)-C(126)-H(12G) 120.0 
C(125)-C(126)-H(12G) 120.0 
C(128)-C(127)-C(126) 120.2(3) 
C(128)-C(127)-H(12H) 119.9 
C(126)-C(127)-H(12H) 119.9 
C(127)-C(128)-C(123) 120.3(2) 
C(127)-C(128)-H(12I) 119.8 
C(123)-C(128)-H(12I) 119.8 
N(5)-C(129)-C(130) 111.22(16) 
N(5)-C(129)-C(136) 112.91(15) 
C(130)-C(129)-C(136) 112.81(16) 
N(5)-C(129)-H(12J) 106.5 
C(130)-C(129)-H(12J) 106.5 
C(136)-C(129)-H(12J) 106.5 
C(135)-C(130)-C(131) 118.28(18) 
C(135)-C(130)-C(129) 119.45(18) 
C(131)-C(130)-C(129) 122.26(17) 
C(130)-C(131)-C(132) 120.33(19) 
C(130)-C(131)-H(13B) 119.8 
C(132)-C(131)-H(13B) 119.8 
C(133)-C(132)-C(131) 120.7(2) 
C(133)-C(132)-H(13C) 119.6 
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C(131)-C(132)-H(13C) 119.6 
C(132)-C(133)-C(134) 119.5(2) 
C(132)-C(133)-H(13D) 120.2 
C(134)-C(133)-H(13D) 120.2 
C(133)-C(134)-C(135) 119.9(2) 
C(133)-C(134)-H(13E) 120.1 
C(135)-C(134)-H(13E) 120.1 
C(130)-C(135)-C(134) 121.2(2) 
C(130)-C(135)-H(13F) 119.4 
C(134)-C(135)-H(13F) 119.4 
C(138)-C(136)-C(137) 111.96(18) 
C(138)-C(136)-C(129) 106.73(17) 
C(137)-C(136)-C(129) 110.21(16) 
C(138)-C(136)-C(140) 109.35(16) 
C(137)-C(136)-C(140) 108.97(17) 
C(129)-C(136)-C(140) 109.59(16) 
C(136)-C(137)-H(13G) 109.5 
C(136)-C(137)-H(13H) 109.5 
H(13G)-C(137)-H(13H) 109.5 
C(136)-C(137)-H(13I) 109.5 
H(13G)-C(137)-H(13I) 109.5 
H(13H)-C(137)-H(13I) 109.5 
C(139)-C(138)-C(136) 127.3(3) 
C(139)-C(138)-H(13J) 116.4 
C(136)-C(138)-H(13J) 116.4 
C(138)-C(139)-H(13K) 120.0 
C(138)-C(139)-H(13L) 120.0 
H(13K)-C(139)-H(13L) 120.0 
C(145)-C(140)-C(141) 108.34(18) 
C(145)-C(140)-C(136) 114.06(17) 
C(141)-C(140)-C(136) 112.79(18) 
C(145)-C(140)-H(14A) 107.1 
C(141)-C(140)-H(14A) 107.1 
C(136)-C(140)-H(14A) 107.1 
C(142)-C(141)-C(140) 111.9(2) 
C(142)-C(141)-H(14B) 109.2 
C(140)-C(141)-H(14B) 109.2 
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C(142)-C(141)-H(14C) 109.2 
C(140)-C(141)-H(14C) 109.2 
H(14B)-C(141)-H(14C) 107.9 
C(141)-C(142)-C(143) 112.0(2) 
C(141)-C(142)-H(14D) 109.2 
C(143)-C(142)-H(14D) 109.2 
C(141)-C(142)-H(14E) 109.2 
C(143)-C(142)-H(14E) 109.2 
H(14D)-C(142)-H(14E) 107.9 
C(144)-C(143)-C(142) 109.4(2) 
C(144)-C(143)-H(14F) 109.8 
C(142)-C(143)-H(14F) 109.8 
C(144)-C(143)-H(14G) 109.8 
C(142)-C(143)-H(14G) 109.8 
H(14F)-C(143)-H(14G) 108.2 
C(143)-C(144)-C(145) 111.3(2) 
C(143)-C(144)-H(14H) 109.4 
C(145)-C(144)-H(14H) 109.4 
C(143)-C(144)-H(14I) 109.4 
C(145)-C(144)-H(14I) 109.4 
H(14H)-C(144)-H(14I) 108.0 
C(144)-C(145)-C(140) 111.41(17) 
C(144)-C(145)-H(14J) 109.3 
C(140)-C(145)-H(14J) 109.3 
C(144)-C(145)-H(14K) 109.3 
C(140)-C(145)-H(14K) 109.3 
H(14J)-C(145)-H(14K) 108.0 
O(6)-P(6)-N(6) 110.90(9) 
O(6)-P(6)-C(152) 111.01(9) 
N(6)-P(6)-C(152) 112.32(9) 
O(6)-P(6)-C(146) 112.79(9) 
N(6)-P(6)-C(146) 104.33(8) 
C(152)-P(6)-C(146) 105.23(10) 
C(158)-N(6)-P(6) 117.85(13) 
C(158)-N(6)-H(6N) 121.1 
P(6)-N(6)-H(6N) 121.1 
C(151)-C(146)-C(147) 118.64(18) 
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C(151)-C(146)-P(6) 123.86(16) 
C(147)-C(146)-P(6) 117.38(16) 
C(148)-C(147)-C(146) 120.4(2) 
C(148)-C(147)-H(14L) 119.8 
C(146)-C(147)-H(14L) 119.8 
C(147)-C(148)-C(149) 120.7(2) 
C(147)-C(148)-H(14M) 119.7 
C(149)-C(148)-H(14M) 119.7 
C(150)-C(149)-C(148) 119.9(2) 
C(150)-C(149)-H(14N) 120.0 
C(148)-C(149)-H(14N) 120.0 
C(149)-C(150)-C(151) 119.7(2) 
C(149)-C(150)-H(15B) 120.2 
C(151)-C(150)-H(15B) 120.2 
C(146)-C(151)-C(150) 120.7(2) 
C(146)-C(151)-H(15C) 119.7 
C(150)-C(151)-H(15C) 119.7 
C(153)-C(152)-C(157) 119.6(2) 
C(153)-C(152)-P(6) 120.22(17) 
C(157)-C(152)-P(6) 120.14(15) 
C(154)-C(153)-C(152) 119.7(2) 
C(154)-C(153)-H(15D) 120.2 
C(152)-C(153)-H(15D) 120.2 
C(155)-C(154)-C(153) 120.3(2) 
C(155)-C(154)-H(15E) 119.9 
C(153)-C(154)-H(15E) 119.9 
C(154)-C(155)-C(156) 120.8(2) 
C(154)-C(155)-H(15F) 119.6 
C(156)-C(155)-H(15F) 119.6 
C(155)-C(156)-C(157) 119.8(2) 
C(155)-C(156)-H(15G) 120.1 
C(157)-C(156)-H(15G) 120.1 
C(156)-C(157)-C(152) 119.8(2) 
C(156)-C(157)-H(15H) 120.1 
C(152)-C(157)-H(15H) 120.1 
N(6)-C(158)-C(159) 112.44(16) 
N(6)-C(158)-C(165) 112.12(15) 
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C(159)-C(158)-C(165) 113.06(16) 
N(6)-C(158)-H(15I) 106.2 
C(159)-C(158)-H(15I) 106.2 
C(165)-C(158)-H(15I) 106.2 
C(164)-C(159)-C(160) 118.8(2) 
C(164)-C(159)-C(158) 119.19(19) 
C(160)-C(159)-C(158) 121.96(18) 
C(159)-C(160)-C(161) 119.9(2) 
C(159)-C(160)-H(16B) 120.0 
C(161)-C(160)-H(16B) 120.0 
C(162)-C(161)-C(160) 120.4(2) 
C(162)-C(161)-H(16C) 119.8 
C(160)-C(161)-H(16C) 119.8 
C(163)-C(162)-C(161) 119.8(2) 
C(163)-C(162)-H(16D) 120.1 
C(161)-C(162)-H(16D) 120.1 
C(162)-C(163)-C(164) 120.3(2) 
C(162)-C(163)-H(16E) 119.8 
C(164)-C(163)-H(16E) 119.8 
C(163)-C(164)-C(159) 120.8(2) 
C(163)-C(164)-H(16F) 119.6 
C(159)-C(164)-H(16F) 119.6 
C(167)-C(165)-C(166) 111.10(18) 
C(167)-C(165)-C(158) 106.57(17) 
C(166)-C(165)-C(158) 109.55(16) 
C(167)-C(165)-C(169) 109.89(17) 
C(166)-C(165)-C(169) 109.43(17) 
C(158)-C(165)-C(169) 110.27(17) 
C(165)-C(166)-H(16G) 109.5 
C(165)-C(166)-H(16H) 109.5 
H(16G)-C(166)-H(16H) 109.5 
C(165)-C(166)-H(16I) 109.5 
H(16G)-C(166)-H(16I) 109.5 
H(16H)-C(166)-H(16I) 109.5 
C(168)-C(167)-C(165) 128.0(2) 
C(168)-C(167)-H(16J) 116.0 
C(165)-C(167)-H(16J) 116.0 
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C(167)-C(168)-H(16K) 120.0 
C(167)-C(168)-H(16L) 120.0 
H(16K)-C(168)-H(16L) 120.0 
C(174)-C(169)-C(170) 109.05(19) 
C(174)-C(169)-C(165) 114.35(19) 
C(170)-C(169)-C(165) 112.72(19) 
C(174)-C(169)-H(16N) 106.7 
C(170)-C(169)-H(16N) 106.7 
C(165)-C(169)-H(16N) 106.7 
C(169)-C(170)-C(171) 112.6(2) 
C(169)-C(170)-H(17B) 109.1 
C(171)-C(170)-H(17B) 109.1 
C(169)-C(170)-H(17C) 109.1 
C(171)-C(170)-H(17C) 109.1 
H(17B)-C(170)-H(17C) 107.8 
C(172)-C(171)-C(170) 110.7(3) 
C(172)-C(171)-H(17D) 109.5 
C(170)-C(171)-H(17D) 109.5 
C(172)-C(171)-H(17E) 109.5 
C(170)-C(171)-H(17E) 109.5 
H(17D)-C(171)-H(17E) 108.1 
C(173)-C(172)-C(171) 109.8(2) 
C(173)-C(172)-H(17F) 109.7 
C(171)-C(172)-H(17F) 109.7 
C(173)-C(172)-H(17G) 109.7 
C(171)-C(172)-H(17G) 109.7 
H(17F)-C(172)-H(17G) 108.2 
C(174)-C(173)-C(172) 111.6(2) 
C(174)-C(173)-H(17H) 109.3 
C(172)-C(173)-H(17H) 109.3 
C(174)-C(173)-H(17I) 109.3 
C(172)-C(173)-H(17I) 109.3 
H(17H)-C(173)-H(17I) 108.0 
C(173)-C(174)-C(169) 111.9(2) 
C(173)-C(174)-H(17J) 109.2 
C(169)-C(174)-H(17J) 109.2 
C(173)-C(174)-H(17K) 109.2 
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C(169)-C(174)-H(17K) 109.2 
H(17J)-C(174)-H(17K) 107.9 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 
 
Table 4. Anisotropic displacement parameters (Å2 x 103) for C29H34NOP. The anisotropic 
displacement factor exponent takes the form: -2p2[ h2 a*2U11 +  ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
P(1) 23(1)  14(1) 19(1)  -1(1) 12(1)  -1(1) 
O(1) 30(1)  14(1) 24(1)  0(1) 15(1)  1(1) 
N(1) 31(1)  13(1) 22(1)  0(1) 17(1)  1(1) 
C(1) 22(1)  22(1) 22(1)  -2(1) 12(1)  -5(1) 
C(2) 26(1)  21(1) 30(1)  6(1) 10(1)  -1(1) 
C(3) 24(1)  32(1) 43(1)  13(1) 13(1)  -4(1) 
C(4) 22(1)  40(1) 41(1)  3(1) 18(1)  -1(1) 
C(5) 28(1)  27(1) 42(1)  -6(1) 19(1)  -2(1) 
C(6) 28(1)  19(1) 35(1)  -4(1) 17(1)  -5(1) 
C(7) 26(1)  13(1) 21(1)  1(1) 12(1)  -2(1) 
C(8) 26(1)  29(1) 26(1)  -2(1) 16(1)  -5(1) 
C(9) 37(1)  33(1) 26(1)  -4(1) 19(1)  -5(1) 
C(10) 33(1)  32(1) 21(1)  0(1) 8(1)  -3(1) 
C(11) 24(1)  32(1) 31(1)  3(1) 13(1)  0(1) 
C(12) 28(1)  26(1) 25(1)  0(1) 17(1)  -2(1) 
C(13) 29(1)  16(1) 21(1)  -3(1) 14(1)  -2(1) 
C(14) 27(1)  23(1) 18(1)  3(1) 13(1)  -2(1) 
C(15) 36(1)  23(1) 33(1)  -2(1) 20(1)  -4(1) 
C(16) 32(1)  31(1) 40(1)  2(1) 17(1)  -9(1) 
C(17) 29(1)  42(1) 41(1)  8(1) 22(1)  -3(1) 
C(18) 38(1)  37(1) 33(1)  6(1) 24(1)  7(1) 
C(19) 34(1)  27(1) 24(1)  -2(1) 20(1)  -2(1) 
C(20) 31(1)  18(1) 19(1)  0(1) 11(1)  2(1) 
C(21) 40(1)  20(1) 25(1)  1(1) 16(1)  1(1) 
C(22) 40(1)  21(1) 22(1)  -1(1) 13(1)  3(1) 
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C(23) 68(2)  34(1) 29(1)  1(1) 27(1)  9(1) 
C(24) 29(1)  25(1) 29(1)  -2(1) 10(1)  1(1) 
C(25) 37(1)  36(1) 39(1)  5(1) 4(1)  3(1) 
C(26) 32(1)  47(2) 58(2)  -1(1) 2(1)  4(1) 
C(27) 30(1)  46(2) 53(2)  -8(1) 7(1)  -3(1) 
C(28) 29(1)  37(1) 52(2)  -10(1) 18(1)  -6(1) 
C(29) 28(1)  23(1) 36(1)  -5(1) 13(1)  -3(1) 
P(2) 27(1)  16(1) 23(1)  -3(1) 17(1)  -4(1) 
O(2) 42(1)  16(1) 31(1)  -3(1) 24(1)  -4(1) 
N(2) 31(1)  17(1) 23(1)  -1(1) 18(1)  -6(1) 
C(30) 26(1)  31(1) 25(1)  -6(1) 16(1)  -5(1) 
C(31) 31(1)  35(1) 30(1)  -5(1) 19(1)  -1(1) 
C(32) 32(1)  54(2) 44(1)  -13(1) 20(1)  7(1) 
C(33) 25(1)  85(2) 76(2)  -35(2) 19(1)  -1(1) 
C(34) 29(1)  74(2) 111(3)  -52(2) 29(2)  -19(1) 
C(35) 38(1)  42(2) 68(2)  -28(1) 28(1)  -13(1) 
C(36) 25(1)  19(1) 22(1)  -5(1) 16(1)  -6(1) 
C(37) 34(1)  30(1) 29(1)  5(1) 20(1)  4(1) 
C(38) 52(1)  29(1) 33(1)  4(1) 29(1)  0(1) 
C(39) 47(1)  32(1) 35(1)  -10(1) 32(1)  -15(1) 
C(40) 26(1)  30(1) 31(1)  -7(1) 17(1)  -5(1) 
C(41) 29(1)  22(1) 30(1)  -4(1) 18(1)  -3(1) 
C(42) 30(1)  15(1) 23(1)  0(1) 18(1)  -1(1) 
C(43) 29(1)  25(1) 20(1)  -4(1) 15(1)  -5(1) 
C(44) 40(1)  31(1) 29(1)  -4(1) 21(1)  -11(1) 
C(45) 47(1)  53(2) 36(1)  -14(1) 30(1)  -25(1) 
C(46) 30(1)  68(2) 37(1)  -22(1) 22(1)  -13(1) 
C(47) 31(1)  51(2) 25(1)  -10(1) 12(1)  4(1) 
C(48) 30(1)  29(1) 22(1)  -2(1) 13(1)  -1(1) 
C(49) 28(1)  14(1) 25(1)  2(1) 16(1)  0(1) 
C(50) 30(1)  21(1) 22(1)  -2(1) 14(1)  -2(1) 
C(51) 34(1)  20(1) 28(1)  2(1) 16(1)  -2(1) 
C(52) 53(1)  31(1) 29(1)  7(1) 19(1)  -6(1) 
C(53) 28(1)  19(1) 31(1)  1(1) 17(1)  1(1) 
C(54) 34(1)  33(1) 37(1)  -8(1) 18(1)  -3(1) 
C(55) 29(1)  45(1) 55(2)  -12(1) 22(1)  -5(1) 
C(56) 32(1)  43(1) 52(2)  -6(1) 22(1)  3(1) 
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C(57) 36(1)  32(1) 43(1)  -3(1) 25(1)  6(1) 
C(58) 32(1)  21(1) 32(1)  -1(1) 19(1)  2(1) 
P(3) 19(1)  14(1) 21(1)  0(1) 9(1)  -1(1) 
O(3) 25(1)  18(1) 25(1)  0(1) 11(1)  0(1) 
N(3) 21(1)  12(1) 21(1)  -2(1) 8(1)  -4(1) 
C(59) 22(1)  15(1) 21(1)  -1(1) 8(1)  0(1) 
C(60) 26(1)  27(1) 29(1)  4(1) 14(1)  2(1) 
C(61) 24(1)  34(1) 36(1)  5(1) 11(1)  -1(1) 
C(62) 25(1)  27(1) 29(1)  -2(1) 4(1)  -1(1) 
C(63) 35(1)  46(1) 22(1)  4(1) 10(1)  -3(1) 
C(64) 26(1)  36(1) 25(1)  2(1) 12(1)  -4(1) 
C(65) 20(1)  18(1) 26(1)  0(1) 11(1)  1(1) 
C(66) 25(1)  21(1) 29(1)  -3(1) 11(1)  -2(1) 
C(67) 28(1)  26(1) 40(1)  2(1) 20(1)  -5(1) 
C(68) 25(1)  31(1) 44(1)  1(1) 23(1)  4(1) 
C(69) 33(1)  20(1) 44(1)  -4(1) 24(1)  1(1) 
C(70) 27(1)  18(1) 38(1)  -2(1) 18(1)  -3(1) 
C(71) 29(1)  17(1) 24(1)  -2(1) 13(1)  0(1) 
C(72) 27(1)  22(1) 26(1)  -1(1) 13(1)  -2(1) 
C(73) 27(1)  25(1) 30(1)  -4(1) 13(1)  -1(1) 
C(74) 32(1)  29(1) 46(1)  0(1) 23(1)  1(1) 
C(75) 24(1)  31(1) 49(1)  6(1) 17(1)  0(1) 
C(76) 30(1)  32(1) 41(1)  -8(1) 11(1)  -9(1) 
C(77) 29(1)  24(1) 42(1)  -3(1) 16(1)  0(1) 
C(78) 30(1)  20(1) 27(1)  -1(1) 16(1)  0(1) 
C(79) 26(1)  18(1) 29(1)  6(1) 13(1)  2(1) 
C(80) 39(1)  32(1) 28(1)  -3(1) 18(1)  0(1) 
C(81) 62(2)  45(2) 25(1)  1(1) 14(1)  3(1) 
C(82) 28(1)  22(1) 33(1)  0(1) 19(1)  0(1) 
C(83) 40(1)  28(1) 44(1)  5(1) 28(1)  -1(1) 
C(84) 42(1)  28(1) 66(2)  3(1) 37(1)  -3(1) 
C(85) 43(1)  32(1) 69(2)  4(1) 43(1)  4(1) 
C(86) 34(1)  27(1) 63(2)  4(1) 32(1)  3(1) 
C(87) 37(1)  21(1) 52(1)  1(1) 30(1)  0(1) 
P(4) 17(1)  15(1) 25(1)  1(1) 9(1)  1(1) 
O(4) 25(1)  16(1) 32(1)  3(1) 14(1)  3(1) 
N(4) 18(1)  15(1) 30(1)  -1(1) 12(1)  -1(1) 
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C(88) 25(1)  17(1) 29(1)  3(1) 14(1)  2(1) 
C(89) 25(1)  25(1) 32(1)  1(1) 13(1)  1(1) 
C(90) 41(1)  26(1) 31(1)  -2(1) 15(1)  1(1) 
C(91) 50(1)  32(1) 38(1)  0(1) 29(1)  1(1) 
C(92) 38(1)  32(1) 46(1)  -1(1) 29(1)  -3(1) 
C(93) 28(1)  23(1) 36(1)  -1(1) 18(1)  -2(1) 
C(94) 18(1)  19(1) 27(1)  2(1) 13(1)  -4(1) 
C(95) 23(1)  24(1) 33(1)  3(1) 10(1)  1(1) 
C(96) 23(1)  36(1) 40(1)  13(1) 12(1)  4(1) 
C(97) 24(1)  49(2) 33(1)  5(1) 6(1)  -4(1) 
C(98) 35(1)  37(1) 39(1)  -11(1) 10(1)  -12(1) 
C(99) 24(1)  25(1) 36(1)  -1(1) 12(1)  -3(1) 
C(100) 16(1)  17(1) 29(1)  -2(1) 9(1)  2(1) 
C(101) 16(1)  30(1) 30(1)  -2(1) 8(1)  -1(1) 
C(102) 21(1)  36(1) 30(1)  1(1) 9(1)  7(1) 
C(103) 30(1)  59(2) 32(1)  0(1) 7(1)  17(1) 
C(104) 38(1)  76(2) 28(1)  -13(1) -1(1)  12(1) 
C(105) 42(1)  64(2) 39(1)  -26(1) 4(1)  9(1) 
C(106) 26(1)  42(1) 36(1)  -12(1) 4(1)  3(1) 
C(107) 16(1)  19(1) 26(1)  1(1) 8(1)  -1(1) 
C(108) 23(1)  22(1) 33(1)  4(1) 10(1)  -2(1) 
C(109) 17(1)  26(1) 28(1)  1(1) 8(1)  2(1) 
C(110) 39(1)  49(2) 42(1)  10(1) 25(1)  13(1) 
C(111) 16(1)  17(1) 27(1)  0(1) 10(1)  0(1) 
C(112) 19(1)  23(1) 27(1)  3(1) 10(1)  -2(1) 
C(113) 21(1)  32(1) 30(1)  -4(1) 11(1)  -5(1) 
C(114) 23(1)  36(1) 24(1)  3(1) 8(1)  1(1) 
C(115) 24(1)  32(1) 28(1)  8(1) 13(1)  2(1) 
C(116) 19(1)  23(1) 28(1)  3(1) 9(1)  1(1) 
P(5) 24(1)  13(1) 19(1)  2(1) 10(1)  1(1) 
O(5) 28(1)  14(1) 24(1)  2(1) 11(1)  1(1) 
N(5) 32(1)  10(1) 21(1)  1(1) 16(1)  0(1) 
C(117) 25(1)  24(1) 17(1)  2(1) 10(1)  6(1) 
C(118) 35(1)  23(1) 26(1)  -1(1) 10(1)  6(1) 
C(119) 33(1)  41(1) 24(1)  -8(1) 10(1)  4(1) 
C(120) 29(1)  50(2) 20(1)  4(1) 8(1)  2(1) 
C(121) 29(1)  35(1) 31(1)  15(1) 11(1)  3(1) 
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C(122) 26(1)  21(1) 29(1)  4(1) 13(1)  2(1) 
C(123) 26(1)  17(1) 31(1)  4(1) 14(1)  2(1) 
C(124) 33(1)  50(2) 33(1)  13(1) 19(1)  9(1) 
C(125) 41(1)  67(2) 63(2)  19(2) 37(1)  13(1) 
C(126) 30(1)  44(2) 71(2)  12(1) 24(1)  4(1) 
C(127) 32(1)  36(1) 54(2)  -8(1) 10(1)  -5(1) 
C(128) 33(1)  31(1) 36(1)  -8(1) 15(1)  -3(1) 
C(129) 27(1)  18(1) 21(1)  0(1) 12(1)  -2(1) 
C(130) 26(1)  20(1) 21(1)  0(1) 12(1)  1(1) 
C(131) 33(1)  21(1) 24(1)  -1(1) 13(1)  -2(1) 
C(132) 32(1)  29(1) 26(1)  -9(1) 8(1)  -2(1) 
C(133) 27(1)  48(1) 20(1)  -3(1) 8(1)  6(1) 
C(134) 38(1)  53(2) 24(1)  13(1) 15(1)  4(1) 
C(135) 31(1)  32(1) 28(1)  7(1) 14(1)  -4(1) 
C(136) 24(1)  26(1) 24(1)  -1(1) 12(1)  -2(1) 
C(137) 33(1)  27(1) 34(1)  -8(1) 15(1)  4(1) 
C(138) 28(1)  48(1) 29(1)  -1(1) 14(1)  -8(1) 
C(139) 46(2)  86(2) 45(2)  -4(2) 31(1)  -6(1) 
C(140) 25(1)  26(1) 24(1)  0(1) 9(1)  -1(1) 
C(141) 27(1)  43(1) 40(1)  -8(1) 5(1)  7(1) 
C(142) 40(1)  48(2) 44(2)  -3(1) 0(1)  14(1) 
C(143) 35(1)  46(2) 34(1)  -3(1) 0(1)  -1(1) 
C(144) 36(1)  31(1) 30(1)  -4(1) 8(1)  -7(1) 
C(145) 28(1)  24(1) 26(1)  -1(1) 11(1)  -4(1) 
P(6) 30(1)  15(1) 18(1)  1(1) 11(1)  3(1) 
O(6) 41(1)  16(1) 29(1)  1(1) 17(1)  4(1) 
N(6) 31(1)  15(1) 20(1)  4(1) 13(1)  5(1) 
C(146) 33(1)  16(1) 20(1)  1(1) 14(1)  7(1) 
C(147) 35(1)  22(1) 26(1)  -3(1) 14(1)  -5(1) 
C(148) 40(1)  26(1) 21(1)  -3(1) 10(1)  0(1) 
C(149) 50(1)  34(1) 26(1)  2(1) 21(1)  0(1) 
C(150) 45(1)  51(2) 36(1)  4(1) 23(1)  -10(1) 
C(151) 32(1)  46(2) 29(1)  2(1) 14(1)  -2(1) 
C(152) 29(1)  25(1) 20(1)  0(1) 9(1)  5(1) 
C(153) 42(1)  26(1) 28(1)  1(1) 9(1)  12(1) 
C(154) 43(1)  43(2) 41(1)  -2(1) 0(1)  22(1) 
C(155) 31(1)  55(2) 54(2)  -15(1) -3(1)  6(1) 
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C(156) 37(1)  31(1) 46(1)  -6(1) 6(1)  -1(1) 
C(157) 31(1)  22(1) 31(1)  3(1) 8(1)  5(1) 
C(158) 38(1)  13(1) 24(1)  2(1) 18(1)  -2(1) 
C(159) 35(1)  24(1) 22(1)  6(1) 16(1)  8(1) 
C(160) 32(1)  31(1) 23(1)  2(1) 15(1)  3(1) 
C(161) 32(1)  51(2) 26(1)  -10(1) 13(1)  -1(1) 
C(162) 42(1)  75(2) 17(1)  8(1) 12(1)  26(1) 
C(163) 60(2)  45(2) 33(1)  18(1) 30(1)  26(1) 
C(164) 56(1)  28(1) 32(1)  10(1) 30(1)  13(1) 
C(165) 34(1)  22(1) 25(1)  -2(1) 16(1)  -7(1) 
C(166) 27(1)  28(1) 25(1)  -2(1) 12(1)  0(1) 
C(167) 43(1)  32(1) 38(1)  -2(1) 22(1)  -11(1) 
C(168) 69(2)  52(2) 57(2)  -5(1) 43(2)  -22(1) 
C(169) 36(1)  30(1) 25(1)  -2(1) 12(1)  -9(1) 
C(170) 36(1)  56(2) 41(1)  -12(1) 11(1)  -12(1) 
C(171) 37(1)  83(2) 38(2)  -11(2) 5(1)  -12(1) 
C(172) 56(2)  82(2) 35(1)  -17(2) 12(1)  -29(2) 
C(173) 64(2)  52(2) 33(1)  -12(1) 22(1)  -22(1) 
C(174) 55(2)  36(1) 33(1)  -12(1) 22(1)  -18(1) 
______________________________________________________________________________  
 
 
Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2 x 10 3) 
for C29H34NOP 
______________________________________________________________________________ 
 x  y  z  U(eq) 
______________________________________________________________________________ 
H(1N) 55 1812 508 25 
H(2A) 915 3656 -62 32 
H(3A) 1925 3591 -105 41 
H(4A) 2410 2593 -70 40 
H(5A) 1903 1644 32 38 
H(6A) 897 1701 89 32 
H(8A) -41 2485 -1245 31 
H(9A) -927 2321 -2324 36 
H(10A) -2036 2248 -2519 37 
H(11A) -2266 2323 -1635 35 
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H(12A) -1390 2491 -561 29 
H(13A) 90 2916 1208 25 
H(15A) -985 1514 563 35 
H(16A) -2109 1489 330 42 
H(17A) -2560 2339 656 42 
H(18A) -1878 3226 1213 40 
H(19A) -754 3263 1436 31 
H(21A) -113 1369 1796 42 
H(21B) 674 1203 2250 42 
H(21C) 335 1172 1458 42 
H(22A) 587 2945 2385 34 
H(23A) 320 1814 2873 51 
H(23B) 409 2547 3185 51 
H(24A) 1212 1909 1490 35 
H(25A) 1831 2106 2899 52 
H(25B) 1684 1411 2547 52 
H(26A) 2836 1711 2963 65 
H(26B) 2467 1613 2174 65 
H(27A) 3114 2558 2437 59 
H(27B) 2755 2837 2838 59 
H(28A) 2093 2634 1426 48 
H(28B) 2252 3327 1781 48 
H(29A) 1091 3050 1378 36 
H(29B) 1470 3128 2170 36 
H(2N) 9921 9442 9713 26 
H(31A) 11246 8955 10768 36 
H(32A) 12379 8675 11386 51 
H(33A) 13180 9464 12000 77 
H(34A) 12856 10532 11947 88 
H(35A) 11716 10829 11327 58 
H(37A) 10775 9134 11551 35 
H(38A) 10129 8693 11995 42 
H(39A) 9030 9054 11633 39 
H(40A) 8576 9875 10846 33 
H(41A) 9214 10317 10395 30 
H(42A) 10057 10646 9300 25 
H(44A) 10795 11039 8922 38 
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H(45A) 11844 10984 8964 50 
H(46A) 12487 10040 9325 52 
H(47A) 12054 9135 9602 43 
H(48A) 10988 9181 9530 32 
H(50A) 9966 9297 8297 36 
H(50B) 9162 9193 7930 36 
H(50C) 9614 9003 8697 36 
H(51A) 9381 10927 8145 32 
H(52A) 9387 9934 7330 45 
H(52B) 9325 10715 7170 45 
H(53A) 8865 9669 8950 30 
H(54A) 8114 10217 7647 41 
H(54B) 8214 9457 7801 41 
H(55A) 7135 9800 7631 51 
H(55B) 7580 9512 8364 51 
H(56A) 7072 10477 8440 51 
H(56B) 7378 10864 8042 51 
H(57A) 8061 11075 9188 42 
H(57B) 8167 10316 9346 42 
H(58A) 9141 10741 9357 32 
H(58B) 8692 11021 8621 32 
H(3N) 5035 2062 9622 23 
H(60A) 6176 1480 10266 32 
H(61A) 7236 1464 11227 39 
H(62A) 7326 1178 12243 37 
H(63A) 6363 900 12305 43 
H(64A) 5305 908 11358 35 
H(66A) 3822 411 10127 31 
H(67A) 3117 608 10586 36 
H(68A) 3122 1621 11037 37 
H(69A) 3800 2453 10984 36 
H(70A) 4497 2262 10522 32 
H(71A) 4510 1161 8650 28 
H(73A) 3610 2300 9110 34 
H(74A) 2448 2292 8715 41 
H(75A) 1747 1566 7874 42 
H(76A) 2242 833 7469 44 
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H(77A) 3414 833 7882 38 
H(79A) 3788 2728 8133 36 
H(79B) 4393 3054 8063 36 
H(79C) 4477 2924 8784 36 
H(80A) 4406 1387 7615 39 
H(81A) 3743 2536 7073 57 
H(81B) 3739 1874 6675 57 
H(82A) 5539 2333 9110 31 
H(83A) 5437 2429 7823 41 
H(83B) 5386 3032 8235 41 
H(84A) 6513 2884 9063 49 
H(84B) 6491 2950 8361 49 
H(85A) 6608 1827 8307 50 
H(85B) 7213 2085 8999 50 
H(86A) 6641 1741 9565 46 
H(86B) 6704 1139 9160 46 
H(87A) 5574 1296 8307 40 
H(87B) 5585 1200 9002 40 
H(4N) 5189 9544 9926 25 
H(89A) 5427 9325 11016 33 
H(90A) 5292 9730 11892 41 
H(91A) 4242 9676 11845 44 
H(92A) 3310 9231 10916 42 
H(93A) 3441 8824 10047 34 
H(95A) 3606 9665 9074 33 
H(96A) 2566 9701 8107 41 
H(97A) 2095 8761 7495 47 
H(98A) 2666 7775 7863 49 
H(99A) 3703 7729 8834 35 
H(10B) 5557 8468 9477 25 
H(10C) 4567 9857 8602 36 
H(10D) 3914 9936 7450 53 
H(10E) 3916 9098 6776 66 
H(10F) 4601 8197 7250 66 
H(10G) 5255 8110 8405 47 
H(10H) 6463 10200 9506 41 
H(10I) 5759 10217 9514 41 
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H(10J) 5781 9972 8866 41 
H(10K) 6700 8495 9573 29 
H(11B) 6542 9444 8667 49 
H(11C) 6939 8748 8788 49 
H(11E) 6274 9607 10536 24 
H(11F) 7518 9372 10518 29 
H(11G) 7188 10072 10458 29 
H(11H) 8069 9885 11567 34 
H(11I) 7358 9989 11553 34 
H(11J) 7973 8751 11632 35 
H(11K) 7916 9088 12230 35 
H(11L) 6724 9004 11634 33 
H(11M) 7047 8300 11698 33 
H(11N) 6871 8368 10599 29 
H(11O) 6164 8479 10589 29 
H(5N) 9630 2781 5191 24 
H(11P) 9295 940 3837 37 
H(11Q) 8703 1036 2684 41 
H(12B) 8444 2050 2185 42 
H(12C) 8778 2979 2842 40 
H(12D) 9367 2897 3996 30 
H(12E) 10660 1904 4249 45 
H(12F) 11801 2070 4597 63 
H(12G) 12554 2298 5710 59 
H(12H) 12168 2332 6480 54 
H(12I) 11025 2187 6137 42 
H(12J) 9235 1713 5647 26 
H(13B) 10198 3172 6317 32 
H(13C) 10949 3335 7443 38 
H(13D) 11018 2590 8230 40 
H(13E) 10368 1648 7885 46 
H(13F) 9617 1479 6760 37 
H(13G) 8976 3288 6129 48 
H(13H) 8242 3428 5512 48 
H(13I) 8897 3451 5416 48 
H(13J) 8262 1689 5778 41 
H(13K) 8058 2849 6267 66 
 
Page 393
	  	  
H(13L) 7859 2118 6399 66 
H(14A) 8366 2669 4485 32 
H(14B) 7194 2514 4647 50 
H(14C) 7488 3198 4581 50 
H(14D) 7235 2954 3489 63 
H(14E) 6561 2885 3550 63 
H(14F) 6666 1748 3606 55 
H(14G) 6684 1992 2953 55 
H(14H) 7876 1918 3503 43 
H(14I) 7576 1233 3561 43 
H(14J) 8494 1530 4608 32 
H(14K) 7811 1483 4656 32 
H(6N) 9460 10116 4844 26 
H(14L) 9180 9395 3630 34 
H(14M) 9023 9733 2603 37 
H(14N) 9881 10278 2520 43 
H(15B) 10900 10507 3476 51 
H(15C) 11077 10140 4510 43 
H(15D) 11481 8737 5822 43 
H(15E) 12574 9069 6595 62 
H(15F) 12825 10157 6797 68 
H(15G) 11989 10936 6253 53 
H(15H) 10887 10618 5492 37 
H(15I) 9400 8945 5366 29 
H(16B) 10197 10428 6187 34 
H(16C) 10965 10506 7324 44 
H(16D) 11161 9617 8017 55 
H(16E) 10582 8656 7581 51 
H(16F) 9819 8571 6454 42 
H(16G) 8969 10304 6023 40 
H(16H) 8213 10411 5431 40 
H(16I) 8845 10599 5331 40 
H(16J) 8431 8681 5483 44 
H(16K) 8249 9648 6211 65 
H(16L) 8112 8868 6230 65 
H(16N) 8367 9936 4322 39 
H(17B) 7445 10181 4489 57 
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H(17C) 7288 9427 4500 57 
H(17D) 6532 9843 3441 70 
H(17E) 7149 10120 3357 70 
H(17F) 6865 8769 3399 74 
H(17G) 6777 9146 2753 74 
H(17H) 7809 8554 3250 61 
H(17I) 7955 9313 3255 61 
H(17J) 8701 8865 4297 49 
H(17K) 8074 8599 4370 49 
 
 
Table 6. Torsion angles [°] for C29H34NOP 
________________________________________________________________  
O(1)-P(1)-N(1)-C(13) -5.86(17) 
C(1)-P(1)-N(1)-C(13) 117.80(15) 
C(7)-P(1)-N(1)-C(13) -127.98(15) 
O(1)-P(1)-C(1)-C(2) -17.79(19) 
N(1)-P(1)-C(1)-C(2) -141.16(16) 
C(7)-P(1)-C(1)-C(2) 102.50(17) 
O(1)-P(1)-C(1)-C(6) 164.56(15) 
N(1)-P(1)-C(1)-C(6) 41.19(18) 
C(7)-P(1)-C(1)-C(6) -75.15(18) 
C(6)-C(1)-C(2)-C(3) -0.4(3) 
P(1)-C(1)-C(2)-C(3) -178.03(16) 
C(1)-C(2)-C(3)-C(4) 0.7(3) 
C(2)-C(3)-C(4)-C(5) -0.7(3) 
C(3)-C(4)-C(5)-C(6) 0.3(3) 
C(4)-C(5)-C(6)-C(1) 0.1(3) 
C(2)-C(1)-C(6)-C(5) 0.0(3) 
P(1)-C(1)-C(6)-C(5) 177.62(16) 
O(1)-P(1)-C(7)-C(8) 107.14(17) 
N(1)-P(1)-C(7)-C(8) -130.38(17) 
C(1)-P(1)-C(7)-C(8) -13.84(19) 
O(1)-P(1)-C(7)-C(12) -63.94(17) 
N(1)-P(1)-C(7)-C(12) 58.54(17) 
C(1)-P(1)-C(7)-C(12) 175.08(15) 
C(12)-C(7)-C(8)-C(9) 0.2(3) 
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P(1)-C(7)-C(8)-C(9) -170.88(16) 
C(7)-C(8)-C(9)-C(10) 0.1(3) 
C(8)-C(9)-C(10)-C(11) -0.5(3) 
C(9)-C(10)-C(11)-C(12) 0.7(3) 
C(10)-C(11)-C(12)-C(7) -0.4(3) 
C(8)-C(7)-C(12)-C(11) 0.0(3) 
P(1)-C(7)-C(12)-C(11) 171.42(16) 
P(1)-N(1)-C(13)-C(14) 97.76(17) 
P(1)-N(1)-C(13)-C(20) -132.96(15) 
N(1)-C(13)-C(14)-C(15) 41.2(2) 
C(20)-C(13)-C(14)-C(15) -87.6(2) 
N(1)-C(13)-C(14)-C(19) -135.59(18) 
C(20)-C(13)-C(14)-C(19) 95.6(2) 
C(19)-C(14)-C(15)-C(16) 0.0(3) 
C(13)-C(14)-C(15)-C(16) -176.83(19) 
C(14)-C(15)-C(16)-C(17) -0.4(3) 
C(15)-C(16)-C(17)-C(18) 0.3(3) 
C(16)-C(17)-C(18)-C(19) 0.2(3) 
C(17)-C(18)-C(19)-C(14) -0.6(3) 
C(15)-C(14)-C(19)-C(18) 0.5(3) 
C(13)-C(14)-C(19)-C(18) 177.42(18) 
N(1)-C(13)-C(20)-C(22) 167.21(16) 
C(14)-C(13)-C(20)-C(22) -65.4(2) 
N(1)-C(13)-C(20)-C(21) -71.3(2) 
C(14)-C(13)-C(20)-C(21) 56.0(2) 
N(1)-C(13)-C(20)-C(24) 49.1(2) 
C(14)-C(13)-C(20)-C(24) 176.52(15) 
C(21)-C(20)-C(22)-C(23) 3.6(3) 
C(13)-C(20)-C(22)-C(23) 124.4(3) 
C(24)-C(20)-C(22)-C(23) -118.4(3) 
C(22)-C(20)-C(24)-C(29) -61.6(2) 
C(21)-C(20)-C(24)-C(29) 175.20(17) 
C(13)-C(20)-C(24)-C(29) 54.1(2) 
C(22)-C(20)-C(24)-C(25) 62.9(2) 
C(21)-C(20)-C(24)-C(25) -60.3(2) 
C(13)-C(20)-C(24)-C(25) 178.63(18) 
C(29)-C(24)-C(25)-C(26) -55.4(3) 
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C(20)-C(24)-C(25)-C(26) 176.9(2) 
C(24)-C(25)-C(26)-C(27) 56.4(3) 
C(25)-C(26)-C(27)-C(28) -55.3(3) 
C(26)-C(27)-C(28)-C(29) 55.5(3) 
C(27)-C(28)-C(29)-C(24) -57.7(3) 
C(25)-C(24)-C(29)-C(28) 56.5(2) 
C(20)-C(24)-C(29)-C(28) -176.81(18) 
O(2)-P(2)-N(2)-C(42) 33.75(17) 
C(30)-P(2)-N(2)-C(42) -90.82(16) 
C(36)-P(2)-N(2)-C(42) 155.16(14) 
O(2)-P(2)-C(30)-C(31) -170.72(16) 
N(2)-P(2)-C(30)-C(31) -46.1(2) 
C(36)-P(2)-C(30)-C(31) 65.80(19) 
O(2)-P(2)-C(30)-C(35) 10.1(2) 
N(2)-P(2)-C(30)-C(35) 134.69(19) 
C(36)-P(2)-C(30)-C(35) -113.4(2) 
C(35)-C(30)-C(31)-C(32) 0.6(3) 
P(2)-C(30)-C(31)-C(32) -178.56(18) 
C(30)-C(31)-C(32)-C(33) 0.6(4) 
C(31)-C(32)-C(33)-C(34) -1.8(5) 
C(32)-C(33)-C(34)-C(35) 1.8(6) 
C(33)-C(34)-C(35)-C(30) -0.6(5) 
C(31)-C(30)-C(35)-C(34) -0.6(4) 
P(2)-C(30)-C(35)-C(34) 178.6(2) 
O(2)-P(2)-C(36)-C(37) -134.23(18) 
N(2)-P(2)-C(36)-C(37) 105.46(19) 
C(30)-P(2)-C(36)-C(37) -11.8(2) 
O(2)-P(2)-C(36)-C(41) 45.76(17) 
N(2)-P(2)-C(36)-C(41) -74.55(16) 
C(30)-P(2)-C(36)-C(41) 168.22(15) 
C(41)-C(36)-C(37)-C(38) 0.9(3) 
P(2)-C(36)-C(37)-C(38) -179.15(17) 
C(36)-C(37)-C(38)-C(39) -0.1(3) 
C(37)-C(38)-C(39)-C(40) -0.8(3) 
C(38)-C(39)-C(40)-C(41) 0.9(3) 
C(39)-C(40)-C(41)-C(36) -0.2(3) 
C(37)-C(36)-C(41)-C(40) -0.7(3) 
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P(2)-C(36)-C(41)-C(40) 179.30(15) 
P(2)-N(2)-C(42)-C(43) 79.29(18) 
P(2)-N(2)-C(42)-C(49) -151.37(13) 
N(2)-C(42)-C(43)-C(48) 35.6(2) 
C(49)-C(42)-C(43)-C(48) -91.7(2) 
N(2)-C(42)-C(43)-C(44) -140.93(18) 
C(49)-C(42)-C(43)-C(44) 91.8(2) 
C(48)-C(43)-C(44)-C(45) 0.0(3) 
C(42)-C(43)-C(44)-C(45) 176.59(19) 
C(43)-C(44)-C(45)-C(46) -1.1(3) 
C(44)-C(45)-C(46)-C(47) 1.3(3) 
C(45)-C(46)-C(47)-C(48) -0.4(3) 
C(44)-C(43)-C(48)-C(47) 1.0(3) 
C(42)-C(43)-C(48)-C(47) -175.56(18) 
C(46)-C(47)-C(48)-C(43) -0.8(3) 
N(2)-C(42)-C(49)-C(51) 165.82(16) 
C(43)-C(42)-C(49)-C(51) -66.4(2) 
N(2)-C(42)-C(49)-C(50) -72.92(19) 
C(43)-C(42)-C(49)-C(50) 54.9(2) 
N(2)-C(42)-C(49)-C(53) 47.5(2) 
C(43)-C(42)-C(49)-C(53) 175.28(16) 
C(50)-C(49)-C(51)-C(52) 5.0(3) 
C(42)-C(49)-C(51)-C(52) 124.9(2) 
C(53)-C(49)-C(51)-C(52) -116.2(2) 
C(51)-C(49)-C(53)-C(54) 59.0(2) 
C(50)-C(49)-C(53)-C(54) -63.2(2) 
C(42)-C(49)-C(53)-C(54) 176.68(17) 
C(51)-C(49)-C(53)-C(58) -65.4(2) 
C(50)-C(49)-C(53)-C(58) 172.33(17) 
C(42)-C(49)-C(53)-C(58) 52.2(2) 
C(58)-C(53)-C(54)-C(55) -55.8(2) 
C(49)-C(53)-C(54)-C(55) 177.10(19) 
C(53)-C(54)-C(55)-C(56) 56.8(3) 
C(54)-C(55)-C(56)-C(57) -55.6(3) 
C(55)-C(56)-C(57)-C(58) 55.9(3) 
C(56)-C(57)-C(58)-C(53) -57.2(2) 
C(54)-C(53)-C(58)-C(57) 56.0(2) 
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C(49)-C(53)-C(58)-C(57) -177.83(17) 
O(3)-P(3)-N(3)-C(71) 27.24(16) 
C(59)-P(3)-N(3)-C(71) 150.96(14) 
C(65)-P(3)-N(3)-C(71) -97.50(15) 
O(3)-P(3)-C(59)-C(60) 86.49(18) 
N(3)-P(3)-C(59)-C(60) -36.06(18) 
C(65)-P(3)-C(59)-C(60) -153.49(16) 
O(3)-P(3)-C(59)-C(64) -86.94(17) 
N(3)-P(3)-C(59)-C(64) 150.50(16) 
C(65)-P(3)-C(59)-C(64) 33.08(18) 
C(64)-C(59)-C(60)-C(61) -0.8(3) 
P(3)-C(59)-C(60)-C(61) -174.27(17) 
C(59)-C(60)-C(61)-C(62) 0.2(3) 
C(60)-C(61)-C(62)-C(63) 0.3(3) 
C(61)-C(62)-C(63)-C(64) -0.2(4) 
C(62)-C(63)-C(64)-C(59) -0.4(4) 
C(60)-C(59)-C(64)-C(63) 0.9(3) 
P(3)-C(59)-C(64)-C(63) 174.52(18) 
O(3)-P(3)-C(65)-C(66) 10.76(19) 
N(3)-P(3)-C(65)-C(66) 135.73(16) 
C(59)-P(3)-C(65)-C(66) -110.82(17) 
O(3)-P(3)-C(65)-C(70) -174.08(15) 
N(3)-P(3)-C(65)-C(70) -49.11(18) 
C(59)-P(3)-C(65)-C(70) 64.35(18) 
C(70)-C(65)-C(66)-C(67) 0.0(3) 
P(3)-C(65)-C(66)-C(67) 175.28(16) 
C(65)-C(66)-C(67)-C(68) -0.8(3) 
C(66)-C(67)-C(68)-C(69) 1.4(3) 
C(67)-C(68)-C(69)-C(70) -1.2(3) 
C(68)-C(69)-C(70)-C(65) 0.4(3) 
C(66)-C(65)-C(70)-C(69) 0.2(3) 
P(3)-C(65)-C(70)-C(69) -175.01(17) 
P(3)-N(3)-C(71)-C(72) 66.48(19) 
P(3)-N(3)-C(71)-C(78) -165.79(13) 
N(3)-C(71)-C(72)-C(77) -139.0(2) 
C(78)-C(71)-C(72)-C(77) 93.5(2) 
N(3)-C(71)-C(72)-C(73) 39.8(3) 
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C(78)-C(71)-C(72)-C(73) -87.7(2) 
C(77)-C(72)-C(73)-C(74) -3.4(3) 
C(71)-C(72)-C(73)-C(74) 177.75(19) 
C(72)-C(73)-C(74)-C(75) 0.8(3) 
C(73)-C(74)-C(75)-C(76) 1.4(4) 
C(74)-C(75)-C(76)-C(77) -0.8(4) 
C(73)-C(72)-C(77)-C(76) 3.9(3) 
C(71)-C(72)-C(77)-C(76) -177.2(2) 
C(75)-C(76)-C(77)-C(72) -1.9(4) 
N(3)-C(71)-C(78)-C(80) 163.30(16) 
C(72)-C(71)-C(78)-C(80) -68.8(2) 
N(3)-C(71)-C(78)-C(79) -75.3(2) 
C(72)-C(71)-C(78)-C(79) 52.6(2) 
N(3)-C(71)-C(78)-C(82) 45.8(2) 
C(72)-C(71)-C(78)-C(82) 173.65(16) 
C(79)-C(78)-C(80)-C(81) 6.1(3) 
C(71)-C(78)-C(80)-C(81) 127.4(3) 
C(82)-C(78)-C(80)-C(81) -114.6(3) 
C(80)-C(78)-C(82)-C(87) -63.3(2) 
C(79)-C(78)-C(82)-C(87) 174.91(18) 
C(71)-C(78)-C(82)-C(87) 52.7(2) 
C(80)-C(78)-C(82)-C(83) 61.9(2) 
C(79)-C(78)-C(82)-C(83) -59.9(2) 
C(71)-C(78)-C(82)-C(83) 177.87(17) 
C(87)-C(82)-C(83)-C(84) -56.2(2) 
C(78)-C(82)-C(83)-C(84) 175.86(18) 
C(82)-C(83)-C(84)-C(85) 56.3(3) 
C(83)-C(84)-C(85)-C(86) -55.3(3) 
C(84)-C(85)-C(86)-C(87) 55.8(3) 
C(83)-C(82)-C(87)-C(86) 57.6(2) 
C(78)-C(82)-C(87)-C(86) -174.83(19) 
C(85)-C(86)-C(87)-C(82) -58.5(3) 
O(4)-P(4)-N(4)-C(100) 42.26(16) 
C(94)-P(4)-N(4)-C(100) -81.41(15) 
C(88)-P(4)-N(4)-C(100) 166.05(14) 
O(4)-P(4)-C(88)-C(93) -93.59(18) 
N(4)-P(4)-C(88)-C(93) 144.69(17) 
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C(94)-P(4)-C(88)-C(93) 28.54(19) 
O(4)-P(4)-C(88)-C(89) 82.49(18) 
N(4)-P(4)-C(88)-C(89) -39.23(18) 
C(94)-P(4)-C(88)-C(89) -155.38(16) 
C(93)-C(88)-C(89)-C(90) 0.7(3) 
P(4)-C(88)-C(89)-C(90) -175.44(16) 
C(88)-C(89)-C(90)-C(91) -0.2(3) 
C(89)-C(90)-C(91)-C(92) -0.5(4) 
C(90)-C(91)-C(92)-C(93) 0.6(4) 
C(91)-C(92)-C(93)-C(88) -0.1(3) 
C(89)-C(88)-C(93)-C(92) -0.6(3) 
P(4)-C(88)-C(93)-C(92) 175.54(17) 
O(4)-P(4)-C(94)-C(95) -179.96(16) 
N(4)-P(4)-C(94)-C(95) -55.50(18) 
C(88)-P(4)-C(94)-C(95) 55.08(18) 
O(4)-P(4)-C(94)-C(99) -2.38(19) 
N(4)-P(4)-C(94)-C(99) 122.08(16) 
C(88)-P(4)-C(94)-C(99) -127.34(16) 
C(99)-C(94)-C(95)-C(96) 1.0(3) 
P(4)-C(94)-C(95)-C(96) 178.64(17) 
C(94)-C(95)-C(96)-C(97) -0.8(3) 
C(95)-C(96)-C(97)-C(98) 0.3(4) 
C(96)-C(97)-C(98)-C(99) -0.1(4) 
C(97)-C(98)-C(99)-C(94) 0.3(4) 
C(95)-C(94)-C(99)-C(98) -0.8(3) 
P(4)-C(94)-C(99)-C(98) -178.40(18) 
P(4)-N(4)-C(100)-C(101) 78.44(18) 
P(4)-N(4)-C(100)-C(107) -154.70(13) 
N(4)-C(100)-C(101)-C(102) 41.9(3) 
C(107)-C(100)-C(101)-C(102) -84.3(2) 
N(4)-C(100)-C(101)-C(106) -137.7(2) 
C(107)-C(100)-C(101)-C(106) 96.2(2) 
C(106)-C(101)-C(102)-C(103) -2.5(3) 
C(100)-C(101)-C(102)-C(103) 178.0(2) 
C(101)-C(102)-C(103)-C(104) 1.6(4) 
C(102)-C(103)-C(104)-C(105) -0.8(5) 
C(103)-C(104)-C(105)-C(106) 1.0(5) 
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C(102)-C(101)-C(106)-C(105) 2.6(4) 
C(100)-C(101)-C(106)-C(105) -177.9(2) 
C(104)-C(105)-C(106)-C(101) -1.9(4) 
N(4)-C(100)-C(107)-C(109) 163.53(15) 
C(101)-C(100)-C(107)-C(109) -69.60(19) 
N(4)-C(100)-C(107)-C(108) -75.4(2) 
C(101)-C(100)-C(107)-C(108) 51.5(2) 
N(4)-C(100)-C(107)-C(111) 44.3(2) 
C(101)-C(100)-C(107)-C(111) 171.17(15) 
C(108)-C(107)-C(109)-C(110) -10.8(3) 
C(111)-C(107)-C(109)-C(110) -131.9(2) 
C(100)-C(107)-C(109)-C(110) 109.3(3) 
C(109)-C(107)-C(111)-C(116) -64.6(2) 
C(108)-C(107)-C(111)-C(116) 172.48(16) 
C(100)-C(107)-C(111)-C(116) 51.9(2) 
C(109)-C(107)-C(111)-C(112) 60.3(2) 
C(108)-C(107)-C(111)-C(112) -62.6(2) 
C(100)-C(107)-C(111)-C(112) 176.82(15) 
C(116)-C(111)-C(112)-C(113) -55.4(2) 
C(107)-C(111)-C(112)-C(113) 177.01(16) 
C(111)-C(112)-C(113)-C(114) 57.2(2) 
C(112)-C(113)-C(114)-C(115) -57.4(2) 
C(113)-C(114)-C(115)-C(116) 57.5(2) 
C(112)-C(111)-C(116)-C(115) 55.4(2) 
C(107)-C(111)-C(116)-C(115) -178.81(15) 
C(114)-C(115)-C(116)-C(111) -57.5(2) 
O(5)-P(5)-N(5)-C(129) -2.62(17) 
C(117)-P(5)-N(5)-C(129) 120.99(15) 
C(123)-P(5)-N(5)-C(129) -125.62(15) 
O(5)-P(5)-C(117)-C(122) 164.31(15) 
N(5)-P(5)-C(117)-C(122) 39.93(19) 
C(123)-P(5)-C(117)-C(122) -74.52(18) 
O(5)-P(5)-C(117)-C(118) -16.08(19) 
N(5)-P(5)-C(117)-C(118) -140.47(16) 
C(123)-P(5)-C(117)-C(118) 105.09(17) 
C(122)-C(117)-C(118)-C(119) 0.3(3) 
P(5)-C(117)-C(118)-C(119) -179.32(17) 
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C(117)-C(118)-C(119)-C(120) -0.1(3) 
C(118)-C(119)-C(120)-C(121) 0.0(3) 
C(119)-C(120)-C(121)-C(122) -0.1(3) 
C(120)-C(121)-C(122)-C(117) 0.3(3) 
C(118)-C(117)-C(122)-C(121) -0.4(3) 
P(5)-C(117)-C(122)-C(121) 179.19(16) 
O(5)-P(5)-C(123)-C(124) 98.62(19) 
N(5)-P(5)-C(123)-C(124) -138.21(18) 
C(117)-P(5)-C(123)-C(124) -21.9(2) 
O(5)-P(5)-C(123)-C(128) -74.83(18) 
N(5)-P(5)-C(123)-C(128) 48.35(18) 
C(117)-P(5)-C(123)-C(128) 164.69(16) 
C(128)-C(123)-C(124)-C(125) -0.3(4) 
P(5)-C(123)-C(124)-C(125) -173.8(2) 
C(123)-C(124)-C(125)-C(126) 0.1(4) 
C(124)-C(125)-C(126)-C(127) 0.8(4) 
C(125)-C(126)-C(127)-C(128) -1.5(4) 
C(126)-C(127)-C(128)-C(123) 1.2(4) 
C(124)-C(123)-C(128)-C(127) -0.3(3) 
P(5)-C(123)-C(128)-C(127) 173.34(19) 
P(5)-N(5)-C(129)-C(130) 104.68(17) 
P(5)-N(5)-C(129)-C(136) -127.32(15) 
N(5)-C(129)-C(130)-C(135) -138.55(19) 
C(136)-C(129)-C(130)-C(135) 93.4(2) 
N(5)-C(129)-C(130)-C(131) 40.9(2) 
C(136)-C(129)-C(130)-C(131) -87.2(2) 
C(135)-C(130)-C(131)-C(132) -1.6(3) 
C(129)-C(130)-C(131)-C(132) 178.96(19) 
C(130)-C(131)-C(132)-C(133) 0.0(3) 
C(131)-C(132)-C(133)-C(134) 1.6(3) 
C(132)-C(133)-C(134)-C(135) -1.5(3) 
C(131)-C(130)-C(135)-C(134) 1.7(3) 
C(129)-C(130)-C(135)-C(134) -178.9(2) 
C(133)-C(134)-C(135)-C(130) -0.2(4) 
N(5)-C(129)-C(136)-C(138) 164.53(16) 
C(130)-C(129)-C(136)-C(138) -68.3(2) 
N(5)-C(129)-C(136)-C(137) -73.7(2) 
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C(130)-C(129)-C(136)-C(137) 53.5(2) 
N(5)-C(129)-C(136)-C(140) 46.2(2) 
C(130)-C(129)-C(136)-C(140) 173.39(16) 
C(137)-C(136)-C(138)-C(139) 6.1(3) 
C(129)-C(136)-C(138)-C(139) 126.8(3) 
C(140)-C(136)-C(138)-C(139) -114.8(3) 
C(138)-C(136)-C(140)-C(145) -60.4(2) 
C(137)-C(136)-C(140)-C(145) 176.98(18) 
C(129)-C(136)-C(140)-C(145) 56.3(2) 
C(138)-C(136)-C(140)-C(141) 63.8(2) 
C(137)-C(136)-C(140)-C(141) -58.9(2) 
C(129)-C(136)-C(140)-C(141) -179.54(18) 
C(145)-C(140)-C(141)-C(142) -56.5(3) 
C(136)-C(140)-C(141)-C(142) 176.3(2) 
C(140)-C(141)-C(142)-C(143) 57.0(3) 
C(141)-C(142)-C(143)-C(144) -55.4(3) 
C(142)-C(143)-C(144)-C(145) 56.0(3) 
C(143)-C(144)-C(145)-C(140) -58.7(2) 
C(141)-C(140)-C(145)-C(144) 57.3(2) 
C(136)-C(140)-C(145)-C(144) -176.22(17) 
O(6)-P(6)-N(6)-C(158) 35.89(16) 
C(152)-P(6)-N(6)-C(158) -88.97(16) 
C(146)-P(6)-N(6)-C(158) 157.59(14) 
O(6)-P(6)-C(146)-C(151) -116.69(19) 
N(6)-P(6)-C(146)-C(151) 122.87(18) 
C(152)-P(6)-C(146)-C(151) 4.5(2) 
O(6)-P(6)-C(146)-C(147) 59.19(18) 
N(6)-P(6)-C(146)-C(147) -61.25(17) 
C(152)-P(6)-C(146)-C(147) -179.66(15) 
C(151)-C(146)-C(147)-C(148) 0.5(3) 
P(6)-C(146)-C(147)-C(148) -175.61(16) 
C(146)-C(147)-C(148)-C(149) -0.5(3) 
C(147)-C(148)-C(149)-C(150) -0.5(4) 
C(148)-C(149)-C(150)-C(151) 1.6(4) 
C(147)-C(146)-C(151)-C(150) 0.6(3) 
P(6)-C(146)-C(151)-C(150) 176.43(19) 
C(149)-C(150)-C(151)-C(146) -1.7(4) 
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O(6)-P(6)-C(152)-C(153) 7.3(2) 
N(6)-P(6)-C(152)-C(153) 132.13(18) 
C(146)-P(6)-C(152)-C(153) -114.98(18) 
O(6)-P(6)-C(152)-C(157) -174.65(17) 
N(6)-P(6)-C(152)-C(157) -49.9(2) 
C(146)-P(6)-C(152)-C(157) 63.03(19) 
C(157)-C(152)-C(153)-C(154) -1.2(4) 
P(6)-C(152)-C(153)-C(154) 176.8(2) 
C(152)-C(153)-C(154)-C(155) -0.1(4) 
C(153)-C(154)-C(155)-C(156) 0.8(5) 
C(154)-C(155)-C(156)-C(157) -0.2(5) 
C(155)-C(156)-C(157)-C(152) -1.1(4) 
C(153)-C(152)-C(157)-C(156) 1.8(3) 
P(6)-C(152)-C(157)-C(156) -176.21(19) 
P(6)-N(6)-C(158)-C(159) 75.68(18) 
P(6)-N(6)-C(158)-C(165) -155.60(13) 
N(6)-C(158)-C(159)-C(164) -139.86(19) 
C(165)-C(158)-C(159)-C(164) 91.9(2) 
N(6)-C(158)-C(159)-C(160) 38.2(3) 
C(165)-C(158)-C(159)-C(160) -90.0(2) 
C(164)-C(159)-C(160)-C(161) -1.3(3) 
C(158)-C(159)-C(160)-C(161) -179.45(19) 
C(159)-C(160)-C(161)-C(162) 0.8(3) 
C(160)-C(161)-C(162)-C(163) -0.3(3) 
C(161)-C(162)-C(163)-C(164) 0.3(4) 
C(162)-C(163)-C(164)-C(159) -0.8(4) 
C(160)-C(159)-C(164)-C(163) 1.3(3) 
C(158)-C(159)-C(164)-C(163) 179.5(2) 
N(6)-C(158)-C(165)-C(167) 164.93(16) 
C(159)-C(158)-C(165)-C(167) -66.7(2) 
N(6)-C(158)-C(165)-C(166) -74.8(2) 
C(159)-C(158)-C(165)-C(166) 53.6(2) 
N(6)-C(158)-C(165)-C(169) 45.7(2) 
C(159)-C(158)-C(165)-C(169) 174.09(16) 
C(166)-C(165)-C(167)-C(168) 0.4(4) 
C(158)-C(165)-C(167)-C(168) 119.6(3) 
C(169)-C(165)-C(167)-C(168) -120.9(3) 
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C(167)-C(165)-C(169)-C(174) -64.6(2) 
C(166)-C(165)-C(169)-C(174) 173.13(19) 
C(158)-C(165)-C(169)-C(174) 52.6(2) 
C(167)-C(165)-C(169)-C(170) 60.7(3) 
C(166)-C(165)-C(169)-C(170) -61.6(2) 
C(158)-C(165)-C(169)-C(170) 177.87(19) 
C(174)-C(169)-C(170)-C(171) -54.5(3) 
C(165)-C(169)-C(170)-C(171) 177.4(2) 
C(169)-C(170)-C(171)-C(172) 55.8(3) 
C(170)-C(171)-C(172)-C(173) -55.8(3) 
C(171)-C(172)-C(173)-C(174) 57.5(3) 
C(172)-C(173)-C(174)-C(169) -58.3(3) 
C(170)-C(169)-C(174)-C(173) 55.3(3) 
C(165)-C(169)-C(174)-C(173) -177.5(2) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 
 
Table 7. Hydrogen bonds for C29H34NOP [Å and °] 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
 N(1)-H(1N)...O(2)#1 0.88 2.12 2.979(2) 164.7 
 N(2)-H(2N)...O(1)#2 0.88 2.15 2.907(2) 144.4 
 N(3)-H(3N)...O(4)#3 0.88 2.11 2.913(2) 151.1 
 N(4)-H(4N)...O(3)#4 0.88 2.19 2.882(2) 135.5 
 N(5)-H(5N)...O(6)#5 0.88 1.96 2.833(2) 173.0 
 N(6)-H(6N)...O(5)#4 0.88 2.26 2.923(2) 131.8 
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 x-1,y-1,z-1    #2 -x+1,y+1/2,-z+1    #3 -x+1,y-1/2,-z+2       
#4 x,y+1,z    #5 -x+2,y-1/2,-z+1  
 
Absolute Stereochemical Identity of 1.39a  
 
Page 406
	  	  
	  
Table 1.  Crystal data and structure refinement for C11H11NO2  
Identification code  C11H11NO2 
Empirical formula  C11H11NO2 
Formula weight  189.21 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 7.4763(3) Å α= 90º 
 b = 7.5057(3) Å β= 90º 
 c = 16.9951(7) Å γ = 90º 
Volume 953.68(7) Å3 
Z 4 
Density (calculated) 1.318 Mg/m3 
Absorption coefficient 0.745 mm-1 
F(000) 400 
Crystal size 0.20 x 0.10 x 0.07 mm3 
Theta range for data collection 5.20 to 67.32º 
Index ranges -6<=h<=8, -8<=k<=8, -20<=l<=19 
Reflections collected 5081 
Independent reflections 1626 [R(int) = 0.0390] 
Completeness to theta = 67.32º 97.4 %  
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Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9497 and 0.8652 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1626 / 0 / 134 
Goodness-of-fit on F2 1.069 
Final R indices [I>2sigma(I)] R1 = 0.0298, wR2 = 0.0746 
R indices (all data) R1 = 0.0308, wR2 = 0.0751 
Absolute structure parameter 0.0(2) 
Extinction coefficient 0.0093(12) 
Largest diff. peak and hole 0.213 and -0.186 e.Å-3 
 
 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103)	  
for C11H11NO2	  .U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________ x y z U(eq) 
________________________________________________________________________  
O(1) 2482(1) 7117(1) 10115(1) 21(1) 
O(2) 4795(1) 7911(1) 8720(1) 22(1) 
N(1) 616(2) 6638(2) 9063(1) 20(1) 
C(1) 2220(2) 6744(2) 9414(1) 18(1) 
C(2) 3694(2) 6381(2) 8795(1) 19(1) 
C(3) 2590(2) 6138(2) 8062(1) 19(1) 
C(4) 3115(2) 5825(2) 7292(1) 23(1) 
C(5) 1792(2) 5651(2) 6720(1) 28(1) 
C(6) -3(2) 5773(2) 6921(1) 27(1) 
C(7) -546(2) 6101(2) 7695(1) 24(1) 
C(8) 792(2) 6280(2) 8248(1) 20(1) 
C(9) 4814(2) 4750(2) 9025(1) 21(1) 
C(10) 3789(2) 3043(2) 9088(1) 24(1) 
C(11) 3807(2) 1972(2) 9698(1) 28(1) 
________________________________________________________________________
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 Table 3.   Bond lengths [Å] and angles [º] for C11H11NO2 
_____________________________________________________  
O(1)-C(1)  1.2390(17) 
O(2)-C(2)  1.4187(17) 
O(2)-H(2O)  0.86(2) 
N(1)-C(1)  1.341(2) 
N(1)-C(8)  1.4179(17) 
N(1)-H(1N)  0.846(19) 
C(1)-C(2)  1.5477(19) 
C(2)-C(3)  1.5064(19) 
C(2)-C(9)  1.533(2) 
C(3)-C(4)  1.3852(19) 
C(3)-C(8)  1.386(2) 
C(4)-C(5)  1.394(2) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.388(2) 
C(5)-H(5)  0.9500 
C(6)-C(7)  1.398(2) 
C(6)-H(6)  0.9500 
C(7)-C(8)  1.379(2) 
C(7)-H(7)  0.9500 
C(9)-C(10)  1.497(2) 
C(9)-H(9A)  0.9900 
C(9)-H(9B)  0.9900 
C(10)-C(11)  1.312(2) 
C(10)-H(10)  0.9500 
C(11)-H(11A)  0.9500 
C(11)-H(11B)  0.9500 
 
C(2)-O(2)-H(2O) 108.3(14) 
C(1)-N(1)-C(8) 111.26(12) 
C(1)-N(1)-H(1N) 120.1(12) 
C(8)-N(1)-H(1N) 128.1(12) 
O(1)-C(1)-N(1) 125.55(13) 
O(1)-C(1)-C(2) 125.49(13) 
N(1)-C(1)-C(2) 108.93(11) 
O(2)-C(2)-C(3) 109.98(11) 
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O(2)-C(2)-C(9) 110.65(11) 
C(3)-C(2)-C(9) 114.43(11) 
O(2)-C(2)-C(1) 109.34(11) 
C(3)-C(2)-C(1) 101.16(11) 
C(9)-C(2)-C(1) 110.86(11) 
C(4)-C(3)-C(8) 120.25(13) 
C(4)-C(3)-C(2) 130.28(14) 
C(8)-C(3)-C(2) 109.47(11) 
C(3)-C(4)-C(5) 118.27(14) 
C(3)-C(4)-H(4) 120.9 
C(5)-C(4)-H(4) 120.9 
C(6)-C(5)-C(4) 120.55(13) 
C(6)-C(5)-H(5) 119.7 
C(4)-C(5)-H(5) 119.7 
C(5)-C(6)-C(7) 121.58(14) 
C(5)-C(6)-H(6) 119.2 
C(7)-C(6)-H(6) 119.2 
C(8)-C(7)-C(6) 116.63(14) 
C(8)-C(7)-H(7) 121.7 
C(6)-C(7)-H(7) 121.7 
C(7)-C(8)-C(3) 122.71(13) 
C(7)-C(8)-N(1) 128.16(14) 
C(3)-C(8)-N(1) 109.14(13) 
C(10)-C(9)-C(2) 114.96(12) 
C(10)-C(9)-H(9A) 108.5 
C(2)-C(9)-H(9A) 108.5 
C(10)-C(9)-H(9B) 108.5 
C(2)-C(9)-H(9B) 108.5 
H(9A)-C(9)-H(9B) 107.5 
C(11)-C(10)-C(9) 125.14(14) 
C(11)-C(10)-H(10) 117.4 
C(9)-C(10)-H(10) 117.4 
C(10)-C(11)-H(11A) 120.0 
C(10)-C(11)-H(11B) 120.0 
H(11A)-C(11)-H(11B) 120.0 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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Table 4.   Anisotropic displacement parameters  (Å2x 103) for C11H11NO2 .  The anisotropic	  
displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________  
O(1) 21(1)  23(1) 18(1)  -1(1) 0(1)  0(1) 
O(2) 24(1)  21(1) 22(1)  2(1) -1(1)  -6(1) 
N(1) 18(1)  25(1) 18(1)  -1(1) 1(1)  2(1) 
C(1) 21(1)  14(1) 18(1)  2(1) 1(1)  0(1) 
C(2) 19(1)  19(1) 18(1)  0(1) 1(1)  -2(1) 
C(3) 24(1)  14(1) 20(1)  1(1) 0(1)  1(1) 
C(4) 26(1)  22(1) 21(1)  0(1) 2(1)  3(1) 
C(5) 39(1)  26(1) 18(1)  -3(1) -1(1)  7(1) 
C(6) 35(1)  26(1) 22(1)  -4(1) -10(1)  7(1) 
C(7) 24(1)  24(1) 26(1)  0(1) -4(1)  3(1) 
C(8) 23(1)  17(1) 18(1)  0(1) 1(1)  1(1) 
C(9) 19(1)  22(1) 23(1)  -1(1) 0(1)  1(1) 
C(10) 24(1)  22(1) 26(1)  -3(1) -2(1)  0(1) 
C(11) 29(1)  22(1) 33(1)  0(1) 3(1)  1(1) 
________________________________________________________________________ 
Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x	  103)	  for 
C11H11NO2  
________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________ 
  
H(2O) 5560(30) 7910(30) 9102(11) 33 
H(1N) -320(30) 6910(20) 9315(10) 24 
H(4) 4345 5731 7158 28 
H(5) 2121 5447 6187 33 
H(6) -885 5630 6523 33 
H(7) -1773 6195 7833 29 
H(9A) 5774 4593 8630 26 
H(9B) 5394 4991 9538 26 
H(10) 3068 2708 8652 29 
H(11A) 4510 2259 10146 34 
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H(11B) 3116 909 9692 34 ________________________________________________________________________	  	  
Table 6.  Torsion angles [º] for C11H11NO2  
________________________________________________________________  
C(8)-N(1)-C(1)-O(1) 176.77(13) 
C(8)-N(1)-C(1)-C(2) -1.54(15) 
O(1)-C(1)-C(2)-O(2) -60.30(18) 
N(1)-C(1)-C(2)-O(2) 118.01(12) 
O(1)-C(1)-C(2)-C(3) -176.30(13) 
N(1)-C(1)-C(2)-C(3) 2.01(14) 
O(1)-C(1)-C(2)-C(9) 61.95(17) 
N(1)-C(1)-C(2)-C(9) -119.74(12) 
O(2)-C(2)-C(3)-C(4) 62.35(19) 
C(9)-C(2)-C(3)-C(4) -62.90(19) 
C(1)-C(2)-C(3)-C(4) 177.88(15) 
O(2)-C(2)-C(3)-C(8) -117.33(12) 
C(9)-C(2)-C(3)-C(8) 117.42(13) 
C(1)-C(2)-C(3)-C(8) -1.80(14) 
C(8)-C(3)-C(4)-C(5) -0.3(2) 
C(2)-C(3)-C(4)-C(5) 180.00(14) 
C(3)-C(4)-C(5)-C(6) -0.6(2) 
C(4)-C(5)-C(6)-C(7) 1.1(2) 
C(5)-C(6)-C(7)-C(8) -0.6(2) 
C(6)-C(7)-C(8)-C(3) -0.4(2) 
C(6)-C(7)-C(8)-N(1) 179.05(14) 
C(4)-C(3)-C(8)-C(7) 0.8(2) 
C(2)-C(3)-C(8)-C(7) -179.43(12) 
C(4)-C(3)-C(8)-N(1) -178.67(13) 
C(2)-C(3)-C(8)-N(1) 1.05(15) 
C(1)-N(1)-C(8)-C(7) -179.15(14) 
C(1)-N(1)-C(8)-C(3) 0.34(16) 
O(2)-C(2)-C(9)-C(10) -177.65(11) 
C(3)-C(2)-C(9)-C(10) -52.74(17) 
C(1)-C(2)-C(9)-C(10) 60.87(16) 
C(2)-C(9)-C(10)-C(11) -127.70(16) 
________________________________________________________________  
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Symmetry transformations used to generate equivalent atoms:  
  
Table 7.  Hydrogen bonds for C11H11NO2 [Å and º] 
________________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
________________________________________________________________________ 
 O(2)-H(2O)...O(1)#1 0.86(2) 1.96(2) 2.8209(14) 174.0(18) 
 N(1)-H(1N)...O(1)#2 0.846(19) 2.04(2) 2.8836(16) 173.0(17) 
________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 x+1/2,-y+3/2,-z+2    #2 x-1/2,-y+3/2,-z+2 
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 Chapter Two 
 
Enantioselective Additions to Fluorinated 
Ketones: A Platform for Studying the 
Interaction Between Organofluorine and a 
Small Molecule 
 
"Fluorine leaves nobody indifferent; it inflames emotions be that affections 
or aversions.  As a substituent, it is rarely boring, always good for a 
surprise, but often completely unpredictable." 
-Manfred Schlosser, 19981 
2.1 Introduction 
 The element fluorine has been of intense interest to chemists ever since it was 
proposed to exist in 1810 by Humphrey Davy and André-Marie Ampére.2 The race to be 
the first to isolate elemental fluorine claimed the lives of at least two chemists; many 
others were seriously injured.  Fluorine gas proved so difficult to isolate, that some 
believed it to be what alchemists had termed "the universal solvent", since it seemed to 
react (often violently) with any material it came in contact with. It wasn't until 76 years 
after Davy and Ampére's proposal and "after four interruptions caused by serious 
poisioning" [Weeks pg. 1932] that Henri Moissan was able to isolate fluorine by 
electrolyzing KHF2 in liquid HF and trapping the resultant F2 (g) in a Pt-Ir jar sealed with 
                                                
(1) Schlosser, M. Angew. Chem. Int. Ed. 1998, 110, 1496–1513.  The quotation is taken from page 1497 in 
the manuscript. 
(2) Weeks, M. E. J. Chem. Educ. 1932, 9, 1915–1939. 
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 a stopper made of fluorite (CaF2).  Moissan would later win a Nobel Prize partly due to 
this work.2   
 To this day, there is much interest in the fluorine, particularly because its presence 
in organic molecules has a myriad of effects that have been utilized by chemists in 
applications ranging from material science and engineering to pharmaceuticals and 
agrochemicals.  Most of these effects are largely due to the special properties of the C-F 
bond.3  
 
 Fluorine possesses the highest electronegativity of all the elements in the periodic 
table (4.0 on the Pauling Scale; the next highest is oxygen with a value of 3.4, Table 
2.1),4 which makes the C-F bond unusually polarized for a covalent bond with carbon. As 
a result of this polarization, there is a significant electrostatic component to the C-F bond, 
making it the strongest single bond between carbon and another element (Table 2.2). The 
difference between the C-O bond strength (86 kcal/mol) and the C-F bond strength (105 
kcal/mol)5 is far higher than can be explained by just a decrease in van der Waals radii 
from O to F (1.52 Å to 1.47 Å)6 leading to a stronger bond between carbon and fluorine, 
so there must be a substantial difference in polarization between C-F and C-O.4 That 
oxygen is the second-most electronegative element and does not have nearly the ability to 
                                                
(3) For an excellent review on organofluorine chemistry that is worth reading for any scholar with an 
interest in physical organic chemistry, see: O’Hagan, D. Chem. Soc. Rev. 2008, 37, 308–319. 
(4) Hagmann, W. K. J. Med. Chem. 2008, 51, 4359–4369. 
(5) This value is sometimes cited as 115 kcal/mol, but most sources agree on 105 kcal/mol.    
(6) A common misconception is that fluorine is about the same size as hydrogen in organic molecules.  
While it is true that fluorine is often used as a sterically similar substitute in for hydrogen, a C-F bond is 
much closer to a C-O bond in size than it is to a C-H bond.  See reference 4. 
H C N O F Cl
2.2 2.6 3.0 3.4 4.0 3.2
Table 2.1 Selected Pauling Electronegativities
 
Page 415
 polarize a bond that fluorine does illustrates just how alien fluorine is when compared 
with any other element that forms covalent bonds with carbon. 
 
 Consistent with the polarization of the C-F bond, the dipole moment between 
carbon and fluorine is large enough to play a noticeable role in dipole-dipole 
interactions.3 The computed energetic differences between fluorine and a carbonyl being  
syn or anti in selected α-fluorocarbonyls is illustrative (Scheme 2.1).7 While there is 
undoubtedly some detriment to the syn conformer stemming from electron-electron 
repulsion between fluorine and the carbonyl oxygen, the observation that the energy 
difference between syn and anti conformers decreases with decreasing dipole moment of 
the carbonyl moiety supports the importance of a dipole-dipole interaction.3 
 
                                                
(7) (a) Banks, J. W.; Batsanov, A. S.; Howard, A. K.; O'Hagan, D.; Rzepa, H. S.; Martin-Santamaria, S. J. 
Chem. Soc., Perkin Trans 2 1999, 2409–2411. (b) van der Veken, B. J.; Truyen, S.; Herrebout, W. A.; 
Watkins, G. J. Mol. Struct. 1993, 293, 55–58. (c) Abraham, R. J.; Jones, A. D.; Warne, M. A.; Rittner, R.; 
Tormena, C. F. J. Chem. Soc., Perkin Trans 2 1996, 533–539. 
C-H C-C C-N C-O C-F C-Cl
99 83 75 86 105 79
Table 2.2 Selected Bond Strengths (kcal/mol) with Carbon
O
OMe
F
O
OMe
F
O
Me
F
O
Me
F
O
NH2
F
O
NH2
F
DisfavoredFavored
ΔG ~7.5 kcal/mol
DisfavoredFavored
DisfavoredFavored
ΔG ~4.5 kcal/mol
ΔG ~2.2 kcal/mol
Scheme 2.1 Conformational Preferences of α-Fluorocarbonyls
Decreasing dipole
moment of 
carbonyl moiety
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  A surprising consequence of the extreme electronegativity of fluorine is that when 
it is present in an organic molecule, unlike nitrogen and oxygen, is reluctant to act as a 
hydrogen-bond acceptor.8 Whether or not fluorine participates in hydrogen-bonding9 is 
currently a controversial topic in chemistry,8 although most of the controversy seems to 
stem from differences in how exactly one defines a hydrogen-bond,10 rather than from 
anything specifically regarding fluorine.  The general consensus is that C-F can 
occasionally act as a hydrogen-bond acceptor, but the hydrogen bonds it forms do not 
have a great deal covalent character and are nearly always half or less of the strength of 
traditional H-bonds (~2-2.5 kcals for an F hydrogen-bond).3 The rationale for why 
fluorine in organic molecules is less likely than nitrogen or oxygen to engage in 
hydrogen-bonding is that lone pairs of fluorine, which are needed for hydrogen-bonding, 
are held tightly to fluorine due to fluorine's massive electronegativity.3   
 A class of significant interactions that is known for organofluorine to participate 
in is charge-dipole interactions.3 In protonated 3-fluoropiperidine 2.1, the fluorine is 
observed by NMR to be exclusively in the axial position (axial-2.1, Scheme 2.2); the 
energy difference between axial-2.1 and equatorial-2.1, which mainly is a result of the 
attraction between the protonated amine and fluorine, is calculated to be 5.4 kcal/mol.11 
Suggesting this observation is not a rare case of organofluorine hydrogen-bonding, the  
                                                
(8) (a) For a review stating that organofluorine is highly unlikely to participate in hydrogen bonding, see: 
Dunitz, J. D. ChemBioChem 2004, 5, 614–621. (b) For a review stating it is completely plausible for 
organofluorine to participate in hydrogen bonding, see: Schneider, H.-J. Chem. Sci. 2012, 3, 1381–1394. 
(9) Specifically, fluorine as it exists in organofluorine compounds. Hydrogen-bonding is widely accepted to 
be a major interaction between molecules of hydrofluoric acid. Steiner, T. Angew. Chem. Int. Ed. 2002, 41, 
48–76. 
(10) A pertinent statement about definitions with regard to hydrogen-bonding has been made by Professor 
Gautam R. Desiraju in Acc. Chem. Res. 2002, 35, 565–573. He states, "By definition, a definition cannot be 
correct or incorrect.  It can, however, be useful or have outlived its usefulness.  It should never, in any case, 
hinder the study of a phenomenon because of linguistic limitations and psychological difficulties" (pg. 572). 
(11) Sun, A.; Lankin, D. C.; Hardcastle, K.; Snyder, J. P. Chem. Eur. J. 2005, 11, 1579–1591. 
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dimethyl piperidinium salt 2.2 also displays a large conformational preference for the 
fluorine to be situated axially (Scheme 2.2).11 It is worth noting that the large axial 
preference observed for 2.1 and 2.2 is overcoming the inherent steric bias that similar  
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 molecules have for the equatorial conformation (see 2.4 and 2.5 in Scheme 2.3). Further 
evidence for the importance of charge in these interactions is that gauche-2.3 (Scheme 
2.2) is preferred over anti-2.3 by 5.8 kcal/mol.12 The neutral form of this molecule (2.6, 
Scheme 2.3) also prefers a gauche conformation, in large part due to the well known 
gauche-effect,13 but only by 0.9 kcal/mol.12 Obtaining a change in magnitude from 0.9 to 
5.8 kcal/mol is not consistent with simply a stronger gauche effect upon protonation of 
2.6 (thus making the nitrogen substituent more electron withdrawing), indicating 
significant electrostatic interactions favor gauche-2.3 over anti-2.3.12 Our laboratory 
became interested in possibly using such interactions to dictate enantioselectivities in 
fluorinated substrates. 
2.2 Background 
 In a recently published manuscript (see Section 1),14 our proposed stereochemical 
model for the allyl-addition to an isatin 2.7 involves a hydrogen bonding interaction 
between the amide oxygen of the isatin and a proton residing in a protonated 
aminophenol (Scheme 2.4a). Additional support for this proposal comes from the low 
enantioselectivity obtained when using substrates that contain only one H-bond acceptor; 
one example, shown in Scheme 2.4b, is acetophenone (2.9a).  To further probe this 
hypothesis, we chose to examine fluorinated substrates such as trifluoroacetophenone 
2.11a (Scheme 2.4c) with the thought that perhaps fluorine will provide the dipole for a 
cation- dipole interaction. Any increase in the level at which a reaction mechanism is 
                                                
(12) Briggs, C. R. S.; Allen, M. J.; O'Hagan, D.; Tozer, D. J.; Slawin, A. M. Z.; Goeta, A. E.; Howard, J. A. 
K. Org. Biomol. Chem. 2004, 2, 732–740. 
(13) For a review of this phenomenon, see: Wolfe, S. Acc. Chem. Res. 1972, 5, 102–111. 
(14) Silverio, D. L.; Torker, S.; Pilyugina, T.; Vieira, E. M.; Snapper, M. L.; Haeffner, F.; Hoveyda, A. H. 
Nature 2013, 494, 216–221. 
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 understood not only provides useful information regarding the reaction in question but 
can also illuminate fundamental principles relevant to the field of chemistry and beyond. 
 
 Fluorine in a substrate has been observed (or proposed) in a number of cases to 
greatly affect the stereoselectivity of a transformation;15,16 however those that invoke a 
                                                
(15) For a review involving this subject, see: (a) Cahard, D.; Bizet, V. Chem. Soc. Rev. 2014, 43, 135–147. 
For examples not included in the review, see: (b) Ojima, I.; Kwon, H. B. J. Am. Chem. Soc. 1988, 110, 
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 fluorine-hydrogen interaction are quite scare. A notable example that does not involve 
such an interaction is the oxazaborolidine-catalyzed reduction of trifluoromethyl 
ketones.17 Based on the model for enantioselectivity of the CBS reduction of ketones 
(2.13, Equation 1), the sterically larger substituent on the ketone points down (away from  
 
the catalyst) and the sterically smaller substituent point up (towards the catalyst) to give 
the enantiomer shown in Equation 1.  In the case of acetophenone, as expected by the size 
difference between a methyl and a phenyl group (A-values of 1.74 and 2.8 kcal/mol 
respectively; Charton values of 1.66 and 0.52 respectively), the reduction affords the 
desired product as nearly a single enantiomer of the alcohol shown in Equation 1, with 
the phenyl group being the large group and the methyl group being the small group. In 
contrast, reduction of trifluoroacetophenone affords the opposite relative enantiomer to 
acetophenone (and in high e.r.), implying that now the phenyl group is the small group  
 
                                                                                                                                            
5617–5621. (c) Soloshonok, V. A.; Hayashi, T. Tetrahedron Lett., 1994, 35, 2713–2716. (d) Soloshonok, 
V. A.; Avilov, D. V.; Kukhar, V. P. Tetrahedron, 1996, 38, 12433–12442. (e) Katagiri, T.; Yamaji, S.; 
Handa, M.; Irie, M.; Uneyama, K. Chem. Commun. 2001, 2054–2055. 
(16) Incorporation of fluorine into a catalyst can also greatly change enantioselectivity. For a review of this 
growing field, see: Zimmer, L. E.; Sparr, C.; Gilmour, R. Angew. Chem. Int. Ed. 2011, 50, 11860–11871. 
(17) (a) Corey, E. J.; Link, J. O.; Bakshi, R. K. Tetrahedron Lett. 1992, 47, 7107–7110. (b) Corey, E. J.; 
Link, J. O.; Sarshar, S.; Shao, Y.  Tetrahedron Lett. 1992, 47, 7103–7106. 
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 and the trifluoromethyl group is the large group (Equation 2).17a This result is surprising, 
since traditional steric parameters suggest that a phenyl substituent is sterically larger 
group than a trifluoromethyl substituent (A-values of 2.8 and 2.45 kcal/mol respectively; 
Charton values of 0.91 and 1.66 respectively). Professor Corey explains this anomaly by 
invoking hyperconjugation from the carbonyl lone pair into the C–CF3 σ* resulting in a 
decreased angle between the carbonyl and the CF3 group (illustrated by the "no bond' 
resonance structure 2.16 in Figure 2.1), which effectively shields the carbonyl lone pair  
 
syn to the CF3 from binding to the catalyst.  This hypothesis is supported by the X-ray 
crystal structure of 9-trifluoroacetyl anthracene 2.15 (a substrate which is undergoes 
catalytic enantioselective reduction to afford the corresponding tertiary alcohol in 97:3 
e.r) that shows a highly distorted angle of 126.4º between the ketone and the anthracene 
group, as well as a 117.4º angle between the carbonyl and the trifluoromethyl group 
(Figure 2.1).18  
 A fluorine-hydrogen bond is proposed to explain the large difference between 
fluorinated and non-fluorinated substrates in a Strecker reaction of ketimines catalyzed  
                                                
(18) For similar observations that enantioselective reduction of 2,2,2-trifluoromethylacetophenones is 
highly selective for the opposite relative enantiomer of acetophenone, see: (a) Ramachandran, P. V.; 
Teodorovic´, A. V.; Gong, B.; Brown, H. C. Tetrahedron: Asymmetry 1994, 5, 1075–1086. (b) 
Ramachandran, P. V.; Gong, B.; Teodorovic´, A. V. J. Fluorine Chem. 2007, 128, 844–850. For a catalytic 
enantioselective aldol reaction where a major change in stereoselectivity occurs when the substrate is 
changed from benzaldehyde to pentafluorobenzaldehyde, see reference 15c. 
CF3
O
117.4º
126.4º O
CF3
2.15 2.16
Structure from
X-ray crystallography
"No bond" resonance
structure
Angles are distorted from
hyperconjugation of carbonyl lone pair
into C-CF3 σ*
Figure 2.1 Rationale for Catalyst Coordination to Lone Pair Anti to CF3 Group
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by urea-quinidine containing 2.17 (Scheme 2.5).19 Ketimines bearing a trifluoro- or 
difluoromethyl undergo cyanide-addition enantioselectively (>94:6 e.r.), but those 
without such fluorination afford racemic products under identical conditions. The authors 
note that thioureas without a Lewis-basic quinidine moiety are not competent catalysts 
(<5% conv. in five days) for the addition of TMSCN to fluorine containing ketimines 
(R=CF3 or CF2H, Scheme 2.5), but do promote addition to the ketimine where R=Me 
(48% yield). The authors propose that the Lewis basic nitrogen from the quinidine-
derived section of the catalyst is critical for activating the TMSCN. To explain the impact 
of fluorination, the authors hypothesize one proton of the urea binds to the imine nitrogen 
while the other binds to the fluorine. Density functional theory (DFT)-based calculations 
support this rare fluorine-hydrogen bond, but it should be noted that these calculations 
were performed using a simplified dimethylthiourea catalyst (Scheme 2.5) that, since it 
does not contain a quinidine moiety, likely will not promote the addition to the 
fluorinated substrates. As the acidic hexafluoroisopropanol additive does not affect the 
enantioselectivity of the transformation (it is added to increase conversion), it is unlikely 
that a protonated catalyst interacting with fluorine through a charge-dipole interaction is 
significant in determining the stereochemical outcome of the addition.  
                                                
(19) Liu, Y.-L.; Shi, T.-D.; Zhou, F.; Zhao, X.-L.; Wang, X.; Zhou, J. Org. Lett. 2011, 13, 3826–3829. 
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  A fluorine-hydrogen interaction has also been speculated to be important in the 
enantioselective reduction of trifluoroacetophenone catalyzed by a Pt/Al surface 
impregnated with cinchonidine (Scheme 2.6).20 When the reduction is carried out in the  
 
presence of trifluoroacetic acid, the desired alcohol is obtained in 93:7 e.r.  Omitting the 
acid causes the enantiomeric ratio to significantly drop to 68:32. One proposal explaining 
this change in enantioselectivity is that trifluoroacetic acid protonates the cinchonidine, 
and this has a charge-dipole interaction with the fluorine of the substrate that favors the 
observed enantiomer. There are many other proposals for this transformation, and the 
mechanism is still very much under debate.21 Even with little precedence, we were 
interested in examining the possibility of an F-H interaction in our system.  
 In addition to giving information about the interplay between fluorine and an 
ammonium cation in the stereochemistry-determining step, developing the 
enantioselective allyl- and allenyl-addition to fluorinated ketones is a worthwhile 
synthetic endeavor, in large part due to the utility of fluorine in biologically active 
molecules. Approximately 20% of all pharmaceuticals, as well as ~30% of all 
                                                
(20) Szőri, K.; Balázsik, K.; Crerényi, S.; Szőllősi, G.; Bartók, M. Appl. Catal., A 2009, 362 178–184. 
(21) For a reference that summarizes this debate while suggesting this fluorine interaction, while possible, 
is not the most likely scenario, see: Pereñiguez, R.; Santarossa, G.; Mallat, T.; Baiker, A. J. Mol. Catal. A: 
Chem. 2012, 365, 39–49. 
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 agrochemicals, contain fluorine.22 Compared with nitrogen which appears in ~90% of all 
pharmaceuticals (see discussion in Section 1.1), this may not seem like a lot, but whereas 
nitrogen is also ubiquitous in biology (and therefore can be expected to reside in 
biologically active molecules), there are only thirteen known natural products containing 
fluorine. 23   
 
 Structural incorporation of fluorine is well established to have a variety of 
beneficial effects in compounds of pharmaceutical significance. 24  In particular, 
trifluoromethyl25-substituted tertiary alcohols are contained in many biologically active 
molecules, such as HIV medicine Efavirenz,26 anti-asthma molecule setileuton,27 and 
                                                
(22) Müller, K.; Faeh, C.; Diederich, F. Science 2007, 317, 1881–1886.  
(23) Bégué, J.-P.; Delpon-Bonnet, D. Bioorganic and Medicinal Chemistry of Fluorine; John C. Wiley and 
Sons: Hoboken, New Jersey, United States, 2008. 
(24) For reviews/books detailing reasons why fluorine has these effects as well a specific examples, see 
references 4, 22, and 23 as well as (a) Purser, S.; Moore, P. R.; Swallow, S.; Gouverneur, V. Chem. Soc. 
Rev. 2008, 37, 320–330. (b) Fluorine in Pharmaceutical and Medicinal Chemistry: From Biophysical 
Aspects to Clinical Applications; Gouverneur, V., Müller, K., Eds.; Imperial College Press: London, 2012. 
(c) Böhm, H.-J. et al. ChemBioChem 2004, 5, 637–643. (d) Smart, B. E. J. Fluorine Chem. 2001, 109, 3–
11. (e) Filler, R.; Saha, R. Future Med. Chem. 2009, 1, 777–791. (f) Wang, J. et al. Chem. Rev. 2014, 114, 
2432–2506. 
(25) For a review on the trifluoromethyl group in new pharmaceuticals, see: W. Zhu, et al., J. Fluorine 
Chem. (2014), http://dx.doi.org/10.1016/j.jfluchem.2014.06.026 In Press 
(26) Muchiri, J. M., Li, D., Dykes, C., & Bambara, R. A. Biochemistry 2013, 52, 4981–4990. 
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 non-steroidal anti-inflammatory compound BI 653048 BS H3PO4 (Scheme 2.7).28 In all 
cases, the stereochemistry of the trifluoromethyl-substituted tertiary alcohol is critical to 
the biological activity. Allyl and allenyl groups can be reliably transformed into various 
functional groups29,30 and therefore, a method for the efficient and practical synthesis of 
trifluoromethyl-substituted tertiary homoallyl- and homoallenylalcohols is valuable. 
 Unfortunately, even though many enantioselective allyl-additions to ketones are 
known,29 very few of them study 2,2,2-trifluoromethylacetophenone.31   The three extant 
reports afford products in ≤ 90:10 e.r. and require 0.3–2.0 equivalents of indium as well 
as at least that much of the chiral ligand (Schemes 2.8–2.10).32 Enantioselective allenyl-
additions to trifluoromethyl ketones are completely unknown to the best of our 
knowledge. 
                                                                                                                                            
(27) Ducharme, Y. et al. ACS Med. Chem. Lett. 2010, 1, 170–174. 
(28) Reeves, J. T. et al. J. Org. Chem. 2013, 78, 3616–3635. 
(29) For allyl groups, see: (a) Yus, M.; González-Gómez, J. C.; Foubelo, F. Chem. Rev. 2011, 111, 7774–
7854. (b) Yus, M.; González-Gómez, J. C.; Foubelo, F. Chem. Rev. 2013, 113, 5595–5698. 
(30) Modern Allene Chemistry, Krause, N., Hashmi, A. S. K., Eds; Wiley−VCH: Weinheim, Germany, 
2004. 
(31) There are many more reports of enantioselective ene reactions to generate trifluoromethyl-substituted 
tertiary homoallylalcohols, but the substrates in these methods are restricted to extremely electrophilic 
trifluoromethyl pyruvates (a) Mikami, et al. Tetrahedron: Asymmetry 2004, 15, 3885–3889. (b) Aikawa, 
K.; Kainuma, S.; Hatano, M.; Mikami, K 2004, 45, 183–185. (c) Mikami, K.; Kakuno, H.; Aikawa, K. 
Angew. Chem. Int. Ed. 2005, 44, 7257–7260. (d) Aikawa, K.; Miyazaki, Y.; Mikami, K. Bull. Chem. Soc. 
Jpn. 2012, 85, 201–218. (e) Doherty, S.; Knight, J. G.; Smyth, C. H.; Harrington, S. W.; Clegg, W. J. Org. 
Chem. 2006, 71, 9751–9764. (f) Doherty, S.; Knight, J. G.; Smyth, C. H.; Harrington, S. W.; Clegg, W. 
Organometallics 2007, 26, 6453–6461. (g) Doherty, S.; Knight, J. G.; Mehdi-Zodeh, H. Tetrahedron: 
Asymmetry 2012, 23, 209–216. (h) Clarke, M. L.; Jones, C. E. S.; France, M. B. Beilstein J. Org. Chem. 
2007, 3, No. 24. (i) Rueping, M.; Theissmann, T.; Kuenkel, A.; Koenigs, R. M. Angew. Chem. Int. Ed. 
2008, 47, 6798–6801. (j) Rueping, M.; Bootwicha, T.; Kambutong, S.; Sugiono, E. Chem. Asian J. 2012, 7, 
1195–1198. (k) Luo, H.-K. et al. Adv. Synth. Catal. 2010, 352, 1356–1364. (l) Zhao, J. F.; Tan, B. H.; Zhu, 
M. K.; Tjan, T. B. W.; Loh, T. P. Adv. Synth. Catal. 2010, 352, 2085–2088. (m) Zheng, K. et al. Chem. 
Eur. J. 2010, 16, 9969–9972. (n) Didier, D.; Schulz, E. ChemCatChem 2011, 3, 1880–1884. 
(32) (a) Loh, T.-P.; Zhou, J.-R.; Li, X.-R. Tetrahedron Lett. 1999, 40, 9333–9336. (b) Zhang, X.; Chen, D.; 
Liu, X.; Feng, X. J. Org. Chem. 2004, 72, 5227–5233. (c) Haddad, T. D.; Hirayama, L. C.; Singaram, B. J. 
Org. Chem. 2010, 75, 642–649. 
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2.3 Development and Scope of Enantioselective Allyl-Additions to 
Perfluoroalkyl Ketones 
 Performing the enantioselective addition of allylboronic acid pinacol ester 2.20 to 
trifluoroacetophenone 2.11a under essentially the same conditions employed for 
additions to aldimines (see Chapter 1) generates chiral tertiary alcohol 2.12a in 93% yield 
and 93:7 e.r. (Equation 3). Using what was learned in the synthesis of  
 
homoallylamide 1.21k (Chapter 1, Section 1.4, Table 1.7), increasing the amount of 
NaOt-Bu to 10 mol % boosts the enantiomeric ratio to 94:6 without causing any 
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 deleterious side effects.  Increasing the amount of base further (as high as 20 mol %) did 
not greatly change the outcome of the reaction. Making the method more practical, 
reduction in the amount of allylB(pin) to 1.1 equivalents and the amount of methanol to 
1.3 equivalents led to no noticeable change in efficiency or enantioselectivity. We next 
carried out an investigation of the structure of the aminophenol. 
 
 Changing the structure of aminophenol 2.21a led to no major differences in the 
resulting transformation, with the exception the shrinking the size of the substituent ortho  
to the phenol from a tert-butyl group (2.21a) to a methyl group (2.21f) afforded the 
homoallyl alcohol 2.12 in noticeably diminished enantiomeric enrichment (Scheme 2.10). 
Moving forward with initial aminophenol 2.21a as optimal, we next cooled the reaction 
in efforts in increase enantioselectivity.  A reaction temperature of 4 ºC slightly increased 
the enantiomeric ratio to 94.5:5.5 while maintaining full conversion to product in only 
 1.5 equiv. allylB(pin) 2.20a,
1.3 equiv. MeOH, 
toluene, 22 ºC, 4 h
10 mol % NaOt-Bu
2.5 mol % Aminophenol
F3C
O
2.11a
OH
F3C
2.12a
N
H
NMe2
OH
i-Pr
O
t-Bu
N
H
NMe2
OH
O
t-Bu
N
H
N
OH
i-Pr
O
t-Bu
N
H
NMe2
OH
i-Pr
O
Si(i-Pr)3
N
H
NMe2
OH
i-Pr
O
SiPh3
N
H
NMe2
OH
i-Pr
O
Me
2.21a 2.21b 2.21c
2.21d 2.21e 2.21fc
>98% conv.,a 94:6 e.r.b >98% conv.,a 93:7 e.r.b >98% conv.,a 93:7 e.r.b
>98% conv.,a 93.5:6.5 e.r.b 93% conv.,a 94:6 e.r.b >98% conv.,a 87:13 e.r.b
Scheme 2.10 Screening of Aminophenols
aConsumption of starting material as determined by 376 MHz 19F analysis of the unpurified reaction mixture. 
bDetermined by HPLC analysis. cReaction performed at 4 ºC.
 
Page 428
 four hours.  Cooling the reaction further to -15 ºC gave the desired product in 95:5 e.r., 
but the reaction requires 18 hours to reach completion. Following this optimization, we 
then probed how the transformation behaves as the substrate is modified.  
 Aminophenol 2.21a also promotes selective allyl addition to pentafluoroethyl 
phenyl ketone 2.11b and heptafluoropropyl phenyl ketone 2.11c with even greater levels 
of efficiency and enantioselectivity than to 2.11a (Scheme 2.11).  Both electron  
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 withdrawing and donating groups are tolerated (2.11d–f) as well as Boc-protected pyrrole 
2.11g.33 Sterically hindered substrates 2.11j to 2.11m afford products in lower levels of 
enantioselectivity (Scheme 2.11).  This drop in selectivity may be due to an increase of 
the steric repulsion between the aromatic group of the substrate and the tert-butyl group 
of the catalyst in TS-2.3 (Scheme 2.4) resulting in a TS similar to TS-2.2 becoming more 
competitive (see Section 2.5 for a discussion).  The increase in selectivity observed for 
the addition to 3-thiophene trifluoromethyl ketone 2.11i compared with 2.12h potentially 
suggests a sulfur-ammonium interaction competing with the F-H cation-dipole interaction 
since the sulfur in less selective 2.11h is well situated to have such an interaction while 
the sulfur in 2.11i is much too far away from the ammonium of the catalyst to do so.  
Trifluoromethyl ketones substituted bearing an α,β-unsaturated or an alkyl group 
underwent catalytic, enantioselective allyl addition in ≥ 94% yield and ≥93.5:6.5 e.r. to 
afford homoallyl alcohols 2.12n and 2.12o.  
 To further increase the synthetic scope of the method, we next examined different 
boronate nucleophiles.  Increasing the reaction temperature to 22 ºC (and in the case of  
 
                                                
(33) Without the Boc group, the reaction did not proceed (<2% conversion to product). 
Table 2.3 Enantioselective Additions of Substituted Allylboronates
F3C Ph
O
+ B(pin)
R
2.20b, R=Me
2.20c, R=Cl
2.22a, R=Me
2.22b, R=Cl
1 2.20b (1.4) >98; 85 97.5:2.5
2 2.20c (1.1) >98; 96 96.5:4.5
10  mol % NaOt-Bu
 1.3 equiv. MeOH, 
toluene, 22 ºC, 4 h
2.5 mol % 2.21a
2.11a
entry e.r.cconv. (%)a; yield (%)bboronate (equiv.)
All data are the average of at least two experiments. aConversion to the 
desired product as measured by analysis of 376 MHz 19F NMR spectra 
of unpurified mixtures vs. an internal standard of trifluorotoluene.  bYield 
of isolated product. cDetermined by HPLC analysis.
Ph
OH
F3CR
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 methallylboronic acid pinacol ester 2.20b, increasing the amount of 2.20b to 1.4 equiv.) 
allows for the addition of 2-substituted allylboronates to trifluoroacetophenone 2.11a in 
four hours with at least 96.5:3.5 e.r. (Table 2.3).  Even the electron withdrawing and 
sterically encumbered chloride of boronate 2.20c did not slow down this transformation 
(entry 2). 
2.4 Development and Scope of Enantioselective Allenyl-Additions to 
Perfluoroalkyl Ketones 
 Changing the nucleophile to allenylboronic acid pinacol ester (2.23, Scheme 2.12)  
resulted in a reaction that was more than 98% regioselective for homoallenyl alcohol 
2.24a-α (addition of 2.23 to ketone 2.11a in an α-selective manner) versus  
 
2.0 equiv. MeOH, 
toluene, 22 ºC, 4 h
10 mol % NaOt-Bu
2.5 mol % Aminophenol
F3C
O
2.11a
OH
F3C
2.24a-α
N
H
NMe2
OH
i-Pr
O
t-Bu
N
H
NMe2
OH
O
t-Bu
N
H
N
OH
i-Pr
O
t-Bu
N
H
NMe2
OH
i-Pr
O
Si(i-Pr)3
N
H
NMe2
OH
i-Pr
O
SiPh3
N
H
NMe2
OH
i-Pr
O
Me
2.21a 2.21b 2.21c
2.21d 2.21e 2.21f
>98% conv.,a 93:7 e.r.,b
 >98:2 α:γc
>98% conv.,a 93:7 e.r.,b
 98:2 α:γc
>98% conv.,a 93:7 e.r.,b
 >98:2 α:γc
>98% conv.,a 94.5:5.5 e.r.,b
 >98:2 α:γc
>98% conv.,a 95:5 e.r.,b
 >98:2 α:γc
>98% conv.,a 91.5:8.5 e.r.,b
 96:4 α:γc
Scheme 2.12 Screening of Aminophenols for Enantioselective Allene-Addition
aConsumption of starting material as determined by 376 MHz 19F analysis of the unpurified reaction 
mixture. bDetermined by HPLC analysis. cDetermined by 376 MHz 19F analysis of the unpurified reaction 
mixture.
• B(pin)
1.4 equiv.
2.23
• +
OH
F3C
2.24a-γ
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 homopropargyl alcohol 2.24a-γ (addition of 2.23 to ketone 2.11a in a γ-selective 
manner).34  Efforts to increase the enantioselectivity of this transformation by decreasing 
the reaction temperature were unsuccessful, so we carried out a screening of 
aminophenols in an attempt to raise this selectivity (Scheme 2.12). 
 We first changed the amide terminus of the aminophenol to a more Lewis basic 
pyrrolidinyl amide 2.21b, which results in negligible change in the transformation. Use of 
tert-leucine derived 2.21c also leads to an essentially identical reaction. By increasing the 
size of the group ortho to the phenol to triphenylsilyl (2.21d) and triisoproylsilyl (2.21e), 
the enantioselectivity of the desired product is increased. It is worth noting again that 
aminophenol 2.21e does not lead to higher enantioselectivities for the allyl-addition 
(Scheme 2.10). Exchanging the tert-butyl group for a smaller methyl group in 2.21f 
produced the product somewhat inferior enantio- and regioselectivity.  
 Decreasing the amount of methanol and allenylboronic acid pinacol ester 2.23 not 
only still resulted in >98% conversion after four hours, it also caused a slight increase in 
the enantiomeric enrichment of 2.24a-α (Scheme 2.13), possibly due to decreasing the  
 
advantageous background reaction (Equation 4). The loading of 2.21e can be decreased 
to 1.0 mol % without negatively affecting the transformation.  
 Examination of a range of substrates (Scheme 2.13) showed that this reaction  
                                                
(34) It is worth noting that order of addition matters for this regioselectivity.  The data shown in this 
manuscript for allenyl-addition are all performed with the allenylB(pin) being added to the reaction mixture 
last. When the ketone substrate is added last, α:γ ratio is ~93:7. 
2.0 equiv. MeOH, 
toluene, 22 ºC, 4 h
F3C
O
2.11a
OH
F3C
2.24a-α
• B(pin)
2.23
•
71% conv. to product
92:8 α:γ
(4)
1.4 equiv.
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occurs selectively and efficiently to afford pentafluoroethyl-substituted 2.24b and 
trifluoromethyl-substituted alcohols containing electronically modified aryl-rings (2.24c 
to 2.24d).  Similar to the allyl additions (Scheme 2.11), a drop in enantioselectivity is 
observed when 2-trifluoroacetylthiophene is the electrophile (yielding 2.24e in 92:8 e.r.), 
but 3-trifluoroacetylthiophene leads to the desired product 2.24f in >99:1 enantiomeric 
ratio (Scheme 2.13). Unlike for the enantioselective allyl additions, trifluoromethyl 
ketones bearing ortho-substituents underwent enantioselective allenyl-addition with 
approximately no drop in selectivity (2.24g and 2.24h, Scheme 2.13).  Since the sterically 
hindered substrates lead to no drop in enantioselectivity, while 2-trifluoroacetylthiophene 
does lead to such a decrease, the idea is supported that the low enantioselectivity for 
1.3 equiv. MeOH, 
toluene, 22 ºC, 4 h
10 mol % NaOt-Bu
1.0 mol % Aminophenol 2.21e
R2R1
O
2.11
R2
OH
R1
2.24
Scheme 2.13 Substrate Scope of Allenyl-Addition to Perfluoroalkyl Ketones
• B(pin)
2.23
• + R2
OH
R1
2.24-γ
OH
F3C
2.24a
•
96% yield,a 
 95.5:4.5 e.r.,b >98:2 α:γc
OH
F3CF2C
2.24b
•
89% yield,a 
 97:3 e.r.,b >98:2 α:γc
OH
F3C
2.24c
•
87% yield,a 
 97:3 e.r.,b >98:2 α:γc
F
OH
F3C
2.24d
•
91% yield,a 
 96.5:3.5 e.r.,b >98:2 α:γc
OH
F3C
2.24e
•
92% yield,a 
 92:8 e.r.,b >98:2 α:γc
OH
F3C
2.24f
•
88% yield,a 
 >99:1 e.r.,b >98:2 α:γc
OH
F3C
2.24g
•
96% yield,a 
 97.5:2.5 e.r.,b 98:2 α:γc
NMe2
S S
OMe OH
F3C
2.24h
•
86% yield,a 
 94.5:5.5 e.r.,b 97:3 α:γc
OH
F3C
2.24i
•
96% yield,a 
 94:6 e.r.,b >98:2 α:γc
Me
All data are the average of at least two experiments. aYield of isolated product. bDetermined by HPLC analysis.cDetermined 
by 400 MHz 1H analysis of the isolated product.
1.1 equiv. α-addition γ-addition
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 observed in 2.24e (and 2.21h, Scheme 2.11) is due to an interaction of sulfur with the 
catalyst rather than unfavorable sterics. Additionally, alkyl-substituted (2.24i) 
homoallenyl alcohol is obtained in 96% yield and 94:6 e.r.  
2.5 Mechanistic Investigations 
 Following the development of methods for enantioselective allyl- and allenyl-
addition to perfluoroalkyl-substituted ketones, we focused on studying the mechanism, 
specifically the proposed charge-dipole interaction between the substrate and the catalyst 
(Scheme 2.4). The difference in both the sense and magnitude of enantioselectivity 
between homoallyl alcohols 2.10 (Scheme 2.14) and 2.12a (Scheme 2.14) led us to 
consider what impact on molecular properties changing the methyl group in ketone 2.9 
for a trifluoromethyl group in 2.11a has.  First, a trifluoromethyl group is sterically much 
larger (between the size of a isopropyl and isobutyl group)24d than a methyl group.  We 
did not believe that this increases in steric demand (and thus, decrease in the steric  
 
PhR1
O
1.5 equiv. allylBpin,
 2.5 equiv. MeOH
toluene, 22 ºC, 4 h
Ph
OH
F3C
2.12a
>98% conv.,d
93% yield,b 93:7 e.r.c
Ph
OH
Me
2.10a
92% conv.,a
78% yield,b 70:30 e.r.c
Ph
OH
i-Pr
2.451.74 2.21
2.5 mol % 2.21a
2.5 mol % NaOt-Bu
n.d.A-values (kcal/mol):
0.910.52 0.76 0.98Charton-values:
2.26a
18 h, 50% conv.,a
32% yield,b 66:34 e.r.c
Ph
OH
i-Bu
2.26b
18 h, 75% conv.,a
59% yield,b 60:40 e.r.c
R1 Ph
O
1.5 equiv. allylBpin,
 2.5 equiv. MeOH
toluene, 22 ºC, 4 h
<10% conv. 15% conv. 18 h, 17% conv. 18 h, 34% conv.
Ph
1.66
2.8
Me CF3 i-Pr i-Bu A more sterically hindered 
substrate does not lead
to higher stereoselectivity.
Scheme 2.14 Examination of Enantioselectivity Versus Steric Hindrance of the Substrate
R1=Me, 2.9a
R1=CF3, 2.11a
R1=i-Pr, 2.25a
R1=i-Bu, 2.25b
All data are the average of at least two experiments. aDetermined by 400 MHz 1H analysis of the unpurified reaction mixture vs. 
an internal standard of 9-methylanthracene. bYield of isolated product. cDetermined by HPLC analysis. dDetermined by 376 MHz 
19F analysis of the unpurified reaction mixture vs. an internal standard of α,α,α-trifluorotoluene.
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 difference between the two substituents of the ketone) was the explanation for the higher 
stereoselectivity for the allyl-addition to 2.12a. When we examined the sterically bulky 
isobutyrophenone 2.25a or isovalerophenone 2.25b, we obtained the desired homoallyl 
alcohols (Scheme 2.14) in at most 66:34 e.r. which suggests increased sterics alone does 
not explain the high enantioselectivity of 2.12a. While the lower reactivity of 2.25a and 
2.25b raises the question of whether the low selectivity is due to a competitive 
background reaction, control reactions suggest this is not the case (Scheme 2.14, data 
below the catalytic reactions). 
 Second, a trifluoromethyl group is more electron withdrawing than a methyl 
group and therefore allows for better hyperconjugation of the lone pair of the carbonyl 
into the C-CF3 σ* orbital.  This in turn decreases energy of the lone pair anti to the 
trifluoromethyl group, which may impact binding of the substrate to the catalyst.  Probing 
whether or not an electron-withdrawing group would affect the enantioselectivity, we 
performed the enantioselective allyl addition to electron-poor acetophenones 2.27a and 
2.27b (Equation 5). That the enantiomeric enrichment of the resulting homoallyl alcohols  
 
is not notably different than acetophenone suggests the difference in electronics between 
CF3 and Ph is not the major factor in determining enantioselectivity in enantioselective 
additions to trifluoromethyl acetophenone using an aminophenol-based catalyst. 
2.5.1 Mechanistic Investigations-Stereochemical Proofs 
 
Ar Me
O
HO
Me
F
F
94% yield, 74:26 e.r.
HO
Me
O2N
>98% yield, 69:31 e.r.
1.5 equiv. allylBpin,
 2.5 equiv. MeOH
toluene, 22 ºC, 4 h
2.5 mol % 2.21a
2.5 mol % NaOt-Bu
Ar=p-O2N-C6H4, 2.27a
Ar=3,5-F2C6H3, 2.27b
or
2.28a 2.28b
(5)
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  Critically important to proposing a compelling enantioselectivity model is 
determining the absolute configuration for the allyl- and allenyl-additions to 
trifluoroacetophenone 2.11a. After attempting multiple other derivatizations of the 2.12a, 
a Wacker oxidation, using conditions developed by the laboratory of Professor Sigman,35  
 
afforded β-keto alcohol 2.29 in 90% yield (Equation 6). Under other Wacker conditions, 
a 2:1 ratio of desired ketone 2.29 to the undesired regioisomeric aldehyde is obtained.36 
Comparing both the enantiomerically enriched HPLC trace and the specific rotation of 
2.29 with data in the literature37 proved the stereochemistry of 2.12a to be (R), consistent 
with the model we propose in Scheme 2.4. The product of methallyl-addition to 
trifluoroacetophenone, 2.22a, the relative stereochemistry of which we assume to be the  
 
same as 2.12a, can be converted to 2.29 (Equation 7). Further supporting our 
stereochemical assignment of 2.12a, the methallyl-addition product 2.22a is also 
confirmed to be (R) by its specific rotation and its enantiomerically enriched HPLC trace. 
 Determination of the absolute stereochemistry of the allene-addition product 
2.24a-α was accomplished by converting the homoallenyl alcohols to Mosher's acid over  
                                                
(35) McCombs, J. R.; Michel, B. W.; Sigman, M. S. J. Org. Chem. 2011, 76, 3609–3613. 
(36) Vlad, P., Gorincioi, E.; Aricu, A.; Barba, A.; Manzocchi, A.; Santaniello, E. Tetreahedron:Asymmetry, 
2010, 21, 2108–2116. 
(37) Duangdee, N.; Harnying, W.; Rulli, G.; Neudörfl, J.-M.; Gröger, H.; Berkessel, A. J. Am. Chem. Soc. 
2012, 134, 11196–11205. 
N
N
O
10 mol% Pd(Quinox)Cl2
25 mol% AgSbF6
12 equiv. TBHP (70% in H2O),
CH2Cl2, 0 ºC to 22 ºC, 14 h >98% conv., single 
regioisomer, 90 % yield
Quinox2.29
Ph
OH
F3C
2.12a
Ph
OH
F3C
Me
O (6)
O3/O2, -78 ºC MeOH, 3 min.;
-78 ºC to 22 ºC, 30 min.;
1.3 equiv. DMS, -78 ºC to 22 ºC,
14 h >98% conv., 67% yield
Ph
OH
F3C
2.22a 2.29
Ph
OH
F3C
Me
O (7)
Me
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three steps (Scheme 2.15).38 The large negative value of the specific rotation is consistent 
with the (S) enantiomer of Mosher's acid,39 which proves the stereochemistry of 2.24a to 
be (R) and therefore the same relative configuration as allyl-addition product 2.12a. 
2.5.2 Mechanistic Investigations-Computational Studies 
 The proposed cation-dipole interaction between the organofluorine of the 
substrate and the proton of the catalyst was investigated both computationally40 and by 
modification of the ketone substrate. The aminophenol derived from L-tert-leucine 2.21c 
(Scheme 2.10) was modeled instead of 2.21a due to fewer possible conformers present in 
2.21c (Scheme 2.16).  For addition to trifluoroacetophenone, DFT calculations point to 
transition state TS-2.4 as the lowest energy transition state for the observed enantiomer 
(Scheme 2.16a) and TS-2.6 to be the lowest energy transition state for the minor 
enantiomer (Scheme 2.16b).  Congruent with our hypothesis, the lowest energy transition 
state TS-2.4 contains a F-H distance of only 2.06 Å, which is within the van der Waals 
radius of these nuclei (1.20 Å for H, 1.47 Å for F). Moving the CF3 group away from the 
ammonium results in TS-2.5 which is 4.0 kcal/mol higher in energy than TS-2.4, both 
because of a lack of the stabilizing cation-dipole interaction as well as steric repulsion 
between the t-Bu group ortho to the phenol of the catalyst and the phenyl group of the 
substrate (Scheme 2.16a). Transition state TS-2.6, the lowest in energy for the minor  
                                                
(38) Chong, J. M.; Loewith, R. Synth. Comm. 1993, 23, 2145–2150. 
(39) Dale, J. A.; Dull, D. L.; Mosher, H. S. J. Org. Chem. 1969, 34, 2543–2549. 
(40) Calculations were carried out by Dr. Fredrik Haeffner. 
NaH, MeI,
thf, 45 ºC to reflux, 20 h
>98% conv.,
66% yield
O3/O2, acetone, -78 ºC, ~45 s;
CrO3/H2SO4/H2O
-78 ºC to 22 ºC 30 min; 22 ºC, 2 h
2.31(Mosher's acid)
[α]D= -58º
2.24a 2.30 37% yield [α]D= -65º (lit.)
Scheme 2.15 Proof of Absolute Stereochemistry for 2.24a
Ph
OH
F3C
•
Ph
OMe
F3C
•
Ph
OMe
F3C
O
HO
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N
O
Bt-Bu
O
Me2N
O
F
H
t-Bu
F
F
0.0 kcal/mol
TS-2.4
+5.9 kcal/mol
TS-2.8
N
O
Bt-Bu
O
Me2N O
H
t-Bu
"Boat" T.S.
F
F
F
+4.0 kcal/mol
TS-2.5
Steric Repulsion
+2.0 kcal/mol
TS-2.6
2.06 Å
Scheme 2.16 Calculated Stereochemical Models for Allyl-Addition to 2.11a
a. Transition State Leading to the R  (Major) Enantiomer
b. Transition States Leading to the S (Minor) Enantiomer
TS-2.4
TS-2.6
Calculations
always relax to
TS-2.8
N
O
Bt-Bu
O
Me2N
O
H
t-Bu
F
F F
Too high in energy
TS-2.7
Lone-Pair
Repulsion
Please Note: The energy 
of TS-2.4 is used as a 
zero point reference
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b3lyp/6-31G** and pcm=toluene
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O
Me2N
H
t-Bu
O
F
F
F
Steric Repulsion
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O
Bt-Bu
O
Me2N
H
t-Bu
O
2.37 Å
F F
F
 
Page 438
 enantiomer, is disfavored due to the steric clash between the t-Bu group ortho to the 
phenol of the catalyst and the CF3 group of the substrate (2.37 Å between a proton of the 
t-Bu group and a fluorine of the CF3 group). The steric clash is easier to see in the 
computer-generated structure of TS-2.6 (Scheme 2.16b). All attempts to calculate TS-
2.7, which is TS-2.4 only with the substituents on the ketones switched, minimize to boat 
transition state TS-2.8. A possible reason for the implausibility of TS-2.7 is the lone pair 
lone pair repulsion shown in Scheme 2.16b. This interaction does not seem to be as 
important in TS-2.4, likely because in TS-2.4 the electron withdrawing CF3 group 
absorbing much of the electron density in the lone-pair anti to it, minimizing the 
repulsion of this substrate lone pair with those on the phenol oxygen of the catalyst.  
 Sterically more hindered substrates, such as trifluoromethyl ketone 2.11k, lead to 
lower enantioselectivities in the aminophenol-promoted allyl-addition reaction (Scheme  
 
N
O
Bt-Bu
O
Me2N
O
F
H
t-Bu
F
F
TS-2.9
OMe
Steric Repulsion 2.02 Å
TS-2.10
As sterics of artl-
group increases,
TS-2.9 becomes less 
favored versus
TS-2.10
TS-2.9
Scheme 2.17 Rationale for Lower Enantioselectivity with Sterically-Hindered Substrates
Steric Repulsion
N
O
Bt-Bu
O
Me2N
H
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O
F F
F
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 2.11). Studying models based on the ones in Scheme 2.16, it becomes clear that a very 
large aryl-substituent begins to clash with the tert-Bu group ortho to the phenol of the 
catalyst in TS-2.9 (Scheme 2.17). This leads to TS-2.10 becoming more competitive 
(Scheme 2.17). A short screening of aminophenols showed a small improvement in the 
enantioselectivity of the transformation with larger aminophenol 2.21e, indicating that 
further increasing the sterics of the group ortho to the phenol in the catalyst begins to 
shift the enantioselectivity back towards the major enantiomer (that is, TS-2.9). Sterically 
less hindered substrates (vs. trifluoroacetophenone), such as alkyl-substituted 2.11n, 
undergo addition with similar levels of selectivity to trifluoroacetophenone. 
 
 The calculated transition states leading to the (R) enantiomer for 
monofluoroacetophenone 2.32a (TS-2.11-(R), Scheme 2.19) and difluoroacetophenone 
2.32b (TS-2.12-(R), Scheme 2.19) and contain similar F-H distances and geometries as 
 1.5 equiv. allylB(pin) 2.20a,
1.3 equiv. MeOH, 
toluene, 22 ºC, 4 h
10 mol % NaOt-Bu
2.5 mol % Aminophenol
F3C
O
2.11k
OH
F3C
2.12k
N
H
NMe2
OH
i-Pr
O
t-Bu
N
H
NMe2
OH
O
t-Bu
N
H
N
OH
i-Pr
O
t-Bu
N
H
NMe2
OH
i-Pr
O
SiPh3
N
H
NMe2
OH
i-Pr
O
Me
2.21a 2.21b 2.21c
2.21e 2.21f
>98% conv.,a 87:13 e.r.b >98% conv.,a 87.5:12.5 e.r.b >98% conv.,a 85.5:14.5 e.r.b
>98% conv.,a 91.5:8.5 e.r.b >98% conv.,a 86.5:13.5 e.r.b
Scheme 2.18 Screening of Aminophenols for Sterically Hindered Ketones
aConsumption of starting material as determined by 376 MHz 19F analysis of the unpurified reaction 
mixture. bDetermined by HPLC analysis.
OMe OMe
 
Page 440
 TS-2.4 (Scheme 2.16a), suggesting the cation-dipole interaction is plausible for these 
substrates. A fact worth considering when changing the degree of fluorination on carbon 
is that, as more fluorines are added to a carbon, the net charge on each fluorine remains  
 
 1.1 equiv. allylB(pin) 2.20a,
1.3 equiv. MeOH, 
toluene, 22 ºC, 16 h
10 mol % NaOt-Bu
2.5 mol % Aminophenol 2.21a
R2R1
O
2.32
R2
OH
R1
2.33
OH
HF2C
OH
H2FC
OH
MeF2C
OH
F
F
2.33a 2.33b
2.33c 2.33d
85% yield,a 
55:45 e.r.,b
97% yield,a 
58:43 e.r.,b
97% yield,a 
79:21 e.r.,b
83% yield,a 
94:6 e.r.,b
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Scheme 2.19 Modifying Substrates to Examine Enantioselectivity
All data are the average of at least two experiments. aYield of isolated 
product. bDetermined by HPLC analysis.
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 the same, but the C-F bond length is decreasing with increasing fluorination (e.g. 1.38 Å 
in methyl fluoride to 1.32 Å in carbon tetrafluoride).41 This decrease in bond length is 
primarily due to an increased positive charge on carbon with increasing fluorines, and 
thus, a stronger columbic attraction between C and F. 
 However, when substrates 2.32a and 2.32b are subjected to the catalytic 
enantioselective allyl-addition conditions, the desired products are afforded with 
essentially no enantiomeric enrichment (2.33a and 2.33b, Scheme 2.19).  The 
background reaction was not significantly different for 2.32a and 2.32b versus 
trifluoroacetophenone 2.11a, which minimalizes the possibility that this drop in 
enantioselectivity is a result of an adventitious uncatalyzed reaction.  Additionally, it is 
worth noting that the proton(s) geminal to fluorine in 2.32a and 2.32b are rendered less 
acidic by the fluorine(s) (rather than more) due to the closely held lone pairs of fluorine, 
indicating that the change in enantioselectivity is not due to change in the pH of the 
reaction involving these substrates versus 2.11a.3 All these facts taken together imply that 
the low enantioselectivity observed is due a structural change in the substrates resulting 
in TS-2.12-(S) becoming energetically similar to TS-2.12-(R).42  Examining transition 
state TS-2.6 in Scheme 2.16 versus TS-2.12-(S) in Scheme 2.19 and TS-2.4 versus TS-
2.12-(R) reveals two major differences.  First, there is far less steric repulsion disfavoring 
TS-2.12-(S) than exists in TS-2.6; the same scenario is true for monofluoroacetophenone 
containing TS-2.12-(S).  Secondly, in order for a fluorine in in 2.32a or 2.32b to form a 
cation-dipole interaction with the catalyst, as in TS-2.11-(R) and TS-2.12-(R), the 
substrate must adopt a conformation that is disfavored due to the dipole repulsion 
                                                
(41) Wiberg, K. J. Chem. Educ. 1996, 73, 1089–1095. 
(42) The same is true for TS-2.11 (R) and (S).  
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 between F–C and O=C. For example, compare the substrate dipole in TS-2.12-(R) with 
that of TS-2.12-(S) in Scheme 2.19.  In trifluoroacetophenone 2.11a, there is no 
difference in dipole as the trifluoromethyl group is symmetric, which results in there 
being no conformational preference within the substrate between transitions states TS-2.4 
and TS-2.6 (Scheme 2.16). 
 To determine the importance of these two factors, we next employed 
difluoropropiophenone 2.32c as a substrate which should restore the aforementioned 
steric repulsion (disfavoring TS-2.13-(S)) while maintaining the discrepancy in 
conformational preference due to dipolar interactions.  The desired product 2.33c is 
obtained in 79:21 enantiomeric ratio (Scheme 2.19), implying that, while it plays some 
role, the size difference between the trifluoromethyl group and difluoromethyl group is 
not exclusively responsible for change in selectivity when comparing 2.11a as a substrate 
vs. 2.32b (or 2.32a).  To support the hypothesis that the conformational preferences 
within the substrate strongly dictate our enantioselectivity, we synthesized substrate 
2.32d that is conformationally locked and sterically similar to difluoropropiophenone 
2.32c (Scheme 2.19).  As expected, due to elimination of the steric and conformational 
factors mentioned above (cf. TS-2.14-(R) and TS-2.14-(S), Scheme 2.19), the allyl 
addition to 2.32d  proceeds with nearly identical enantioselectivity to that of 
trifluoroacetophenone 2.11a. Importantly, the ability to hyperconjugate with a ketone 
lone pair is not significantly weaker for the difluoromethyl substituent of 
difluoropropiophenone 2.32c than the difluoro substituent of difluorotetralone 2.32d, 
meaning that it is unlikely that the tilting of the carbonyl towards the fluorine, proposed 
by Professor Corey (Figure 2.1) to account for why a trifluoromethyl behaves as the 
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 "large" group in his case, is operative in our case. Additionally, 2.32d is restricted into a 
ring, which hinders its ability to make such a tilt. Finally, in the computed lowest energy 
transitions states in Scheme 2.16, the catalyst coordinates to what, based on Corey's 
model, would be the more sterically shielded lone pair of the ketone. 
2.6 Additions to Ketones Containing an Aryl-Fluoride  
 Having examined a wide range of ketones that contain an aliphatic 
organofluorine, we were curious to see if aromatic fluorination ortho to the ketone can 
serve as a controlling element for enantioselectivity. Homoallyl alcohols resulting from 
allylation of pentafluoroacetophenone 2.9b and 2,6-difluoroacetophenone 2.9c are 
obtained in 95.5:4.5 and 93.5:6.5 e.r. (Scheme 2.20). However, the desired product of  
 
allyl addition to o-fluoroacetophenone 2.9d is afforded nearly racemically. Before 
devising a stereochemical model, we needed to prove the stereochemistry to 2.10b and 
2.10c. After many unsuccessful attempts, we were able to establish this stereochemistry 
through converting 2.10c to 2.36 by a three-step procedure (Scheme 2.21).  The 
 1.5 equiv. allylB(pin) 2.20a,
1.3 equiv. MeOH, 
toluene, 22 ºC, 4 h
2.5 mol % NaOt-Bu
2.5 mol % Aminophenol 2.21aO
Me
2.9a 2.10a
HO
Me
92% conv.,a
78% yield,b 70:30 e.r.c
HO
Me
F
F
F
F
F
>98% conv.,d
90% yield,b 95.5:4.5 e.r.c
Scheme 2.20 Effect of Fluorination of the Phenyl Group on Enantioselectivity
2.10b
HO
Me
F
F
85% conv.,d
65% yield,b 93.5:6.5 e.r.c
2.10c
HO
Me
F
>98% conv.,d
91% yield,b 59:41 e.r.c
2.10d
All data are the average of at least two experiments. aConversion to product as determined 
by 400 MHz 1H analysis of the unpurified reaction mixture versus an internal standard of 9-
methylanthracene. bYield of isolated product. cDetermined by HPLC analysis. dConversion 
to product as determined by 376 MHz 19F analysis of the unpurified reaction mixture versus 
an internal standard of monofluorobenzene.
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 stereochemistry of 2.36 was then established by converting known (S)–2.10a to 2.36.  By 
comparing the HPLC traces of the two samples of 2.36 synthesized by the 
aforementioned pathway, we established the stereochemistry of 2.10c (and by correlation, 
2.10b as well) to be (S) as shown in Scheme 2.20.   
 
 We again turned to DFT calculations43 to get a better understanding of how 
substrates containing two fluorines at the ortho-position of the aryl ring are noticeably 
more enantioselective than acetophenone 2.9a.  The lowest locatable transition state for 
formation of the major enantiomer (TS-2.14-(S), Scheme 2.22) shows a large F-H 
distance of 3.04 Å.  Furthermore, the aryl ring twists out of conjugation of the carbonyl 
by 9º (dihedral angle between the C-C bond of the ring that is directly attached to the 
carbonyl and the C=O bond of the carbonyl; there are two such C-C bonds, so the number 
is an average between the two), putting the fluorine even further from the ammonium 
proton (than it would be if the aryl ring and carbonyl were perfectly coplanar) further 
suggesting the weakness of this attractive force.  Instead of an attractive force, we 
propose a repulsive steric interaction between the fluorines of the substrate and the 
catalyst (Scheme 2.22) is behind the enantioselectivities observed in Scheme 2.20, as the  
                                                
(43) As usual, performed by Dr. Fredrik Haeffner. 
>98% conv.
10 mol % Pd/C,
 H2 (1 atm),
thf, 22 ºC, 6 h
>98% conv.,
74% yield2.10c 2.34 2.35
10 mol % Ni(PCy3)2Cl2,
4 equiv. LiEt3BH,
thf, reflux, 14 h
NaH, MeI,
thf, 45 ºC to reflux, 20 h
10 mol % Crabtree's Catalyst
H2 (1 atm), CH2Cl2, 22 ºC, 18 h
1)
2)  NaH, MeI, thf, 22 ºC, 12 h
87% yield over 2 steps 2.36 48% yield, 93.5:6.5 er
Scheme 2.21 Proof of Absolute Stereochemistry of 2.10c
HO
Me
F
F
2.10a
HO
Me
MeO
Me
O
Me
F
F
Me
O
Me
F
F
Me
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aryl ring in TS-2.15-(R) twists 25º out of conjugation with the carbonyl, mainly to avoid 
the phenol oxygen of the catalyst.  The observation that 2.10d is so much less 
enantiomerically enriched than 2.10b or 2.10c also fits this hypothesis, as the aryl group 
in 2.9d is sterically much smaller than the aryl group of either 2.9b or 2.9c (Scheme 
2.20). 
2.7 Conclusions  
 The method disclosed here is valuable not only because it allows access to 
molecules that are otherwise difficult to obtain, but it also lays the groundwork for future 
developments in enantioselective catalysis with fluorinated ketones by outlining 
parameters important for substrate binding, namely that a protonated nitrogen is more 
likely to be attracted to a fluorine than a neutral nitrogen due to fluorine’s propensity for 
cation-dipole interactions vs. traditional hydrogen bonding. 
N
O
Bt-Bu
O
Me2N
H
t-Bu
O
Me
F
F
TS-2.15-(S): 0.0 kcal/mol
Aryl Ring Twists
to Avoid Carbonyl-
Fluorine Clash
F-H Distance= 3.04 Å
N
O
Bt-Bu
O
Me2N
H
t-Bu
O
Me
TS-2.15-(R): 3.7 kcal/mol
Aryl Ring Twists
to Avoid Oxygen-
Fluorine Clash
F
F
TS-2.15-(R)
TS-2.15-(S)
Calculations carried out with
b3lyp/6-31G** and pcm=toluene
Scheme 2.22 Calculated Stereochemical Model for Allyl-Addition to 2.10c
9º Twist
25º Twist
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 2.8 Experimental Section 
 ■  General. Infrared (IR) spectra were recorded on a Bruker alpha 
spectrophotometer, λmax in cm-1.  Bands are characterized as broad (br), strong (s), 
medium (m), and weak (w).  1H NMR spectra were recorded on a Varian Unity INOVA 
400 (400 MHz) or 500 (500 MHz) spectrometer.  Chemical shifts are reported in ppm 
from tetramethylsilane with the solvent resonance as the internal standard (CDCl3: δ 7.26 
ppm).  Data are reported as follows: chemical shift, integration, multiplicity (s = singlet, 
d = doublet, dd = doublet of doublets, t = triplet, q = quartet, br = broad, m = multiplet), 
and coupling constants (Hz).  Well resolved AB splitting patterns are reported as follows: 
chemical shift of A and chemical shift of B, integration, multiplicity (ABq = AB quartet, 
d of ABq = doublet of AB quartets, etc), and coupling constants (Hz). 13C NMR spectra 
were recorded on a Varian Unity INOVA 400 (100 MHz) spectrometer with complete 
proton decoupling.  Chemical shifts are reported in ppm from tetramethylsilane with the 
solvent resonance as the internal standard (CDCl3: δ 77.16 ppm). Data are reported as 
follows: chemical shift, multiplicity (singlet unless otherwise noted), and coupling 
constants (Hz). 19F NMR spectra were recorded on a Varian Unity INOVA 400 (376 
MHz).  Chemical shifts are reported in ppm with BF3OEt2 as an external standard 
(BF3OEt2: δ 0.00 ppm).  Data are reported as follows: chemical shift, integration, 
multiplicity, and coupling constants (Hz).  High-resolution mass spectrometry was 
performed on a JEOL AccuTOF-DART (positive mode) or an Advion Expression CMS 
(ESI+ or ESI-) at the Mass Spectrometry Facility, Boston College. Enantiomer ratios 
(e.r.) values were determined by HPLC analysis using a Shimadzu LC-2010AHT 
chromatograph (Chiral Technologies Chiralcel OD-H (4.6 x 250 mm), Chiral 
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 Technologies Chiralcel OJ-H (4.6 x 250 mm), Chiral Technologies Chiralpak AD-H (4.6 
x 250 mm). Specific rotations were measured using either an Atago AP-300 Automated 
Polarimeter or a Rudolph Research Analytical Autopol IV Polarimeter. Melting points 
were determined using a Thomas Hoover Uni-melt capillary melting point apparatus. 
Unless otherwise noted, reactions were carried out under an atmosphere of dry N2 in 
oven-dried (135 ºC) glassware with the appropriate oven-dried (65 ºC) septa. 
■  Solvents: Unless otherwise noted, solvents were purged with Ar and purified under a 
positive pressure of dry Ar by a modified Innovative Technologies purification system.  
Toluene (Fisher, ACS Grade) was passed successively through activated copper and 
alumina columns.  Dichloromethane (Fisher, ACS Grade) and diethyl ether (Aldrich, 
Chromasolv®) were passed successively through two activated alumina columns. 
Tetrahydrofuran was purified by distillation from sodium benzophenone ketyl 
immediately prior to use. CDCl3 was purchased from Cambridge Isotope Laboratories 
and stored over activated 4Å molecular sieves prior to use. All work-up and purification 
procedures were carried out in air with reagent grade solvents (purchased from Fisher). 
C6D5CD3 was purchased from Cambridge Isotope Laboratories and used as received. 
■  Reagents and Catalysts: 
Allenylboronic Acid Pinacol Ester (2.23) was obtained from Frontier Scientific and 
distilled under vacuum prior to use. 
Allylboronates: Allylboronic acid pinacol ester (2.20a) was purchased from Aldrich or 
obtained as a gift from Frontier Scientific, Inc and distilled prior to use. 2-(2-
Methylallyl)boronic acid pinacol ester 2.20b) and 2-(2-Chloroallyl)boronic acid pinacol 
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 ester (2.20c) were synthesized and purified in accordance with a procedure in the 
literature.44 
Bis(tricyclohexylphosphine)Nickel(II) Dichloride was purchased from Aldrich (97%) 
and used as received. 
Crabtree's Catalyst ([Tricyclohexylphosphine] (1,5-Cyclooctadiene) (Pyridine) 
Iridium(I) Hexafluorophosphate) was purchased from Strem (99%) and used as 
received. 
Fluorobenzene was purchased from Aldrich and used as received. 
Hydrogen Gas was purchased from Airgas (industrial grade) and used as received. 
Methanol was purchased from Acros (99.8% anhydrous) and distilled at 1 atm from 
sodium metal prior to use. 
Methyl Iodide was purchased from Aldrich and distilled at 1 atm from calcium chloride 
prior to use. 
Palladium, 10% on Activated Carbon was purchased from Strem and used as received. 
Sodium tert-Butoxide was purchased from Strem (min. 98%) and used as received. 
Sodium Hydride was purchased from Aldrich (95%, dry) and used as received. 
Super-Hydride® (Lithium Triethylborohydride, 1.0 M in Tetrahydrofuran) was 
purchased from Aldrich and used as received. 
α ,α ,α-Trifluorotoluene was purchased from Aldrich and used as received. 
■  Substrates (Ketones): 
2.10a (acetophenone): Purchased from Aldrich and distilled under vacuum from calcium 
hydride prior to use. 
                                                
(44) Zhang, P.; Roundtree, I. A.; Morken, J. P. Org. Lett. 2012, 14, 1416–1419. 
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 2.10b (2′,3′,4′,5′,6′-pentafluoroacetophenone): Purchased from Aldrich and distilled 
under vacuum from calcium chloride prior to use. 
2.10c (2′,6′-difluoroacetophenone): Purchased from Oakwood and distilled under 
vacuum from calcium chloride prior to use. 
2.10d (2′-fluoroacetophenone): Purchased from Aldrich and distilled under vacuum 
from calcium chloride prior to use. 
2.11a (2,2,2-trifluoroacetophenone): Purchased from Oakwood and distilled under 
vacuum from calcium chloride prior to use. 
2.11b (2,2,3,3,3-pentafluoroacetophenone): Purchased from Matrix and used as 
received. 
2.11c (4,4,4,4,4,4,4-heptafluoroacetophenone): Purchased from Alfa Aesar and used as 
received. 
2.11d (4'-bromo-2,2,2-trifluoroacetophenone): Purchased from Matrix and used as 
received. 
2.11e (4'-fluoro-2,2,2-trifluoroacetophenone): Purchased from Aldrich and used as 
received. 
2.11f (4'-dimethylamino-2,2,2-trifluoroacetophenone): Purchased  from Aldrich as an 
orange-yellow solid. Dissolved in hot HPLC grade hexanes (Fisher) and filtered through 
a hot glass frit to removed dark orange solids. Frit is washed with HPLC grade hexanes 
and minimal dichloromethane (Fisher, reagent grade) to recover maximum amount of 
2.11f. Concentration in vacuo affords 2.11f as a bright yellow solid.  
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 2.11g (tert-butyl 2-(2,2,2-trifluoroacetyl)-1H-pyrrole-1-carboxylate): Synthesized in 
accordance to a procedure in the literature.45 
2.11h (2-(trifluoroacetyl)thiophene): Purchased from Aldrich and distilled under 
vacuum from calcium chloride prior to use or used as received (no difference in results 
are observed). 
2.11i (3-(trifluoroacetyl)thiophene): Synthesized in accordance to a procedure in the 
literature46 using Knochel's procedure47 to generate the requisite Grignard. 
2.11j (tert-butyl 3-(2,2,2-trifluoroacetyl)-1H-indole-1-carboxylate): Synthesized in 
accordance to a procedure in the literature.45 
2.11k (2'-methoxy-2,2,2-trifluoroacetophenone): Purchased from Oakwood and 
distilled under vacuum (simple distillation) prior to use or used as received (no difference 
in results are observed). 
2.11l (2'-methyl-2,2,2-trifluoroacetophenone): Synthesized in accordance to a 
procedure in the literature.46  
2.11m (3'-methyl-2,2,2-trifluoroacetophenone): Purchased from Oakwood and used as 
received. 
2.11n (1,1,1-Trifluoro-3-phenylacetone): Purchased from Oakwood and distilled under 
vacuum from calcium chloride or used as received (no difference in results are observed). 
2.11o ((E)-1,1,1-trifluoro-4-phenylbut-3-en-2-one): Synthesized in accordance to a 
procedure in the literature.48 
                                                
(45) Son, S.; Fu, G. C. J. Am. Chem. Soc. 2007, 129, 1046–1047. 
(46) Shaw, D. A.; Tuominen, T. C.; Synth. Commun. 1985, 15, 1291–1297. 
(47) Krasovskiy, A.; Knochel, P. Angew. Chem. Int. Ed. 2004, 43, 3333–3336. 
(48) Kawano, Y.; Kaneko, N.; Mukaiyama, T. Bull. Chem. Soc. Jpn. 2006, 79, 1133–1145. 
 
Page 451
 2.26a (isobutyrophenone): Purchased from Aldrich and distilled under vacuum from 
calcium hydride prior to use. 
2.26b (isovalerophenone): Purchased from Aldrich and distilled under vacuum from 
calcium hydride prior to use. 
2.28a (4'-nitroacetophenone): Purchased from Aldrich and used as received. 
2.28b (3',5'-difluoroacetophenone): Purchased from Oakwood and used as received. 
2.33a (2-fluoroacetophenone): Synthesized in accordance to a procedure in the 
literature.49 
2.33b (2,2-difluoroacetophenone): Purchased from Alfa Aesar and distilled under 
vacuum (simple distillation) prior to use. 
2.33c (2,2-difluoropropiophenone): Synthesized in accordance to a procedure in the 
literature.50 
2.33d (2,2-difluoro-α-tetralone): Synthesized in accordance to a procedure in the 
literature.50  
■  Experimental Procedures and Analytical Data 
Representative Procedure for Catalytic Enantioselective Allyl Additions to Ketones 
Bearing a Perfluoroalkyl Group (Scheme 2.11):  In a nitrogen-filled glovebox, 
aminophenol 2.21a (7.7 mg, 0.025 mmol) is added to a two-dram vial equipped with a 
stir bar and dissolved in 1.0 mL of toluene. A second stock solution is prepared by 
dissolving 19.2 mg NaOt-Bu in 8.0 mL toluene. A two-dram vial equipped with a stir bar 
is charged with 200 mmol of the stock solution of 2.21a (1.5 mg, 5.0 mmol) followed by 
800 µL of the stock solution of NaOt-Bu (1.9 mg, 20 mmol). This vial is sealed with a 
                                                
(49) Wei, Z.-L.; Li, Z.-Y.; Lin, G.-Q. Tetrahedron 1998, 54, 13059–13072. 
(50) Pravst, I.; Zupan, M.; Stavber, S. Synthesis 2005, 18, 3140–3146. 
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 cap (phenolic open top cap with a white PFTE/gray silicone septa) and electrical tape and 
removed from the glovebox. Methanol (10 µL, 0.25 mmol) and trifluoroacetophenone 
2.11a (28 µL, 0.20 mmol) are added by syringe under N2 in the stated order. The reaction 
vessel placed in a 0 ºC ice/water bath and allowed to stir for 15 minutes. Allylboronic 
acid pinacol ester 2.20a (42 µL, 0.22 mmol) is added by syringe under N2 and the 
reaction mixture is allowed to stir at 4 ºC for 4 h after which time the cap is removed and 
α,α,α-trifluorotoluene (24.4 µL, 0.199 mmol) is added as an internal standard. Following 
19F NMR analysis of the reaction mixture, it is passed through a short plug of silica gel 
(eluted with Et2O) and concentrated in vacuo being careful not to remove all of the 
solvent, as the product is volatile. The resulting pale yellow oil is purified by silica gel 
chromatography (10 mm diameter column slurry packed with 2.5 g of silica gel in 
pentane and eluted successively with 10 mL pentane, 14 mL 19:1 pentane:Et2O, and 15 
mL 9:1 pentane:Et2O) to afford desired product 2.12a (39.9 mg, 0.185 mmol, 92% yield) 
as a clear, colorless oil. 
(R)-1,1,1-Trifluoro-2-phenylpent-4-en-2-ol (2.12a, Scheme 2.11): The analytical data 
are fully consistent with those reported previously.51 1H NMR (500 MHz, CDCl3): δ 
7.62–7.54 (2H, m), 7.45–7.32 (3H, m), 5.62–5.50 (1H, m), 5.30–5.18 (2H, m), 2.99 (1H, 
dd, J = 14.3, 6.6 Hz), 2.85 (1H, dd, J = 14.3, 8.1 Hz), 2.58 (1H, s); HRMS Calcd for 
C11H10F3 [M + H – H2O]+: 199.07346; Found: 199.07335; [α]23.3D	   = +50.0 (c = 2.20, 
CHCl3) for a 94:6 e.r. sample.	    The enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material (Chiracel AS-H, 98:2 hexanes:i-
PrOH, 0.5 mL/min, 220 nm): tR: 13 min (major) and 14 min (minor).  
                                                
(51) Xie, Z.; Li, G.; Zhao, G.; Wang, J. Chin. J. Chem. 2010, 28, 1212–1216. 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 11.5 min 49.600 1 13.1 min 94.312 
2 12.3 min 50.400 2 14.1 min 5.688 
 
(R)-1,1,1,2,2-Pentafluoro-3-phenylhex-5-en-3-ol (2.12b, Scheme 2.11): The title 
compound is synthesized analogously to 2.12a except that the amount of aminophenol 
2.21a is 1.0 mol% (vs. 2.5 mol%). The title compound is purified by silica gel 
chromatography (10 mm diameter column slurry packed with ~2.5 g of silica gel and 
eluted with 10 mL pentanes, 20 mL 30:1, 10 mL 19:1 pentanes : diethyl ether) affording 
2.12b (45.1 mg, 0.169 mmol, 85% yield) as a clear colorless oil. IR (neat): 3551 (w, br), 
3068 (w, br), 3032 (w), 2986 (w), 1450 (w), 1339 (w), 1214 (m), 1173 (s), 1173 (s), 1132 
(s), 1057 (m), 1001 (s), 983 (w), 937 (w), 849 (w), 765 (w), 713 (s), 699 (m) cm-1; 1H 
NMR (400 MHz, CDCl3): δ 7.56–7.53 (2H, m), 7.42–7.32 (3H, m), 5.49–5.38 (1H, m), 
5.28–5.20 (2H, m), 3.08–3.03 (1H, m), 2.89 (1H, dd, J = 14.2, 8.3 Hz), 2.57 (1H, s); 13C 
NMR (100 MHz, CDCl3): δ 136.9 (m), 130.5, 128.6, 128.4, 126.6, 122.5, 119.2 (qt, J = 
288.5, 36.6 Hz), 114.5 (tq, J = 261.5, 34.8 Hz), 76.0 (t, J = 23.5 Hz), 40.5 (m); 19F NMR 
(376 MHz, CDCl3): δ 74.86 (3F, s), 31.76 and 30.56 (2F, ABq, JAB = 276.6 Hz); HRMS 
Calcd for C12H10F5 [M + H – H2O]+: 249.07027; Found: 249.06989. [α]23.5D = +61.7 (c = 
1.94, CHCl3) for a 95:5 er sample.  The enantiomeric purity of this compound was 
determined by HPLC analysis in comparison with authentic racemic material (Chiracel 
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 AD-H, 99:1 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 7.2 min (minor) and 7.9 min 
(major).  
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 7.4 min 50.769 1 7.2 min 4.959 
2 8.1 min 49.231 2 7.9 min 95.041 
 
(R)-5,5,6,6,7,7,7-Heptafluoro-4-phenylhept-1-en-4-ol (2.12c, Scheme 2.11): The title 
compound is synthesized analogously to 2.12a except that the amount of aminophenol 
2.21a is 1.0 mol% (vs. 2.5 mol%). The title compound is purified by silica gel 
chromatography (10 mm diameter column slurry packed with ~2.5 g of silica gel and 
eluted with 10 mL pentanes, 20 mL 30:1, 10 mL 20:1 pentanes:diethyl ether) affording 
2.12c (56.6 mg, 0.179 mmol, 89% yield) as a clear colorless oil. IR (neat): 3553 (w, br), 
3068 (w), 1641 (w), 1450 (w), 1341 (m), 1213 (s), 1189 (s), 1116 (s), 1072 (m), 997 (m), 
937 (m), 710 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.59–7.56 (2H, m), 7.42–7.34 (3H, 
m), 5.48–5.38 (1H, m), 5.29–5.20 (2H, m), 3.09–3.03 (1H, m), 2.91 (1H, dd, J = 14.1, 8.4 
Hz), 2.65 (1H, s); 13C NMR (100 MHz, CDCl3):  Note: Peaks assigned as apparent due to 
complexity of the spectrum. δ 136.9 (m), 130.4, 128.6, 128.4, 126.7 (m), 122.8–121.9 
(m), 122.5, 119.7–118.3 (m), 116.5–115.7 (m), 114.0–112.0 (m), 111.2–109.3 (m), 
108.5–106.6 (m), 77.0–76.7 (m), 41.0 (t, 3.1 Hz); 19F NMR (376 MHz, CDCl3): Note: 
Peaks assigned as apparent due to complexity of the spectrum. δ 71.87–71.81 (3F, m), 
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 35.62 (1F, app. ddq, J = 283.6, 19.9, 9.9 Hz), 34.24 (1F, app. dp, J = 283.5, 11.8 Hz), 
31.33 (1F, app. ddd, J = 289.5, 11.3, 6.2 Hz), 28.59 (1F, app. dd, J = 289.4, 10.9 Hz); 
HRMS Calcd for C13H10F7 [M + H – H2O]+: 299.06707; Found: 299.06783. [α]21.4D = 
+54.9 (c = 2.55, CHCl3) for a 97:3 e.r. sample.  The enantiomeric purity of this 
compound was determined by HPLC analysis in comparison with authentic racemic 
material (Chiracel AD-H, 98:2 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 9.8 min 
(minor) and 11 min (major). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 9.7 min 49.535 1 9.8 min 3.651 
2 11.0 min 50.465 2 10.8 min 96.349 
 
(R)-2-(4-Bromophenyl)-1,1,1-trifluoropent-4-en-2-ol (2.12d, Scheme 2.11):  The title 
compound is synthesized analogously to 2.12a except for the following changes: 1) The 
substrate is weighed out into the reaction vessel before any other components were 
added. 2) The amount of aminophenol 2.21a is 1.0 mol% (vs. 2.5 mol%).  The title 
compound is purified by silica gel chromatography (10 mm diameter column slurry 
packed with ~2.5 g of silica gel and eluted with 10 mL pentanes, 20 mL 30:1, 20 mL 19:1 
pentanes : diethyl ether) affording 2.12d (53.6 mg, 0.182 mmol, 94% yield) as a clear 
colorless oil.  The analytical data are fully consistent with those reported previously.2 1H 
NMR (400 MHz, CDCl3): δ 7.55–7.52 (2H, m), 7.45 (2H, d, J = 8.4 Hz), 5.60–5.49 (1H, 
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 m), 5.29–5.23 (2H, m), 2.93 (2H, dd, J = 14.4, 6.7 Hz), 2.83 (2H, dd, J = 14.4, 7.9 Hz), 
2.61 (1H, s); 19F NMR (376 MHz, CDCl3): δ 73.59 (3F, s); HRMS Calcd for C11H9BrF3 
[M + H – H2O]+: 276.98397; Found: 276.98282. [α]21.8D = +71.6 (c = 2.37, CHCl3) for a 
96:4 e.r. sample.  The enantiomeric purity of this compound was determined by HPLC 
analysis in comparison with authentic racemic material (Chiracel AD-H, 98:2 hexanes:i-
PrOH, 0.5 mL/min, 220 nm): tR: 19 min (major) and 22 min (minor). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 19.4 min 55.305 1 18.8 min 95.887 
2 21.7 min 44.695 2 21.1 min 4.113 
 
(R)-1,1,1-Trifluoro-2-(4-fluorophenyl)pent-4-en-2-ol (2.12e, Scheme 2.11): The 
analytical data are fully consistent with those reported previously.51 1H NMR (400 MHz, 
CDCl3): δ 7.68–7.47 (2H, m), 7.17–7.00 (2H, m), 5.66–5.45 (1H, m), 5.37–5.15 (2H, m), 
3.02–2.90 (1H, m), 2.89–2.78 (1H, m), 2.61 (1H, br s); HRMS Calculated for C11H9F4 [M 
+ H – H2O]+: 217.06387; Found: 217.06404. [α]22D = +40.4 (c = 0.99, CHCl3) for a 95:5 
e.r. sample. The enantiomeric purity of this compound was determined by HPLC analysis 
in comparison with an authentic sample of racemic material (Chiracel AS-H, 98:2 
hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 15 min (major) and 17 min (minor). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 13.2 49.209 1 15.0 94.802 
2 15.3 50.791 2 17.7 5.198 
 
(R)-2-(4-(Dimethylamino)phenyl)-1,1,1-trifluoropent-4-en-2-ol (2.12f, Scheme 2.11):  
IR (neat): 3543 (br w), 2921 (br, w), 2854 (br, w), 2807 (br, w), 1614 (m), 1523 (m), 
1445 (w), 1358 (w), 1269 (m), 1227 (m), 1145 (s), 994 (m), 944 (m), 814 (s), 710 (w) cm-
1; 1H NMR (400 MHz, CDCl3): δ 7.39 (2H, d, J = 8.8 Hz), 6.73–6.70 (2H, m), 5.65–5.54 
(1H, m), 5.26–5.18 (2H, m),  3.00–2.95(1H, m,), 2.97 (6H, s), 2.81–2.75 (1H, m), 2.46 
(1H, br s); 13C NMR (100 MHz, CDCl3): δ150.5, 131.1, 127.5 ,125.7 (q, J = 285.4 Hz), 
124.1 (s), 121.6 (s), 112.0 (s), 75.7 (q, J =28.2 Hz), 40.4, 40.0; 19F NMR (376 MHz, 
CDCl3): 79.85 (3F, s); HRMS Calculated for C13H17F3NO [M + H]+: 260.12622; Found: 
260.12544; [α]26D = +59.8 (c = 1.17, CHCl3) for a 93:7 e.r. sample. The enantiomeric 
purity of this compound was determined by HPLC analysis in comparison with an 
authentic sample of racemic material (Chiracel AD-H, 97:3 hexanes:i-PrOH, 0.8 mL/min, 
220 nm): tR: 15 min (major) and 19 min (minor). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 13.2 49.807 1 14.9 93.527 
2 16.9 50.193 2 19.2 6.473 
 
tert-Butyl-(R)-2-(1,1,1-trifluoro-2-hydroxypent-4-en-2-yl)-1H-pyrrole-1-carboxylate 
(2.12g, Scheme 2.11): IR (neat): 3299 (br w), 2984 (w), 1718 (m), 1444 (w), 1398 (m), 
1373 (m), 1337 (s), 1264 (m), 1145 (s), 1100 (m), 848 (w), 733 (m) cm-1; 1H NMR (400 
MHz, CDCl3): δ 7.69 (1H, s), 7.28 (1H, dd, J = 3.6, 1.8 Hz), 6.39 (1H, m), 6.16 (1H, app 
t, J = 3.5 Hz), 6.06–5.76 (1H, m), 5.27–5.03 (2H, m), 2.90 (2H, m), 1.61 (9H, s); 13C 
NMR (100 MHz, CDCl3): δ151.8, 132.4, 130.3, 125.6 (q, J = 286.9 Hz), 125.4, 118.7, 
118.5, 110.4, 86.6, 74.3 (q, J = 28.6 Hz); 19F NMR (376 MHz, CDCl3): δ 73.85 (3F, s); 
HRMS Calculated for C14H19F3NO3 [M + H]+: 305.12388; Found: 306.13267; [α]23D = -
10.9 (c = 0.92, CHCl3) for a >99:1 e.r. sample. The enantiomeric purity of this compound 
was determined by HPLC analysis in comparison with an authentic sample of racemic 
material (Chiracel AD-H, 97:3 hexanes:i-PrOH, 0.8 mL/min, 220 nm): tR: 5 min (major) 
and 3 min (minor). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 3.5 49.944 1 5.2 100 
2 5.1 50.056 2 N.A. 0 
 
(S)-1,1,1-Trifluoro-2-(thiophen-2-yl)pent-4-en-2-ol (2.12h, Scheme 2.11): : IR (neat): 
3531 (w, br), 3083 (w), 2984 (w), 2957 (w), 2929 (w), 1642 (w), 1437 (w), 1274 (m), 
1228 (w), 1154 (s, br), 1048 (m), 991 (m), 931 (m), 724 (m), 702 (s) cm-1; 1H NMR (400 
MHz, CDCl3): δ 7.35 (1H, dd, J = 5.1, 1.2 Hz), 7.14–7.12 (1H, m), 7.05 (1H, dd, J = 5.1, 
3.6 Hz), 5.71–5.60 (1H, m), 5.32–5.26 (2H, m), 2.97–2.91 (1H,m), 2.88–2.82 (2H, m); 
13C NMR (100 MHz, CDCl3): δ 141.2, 130.1, 127.3, 126.4, 125.9 (q, J = 1.2 Hz),  124.8 
(q, J = 285.1 Hz), 122.5, 75.7 (q, J = 29.8 Hz), 41.4 (m); 19F NMR (376 MHz, CDCl3): δ 
72.35 (3F, s); HRMS Calculated for C9H8F3S [M + H – H2O]+: 205.02998; Found: 
205.02988. [α]22D = +52 (c = 0.96, CHCl3) for a 84:16 e.r. sample. The enantiomeric 
purity of this compound was determined by HPLC analysis in comparison with an 
authentic sample of racemic material (Chiracel AS-H, 98:2 hexanes:i-PrOH, 0.5 mL/min, 
220 nm): tR: 16 min (major) and 18 min (minor). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 19.0 49.983 1 16.2 84.226 
2 21.5 50.017 2 18.2 15.774 
 
(R)-1,1,1-Trifluoro-2-(thiophen-3-yl)pent-4-en-2-ol (2.12i, Scheme 2.11): IR (neat): 
3540 (br, w), 3115 (w), 3083 (w), 2928 (w), 1275 (m), 1226 (m), 1150 (s), 1086 (m), 
1019 (m), 920 (m), 853 (s), 785 (s), 724 (s), 688 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 
7.42 (1H, m), 7.38–7.29 (1H, m), 7.14–7.13 (1H, m), 5.65–5.43 (1H, m), 5.26–5.22 (2H, 
m), 2.92–2.83 (1H, m), 2.83–2.75 (1H, m), 2.63–2.55 (1H, br s); 13C NMR (100 MHz, 
CDCl3): δ 138.8, 130.4, 126.4, 126.0, 125.2 (q, J = 284.0 Hz), 123.9, 121.9, 75.4 (q, J = 
29.1 Hz), 40.7;19F NMR (376 MHz, CDCl3): δ 73.00 (3F, s); HRMS Calculated for 
C9H8F3S [M + H – H2O]+: 205.02998; Found: 205.03052. [α]22D = +49.4 (c = 1.01, 
CHCl3) for a 96.5:3.5 e.r. sample. The enantiomeric purity of this compound was 
determined by HPLC analysis in comparison with an authentic sample of racemic 
material (Chiracel AS-H, 98:2 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 14 min (major) 
and 15 min (minor). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 14.4 49.750 1 14.1 96.474 
2 15.7 50.250 2 15.4 3.526 
 
tert-Butyl (R)-3-(1,1,1-trifluoro-2-hydroxypent-4-en-2-yl)-1H-indole-1-carboxylate 
(2.12j, Scheme 2.11): M.p. = 63–65ºC; IR (neat): 3501 (br w), 2981 (w), 1737 (m), 1452 
(m), 1372 (s), 1254 (s), 1153 (s), 1078 (m), 1028 (w), 990 (w), 838 (w), 764 (m), 748 (m) 
cm-1; 1H NMR (400 MHz, CDCl3): δ 8.18 (1H, d, J = 8.3 Hz), 7.82 (1H, d, J = 8.0 Hz), 
7.70 (1H, s), 7.45–7.12 (2H, m), 5.66 (1H, app ddd, J = 16.7, 8.7, 8.0 Hz), 5.36–5.10 (2H, 
m), 3.17–2.86 (2H, m), 2.67 (1H, s), 1.68 (9H, d, J = 1.6 Hz); 13C NMR (100 MHz, 
CDCl3): δ 149.6, 136.0, 130.6, 127.9, 125.7, 125.5 (q, J = 284.1 Hz), 124.7, 123.0, 122.0, 
121.6, 117.4, 115.5, 84.5, 75.0 (q, J = 30.0 Hz), 39.6, 28.3; 19F NMR (376 MHz, CDCl3): 
δ 73.50 (3F, s); HRMS Calculated for C18H20F3NO3 [M + H]+: 356.14813; Found: 
356.14735; [α]22D = +21.7 (c = 0.92, CHCl3) for a 85.5:14.5 e.r. sample. The 
enantiomeric purity of this compound was determined by HPLC analysis in comparison 
with an authentic sample of racemic material (Chiracel AS-H, 98:2 hexanes:i-PrOH, 0.5 
mL/min, 220 nm): tR: 54 min (minor) and 59 min (major).  
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 54.1 49.842 1 53.9 16.364 
2 59.8 50.158 2 59.3 83.636 
 
(R)-1,1,1-Trifluoro-2-(2-methoxyphenyl)pent-4-en-2-ol (2.12k, Scheme 2.11):  The 
title compound is synthesized analogously to 2.12a and purified by silica gel 
chromatography (10 mm diameter column slurry packed with ~2.5 g of silica gel and 
eluted with 10 mL pentanes, 25 mL 30:1 pentanes : diethyl ether) affording 2.12k (44.4 
mg, 0.180 mmol, 90% yield) as a clear pale yellow oil. IR (neat): 3452 (w, br), 3081 (w), 
3015 (w), 2981 (w), 2947 (w), 2845 (w), 1603 (w), 1584 (w), 1438 (m), 1267 (m), 1238 
(m), 1182 (m), 1156 (s), 1137 (m), 1022 (m), 912 (m), 753 (s); 1H NMR (400 MHz, 
CDCl3): δ 7.37–7.31 (2H, m), 7.05–6.98 (2H, m), 6.07 (1H, s), 5.74 (1H, dddd, J = 17.2, 
10.3, 7.2, 6.4 Hz), 5.25–5.06 (2H, m), 3.92–3.91 (3H, m), 3.06 (1H, dd, J = 15.0, 7.2 Hz), 
2.85 (1H, dd, J = 14.9,  6.4 Hz); 13C NMR (100 MHz, CDCl3): δ 158.8, 131.9, 130.7, 
130.3, 125.9 (q, J = 285.9 Hz), 123.2, 121.5, 119.3, 112.8, 78.4 (q, J = 28.5 Hz), 56.5–
56.3 (m), 38.3–38.2 (m); 19F NMR (376 MHz, CDCl3): δ 71.94 (3F, s); HRMS Calcd for 
C12H12F3O [M + H – H2O]+: 229.08402; Found: 229.08451. [α]21.7D = –0.82 (c = 2.92, 
CHCl3) for a 88:12 e.r. sample.  The enantiomeric purity of this compound was 
determined by HPLC analysis in comparison with authentic racemic material (Chiracel 
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 OJ-H, 98:2 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 14 min (minor) and 17 min 
(major).  
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 14.5 min 51.052 1 14.3 min 12.260 
2 17.2 min 48.948 2 17.0 min 87.740 
 
(R)-1,1,1-Trifluoro-2-(o-tolyl)pent-4-en-2-ol (2.12l, Scheme 2.11): The title compound 
is synthesized analogously to 2.12a and purified by silica gel chromatography (10 mm 
diameter column slurry packed with ~2.5 g of silica gel and eluted with 10 mL pentanes, 
20 mL 30:1, 15 mL 15:1 pentanes : diethyl ether) affording 2.12l (40.0 mg, 0.174 mmol, 
87% yield) as a clear colorless oil. IR (neat): 3544 (w, br), 1641 (w), 1452 (w), 1296 (w), 
1228 (w), 1157 (s), 1011 (w), 994 (w), 941 (w), 912 (w), 761 (w), 731 (m); 1H NMR 
(400 MHz, CDCl3): δ 7.37–7.33 (1H, m), 7.19–7.06 (3H, m), 5.62–5.51 (1H, m), 5.22–
5.13 (2H, m), 3.10 (1H, dd, J = 14.6, 6.7 Hz), 2.75 (1H, dd, J = 14.6, 7.9 Hz), 2.50–2.45 
(4H, m); 13C NMR (100 MHz, CDCl3): δ 138.5, 134.3, 133.5, 134.0, 128.7 (m), 128.7 
(m), 126.0 (q, J = 286.3 Hz), 125.8, 122.4, 78.0 (q, J = 28.3 Hz), 40.8, 23.1 (q, J = 2.1 
Hz); 19F NMR (376 MHz, CDCl3): δ 75.73 (3F, s); HRMS Calcd for C12H12F3 [M + H – 
H2O]+: 213.08911; Found: 213.09248. [α]22.4D = +30.4 (c = 2.30, CHCl3) for a 82:18 e.r. 
sample.  The enantiomeric purity of this compound was determined by HPLC analysis in 
comparison with authentic racemic material (Chiracel OJ-H, 98:2 hexanes:i-PrOH, 0.5 
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 mL/min, 220 nm): tR: 20 min (major) and 25 min (minor). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 18.4 min 49.987 1 19.8 min 82.260 
2 23.1 min 50.013 2 25.2 min 17.740 
 
(R)-1,1,1-Trifluoro-2-(m-tolyl)pent-4-en-2-ol (2.12m, Scheme 2.11): The title 
compound is synthesized analogously to 2.12a and purified by silica gel chromatography 
(10 mm diameter column slurry packed with ~2.5 g of silica gel and eluted with 10 mL 
pentanes, 20 mL 30:1, 15 mL 15:1 pentanes : diethyl ether) affording 2.12m (43.1 mg, 
0.190 mmol, 94% yield) as a clear colorless oil.  IR (neat): 3549 (w, br), 2927 (w), 1642 
(w), 1609 (w), 1370 (w), 1269 (m), 1230 (m), 1147 (s), 1023 (m), 993 (m), 785 (m), 708 
(s), 646 (m); 1H NMR (400 MHz, CDCl3): δ 7.41–7.35 (2H, m), 7.30 (1H, app t, J = 7.6 
Hz), 7.20–7.17 (1H, m), 5.63–5.53 (1H, m), 5.29–5.22 (2H, m), 2.99 (1H, dd, J = 14.3, 
6.5 Hz), 2.85 (1H, dd, J = 14.2, 8.1 Hz), 2.60 (1H, s), 2.40 (3H, s); 13C NMR (100 MHz, 
CDCl3): δ 138.2, 136.9, 130.7, 129.4, 128.4, 127.2, 125.5 (q, J = 285.4 Hz), 123.6, 121.2, 
75.9 (q, J = 28.3 Hz), 40.5, 21.5; 19F NMR (376 MHz, CDCl3): δ 73.68 (3F, s); HRMS 
Calcd for C12H12F3 [M + H – H2O]+: 213.08911; Found: 213.08958. [α]21.5D = +61.7 (c = 
1.94, CHCl3) for a 92.5:7.5 e.r. sample.  The enantiomeric purity of this compound was 
determined by HPLC analysis in comparison with authentic racemic material (Chiracel 
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 OJ-H, 98:2 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 21 min (major) and 23 min 
(minor). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 20.8 min 49.109 1 20.8 min 92.482 
2 22.9 min 50.891 2 23.0 min 7.518 
 
(R)-2-Benzyl-1,1,1-trifluoropent-4-en-2-ol (2.12n, Scheme 2.11): The analytical data 
are fully consistent with those reported previously.52 1H NMR (500 MHz, CDCl3): δ 
7.46–7.15 (5H, m), 5.92–5.68 (1H, m), 5.24–5.21 (1H, m), 5.15–5.09 (1H, m), 3.12 and 
2.90 (2H, ABq, JAB = 13.8 Hz), 2.52 (2H, dd, J = 14.4, 6.5 Hz), 2.33–2.23 (2H, m), 2.22 
(1H, s); HRMS Calculated for C12H17F3N1O1 [M + NH4]+: 248.12622; Found: 248.12609. 
[α]22D = +52.0 (c = 0.96, CHCl3) for a 94:6 e.r. sample. The enantiomeric purity of this 
compound was determined by HPLC analysis in comparison with an authentic sample of 
racemic material (Chiracel AD-H, 97:3 hexanes:i-PrOH, 0.8 mL/min, 220 nm): tR: 9 min 
(minor) and 10 min (major). 
                                                
(52) Felix, C.; Laurent, A.; Mison, P.; J. Fluorine Chem., 1995, 70, 71–82 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 8.1 49.814 1 9.2 6.287 
2 9.5 50.186 2 10.8 93.713 
 
(S,E)-1-Phenyl-3-(trifluoromethyl)hexa-1,5-dien-3-ol (2.12o, Scheme 2.11): IR (neat): 
3543 (br w), 2921 (br, w), 2854 (br, w), 2807 (br, w), 1614 (m), 1523 (m), 1445 (w), 
1358 (w), 1269 (m), 1227 (m), 1145 (s), 994 (m), 944 (m), 814 (s), 710 (w) cm-1; 1H 
NMR (400 MHz, CDCl3): δ 7.44–7.40 (2H, m), 7.37–7.35 (2H, m), 7.32–7.26 (1H, m), 
6.87 (1H, d, J = 16.0 Hz), 6.21 (1H, d, J = 16.0 Hz), 5.87–5.69 (1H, m), 5.28–5.23 (2H, 
m), 2.70–2.59 (2H, m), 2.32 (1H, s); 13C NMR (100 MHz, CDCl3): δ 135.8, 133.4, 130.5, 
128.8, 128.5, 127.0, 125.4 (q, J = 283.7 Hz), 124.8, 121.5, 75.3 (q, J = 28.3 Hz), 39.7; 19F 
NMR (376 MHz, CDCl3): δ 72.37 (3F, s); HRMS Calculated for C13H12F3 [M + H – 
H2O]+: 225.08911; Found: 225.08909. [α]22D = +19.9 (c = 1.00, CHCl3) for a 96.5:3.5 e.r. 
sample. The enantiomeric purity of this compound was determined by HPLC analysis in 
comparison with an authentic sample of racemic material (Chiracel AS-H, 98:2 
hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 14 min (major) and 19 min (minor). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 16.0 49.885 1 13.7 96.432 
2 17.9 50.115 2 15.2 3.568 
 
(R)-1,1,1-Trifluoro-4-methyl-2-phenylpent-4-en-2-ol (2.22a, Table 2.3):  The title 
compound is synthesized analogously to 2.12a except for the following changes: 1) 
Boronic ester 2.20b (60 µL, 0.28 mmol) is used instead of 2.20a. 2) The reaction 
temperature is 22 ºC.  The title compound is purified by silica gel chromatography (10 
mm diameter column slurry packed with ~2.5 g of silica gel and eluted with 10 mL of 
pentanes, 20 mL 30:1 and 15 mL 19:1 pentanes: diethyl ether.  Three purifications were 
needed to obtain analytically pure compound) to afford 2.22a (41.1 mg, 0.179 mmol, 
89% yield) as a pale yellow oil.  IR (neat): 3520 (w, br), 3076 (w), 3034 (w), 2973 (w), 
2953 (w), 2924 (w), 1645 (w), 1450 (w), 1378 (w), 1265 (m), 1151 (s), 1073 (m), 911 
(m), 721 (m), 699 (s); 1H NMR (400 MHz, CDCl3): δ 7.62 (2H, d, J = 7.4 Hz), 7.45–7.31 
(3H, m), 4.99–4.96 (1H, m), 4.85 (1H, s), 2.97 (1H, app d, J = 13.9 Hz), 2.87–2.83 (1H, 
m), 2.83 (1H, s), 1.40 (3H, s); 13C NMR (100 MHz, CDCl3): δ 139.8, 137.5, 128.6, 128.4, 
126.6 (m), 125.5 (q, J = 285.4 Hz), 118.2, 75.3 (q, J = 28.2), 43.5, 23.9; 19F NMR (376 
MHz, CDCl3): δ 73.26 (3F, s); HRMS Calcd. for C12H12F3 [M + H – H2O]+: 213.08911; 
Found: 213.08958. [α]21.0D = +88.7 (c = 1.80, CHCl3) for a 97:3 e.r. sample.  The 
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 enantiomeric purity of this compound was determined by HPLC analysis in comparison 
with authentic racemic material (Chiracel AS-H, 98:2 hexanes:i-PrOH, 0.5 mL/min, 220 
nm): tR: 11 min (major) and 12 min (minor). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 10.7 min 49.919 1 10.8 min 96.695 
2 11.6 min 50.081 2 11.6 min 3.305 
 
(R)-4-Chloro-1,1,1-trifluoro-2-phenylpent-4-en-2-ol (2.22b, Table 2.3): The title 
compound is synthesized analogously to 2.12a except for the following changes: 1) 
Boronic ester 2.20c (43 µL, 0.22 mmol) is used instead of 2.20a. 2) The reaction 
temperature is 22 ºC. The title compound is purified by silica gel chromatography (10 
mm diameter column slurry packed with ~2.5 g of silica gel and eluted with 10 mL 
pentanes, 20 mL 30:1, 20 mL 15:1 pentanes: diethyl ether) affording 2.22b (49.3 mg, 
0.197 mmol, 98% yield) as a clear pale yellow oil. IR (neat): 3567 (w, br), 1634 (w), 
1451 (w), 1267 (m), 1145 (s), 1074 (m), 1012 (w), 968 (w), 896 (m), 765 (m), 721 (m), 
697 (s); 1H NMR (400 MHz, CDCl3): δ 7.61–7.58 (2H, m), 7.45–7.36 (3H, m), 5.32–5.30 
(1H, m), 5.15 (1H, s), 3.31 and 3.13 (2H, ABq, JAB = 15.2), 3.09 (1H, s); 13C NMR (100 
MHz, CDCl3): δ 135.8, 134.6, 126.9, 128.4, 126.6 (m), 125.1 (q, J = 286.0 Hz), 118.9, 
77.0 (q, J = 28.1 Hz, one peak is overlapping with CDCl3), 44.4; 19F NMR (376 MHz, 
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 CDCl3): δ 73.32 (3F, s); HRMS Calcd for C11H9ClF3 [M + H – H2O]+: 233.03449; 
Found: 233.03489. [α]22D = +36.7 (c = 2.18, CHCl3) for a 96.5:3.5 er sample.  The 
enantiomeric purity of this compound was determined by HPLC analysis in comparison 
with authentic racemic material (Chiracel AS-H, 98:2 hexanes:i-PrOH, 0.5 mL/min, 220 
nm): tR: 15 min (major) and 16 min (minor). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 15.0 min 49.795 1 14.9 min 96.195 
2 16.2 min 50.205 2 16.1 min 3.805 
 
■  Representative Procedure for Catalytic Enantio- and Regioselective Allenyl 
Additions to Ketones Bearing a Perfluoroalkyl Group (Scheme 2.13):  In a nitrogen-
filled glovebox, 2.21e (5.1 mg, 0.010 mmol) is added to a two-dram vial equipped with a 
stir bar and dissolved in 1.0 mL of toluene. A second stock solution is prepared by 
dissolving 19.2 mg NaOt-Bu in 8.0 mL toluene. A two-dram vial equipped with a stir bar 
is charged with 200 µmol of the stock solution of 2.21e (1.5 mg, 20.0 µmol) followed by 
800 µL of the stock solution of NaOt-Bu (1.9 mg, 5.0 µmol). This vial is sealed with a 
cap (phenolic open top cap with a white PFTE/gray silicone septa) and electrical tape and 
removed from the glovebox. Methanol (10. µL, 0.25 mmol), trifluoroacetophenone 2.11a 
(28 µL, 0.20 mmol), and allenylboronic acid pinacol ester 2.23 (40. µL, 0.22 mmol) are 
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 added by syringe under N2 in the stated order and the reaction mixture is allowed to stir at 
22 ºC for 4 h after which time the cap is removed and α,α,α-trifluorotoluene (24.4 µL, 
0.199 mmol) is added as an internal standard. Following 19F NMR analysis of the reaction 
mixture, it is passed through a short plug of silica gel (eluted with Et2O) and concentrated 
in vacuo being careful not to remove all of the solvent, as the product is volatile. The 
resulting pale yellow oil is purified by silica gel chromatography (10 mm diameter 
column slurry packed with 2.5 g of silica gel in pentane and eluted successively with 10 
mL of pentanes and 35 mL 11:1 pentanes : diethyl ether) to afford 2.24a (43.0 mg, 0.201 
mmol, >98% yield, >98:2 allene:propargyl) as a pale yellow oil. 
(R)-1,1,1-Trifluoro-2-phenylpenta-3,4-dien-2-ol (2.24a, Scheme 2.13): IR (neat): 3548 
(w, br), 3065 (w), 1959 (w), 1451 (w), 1264 (m), 1154 (s), 1073 (m), 1059 (m), 910 (m), 
855 (m), 761 (m), 708 (s); 1H NMR (400 MHz, CDCl3): δ 7.66–7.63 (2H, m), 7.44–7.36 
(3H, m), 5.87 (1H, t, J = 6.7 Hz), 5.23–5.13 (2H, m), 2.83 (1H, s); 13C NMR (100 MHz, 
CDCl3): δ 206.6, 136.9, 129.0, 128.4, 126.7 (q, J = 1.2 Hz), 124.8 (q, J = 285.9 Hz), 93.1, 
82.4, 74.7 (q, J = 29.3 Hz); 19F NMR (376 MHz, CDCl3): δ 73.40 (3F, s); HRMS Calcd 
for C11H10F3O [M + H]+: 215.06837; Found: 215.06899. [α]21.7D = +117 (c = 1.88, 
CHCl3) for a 95.5:4.5 e.r. sample.  The enantiomeric purity of this compound was 
determined by HPLC analysis in comparison with authentic racemic material (Chiracel 
AS-H, 99:1 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 21 min (major) and 22 min 
(minor). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 22.0 min 49.895 1 21.4 min 94.794 
2 23.4 min 50.105 2 22.8 min 5.204 
 
(R)-1,1,1,2,2-Pentafluoro-3-phenylhexa-4,5-dien-3-ol (2.24b, Scheme 2.13): The title 
compound is synthesized analogously to 2.24a and purified by silica gel chromatography 
(10 mm diameter column slurry packed with ~2.5 g of silica gel and eluted with 10 mL 
pentanes, 20 mL 30:1, 20 mL 15:1 pentanes : diethyl ether) affording 2.24b (46.3 mg, 
0.175 mmol, 88% yield) as a clear pale yellow oil. IR (neat): 3559 (w, br), 1959 (w), 
1496 (w), 1451 (w), 1336 (m), 1213 (s), 1172 (s), 1138 (s), 1060 (s), 869 (s), 715 (s), 697 
(s); 1H NMR (400 MHz, CDCl3): δ 7.64–7.61 (2H, m), 7.44–7.35 (3H, m), 5.99 (1H, t, J 
= 6.6 Hz), 5.27–5.22 (1H, m), 5.19–5.14 (1H, m), 2.85 (1H, m); 13C NMR (100 MHz, 
CDCl3): δ 205.9, 137.1, 128.9, 128.4, 126.6 (t, J = 1.9 Hz), 119.3 (qt, J = 288.4, 36.3 
Hz), 113.9 (tq, J = 261.9, 34.4 Hz), 93.8–93.7 (m), 83.2, 74.2 (t, J = 23.9 Hz); 19F NMR 
(376 MHz, CDCl3): δ 75.11 (3F, s), 30.2 and 29.9 (2F, ABq, JAB = 276.8 Hz); HRMS 
Calcd. for C12H10F5O [M + H]+: 265.06518; Found: 265.06534. [α]22.0D = +135 (c = 1.99, 
CHCl3) for a 97:3 er sample.  The enantiomeric purity of this compound was determined 
by HPLC analysis in comparison with authentic racemic material (Chiracel OJ-H, 98:2 
hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 32 min (minor) and 35 min (major). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 33.0 min 49.920 1 32.2 min 3.775 
2 36.4 min 50.080 2 35.0 min 96.225 
 
(R)-1,1,1-Trifluoro-2-(4-fluorophenyl)penta-3,4-dien-2-ol (2.24c, Scheme 2.13): The 
title compound is synthesized analogously to 2.24a and purified by silica gel 
chromatography (10 mm diameter column slurry packed with ~2.5 g of silica gel and 
eluted with 10 mL pentanes, 35 mL 11:1) affording 2.24c (38.7 mg, 0.167 mmol, 83% 
yield, >98:2 allene:propargyl) as a clear colorless oil. IR (neat): 3568 (w, br), 3490 (w, 
br), 1958 (w), 1604 (w), 1510 (m), 1235 (m), 1156 (s), 1077 (m), 976 (w), 924 (m), 857 
(m), 833 (s), 816 (m), 734 (m), 520 (m); 1H NMR (400 MHz, CDCl3): δ 7.62–7.59 (2H, 
m), 7.11–7.06 (2H, m), 5.84–5.81 (1H, m), 5.24–5.13 (2H, m), 2.80–2.79 (1H, m); 13C 
NMR (100 MHz, CDCl3): δ 206.7, 163.1 (d, J = 248.0 Hz), 132.7 (d, J = 3.1 Hz), 128.9–
128.6 (m), 124.7 (q, J = 285.2 Hz, most downfield peak of quartet is overlapping with 
previous multiplet), 115.3 (d, J = 22.1 Hz), 92.9, 82.5, 74.5 (q, J = 29.6 Hz);  19F NMR 
(376 MHz, CDCl3): δ 73.19 (3F, s), 39.7 (1F, m);  HRMS Calcd for C11H7F3 [M + H – 
H2O]+: 215.04839; Found: 215.04900. [α]22.3D = +124 (c = 2.01, CHCl3) for a 97.5:2.5 er 
sample.  The enantiomeric purity of this compound was determined by HPLC analysis in 
comparison with authentic racemic material (Chiracel AS-H, 99:1 hexanes:i-PrOH, 0.5 
mL/min, 220 nm): tR: 20 min (major) and 22 min (minor). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 21.3 min 50.224 1 20.6 min 97.444 
2 23.0 min 49.776 2 22.2 min 2.556 
 
(R)-2-(4-(Dimethylamino)phenyl)-1,1,1-trifluoropenta-3,4-dien-2-ol (2.24d, Scheme 
2.13): The title compound is synthesized analogously to 2.24a except the substrate is 
weighed out into the reaction vessel before any other components were added. The title 
compound is purified by silica gel chromatography (10 mm diameter column slurry 
packed with ~2.5 g of silica gel and eluted with 10 mL of pentanes, 50 mL 11:1 pentanes 
: diethyl ether, 20 mL 4:1 pentanes : dichloromethane) to afford 2.24d (49.6 mg, 0.193 
mmol, 96% yield, >98:2 allene:propargyl) as white solid. M.p = 63 – 65 ºC. IR (neat): 
3208 (w, br), 3005 (w), 2978 (w), 2894 (w), 2855 (w), 2815 (w), 1976 (w), 1948 (w), 
1608 (w), 1515 (w), 1474 (w), 1387 (w), 1313 (w), 1237 (w), 1189 (m), 1151 (s), 1125 
(s), 1089 (m), 1047 (w), 076 (w), 924 (m), 859 (m), 826 (m), 815 (m), 740 (w), 699 (s); 
1H NMR (400 MHz, CDCl3): δ 7.49–7.45 (2H, m), 6.74–6.71 (2H, m), 5.84 (1H, t, J = 
6.7 Hz), 5.20–5.10 (2H, m), 2.97 (6H, s), 2.73 (1H, s); 13C NMR (100 MHz, CDCl3): δ 
206.6, 150.7, 127.6 (m), 125.0 (q, J = 285.8 Hz), 124.2, 111.9, 93.2 (m), 81.9, 74.6 (q, J 
= 29.3 Hz), 40.5, 40.4; 19F NMR (376 MHz, CDCl3): δ 73.11 (3F, s); HRMS Calcd. for 
C13H15F3NO [M + H]+: 258.11057; Found: 258.10933;  [α]21.8D = +165 (c = 1.70, CHCl3) 
for a 96:4 er sample.  The enantiomeric purity of this compound was determined by 
 
Page 474
 HPLC analysis in comparison with authentic racemic material (Chiracel AD-H, 97:3 
hexanes:i-PrOH, 0.7 mL/min, 220 nm): tR: 21 min (major) and 24 min (minor). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 21.2 min 49.959 1 21.4 min 96.351 
2 24.8 min 50.041 2 22.8 min 3.649 
 
(S)-1,1,1-Trifluoro-2-(thiophen-2-yl)penta-3,4-dien-2-ol (2.24e, Scheme 2.13): The 
title compound is synthesized analogously to 2.24a and purified by silica gel 
chromatography (10 mm diameter column slurry packed with ~2.5 g of silica gel and 
eluted with 10 mL of pentanes and 20 mL 30:1, 25 mL 11:1 pentanes : diethyl ether) to 
afford 2.24e (40.3 mg, 0.183 mmol, 92% yield, >98:2 allene:propargyl) as a pale yellow 
oil. IR (neat): 3534 (w, br), 1980 (w), 1959 (w), 1434 (w), 1267 (w), 1164 (s), 1078 (w), 
1047 (w), 996 (w), 890 (w), 853 (m), 716 (m); 1H NMR (400 MHz, CDCl3): δ 7.37–7.35 
(1H, m), 7.22–7.20 (1H, m), 7.06–7.03 (1H, m), 5.82–5.79 (1H, m), 5.27–5.18 (2H, m), 
2.99 (1H, s); 13C NMR (100 MHz, CDCl3): δ 206.5, 140.6, 127.2, 126.6, 126.5 (m), 
124.3 (q, J = 285.6 Hz), 93.0, 82.9, 74.0 (q, J = 31.0 Hz); 19F NMR (376 MHz, CDCl3): 
δ 72.80 (3F, s); HRMS Calcd. for C9H6F3S [M + H – H2O]+: 203.01423; Found: 
203.01423;  [α]22.4D = +104 (c = 2.30, CHCl3) for a 93:7 er sample.  The enantiomeric 
purity of this compound was determined by HPLC analysis in comparison with authentic 
racemic material (Chiracel AS-H, 98:2 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 22 min 
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 (major) and 23 min (minor).  
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 22.5 min 49.785 1 21.7 min 91.513 
2 23.7 min 50.215 2 23.0 min 8.487 
 
(R)-1,1,1-Trifluoro-2-(thiophen-3-yl)penta-3,4-dien-2-ol (2.24f, Scheme 2.13): IR 
(neat) : 3540 (br w), 3115 (w), 3083 (w), 2928 (w), 1275 (m), 1226 (w), 1150 (s), 1086 
(m), 1019 (m), 995(m), 920 (m), 854 (m), 785 (s), 724 (s), 688(s) cm-1;  1H NMR (400 
MHz, CDCl3): δ 7.56–7.42 (1H, m), 7.42–7.29 (1H, m), 7.25–7.13 (1H, m), 5.76 (1H, t, J 
= 6.7 Hz), 5.28–5.05 (2H, m), 2.80 (1H, s); 13C NMR (100 MHz, CDCl3): δ 206.6, 138.2, 
126.2 (m), 124.6 (q, J = 285.5 Hz), 124.1 (m), 92.8–92.7 (m), 82.4, 73.9 (q, J = 30.7 Hz); 
19F NMR (376 MHz, CDCl3): δ 72.81; HRMS Calculated for C9H6F3S [M + H – H2O]+: 
203.01423; Found: 203.01483. [α]22D = +82 (c = 0.97, CHCl3) for a >99:1 e.r. sample. 
The enantiomeric purity of this compound was determined by HPLC analysis in 
comparison with an authentic sample of racemic material (Chiracel AS-H, 98:2 
hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 19 min (major) and 20 min (minor). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 19.2 min 49.181 1 18.9 min 99.517 
2 20.0 min 50.819 2 20.4 min 0.483 
 
(R)-1,1,1-Trifluoro-2-(2-methoxyphenyl)penta-3,4-dien-2-ol (2.24g, Scheme 2.13): 
The title compound is synthesized analogously to 2.24a and purified by silica gel 
chromatography (10 mm diameter column slurry packed with ~2.5 g of silica gel and 
eluted with 10 mL of pentanes and 35 mL 11:1 pentanes : diethyl ether) to afford 2.24g 
(46.3 mg, 0.190 mmol, 95% yield, >98:2 allene:propargyl) as a clear colorless oil.   IR 
(neat): 3442 (w, br), 1961 (w), 1601 (w), 1585 (w), 1491 (w), 1465 (w), 1465 (w), 1239 
(s), 1158 (s), 1083 (m), 1050 (m), 1021 (m), 923 (m), 852 (m), 753 (s);  1H NMR (400 
MHz, CDCl3): δ 7.51–7.46 (1H, m), 7.39–7.34 (1H, m), 7.05–6.98 (2H, m), 5.82 (1H, s), 
5.79 (1H, t, J = 6.8 Hz), 5.10–4.99 (2H, m), 3.93 (1H, m);  13C NMR (100 MHz, CDCl3): 
δ 208.0, 158.0, 130.5, 130.1 (q, J = 1.2 Hz), 125.1 (q, J = 287.2 Hz), 124.8, 121.4, 112.5, 
92.0 (q, J = 1.2 Hz), 79.9, 77.5 (q, J = 29.4 Hz), 56.3;  19F NMR (376 MHz, CDCl3): 
δ 73.95 (3F, s);  HRMS Calcd for C12H10F3O [M + H – H2O]+: 227.06837; Found: 
227.06884. [α]22D = +27.9 (c = 1.79, CHCl3) for a 97.5:2.5 er sample.  The enantiomeric 
purity of this compound was determined by HPLC analysis in comparison with authentic 
racemic material (Chiracel OJ-H, 98:2 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 29 min 
(minor) and 40 min (major). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 30.2 min 49.757 1 29.2 min 2.329 
2 42.2 min 50.243 2 40.4 min 97.671 
 
(R)-1,1,1-Trifluoro-2-(o-tolyl)penta-3,4-dien-2-ol (2.24h, Scheme 2.13): The title 
compound is synthesized analogously to 2.24a and purified by silica gel chromatography 
(10 mm diameter column slurry packed with ~2.5 g of silica gel and eluted with 10 mL of 
pentanes and 20 mL 12:1 pentanes : diethyl ether) to afford 2.24h (39.4 mg, 0.173 mmol, 
86% yield, 97:3 allene:propargyl) as a clear colorless oil. IR (neat): 3537 (w, br), 1958 
(w), 1488 (w), 1458 (w), 1363 (w), 1262 (m), 1156 (s), 1078 (w), 1048 (w), 966 (w), 924 
(m), 853 (m), 759 (m), 727 (m); 1H NMR (400 MHz, CDCl3): δ 7.59 (1H, d, J = 7.8 Hz), 
7.32–7.22 (3H, m), 5.82 (1H, s), 5.86–5.82 (1H, m), 5.22–5.12 (2H, m), 2.79–2.78 (1H, 
m), 2.60–2.59 (3H, m); 13C NMR (100 MHz, CDCl3): δ 206.9, 138.4, 134.5, 133.2, 
128.9, 128.0–127.9 (m), 125.6, 125.3 (q, J = 286.6 Hz), 93.4 (m), 81.6, 77.1 (q, J = 29.0 
Hz), 22.4 (m); 19F NMR (376 MHz, CDCl3): δ 74.60 (3F, s); HRMS Calcd. for C12H10F3 
[M + H – H2O]+: 211.07346; Found: 211.07439;  [α]22.5D = +63.9 (c = 2.19, CHCl3) for a 
95:5 er sample (97:3 ratio of allene to propargyl addition).  The enantiomeric purity of 
this compound was determined by HPLC analysis in comparison with authentic racemic 
material (Chiracel OJ-H, 98:2 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 35 min (minor) 
and 37 min (major).   
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 35.5 min 49.814 1 34.5 min 4.778 
2 38.4 min 50.186 2 37.3 min 95.222 
 
(S)-2-Benzyl-1,1,1-trifluoropenta-3,4-dien-2-ol (2.24i, Scheme 2.13): The title 
compound is synthesized analogously to 2.24a and purified by silica gel chromatography 
(10 mm diameter column slurry packed with ~2.5 g of silica gel and eluted with 10 mL of 
pentanes and 35 mL 11:1 pentanes : diethyl ether) to afford 2.24i (42.7 mg, 0.187 mmol, 
94% yield, >98:2 allene:propargyl) as a pale yellow oil.  IR (neat): 3549 (w, br), 3066 
(w), 1959 (w), 1497 (w), 1456 (w), 1273 (m), 1164 (s), 1124 (m), 1088 (m), 1032 (m), 
969 (m), 857 (m), 714 (m), 698 (s); 1H NMR (400 MHz, CDCl3): δ 7.33–7.21 (5H, m), 
5.34–5.30 (1H, m), 5.02–4.97 (1H, m), 4.83–4.78 (1H, m), 3.19–3.18 (1H, m), 3.16–3.15 
(1H, m), 2.29–2.27 (1H, m); 13C NMR (100 MHz, CDCl3): δ 206.9, 134.0, 131.2, 128.2, 
127.3, 125.4 (q, J = 285.7 Hz), 91.3 (m), 81.5, 74.1 (q, J = 28.1 Hz), 40.0;  19F NMR (376 
MHz, CDCl3): δ 71.86 (3F, s);  HRMS Calcd. for C12H12F3O [M + H]+: 229.08402; 
Found: 229.08487. [α]22.0D = +42.6 (c = 1.64, CHCl3) for a 94:6 e.r. sample.  The 
enantiomeric purity of this compound was determined by HPLC analysis in comparison 
with authentic racemic material (Chiracel AS-H, 98:2 hexanes:i-PrOH, 0.5 mL/min, 220 
nm): tR: 14 min (minor) and 15 min (major). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 13.8 min 49.683 1 13.8 min 5.709 
2 14.8 min 50.317 2 14.8 min 94.291 
 
■  Representative Procedure for Catalytic Enantioselective Allyl Additions to 
Ketones in Scheme 2.14:  In a nitrogen-filled glovebox, 2.21a (7.7 mg, 0.025 mmol) is 
added to a two-dram vial equipped with a stir bar and dissolved in 1.0 mL of toluene. A 
second stock solution is prepared by dissolving 4.8 mg NaOt-Bu in 8.0 mL toluene. A 
two-dram vial equipped with a stir bar is charged with 200 µmol of the stock solution of 
2.21a (1.5 mg, 5.0 µmol) followed by 800 µL of the stock solution of NaOt-Bu (1.9 mg, 
5.0 µmol). This vial is sealed with a cap (phenolic open top cap with a white PFTE/gray 
silicone septa) and electrical tape and removed from the glovebox. Methanol (20 µL, 0.50 
mmol), acetophenone 2.9 (24 µL, 0.20 mmol) and allylboronic acid pinacol ester 2.20a 
(56 µL, 0.29 mmol) are added by syringe under N2 in the stated order. The clear, 
colorless solution is allowed to stir at 22 ºC for 4 h after which time the cap is removed, 
and 9-methylanthracene (6.4 mg, 0.033 mmol; stock solution in ethyl acetate) is added as 
an internal standard for 1H NMR. The solution is passed through a short plug of silica gel 
(eluted with Et2O) and concentrated in vacuo being careful not to remove all of the 
solvent, as the product is volatile.  The resulting yellow oil is purified by silica gel 
chromatography (10 mm diameter column slurry packed with ~2.5 g of silica gel and 
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 eluted with 10 mL pentanes, 50 mL 98:2, 10 mL 97:3, 20 mL 95:5 pentanes : diethyl 
ether) affording 2.10 (26.0 mg, 0.160 mmol, 80% yield) as a clear colorless oil. 
(S)-2-Phenylpent-4-en-2-ol  (2.10, Scheme 2.14): The analytical data are fully 
consistent with those reported previously.53 1H NMR (400 MHz, CDCl3): δ 7.46–7.43 
(2H, m), 7.37–7.32 (2H, m), 7.27–7.22 (1H, m), 5.68–5.57 (1H, m), 5.17–5.10 (2H, m), 
2.72–2.67 (1H, m), 2.57–2.48 (1H, m), 2.03 (1H, s), 1.55 (3H, s); HRMS Calcd for 
C11H13 [M + H – H2O]+: 145.10173; Found: 145.10166; [α]23.5D	   = –27.8 (c = 1.08, 
CHCl3) for a 70:30 er sample.	    The enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material (Chiracel AD-H, 99:1 hexanes:i-
PrOH, 1.0 mL/min, 220 nm): tR of: 15 min (minor) and 16 min (major). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 10.8 min 49.983 1 15.1 min 29.699 
2 11.6 min 50.020 2 16.1 min 70.301 
 
2-Methyl-3-phenylhex-5-en-3-ol (2.26a, Scheme 2.14):  The title compound is 
synthesized analogously to 2.10 except the reaction time was 18 h. The title compound is 
purified by silica gel chromatography (10 mm diameter column slurry packed with ~2.5 g 
of silica gel and eluted with 10 mL pentanes, 40 mL 99:1, 10 mL 96:4 pentanes : diethyl 
ether) affording 2.26a (12.4 mg, 0.0652 mmol, 33% yield) as a clear colorless oil. The 
                                                
(53) Lou, S.;  Moquist, P. N.; Schaus, S. E. J. Am. Chem. Soc. 2006, 128, 12660–12661. 
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 analytical data are fully consistent with those reported previously.54 1H NMR (400 MHz, 
CDCl3): δ 7.39–7.31 (4H, m), 7.24–7.21 (1H, m), 5.53–5.42 (1H, m), 5.15–5.05 (2H, m), 
2.81 (1H, dd, J = 13.8, 5.4 Hz), 2.54 (1H, dd, J = 13.8, 9.1 Hz), 2.02 (1H, hept, J = 6.9 
Hz), 1.93 (1H, s), 0.95 (3H, d, J = 6.9 Hz), 0.77 (3H, d, J = 6.9 Hz); HRMS Calcd for 
C13H17 [M + H – H2O]+: 173.13303; Found: 173.13343; [α]23.5D	   = +54.5 (c = 0.55, 
CHCl3) for a 65:35 e.r. sample.	    The enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material (Chiracel AD-H, 99:1 hexanes:i-
PrOH, 1.0 mL/min, 220 nm): tR: 6.6 min (major) and 7.0 min (minor). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 6.9 min 47.849 1 6.6 min 65.411 
2 7.3 min 52.151 2 7.0 min 34.589 
 
6-Methyl-4-phenylhept-1-en-4-ol (2.26b, Scheme 2.14): The title compound is 
synthesized analogously to 2.10 except the reaction time was 18 h. The title compound is 
purified by silica gel chromatography (10 mm diameter column slurry packed with ~2.5 g 
of silica gel and eluted with 10 mL pentanes, 40 mL 99:1, 10 mL 96:4 pentanes : diethyl 
ether) affording 2.26b (25.5 mg, 0.126 mmol, 63% yield) as a clear colorless oil. IR 
(neat): 3555 (w, br), 3076 (w), 3027 (w), 2952 (w), 2925 (w, br), 2868 (w), 1638 (w), 
                                                
(54) Uccello-Barretta, G.; Bernardini, R.; Lazzaroni, R.; Salvadori, P. J. Organomet. Chem. 2000, 598, 
174–178. 
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 1602 (w), 1494 (w), 1365 (w), 1297 (w), 1259 (w), 1171 (w), 1146 (w), 1061 (w), 1032 
(w), 1000 (w), 920 (m), 763 (w), 701 (s); 1H NMR (400 MHz, CDCl3): δ 7.41–7.32 (4H, 
m), 7.25–7.20 (1H, m), 5.57–5.47 (1H, m), 5.17–5.09 (2H, m), 2.71 (1H, dd, J = 13.6, 5.8 
Hz), 2.48 (1H, dd, J = 13.6, 8.9 Hz), 2.03 (1H, s), 1.83 (1H, dd, J = 14.2, 5.1 Hz), 1.69 
(1H, dd, J = 14.2, 6.7 Hz), 1.62–1.53 (1H, m), 0.91 (3H, d, J = 6.6 Hz), 0.69 (3H, d, J = 
6.8 Hz); 13C NMR (100 MHz, CDCl3): δ 146.4, 133.6, 128.1, 126.4, 125.5, 119.9, 76.3, 
51.4, 48.8, 24.6, 24.3, 24.3; HRMS Calcd for C14H19 [M + H – H2O]+: 187.14868; Found: 
187.14941; [α]21.8D	  = –5.77 (c = 1.73, CHCl3) for a 60:40 e.r. sample.	   The enantiomeric 
purity was determined by HPLC analysis in comparison with authentic racemic material 
(Chiracel AD-H, 99:1 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 5.5 min (major) and 5.9 
min (minor). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 5.5 min 49.631 1 5.5 min 39.811 
2 5.9 min 50.369 2 5.9 min 60.189 
 
(S)-2-(4-Nitrophenyl)pent-4-en-2-ol (2.28a, Equation 5): The title compound is 
synthesized analogously to 2.10 except the substrate was weighed out into the reaction 
vessel before any other components were added.  The title compound is purified by silica 
gel chromatography (10 mm diameter column slurry packed with ~2.5 g of silica gel and 
eluted with 15 mL 1:1 hexanes: dichloromethane, 25 mL dichloromethane) affording 
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 2.28a (41.7 mg, 0.201 mmol, >98% yield) as a clear yellow oil. The analytical data are 
fully consistent with those reported previously.55 1H NMR (400 MHz, CDCl3): δ 8.20–
8.16 (2H, m), 7.63–7.59 (2H, m), 5.64–5.53 (1H, m), 5.17–5.11 (2H, m), 2.70–2.64 (1H, 
m), 2.56–2.50 (1H, m), 2.21 (1H, s), 1.57 (3H, m); HRMS Calcd for C11H14N1O2 [M + 
H]+: 208.09737; Found: 208.09708; [α]21.8= –30.6 (c =  1.96, CHCl3) for a 70:30 er 
sample. The enantiomeric purity of this compound was determined by HPLC analysis in 
comparison with authentic racemic material (Chiracel AS-H, 95:5 hexanes:i-PrOH, 0.8 
mL/min, 220 nm): tR: 18 min (major) and 22 min (minor).  
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 17.0 min 49.616 1 18.1 min 69.341 
2 20.4 min 50.384 2 22.5 min 30.659 
 
(S)-2-(3,5-Difluorophenyl)pent-4-en-2-ol (2.28b, Equation 5): The title compound is 
synthesized analogously to 2.10 and purified by silica gel chromatography (10 mm 
diameter column slurry packed with ~2.5 g of silica gel and eluted with 10 mL pentanes, 
10 mL 30:1, 20 mL 19:1, 10 mL 15:1  pentanes : diethyl ether) affording 2.28b (33.3 mg, 
0.168 mmol, 84% yield) as a clear pale yellow oil. IR (neat): 3432 (w, br), 3081 (w, br), 
2980 (w), 2934 (w, br), 1623 (m), 1599 (m), 1433 (m), 1319 (m), 1115 (s), 983 (s), 921 
(m), 856 (s), 838 (m); 1H NMR (400 MHz, CDCl3): δ 6.99–6.93 (2H, m), 6.68 (1H, app 
                                                
(55)Schneider, U.; Kobayashi, S. Angew. Chem. Int. Ed. 2007, 46, 5909–5912. 
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 tt, J = 8.8, 2.3 Hz), 5.60 (1H, dddd, J = 16.2, 11.1, 8.3, 6.5 Hz), 5.19–5.13 (2H, m), 2.66–
2.60 (1H, m), 2.50–2.44 (1H, m), 2.06 (1H, s), 1.52 (3H, s); 13C NMR (100 MHz, 
CDCl3): δ 163.1 (dd, J = 247.7, 12.7 Hz), 152.2 (t, J = 8.0 Hz), 132.8, 120.5, 108.3–108.0 
(m), 102.1 (t, J = 25.4 Hz), 73.5 (t, J = 2.1 Hz), 48.3, 29.9; 19F NMR (376 MHz, CDCl3): 
43.01 (2F, s); HRMS Calcd for C11H11F2 [M + H – H2O]+: 181.08288; Found: 181.08212; 
[α]23.6= –34.0 (c =  1.76, CHCl3) for a 75:25 e.r. sample. The enantiomeric purity of this 
compound was determined by HPLC analysis in comparison with authentic racemic 
material (Chiracel AD-H, 99:1 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 27 min (minor) 
and 29 min (major). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 27.0 min 49.067 1 27.2 min 27.652 
2 28.8 min 50.933 2 29.1 min 72.348 
 
1-Fluoro-2-phenylpent-4-en-2-ol (2.33a, Scheme 2.19): The title compound is 
synthesized analogously to 2.12a except for the following changes: 1) Reaction time is 16 
h. 2) Reaction temperature is 22 ºC. Note product is contaminated with ~10% of the 
starting ketone. IR (neat): 3565 (br w), 3465 (br w), 3064 (w), 2980 (w), 1707 (m), 1640 
(w), 1600 (w), 1495 (w), 1448 (m), 1233 (m), 1089 (m), 1071 (s), 998 (m), 967(s), 761 
(m), 700 (s), 638 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.47–7.46 (2H, m), 7.40–7.36 
(2H, m), 7.34–7.27 (1H, m), 5.75–5.52 (1H, m), 5.25–5.05 (2H, m), 4.49 (2H, d, J = 47.7 
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 Hz), 2.74–2.71 (2H, m), 2.44 (1H, s) ; 13C NMR (100 MHz, CDCl3): δ 141.7, 132.4, 
129.0, 128.5, 128.0, 125.6, 120.1, 88.6 (d, J=178.1 Hz), 75.2 (d, J=18.0 Hz); 19F NMR 
(376 MHz, CDCl3): δ -224.94 (1F, t, J = 47.7 Hz) ; HRMS Calculated for C11H11F [M + 
H – H2O]+: 163.09230; Found: 163.09247; [α]23D = -45.4 (c = 1.10, CHCl3) for a 88:12 
e.r. sample. The enantiomeric purity of this compound was determined by HPLC analysis 
in comparison with an authentic sample of racemic material (Chiracel AZ-H, 98:2 
hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 17 min (major) and 19 min (minor). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 16.8 48.667 1 17.5 87.705 
2 19.0 51.333 2 20.0 12.295 
 
1,1-Difluoro-2-phenylpent-4-en-2-ol (2.33b, Scheme 2.19): The title compound is 
synthesized analogously to 2.12a except for the following changes: 1) Reaction time is 16 
h. 2) Reaction temperature is 22 ºC. IR (neat): 3555 (br w), 3079 (w), 2980 (w), 1641 
(w), 1496 (w), 1448 (m), 1346 (m), 1125 (m), 1063 (s), 996 (m), 970 (m), 923 (m), 763 
(m), 699 (s), 643 (m), 563 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.52 (2H, dd, J = 3.6 
Hz. 1.6 Hz), 7.42–7.34 (2H, m), 7.33–7.31 (1H, m); 5.74 (1H, t, J = 56.4), 5.67–5.56 
(1H, m), 5.25–5.17 (2H, m), 2.90–2.71 (1H, m), 2.42 (1H, s); 13C NMR (100 MHz, 
CDCl3): δ 138.9, 131.4, 128.6, 128.3, 126.4, 121.2, 117.0 (t, J = 248.9Hz), 75.6 (t, J = 
21.2Hz), 39.8 (t, J = 2.3 Hz); 19F NMR (376 MHz, CDCl3): δ 23.72 and 22.07 (2F, d of 
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 ABq, 2JF-F = 277.9 Hz, 2JF-H = 56.0 Hz); HRMS Calculated for C11H11F2 [M + H – H2O]+: 
181.08277; Found: 181.08288. [α]21D = +9.88 (c = 1.01, CHCl3) for a 58:42 e.r. sample. 
The enantiomeric purity of this compound was determined by HPLC analysis in 
comparison with an authentic sample of racemic material (Chiracel AS-H, 99:1 
hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 20 min (major) and 21 min (minor). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 20.9 50.112 1 20.2 58.077 
2 22.1 49.888 2 21.4 41.923 
 
(R)-2,2-Difluoro-3-phenylhex-5-en-3-ol (2.33c, Scheme 2.19): The title compound is 
synthesized analogously to 2.12a except for the following changes: 1) Reaction time is 16 
h. 2) Reaction temperature is 22 ºC. The title compound is purified by silica gel 
chromatography (10 mm diameter column slurry packed with ~2.5 g of silica gel and 
eluted with 10 mL pentanes, 10 mL 19:1, 10 mL 11:1 pentanes : diethyl ether) affording 
2.33c (42.5 mg, 0.200 mmol, >98% yield) as a clear colorless oil. IR (neat): 3555 (w, br), 
3078 (w), 3010 (w), 2982 (w), 2950 (w), 1640 (w), 1497 (w), 1448 (w), 1385 (w), 1203 
(m), 1142 (s), 1069 (m), 925 (s), 763 (m), 727 (m), 669 (s), 617 (m); 1H NMR (400 MHz, 
CDCl3): δ 7.57–7.54 (2H, m), 7.39–7.29 (3H, m), 5.57–5.46 (1H, m), 5.22–5.12 (2H, m), 
3.01 (1H, dd, J = 14.2, 6.0 Hz), 2.82 (1H, dd, J = 14.4, 8.5 Hz), 2.39 (1H, s), 1.41 (3H, t, 
J = 19.2 Hz); 13C NMR (100 MHz, CDCl3): δ 139.8 (app d, J = 3.8 Hz), 132.4, 128.3, 
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 127.7, 126.6 (m), 124.6 (t, J = 247.6 Hz), 120.7, 77.3 (t, J = 26.2 Hz), 39.8 (t, J = 2.7 
Hz), 19.3 (dd, J = 27.4, 25.9 Hz); 19F NMR (376 MHz, CDCl3): 50.73 and 49.35 (2F, q of 
ABq, 2JF-F = 245.2 Hz, 3JF-H = 19.0 Hz); HRMS Calcd. for C12H13F2O [M – H]–: 
211.09345; Found: 211.09257;  [α]22.0D = +47.2 (c = 2.33, CHCl3) for a 79:21 e.r. 
sample.  The enantiomeric purity of this compound was determined by HPLC analysis in 
comparison with authentic racemic material (Chiracel OJ-H, 98:2 hexanes:i-PrOH, 0.5 
mL/min, 220 nm): tR 15 min (minor) and 18 min (major).  
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 15.3 min 50.524 1 14.8 min 21.344 
2 18.1 min 49.476 2 17.5 min 78.656 
 
(R)-1-Allyl-2,2-difluoro-1,2,3,4-tetrahydronaphthalen-1-ol (2.33d, Scheme 2.19): The 
title compound is synthesized analogously to 2.12a except for the following changes: 1) 
Reaction time is 16 h. 2) Reaction temperature is 22 ºC. 3) The substrate is weighed out 
into the reaction vessel before any other components were added. The title compound is 
purified by silica gel chromatography (10 mm diameter column slurry packed with ~2.5 g 
of silica gel and eluted with 10 mL pentanes, 20 mL 25:1, 20 mL 19:1, 15 mL 11:1 
pentanes : diethyl ether.  Three purifications were needed to completely purify the 
compound) affording 2.33d (35.1 mg, 0.156 mmol, 78% yield) as a clear colorless oil. IR 
(neat): 3587 (w, br), 3459 (w, br), 3076 (w), 3023 (w), 2948 (w), 2855 (w), 1640 (w), 
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 1489 (w), 1454 (w), 1364 (w), 1340 (w), 1212 (w), 1146 (m), 1087 (m), 1057 (s), 1001 
(m), 959 (s), 915 (m), 758 (s), 731 (s), 655 (m); 1H NMR (400 MHz, CDCl3): δ 7.58–
7.57 (1H, m), 7.29–7.23 (2H, m), 7.13–7.11 (1H, m), 5.78–5.68 (1H, m), 5.13–5.06 (2H, 
m), 3.12–2.97 (2H, m), 2.78 (1H, dd, J = 14.5, 6.1 Hz), 2.65 (1H, dd, J = 14.5, 8.5 Hz), 
2.55 (1H, app d, J = 3.3 Hz), 2.46–2.30 (2H, m); 13C NMR (100 MHz, CDCl3): δ 136.7 
(app d, J = 3.8 Hz), 133.9 (app d, J = 1.6 Hz ), 133.0, 128.3, 128.1, 127.3 (app d, J = 1.5 
Hz ), 123.2 (dd, J = 250.2, 241.9 Hz), 119.3, 74.4 (dd, J = 23.7, 21.4 Hz), 28.4 (dd, J = 
24.8, 23.3 Hz), 26.3 (dd, J = 7.6, 3.6 Hz); 19F NMR (376 MHz, CDCl3): δ 43.27–43.16 
and 42.63–42.53 (1F, m), 41.27–41.20 and 40.62–40.58 (1F, m); HRMS Calcd. for 
C13H13F2 [M + H – H2O]+: 207.09853; Found: 207.09863;  [α]22.0D = +36.8 (c = 1.90, 
CHCl3) for a 94:6 e.r. sample.  The enantiomeric purity of this compound was determined 
by HPLC analysis in comparison with authentic racemic material (Chiracel OJ-H, 98:2 
hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 26 min (major) and 44 min (minor).   
 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 30.0 min 48.790 1 26.4 min 94.487 
2 47.3 min 51.210 2 44.2 min 5.513 
 
(S)-2-(Perfluorophenyl)pent-4-en-2-ol (2.10b, Scheme 2.20): The title compound is 
synthesized analogously to 2.10a and purified by silica gel chromatography (10 mm 
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 diameter column slurry packed with ~2.5 g of silica gel and eluted with 10 mL pentanes 
and  40 mL 19:1 pentanes : diethyl ether) affording 2.10b (21.3 mg, 0.0.085 mmol, 85% 
yield) as a clear colorless oil. IR (neat): 3466 (w, br), 2985 (w), 1650 (w), 1523 (m), 1483 
(s), 1348 (w), 1305 (w), 1099 (m), 982 (s), 923 (m);  1H NMR (400 MHz, CDCl3): 
δ 5.74–5.63 (1H, m), 5.20–5.14 (2H, m), 2.84–2.78 (2H, m), 2.59–2.53 (1H, m), 1.72 
(3H, t, J = 2.1 Hz); 13C NMR (100 MHz, CDCl3): δ 146.3–145.9 (m), 143.8–143.5 (m), 
141.4–141.1 (m), 139.4–139.0 (m), 138.9–138.5 (m), 136.9–136.6 (m), 132.3, 120.8, 
120.1–119.8 (m), 75.5, 47.5 (t, J = 2.6 Hz), 28.9 (t, J = 4.3 Hz); 19F NMR (376 MHz, 
CDCl3): 12.33 (2F, d, J = 18.8 Hz); -3.09 (1F, tt, J = 21.1, 2.5 Hz), -9.02 – -9.15 (2F, m); 
HRMS Calcd. for C11H8F5 [M + H – H2O]+: 235.05462; Found: 235.05475; [α]21.5= –
6.49 (c =  1.54, CHCl3) for a 95:5 e.r. sample. The enantiomeric purity of this compound 
was determined by HPLC analysis in comparison with authentic racemic material 
(Chiracel AD-H, 97.5:2.5 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR of XX: 6.5 min 
(major) and 7.5 min (minor). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 6.8 min 49.024 1 6.8 min 95.203 
2 7.6 min 50.976 2 7.5 min 4.797 
 
(S)-2-(2,6-Difluorophenyl)pent-4-en-2-ol (2.10c, Scheme 2.20): The title compound is 
synthesized analogously to 2.10a and purified by silica gel chromatography (10 mm 
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 diameter column slurry packed with ~2.5 g of silica gel and eluted with 10 mL pentanes, 
15 mL 30:1, 25 mL 19:1 pentanes : diethyl ether) affording 2.10c (14.6 mg, 0.0737 
mmol, 74% yield) as a clear yellow oil. IR (neat): 3629 (w, br), 3484 (w, br), 2981 (w), 
2943 (w, br), 1621 (m), 1574 (w), 1462 (s), 1351 (m), 1286 (m), 1262 (m), 1223 (m), 985 
(s), 918 (m), 786 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.22–7.15 (1H, m), 6.90–6.82 
(2H, m), 5.77–5.66 (1H, m), 5.14–5.09 (2H, m), 3.13–3.10 (1H, m), 2.84–2.79 (1H, m), 
2.59–2.53 (1H, m), 1.71–1.70 (3H, m); 13C NMR (100 MHz, CDCl3): δ 160.7 (dd, J = 
247.0, 8.9 Hz), 133.4, 128.6 (t, J = 11.9 Hz), 122.1 (t, J = 13.7 Hz), 116.4, 112.9–112.6 
(m), 74.9 (t, J = 2.8 Hz), 47.8 (t, J = 2.7 Hz), 28.8 (t, J = 4.8 Hz); 19F NMR (376 MHz, 
CDCl3): 42.75–42.69 (2F, m); HRMS Calcd. for C11H11F2 [M + H – H2O]+: 181.08288; 
Found: 181.08301; [α]23.4= –79.9 (c=0.25, CHCl3) for a 94.5:5.5 e.r. sample. The 
enantiomeric purity of this compound was determined by HPLC analysis in comparison 
with authentic racemic material (Chiracel OJ-H, 99:1 hexanes:i-PrOH, 0.5 mL/min, 220 
nm): tR: 13 min (major) and 14 min (minor). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 13.4 min 48.986 1 13.1 min 93.611 
2 14.4 min 51.032 2 14.2 min 6.389 
 
2-(2-Fluorophenyl)pent-4-en-2-ol (2.10d, Scheme 2.20): The title compound is 
synthesized analogously to 2.10a and purified by silica gel chromatography (10 mm 
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 diameter column slurry packed with ~2.5 g of silica gel and eluted with 10 mL pentanes, 
14 mL 49:1, 10 mL 19:1, 25 mL 9:1  pentanes : diethyl ether) affording 2.10d (36.6 mg, 
0.203 mmol, >98% yield) as a clear colorless oil. The analytical data are fully consistent 
with those reported previously.55 1H NMR (400 MHz, CDCl3): δ 7.56–7.52 (1H, m), 
7.27–7.21 (1H, m), 7.15–7.11 (1H, m), 7.02 (2H, ddd, J = 12.2, 8.1, 1.3 Hz), 5.63–5.53 
(1H, m), 5.17–5.09 (2H, m), 2.93–2.87 (1H, m), 2.58–2.51 (1H, m), 2.28 (1H, d, J = 1.8 
Hz), 1.61 (3H, d, J = 1.1 Hz); 19F NMR (376 MHz, CDCl3): δ 39.75 (1F, s); HRMS 
Calcd. for C11H12F [M + H – H2O]+: 163.09230; Found: 163.09230; [α]24.0D = –15.4 (c =  
1.30, CHCl3) for a 58:42 er sample.  The enantiomeric purity of this compound was 
determined by HPLC analysis in comparison with authentic racemic material (Chiracel 
AD-H, 98:2 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 17 min (minor) and 19 min 
(major). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 17.3 min 49.666 1 16.7 min 41.545 
2 18.7 min 50.334 2 18.1 min 58.455 
 
■■  PROOF of ABSOLUTE STEREOCHEMISTRY of PRODUCTS 
Absolute configuration of homoallylalcohol 2.10c: 
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 (S)-1,3-Difluoro-2-(2-methoxypentan-2-yl)benzene (2.35, Scheme 2.21): A 10 mL 
Schlenk flask equipped with a stirbar is charged with 2.3456 (25 mg, 0.12 mmol), 10 wt % 
Pd/C (13 mg, 10 mol% Pd), and tetrahydrofuran (1.5 mL). The flask is purged with N2 
gas followed by H2 gas, sealed with a rubber septum, and connected to a balloon of H2 
gas by a needle in order to keep the H2 pressure above the solution at ~ 1 atm.  The 
reaction is allowed to stir at 22 ºC for 6 h after which the balloon is removed and the 
reaction vessel is purged with N2 to remove excess H2 (IMPORTANT! Opening a Pd/C 
reduction without first removing H2 gas can lead to fires) and the reaction vessel is 
opened. The cloudy black reaction mixture is passed through a short plug of Celite 
(eluted with diethyl ether) and carefully concentrated in vacuo to minimize loss of 
volatile 2.35 to afford a clear, colorless oil.  This oil is purified by silica gel 
chromatography (10 mm diameter column slurry packed with ~2.5 g of silica gel and 
eluted with 10 mL pentanes, 30 mL 99:1, 10 mL 49:1 pentanes : diethyl ether) affording 
2.35 (19.0 mg, 0.089 mmol, 74% yield) as a clear colorless oil. IR (neat): 2961 (m), 2933 
(w), 2874 (w), 2827 (w), 1619 (m), 1460 (s), 1286 (m), 1230 (w), 1087 (m), 986 (m), 789 
(m); 1H NMR (400 MHz, CDCl3): δ 7.23–7.15 (1H, m), 6.88–6.80 (2H, m), 3.16 (3H, m), 
1.99 (1H, td, J = 12.8, 4.7 Hz), 1.81 (1H, td, J = 12.9, 4.6 Hz), 1.70–1.68 (3H, m), 1.43–
1.31 (1H, m), 1.24–1.15 (1H, m), 0.89–0.85 (3H, m); 13C NMR (100 MHz, CDCl3): δ 
161.8 (dd, J = 250.9, 9.1 Hz), 128.9 (t, J = 11.6 Hz), 119.4 (t, J = 14.4 Hz), 112.8–112.5 
(m), 80.4 (t, J = 3.3 Hz), 51.1, 44.5 (t, J = 2.4 Hz), 24.2 (t, J = 6.3 Hz), 17.8, 14.5; 19F 
NMR (376 MHz, CDCl3): 44.80–44.75 (2F, m); HRMS Calcd for C9H9F2O [M – C3H7]+: 
                                                
(56) 2.34 is prepared from 2.10c in accordance to a procedure in the literature, passed through a short plug 
of silica gel (elute with pentanes), concentrated in vacuo, and used without further purification. See: Chong, 
J. M.; Loewith, R. Synth. Comm. 1993, 23, 2145–2150. 
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 171.06215; Found: 171.06238; [α]21.6= –26.3 (c =  0.38, CHCl3) for a 94:6 e.r. sample 
(based on e.r. of 2.10c). 
(S)-(2-methoxypentan-2-yl)benzene (2.36, From 2.35, Scheme 2.21):   In a nitrogen-
filled glovebox, a 5 mL Schlenk flask equipped with a stirbar is charged with 
Ni(PCy3)2Cl257 (2.8 mg, 4.0 µmol), connected to a reflux condenser, and the entire 
apparatus is sealed with a rubber septum and electrical tape and removed from the 
glovebox. Nitrogen gas is connected to the apparatus with a needle and tetrahydrofuran 
(300 µL) is added via syringe followed by dropwise addition of a 1.0 M solution of 
LiEt3BH (320 µL, 0.32 mmol) in tetrahydrofuran.  2.35 (8.5 mg, 0.040 mmol) is added 
dropwise as a solution in tetrahydrofuran (200 µL) and the orange solution is heated to 
reflux and allowed to stir for 14 h during which time the solution darkens from orange to 
black.  The reaction is cooled to 0 ºC, and following removal of the reflux condenser, the 
reaction mixture is diluted dropwise with diethyl ether (3 mL) followed by water (1 mL) 
which causes a color change of the solution from black to yellow as well as bubbling.  
The layers are separated and the aqueous layer is washed with diethyl ether (3 x 5 mL) 
and the combined organic layers are dried over MgSO4 and carefully concentrated in 
vacuo to minimize loss of volatile 2.36 to afford a yellow oil (>98% consumption of 2.35 
by 1H NMR).  The product is purified by silica gel chromatography (10 mm diameter 
column slurry packed with ~2.5 g of silica gel and eluted sequentially with 15 mL 
pentanes, 20 mL 99:1, and 20 mL 49:1 pentanes : diethyl ether) to afford 2.36 (3.3 mg, 
0.019 mmol, 46% yield) as a clear, colorless oil. 
(S)-(2-methoxypentan-2-yl)benzene (2.36, From 2.10a, Scheme 2.21): In a nitrogen-
                                                
(57) Procedure is based on a report in the literature. See: Zhao, W.; Wu, J.; Cao, S. Adv. Synth. Catal. 
2012, 354, 574–578.  
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 filled glovebox, a 10 mL Schlenk flask equipped with a stirbar is charged with Crabtree’s 
catalyst58 (32 mg, 0.04 mmol), sealed with a rubber septum and electrical tape, and 
removed from the glovebox.  The reaction vessel is purged with H2 gas and connected to 
a balloon of H2 gas with a needle in order to keep the H2 pressure above the solution at ~ 
1 atm. 2.10a (65 mg, 0.4 mmol) is added by syringe in a solution of dichloromethane (2.5 
mL).  The orange solution is allowed to stir at 22 ºC for 18 h after which time the solution 
is transferred to a 15 mL RBF and concentrated in vacuo to afford a green oil.  Diethyl 
ether (5 mL) is added to this, which causes a gummy green precipitate to form.  This 
mixture is passed through a short plug of Celite® (eluted with diethyl ether) and 
concentrated in vacuo to give an olive green oil which was used without further 
purification. 
           In a nitrogen-filled glovebox, a RBF equipped with a stirbar is charged with NaH 
(24.0 mg, 1.00 mmol), sealed with a rubber septum and electrical tape, and removed from 
the glovebox. Nitrogen gas is connected to the apparatus with a needle and 
tetrahydrofuran (400 µL) and methyl iodide (100. µL, 1.61 mmol) are added via syringe 
followed by dropwise addition of the olive green oil from the previous step (~0.4 mmol 
from previous reduction; transferred to reaction vessel with 3 x 200 µL of 
tetrahydrofuran) via syringe with a rate slow enough that the bubbling from H2 gas 
production subsides between drops.  The cloudy yellow solution is allowed to stir at 22 
ºC for 12 h during which time it becomes a cloudy tan solution.  The reaction is cooled to 
0 ºC, and water is added dropwise via syringe with a rate slow enough that the bubbling 
from H2 gas production subsides between drops.  After no bubbling occurs upon addition 
                                                
(58) Crabtree, R. H.; Felkin, H.; Morris, G. E. J. Organomet. Chem. 1977, 141, 205. 
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 of water, the septum and nitrogen line are removed from the flask and the solution is 
diluted with diethyl ether (3 mL) and water (0.5 mL). The aqueous and organic layers are 
separated and the organic layer is washed sequentially with a saturated aqueous solution 
of NH4Cl (1 mL), an aqueous solution of Na2S2O3 (5 wt %, 1 mL), and brine (1 mL).  
The organic layer is dried over MgSO4, carefully concentrated in vacuo to minimize loss 
of volatile 2.36 to afford a yellow oil which is purified by silica gel chromatography (19 
mm diameter column slurry packed with ~6 g of silica gel and eluted with 100 mL of 
pentanes and 100 mL 99:1 pentanes : diethyl ether) to afford 2.36 (50.5 mg, 0.28 mmol, 
71% yield over 2 steps) as a clear pale yellow oil. IR (neat): 2958 (m), 2935 (m), 2872 
(w), 2824 (w), 1494 (w), 1446 (m), 1371 (w), 1225 (m), 1167 (m), 1072 (s), 764 (s), 669 
(s); 1H NMR (400 MHz, CDCl3): δ 7.39–7.32 (4H, m), 7.26–7.22 (1H, m), 3.09–3.08 
(3H, m), 1.78–1.70 (2H, m), 1.53 (3H, s), 1.33–1.12 (2H, m), 0.86 (3H, t, J = 7.4 Hz); 13C 
NMR (100 MHz, CDCl3): δ 145.5, 128.2, 126.7, 126.3, 79.2, 50.4, 45.3, 23.1, 17.3, 14.6; 
HRMS Calcd for C11H15O [M + H]+: 163.11229; Found: 163.11180; [α]21.8= –24.8 (c = 
2.42, CHCl3) for an 80:20 e.r. sample. The enantiomeric purity of this compound was 
determined by HPLC analysis in comparison with authentic racemic material (Chiracel 
OJ-H, 99:1 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 9 min (minor) and 10 min (major). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 9.3 min 47.873 1 9.2 min 20.582 
2 10.4 min 52.127 2 10.1 min 79.418 
Peak # Ret. Time Area % 
1 9.4 min 6.495 
2 10.4 min 93.505 
 
Absolute configuration of homoallylalcohol 2.12a: 
(R)-5,5,5-Trifluoro-4-hydroxy-4-phenylpentan-2-one (2.29, Equation 6): 2.12a is 
converted to 2.29 in accordance to a procedure in the literature.59 The title compound is 
purified by silica gel chromatography (10 mm diameter column slurry packed with ~2.5 g 
of silica gel and eluted with 10 mL hexanes, 40 mL 99:1, 50 mL 1:1 hexanes : 
dichloromethane) affording 2.29 (41.6 mg, 0.179 mmol, 90% yield) as a clear colorless 
oil. The analytical data are fully consistent with those reported previously and 
comparison of the specific rotation of 2.29 and its HPLC trace with data in literature 
                                                
(59) McCombs, J. R.; Michel, B. W.; Sigman, M. S. J. Org. Chem. 2011, 76, 3609–3613.  
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 establishes the absolute stereochemistry of 2.11a.60 1H NMR (400 MHz, CDCl3): δ 7.58–
7.55 (2H, m), 7.42–7.34 (3H, m), 5.44 (1H, s), 3.37 and 3.21 (2H, ABq, JAB = 17.1 Hz), 
2.21 (3H, s); HRMS Calcd for C11H12F3O2 [M + H]+: 233.07894; Found: 233.07928; 
[α]23.4= –20.0 (c = 1.00, CHCl3) for a 95:5 e.r. sample. The enantiomeric purity of this 
compound was determined by HPLC analysis in comparison with authentic racemic 
material (Chiracel OD-H, 99:1 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 13 min (major) 
and 25 min (minor). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 13.6 min 48.378 1 13.4 min 93.561 
2 25.6 min 51.624 2 25.4 min 6.439 
 
Absolute configuration of homoallylalcohol 2.22a:  
(R)-5,5,5-Trifluoro-4-hydroxy-4-phenylpentan-2-one (2.29, Equation 9): 2.22a is 
converted to 2.29 in accordance to a procedure in the literature and purified as above to 
obtain 2.29 (18.8 mg, 0.0810 mmol, 67% yield) as a clear, colorless oil.61 Comparison of 
the HPLC trace of 2.29 with data in literature establishes the absolute stereochemistry of 
2.22a. 
                                                
(60) Duangdee, N.; Harnying, W.; Rulli, G.; Neudörfl, J.-M.; Gröger, H.; Berkessel, A. J. Am. Chem. Soc. 
2012, 134, 11196–11205. 
(61) Román, J. G.; Soderquist, J. A. J. Org. Chem. 2007, 72, 9772–9775. 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 12.9 min 49.233 1 12.9 min 98.457 
2 21.8 min 50.767 2 21.8 min 1.543 
 
Absolute configuration of homoallenylalcohol 2.24a:  
(R)-(1,1,1-Trifluoro-2-methoxypenta-3,4-dien-2-yl)benzene (2.30, Scheme 2.15): The 
title compound is synthesized in accordance to a procedure in the literature62 and purified 
by silica gel chromatography (10 mm diameter column slurry packed with ~2.5 g of silica 
gel and eluted with 40 mL pentanes, 30 mL 99:1 pentanes : diethyl ether) affording XX 
(33.1 mg, 0.145 mmol, 73% yield as a 95:5 ratio of allene to propargyl product) as a clear 
pale yellow oil. IR (neat): 2945 (w, br), 2838 (w), 1981 (w), 1958 (w), 1489 (w) 1450 
(w), 1276 (m), 1165 (s), 1094 (s), 1094 (s), 1078 (s), 1026 (m), 974 (w), 849 (m), 762 
(m), 714 (m), 669 (s); 1H NMR (400 MHz, CDCl3): δ 7.59–7.56 (2H, m), 7.44–7.36 (3H, 
m), 5.54 (1H, t, J = 6.8 Hz), 5.06–4.96 (2H, m), 3.38–3.37 (3H, m); 13C NMR (100 MHz, 
CDCl3): δ 210.7, 134.3, 129.1, 128.8 (m), 128.2, 124.5 (q, J = 284.7 Hz, one peak 
overlaps with m at 128.8), 87.4 (q, J = 1.4 Hz), 82.4 (q, J = 27.7 Hz), 79.1, 52.6; 19F 
NMR (376 MHz, CDCl3): 75.59 (3F, s); HRMS Calcd for C12H12OF3 [M + H]+: 
229.08402; Found: 229.08391; [α]21.8= +22.2 (c =  1.35, CHCl3) for a 95:5 e.r. sample 
(95:5 allene:propargyl). 
                                                
(62) Chong, J. M.; Loewith, R. Synth. Comm. 1993, 23, 2145–2150. 
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 (S)-3,3,3-Trifluoro-2-methoxy-2-phenylpropanoic acid (Mosher's Acid) (2.31, 
Scheme 2.15): The title compound is synthesized in accordance to a procedure in the 
literature62 and purified by silica gel chromatography (10 mm diameter column slurry 
packed with ~2.5 g of silica gel and eluted with 10 mL dichloromethane and 30 mL 99:1 
dichloromethane : acetic acid) affording 2.31 (18.4 mg, 0.0786 mmol, 37% yield) as a 
clear colorless sticky oil. The analytical data are fully consistent with those reported 
previously; comparison of the specific rotation of 2.31 and its HPLC trace with data in 
literature establishes the absolute stereochemistry of 2.24a.63  1H NMR (400 MHz, 
CDCl3): δ 9.27 (1H, br s), 7.59–7.57 (2H, m), 7.46–7.41 (3H, m), 3.57 (3H, s); HRMS 
Calcd for C10H10F3O3 [M + H]+: 235.05820; Found: 235.05735; [α]23.7= –58.3 (c =  1.15, 
CHCl3) for a 94:6 e.r. sample (based on e.r. of 2.24a). 
■  DFT Calculations:  All geometry and frequency calculations of the transition states 
shown in Scheme S2 were carried out employing the hybrid functional B3LYP64 and the 
split-valence 6-31G** basis set. The calculations were carried out in toluene, which was 
simulated by the polarizable dielectric continuum solvation model PCM.65 Frequency 
calculations were carried out on the fully optimized geometries. All computed 
frequencies are real except for the transition state structures, which have one imaginary 
frequency. Free energies were computed at 298.15 K and 1.0 atm. with harmonic, 
                                                
(63) Dale, J. A.; Dull, D. L.; Mosher, H. S. J. Org. Chem. 1969, 34, 2543–2549.  
(64) (a) Becke, A. D.  J. Chem. Phys. 1993, 98, 5648-5652; Lee, C.; Yang, W.; Parr, R. G. Phys. Rev. B. 
1988, 37, 785–789. (b) Vosko, S. H.; Wilk, L.; Nusair, M. Can. J. Phys. 1980, 58, 1200–1211. (c) 
Stephens, P. J.; Devlin, F. J.; Chabalowski, C. F.; Frisch, M. J. J. Phys. Chem. 1994, 98, 11623–11627. 
(65)  Tomasi, J.; Mennucci, B.; Cammi, R. Chem. Rev. 2005, 105, 2999−3093. 
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 unscaled frequencies. All quantum chemical calculations were carried out with the 
Gaussian 09 computer program.66 
Transition State Energy for Complex TS-2.4 (Scheme 2.16a): 
----------------------------------------- 
 Cartesian coordinates (Angstroms): 
----------------------------------------- 
H    -1.758     4.105    -1.113 
C    -0.963     3.718    -1.759 
H    -1.099     2.641    -1.869 
H    -1.080     4.179    -2.746 
C    -6.150    -0.683     0.095 
C    -4.907    -1.302     0.178 
C    -6.243     0.680    -0.193 
C    -3.730    -0.550    -0.019 
C    -5.082     1.432    -0.396 
C    -3.835     0.826    -0.311 
C     3.372    -2.939    -2.850 
O     1.909    -2.948    -0.535 
N     3.259    -1.785    -1.953 
C     2.546    -1.919    -0.808 
C     4.906    -1.531     0.701 
C     3.927     0.178     2.184 
C     3.960    -0.591    -2.421 
C     3.580    -1.095     1.378 
C     2.508    -0.787     0.244 
                                                
(66) Gaussian 09, Revision A.02, M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, 
J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato, X. Li, 
H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. 
Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. 
Montgomery, Jr., J. E. Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. N. 
Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, 
M. Cossi, N. Rega, J. M. Millam, M. Klene, J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. 
Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, 
K. Morokuma, V. G. Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, 
O. Farkas, J. B. Foresman, J. V. Ortiz, J. Cioslowski, and D. J. Fox, Gaussian, Inc., Wallingford CT, 2009. 
 
Page 501
 C     3.146    -2.252     2.305 
B     0.004    -0.158    -0.456 
N     1.039    -0.766     0.676 
C     0.694    -0.001     1.932 
O     0.329     1.212    -0.622 
C     0.729     1.493     1.725 
C     0.544     2.049     0.450 
C     0.923     2.335     2.824 
C     0.589     3.446     0.230 
C     0.429     4.064    -1.176 
C     0.942     3.711     2.645 
C     1.544     3.540    -2.115 
C     0.786     4.245     1.364 
C     0.542     5.602    -1.143 
O    -1.391    -0.287     0.116 
C    -0.083    -0.871    -1.966 
C    -0.867    -2.095    -1.919 
C    -2.375    -1.135     0.067 
C    -2.238    -2.077    -1.972 
H    -7.048    -1.269     0.255 
H    -4.862    -2.359     0.396 
H    -7.217     1.156    -0.258 
H    -5.150     2.493    -0.614 
H    -2.934     1.410    -0.454 
H     2.867    -2.730    -3.799 
H     2.916    -3.805    -2.378 
H     4.428    -3.140    -3.055 
H     5.664    -1.662     1.478 
H     5.284    -0.775     0.007 
H     4.816    -2.482     0.171 
H     3.107     0.582     2.774 
H     4.276     0.977     1.521 
H     4.742    -0.052     2.878 
H     3.639    -0.365    -3.442 
H     5.042    -0.761    -2.431 
H     3.750     0.277    -1.801 
H     2.714     0.196    -0.174 
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 H     2.277    -2.018     2.925 
H     3.966    -2.483     2.991 
H     2.920    -3.153     1.731 
H    -0.306    -0.339     2.214 
H     1.363    -0.296     2.734 
H     1.058     1.905     3.813 
H     1.089     4.372     3.493 
H     2.532     3.814    -1.731 
H     1.436     3.989    -3.109 
H     1.503     2.456    -2.225 
H     0.821     5.321     1.253 
H     1.514     5.937    -0.768 
H    -0.241     6.061    -0.530 
H     0.431     5.991    -2.160 
H     0.929    -1.025    -2.340 
H    -0.571    -0.092    -2.559 
H    -0.351    -3.016    -1.656 
C    -2.178    -2.417     0.915 
H    -2.749    -1.223    -2.402 
H    -2.814    -2.991    -1.885 
H     0.820    -1.757     0.821 
F    -2.421    -2.105     2.201 
F    -0.907    -2.870     0.843 
F    -2.975    -3.435     0.566 
 
                     1                      2                      3 
                     A                      A                      A 
 Frequencies --  -196.1530                14.6905                27.5050 
 Red. masses --     7.1961                 3.7800                 4.1391 
 Zero-point correction=                           0.675275 (Hartree/Particle) 
 Thermal correction to Energy=                    0.714076 
 Thermal correction to Enthalpy=                  0.715020 
 Thermal correction to Gibbs Free Energy=         0.605956 
 Sum of electronic and zero-point Energies=          -1826.716932 
 Sum of electronic and thermal Energies=             -1826.678131 
 Sum of electronic and thermal Enthalpies=           -1826.677187 
 Sum of electronic and thermal Free Energies=        -1826.786251 
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         Item               Value     Threshold  Converged? 
 Maximum Force            0.000013     0.000450     YES 
 RMS     Force            0.000001     0.000300     YES 
 
Transition State Energy for Complex TS-2.5 (Scheme 2.16a): 
----------------------------------------- 
 Cartesian coordinates (Angstroms): 
----------------------------------------- 
H     2.539     3.355     1.310 
C     1.691     3.024     1.917 
H     1.662     1.935     1.894 
H     1.876     3.342     2.949 
C     5.702    -0.215     0.349 
C     4.630    -1.100     0.356 
C     5.534     1.095    -0.110 
C     3.360    -0.677    -0.090 
C     4.284     1.517    -0.565 
C     3.201     0.642    -0.551 
C    -3.874    -2.588     2.694 
O    -2.675    -2.724     0.236 
N    -3.552    -1.413     1.879 
C    -2.995    -1.603     0.659 
C    -5.255    -0.477    -0.611 
C    -3.954     1.054    -2.043 
C    -3.930    -0.141     2.489 
C    -3.905    -0.332    -1.361 
C    -2.730    -0.413    -0.291 
C    -3.839    -1.469    -2.403 
B    -0.114    -0.500     0.264 
N    -1.325    -0.706    -0.824 
C    -0.859     0.064    -2.039 
O     0.018     0.883     0.543 
C    -0.540     1.503    -1.706 
C    -0.144     1.866    -0.409 
C    -0.640     2.483    -2.698 
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 C     0.075     3.218    -0.046 
C     0.372     3.650     1.408 
C    -0.367     3.808    -2.389 
C    -0.804     3.222     2.322 
C    -0.035     4.159    -1.079 
C     0.513     5.181     1.533 
O     1.019    -1.175    -0.486 
C    -0.218    -1.360     1.698 
C     1.128    -1.419     2.243 
C     2.206    -1.597    -0.170 
C     1.998    -2.433     1.942 
H     6.672    -0.549     0.701 
H     4.781    -2.111     0.710 
H     6.376     1.779    -0.118 
H     4.150     2.527    -0.939 
H     2.242     0.969    -0.928 
H    -3.355    -2.524     3.656 
H    -3.561    -3.485     2.166 
H    -4.952    -2.626     2.881 
H    -6.067    -0.344    -1.330 
H    -5.380     0.285     0.163 
H    -5.381    -1.464    -0.159 
H    -3.112     1.265    -2.699 
H    -4.001     1.857    -1.300 
H    -4.860     1.117    -2.654 
H    -3.478    -0.070     3.484 
H    -5.017    -0.081     2.603 
H    -3.596     0.712     1.903 
H    -2.663     0.545     0.222 
H    -2.962    -1.417    -3.055 
H    -4.717    -1.407    -3.053 
H    -3.841    -2.449    -1.921 
H     0.020    -0.475    -2.400 
H    -1.611     0.006    -2.819 
H    -0.936     2.200    -3.705 
H    -0.434     4.574    -3.154 
H    -1.736     3.698     2.000 
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 H    -0.608     3.534     3.353 
H    -0.947     2.140     2.315 
H     0.136     5.205    -0.861 
H    -0.397     5.707     1.229 
H     1.350     5.568     0.943 
H     0.706     5.438     2.579 
H    -0.621    -2.351     1.484 
H    -0.894    -0.789     2.338 
H     1.508    -0.542     2.763 
C     2.435    -2.993    -0.811 
H     3.013    -2.422     2.321 
H     1.614    -3.387     1.597 
H    -1.359    -1.708    -1.054 
F     2.729    -2.806    -2.110 
F     1.322    -3.740    -0.739 
F     3.439    -3.686    -0.250 
 
                     1                      2                      3 
                     A                      A                      A 
 Frequencies --  -203.2086                18.4901                19.1728 
 Red. masses --     6.9236                 4.2706                 5.0338 
 Zero-point correction=                           0.675795 (Hartree/Particle) 
 Thermal correction to Energy=                    0.714404 
 Thermal correction to Enthalpy=                  0.715349 
 Thermal correction to Gibbs Free Energy=         0.606904 
 Sum of electronic and zero-point Energies=          -1826.711062 
 Sum of electronic and thermal Energies=             -1826.672452 
 Sum of electronic and thermal Enthalpies=           -1826.671508 
 Sum of electronic and thermal Free Energies=        -1826.779953 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000018     0.000450     YES 
 RMS     Force            0.000002     0.000300     YES 
 
Transition State Energy for Complex TS-2.6 (Scheme 2.16b): 
----------------------------------------- 
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  Cartesian coordinates (Angstroms): 
----------------------------------------- 
H    -0.331     2.950     1.868 
H    -1.149     4.342     2.595 
C    -0.926     3.834     1.650 
H    -0.322     4.512     1.039 
C     6.173    -0.703    -0.793 
C     5.117     0.075    -0.326 
C     5.953    -2.016    -1.210 
C     3.813    -0.456    -0.284 
C     4.664    -2.556    -1.161 
C     3.603    -1.786    -0.703 
C    -1.813    -3.996     2.870 
O    -0.544    -3.491     0.498 
N    -2.198    -2.920     1.953 
C    -1.525    -2.787     0.787 
C    -3.915    -3.321    -0.655 
C    -3.644    -1.422    -2.208 
C    -3.293    -2.083     2.438 
C    -2.850    -2.455    -1.377 
C    -1.957    -1.744    -0.272 
C    -2.037    -3.401    -2.286 
B     0.090    -0.159     0.377 
N    -0.618    -1.159    -0.721 
C    -0.564    -0.375    -2.013 
O    -0.696     1.015     0.464 
C    -1.196     0.989    -1.878 
C    -1.278     1.621    -0.628 
C    -1.716     1.621    -3.012 
C    -1.978     2.841    -0.456 
C    -2.245     3.468     0.932 
C    -2.330     2.859    -2.889 
C    -3.049     2.468     1.800 
C    -2.472     3.436    -1.625 
C    -3.083     4.760     0.824 
O     1.480    -0.095    -0.222 
C     0.350    -0.762     1.927 
 
Page 507
 C     1.372     0.090     2.508 
C     2.645     0.328     0.182 
C     2.712    -0.169     2.344 
H     7.171    -0.279    -0.830 
H     5.316     1.088    -0.006 
H     6.781    -2.619    -1.569 
H     4.488    -3.578    -1.481 
H     2.607    -2.211    -0.661 
H    -1.408    -3.575     3.796 
H    -1.061    -4.620     2.394 
H    -2.693    -4.598     3.116 
H    -4.597    -3.729    -1.406 
H    -4.519    -2.734     0.043 
H    -3.479    -4.167    -0.118 
H    -3.030    -0.773    -2.829 
H    -4.250    -0.779    -1.561 
H    -4.328    -1.955    -2.876 
H    -3.041    -1.702     3.433 
H    -4.214    -2.670     2.520 
H    -3.480    -1.233     1.787 
H    -2.524    -0.915     0.146 
H    -1.321    -2.884    -2.931 
H    -2.725    -3.935    -2.948 
H    -1.489    -4.141    -1.698 
H     0.498    -0.307    -2.261 
H    -1.042    -0.943    -2.805 
H    -1.639     1.135    -3.981 
H    -2.727     3.364    -3.763 
H    -4.010     2.231     1.330 
H    -3.257     2.908     2.781 
H    -2.499     1.538     1.954 
H    -2.996     4.380    -1.556 
H    -4.058     4.584     0.360 
H    -2.565     5.541     0.259 
H    -3.264     5.150     1.830 
H     0.669    -1.802     1.851 
H    -0.608    -0.675     2.444 
 
Page 508
 H     1.067     1.048     2.925 
C     2.799     1.867     0.280 
H     3.462     0.501     2.746 
H     3.035    -1.179     2.122 
H    -0.024    -1.993    -0.815 
F     3.794     2.246     1.105 
F     1.675     2.450     0.703 
F     3.079     2.336    -0.949 
 
                     1                      2                      3 
                     A                      A                      A 
 Frequencies --  -236.7114                20.4308                27.4711 
 Red. masses --     7.6378                 6.2395                 4.6727 
 Zero-point correction=                           0.675817 (Hartree/Particle) 
 Thermal correction to Energy=                    0.714573 
 Thermal correction to Enthalpy=                  0.715517 
 Thermal correction to Gibbs Free Energy=         0.606617 
 Sum of electronic and zero-point Energies=          -1826.713886 
 Sum of electronic and thermal Energies=             -1826.675130 
 Sum of electronic and thermal Enthalpies=           -1826.674186 
 Sum of electronic and thermal Free Energies=        -1826.783086 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000002     0.000450     YES 
 RMS     Force            0.000000     0.000300     YES 
 
Transition State Energy for Complex TS-2.8 (Scheme 2.16b): 
----------------------------------------- 
 Cartesian coordinates (Angstroms): 
----------------------------------------- 
H     0.639    -3.364     1.298 
H     1.607    -4.608     2.106 
C     1.459    -4.067     1.165 
H     1.163    -4.797     0.403 
C    -6.032     0.099    -1.200 
C    -5.003    -0.584    -0.553 
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 C    -5.825     1.386    -1.693 
C    -3.738     0.016    -0.408 
C    -4.576     1.996    -1.541 
C    -3.543     1.318    -0.908 
C     1.112     3.945     3.102 
O    -0.141     3.223     0.778 
N     1.708     3.060     2.097 
C     1.012     2.799     0.964 
C     3.101     4.024    -0.536 
C     3.237     2.217    -2.207 
C     3.025     2.540     2.462 
C     2.254     2.951    -1.267 
C     1.633     1.965    -0.182 
C     1.171     3.703    -2.072 
B    -0.049    -0.089     0.407 
N     0.461     1.098    -0.637 
C     0.580     0.380    -1.964 
O     0.901    -1.135     0.393 
C     1.529    -0.786    -1.890 
C     1.659    -1.506    -0.694 
C     2.259    -1.173    -3.018 
C     2.564    -2.588    -0.570 
C     2.770    -3.356     0.755 
C     3.122    -2.257    -2.940 
C     3.222    -2.383     1.872 
C     3.272    -2.935    -1.729 
C     3.862    -4.438     0.627 
O    -1.401    -0.372    -0.197 
C    -0.339     0.284     2.032 
C    -1.673     0.814     2.203 
C    -2.596    -0.682     0.233 
C    -2.773    -0.009     2.308 
H    -6.998    -0.382    -1.315 
H    -5.194    -1.581    -0.182 
H    -6.632     1.916    -2.190 
H    -4.410     3.001    -1.916 
H    -2.584     1.809    -0.785 
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 H     0.878     3.380     4.011 
H     0.203     4.385     2.700 
H     1.824     4.735     3.357 
H     3.579     4.658    -1.287 
H     3.901     3.579     0.063 
H     2.501     4.674     0.105 
H     2.767     1.514    -2.893 
H     3.993     1.666    -1.638 
H     3.761     2.958    -2.818 
H     2.963     2.064     3.446 
H     3.752     3.356     2.520 
H     3.386     1.802     1.750 
H     2.410     1.281     0.154 
H     0.553     3.052    -2.696 
H     1.660     4.410    -2.748 
H     0.508     4.269    -1.413 
H    -0.437     0.054    -2.198 
H     0.876     1.082    -2.736 
H     2.144    -0.625    -3.949 
H     3.690    -2.570    -3.810 
H     4.165    -1.896     1.602 
H     3.388    -2.938     2.802 
H     2.476    -1.611     2.067 
H     3.970    -3.761    -1.693 
H     4.833    -4.014     0.354 
H     3.599    -5.205    -0.108 
H     3.980    -4.939     1.592 
H     0.445     0.956     2.378 
H    -0.220    -0.698     2.498 
H    -1.817     1.878     2.025 
C    -2.730    -2.193     0.555 
H    -2.653    -0.998     2.735 
H    -3.772     0.411     2.351 
H    -0.309     1.772    -0.698 
F    -3.822    -2.493     1.281 
F    -1.658    -2.627     1.239 
F    -2.796    -2.873    -0.601 
 
Page 511
  
                     1                      2                      3 
                     A                      A                      A 
 Frequencies --  -259.2548                12.6420                27.1256 
 Red. masses --     7.7480                 5.2342                 4.5174 
 Zero-point correction=                           0.675616 (Hartree/Particle) 
 Thermal correction to Energy=                    0.714487 
 Thermal correction to Enthalpy=                  0.715431 
 Thermal correction to Gibbs Free Energy=         0.605678 
 Sum of electronic and zero-point Energies=          -1826.706913 
 Sum of electronic and thermal Energies=             -1826.668042 
 Sum of electronic and thermal Enthalpies=           -1826.667098 
 Sum of electronic and thermal Free Energies=        -1826.776851 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000004     0.000450     YES 
 RMS     Force            0.000001     0.000300     YES 
 
Transition State Energy for Complex TS-2.11-(R) (Scheme 2.19): 
----------------------------------------- 
 Cartesian coordinates (Angstroms): 
----------------------------------------- 
H     2.255     3.797     1.176 
C     1.464     3.412     1.829 
H     1.540     2.324     1.857 
H     1.648     3.795     2.838 
C     6.172    -1.690    -0.368 
C     4.841    -2.095    -0.371 
C     6.494    -0.339    -0.218 
C     3.809    -1.147    -0.226 
C     5.478     0.607    -0.067 
C     4.145     0.210    -0.068 
C    -3.474    -2.713     2.779 
O    -2.048    -2.906     0.450 
N    -3.241    -1.586     1.873 
C    -2.556    -1.809     0.722 
C    -4.847    -1.280    -0.801 
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 C    -3.765     0.387    -2.260 
C    -3.806    -0.320     2.335 
C    -3.496    -0.918    -1.473 
C    -2.405    -0.695    -0.334 
C    -3.133    -2.084    -2.416 
B     0.165    -0.323     0.378 
N    -0.942    -0.787    -0.764 
C    -0.551     0.020    -1.979 
O    -0.053     1.061     0.623 
C    -0.498     1.501    -1.690 
C    -0.238     1.968    -0.392 
C    -0.676     2.414    -2.733 
C    -0.183     3.352    -0.096 
C     0.074     3.878     1.333 
C    -0.603     3.777    -2.478 
C    -1.031     3.374     2.294 
C    -0.368     4.225    -1.177 
C     0.060     5.420     1.388 
O     1.528    -0.537    -0.201 
C     0.187    -1.115     1.857 
C     0.841    -2.401     1.714 
C     2.373    -1.539    -0.256 
C     2.213    -2.501     1.676 
H     6.958    -2.429    -0.480 
H     4.622    -3.153    -0.469 
H     7.534    -0.026    -0.216 
H     5.724     1.658     0.048 
H     3.354     0.942     0.038 
H    -2.958    -2.545     3.731 
H    -3.102    -3.625     2.319 
H    -4.546    -2.809     2.977 
H    -5.613    -1.345    -1.577 
H    -5.172    -0.514    -0.090 
H    -4.817    -2.245    -0.291 
H    -2.929     0.736    -2.863 
H    -4.041     1.201    -1.582 
H    -4.607     0.224    -2.939 
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 H    -3.443    -0.113     3.347 
H    -4.899    -0.380     2.368 
H    -3.522     0.513     1.698 
H    -2.533     0.305     0.075 
H    -2.249    -1.895    -3.030 
H    -3.963    -2.258    -3.107 
H    -2.963    -3.005    -1.852 
H     0.431    -0.355    -2.275 
H    -1.231    -0.194    -2.797 
H    -0.870     2.051    -3.739 
H    -0.738     4.493    -3.282 
H    -2.015     3.734     1.973 
H    -0.848     3.757     3.304 
H    -1.059     2.285     2.341 
H    -0.330     5.293    -1.006 
H    -0.903     5.836     1.074 
H     0.846     5.863     0.768 
H     0.235     5.742     2.418 
H    -0.827    -1.181     2.246 
H     0.769    -0.419     2.467 
H     0.228    -3.256     1.440 
C     2.023    -2.702    -1.173 
H     2.817    -1.736     2.152 
H     2.694    -3.464     1.534 
H    -0.784    -1.780    -0.966 
H     2.163    -2.364    -2.207 
F     0.695    -3.086    -1.018 
H     2.650    -3.576    -0.997 
 
                     1                      2                      3 
                     A                      A                      A 
 Frequencies --  -261.3815                19.0327                27.4182 
 Red. masses --     7.0765                 4.2647                 4.2327 
 Zero-point correction=                           0.692049 (Hartree/Particle) 
 Thermal correction to Energy=                    0.729223 
 Thermal correction to Enthalpy=                  0.730167 
 Thermal correction to Gibbs Free Energy=         0.624954 
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  Sum of electronic and zero-point Energies=          -1628.221388 
 Sum of electronic and thermal Energies=             -1628.184214 
 Sum of electronic and thermal Enthalpies=           -1628.183270 
 Sum of electronic and thermal Free Energies=        -1628.288483 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000003     0.000450     YES 
 RMS     Force            0.000001     0.000300     YES 
Transition State Energy for Complex TS-2.11-(S) (Scheme 2.19): 
----------------------------------------- 
 Cartesian coordinates (Angstroms): 
----------------------------------------- 
H    -0.049     2.799     1.991 
H    -0.708     4.308     2.624 
C    -0.538     3.731     1.708 
H     0.142     4.309     1.074 
C     6.287    -0.133    -0.561 
C     5.113     0.407    -0.040 
C     6.276    -1.391    -1.167 
C     3.906    -0.310    -0.131 
C     5.082    -2.113    -1.251 
C     3.905    -1.581    -0.734 
C    -1.902    -4.091     3.045 
O    -0.623    -3.646     0.669 
N    -2.241    -2.996     2.131 
C    -1.567    -2.896     0.962 
C    -3.995    -3.314    -0.463 
C    -3.637    -1.442    -2.027 
C    -3.289    -2.107     2.623 
C    -2.889    -2.509    -1.194 
C    -1.954    -1.835    -0.099 
C    -2.130    -3.502    -2.100 
B     0.177    -0.338     0.508 
N    -0.592    -1.318    -0.562 
C    -0.507    -0.561    -1.867 
O    -0.549     0.889     0.591 
C    -1.047     0.844    -1.755 
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 C    -1.083     1.509    -0.519 
C    -1.518     1.488    -2.903 
C    -1.678     2.788    -0.380 
C    -1.885     3.473     0.992 
C    -2.034     2.773    -2.811 
C    -2.783     2.579     1.882 
C    -2.125     3.392    -1.563 
C    -2.590     4.838     0.849 
O     1.541    -0.321    -0.080 
C     0.381    -0.940     2.083 
C     1.436    -0.123     2.637 
C     2.634     0.264     0.392 
C     2.767    -0.369     2.361 
H     7.212     0.430    -0.492 
H     5.135     1.377     0.439 
H     7.193    -1.809    -1.569 
H     5.069    -3.091    -1.722 
H     2.980    -2.140    -0.803 
H    -1.452    -3.692     3.960 
H    -1.200    -4.761     2.557 
H    -2.812    -4.636     3.312 
H    -4.692    -3.700    -1.211 
H    -4.572    -2.689     0.224 
H    -3.600    -4.171     0.087 
H    -2.996    -0.819    -2.648 
H    -4.214    -0.774    -1.378 
H    -4.344    -1.945    -2.693 
H    -3.019    -1.754     3.624 
H    -4.242    -2.641     2.694 
H    -3.423    -1.239     1.983 
H    -2.478    -0.978     0.320 
H    -1.386    -3.028    -2.746 
H    -2.847    -3.999    -2.760 
H    -1.624    -4.268    -1.509 
H     0.555    -0.564    -2.126 
H    -1.028    -1.111    -2.644 
H    -1.481     0.976    -3.861 
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 H    -2.392     3.286    -3.697 
H    -3.763     2.430     1.418 
H    -2.942     3.059     2.854 
H    -2.329     1.601     2.058 
H    -2.570     4.378    -1.518 
H    -3.578     4.746     0.386 
H    -1.998     5.549     0.264 
H    -2.734     5.270     1.843 
H     0.659    -1.992     2.004 
H    -0.573    -0.810     2.595 
H     1.169     0.827     3.099 
C     2.535     1.786     0.531 
H     3.537     0.277     2.766 
H     3.070    -1.379     2.108 
H    -0.035    -2.178    -0.645 
F     3.407     2.282     1.492 
H     2.796     2.229    -0.437 
H     1.520     2.071     0.798 
 
                     1                      2                      3 
                     A                      A                      A 
 Frequencies --  -279.9058                24.5892                29.9851 
 Red. masses --     8.2363                 4.7956                 4.3825 
 Zero-point correction=                           0.692991 (Hartree/Particle) 
 Thermal correction to Energy=                    0.729955 
 Thermal correction to Enthalpy=                  0.730899 
 Thermal correction to Gibbs Free Energy=         0.626632 
 Sum of electronic and zero-point Energies=          -1628.220284 
 Sum of electronic and thermal Energies=             -1628.183320 
 Sum of electronic and thermal Enthalpies=           -1628.182375 
 Sum of electronic and thermal Free Energies=        -1628.286642 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000021     0.000450     YES 
 RMS     Force            0.000002     0.000300     YES 
Transition State Energy for Complex TS-2.12-(R) (Scheme 2.19): 
----------------------------------------- 
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  Cartesian coordinates (Angstroms): 
----------------------------------------- 
H    -2.113     3.881    -1.160 
C    -1.296     3.532    -1.800 
H    -1.361     2.446    -1.883 
H    -1.446     3.961    -2.797 
C    -6.139    -1.454     0.105 
C    -4.820    -1.894     0.154 
C    -6.420    -0.097    -0.069 
C    -3.760    -0.973     0.034 
C    -5.375     0.823    -0.197 
C    -4.054     0.391    -0.150 
C     3.541    -2.677    -2.853 
O     2.057    -2.877    -0.559 
N     3.317    -1.563    -1.928 
C     2.604    -1.790    -0.797 
C     4.889    -1.319     0.773 
C     3.799     0.324     2.252 
C     3.926    -0.304    -2.350 
C     3.531    -0.959     1.431 
C     2.461    -0.696     0.282 
C     3.143    -2.145     2.340 
B    -0.073    -0.246    -0.461 
N     0.989    -0.777     0.688 
C     0.581    -0.020     1.930 
O     0.178     1.138    -0.646 
C     0.533     1.472     1.702 
C     0.324     1.999     0.418 
C     0.671     2.338     2.790 
C     0.278     3.394     0.182 
C     0.071     3.984    -1.231 
C     0.608     3.711     2.594 
C     1.216     3.530    -2.170 
C     0.421     4.218     1.306 
C     0.075     5.526    -1.215 
O    -1.462    -0.442     0.088 
C    -0.106    -0.983    -1.965 
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 C    -0.782    -2.267    -1.890 
C    -2.345    -1.397     0.100 
C    -2.151    -2.366    -1.906 
H    -6.947    -2.171     0.201 
H    -4.633    -2.956     0.273 
H    -7.450     0.243    -0.104 
H    -5.591     1.878    -0.328 
H    -3.242     1.103    -0.238 
H     3.054    -2.474    -3.813 
H     3.132    -3.588    -2.421 
H     4.615    -2.799    -3.026 
H     5.641    -1.411     1.561 
H     5.235    -0.540     0.087 
H     4.858    -2.271     0.238 
H     2.949     0.683     2.829 
H     4.119     1.144     1.600 
H     4.611     0.130     2.959 
H     3.599    -0.069    -3.368 
H     5.018    -0.390    -2.354 
H     3.643     0.525    -1.706 
H     2.609     0.310    -0.105 
H     2.255    -1.962     2.950 
H     3.964    -2.345     3.034 
H     2.969    -3.050     1.752 
H    -0.401    -0.413     2.202 
H     1.254    -0.265     2.745 
H     0.826     1.930     3.786 
H     0.712     4.390     3.434 
H     2.183     3.881    -1.795 
H     1.070     3.957    -3.168 
H     1.254     2.444    -2.265 
H     0.388     5.293     1.182 
H     1.023     5.933    -0.850 
H    -0.736     5.935    -0.604 
H    -0.069     5.894    -2.236 
H     0.912    -1.055    -2.345 
H    -0.665    -0.254    -2.558 
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 H    -0.183    -3.136    -1.631 
C    -2.037    -2.622     0.977 
H    -2.746    -1.572    -2.344 
H    -2.642    -3.329    -1.805 
H     0.823    -1.777     0.844 
F    -2.145    -2.202     2.273 
F    -0.750    -3.051     0.801 
H    -2.701    -3.471     0.820 
 
                     1                      2                      3 
                     A                      A                      A 
 Frequencies --  -210.7181                20.4033                29.0915 
 Red. masses --     7.2786                 4.0317                 3.8205 
 Zero-point correction=                           0.683996 (Hartree/Particle) 
 Thermal correction to Energy=                    0.722096 
 Thermal correction to Enthalpy=                  0.723040 
 Thermal correction to Gibbs Free Energy=         0.615707 
 Sum of electronic and zero-point Energies=          -1727.464615 
 Sum of electronic and thermal Energies=             -1727.426515 
 Sum of electronic and thermal Enthalpies=           -1727.425571 
 Sum of electronic and thermal Free Energies=        -1727.532905 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000005     0.000450     YES 
 RMS     Force            0.000001     0.000300     YES 
 
Transition State Energy for Complex TS-2.12-(S) (Scheme 2.19): 
----------------------------------------- 
 Cartesian coordinates (Angstroms): 
----------------------------------------- 
H    -0.090     2.741     1.937 
H    -0.722     4.274     2.534 
C    -0.560     3.676     1.631 
H     0.131     4.229     0.986 
C     6.247    -0.172    -0.649 
C     5.073     0.373    -0.137 
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 C     6.238    -1.435    -1.244 
C     3.865    -0.343    -0.228 
C     5.044    -2.157    -1.331 
C     3.866    -1.618    -0.825 
C    -1.955    -4.145     2.970 
O    -0.668    -3.699     0.598 
N    -2.291    -3.051     2.055 
C    -1.614    -2.950     0.888 
C    -4.038    -3.370    -0.544 
C    -3.676    -1.499    -2.108 
C    -3.343    -2.163     2.543 
C    -2.930    -2.565    -1.272 
C    -1.999    -1.891    -0.174 
C    -2.168    -3.558    -2.175 
B     0.130    -0.400     0.437 
N    -0.635    -1.374    -0.635 
C    -0.546    -0.615    -1.940 
O    -0.581     0.835     0.517 
C    -1.089     0.789    -1.827 
C    -1.119     1.456    -0.594 
C    -1.566     1.430    -2.974 
C    -1.711     2.736    -0.453 
C    -1.910     3.425     0.917 
C    -2.079     2.716    -2.882 
C    -2.812     2.538     1.812 
C    -2.163     3.338    -1.635 
C    -2.607     4.794     0.772 
O     1.501    -0.389    -0.149 
C     0.341    -1.000     2.007 
C     1.386    -0.174     2.575 
C     2.590     0.208     0.296 
C     2.721    -0.408     2.313 
H     7.172     0.392    -0.581 
H     5.098     1.352     0.323 
H     7.157    -1.857    -1.639 
H     5.032    -3.138    -1.793 
H     2.941    -2.178    -0.892 
 
Page 521
 H    -1.510    -3.746     3.888 
H    -1.250    -4.815     2.485 
H    -2.866    -4.692     3.233 
H    -4.733    -3.757    -1.294 
H    -4.618    -2.745     0.141 
H    -3.644    -4.227     0.008 
H    -3.034    -0.877    -2.729 
H    -4.254    -0.831    -1.462 
H    -4.381    -2.003    -2.776 
H    -3.079    -1.812     3.546 
H    -4.296    -2.698     2.608 
H    -3.474    -1.294     1.904 
H    -2.524    -1.033     0.242 
H    -1.421    -3.085    -2.818 
H    -2.883    -4.055    -2.838 
H    -1.665    -4.325    -1.582 
H     0.516    -0.616    -2.196 
H    -1.064    -1.166    -2.718 
H    -1.531     0.917    -3.932 
H    -2.440     3.228    -3.768 
H    -3.795     2.397     1.352 
H    -2.963     3.020     2.784 
H    -2.365     1.557     1.985 
H    -2.605     4.324    -1.591 
H    -3.595     4.708     0.311 
H    -2.011     5.500     0.185 
H    -2.746     5.230     1.766 
H     0.629    -2.049     1.929 
H    -0.615    -0.882     2.519 
H     1.105     0.765     3.049 
C     2.454     1.735     0.460 
H     3.485     0.242     2.722 
H     3.036    -1.411     2.045 
H    -0.079    -2.236    -0.718 
F     3.344     2.239     1.366 
F     2.728     2.296    -0.751 
H     1.448     2.018     0.761 
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                     1                      2                      3 
                     A                      A                      A 
 Frequencies --  -258.6533                23.9815                31.5371 
 Red. masses --     8.4096                 5.0699                 4.5318 
 Zero-point correction=                           0.685041 (Hartree/Particle) 
 Thermal correction to Energy=                    0.722819 
 Thermal correction to Enthalpy=                  0.723764 
 Thermal correction to Gibbs Free Energy=         0.617517 
 Sum of electronic and zero-point Energies=          -1727.463668 
 Sum of electronic and thermal Energies=             -1727.425889 
 Sum of electronic and thermal Enthalpies=           -1727.424945 
 Sum of electronic and thermal Free Energies=        -1727.531191 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000007     0.000450     YES 
 RMS     Force            0.000001     0.000300     YES 
 
Transition State Energy for Complex TS-2.15-(S) (Scheme 2.22): 
----------------------------------------- 
 Cartesian coordinates (Angstroms): 
----------------------------------------- 
H    10.853    -1.832    -4.457 
H     9.770    -0.583    -5.111 
C     9.966    -1.227    -4.247 
H     9.111    -1.875    -4.073 
H    12.286    -0.154    -3.222 
H    11.303     1.076    -4.038 
C    11.377     0.452    -3.141 
N    10.200    -0.408    -3.054 
H    11.016    -2.193    -1.139 
H    12.133    -0.855    -0.795 
O     8.314    -1.213    -2.065 
C    11.388    -1.526    -0.358 
H    11.474     1.107    -2.279 
C     9.335    -0.510    -2.017 
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 H    11.905    -2.146     0.380 
H     8.741     1.898    -3.305 
H     7.337     0.768    -3.138 
H     8.793    -2.360     0.075 
C     7.707     1.781    -2.980 
C     9.589     0.244    -0.691 
C    10.251    -0.751     0.357 
H     9.791    -2.509     1.529 
C     9.254    -1.801     0.892 
H    10.241     1.108    -0.807 
C     6.825     2.799    -3.482 
H     5.030     1.663    -3.429 
H     7.244     3.777    -3.713 
H    10.572     3.950    -2.048 
C     5.447     2.665    -3.410 
H     7.573     0.015    -0.524 
H    11.428     5.452    -2.435 
H    11.673     0.730     1.124 
H    11.466    -0.693     2.147 
N     8.209     0.802    -0.347 
C    10.934     0.020     1.510 
H     4.805     3.451    -3.789 
B     7.701     2.053    -1.287 
H    11.949     4.471    -1.057 
C    11.073     4.817    -1.615 
H     8.452    -1.376     1.502 
O     8.534     3.180    -1.022 
O     6.281     2.091    -0.923 
H     8.405     5.340    -2.029 
H    10.252     0.576     2.151 
H     9.284     6.852    -2.287 
C     5.318     2.884    -1.369 
C     7.972     1.304     1.060 
H     8.320     0.563     1.773 
C    10.122     5.622    -0.696 
F     4.696     0.543     0.286 
C     8.930     3.514     0.256 
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 C     8.928     6.152    -1.523 
C     3.941     2.330    -1.122 
C     3.684     1.207    -0.308 
H    11.231     7.447    -1.040 
H     6.490     4.701    -1.409 
H     6.887     1.364     1.159 
C     8.639     2.635     1.312 
F     2.938     3.993    -2.493 
C     2.789     2.933    -1.664 
C     9.646     4.719     0.466 
C     2.403     0.737    -0.043 
C     5.492     4.373    -1.129 
H    11.798     6.567     0.379 
C    10.903     6.850    -0.184 
H     2.290    -0.124     0.604 
H     4.744     4.961    -1.655 
C     1.497     2.491    -1.433 
C     1.308     1.382    -0.610 
H     8.214     6.686    -0.887 
H     0.671     3.014    -1.900 
H     0.305     1.020    -0.414 
C     8.974     2.993     2.621 
C     9.950     5.033     1.797 
H     5.368     4.541    -0.053 
H    10.287     7.497     0.449 
H     8.739     2.318     3.440 
H    10.478     5.951     2.017 
C     9.607     4.203     2.867 
H     9.862     4.494     3.881 
 
                     1                      2                      3 
                     A                      A                      A 
 Frequencies --  -325.7913                18.1846                26.7096 
 Red. masses --     8.4849                 4.8842                 4.2975 
 Zero-point correction=                           0.682388 (Hartree/Particle) 
 Thermal correction to Energy=                    0.720796 
 Thermal correction to Enthalpy=                  0.721740 
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  Thermal correction to Gibbs Free Energy=         0.613919 
 Sum of electronic and zero-point Energies=          -1727.465578 
 Sum of electronic and thermal Energies=             -1727.427171 
 Sum of electronic and thermal Enthalpies=           -1727.426226 
 Sum of electronic and thermal Free Energies=        -1727.534047 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000005     0.000450     YES 
 RMS     Force            0.000001     0.000300     YES 
 
Transition State Energy for Complex TS-2.15-(R) (Scheme 2.22): 
----------------------------------------- 
 Cartesian coordinates (Angstroms): 
----------------------------------------- 
H    -3.055     2.969    -6.539 
H    -2.420     2.072    -5.142 
H    -4.102     1.809    -5.680 
C    -3.313     2.547    -5.561 
H    -8.241     4.273    -8.750 
H    -6.642     3.500    -7.022 
C    -7.701     4.989    -8.144 
C    -6.715     4.558    -7.272 
H    -7.603     5.979    -8.578 
H   -12.208     2.762    -8.732 
H    -2.293     4.987    -5.193 
F   -10.568     4.685    -8.939 
N    -3.772     3.604    -4.656 
H    -5.049     5.132    -6.070 
C   -11.664     2.958    -7.816 
O    -5.902     2.803    -4.718 
H    -1.943     4.069    -3.716 
C    -5.999     5.495    -6.455 
C   -10.751     3.998    -7.788 
C    -2.736     4.565    -4.284 
H    -5.869     6.466    -6.939 
H   -12.556     1.376    -6.662 
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 C   -11.845     2.194    -6.664 
C    -5.072     3.609    -4.269 
C    -9.979     4.351    -6.661 
H    -9.999     6.691    -8.288 
H    -4.137     2.293    -2.306 
C   -11.103     2.475    -5.520 
C    -9.053     5.539    -6.677 
H    -3.130     5.383    -3.687 
C   -10.195     3.524    -5.542 
H   -11.212     1.900    -4.608 
C    -9.595     6.825    -7.288 
B    -6.992     5.942    -5.130 
H    -6.670     2.138    -2.425 
H    -8.814     7.587    -7.293 
H    -7.404     4.143    -3.992 
O    -8.387     5.759    -5.554 
H    -3.353     3.785    -1.740 
C    -4.225     3.136    -1.617 
C    -5.581     4.613    -3.211 
F    -9.510     3.736    -4.392 
H    -4.545     8.348    -5.303 
N    -6.948     5.028    -3.743 
H    -3.900     9.935    -5.755 
H    -4.985     5.523    -3.160 
H    -6.884     9.122    -6.256 
H    -4.184     2.732    -0.602 
O    -6.587     7.268    -4.814 
H   -10.400     7.172    -6.629 
C    -6.695     2.876    -1.620 
C    -5.559     3.909    -1.781 
C    -4.406     9.374    -4.961 
H    -6.150    10.683    -6.662 
H    -6.563     2.348    -0.672 
C    -6.655    10.117    -5.872 
H    -3.744     9.362    -4.088 
H    -7.695     3.317    -1.596 
H    -8.854     5.711    -3.279 
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 C    -7.874     5.773    -2.804 
C    -6.844     7.914    -3.630 
C    -5.754    10.052    -4.614 
H    -7.598    10.625    -5.646 
C    -5.572     4.954    -0.642 
H    -4.725     5.641    -0.733 
H    -7.945     5.242    -1.860 
H    -4.937    12.012    -5.024 
C    -7.462     7.205    -2.591 
C    -6.465     9.270    -3.488 
H    -5.473     4.436     0.317 
H    -6.476     5.558    -0.590 
C    -5.443    11.504    -4.198 
H    -4.781    11.552    -3.328 
H    -6.352    12.072    -3.972 
C    -7.748     7.851    -1.385 
C    -6.775     9.872    -2.260 
H    -8.240     7.305    -0.584 
H    -6.513    10.910    -2.099 
C    -7.411     9.188    -1.223 
H    -7.632     9.700    -0.292 
 
                     1                      2                      3 
                     A                      A                      A 
 Frequencies --  -325.9512                19.3307                30.4146 
 Red. masses --     8.4156                 5.1917                 3.9396 
 Zero-point correction=                           0.682866 (Hartree/Particle) 
 Thermal correction to Energy=                    0.720969 
 Thermal correction to Enthalpy=                  0.721913 
 Thermal correction to Gibbs Free Energy=         0.615713 
 Sum of electronic and zero-point Energies=          -1727.456522 
 Sum of electronic and thermal Energies=             -1727.418419 
 Sum of electronic and thermal Enthalpies=           -1727.417475 
 Sum of electronic and thermal Free Energies=        -1727.523674 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000016     0.000450     YES 
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  RMS     Force            0.000002     0.000300     YES 
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 Chapter Three 
 
Enantioselective Additions of 
Organoboronates to Ketones and 
Alphaketoesters Promoted by an 
Aminophenol Containing Catalyst 
 
3.1 Introduction 
 As discussed in Section 1.1, the presence and absolute configuration of 
stereogenic centers have a substantial impact on the biological activity of organic 
molecules. Although not as copious as amines and amides, alcohols and/or ethers are 
found in a significant amount of compounds created by medicinal chemistry programs. 
Ethers are present in >35% and alcohols are present in ~10% of such molecules 
surveyed.1 A subclass of such oxygen-containing functionality is tertiary alcohols and 
ethers that posses a stereogenic center at the central carbon directly bound to the oxygen. 
Such moieties are present in the natural products fostriecin2 and salinosporamide A,3 both 
of which exhibit significant ability to destroy myriad cancer cell lines, as well as marine 
toxin pectenotoxin 1,4 which is part of a class of molecules implicated in shellfish 
                                                
(1) Roughley, S. D.; Jordan, A. M. J. Med. Chem. 2011, 54, 3451–3479. 
(2) Boger, D. L; Ichikawa, S.; Zhong, W. J. Am. Chem. Soc. 2001, 123, 4161–4167. 
(3) Feling, R. H.; Buchanan, G. O.; Mincer, T. J.; Kauffman, C. A.; Jensen, P. R.; Fenical, W. Angew. 
Chem. Int. Ed. 2003, 42, 355–357. 
(4) (a) Yasumoto, T.; Murata, M.; Oshima, Y.; Sano, M. Tetrahedron 1985, 41, 1019–1025. (b) Sasaki, K.; 
Wright, J. L. C.; Yasumoto, T. J. Org. Chem. 1998, 63, 2475–2480. 
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 toxicity (Scheme 3.1). The blockbuster antidepressant Lexapro is another example of this 
functionality in a compound of medical significance. The (S) enantiomer of Lexapro,  
 
illustrated in Scheme 3.1, is immensely more potent than the (R) enantiomer.5  
 As mentioned in Chapters 1 and 2, the allyl group is a useful handle for the 
installation of diverse functional groups and thus one way to achieve the synthesis of 
chiral tertiary alcohols/ethers is through the intermediacy of chiral tertiary homoallylic 
alcohols.6,7 Examples where such a strategy has been applied are the syntheses of 
acutumine,8 an alkaloid with anti-amnesiac properties and selective T-cell toxicity; a 
fragment of the macrolide spongistatin, a strong antitumor agent;9 Situro, the first new 
tuberculosis drug approved in almost 40 years;10 taurospongin A, an inhibitor of both  
                                                
(5) Hyttel, J.; Boegesoe, K. P.; Perregaard, J.; Sanchez, C.  J. Neural Transm.: Gen. Sect. 1992, 88, 157–
160 
(6) Yus, M.; González-Gómez, J. C.; Foubelo, F. Chem. Rev. 2013, 113, 5595–5698. 
(7) Yus, M.; González-Gómez, J. C.; Foubelo, F. Chem. Rev. 2011, 111, 7774–7854. 
(8) For the isolation, see: (a) Tomita, M. et al. Chem. Pharm. Bull. 1971, 19, 770–791. For the synthesis, 
see: (b) Li, F.; Tartakoff, S. S.; Castle, S. L J. Am. Chem. Soc. 2009, 131, 6674–6675. 
(9) Allais, F.; Cossy, J. Org. Lett. 2006, 8, 3655–3657. 
(10) Saga, Y.; Motoki, R.; Makino, S.; Shimizu, Y.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2010, 
132, 7905–7907. 
O
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Scheme 3.1  Biologically Active Molecules Containing an Tertiary Alcohol/Ether Stereogenic Center
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DNA polymerase and HIV reverse transcriptase,11 and cytotoxic orizaterpenyl benzoate12 
(Scheme 3.2). A common way to access such molecules, which all syntheses described 
above utilize, is by a stereoselective allyl-addition to a ketone. 
3.2 Background 
 Whereas there are a large array of methods for the stereoselective allyl-addition to 
aldehydes, methods applicable to ketones are far less prevalent.6,7, 13  Like the 
stereoselective allyl-addition to imines discussed in Section 1.2 of Chapter 1, the methods 
for stereoselective allyl-addition to ketones can be classified as either stoichiometric6 or 
catalytic.7  
 In stoichiometric methods for the stereoselective addition of an allyl-group to a 
ketone, the chiral compound that controls the stereochemical outcome of a transformation 
                                                
(11) For the isolation, see: (a) Ishiyama, H.; Ishibashi, M.; Ogawa, A.; Yoshida, S.; Kobayashi, J. J. Org. 
Chem. 1997, 62, 3831–3836. For the synthesis, see: (b) Wu, B.; Mallinger, A.; Robertson, J. Org. Lett. 
2010, 12, 2818–2821. 
(12) For the isolation, see: Chung, I. M.; Ali, M.; Hahn, S. J.; Siddiqui, N. A.; Lim, Y. H.; Ahmad, A. 
Chem. Nat. Comp. 2005, 41, 182–189. For the synthesis, see: (b) Tietze, L. F.; Biller, S.; Wolfram, T. 
Synlett, 2010, 14, 2130–2132. 
(13) Denmark, S. E.; Fu, J. Chem. Rev. 2003, 103, 2763–2793. 
Sirturo
tuberculosis medicine
Me OH
O
O
Ph
Me
OOAcO
N
H
HO3S
O
C16H33
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Me OH
Taurospongin A
inhibits HIV reverse transcriptase
N
Br
OMePh
Me2N
OH
R1
R2 OH
Scheme 3.2 Chiral Tertiary Alcohols in the Synthesis of Biologically Active Molecules
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 can have a few different forms. These forms include an in situ generated chiral auxillary 
(Scheme 3.3a)14 and a chiral acid that activates the ketone.15 However, the most common 
stoichiometric methods are those that use a chiral allyl-reagent as the nucleophile. These 
nucleophiles vary from allylsilane (which are only applicable to ketones containing a 2-
hydroxyphenyl ring), 16  allylborons, 17  allylzinc, 18  and allylindiums (Scheme 3.3b). 19 
 While a method from the Chong group involving a chiral allylboronate allows for 
the synthesis of a wide range of homoallylalcohols (both aryl- and alkyl-substituted) in 
high yields (≥80%) and selectivities (≥9:1 e.r),17b like all of the aforementioned methods, 
                                                
(14) (a) Tietze, L. F. et al. Chem. Eur. J. 2001, 7, 1304–1712. (b) Tietze, L. F.; Hölsken, S.; Adrio, J.; 
Kinzel, T.; Wegner, C. Synthesis 2004, 13, 2236–2239. (c) Tietze, L. F.; Kinzel, T.; Schmatz, S. Chem. 
Eur. J. 2009, 15, 1706–1712. (d) Tietze, L. F.; Kinzel, T.; Wolfram, T. Chem. Eur. J. 2009, 15, 6199–6210. 
(15) (a) Yasuda, M.; Kitahara, N.; Fujibayashi, T.; Baba, A. Chem. Lett. 1998, 27, 743–744. (b) 
Yanagisawa, A.; Nakamura, Y.; Arai, N. Tetrahedron: Asymmetry 2004, 15, 1909–1913. 
(16) Burns, N. Z.; Hackman, B. M.; Ng, P. Y.; Powelson, I. A.; Leighton, J. L. Angew. Chem. Int. Ed. 
2006, 45, 3811–3813. 
(17) For methods where the chiral allylboron is synthesized prior to the reaction, see: (a) Jadhav, P. K.; 
Bhat, K. S.; Perumal, T.; Brown, H. C. J. Org. Chem. 1986, 51, 432–439. (b) Wu, T. R.; Shen, L.; Chong, 
J. M. Org. Lett. 2004, 6, 2701–2704. (c) Canales, E.; Prasad, K. G.; Soderquist, J. A. J. Am. Chem. Soc. 
2005, 127, 11572–11573. (d) Boshra, R.; Doshi, A.; Jäkle, F. Angew. Chem. Int. Ed. 2008, 47, 1134–1137. 
For a method where the allylboron is generated in situ, see: (e) Hirayama, L. C.; Haddad, T. D.; Oliver, A. 
G.; Singaram, B. J. Org. Chem. 2012, 77, 4342–4353. 
(18) Nakamura, M.; Hirai, A.; Sogi, M.; Nakamura, E. J. Am. Chem. Soc. 1998, 120, 5846–5847. 
(19) (a) Loh, T.-P. Zhou, J.-R.; Li, X.-R. Tetrahedron Lett. 1999, 40, 9333–9336. (b) Thornqvist, V.; 
Manner, S.; Frejd, T. Tetrahedron: Asymmetry 2006, 17, 410–415. (c) Haddad, T. D.; Hirayama, L. C.; 
Taynton, P.; Singaram, B. Tetrahedron Lett. 2008, 49, 508–511. (d) Haddad, T. D.; Hirayama, L. C.; 
Singaram, B. J. Org. Chem. 2010, 75, 642–649. 
R
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Scheme 3.3 Representative Stoichiometric Methods
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 it requires a stoichiometric amount of the stereocontrolling element, as aspect that is 
unfavorable when compared to catalytic methods.20 
 In 1999, the Tagliavini group reported the first catalytic enantioselective 
allylation of ketones (Scheme 3.4). 21a They used a titanium-based Lewis acidic complex  
 
bearing a bidentate BINOL ligand to catalyze the addition of tetraallyltin to selection of 
ketones, albeit in a maximum of 83:17 e.r. The enantioselectivity of this transformation 
was subsequently improved by modifications of the ligand21b-d and reaction 
conditions,21e,f but these methods all still have the fundamental drawback of involving 
stoichiometric amounts of highly toxic organotin compounds.21 
 Allylsilanes are attractive to use as the source of the allyl group due to their low 
cost and low toxicity. The laboratory of H. Yamamoto has developed the only such 
method utilizing these nucleophiles in a catalytic enantioselective allylation of ketones 
(Scheme 3.5).22 Unlike the mostly sluggish methods for imine allylation that employ this  
                                                
(20) The fundamental advantages and disadvantages of catalytic methods and stoichiometric methods are 
discussed in greater detail in Section 1.2 of Chapter 2. 
(21) (a) Casolari, S.; D'Addario, D.; Tagliavini, E. Org. Lett. 1999, 1, 1061–1063 (b) Hanawa, H.; Kii, S.; 
Maruoka, K. Adv. Synth. Catal. 2001, 343, 57–60. (c) Kii, S.; Maruoka, K. Chirality, 2003, 15, 68–70. (d) 
Cunningham, A.; Woodward, S. Synlett, 2002, 43–44. (e) Waltz, K. M.; Gavenonis, J.; Walsh, P. J. Angew. 
Chem. Int. Ed. 2002, 41, 3697–3699. (f) Kim, J. G.; Waltz, K. M.; Garcia, I. F.; Kwiatkowski, D.; Walsh, 
P. J. J. Am. Chem. Soc. 2004, 126, 12580–12585. For a method that employs allylstannanes, but does not 
use a Ti-base catalyst, see: (g) Zhang, X.; Chen, D.; Liu, X.; Feng, X. J. Org. Chem. 2004, 72, 5227–5233. 
(22) Wadamoto, M.; Yamamoto, H. J. Am. Chem. Soc. 2005, 127, 14556–14557. 
Scheme 3.4 The First Catalytic, Enantioselective Allyl-Addition to Ketones
R
O
+ Sn
4
20 mol % (R)-BINOL,  
20 mol % Ti(Oi-Pr)2Cl2
CH2Cl2, RT,1–24 h
R=Aryl
R=cinnamyl
R=n-hexyl
75–87%, 72:28–83:17 e.r. 
83%, 75:25 e.r.
89%, 65:35 e.r.
1.5 equiv.
Me R
HO Me
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class of nucleophile,23 the transformation reported by Yamamoto is complete in 24 h at -
78 ºC. Promoted by 5 mol % of AgF and the ligand DIFLUOROPHOS,  this reaction 
affords aryl-substituted methyl homoallylalcohols, 1-cyclohexenyl-substituted methyl 
homoallylalcohols, and cyclic homoallylalcohols in 62 to 98% yields and 89:11 to 
97.5:2.5 enantiomeric ratios. A limitation in the scope is acyclic ketones bearing two 
alkyl substituents, the sole example of which is afforded in only 42% yield and an 
enantiomeric ratio of 82.5:17.5 (Scheme 3.5). Additionally, there are no examples of 
substrates bearing functionality that could disrupt the catalyst, such as heterocycles, 
amines, or thiols. Other flaws of the method include the requirement of very low 
temperatures to achieve selective transformations as well as the use of the ligand 
DIFLUOROPHOS which, while commercially available, is quite expensive ($464/mmol 
from Strem Chemicals).  
 A different strategy employed in the enantioselective allyl-addition to ketones is 
to use allylchromiums as the nucleophile. These allylmetals are generated in situ from a 
catalytic amount of chromium and a stoichiometric amount of an allylhalide using 
                                                
(23) See Section 1.2 of Chapter 1 for a discussion. 
5 mol % (R)-DIFLUORPHOS,
5 mol % AgF
thf, -78 ºC, 24 h
+
Si(OMe)3
2.0 equiv.
1.0 equiv. MeOH
PPh2
PPh2
O
O
O
O
F
F
F
F
R
O
Me R
Me OH
(R)-DIFLUOROPHOS
R=Aryl 62–98%, 89:11–97.5:2.5 e.r.
R=Hydrocinnamyl
R=1-Cyclohexenyl
42%, 82.5:17.5 e.r.
56%, 97.5:2.5 e.r.
I
OH
I
OH OH
n=1–3
OH
Ph
63–89%, 95.5:4.5–96.5:3.5 e.r. 96%, 92:8 e.r.92%, 98:2 e.r. 92%, 97:3 e.r.
Scheme 3.5 Silver-Catalyzed Enantioselective Addition of Trimethoxyallylsilane to Ketones
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 Fürstner's modification of the original Nozaki-Hiyama conditions.24 It is advantageous to 
utilize allylhalides as the origin of the allyl functionality, since most other common 
allylic nucleophiles (e.g. allylstannanes, allylsilanes, allylboronates) are synthesized from 
allylhalides. However, the chromium salts used are toxic, both acutely in humans and 
chronically in the environment, which keeps this class of protocols from having a wide 
application.24   M. S. Sigman reported the best of such methods in 2007 (Scheme 3.6).25 
In that report, 10 mol % of an easily accessible amino acid-derived ligand controls the 
 
enantioselectivity of the transformation, which occurs in 24 hours at a mild 0 ºC. Four 
equivalents of TMSCl and 20 mol % of Et3N are needed to facilitate release of the 
chromium-ligand complex from the product. The substrate scope of this method is very 
similar to the one by H. Yamamoto discussed earlier,22 but it is notable that Sigman's 
method tolerates aryl-substituted ketones bearing n-alkyl groups larger than methyl, 
affording these products in 90–93% yield and 95:5 to 96.5:3.5 e.r. (Scheme 3.6). 
 Allylboronates, as mentioned in Section 1.2 of Chapter 1, are useful allyl 
nucleophiles. Although they react readily with aldehydes, the uncatalyzed addition of 
allylboronates to ketones is slow. Unique among catalytic, enantioselective allyl-
                                                
(24) Fürstner, A. Chem. Rev. 1999, 99, 991–1045. 
(25) (a) Miller, J. J.; Sigman, M. S. J. Am. Chem. Soc. 2007, 129, 2752–2753. For another method 
employing allylchromium, see: (b) Huang, X.-R.; Chen, C.; Lee, G.-H.; Peng, S.-M. Adv. Synth. Catal. 
2009, 351, 3089–3095. 
Scheme 3.6 Chromium-Catalyzed Enantioselective Addition of Allyl Bromide to Ketones
R1
O
+ Br
10 mol % Ligand,  
10 mol % CrCl3, 2.0 equiv. Mn(0),
20 mol % Et3N, 4 equiv. TMSCl,
thf, 0 ºC, 24 h
R1=Aryl, R2=Me 63–95%, 93:7–96:4 e.r.
2 equiv.
R2 R1
R2 OH
R1=Aryl, R2=n-Alkyl
R1=Alkyl, R2=Me
90–93%, 95:5–96.5:3.5 e.r.
75–93%, 58:42–66.5:33.5 e.r.
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 additions to ketones since it does not require the use of a metal, the chiral diol catalyst 
developed in the laboratory of S. E. Schaus is one of the most effective methods for the 
enantioselective synthesis of tertiary homoallylic alcohols (Scheme 3.7).26 An improved  
 
version of an earlier report,26b this method uses only 2 mol % of an easily accessed chiral 
diol to catalyze the addition of allylboronate 3.1 (Scheme 3.7) to ketones in a manner that 
is exceptionally enantioselective (≥98:2 e.r. in all cases) and high yielding (≥88% yield in 
all cases). Based on mechanistic studies,26a the authors propose the t-BuOH solvent (1.0 
equiv; the reaction is essentially neat) expedites the regeneration of the active catalyt. 
Such a role is critical for the significantly higher levels of activity of the catalyst in this 
method versus the original (15 mol % for 36 hours in the original report).26b  Notably, this 
method is applicable to 2- and 3-acetyl thiophene, but no other ketones containing basic 
functionality (e.g. pyridine) (or acidic functionality , e.g. phenol) were examined. Also, 
there are no examples of ketones that do not have at least one sp2-hybridized substituent.  
Such ketones tend to be difficult substrates in terms of both reactivity and selectivity (See 
Scheme 3.4 through 3.6). Other than the somewhat limited substrate scope, a drawback of 
this method is that it requires the commercially unavailable allylboronate 3.1 (Scheme 
                                                
(26) (a) Barnett, D. S.; Moquist, P. N.; Schaus, S. E. Angew. Chem. Int. Ed. 2009, 48, 8679–8682. For the 
original report, see: (b) Lou, S.; Moquist, P. N.; Schaus, S. E. J. Am. Chem. Soc. 2006, 128, 12660–12661. 
For a related method, see: (c) Zhang, Y. et al. Org. Lett. 2013, 15, 1710–1713. 
Diol
Scheme 3.7 Enantioselective Addition of Allylboronates to Ketones Catalyzed by a Chiral Diol
OH
OH
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O
R2 R1
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+
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88–95%, 98:2–99:1 e.r.
92–93%, 99:1–>99:1 e.r.
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 3.7). It is true that this reagent is more stable than the allyldiisopropoxyborane used in the 
initial report, but it is still less stable than allylboronic acid pinacol ester.27 
 Another landmark enantioselective allyl-addition to ketones, this time utilizing 
commercially available allylB(pin) 3.2,28  was achieved by the Shibasaki group by way of 
the catalytic generation of an allylcopper29 complex (Scheme 3.8).30  The modular  
 
enantiopure bisphosphine ligand is accessed in ~60% yield over three easy steps (Scheme 
3.9). The substrate scope of this method is very similar to the previously discussed 
method by Schaus, with the noteworthy exception of the allyl-addition to methyl iso-
butyl ketone proceeding in 88% yield and 91.5:8.5 e.r. While inferior to the results  
                                                
(27) (a) Boronic Acids: Preparation and Applications in Organic Synthesis, Medicine and Materials, 2nd 
Edition; Hall, D. G. Ed.; Wiley-VCH: Weinheim, Germany, 2011. (b) Roy, C. D.; Brown, H. C. 
Monatshefte für Chemie, 2007, 138, 879–887. 
(28) A catalytic enantioselective allyl-addition to ketones using this allyl nucleophile and an indium-based 
catalyst has been reported. The only example in the paper occurs to afford the product in 76:24 e.r. See: 
Schneider, U.; Ueno, M.; Kobayashi, S. J. Am. Chem. Soc. 2008, 130, 13824–13825. 
(29) Enantioselective methods involving more functionalized allylcopper species, generated catalytically 
from allenes and allylic nitriles, have been reported. For methods starting with an allene, see: a) Meng, F.; 
Jang, H.; Jung, B.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2013, 52, 5046–5051. (b) Kawai, J.; Chikkade, 
P. K.; Shimizu, Y.; Kanai, M. Angew. Chem. Int. Ed. 2013, 52, 7177–7180. For methods starting with an 
allylic nitrile, see: (c) Yazaki, R.; Kumagai, N.; Shibasaki, M. J. Am. Chem. Soc. 2009, 131, 3195–3197. d) 
Yazaki, R.; Kumagai, N.; Shibasaki, M. J. Am. Chem. Soc. 2010, 132, 5522–5531. 
(30) (a) Yazaki, R.; Kumagai, N.; Shibasaki, M. J. Am. Chem. Soc. 2010, 132, 5522–5523. For related 
previous methods, see: (b) Wada, R.; Oisaki, K.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2004, 126, 
8910–8911. (c) Kanai, M.; Wada, R.; Shibuguchi, T.; Shibasaki, M. Pure Appl. Chem. 2008, 80, 1055–
1062. 
Scheme 3.8 Copper-Catalyzed Addition of Allylboronates to Ketones
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obtained with other substrates, it is one of the best results in the literature for a ketone 
bearing two alkyl-substituents. As with all methods, there are some deficiencies.  In 
addition to the somewhat limited substrate scope, the reaction requires –75 ºC to achieve 
high levels of enantioselectivity and an oxygen sensitive Cu(I) salt. Moreover, the 
synthesis of 3.3, while efficient, does require some expensive components, such as the 
two equivalents of phosphinous chloride 3.9 ($16.5/mmol) as well as a source of chirality 
where one of the enantiomers is far more expensive than the other ($18.0/mmol versus 
$3.8/mmol). Concerns over the practicality of 3.3 are partially eased by the low catalyst 
loadings reported.  
3.3 Enantioselective Additions to Ketones Achieved through 
Modifications to the Structure of the Aminophenol Catalyst 
MeO Br
HO CHO
Br
Br
+
3.4, $3.86/mmol, Aldrich
3.5, $0.21/mmol, Aldrich
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BrMeO
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O
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CHO
HO OH
NH2
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 $18/mmol, Aldrich
3.7, $3.8/mmol, Aldrich
AcOH, ClCH2CH2Cl, 4Å MS
3.8
3.6
85.8% yield, two steps
PAr2MeO
O
O
MeO PAr2
N
O
O
Ph
Ar = p-F-C6H4
3.3, 70% yield
n-BuLi, thf;
P
Cl
F F
3.9, $16.5/mmol, Alfa Aesar
Scheme 3.9 Synthesis of Ligand 3.3
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  As previously discussed in Chapters 1 and 2, we have proposed two-point binding 
of the substrate to the catalyst, such as with isatin 3.10 to be important in obtaining 
products in high levels of enantiomeric enrichment (Scheme 3.10a). Substrates that only  
 
possess one point of binding, such as acetophenone 3.12a, undergo allyl-addition in 
lower levels of enantioselectivity (Scheme 3.10b). The value of tertiary homoallylic 
alcohols led us to consider ways in which the catalyst could be modified to afford 
products, such as 3.13a, in higher enantiomeric ratios. We hypothesized that a major 
source of the minor enantiomer of 3.13a came from acetophenone binding to the catalyst 
in such a way that the phenyl group is axial in the transitions state, rather than equatorial 
(TS-2.2, Scheme 3.10). Supporting this hypothesis, the steric difference between the 
substituents on the ketone plays a major role in enantioselectivity, with substrates bearing 
N
O
B
O
Me2N O
O
H
t-Bu
N
N
OH
O
98:2 e.r.
Two point binding leads to
high enantioselectivity
‡
N
O
B
O
Me2N
H
‡t-Bu
O Ph
Me
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Me
One point binding leads to
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70:30 e.r.
N
O
O  allylB(pin),
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O
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Scheme 3.10 Enantioselectivity Models for Allyl-Additions to Ketones
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 similarly sized groups undergoing less enantioselective additions (Equation 1) and 
substrates bearing more disparately sized groups undergoing more enantioselective 
additions (Equation 2). 
 
 
 We reasoned that by increasing the size of the group ortho to the phenol in the 
catalyst, we could favor the conformer where the smaller methyl group of acetophenone 
is axial versus the one where the large phenyl group is axial (Figure 3.1). Based on this 
rationale, Dr. Daniel Robbins synthesized and screened a variety of modified 
aminophenols (Scheme 3.11).  
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  Changing the size of the group ortho to the phenol in the aminophenol by  
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 installing a variety of sterically modified aryl groups resulted in the increase of the 
enantioselectivity to a maximum of 81:19 e.r. with aminophenol 3.14h (Scheme 3.11). 
Due to synthetic difficulties, installation of aryl rings larger than this was problematic. 
 I hypothesized that a silane ortho to the phenol of the catalyst should be large 
enough to a interact with the ketone (Figure 3.2), due in part to the C-Si bond length 
being significantly longer than a C-C bond (1.85 Å versus 1.54 Å). I synthesized 3.14j 
and 3.14k, and when Dr. Robbins tried them in the reaction, he discovered that 
triphenylsilyl-containing aminophenol 3.14k afforded the desired product in 86:14 e.r.,  
 
the highest selectivity observed so far (Scheme 3.11). Cooling the reaction led to an 
increase in the enantioselectivity to 93:7 e.r., but at the cost of reduced reactivity. 
Hypothesizing that a more Lewis basic amide on the aminophenol could lead to a more 
efficient transformation, aminophenol 3.14l was tried and it resulted in a reaction that 
reached full conversion and proceeded with 95:5 enantioselectivity. Aminophenol 3.14m, 
derived from tert-leucine, did not behave significantly different than 3.14l, so Dr. 
Robbins took the latter to be the optimal aminophenol. Intitially examined to solubilize 
more polar ketones, he also found that changing the solvent mixture to 3:1 toluene:thf 
affords a more enantioselective  transformation, affording 3.14a in 98:2 e.r.  
 Under these optimized conditions, the reaction proceeds to full conversion in 
eight hours. With these conditions, he examined the substrate scope of the reaction 
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 (Scheme 3.12). Now, propiophenone 3.12b undergoes catalytic allyl-addition to afford 
homoallyl alchohol 3.13b in 94:6 e.r. (up from 62.5:37.5 e.r. in Equation 1) and naphthyl-  
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 substituted 3.13c is afforded in >99:1 e.r. (up from 94:6 e.r. in Equation 2). A wide 
variety of other substituted ketones, including as those bearing phenyl groups with ortho-, 
meta-, and para-substituents (e.g. 3.12e to 3.12f); those bearing heterocycles (3.12o and 
3.12p), alkynyl (3.12q), and alkenyl (3.12r) groups; and cyclic ketones (3.12x) react 
under these conditions to give the desired products in high yields and enantiomeric 
enrichment (Scheme 3.12).  Compared with the catalytic methods discussed and cited in 
Section 3.2, one important advantage of this method is that we show it can tolerate 
functional groups no other method has been reported to, to produce products containing 
heterocycles (3.13p), aryl-substituted esters (3.13d), carbamates (3.13i), unprotected 
anilines (3.13j), unprotected phenols (3.13k), and alkynes (3.12q). This is in addition to 
potentially reactive functionality other methods can tolerate, yielding ethers (3.13h and 
3.13i), aryl bromides (3.12e to 3.12g), aryl fluorides (3.13n), vinyl iodides (3.13x), 
sulfur-containing heterocycles (3.13o and 3.13p), and alkyl halides (3.13s and 3.13t). 
One disadvantage of this method compared with some others is that alkyl groups larger 
than ethyl do result in a diminishment in enantioselectivity (3.13s and 3.13t).25a,26a 
Unfortunately, this protocol does not fair better than other methods with ketones bearing 
two alkyl substituents, as 3.13u and 3.13v  are formed in 85.5:14.5 and 80:20 e.r. 
respectively. Reactivity of these substrates can also be problematic, with 3.12v requiring 
a reaction temperature of -15 ºC to reach full conversion. Addition to benzophenone 
derivative 3.12w proceeds with a modest selectivity of 73:27 e.r.,31 but this is a notable 
level of selectivity for additions to this difficult class of substrates.32 
                                                
(31) The absolute stereochemistry of 3.13w has not been established, but we believe it is likely that the 
para-trifluoromethyl-containing side acts as the large group. 
(32) For a rare example of an enantioselective addition of a carbon nucleophile to benzophenones, see: 
Kohn, B. L.; Ichiishi, N.; Jarvo, E. R. Angew. Chem. Int. Ed. 2013, 52, 4414–4417. 
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  To increase the reaction scope, 2-substituted allylboronates were examined 
(Scheme 3.13).26c These transformations are slower than with allylB(pin) 3.2, and are  
 
generally less enantioselective (cf. 3.16b with 3.13q and 3.16c with 3.13r) and the yields 
are also lower. Those with 2-phenyl boronate 3.15b proceed with little to no selectivity.  
2-Chloroallylboronate (not shown) does not react under these conditions, even at 23 ºC. 
Having examined a variety of general ketones, we next turned our attention to a more 
specific class of substrates, α-ketoesters. 
3.4 Catalytic Enantioselective Allyl- and Allenyl-Additions to α-
Ketoesters.   
 The chiral α-hydroxy ester/acid motif is present in a variety of biologically active 
compounds such as the antiviral compound harringtonine (Scheme 3.14)33 and its many 
structurally related natural products, namely homoharringtonine, 
                                                
(33) Kaur, P.; Thiruchelvan, M.; Lee, R. C. H.; Chen, H.; Chen, K. C.; Ng, M. L.; Chu, J. J. H. Antimicrob. 
Agents Chemother. 2013, 57, 155–167.  
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 homodeoxyharringtonine, and anhydroharringtonine, all of which possess anticancer 
activity.34 
 
 Additional compounds of interest containing this moiety are the anti-HIV fukiic 
acid,35 neurotoxic alkaloid dysiherbaine,36 and the antifugal viridofungin family (Scheme 
3.14).37 One way to access flexible building blocks to this chemical structure is by 
carrying out an enantioselective allyl- or allenyl-addition to α-ketoesters. This class of 
homoallylic alcohols has been employed in the synthesis of a variety of the harringtonine 
derivatives34 as well as synthetic studies toward dysiherbaine.36b 
                                                
(34) Eckelbarger, J. D.; Wilmot, J. T.; Epperson, M. T.; Thakur, C. S.; Shum, D.; Antczak, C.; Tarassishin, 
L.; Djaballah, H.; Gin, D. Y. Chem. Eur. J. 2008, 14, 4293–4306. 
(35) Queffélec, C.; Bailly, F.; Mbemba, G.; Mouscadet, J.-F.; Debyser, Z.; Witvrouw, M..; Cotelle, P. Eur. 
J. Med. Chem. 2008, 43, 2268–2271. 
(36) For the isolation, see: (a) Sakai, R.; Kamiya, H.; Murata, M.; Shimamoto, K. J. Am. Chem. Soc. 1997, 
119, 4112–4116. For an effort towards the synthesis of this molecule that employs a stereoselective allyl-
addition to an α-ketoester , see: (b) Huang, J.-M.; Xu, K.-C.; Loh, T.-P. Synthesis 2003, 5, 755–764. 
(37) Goldup, S. M.; Pilkington, C. J.; White, A. J. P.; Burton, A.; Barrett, A. G. M. J. Org. Chem. 2006, 71, 
6185–6191. 
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  To the best of our knowledge, only two catalytic enantioselective allyl-additions 
to α-ketoesters exist. The first requires 10 mol % catalyst loading of the costly and 
precious In(OTf)3 ($4.9/mmol, Strem)  as well as stoichiometric organotin (Scheme 
3.15).38 The second, while promoted by 6 mol % an easily accessible diamine ligand 
 
and 5 mol% of a commercially available zinc salt, the reaction takes 36 hours and has 
very little reported in terms of substrate scope (Scheme 3.16).39 Additionally Zn(HMDS)2 
is quite expensive ($54/mmol from Aldrich). The only catalytic, enantioselective method 
 
to access the products of allenyl-addition to α-ketoesters  is through a rhodium catalyzed 
reaction between propargyl alcohols and α-diazoesters that is proposed to take place 
through a oxonium ylide formation followed by a [2,3]-sigmatropic rearrangement.40 
                                                
(38) Zheng, K.; Qin, B.; Liu, X.; Feng, X. J. Org. Chem. 2007, 27, 8478–8483. 
(39) (a) Cui, Y.; Yamashita, Y.; Kobayashi, S. Chem. Commun. 2012, 48, 10319–10321. (b) Cui, Y.; Li, 
W.; Sato, T.; Yamashita, Y.; Kobayashi, S. Adv. Synth. Catal. 2013, 355, 1193–1205. 
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  In addition to the synthetic benefits inherent in developing an efficient and 
selective method to add allyl and allenyl groups to α-ketoesters, we also wished to use 
these substrates to learn more about our previously reported enantioselective additions of 
boronates promoted by an aminophenol.41 We were curious whether the ester carbonyl of 
an α-ketoester would have a sufficiently strong interaction with the proton present on the 
ammonium ion of the proposed catalyst to engender high levels of stereoselectivity (syn-
I, Figure 3.3).  The α-ketoester should not have as strong a secondary interaction with the  
 
catalyst as the previously reported isatins (cyclic α-ketoamides) for two main reasons: 1) 
The ester carbonyl in the α-ketoesters is not as strong of a hydrogen bond acceptor as the 
amide carbonyl of the isatins 2) The isatins are conformationally-locked such that the 
amide carbonyl is well situated to favorably interact with the catalyst, whereas the ester 
in the α-ketoesters is free to rotate into a variety of conformations where it is not 
favorable to interact with the N-H of the catalyst (Figure 3.3).42 Carrying out the allyl-
addition to α-ketoester 3.18a under conditions similar to those developed for the addition 
                                                                                                                                            
(40) Li, Z.; Boyarskikh, V.; Hansen, J. H.; Autsback, J.; Musaev, D. G.; Davies, H. M. L. J. Am. Chem. 
Soc. 2012, 134, 15497–15504. 
(41) Silverio, D. L.; Torker, S.; Pilyugina, T.; Vieira, E. M.; Snapper, M. L.; Haeffner, F.; Hoveyda, A. H. 
Nature 2013, 494, 216–221. 
(42) Calculations utilizing DFT show ketoester 3.18a prefers an anti-conformation to a syn-by 3.5 
kcal/mol. 
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 to isatins results in a clean transformation (>98% yield of alcohol 3.19a) that is 
promisingly enantioselective (82:18 e.r., see Equation 3). 
 
Modifying the amount of NaOt-Bu added (from 1.25 to 20 mol %) does not effect the 
reaction in either a positive or negative way. Decreasing the reaction temperature does 
not result in a noticeable increase in the enantioselectivity of the transformation, 
suggesting that unlike the reaction with ketones (and similar to the reaction with 
trifluoroacetophenones and aldimines), the stereochemistry is likely determined by 
entropy rather than enthalpy.  
 We next screened a variety of aminophenols for the catalytic enantioselective 
allyl- and allenyl-additions to α-ketoester 3.18a (Scheme 3.17). In all previous studies 
utilizing the aminophenol ligands, we have seen that transforming the t-Bu group ortho to 
the phenol into a triphenylsilyl group either does not affect the enantioselectivity of the 
transformation, or it improves the enantioselectivity (See Scheme 3.11 in Section 3.3, 
Scheme 2.12 in Section 2.4, and Scheme 2.10 in Section 2.3). Interestingly, both 
additions to substrate 3.18a proceed in lower levels of selectivity when SiPh3 containing 
aminophenol 3.14k is employed (Scheme 3.17).  With these four data points in hand, we 
investigated whether decreasing the size of the group ortho to the phenol would be 
beneficial and found a large increase in the enantiomeric ratio of the products when a 
methyl group (3.14n) or a hydrogen (3.14e) are used instead of a t-Bu group.  This is the 
(3)
1.5 equiv. allylB(pin) 3.2, 2.5 equiv. MeOH
toluene, 4 h, 22 ºC
O
N
H
NMe2
OH
i-Pr
O
t-Bu 2.5 mol % NaOt-Bu
OH
>98% conv.,
 >98% yield, 82:18 e.r.
2.5 mol %
O
MeO
O
MeO3.14a
3.18a 3.19a
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 first time we have observed aminophenol 3.14n or 3.14e to be more selective than 3.14a 
in any transformation, and it is especially remarkable that the increase from ~4:1 to ~9:1  
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>98:2 α:γ
>98% conv., 92:8 e.r.
>98% conv., 88:12 e.r.,
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>98% conv., 91.5:8.5 e.r.,
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Scheme 3.17 Screening of Aminophenols
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 e.r. is energetically significant (~0.4 kcal). Thinking that perhaps there is an optimum 
sized aminophenol between tert-butyl-substituted 3.14a and methyl-substituted 3.14n,  
allyl-substituted 3.14o was examined, but it is slightly worse than 3.14n in terms of 
selectivity.  
 We theorized that perhaps by increasing the polarity of the solvent, the syn-
conformation of the substrate needed for two point binding (Figure 3.3) could be favored, 
but increasing solvent polarity (versus pure toluene) resulted in a much less efficient and 
enantioselective reaction (Table 3.1).43 
 
 Since the sterics around the phenol moiety have a profound effect on 
enantioselectivity, we doubt that the structures in Figure 3.3 play a major role in 
determining enantioselectivity because the moiety should have little impact in those 
cases. Instead, we believe that the structures in Figure 3.4 are more important and that the 
major enantiomer is obtained ([R]-III, Figure 3.4) due to electronic repulsion disfavoring 
                                                
(43) This is almost universally the case with reactions promoted by the aminophenol, likely due to 
increasing the solvent polarity decreasing the importance of electrostatic interactions and H-bonding. For 
example, performing the allyl-additions to diphenylphosphinoyl aldimines (Chapter 1) in CH2Cl2 rather 
than toluene (3 mol % of aminophenol 3.14a, 2.5 mol % NaOt-Bu, 75 minutes) results in 78% conv. and 
91:9 e.r. In toluene, this reaction is >98% conversion and 96.5:3.5 e.r. Why the ketone allyl-addition 
(section 3.3) is improved by adding tetrahydrofuran as a co-solvent is not fully understood. 
entry e.r.b
87:13
3
2
1 84:161:1 thf:toluene 79
69
1:1 CH2Cl2:toluene 73 88:12
1:3 thf:toluene
solvent conv. (%)a
4 1:3 CH2Cl2:toluene 58 86:14
1.5 equiv. 3.2, 
2.5 equiv. MeOH
 4 h, 22 ºC
2.5 mol % 3.14y,
2.5 mol % NaOt-Bu
OH
O
MeO
3.19a
O
O
MeO
3.18a
aConversion of starting material to product as 
determined by 400 MHz 1H analysis of the 
unpurified reaction mixture. bDetermined by 
HPLC analysis.
Table 3.1 Solvent Screen
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 (S)-III (Figure 3.4). To perhaps increase this electronic repulsion, we examined p-
methoxycontaining 3.14p, but this aminophenol also did not lead to a more  
 
enantioselective transformation. Next electron poor 3.14q was tried. Based on previous 
results regarding the lack of efficiency of aminophenols which contain an acidic phenol 
(for example, see 1.30e in Scheme 1.28 in Section 1.5 of Chapter 1), we were not 
surprised that the formation of homoallylalcohol 3.19a proceeded in <5% conversion, but 
we were astonished that the allenyl addition went to full conversion. The marked 
difference between the efficiency of the allyl- and alleny-additions when promoted by 
3.14q warrants further study and perhaps will shed light on the mechanism for formation 
of the active catalyst. Continued structural modifications of the aminophenol were carried 
out this time focusing on the C terminus. 
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  We first tried reactions with bis-amino acid containing aminophenol 3.14r which 
affords homoallylalcohol 3.19a less efficiently and in lower selectivity than the reaction 
with 3.14n.  Conversely, it affords the homoallenylalcohol 3.21a in the highest level of 
enantioselectivity so far which again highlights the difference between allyl- and allenyl-
additions.  Employing syn-3.14r, the diastereomer of 3.14r, leads to essentially the same 
reaction.  We thought that the difference in between reactions promoted by aminophenols 
3.14e versus 3.14r could be the fact that the former aminophenol contains a tertiary 
amide while the latter aminophenol contains secondary amides.  To probe this, we tried 
aminophenol 3.14t in the transformations and discovered that this is unlikely to be the 
case since the reactivity and enantioselectivity for allyl-addition was restored while the 
allenyl-addition enantioselectivity dropped noticeably.  Thinking that the second amino 
acid in 3.14r was simply acting as a sterically large group, we synthesized and studied 
reactions promoted by 3.14s–3.14w.  Interestingly, none of these precatalysts are better 
than 3.14r for the allenyl-addition, but 3.14u and 3.14w are among the most 
enantioselective for the allyl-addition.  This renders the interesting reactivity and 
selectivity caused by the second amino acid of 3.14r poorly understood at this time.   
  Next, we carried out some modifications of the amino acid in the aminophenol 
(Scheme 3.17).  Switching from valine to isoleucine (3.14x) led to a catalyst that was 
more enantioselective for allylation, but less selective for allenylation.  Moving to a tert-
leucine containing catalyst 3.14y led to increased enantioselectivities for both 
transformations. 
 Moving forward with aminophenols 3.14u and 3.14r for allyl and allenyl 
additions respectively, we carried out a short probe of the substrate scope of these 
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 transformations.  Compared with the model methyl benzoylformate 3.18a, the electron 
withdrawing para-Cl substrate behaves very similarly (Scheme 3.18 and 3.19). The  
 
 
unprotected 3-indolyl substrate 3.18c is slow to react, but this is in large part due to its 
low solubility.  In the case of the allene-addition to this substrate to form 3.21c (Scheme 
3.19), only 33% conversion is observed even after 24 hours.  This stems from the fact 
that the product is even less soluble than the starting material, and it may be that the 
methanol in the reaction is being occupied, solvating either the starting material or 
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 product, and therefore cannot enter the catalytic cycle. When protected with a Boc group, 
the allyl-addition seems to be slowed down, but the allenyl-addition is much faster.  As 
seen before with the trifluoromethylketones, the enantioselectivity of the allylation is 
more sensitive to sterics than that of the allenylation. 
3.5 Conclusions 
 By employing two aminophenols with opposite steric sizes, the enantioselective 
addition of an allyl unit to a ketone and an allyl or allenyl unit to an α-ketoester can be 
promoted. These transformations occur efficiently and tolerate a wide variety of 
functional groups. The ease of accessibility of the aminophenols coupled with the low 
catalyst loadings needed contribute to the attractiveness of this method.  
3.6 Experimental Section 
 ■  General. Infrared (IR) spectra were recorded on a Bruker alpha 
spectrophotometer, λmax in cm-1.  Bands are characterized as broad (br), strong (s), 
medium (m), and weak (w).  1H NMR spectra were recorded on a Varian Unity INOVA 
400 (400 MHz) or 500 (500 MHz) spectrometer.  Chemical shifts are reported in ppm 
from tetramethylsilane with the solvent resonance as the internal standard (CDCl3: δ 7.26 
ppm).  Data are reported as follows: chemical shift, integration, multiplicity (s = singlet, 
d = doublet, dd = doublet of doublets, t = triplet, q = quartet, br = broad, m = multiplet), 
and coupling constants (Hz).  Well resolved AB splitting patterns are reported as follows: 
chemical shift of A and chemical shift of B, integration, multiplicity (ABq = AB quartet), 
and coupling constants (Hz). 13C NMR spectra were recorded on a Varian Unity INOVA 
400 (100 MHz) spectrometer with complete proton decoupling.  Chemical shifts are 
reported in ppm from tetramethylsilane with the solvent resonance as the internal 
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 standard (CDCl3: δ 77.16 ppm). Data are reported as follows: chemical shift, multiplicity 
(singlet unless otherwise noted), and coupling constants (Hz). 19F NMR spectra were 
recorded on a Varian Unity INOVA 400 (376 MHz).  Chemical shifts are reported in ppm 
with BF3OEt2 as an external standard (BF3OEt2: δ 0.00 ppm).  Data are reported as 
follows: chemical shift, integration, multiplicity, and coupling constants (Hz).  High-
resolution mass spectrometry was performed on a JEOL AccuTOF-DART (positive 
mode) or an Advion Expression CMS (ESI+ or ESI-) at the Mass Spectrometry Facility, 
Boston College. Enantiomer ratios (e.r.) values were determined by HPLC analysis using 
a Shimadzu LC-2010AHT chromatograph (Chiral Technologies Chiralcel OD-H (4.6 x 
250 mm), Chiral Technologies Chiralcel OJ-H (4.6 x 250 mm), Chiral Technologies 
Chiralpak AD-H (4.6 x 250 mm), Chiralpak AS-H (4.6 x 250 mm), or GLPC (gas-liquid 
partition chromatography) with an Agilent chromatograph (Alltech Associated Chiraldex 
CD-BDM column (30 m x 0.25 mm) or a Hewlett Packard 5890 Series II chromatograph 
(Alltech Associated Betadex 120 column (30 m x 0.25 m). Specific rotations were 
measured using either an Atago AP-300 Automated Polarimeter or a Rudolph Research 
Analytical Autopol IV Polarimeter. Melting points were determined using a Thomas 
Hoover Uni-melt capillary melting point apparatus. Unless otherwise noted, reactions 
were carried out under an atmosphere of dry N2 in oven-dried (135 ºC) glassware with the 
appropriate oven-dried (65 ºC) septa. 
■  Solvents: Unless otherwise noted, solvents were purged with Ar and purified under a 
positive pressure of dry Ar by a modified Innovative Technologies purification system.  
Toluene (Fisher, ACS Grade) was passed successively through activated copper and 
alumina columns.  Dichloromethane (Fisher, ACS Grade) and diethyl ether (Aldrich, 
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 Chromasolv®) were passed successively through two activated alumina columns. 
Tetrahydrofuran was purified by distillation from sodium benzophenone ketyl 
immediately prior to use. CDCl3 was purchased from Cambridge Isotope Laboratories 
and stored over activated 4Å molecular sieves prior to use. All work-up and purification 
procedures were carried out in air with reagent grade solvents (purchased from Fisher).  
■  Reagents and Catalysts: 
Allenylboronic Acid Pinacol Ester (3.20) was obtained from Frontier Scientific and 
distilled under vacuum prior to use. 
Allylboronates: Allylboronic acid pinacol ester (3.2) was purchased from Aldrich or 
obtained as a gift from Frontier Scientific, Inc and distilled prior to use. 2-
Methylallyl)boronic acid pinacol ester (3.15a) was synthesized and purified in 
accordance with a procedure in the literature.44 (2-Phenylallyl)boronic acid pinacol ester 
(3.15b) was synthesized and purified in accordance with a procedure in the literature.45 
Hydrochloric Acid (12 M, 36.5-38.0 wt %) was purchased from Alfa Aesar and used as 
received. 
Magnesium Sulfate was purchased from Fisher and flame-dried under vacuum prior to 
use. 
Methanol was purchased from Acros (99.8% anhydrous) and distilled at 1 atm from 
sodium metal prior to use. 
2-Silylsalicylaldehydes were prepared in accordance to a procedure in the literature and 
used to make aminophenols, such as 3.14l, without further purification.46 
                                                
(44) Zhang, P.; Roundtree, I. A.; Morken, J. P. Org. Lett. 2012, 14, 1416–1419. 
(45) Corberan, R.; Mszar, N. W.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2011, 50, 7079–7082. 
(46) Thadani, A. N.; Huang, Y.; Rawal, V. H. Org. Lett. 2007, 9, 3873–3876. 
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 Sodium Borohydride was purchased from Aldrich and used as received. 
Sodium tert-Butoxide was purchased from Strem (min. 98%) and used as received. 
Triethylamine was purchased from Aldrich and distilled from CaH2 prior to use. 
 
Experimental Procedures 
 
 
 
(S)-2-(((2-Hydroxy-[1,1'-biphenyl]-3-yl)methyl)amino)-N,N,3-trimethylbutanamide. 
3-phenyl-2-hydroxybenzaldehyde (198 mg, 1.00 mmol, 1.00 equiv), (S)-2-amino-N,N,3-
trimethylbutanamide hydrochloride (180 mg, 1.00 mmol, 1.50 equiv), MgSO4 (361 mg, 
3.00 mmol, 3.00 equiv), Et3N (0.42 mL, 3.00 mmol, 3.00 equiv), and CH2Cl2 (2 mL) 
were added to a dry flask with a magnetic stir bar.  The reaction mixture was sealed with 
a septum and allowed to stir for 16 hours at room temperature. The reaction mixture was 
filtered through silica gel washing with EtOAc, and concentrated under vacuum. The 
resulting reaction mixture was dissolved in MeOH (5 mL) and cooled to 0 °C with an ice 
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 bath. NaBH4 (304 mg, 8.00 mmol, 8.00 equiv) and concentrated HCl (1 drop) were added 
to the reaction mixture, and the ice bath was removed. The reaction mixture was allowed 
to warm to room temperature for 2 hours. Saturated aqueous NaHCO3 and EtOAc were 
added, and the layers separated. The aqueous layer was extracted with EtOAc, and the 
combined organic layers were combined, dried with MgSO4, filtered and concentrated 
under vacuum. The reaction mixture was purified by column chromatography (2:1 
pentane:EtOAc) to give the product (186 mg, 57%). 1H NMR (400 MHz, Chloroform-d) 
δ 7.66 – 7.56 (m, 2H), 7.48 – 7.35 (m, 2H), 7.36 – 7.20 (m, 2H), 6.97 – 6.88 (m, 1H), 
6.82 (t, J = 7.5 Hz, 1H), 4.07 (d, J = 13.6 Hz, 1H), 3.58 (d, J = 13.5 Hz, 1H), 3.38 (d, J = 
5.7 Hz, 1H), 3.04 (s, 3H), 2.94 (s, 3H), 1.98 – 1.75 (m, 1H), 0.96 (dd, J = 9.6, 6.8 Hz, 
6H). 13C NMR (101 MHz, cdcl3) δ 173.20, 155.17, 138.52, 130.06, 129.35, 129.11, 
127.98, 127.87, 126.70, 122.96, 119.06, 61.68, 51.58, 37.03, 35.74, 31.21, 19.99, 17.86. 
IR (neat): 3291, 2962, 2928, 2872, 1638, 1461, 1429, 1233, 1088, 757, 699. HRMS 
(ESI+): Calcd for C20H26N2O2 [M+H]+: 327.1994; Found: 327.2074. 
 
 
 
4'-(tert-Butyl)-2-hydroxy-[1,1'-biphenyl]-3-carbaldehyde. Inside an N2-filled glove 
box, Pd(OAc)2 (3.4 mg, 0.015 mmol, 0.010 equiv), S-Phos (12.3 mg, 0.03 mmol, 0.020 
equiv), K3PO4 (639 mg, 3.00 mmol, 2.00 equiv), 3-Bromo-2-hydroxybenzaldehyde (303 
mg, 1.50 mmol, 1.00 equiv), 4-tert-butylphenylboronic acid (321 mg, 1.80 mmol, 1.20 
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 equiv) and PhMe (4 mL) were added consecutively to a dry flask with a magnetic stir bar.  
The reaction mixture was sealed with a septum, removed from the glovebox, equipped 
with a reflux condenser and allowed to stir for 16 hours in a bath preheated to 100 °C. 
The reaction mixture was cooled to room temperature, filtered through silica gel washing 
with Et2O, and concentrated under vacuum.  The reaction mixture was purified by 
column chromatography (4:1 pentane:Et2O) to give the product (198 mg, 52%). 1H NMR 
(400 MHz, Chloroform-d) δ 11.63 (d, J = 0.8 Hz, 1H), 9.93 (d, J = 1.1 Hz, 1H), 7.79 – 
7.35 (m, 6H), 7.10 (td, J = 7.6, 1.0 Hz, 1H), 1.42 (s, 9H). 13C NMR (101 MHz, cdcl3) δ 
196.89, 158.95, 150.59, 137.72, 133.35, 132.98, 130.34, 128.94, 125.30, 120.87, 119.95, 
34.63, 31.40. IR (neat): 2962, 2904, 2866, 1658, 1613, 1439, 1387, 1279, 1217, 1117, 
1066, 916, 827, 752, 670, 579. 
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 (S)-2-(((4'-(tert-Butyl)-2-hydroxy-[1,1'-biphenyl]-3-yl)methyl)amino)-N,N,3-
trimethylbutanamide. 4'-(tert-butyl)-2-hydroxy-[1,1'-biphenyl]-3-carbaldehyde (150 
mg, 0.590 mmol, 1.00 equiv), (S)-2-amino-N,N,3-trimethylbutanamide hydrochloride 
(180 mg, 0.590 mmol, 1.00 equiv), MgSO4 (213 mg, 1.77 mmol, 3.00 equiv), Et3N (0.25 
mL, 1.77 mmol, 3.00 equiv), and CH2Cl2 (2 mL) were added to a dry flask with a 
magnetic stir bar.  The reaction mixture was sealed with a septum and allowed to stir for 
16 hours at room temperature. The reaction mixture was filtered through silica gel 
washing with EtOAc, and concentrated under vacuum. The resulting reaction mixture 
was dissolved in MeOH (5 mL) and cooled to 0 °C with an ice bath. NaBH4 (183 mg, 
4.80 mmol, 8.00 equiv) and concentrated HCl (1 drop) were added to the reaction 
mixture, and the ice bath was removed. The reaction mixture was allowed to warm to 
room temperature for 2 hours. Saturated aqueous NaHCO3 and EtOAc were added, and 
the layers separated. The aqueous layer was extracted with EtOAc, and the combined 
organic layers were combined, dried with MgSO4, filtered and concentrated under 
vacuum. The reaction mixture was purified by column chromatography (2:1 
pentane:EtOAc) to give the product (111 mg, 49%). 1H NMR (400 MHz, Chloroform-d) 
δ 7.62 – 7.54 (m, 2H), 7.45 (dd, J = 8.4, 1.1 Hz, 2H), 7.27 (dd, J = 7.6, 1.5 Hz, 1H), 6.96 
– 6.88 (m, 1H), 6.82 (td, J = 7.5, 1.0 Hz, 1H), 4.07 (d, J = 13.7 Hz, 1H), 3.59 (d, J = 13.6 
Hz, 1H), 3.39 (dd, J = 5.8, 1.0 Hz, 1H), 3.04 (s, 3H), 2.94 (s, 3H), 1.97 – 1.73 (m, 1H), 
1.36 (s, 9H), 1.05 – 0.91 (m, 6H). 13C NMR (101 MHz, cdcl3) δ 173.18, 155.21, 149.37, 
135.55, 130.04, 128.98, 128.94, 127.66, 124.98, 122.93, 119.06, 61.68, 51.64, 37.02, 
35.72, 34.50, 31.42, 31.22, 20.00, 17.88. IR (neat): 2960, 2868, 1641, 1456, 1398, 1268, 
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 1118, 824, 750, 579. HRMS (ESI+): Calcd for C24H34N2O2 [M+H]+: 383.2620; Found: 
383.2699. 
 
 
 
2-Hydroxy-3',5'-dimethyl-[1,1'-biphenyl]-3-carbaldehyde. Inside an N2-filled glove 
box, Pd(OAc)2 (3.4 mg, 0.015 mmol, 0.010 equiv), S-Phos (12.3 mg, 0.03 mmol, 0.020 
equiv), K3PO4 (639 mg, 3.00 mmol, 2.00 equiv), 3-Bromo-2-hydroxybenzaldehyde (303 
mg, 1.50 mmol, 1.00 equiv), 3,5-dimethylphenylboronic acid (270 mg, 1.80 mmol, 1.20 
equiv) and PhMe (4 mL) were added consecutively to a dry flask with a magnetic stir bar.  
The reaction mixture was sealed with a septum, removed from the glovebox, equipped 
with a reflux condenser and allowed to stir for 16 hours in a bath preheated to 100 °C. 
The reaction mixture was cooled to room temperature, filtered through silica gel washing 
with Et2O, and concentrated under vacuum.  The reaction mixture was purified by 
column chromatography (4:1 pentane:Et2O) to give the product (185 mg, 55%). 1H NMR 
(400 MHz, Chloroform-d) δ 11.55 (s, 1H), 9.93 (s, 1H), 7.65 – 7.58 (m, 1H), 7.53 (dd, J 
= 7.7, 1.7 Hz, 1H), 7.23 (d, J = 0.8 Hz, 2H), 7.15 – 7.00 (m, 2H), 2.41 (s, 6H). 13C NMR 
(101 MHz, cdcl3) δ 196.83, 158.92, 137.84, 137.77, 136.23, 133.02, 130.80, 129.40, 
127.10, 120.81, 119.83, 21.43. IR (neat): 3410, 3025, 2916, 2856, 1649, 1601, 1442, 
1385, 1297, 1269, 1223, 851, 751, 700, 667. HRMS (DART+): Calcd for C15H14O2 
[M+H]+: 227.1072; Found: 227.1071. 
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(S)-2-(((2-Hydroxy-3',5'-dimethyl-[1,1'-biphenyl]-3-yl)methyl)amino)-N,N,3-
trimethylbutanamide. 2-hydroxy-3',5'-dimethyl-[1,1'-biphenyl]-3-carbaldehyde (95 mg, 
0.420 mmol, 1.00 equiv), (S)-2-amino-N,N,3-trimethylbutanamide hydrochloride (76 mg, 
0.420 mmol, 1.00 equiv), MgSO4 (152 mg, 1.26 mmol, 3.00 equiv), Et3N (0.19 mL, 1.26 
mmol, 3.00 equiv), and CH2Cl2 (2 mL) were added to a dry flask with a magnetic stir bar.  
The reaction mixture was sealed with a septum and allowed to stir for 16 hours at room 
temperature. The reaction mixture was filtered through silica gel washing with EtOAc, 
and concentrated under vacuum. The resulting reaction mixture was dissolved in MeOH 
(5 mL) and cooled to 0 °C with an ice bath. NaBH4 (128 mg, 3.36 mmol, 8.00 equiv) and 
concentrated HCl (1 drop) were added to the reaction mixture, and the ice bath was 
removed. The reaction mixture was allowed to warm to room temperature for 2 hours. 
Saturated aqueous NaHCO3 and EtOAc were added, and the layers separated. The 
aqueous layer was extracted with EtOAc, and the combined organic layers were 
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 combined, dried with MgSO4, filtered and concentrated under vacuum. The reaction 
mixture was purified by column chromatography (2:1 pentane:EtOAc) to give the 
product (99 mg, 66%). 1H NMR (400 MHz, Chloroform-d) δ 7.28 – 7.16 (m, 3H), 6.96 
(d, J = 1.2 Hz, 1H), 6.92 (dd, J = 7.5, 1.7 Hz, 1H), 6.82 (t, J = 7.5 Hz, 1H), 4.06 (d, J = 
13.5 Hz, 1H), 3.59 (d, J = 13.5 Hz, 1H), 3.39 (d, J = 5.7 Hz, 1H), 3.05 (s, 3H), 2.95 (s, 
3H), 2.37 (s, 6H), 2.01 – 1.72 (m, 1H), 0.97 (dd, J = 10.8, 6.8 Hz, 6H). 13C NMR (101 
MHz, cdcl3) δ 173.20, 155.15, 138.47, 137.30, 130.14, 129.50, 128.50, 127.71, 127.23, 
122.90, 118.95, 61.70, 51.63, 37.02, 35.72, 31.24, 21.46, 19.97, 17.89. IR (neat): 3304, 
2961, 2917, 2872, 1636, 1459, 1398, 1234, 1073, 908, 848, 727, 700, 645. HRMS (ESI+): 
Calcd for C22H30N2O2 [M+H]+: 355.2307; Found: 355.2379. 
 
 
 
3',5'-Di-tert-butyl-2-hydroxy-[1,1'-biphenyl]-3-carbaldehyde. Inside an N2-filled 
glove box, Pd(OAc)2 (3.4 mg, 0.015 mmol, 0.010 equiv), S-Phos (12.3 mg, 0.03 mmol, 
0.020 equiv), K3PO4 (639 mg, 3.00 mmol, 2.00 equiv), 3-Bromo-2-hydroxybenzaldehyde 
(303 mg, 1.50 mmol, 1.00 equiv), 3,5-di-tert-butylphenylboronic acid (422 mg, 1.80 
mmol, 1.20 equiv) and PhMe (4 mL) were added consecutively to a dry flask with a 
magnetic stir bar.  The reaction mixture was sealed with a septum, removed from the 
glovebox, equipped with a reflux condenser and allowed to stir for 16 hours in a bath 
preheated to 100 °C. The reaction mixture was cooled to room temperature, filtered 
through silica gel washing with Et2O, and concentrated under vacuum.  The reaction 
 
Page 607
 mixture was purified by column chromatography (4:1 pentane:Et2O) to give the product 
(308 mg, 66%). 1H NMR (400 MHz, Chloroform-d) δ 11.68 (s, 1H), 10.00 (d, J = 0.5 Hz, 
1H), 7.76 (dd, J = 7.5, 1.7 Hz, 1H), 7.60 (td, J = 3.6, 3.2, 1.7 Hz, 4H), 7.18 (t, J = 7.6 Hz, 
1H), 1.52 (s, 18H). 13C NMR (101 MHz, cdcl3) δ 196.91, 159.11, 150.58, 138.04, 135.54, 
132.98, 131.62, 123.83, 121.84, 120.98, 119.94, 35.06, 31.68. IR (neat): 2960, 2903, 
2866, 1655, 1614, 1419, 1384, 1362, 1298, 1249, 1216, 956, 877, 750, 711, 665, 484. 
HRMS (ESI+): Calcd for C21H26O2 [M+H]+: 333.1825; Found: 333.1831. 
 
 
 
(S)-2-(((3',5'-Di-tert-butyl-2-hydroxy-[1,1'-biphenyl]-3-yl)methyl)amino)-N,N,3-
trimethylbutanamide. 3',5'-di-tert-butyl-2-hydroxy-[1,1'-biphenyl]-3-carbaldehyde (308 
mg, 1.00 mmol, 1.00 equiv), (S)-2-amino-N,N,3-trimethylbutanamide hydrochloride (181 
mg, 1.00 mmol, 1.00 equiv), MgSO4 (361 mg, 3.00 mmol, 3.00 equiv), Et3N (0.42 mL, 
3.00 mmol, 3.00 equiv), and CH2Cl2 (2 mL) were added to a dry flask with a magnetic 
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 stir bar.  The reaction mixture was sealed with a septum and allowed to stir for 16 hours 
at room temperature. The reaction mixture was filtered through silica gel washing with 
Et2O, and concentrated under vacuum. The resulting reaction mixture was dissolved in 
MeOH (5 mL) and cooled to 0 °C with an ice bath. NaBH4 (304 mg, 8.00 mmol, 8.00 
equiv) and concentrated HCl (1 drop) were added to the reaction mixture, and the ice bath 
was removed. The reaction mixture was allowed to warm to room temperature for 2 
hours. Saturated aqueous NaHCO3 and EtOAc were added, and the layers separated. The 
aqueous layer was extracted with EtOAc, and the combined organic layers were 
combined, dried with MgSO4, filtered and concentrated under vacuum. The reaction 
mixture was purified by column chromatography (2:1 pentane:EtOAc) to give the 
product (227 mg, 52%). 1H NMR (400 MHz, Chloroform-d) δ 7.49 (d, J = 1.8 Hz, 2H), 
7.41 (t, J = 1.9 Hz, 1H), 7.30 (dd, J = 7.6, 1.7 Hz, 1H), 6.94 (dd, J = 7.5, 1.7 Hz, 1H), 
6.85 (t, J = 7.5 Hz, 1H), 4.19 – 4.03 (m, 1H), 3.61 (d, J = 13.7 Hz, 1H), 3.42 (d, J = 5.7 
Hz, 1H), 3.06 (s, 3H), 2.96 (s, 3H), 1.97 – 1.79 (m, 1H), 1.39 (s, 18H), 1.01 (dd, J = 10.4, 
6.8 Hz, 6H). 13C NMR (101 MHz, cdcl3) δ 173.26, 155.23, 149.90, 137.53, 130.27, 
130.25, 127.59, 123.85, 122.96, 120.83, 118.95, 61.61, 51.60, 37.04, 35.73, 34.89, 31.58, 
31.25, 20.03, 17.86. IR (neat): 2960, 2903, 2868, 1641, 1461, 1416, 1361, 1247, 1122, 
876, 748, 712. HRMS (ESI+): Calcd for C28H42N2O2 [M+H]+: 439.3246; Found: 
439.3322. 
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3-(3a1,5a1-Dihydropyren-1-yl)-2-hydroxybenzaldehyde. Inside an N2-filled glove box, 
Pd(OAc)2 (3.4 mg, 0.015 mmol, 0.010 equiv), S-Phos (12.3 mg, 0.03 mmol, 0.020 
equiv), K3PO4 (639 mg, 3.00 mmol, 2.00 equiv), 3-Bromo-2-hydroxybenzaldehyde (303 
mg, 1.50 mmol, 1.00 equiv), pyrene-1-boronic acid (443 mg, 1.80 mmol, 1.20 equiv) and 
PhMe (4 mL) were added consecutively to a dry flask with a magnetic stir bar.  The 
reaction mixture was sealed with a septum, removed from the glovebox, equipped with a 
reflux condenser and allowed to stir for 16 hours in a bath preheated to 100 °C. The 
reaction mixture was cooled to room temperature, filtered through silica gel washing with 
EtOAc, and concentrated under vacuum.  The reaction mixture was purified by column 
chromatography (4:1 pentane:EtOAc) to give the product (290 mg, 60%). 1H NMR (400 
MHz, Chloroform-d) δ 11.44 (d, J = 0.6 Hz, 1H), 9.94 (s, 1H), 8.26 (d, J = 7.8 Hz, 1H), 
8.20 (ddd, J = 10.2, 7.6, 1.1 Hz, 2H), 8.11 (s, 2H), 8.09 – 7.97 (m, 3H), 7.91 (d, J = 9.2 
Hz, 1H), 7.67 (ddd, J = 7.5, 1.8, 0.6 Hz, 1H), 7.56 (dd, J = 7.8, 1.7 Hz, 1H), 7.12 (t, J = 
7.6 Hz, 1H). 13C NMR (101 MHz, cdcl3) δ 196.78, 159.37, 139.52, 133.57, 131.68, 
131.37, 131.20, 130.96, 129.91, 129.20, 128.00, 127.70, 127.63, 127.41, 126.05, 125.32, 
125.29, 125.14, 124.87, 124.82, 124.66, 120.79, 119.75. IR (neat): 3041, 2844, 1654, 
1613, 1438, 1385, 1268, 1217, 845, 755, 720, 675. 
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(S)-2-((2-Hydroxy-3-(pyren-1-yl)benzyl)amino)-N,N,3-trimethylbutanamide. 3-
(3a1,5a1-dihydropyren-1-yl)-2-hydroxybenzaldehyde (105 mg, 0.324 mmol, 1.00 equiv), 
(S)-2-amino-N,N,3-trimethylbutanamide hydrochloride (59 mg, 0.32 mmol, 1.0 equiv), 
MgSO4 (117 mg, 0.970 mmol, 3.00 equiv), Et3N (0.14 mL, 0.970 mmol, 3.0 equiv), and 
CH2Cl2 (2 mL) were added to a dry flask with a magnetic stir bar.  The reaction mixture 
was sealed with a septum and allowed to stir for 16 hours at room temperature. The 
reaction mixture was filtered through silica gel washing with Et2O, and concentrated 
under vacuum. The resulting reaction mixture was dissolved in MeOH (5 mL) and cooled 
to 0 °C with an ice bath. NaBH4 (99 mg, 2.6 mmol, 8.0 equiv) and concentrated HCl (1 
drop) were added to the reaction mixture, and the ice bath was removed. The reaction 
mixture was allowed to warm to room temperature for 2 hours. Saturated aqueous 
NaHCO3 and EtOAc were added, and the layers separated. The aqueous layer was 
extracted with EtOAc, and the combined organic layers were combined, dried with 
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 MgSO4, filtered and concentrated under vacuum. The reaction mixture was purified by 
column chromatography (2:1 pentane:EtOAc) to give the product (65 mg, 45%). 1H 
NMR (400 MHz, Chloroform-d) δ 8.28 (dd, J = 7.8, 3.4 Hz, 1H), 8.09 – 7.97 (m, 4H), 
8.15 – 8.13 (m, 0H), 8.18 (ddt, J = 8.8, 7.9, 1.2 Hz, 2H), 8.11 (d, J = 5.5 Hz, 2H), 7.39 
(dt, J = 7.5, 1.8 Hz, 1H), 7.14 (dt, J = 7.5, 1.8 Hz, 1H), 7.00 (td, J = 7.5, 1.7 Hz, 1H), 
4.30 – 4.15 (m, 1H), 3.70 (dd, J = 13.8, 5.4 Hz, 1H), 3.46 (dd, J = 29.7, 5.7 Hz, 1H), 3.08 
(d, J = 5.4 Hz, 3H), 2.97 (d, J = 13.7 Hz, 3H), 1.88 (dddd, J = 13.5, 12.3, 10.0, 6.7 Hz, 
1H), 1.07 – 0.84 (m, 6H). IR (neat): 3290, 3039, 2960, 2928, 2872, 1636, 1445, 1398, 
1235, 1083, 908, 845, 724. HRMS (ESI+): Calcd for C30H30N2O2 [M+H]+: 451.2307; 
Found: 451.2383. 
 
 
 
(S)-2-((2-Hydroxy-3-(triisopropylsilyl)benzyl)amino)-N,N,3-trimethylbutanamide. 
1H NMR (400 MHz, Chloroform-d) δ 7.31 (dd, J = 7.3, 1.7 Hz, 1H), 6.91 (ddd, J = 7.3, 
1.7, 0.9 Hz, 1H), 6.75 (td, J = 7.3, 0.8 Hz, 1H), 4.10 (d, J = 13.8 Hz, 1H), 3.46 (d, J = 
13.8 Hz, 1H), 3.28 (d, J = 6.5 Hz, 1H), 3.04 (s, 3H), 2.83 (s, 3H), 1.84 (h, J = 6.7 Hz, 
1H), 1.65 – 1.40 (m, 3H), 1.19 – 1.02 (m, 18H), 0.94 (ddd, J = 19.5, 6.7, 0.8 Hz, 6H). 13C 
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 NMR (101 MHz, cdcl3) δ 173.48, 163.32, 136.26, 129.71, 121.60, 121.27, 118.41, 60.61, 
51.02, 36.92, 35.64, 31.45, 19.91, 19.04, 18.97, 18.15, 11.68. IR (neat): 3293, 2941, 
2888, 2862, 1641, 1461, 1422, 1230, 882, 819, 751, 673. HRMS (ESI+): Calcd for 
C23H42N2O2Si [M+H]+: 407.3016; Found: 407.3092. [α]20D = -60 (c = 1.0, CHCl3). 
 
 
 
 
(S)-2-((2-Hydroxy-3-(triphenylsilyl)benzyl)amino)-N,N,3-trimethylbutanamide. 1H 
NMR (400 MHz, Chloroform-d) δ 7.67 – 7.55 (m, 6H), 7.44 – 7.28 (m, 9H), 7.10 (dd, J = 
7.4, 1.7 Hz, 1H), 7.01 (dd, J = 7.4, 1.7 Hz, 1H), 6.72 (t, J = 7.4 Hz, 1H), 4.17 (d, J = 14.0 
Hz, 1H), 3.46 (d, J = 14.1 Hz, 1H), 3.23 (d, J = 6.4 Hz, 1H), 3.02 (s, 3H), 2.82 (s, 3H), 
1.75 (h, J = 6.8 Hz, 1H), 0.79 (t, J = 6.6 Hz, 6H). 13C NMR (101 MHz, cdcl3) δ 173.41, 
163.29, 137.80, 136.34, 135.10, 131.22, 129.10, 127.53, 121.69, 120.75, 118.96, 60.53, 
50.72, 36.96, 35.66, 31.36, 19.85, 18.02. IR (neat): 3294, 3066, 3047, 2960, 2931, 1642, 
1427, 1107, 823, 743, 701, 508. Calcd for C32H36N2O2Si [M+H]+: 509.2546; Found: 
509.2617. [α]20D = -80 (c = 1.0, CHCl3). 
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(S)-2-((2-Hydroxy-3-(triphenylsilyl)benzyl)amino)-3-methyl-1-(pyrrolidin-1-
yl)butan-1-one. 1H NMR (400 MHz, Chloroform-d) δ 7.74 – 7.61 (m, 6H), 7.39 (ddd, J 
= 13.9, 7.7, 6.0 Hz, 9H), 7.17 (dd, J = 7.5, 1.7 Hz, 1H), 7.04 (dd, J = 7.5, 1.7 Hz, 1H), 
6.77 (t, J = 7.3 Hz, 1H), 4.26 (d, J = 14.1 Hz, 1H), 3.77 – 3.40 (m, 4H), 3.38 – 3.13 (m, 
1H), 3.05 (d, J = 7.1 Hz, 2H), 2.03 – 1.76 (m, 4H), 0.87 (dd, J = 6.8, 5.0 Hz, 6H). 13C 
NMR (101 MHz, cdcl3) δ 171.83, 163.36, 137.83, 136.37, 135.15, 131.14, 129.16, 
127.59, 121.66, 120.82, 118.99, 62.83, 50.58, 46.34, 45.69, 31.44, 26.11, 24.21, 19.86, 
18.45. IR (neat): 3281, 3066, 3048, 2958, 2873, 1635, 1427, 1107, 742, 701, 508. HRMS 
(ESI+): Calcd for C34H38N2O2Si [M+H]+: 535.2703; Found: 535.2773. [α]20D = -80 (c = 
1.0, CHCl3). 
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(S)-2-((2-Hydroxy-3-(triphenylsilyl)benzyl)amino)-3,3-dimethyl-1-(pyrrolidin-1-
yl)butan-1-one. 1H NMR (400 MHz, Chloroform-d) δ 7.67 – 7.53 (m, 6H), 7.46 – 7.27 
(m, 9H), 7.12 (dd, J = 7.3, 1.7 Hz, 1H), 6.98 (dd, J = 7.3, 1.7 Hz, 1H), 6.73 (t, J = 7.3 Hz, 
1H), 4.22 (d, J = 14.0 Hz, 1H), 3.75 – 3.55 (m, 1H), 3.47 (dd, J = 13.2, 4.7 Hz, 2H), 3.31 
– 3.13 (m, 1H), 3.05 (d, J = 9.4 Hz, 2H), 1.87 (q, J = 6.2, 5.7 Hz, 4H), 0.86 (s, 9H). 13C 
NMR (101 MHz, cdcl3) δ 171.25, 163.27, 137.85, 136.32, 135.02, 131.07, 129.10, 
127.53, 121.65, 120.79, 118.92, 64.52, 50.54, 47.01, 45.52, 34.21, 26.78, 26.18, 24.19. IR 
(neat): 3308, 3067, 3047, 2954, 2870, 1632, 1427, 1107, 742, 700, 507. HRMS (ESI+): 
Calcd for C35H40N2O2Si [M+H]+: 549.2859; Found: 549.2934. [α]20D = -70 (c = 1.0, 
CHCl3). 
(S)-N-(tert-Butyl)-2-((2-hydroxy-3-methylbenzyl)amino)-3-methylbutanamide 
(3.14u, Scheme 3.17): Synthesized and purified analogously to the reported procedure to 
afford a white solid.47 M.p. = 106–108 ºC. IR (neat): 3366 (w), 3299 (w), 3254 (w), 2965 
(w, br), 1671 (m), 1639 (s), 1523 (w), 1467 (m), 1389 (w), 1365 (w), 1268 (w), 1259 (w), 
                                                
(47) Silverio, D. L.; Torker, S.; Pilyugina, T.; Vieira, E. M.; Snapper, M. L.; Haeffner, F.; Hoveyda, A. H. 
Nature 2013, 494, 216–221. 
 
Page 615
 1221 (s), 1082 (m), 828 (m), 764 (s), 741 (m) cm-1; 1H NMR (400 MHz, CDCl3): 10.71 
(1H, s), 7.06 (1H, d, J = 8.0 Hz), 6.80–6.78 (1H, m), 6.69 (1H, t, J = 7.4 Hz), 5.29 (1H, 
s), 4.07 and 3.64  (2H, ABq, JAB = 13.8 Hz), 2.51 (1H, d, J = 7.5 Hz), 2.24 (3H, s), 1.90–
1.81 (1H, m), 1.39 (9H, s), 1.01 (3H, d, J = 6.8 Hz), 0.93 (3H, d, J = 6.7 Hz); 13C NMR 
(100 MHz, CDCl3): δ 172.1, 156.3, 130.2, 126.4, 125.4, 121.7, 118.8, 67.9, 52.0, 51.0, 
31.7, 29.0, 19.8, 19.3, 15.8; HRMS Calcd. for C17H29N2O2 [M + H]+: 293.22290; Found: 
293.22305. [α]23.6D = –37.7 (c = 1.06, CHCl3) for a >99:1 e.r. (assumed) sample. 
 
 
 
General Procedure for Allylation of Ketones.  Inside an N2-filled glove box, 
aminophenol (8.5 mg, 0.015 mmol, 0.03 equiv), NaOtBu (7.5 mg, 0.075 mmol, 0.15 
equiv), (pinacolato)allylboron (126 mg, 0.750 mmol, 1.50 equiv), MeOH (0.050 mL, 1.3 
mmol, 2.5 equiv), PhMe (3 mL), and THF (0.5 mL) were added consecutively to a dry 
vial with a magnetic stir bar.  The reaction mixture was sealed with a septum, removed 
from the glovebox and allowed to stir for 30 minutes in a bath precooled to -30 °C. A 
solution of the ketone (0.50 mmol, 1.0 equiv) in THF (0.5 mL) was added via syringe and 
the reaction mixture was allowed to stir at -30 °C for 8 hours. The reaction mixture was 
warmed to room temperature, filtered through silica gel washing with EtOAc, and 
concentrated under vacuum.  The reaction mixture was purified by column 
chromatography to give the product. 
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(S)-2-Phenylpent-4-en-2-ol. Based on the general procedure for allylation of ketones,  1H 
NMR (400 MHz, Chloroform-d) δ 7.35 (m, 2H), 7.25 (dd, J = 8.5, 6.9 Hz, 2H), 7.15 (m, 
1H), 5.54 (dddd, J = 16.8, 10.2, 8.2, 6.5 Hz, 1H), 5.03 (m, 2H), 2.59 (ddt, J = 13.7, 6.5, 
1.3 Hz, 1H), 2.41 (ddt, J = 13.7, 8.2, 1.0 Hz, 1H), 2.05 (s, 1H), 1.45 (s, 3H). 13C NMR 
(101 MHz, cdcl3) δ 147.64, 133.69, 128.15, 126.60, 124.76, 119.39, 73.62, 48.47, 29.86. 
IR (neat): 3433, 3060, 2977, 2929, 1445, 1069, 998, 913, 765, 699. HRMS (DART+): 
Calcd for C11H13 [M-OH]+: 145.1017; Found: 145.1019. [α]20D = -60 (c = 1.0, CHCl3) for 
a 98:2 e.r. sample. Enantiomeric purity was determined by HPLC analysis in comparison 
with authentic racemic material; Chiralcel OJ-H, 97% hexanes, 3% i-PrOH, 1.0 mL/min, 
220 nm. 
 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 9.5 min 59.994 1 9.2 min 2.220 
2 11.0 min 50.006 2 10.7 min 97.780 
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(S)-Methyl 4-(2-hydroxypent-4-en-2-yl)benzoate. 1H NMR (400 MHz, Chloroform-d) 
δ 7.90 (d, J = 7.8 Hz, 2H), 7.42 (d, J = 7.7 Hz, 2H), 5.51 (m, 1H), 5.02 (m, 2H), 3.81 (s, 
3H), 2.57 (m, 1H), 2.42 (m, 1H), 1.47 (s, 3H). 13C NMR (101 MHz, cdcl3) δ 166.98, 
152.89, 133.09, 129.46, 128.38, 124.90, 119.68, 73.68, 52.01, 48.30, 29.64. IR (neat): 
3481, 2978, 2952, 1722, 1610, 1436, 1280, 1114, 1017, 776, 710. Calcd for C13H15O2 [M-
OH]+: 203.1072; Found: 203.1079. [α]20D = -50 (c = 1.0, CHCl3) for a 95:5 e.r. sample. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralcel OJ-H, 97% hexanes, 3% i-PrOH, 0.5 mL/min, 220 nm.
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 55.9 min 32.306 1 72.5 min 5.013 
2 63.5 min 67.694 2 76.9 min 94.987 
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(S)-2-(4-Bromophenyl)pent-4-en-2-ol. 1H NMR (400 MHz, Chloroform-d) δ 7.36 (m, 
2H), 7.23 (m, 2H), 5.51 (m, 1H), 5.04 (ddt, J = 13.9, 2.3, 1.1 Hz, 2H), 2.54 (m, 1H), 2.38 
(ddt, J = 13.7, 8.2, 1.0 Hz, 1H), 2.05 (s, 1H), 1.43 (s, 3H). 13C NMR (101 MHz, cdcl3) δ 
146.67, 133.17, 131.17, 126.73, 120.53, 119.82, 73.40, 48.31, 29.82. IR (neat): 3421, 
3075, 2976, 2929, 1484, 1434, 1075, 1008, 918, 757. HRMS (DART+): Calcd for 
C11H12Br [M-OH]+: 223.0122; Found: 223.0127. [α]20D = -30 (c = 1.0, CHCl3) for a 98:2 
e.r. sample. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material; Chiralcel OJ-H, 99.5% hexanes, 0.5% i-PrOH, 0.5 mL/min, 
220 nm. 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 34.2 min 49.120 1 45.3 min 97.947 
2 37.3 min 50.880 2 51.1 min 2.053 
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(S)-2-(Benzo[d][1,3]dioxol-5-yl)pent-4-en-2-ol. 1H NMR (400 MHz, Chloroform-d) δ 
6.94 (s, 1H), 6.88 (dt, J = 8.1, 1.5 Hz, 1H), 6.78 – 6.70 (m, 1H), 5.92 (s, 2H), 5.73 – 5.50 
(m, 1H), 5.19 – 5.01 (m, 2H), 2.70 – 2.55 (m, 1H), 2.51 – 2.36 (m, 1H), 2.17 (s, 1H), 1.50 
(s, 3H). 13C NMR (101 MHz, cdcl3) δ 147.50, 146.04, 141.92, 133.67, 119.29, 117.81, 
107.71, 105.90, 100.88, 73.53, 48.53, 29.92. IR (neat): 3450, 3077, 2977, 2897, 1504, 
1487, 1434, 1237, 1039, 935, 812. HRMS (DART+): Calcd for C12H13O2 [M-OH]+: 
189.0916; Found: 189.0915. [α]20D = -40 (c = 1.0, CHCl3) for a 96:4 e.r. sample. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralcel OD-H, 99% hexanes, 1% i-PrOH, 1.0 mL/min, 220 nm. 
 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 27.0 min 51.500 1 27.7 min 96.093 
2 29.1 min 48.500 2 30.1 min 3.907 
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(S)-3-(2-Hydroxypent-4-en-2-yl)phenol. 1H NMR (400 MHz, Chloroform-d) δ 7.19 (td, 
J = 7.9, 1.0 Hz, 1H), 7.03 (dt, J = 2.6, 1.2 Hz, 1H), 6.92 (m, 1H), 6.72 (dd, J = 8.1, 2.6 
Hz, 1H), 6.03 (s, 1H), 5.61 (m, 1H), 5.13 (m, 2H), 2.67 (ddt, J = 13.8, 6.4, 1.3 Hz, 1H), 
2.48 (ddt, J = 13.7, 8.3, 1.0 Hz, 1H), 2.40 (s, 1H), 1.53 (s, 3H). 13C NMR (101 MHz, 
cdcl3) δ 155.75, 149.29, 133.38, 129.46, 119.71, 116.98, 113.70, 112.14, 74.06, 48.18, 
29.69. IR (neat): 3371, 2977, 2932, 1589, 1447, 1238, 998, 920, 785, 701. HRMS 
(DART+): Calcd for C11H13O [M-OH]+: 161.0966; Found: 161.0973. [α]20D = -40 (c = 
1.0, CHCl3) for a 96.5:3.5 e.r. sample. Enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material; Chiralcel OD-H, 97% hexanes, 
3% i-PrOH, 0.5 mL/min, 220 nm. 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 64.9 min 51.517 1 65.8 min 3.517 
2 71.9 min 48.483 2 71.7 min 96.483 
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(S)-2-(2-Fluoro-5-(trifluoromethyl)phenyl)pent-4-en-2-ol. 1H NMR (400 MHz, 
Chloroform-d) δ 7.91 (dd, J = 7.4, 2.5 Hz, 1H), 7.57 – 7.43 (m, 1H), 7.12 (dd, J = 11.2, 
8.4 Hz, 1H), 5.68 – 5.45 (m, 1H), 5.22 – 5.04 (m, 2H), 2.88 (ddd, J = 14.0, 6.2, 1.6 Hz, 
1H), 2.66 – 2.48 (m, 1H), 2.37 (s, 1H), 1.62 (s, 3H). 13C NMR (101 MHz, Chloroform-d) 
δ 162.88 – 159.02 (m), 135.16 (d, J = 13.8 Hz), 132.83, 126.59 (dd, J = 32.8, 3.4 Hz), 
126.08 (dq, J = 10.8, 3.8 Hz), 125.38 (dq, J = 5.9, 3.7 Hz), 123.89 (q, J = 273.2 Hz), 
120.20, 116.47 (d, J = 25.5 Hz), 72.48 (d, J = 4.6 Hz), 46.16 (d, J = 4.4 Hz), 28.19 (d, J = 
3.7 Hz). 19F NMR (376 MHz, cdcl3) δ -61.95, -107.96. IR (neat): 3452, 2981, 2931, 1329, 
1267, 1165, 1125, 1078, 917, 828, 619. HRMS (DART+): Calcd for C12H11F4 [M-OH]+: 
231.0797; Found: 231.0802. [α]20D = -50 (c = 1.0, CHCl3) for a 97:3 e.r. sample. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralcel OJ-H, 99.5% hexanes, 0.5% i-PrOH, 0.5 mL/min, 220 nm. 
 
 
 
Page 622
  
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 19.9 min 49.131 1 15.9 min 3.047 
2 21.6 min 50.869 2 16.7 min 96.953 
 
 
 
(S)-2-(3-Aminophenyl)pent-4-en-2-ol. 1H NMR (400 MHz, Chloroform-d) δ 7.12 (td, J 
= 7.7, 1.0 Hz, 1H), 6.88 – 6.75 (m, 2H), 6.57 (ddt, J = 7.9, 2.3, 1.1 Hz, 1H), 5.77 – 5.50 
(m, 1H), 5.22 – 5.05 (m, 2H), 3.67 (s, 2H), 2.67 (ddd, J = 13.8, 6.3, 1.3 Hz, 1H), 2.56 – 
2.35 (m, 1H), 2.01 (s, 1H), 1.51 (s, 3H). 13C NMR (101 MHz, cdcl3) δ 149.02, 146.22, 
133.80, 129.08, 119.30, 115.10, 113.34, 111.71, 73.51, 48.30, 29.83. IR (neat): 3447, 
3354, 3234, 3073, 2975, 2929, 1606, 1452, 1372, 1145, 997, 915, 785, 701. HRMS 
(DART+): Calcd for C11H14N [M-OH]+: 160.1126; Found: 160.1123. [α]20D = -40 (c = 
0.5, CHCl3) for a 91.5:8.5 e.r. sample. For determination of enantioselectivity, the 
product was treated with Boc2O and guanidinium chloride in EtOH at 50 °C. 
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 Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralcel OJ-H, 98% hexanes, 2% i-PrOH, 1.0 mL/min, 220 nm. 
 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 41.2 min 49.893 1 30.9 min 8.655 
2 45.1 min 50.107 2 33.0 min 91.345 
 
 
 
 
(S)-2-(Benzo[b]thiophen-2-yl)pent-4-en-2-ol. 1H NMR (400 MHz, Chloroform-d) δ 
7.68 (m, 1H), 7.59 (dd, J = 7.7, 1.2 Hz, 1H), 7.20 (m, 2H), 7.02 (s, 1H), 5.65 (dddd, J = 
16.9, 10.1, 8.1, 6.4 Hz, 1H), 5.07 (m, 2H), 2.65 (m, 1H), 2.50 (ddd, J = 13.7, 8.2, 1.0 Hz, 
1H), 2.39 (s, 1H), 1.56 (s, 3H). 13C NMR (101 MHz, cdcl3) δ 153.60, 139.88, 139.29, 
133.05, 124.21, 123.92, 123.34, 122.29, 119.98, 118.93, 73.15, 48.77, 30.18. IR (neat): 
3411, 2976, 1434, 1374, 1111, 997, 920, 829, 745, 726, 607. HRMS (DART+): Calcd for 
C13H13S [M-OH]+: 201.0738; Found: 201.0741. [α]20D = -70 (c = 1.0, CHCl3) for a 
97.5:2.5 e.r. sample. Enantiomeric purity was determined by HPLC analysis in 
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 comparison with authentic racemic material; Chiralcel OD-H, 99% hexanes, 1% i-PrOH, 
0.5 mL/min, 220 nm. 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 70.4 min 50.098 1 67.6 min 97.556 
2 87.1 min 49.902 2 89.9 min 2.444 
 
 
 
 
(S,E)-3-Methyl-1-phenylhexa-1,5-dien-3-ol. 1H NMR (400 MHz, Chloroform-d) δ 7.28 
(d, J = 7.5 Hz, 2H), 7.21 (t, J = 7.6 Hz, 2H), 7.12 (m, 1H), 6.50 (d, J = 16.0 Hz, 1H), 6.20 
(d, J = 16.0 Hz, 1H), 5.74 (dddd, J = 16.0, 11.3, 8.2, 6.8 Hz, 1H), 5.05 (m, 2H), 2.34 (ddt, 
J = 13.7, 6.7, 1.3 Hz, 1H), 2.26 (ddt, J = 13.5, 8.0, 0.9 Hz, 1H), 1.86 (s, 1H), 1.28 (s, 3H). 
13C NMR (101 MHz, cdcl3) δ 136.93, 136.25, 133.62, 128.57, 127.41, 126.43, 119.24, 
72.37, 47.36, 27.95. IR (neat): 3409, 3077, 3026, 2975, 2928, 1493, 1447, 1102, 969, 
916, 747, 693. HRMS (DART+): Calcd for C13H15 [M-OH]+: 171.1174; Found: 171.1175. 
[α]20D = -80 (c = 1.0, CHCl3) for a 95.5:4.5 e.r. sample. Enantiomeric purity was 
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 determined by HPLC analysis in comparison with authentic racemic material; Chiralcel 
OD-H, 90% hexanes, 10% i-PrOH, 0.5 mL/min, 220 nm. 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 21.8 min 50.124 1 24.3 min 4.730 
2 23.9 min 49.876 2 26.8 min 95.270 
 
 
 
 
(S)-3-Methyl-1-phenylhex-5-en-1-yn-3-ol. 1H NMR (400 MHz, Chloroform-d) δ 6.86 
(dd, J = 6.6, 3.1 Hz, 2H), 6.73 (dd, J = 4.7, 1.9 Hz, 3H), 5.48 (m, 1H), 4.66 (m, 2H), 2.01 
(m, 1H), 1.93 (m, 2H), 1.03 (s, 3H). 13C NMR (101 MHz, cdcl3) δ 133.41, 131.66, 
128.27, 128.23, 122.68, 119.51, 92.50, 83.59, 67.48, 48.31, 29.30. IR (neat): 3378, 3078, 
2980, 2931, 1489, 1369, 1108, 996, 917, 755, 690. HRMS (DART+): Calcd for C13H13 
[M-OH]+: 169.1017; Found: 169.1012. [α]20D = -40 (c = 1.0, CHCl3) for a 99.5:0.5 e.r. 
sample. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material; Chiralcel OD-H, 90% hexanes, 10% i-PrOH, 0.5 mL/min, 
220 nm. 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 18.1 min 49.537 1 18.6 min 0.557 
2 21.3 min 50.463 2 21.7 min 99.443 
 
 
 
 
(S)-7-Chloro-4-phenylhept-1-en-4-ol. 1H NMR (400 MHz, Chloroform-d) δ 7.36 (m, 
4H), 7.24 (m, 1H), 5.54 (dddd, J = 17.2, 10.1, 8.7, 6.0 Hz, 1H), 5.14 (m, 2H), 3.46 (m, 
2H), 2.74 (ddt, J = 13.7, 6.0, 1.3 Hz, 1H), 2.50 (dd, J = 13.7, 8.8 Hz, 1H), 2.12 (s, 1H), 
1.90 (m, 3H), 1.53 (ddtd, J = 13.9, 10.7, 6.7, 5.0 Hz, 1H). 13C NMR (101 MHz, cdcl3) δ 
145.33, 133.07, 128.23, 126.65, 125.17, 120.12, 75.37, 47.69, 45.54, 39.90, 26.94. IR 
(neat): 3555, 3443, 3060, 3026, 2957, 1445, 998, 920, 764, 702. HRMS (DART+): Calcd 
for C13H16Cl [M-OH]+: 207.0941; Found: 207.0941. [α]20D = -40 (c = 1.0, CHCl3) for a 
89:11 e.r. sample. Enantiomeric purity was determined by HPLC analysis in comparison 
with authentic racemic material; Chiralcel OD-H, 99% hexanes, 1% i-PrOH, 1.0 mL/min, 
220 nm. 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 17.7 min 50.210 1 14.9 min 89.240 
2 21.7 min 49.790 2 18.1 min 10.760 
 
 
 
 
(S)-tert-Butyl (3-(2-hydroxypent-4-en-2-yl)phenyl)carbamate. 1H NMR (400 MHz, 
Chloroform-d) δ 7.40 (s, 1H), 7.24 (m, 2H), 7.06 (dt, J = 7.4, 1.6 Hz, 1H), 6.59 (s, 1H), 
5.60 (dddd, J = 16.8, 10.2, 8.3, 6.4 Hz, 1H), 5.09 (m, 2H), 2.65 (ddt, J = 13.7, 6.4, 1.3 
Hz, 1H), 2.46 (ddt, J = 13.7, 8.3, 1.0 Hz, 1H), 2.20 (s, 1H), 1.49 (s, 12H). 13C NMR (101 
MHz, cdcl3) δ 152.76, 148.73, 138.27, 133.61, 128.75, 119.48, 119.41, 116.81, 115.17, 
80.40, 73.59, 48.32, 29.82, 28.33. IR (neat): 3330, 2976, 2931, 1700, 1609, 1542, 1432, 
1367, 1240, 1159, 702. HRMS (DART+): Calcd for C16H22NO2 [M-OH]+: 260.1651; 
Found: 260.1656. [α]20D = -30 (c = 1.0, CHCl3) for a 97.5:2.5 e.r. sample. Enantiomeric 
purity was determined by HPLC analysis in comparison with authentic racemic material; 
Chiralcel OJ-H, 98% hexanes, 2% i-PrOH, 1.0 mL/min, 220 nm. 
 
Page 628
  
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 41.2 min 49.893 1 41.9 min 2.554 
2 45.1 min 50.107 2 44.8 min 97.446 
 
 
 
 
(S)-2-(3-Bromophenyl)pent-4-en-2-ol. 1H NMR (400 MHz, Chloroform-d) δ 7.59 (t, J = 
1.9 Hz, 1H), 7.38 – 7.28 (m, 2H), 7.17 (t, J = 7.9 Hz, 1H), 5.67 – 5.49 (m, 1H), 5.10 (dtt, 
J = 13.7, 2.1, 0.9 Hz, 2H), 2.60 (ddt, J = 13.8, 6.5, 1.3 Hz, 1H), 2.44 (ddt, J = 13.8, 8.2, 
1.0 Hz, 1H), 2.33 (s, 1H), 1.49 (s, 3H). 13C NMR (101 MHz, cdcl3) δ 150.09, 133.14, 
129.76, 129.68, 128.16, 123.55, 122.52, 119.87, 73.40, 48.32, 29.76. IR (neat): 3433, 
2976, 1565, 1415, 1072, 996, 918, 784, 764, 698. HRMS (DART+): Calcd for C11H12Br 
[M-OH]+: 223.0122; Found: 223.0121. [α]20D = -50 (c = 1.0, CHCl3) for a 96:4 e.r. 
sample. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material; Chiralcel OD-H, 99% hexanes, 1% i-PrOH, 0.5 mL/min, 220 
nm. 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 48.9 min 49.777 1 42.9 min 96.073 
2 54.2 min 50.223 2 48.4 min 3.919 
 
 
 
 
(S)-2-(2-Bromophenyl)pent-4-en-2-ol. 1H NMR (400 MHz, Chloroform-d) δ 7.70 (dd, J 
= 7.9, 1.7 Hz, 1H), 7.58 (dd, J = 7.9, 1.3 Hz, 1H), 7.30 (ddd, J = 8.0, 7.2, 1.3 Hz, 1H), 
7.09 (ddd, J = 7.9, 7.3, 1.8 Hz, 1H), 5.65 – 5.45 (m, 1H), 5.20 – 5.02 (m, 2H), 3.28 (ddt, J 
= 14.0, 6.3, 1.3 Hz, 1H), 2.74 – 2.55 (m, 2H), 1.73 (s, 3H). 13C NMR (101 MHz, cdcl3) δ 
144.98, 135.00, 133.58, 128.50, 128.22, 127.38, 119.93, 119.31, 74.61, 45.04, 27.29. IR 
(neat): 3447, 3091, 2974, 2930, 2196, 2179, 1431, 1374, 1269, 1016, 919, 758, 640, 462, 
419. Calcd for C11H12Br [M-OH]+: 223.0122; Found: 223.0118.  [α]20D = -32 (c = 1.3, 
CHCl3) for a 99:1 e.r. sample. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material; Chiralcel OD-H, 99% hexanes, 1% i-PrOH, 
0.5 mL/min, 220 nm. 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 16.1 min 47.393 1 15.6 min 1.182 
2 18.0 min 52.607 2 17.3 min 98.818 
 
 
 
 
(S)-2-(2-(Trifluoromethyl)phenyl)pent-4-en-2-ol. 1H NMR (400 MHz, Chloroform-d) δ 
7.74 (dd, J = 8.1, 1.5 Hz, 1H), 7.56 (d, J = 8.0 Hz, 1H), 7.47 (td, J = 7.7, 1.5 Hz, 1H), 
7.31 (tq, J = 7.1, 1.1 Hz, 1H), 5.74 – 5.51 (m, 1H), 5.21 – 5.06 (m, 2H), 2.98 – 2.83 (m, 
1H), 2.61 – 2.46 (m, 1H), 2.41 (s, 1H), 1.62 (s, 3H). 13C NMR (101 MHz, Chloroform-d) 
δ 146.69, 133.25, 131.40, 128.50, 127.95 (q, J = 7.4 Hz), 127.32 (q, J = 30.9 Hz), 126.81, 
124.79 (q, J = 274.4 Hz), 120.01, 74.57, 48.25, 30.56. 19F NMR (376 MHz, cdcl3) δ -
54.07. IR (neat): 3469, 3076, 2980, 2932, 1302, 1271, 1131, 1033, 920, 767. HRMS 
(DART+): Calcd for C12H12F3 [M-OH]+: 213.0891; Found: 213.0895. [α]20D = -30 (c = 
1.0, CHCl3) for a 99.5:0.5 e.r. sample. Enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material; Chiralcel AD-H, 99% hexanes, 
1% i-PrOH, 0.5 mL/min, 220 nm. 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 15.4 min 50.261 1 15.7 min 0.277 
2 16.7 min 49.739 2 17.2 min 99.723 
 
 
 
 
(S)-2-(2-Methoxyphenyl)pent-4-en-2-ol. 1H NMR (400 MHz, Chloroform-d) δ 7.32 
(dd, J = 7.7, 1.7 Hz, 1H), 7.23 (ddd, J = 8.2, 7.4, 1.7 Hz, 1H), 6.98 – 6.86 (m, 2H), 5.77 – 
5.52 (m, 1H), 5.11 – 4.94 (m, 2H), 3.89 (s, 1H), 3.86 (s, 3H), 2.82 (ddt, J = 13.7, 6.9, 1.3 
Hz, 1H), 2.60 (ddt, J = 13.8, 7.7, 1.2 Hz, 1H), 1.57 (s, 3H). 13C NMR (101 MHz, cdcl3) δ 
156.60, 134.79, 134.54, 128.18, 126.79, 120.79, 117.71, 111.23, 74.20, 55.25, 46.58, 
26.96. IR (neat): 3528, 3073, 2974, 2940, 2838, 1672, 1598, 1486, 1436, 1358, 1291, 
1179, 1024, 754, 594. HRMS (DART+): Calcd for C12H15O [M-OH]+: 175.1123; Found: 
175.1123. [α]20D = -20 (c = 1.0, CHCl3) for a 93:7 e.r. sample. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material; Chiralcel 
OD-H, 99% hexanes, 1% i-PrOH, 1.0 mL/min, 220 nm. 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 10.4 min 49.223 1 8.8 min 7.024 
2 13.6 min 50.777 2 11.1 min 92.976 
 
 
 
(S)-2-(Naphthalen-1-yl)pent-4-en-2-ol. 1H NMR (400 MHz, Chloroform-d) δ 8.78 (dd, 
J = 8.6, 1.4 Hz, 1H), 7.89 (m, 1H), 7.80 (d, J = 8.0 Hz, 1H), 7.61 (dd, J = 7.3, 1.2 Hz, 
1H), 7.49 (m, 3H), 5.69 (dddd, J = 17.0, 10.1, 7.9, 6.8 Hz, 1H), 5.15 (m, 2H), 3.13 (ddt, J 
= 13.8, 6.7, 1.2 Hz, 1H), 2.86 (ddt, J = 13.9, 8.0, 1.1 Hz, 1H), 2.37 (s, 1H), 1.85 (s, 3H). 
13C NMR (101 MHz, cdcl3) δ 142.18, 134.92, 133.93, 130.82, 129.22, 128.60, 126.83, 
125.33, 125.13, 124.79, 123.69, 119.23, 75.25, 47.25, 29.61. IR (neat): 3351, 2976, 2202, 
2165, 2045, 1971, 1375, 923, 804, 777, 419. HRMS (DART+): Calcd for C15H15 [M-
OH]+: 195.1174; Found: 195.1176. [α]20D = -20 (c = 1.0, CHCl3) for a 99:1 e.r. sample. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralcel OJ-H, 95% hexanes, 5% i-PrOH, 0.5 mL/min, 220 nm. 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 27.5 min 49.388 1 29.1 min 0.811 
2 34.9 min 50.612 2 36.0 min 99.189 
 
 
 
 
(S)-3-Phenylhex-5-en-3-ol. 1H NMR (400 MHz, Chloroform-d) δ 7.30 (m, 2H), 7.24 (m, 
2H), 7.14 (m, 1H), 5.49 (dddd, J = 17.1, 10.1, 8.6, 6.1 Hz, 1H), 5.03 (m, 2H), 2.63 (ddt, J 
= 13.7, 6.1, 1.4 Hz, 1H), 2.41 (ddt, J = 13.8, 8.7, 0.9 Hz, 1H), 1.95 (s, 1H), 1.76 (m, 2H), 
0.68 (t, J = 7.4 Hz, 3H). 13C NMR (101 MHz, cdcl3) δ 145.74, 133.59, 128.02, 126.39, 
125.38, 119.46, 75.99, 46.91, 35.21, 7.82. IR (neat): 3464, 3060, 2974, 1446, 979, 916, 
761, 700. HRMS (DART+): Calcd for C12H15 [M-OH]+: 159.1174; Found: 159.1168. 
[α]20D = -60 (c = 1.0, CHCl3) for a 94:6 e.r. sample. Enantiomeric purity was determined 
by HPLC analysis in comparison with authentic racemic material; Chiralcel AD-H, 99% 
hexanes, 1% i-PrOH, 0.5 mL/min, 220 nm. 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 19.9 min 49.870 1 22.4 min 5.846 
2 21.9 min 50.130 2 23.9 min 94.154 
 
 
 
(R)-1-Chloro-3-phenylhex-5-en-3-ol. 1H NMR (400 MHz, Chloroform-d) δ 7.35 (m, 
4H), 7.24 (tdd, J = 5.7, 3.2, 2.0 Hz, 1H), 5.51 (ddddd, J = 17.2, 10.0, 8.6, 6.0, 1.3 Hz, 
1H), 5.15 (m, 2H), 3.55 (m, 1H), 3.20 (m, 1H), 2.72 (m, 1H), 2.50 (dd, J = 13.7, 8.7 Hz, 
1H), 2.30 (m, 2H), 2.20 (s, 1H). 13C NMR (101 MHz, cdcl3) δ 144.31, 132.47, 128.40, 
126.94, 124.96, 120.57, 75.16, 47.75, 45.46, 40.11. IR (neat): 3553, 3462, 3060, 3027, 
2976, 2929, 1446, 1059, 998, 923, 701, 668, 584. HRMS (DART+): Calcd for C13H14Cl 
[M-OH]+: 193.0784; Found: 193.0786. [α]20D = -42 (c = 1.2, CHCl3) for a 92.5:7.5 e.r. 
sample. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material; Chiralcel OD-H, 99.5% hexanes, 0.5% i-PrOH, 0.5 mL/min, 
220 nm. 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 47.6 min 49.929 1 43.6 min 92.305 
2 50.4 min 50.071 2 46.0 min 7.695 
 
 
 
 
(S)-2-(Benzo[d]thiazol-2-yl)pent-4-en-2-ol. 1H NMR (400 MHz, Chloroform-d) δ 7.99 
(d, J = 8.8 Hz, 1H), 7.88 (d, J = 8.0 Hz, 1H), 7.47 (m, 1H), 7.37 (t, J = 8.2 Hz, 1H), 5.76 
(dddd, J = 16.8, 10.1, 8.3, 6.4 Hz, 1H), 5.19 (m, 2H), 3.23 (s, 1H), 2.95 (ddt, J = 13.7, 
6.3, 1.2 Hz, 1H), 2.67 (ddt, J = 13.7, 8.3, 1.0 Hz, 1H), 1.71 (s, 3H). 13C NMR (101 MHz, 
cdcl3) δ 179.29, 153.25, 135.31, 132.40, 125.95, 124.81, 122.86, 121.73, 120.39, 74.98, 
47.46, 29.00. IR (neat): 3205, 2927, 2017, 1589, 1499, 1452, 1316, 745. HRMS 
(DART+): Calcd for C12H14NOS [M+H]+: 220.0796; Found: 220.0792. [α]20D = -20 (c = 
1.0, CHCl3) for a 96:4 e.r. sample. Enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material; Chiralcel OD-H, 99.5% hexanes, 
0.5% i-PrOH, 1.0 mL/min, 220 nm. 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 38.8 min 48.921 1 33.4 min 96.234 
2 58.0 min 51.079 2 49.4 min 3.766 
 
 
 
 
(S)-1-(2-Methoxyphenyl)-2-methylpent-4-en-2-ol. 1H NMR (400 MHz, Chloroform-d) 
δ 7.29 – 7.18 (m, 1H), 7.14 (dd, J = 7.4, 1.7 Hz, 1H), 6.99 – 6.82 (m, 2H), 6.05 – 5.83 (m, 
1H), 5.20 – 5.01 (m, 2H), 3.81 (s, 3H), 3.00 – 2.71 (m, 4H), 2.35 – 2.17 (m, 1H), 1.13 (s, 
3H). 13C NMR (101 MHz, cdcl3) δ 157.56, 134.79, 132.59, 127.88, 126.22, 120.70, 
117.86, 110.58, 72.97, 55.28, 47.00, 42.03, 26.58. IR (neat): 3443, 3074, 2973, 2929, 
2836, 1492, 1460, 1241, 1125, 1027, 913, 753. HRMS (DART+): Calcd for C13H17O [M-
OH]+: 189.1279; Found: 189.1283. [α]20D = -10 (c = 1.0, CHCl3) for a 85.5:14.5 e.r. 
sample. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material; Chiralcel OD-H, 99.5% hexanes, 0.5% i-PrOH, 0.5 mL/min, 
220 nm. 
 
Page 637
  
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 24.5 min 49.459 1 30.7 min 85.697 
2 25.7 min 50.541 2 32.7 min 14.303 
 
 
 
 
(S)-2-Cyclohexylpent-4-en-2-ol. 1H NMR (400 MHz, Chloroform-d) δ 5.84 (ddt, J = 
17.4, 10.2, 7.4 Hz, 1H), 5.14 – 4.98 (m, 2H), 2.28 – 2.07 (m, 2H), 1.88 – 1.53 (m, 5H), 
1.36 – 0.82 (m, 9H).  IR (neat): 3432, 2976, 2924, 2852, 1450, 1376, 1145, 998, 910. 
HRMS (DART+): Calcd for C11H19 [M-OH]+: 151.1487; Found: 151.1489. 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 94.7 min 50.343 1 97.7 min 79.791 
2 102.4 min 49.657 2 106.1 min 20.209 
 
 
 
 
 
 
(R)-1-Phenyl-1-(4-(trifluoromethyl)phenyl)but-3-en-1-ol. 1H NMR (400 MHz, 
Chloroform-d) δ 7.56 (s, 4H), 7.50 – 7.39 (m, 2H), 7.33 (ddd, J = 7.8, 6.9, 1.3 Hz, 2H), 
7.24 (ddt, J = 7.8, 6.3, 1.3 Hz, 1H), 5.64 (ddt, J = 17.3, 10.1, 7.2 Hz, 1H), 5.36 – 5.09 (m, 
2H), 3.08 (qdt, J = 13.9, 7.4, 1.2 Hz, 2H), 2.62 (s, 1H). 13C NMR (101 MHz, cdcl3) δ 
150.44, 145.66, 132.69, 129.00 (q, J = 32.4 Hz), 128.41, 127.28, 126.28, 125.88, 125.11 
(q, J = 3.8 Hz), 124.13 (q, J = 273.3 Hz), 121.14, 76.64, 46.47. 19F NMR (376 MHz, 
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 cdcl3) δ -62.49. IR (neat): 3546, 3078, 3028, 2980, 2924, 1409, 1324, 1163, 120, 1067, 
1016, 834, 699. Calcd for C17H14F3 [M-OH]+: 275.1048; Found: 275.1047. [α]20D = +10 
(c = 1.0, CHCl3) for a 73:27 e.r. sample. Enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material; Chiralcel OD-H, 99% hexanes, 
1% i-PrOH, 1.0 mL/min, 220 nm. 
  
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 13.3 min 51.407 1 13.3 min 10.149 
2 15.1 min 48.593 2 14.8 min 89.851 
 
 
 
 
(S)-1-Allyl-2-iodocyclohex-2-en-1-ol. 1H NMR (400 MHz, Chloroform-d) δ 6.55 (dd, J 
= 4.7, 3.7 Hz, 1H), 5.87 – 5.69 (m, 1H), 5.23 – 5.06 (m, 2H), 2.42 (ddt, J = 7.1, 2.2, 1.2 
Hz, 2H), 2.19 – 1.96 (m, 3H), 1.93 (s, 1H), 1.91 – 1.82 (m, 1H), 1.81 – 1.61 (m, 2H). 13C 
NMR (101 MHz, cdcl3) δ 141.82, 132.87, 118.87, 111.75, 72.92, 47.14, 34.17, 29.64, 
18.86. IR (neat): 3431, 3073, 2935, 2866, 2829, 1638, 1435, 1328, 1169, 1082, 964, 915, 
806, 763, 709, 635. HRMS (DART+): Calcd for C9H12I [M-OH]+: 246.9984; Found: 
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 246.9977. [α]20D = +30 (c = 1.0, CHCl3) for a 99:1 e.r. sample. For determination of 
enantioselectivity, the product was converted to the benzoate for HPLC analysis. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralcel OD-H, 99% hexanes, 1% i-PrOH, 0.5 mL/min, 220 nm. 
 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 11.2 min 51.025 1 10.9 min 99.174 
2 13.6 min 48.975 2 13.2 min 0.826 
 
 
 
 
(S)-4-Methyl-2-(2-(trifluoromethyl)phenyl)pent-4-en-2-ol. 1H NMR (400 MHz, 
Chloroform-d) δ 7.75 (dd, J = 8.0, 1.5 Hz, 1H), 7.66 – 7.56 (m, 1H), 7.55 – 7.44 (m, 1H), 
7.40 – 7.29 (m, 1H), 5.01 – 4.90 (m, 1H), 4.76 (dd, J = 2.1, 1.0 Hz, 1H), 2.86 (dd, J = 
13.8, 1.0 Hz, 1H), 2.64 (d, J = 1.1 Hz, 1H), 2.54 (dd, J = 13.8, 0.9 Hz, 1H), 1.67 (s, 3H), 
1.48 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 147.20, 141.99, 131.26, 128.75, 
127.89 (q, J = 7.5 Hz), 127.02 (q, J = 31.0 Hz), 126.73, 124.79 (q, J = 274.5 Hz), 116.21, 
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 74.18, 51.73 (q, J = 2.0 Hz), 31.56 (q, J = 2.1 Hz), 24.05. 19F NMR (376 MHz, cdcl3) δ -
53.75. IR (neat): 3546, 3074, 2978, 2925, 1443, 1303, 1269, 1125, 1034, 898, 767. Calcd 
for C13H14F3 [M-OH]+: 227.1048; Found: 227.1042. [α]20D = -30 (c = 1.0, CHCl3) for a 
99.5:0.5 e.r. sample. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material; Chiralcel OD-H, 99.5% hexanes, 0.5% i-
PrOH, 1.0 mL/min, 220 nm. 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 6.8 min 50.297 1 6.9 min 99.796 
2 7.9 min 49.703 2 8.1 min 0.204 
 
 
 
 
(S,E)-3,5-Dimethyl-1-phenylhexa-1,5-dien-3-ol. 1H NMR (400 MHz, Chloroform-d) δ 
7.42 – 7.33 (m, 2H), 7.30 (ddd, J = 7.7, 6.8, 1.2 Hz, 2H), 7.26 – 7.16 (m, 1H), 6.60 (d, J = 
16.0 Hz, 1H), 6.29 (d, J = 16.0 Hz, 1H), 4.94 (dq, J = 2.2, 1.5 Hz, 1H), 4.81 (dq, J = 2.4, 
0.9 Hz, 1H), 2.38 (s, 2H), 2.03 (s, 1H), 1.78 (s, 3H), 1.39 (s, 3H). 13C NMR (101 MHz, 
 
Page 642
 cdcl3) δ 142.30, 137.03, 136.91, 128.54, 127.28, 126.61, 126.34, 115.47, 72.13, 50.86, 
28.71, 24.69. IR (neat): 3442, 2971, 2928, 1642, 1493, 1448, 1373, 1091, 970, 893, 748, 
692. HRMS (ESI+): Calcd for C14H18O [M+Na]+: 225.1250; Found: 225.1250. [α]20D = -
80 (c = 1.0, CHCl3) for a 88:12 e.r. sample. Enantiomeric purity was determined by 
HPLC analysis in comparison with authentic racemic material; Chiralcel OD-H, 99% 
hexanes, 1% i-PrOH, 0.5 mL/min, 220 nm. 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 36.9 min 49.939 1 37.8 min 11.756 
2 58.4 min 50.061 2 59.9 min 88.244 
 
 
 
 
(S)-3,5-Dimethyl-1-phenylhex-5-en-1-yn-3-ol. 1H NMR (400 MHz, Chloroform-d) δ 
7.42 – 7.34 (m, 2H), 7.32 – 7.25 (m, 3H), 5.01 (dq, J = 2.2, 1.5 Hz, 1H), 4.91 (dt, J = 2.3, 
0.9 Hz, 1H), 2.63 – 2.39 (m, 3H), 1.98 (s, 3H), 1.59 (s, 3H). 13C NMR (101 MHz, cdcl3) δ 
141.88, 131.48, 128.22, 123.52, 122.75, 115.82, 93.12, 83.36, 66.58, 51.35, 30.16, 24.29. 
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 IR (neat): 3403, 3076, 2979, 2934, 1490, 1443, 1372, 1112, 892, 755, 691. HRMS 
(ESI+): Calcd for C14H16ONa [M+Na]+: 223.1093; Found: 223.1087. [α]20D = -30 (c = 1.0, 
CHCl3) for a 96:4 e.r. sample. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material; Chiralcel OD-H, 99% hexanes, 1% i-PrOH, 
0.5 mL/min, 220 nm. 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 21.6 min 50.600 1 21.1 min 4.130 
2 34.6 min 49.400 2 33.5 min 95.870 
 
 
 
 
(R)-1-Chloro-5-methyl-3-phenylhex-5-en-3-ol. 1H NMR (400 MHz, Chloroform-d) δ 
7.44 – 7.28 (m, 4H), 7.27 – 7.16 (m, 1H), 4.91 (dq, J = 2.8, 1.5 Hz, 1H), 4.76 (dq, J = 1.9, 
1.0 Hz, 1H), 3.56 (td, J = 10.8, 5.6 Hz, 1H), 3.13 (td, J = 10.8, 5.2 Hz, 1H), 2.66 (dd, J = 
13.4, 0.9 Hz, 1H), 2.58 – 2.49 (m, 2H), 2.44 – 2.19 (m, 2H), 1.28 (s, 3H). 13C NMR (101 
MHz, cdcl3) δ 144.54, 141.70, 128.30, 126.87, 125.06, 116.48, 74.45, 51.46, 46.34, 
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 40.19, 24.23. IR (neat): 3534, 3070, 2950, 1446, 1337, 1064, 903, 701, 631. [α]20D = -40 
(c = 1.0, CHCl3) for a 72:28 e.r. 
■  Representative Procedure for Catalytic Enantioselective Allyl- or Allenyl- 
Additions to α-Ketoesters in Scheme 3.18:  In a nitrogen-filled glovebox, aminophenol 
3.14u (7.3 mg, 0.025 mmol) is added to a two-dram vial equipped with a stir bar and 
dissolved in 1.0 mL of toluene. A second stock solution is prepared by dissolving 4.8 mg 
NaOt-Bu in 8.0 mL toluene. A two-dram vial equipped with a stir bar is charged with 200 
mmol of the stock solution of 3.14u (1.5 mg, 5.0 mmol) followed by 800 mL of the stock 
solution of NaOt-Bu (1.9 mg, 5.0 mmol). This vial is sealed with a cap (phenolic open 
top cap with a white PFTE/gray silicone septa) and electrical tape and removed from the 
glovebox. Methanol (20 mL, 0.50 mmol), methyl benzoylformate 3.18a (28 mL, 0.20 
mmol) and allylboronic acid pinacol ester 3.2 (56 mL, 0.29 mmol) are added by syringe 
under N2 in the stated order. The clear, colorless solution is allowed to stir at 22 ºC for 4 
h after which time the cap is removedand the solution is passed through a short plug of 
silica gel (eluted with Et2O) and concentrated in vacuo, being careful not to remove all of 
the solvent, as the product is volatile.  The resulting yellow oil is purified by silica gel 
chromatography (10 mm diameter column slurry packed with ~2.5 g of silica gel and 
eluted sucessively with 10 mL hexanes, 20 mL 30:1 and 20 mL 10:1 hexanes : diethyl 
ether) affording 3.19a (41.2 mg, 0.200 mmol, >98% yield) as a clear colorless oil. 
(R)-2-Hydroxy-2-phenylpent-4-enoate (3.19a, Scheme 3.18): The analytical data are 
fully consistent with those reported previously.48 1H NMR (400 MHz, CDCl3): δ 7.62–
7.60 (2H, m), 7.39–7.35 (2H, m), 7.32–7.28 (1H, m), 5.86–5.75 (1H, m), 5.21–5.13 (2H, 
                                                
(48) Zheng, K.; Qin, B.; Liu, X.; Feng, X. J. Org. Chem. 2007, 27, 8478–8483. 
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 m), 3.78 (3H, s), 3.73 (1H, s), 2.98 (1H, dd, J = 14.0, 7.6 Hz), 2.78 (1H, dd, J = 14.0, 6.5 
Hz); HRMS Calcd for C12H13O2 [M + H – H2O]+: 189.09155; Found: 189.09243; [α]21.7= 
–9.94 (c = 2.01, CHCl3) for a 82:18 e.r. sample. The enantiomeric purity of this 
compound was determined by HPLC analysis in comparison with authentic racemic 
material (Chiracel OJ-H, 80:20 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 6.9 min 
(minor) and 12 min (major). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 6.8 min 49.628 1 8.4 min 7.912 
2 12.7 min 50.372 2 15.6 min 92.088 
 
Methyl (R)-2-(4-chlorophenyl)-2-hydroxypent-4-enoate (3.19b, Scheme 3.18): The 
title compound is purified by silica gel chromatography (10 mm diameter column slurry 
packed with ~2.5 g of silica gel and eluted successively with 10 mL hexanes, 20 mL 
20:1, 10 mL 10:1 pentanes:ethyl acetate) affording 3.19b (47.5 mg, 0.197 mmol, >98% 
yield) as a clear sticky white oil. IR (neat): 3505 (w, br), 3078 (w), 2954 (w), 1728 (s), 
1490 (m), 1437 (w), 1227 (s), 1144 (m), 1091 (s), 1033 (m), 921 (m), 830 (m), 760 (s) 
cm-1; 1H NMR (400 MHz, CDCl3): δ 7.56–7.53 (2H, m), 7.34–7.31 (2H, m), 5.81–5.71 
(1H, m), 5.19–5.13 (2H, m), 3.78 (3H, s), 3.73 (1H, s), 2.96–2.90 (1H, m), 2.76–2.70 
(1H, m); 13C NMR (100 MHz, CDCl3): δ 174.9, 139.8, 134.0, 132.1, 128.6, 127.3, 119.9, 
77.9, 53.5, 44.4; HRMS Calcd. for C12H12Cl1O2 [M + H – H2O]+: 223.05258; Found: 
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 223.05350. [α]24.1D = –24.2 (c = 1.65, CHCl3) for a  92:8 e.r. sample. The enantiomeric 
purity of this compound was determined by HPLC analysis in comparison with authentic 
racemic material (Chiracel OJ-H, 80:20 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 11 
min (minor) and 12 min (major). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 11.0 min 48.721 1 9.3 min 7.925 
2 12.4 min 51.279 2 10.3 min 93.687 
 
Methyl (R)-2-hydroxy-2-(1H-indol-3-yl)pent-4-enoate (3.19c, Scheme 3.18): The title 
compound is purified by silica gel chromatography (10 mm diameter column slurry 
packed with ~2.5 g of silica gel and eluted successively with 10 mL dichloromethane, 25 
mL 19:1 dichloromethane:diethyl ether) affording 3.19c (44.1 mg, 0.180 mmol, 90% 
yield) as a light tan solid. M.p. = 100–101 ºC. IR (neat): 3486 (w), 3299 (w, br), 1717 (s), 
1460 (w), 1334 (m), 1260 (s), 1225 (m), 1138 (m), 1101 (m), 961 (m), 743 (s) cm-1; 1H 
NMR (400 MHz, CDCl3): δ 8.13 (1H, br s), 7.85–7.82 (1H, d), 7.38–7.35 (1H, m), 7.30–
7.29 (1H, m), 7.23–7.18 (1H, m), 7.16–7.11 (1H, m), 5.94–5.83 (1H, m), 5.24–5.15 (2H, 
m), 3.79–3.78 (1H, m), 3.77–3.76 (3H, m), 3.12–3.07 (1H, m), 3.02–2.96 (1H, m); 13C 
NMR (100 MHz, CDCl3): δ 175.7, 136.9, 132.6, 125.1, 122.4, 120.9, 120.2, 119.4, 117.6, 
111.4, 76.1, 53.2, 43.4; HRMS Calcd. for C14H14N1O2 [M + H – H2O]+: 228.10245; 
Found: 228.10211. [α]23.9D = –17.5 (c = 1.71, CHCl3) for a  71.5:28.5 e.r. sample. The 
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 enantiomeric purity of this compound was determined by HPLC analysis in comparison 
with authentic racemic material (Chiracel OJ-H, 80:20 hexanes:i-PrOH, 0.5 mL/min, 220 
nm): tR: 70 min (minor) and 76 min (major). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 70.6 min 49.710 1 70.1 min 28.573 
2 76.7 min 50.290 2 76.1 min 71.427 
 
tert-Butyl (R)-3-(2-hydroxy-1-methoxy-1-oxopent-4-en-2-yl)-1H-indole-1-
carboxylate (3.19d, Scheme 3.18): The title compound is purified by silica gel 
chromatography (10 mm diameter column slurry packed with ~2.5 g of silica gel and 
eluted successively with 10 mL hexanes, 20 mL 20:1, 30 mL 10:1 hexanes:ethyl acetate 
affording 3.19d (61.3 mg, 0.177 mmol, 89% yield) as a clear colorless sticky oil. IR 
(neat): 3503 (w, br), 2980 (w), 1729 (s), 1452 (m), 1369 (s), 1251 (m), 1225 (m), 1152 
(s), 1075 (m), 1023 (m), 745 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 8.16 (1H, d, J = 8.3 
Hz), 7.81–7.74 (1H, m), 7.68 (1H, s), 7.31 (1H, m), 7.26–7.20 (1H, m), 5.91–5.81 (1H, 
m), 5.26–5.14 (2H, m), 3.78 (1H, s), 3.77 (3H, s), 1.67 (9H, s); 13C NMR (100 MHz, 
CDCl3): δ 175.0, 149.7, 136.2, 132.0, 127.9, 124.6, 123.9, 122.9, 121.5, 121.1, 119.9, 
115.4, 84.1, 75.6, 53.4, 43.0, 28.3; HRMS Calcd. for C19H22N1O4 [M + H – H2O]+: 
328.15488; Found: 328.15351. [α]24.3D = –15.6 (c = 3.19, CHCl3) for a 79:21 e.r. sample. 
The enantiomeric purity of this compound was determined by HPLC analysis in 
 
Page 648
 comparison with authentic racemic material (Chiracel AS-H, 90:10 hexanes:i-PrOH, 0.5 
mL/min, 220 nm): tR: 11 min (minor) and 12 min (major). 
 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 11.4 min 50.352 1 11.4 min 10.046 
2 12.6 min 49.648 2 12.6 min 89.954 
 
Methyl (R)-2-hydroxy-2-phenylpenta-3,4-dienoate (3.21a, Scheme 3.19): The title 
compound is purified by silica gel chromatography (10 mm diameter column slurry 
packed with ~2.5 g of silica gel and eluted successively with 10 mL hexanes, 10 mL 
25:1, 30 mL 10:1 hexanes:ethyl acetate affording 3.21a (37.6 mg, 0.184 mmol, 92% 
yield, >98:2 allene:propargyl) as clear colorless oil. IR (neat): 3497 (w, br), 2954 (w), 
1958 (w), 1728 (s), 1447 (w), 1436 (w), 1246 (s), 1176 (m), 1151 (m), 1090 (m), 852 
(m), 751 (s), 697 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.60–7.57 (2H, m), 7.40–7.30 
(3H, m), 5.78–5.75 (1H, m), 5.02–5.00 (2H, m), 3.87–3.86 (1H, m), 3.79–3.78 (3H, m); 
13C NMR (100 MHz, CDCl3): δ 207.1, 174.2, 140.6, 128.4, 128.4, 126.4, 95.5, 79.8, 
76.8, 53.5; HRMS Calcd. for C12H21O2 [M + H – H2O]+: 187.07590; Found: 187.07632. 
[α]23.8D = –52.9 (c = 1.32, CHCl3) for a 92:8 e.r. sample. The enantiomeric purity of this 
compound was determined by HPLC analysis in comparison with authentic racemic 
material (Chiracel OJ-H, 80:20 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 13 min 
(minor) and 15 min (major). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 13.3 min 51.407 1 13.3 min 10.149 
2 15.1 min 48.593 2 14.8 min 89.851 
 
Methyl (R)-2-(4-chlorophenyl)-2-hydroxypenta-3,4-dienoate (3.21b, Scheme 3.19): 
The title compound is purified by silica gel chromatography (10 mm diameter column 
slurry packed with ~2.5 g of silica gel and eluted successively with 10 mL hexanes, 20 
mL 20:1, 20 mL 10:1 hexanes:ethyl acetate) affording 3.21b (47.6 mg, 0.199 mmol, 
>98% yield, >98:2 allene:propargyl) as a clear sticky white oil. IR (neat): 3497 (w, br), 
2954 (w), 1958 (w), 1729 (s), 1489 (m), 1436 (w), 1400 (w), 1246 (s), 1173 (m), 1154 
(m), 1079 (s), 1014 (m), 853 (m), 831 (s), 762 (m), 725 (m) cm-1; 1H NMR (400 MHz, 
CDCl3): δ 7.55–7.51 (2H, m), 7.34–7.31 (2H, m), 5.70 (1H, t, J = 6.6 Hz), 5.00 (2H, d, J 
= 6.6 Hz), 3.88 (1H, s), 3.78 (3H, s); 13C NMR (100 MHz, CDCl3): δ 207.2, 173.8, 139.0, 
134.3, 128.5, 128.0, 95.3, 80.0, 76.7, 53.7; HRMS Calcd. for C12H21O2 [M + H – H2O]+: 
221.03693; Found: 221.03668. [α]24.2D = –36.8 (c = 2.17, CHCl3) for a 93.5:6.5 e.r. 
sample. The enantiomeric purity of this compound was determined by HPLC analysis in 
comparison with authentic racemic material (Chiracel AS-H, 90:10 hexanes:i-PrOH, 0.5 
mL/min, 220 nm): tR: 14 min (minor) and 16 min (major). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 14.0 min 51.425 1 13.5 min 6.533 
2 16.6 min 48.575 2 15.7 min 93.467 
 
tert-Butyl (R)-3-(2-hydroxy-1-methoxy-1-oxopenta-3,4-dien-2-yl)-1H-indole-1-
carboxylate (3.21d, Scheme 3.19): The title compound is purified by silica gel 
chromatography (10 mm diameter column slurry packed with ~2.5 g of silica gel and 
eluted successively with 10 mL hexanes, 10 mL 20:1, 40 mL 9:1 hexanes:ethyl acetate) 
affording 3.21d (71.6 mg, 0.209 mmol, >98% yield, >98:2 allene:propargyl) as a white 
solid. M.p. = 115–117 ºC. IR (neat): 3504 (w), 1960 (w), 1727 (s), 1453 (w), 1373 (s), 
1249 (s), 1225 (m), 1156 (s), 1091 (s), 1020 (m), 853 (m), 831 (s), 776 (m), 744 (s) cm-1; 
1H NMR (400 MHz, CDCl3): δ 8.14 (1H, d, J = 8.3 Hz), 7.70 (1H, s), 7.69–7.66 (1H, m), 
7.34–7.29 (1H, m), 7.25–7.21 (1H, m), 5.83 (1H, t, J = 6.6 Hz), 5.04 (2H, d, J = 6.6 Hz), 
3.84 (1H, s), 3.78 (3H, s), 1.67 (9H, s); 13C NMR (100 MHz, CDCl3): δ 207.3, 174.0, 
149.7, 136.1, 128.0, 124.7, 122.9, 120.9, 120.8, 115.4, 110.6, 94.5, 84.2, 80.2, 73.8, 53.6, 
28.3; HRMS Calcd. for C19H20N1O4 [M + H – H2O]+: 326.13923; Found: 326.14036. 
[α]24.2D = –47.2 (c = 2.75, CHCl3) for a 90:10 e.r. sample. The enantiomeric purity of this 
compound was determined by HPLC analysis in comparison with authentic racemic 
material (Chiracel OD-H, 90:10 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 11 min 
(minor) and 13 min (major).    
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 11.4 min 50.352 1 11.4 min 10.046 
2 12.6 min 49.648 2 12.6 min 89.954 
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Chapter Four 
 
Ag-Catalyzed Enantioselective Vinylogous 
Mannich Reactions of γ-Substituted 
Siloxyfurans with Aldimines 
 
4.1 Introduction 
 The Mannich reaction is one of the most popular approaches, in both nature and 
the work of humankind, to create nitrogen-containing compounds.1  In general terms, it is 
a reaction between an enol and an iminium ion to afford a β-amino carbonyl (Equation 
1), although modern variants also include a variety of enolates and enol ethers 
 
(e.g. silyl enol ethers) as the nucleophile and imines as the electrophile.1 The vinylogous 
Mannich reaction,2 in which a dienol (or its equivalent) is the nucleophile (Equation 2), 
has proven to be a powerful method to access chiral amines.3 Harnessing the power of 
 
                                                
(1) For a review on the Mannich reaction and its modern variants, see: Arend, M.; Westermann, B.; Risch, 
N. Angew. Chem. Int. Ed. 1998, 37, 1044–1070. 
(2) For recent reviews covering the vinylogous Mannich reaction, see: (a) Bur, S. K.; Martin, S. F. 
Tetrahedron 2001, 57, 3221–3242. (b) Martin, S. F. Acc. Chem. Res. 2002, 35, 895–904. (c) Casiraghi, G.; 
Battistini, L.; Curti, C.; Rassu, G.; Zanardi, F. Chem. Rev. 2011, 111, 3076–3154. 
(3) For a discussion on the importance to medicine of stereochemical pure compounds in general and chiral 
amines in particular, see Section 1.1 of Chapter 1 of this dissertation. 
R1
OH
+
R3
NR2
R1
O NR2
R3
(1)
R1
OH
+
R3
NR2 NR2
R3
(2)
O
R1
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vinylogous4 nucleophiles can come with a price. As illustrated in Scheme 4.1, when 
adding to an electrophile, these molecules can potentially react from the α-position (C2 
carbon) or the γ-position (C4 carbon). Much of the selectivity obtained hinges on the 
structure of the nucleophile.5 Electronically, lithium dienolates preferentially react from 
 
the α-position and silyl ketene acetals (and siyl enol ethers) preferentially react from the 
γ-position. Calculation of the Fukui orbital densities shows the highest HOMO 
coefficient resides on the C2 carbon (α-position) for lithium dienolate 4.1a and on the C4 
carbon (γ-position) for silyl ketene acetal 4.1b (Figure 4.1).5  Under the conditions shown 
in equation 3, a lithium dienolate reacts with methyl iodide to exclusively form the α-
addition product.6 In the Mukaiyama aldol in Equation 4, a silyl enol ether reacts to  
 
                                                
(4) Krishnamurthy, S. J. J. Chem. Educ. 1982, 59, 543–547. 
(5) For a review on catalytic enantioselective vinylogous aldol reaction that skillfully discusses the issue of 
γ- to α-selectivity, see: Denmark, S. E.; Heemstra, J. R.; Beutner, G. L. Angew. Chem. Int. Ed. 2005, 44, 
4682–4698.   
(6) Rathke, M. W.; Sullivan, D. Tetrahedron Lett. 1972, 13, 4249–4252. 
R1
OM
C1
C2
α
C3
C4
γ
E++
α-selective
γ-selective
R1
O
E
O
R1
Scheme 4.1 Vinylogous Nucleophiles can React from the α- or γ-Position
E
(H2O)3LiO
OMe
C1
C2
α
C3
C4
γ
4.1a
C1
C2
C3
C4
0.130
0.311
0.042
0.280
Me3SiO
OMe
C1
C2
α
C3
C4
γ
4.1b
C1
C2
C3
C4
0.219
0.230
0.090
0.302
Figure 4.1 HOMO Coefficients of Two Different Vinylogous Nucleophiles
Values are calculated HOMO orbital coefficients
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exclusively form the α-addition product.7 While the electronic features discussed in 
Figure 4.1 certainly play a role in determining the selectivities shown in Equations 3 and 
4, steric effects should not be ignored. In equation 4, the C4 carbon that the nucleophile 
adds from is less sterically hindered than the competing C2 carbon. Key to data discussed 
later in this Chapter, substitution at the C4 carbon (γ-position) of these nucleophiles can 
lead to competitive formation of the α-addition product. 
 
 
4.2 Background 
 Enantioselective vinylogous Mannich (EVM) reaction of siloxyfurans8 gives rise 
to formation of two contiguous stereogenic centers and the generation of a C-C bond. 
Substitution at the γ-position of such nucleophiles (e.g. 4.3, Scheme 4.2) allows for the 
generation of a quaternary stereogenic center adjacent to a tertiary stereogenic center. 
This transformation was pioneered by Professor S. F. Martin and has been exploited in 
synthesis of a variety of amine-containing targets.9 Such an approach was used in a key 
                                                
(7) Mukaiyama, T.; Ishida, A. Chem. Lett. 1975, 319–322. 
(8) For a review encompassing this class vinylogous nucleophiles, see: Rassu, G.; Zanardi, F.; Battistini, 
L.; Casiraghi, G. Chem. Soc. Rev. 2000, 29, 109–118. 
(9) For representative examples, see: (a) Martin, S. F.; Barr, K. J.; Smith, D. W.; Bur, S. K. J. Am. Chem. 
Soc. 1999, 121, 6990–6997. (b) Liras, S.; Davoren, J. E.; Bordner, J. Org. Lett. 2001, 3, 703–706. (c) Liras, 
S.; Lynch, C. L.; Fryer, A. M.; Vu, B. T.; Martin, S. F. J. Am. Chem. Soc. 2001, 123, 5918–5924. (d) 
Reichelt, A.; Bur, S. K.; Martin, S. F. Tetrahedron, 2002, 58, 6323–6328. (e) Bardají, G. G. et al. J. Org. 
Chem. 2008, 73, 7657–7662. 
LiO
OEt
MeI,
thf, HMPA, -78 ºC
EtO
O
Me
α:γ >99:1
(3)
OSiMe3
+
Ph
OMe
MeO
3.0 equiv. TiCl4
thf, –78 ºC
O
H
OMe
Ph
γ:α >99:1
(4)
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step by Pilli and co-workers in the synthesis of the alkaloid (±)-homopumiliotoxin 223G 
(Scheme 4.2).10  
 
 Although the process of combining 4.3 with the in situ-generated iminium ion in 
Scheme 4.2 is diastereoselective (6:1), it does not afford enantiomerically enriched 
products. Development of a catalytic enantioselective method to access such quaternary 
stereogenic centers would represent a notable advance in enantioselective catalysis. 
 Our group became interested in this challenge from our reports (in collaboration 
with Prof. M. L. Snapper) of using highly modular amino acid-derived ligands in 
enantioselective syntheses of amines, 11  specifically in Ag-catalyzed 12  Mannich-type 
reactions. Under similar conditions and with the same bidentate phosphine ligand 4.4a 
(Scheme 4.2), siloxy-containing nucleophiles13 such as Danishefsky's diene,14 silyl enol 
                                                
(10) (a) Santos, L. S.; Pilli, R. A. Tetrahedron Lett. 2001, 42, 6999–7001. For an earlier enantioselective 
formal synthesis of this molecule using a similar key step, see: (b) Martin, S. F.; Bur, S. F. Tetrahedron 
1999, 55, 8905–8914. 
(11) For representative examples, see: (a) Cole, B. M.; Shimizu, K. D.; Krueger, C. A.; Harrity, J. P. A.; 
Snapper, M. L.; Hoveyda, A. H. Angew. Chem. Int. Ed. Engl. 1996, 35, 1668–1671.  (b) Shimizu, K. D.; 
Cole, B. M.; Krueger, C. A.; Kuntz, K. W.; Snapper, M. L.; Hoveyda, A. H. Angew. Chem. Int. Ed. Engl. 
1997, 36, 1703–1707. (c) Krueger, C. A.; Kuntz, K. W.; Dzierba, C. D.; Wirschun, W. G.; Gleason, J. D.; 
Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 1999, 121, 4284–4285. (d) Porter, J. R.; Wirschun, W. 
G.; Kuntz, K. W.; Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2000, 122, 2657–2658. (e) 
Josephsohn, N. S.; Kuntz, K. W.; Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2001, 123, 11594–
11599. (f) Deng, H.; Isler, M. P.; Snapper, M. L.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2002, 41, 1009–
1012. (g) Akullian, L. C.; Snapper, M. L.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2003, 42, 4244–4247. 
(12) For a review of Ag-catalyzed enantioselective transformations, see: (a) Naodovic, M.; Yamamoto, H. 
Chem. Rev. 2008, 108, 3132–3148. For a review specific to those that involve chiral Ag-phosphine 
complexes, see: (b) Yanagisawa, A.; Arai, T. Chem. Commun. 2008, 1165–1172. 
(13) For a study of the relative nucleophilicities of various silyl and alkyl enol ethers, see: Burfeindt, J.; 
Patz, M.; Müller, M.; Mayr, H. J. Am. Chem. Soc. 1998, 120, 3629–3634. 
N
Cbz
OMe
OMe OTIPS
10 mol % TMSOTf,
thf/dcm, -78 ºC
80%, 6:1 d.r.
Scheme 4.2 Racemic Synthesis of Homopumiliotoxin 223G Reported by Pilli
N
Cbz
O
Me
O
N
Me
OHH
(±)-Homopumillotoxin 223G
hydrocholride salt
Cl-
8 steps
54 % yield
4.3
4.2a (±)-4.2b
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ethers,15 and silyl ketene acetals16 can all be added to aldimines containing an o-anisidyl 
protecting group in high (≥95:5 e.r.) levels of selectivity. The o-anisidine group is critical 
to the enantioselectivity of these transformations, but not their efficiency.14 We propose 
this group allows for the substrate to act as a bidentate ligand (involving the anisidyl 
oxygen and imine nitrogen) for chelation of the Lewis acidic silver species. 
 
 Our group subsequently investigated the Ag-catalyzed EVM reaction promoted 
by chiral phosphine ligands with three different classes of siloxyfurans (Scheme 4.3); 
transformations proceed to afford the desired compounds in >99:<1 d.r. and >89.5:<10.5 
e.r. (4.5a-c, Scheme 4.3).17 The substrate scope of this method was expanded to allow for 
additions to alkyl-substituted imines (generated in situ), which yield products such as 4.6 
                                                                                                                                            
(14) Josephsohn, N. S.; Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2003, 125, 4018–4019. 
(15) Josephsohn, N. S.; Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2004, 126, 3734–3735. 
(16) Josephsohn, N. S.; Carswell, E. L.; Snapper, M. L.; Hoveyda, A. H. Org. Lett. 2005, 7, 2711–2713. 
(17) Carswell, E. L.; Snapper, M. L.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2006, 41, 6355–6359. 
 
NH
OMe
O
Ph
94% yield,
96:4 e.r.
NH
OMe
O
OPh
91% yield,
97:3 e.r
Ph
N
O
O
OMe
89% yield,
96:4 e.r.
PPh2
N
H
N
O
OMe
1-5 mol %
 1.1 equiv i-PrOH,  undist. thf , in air, 
-10 to 4 ºC, 16 h
Me Et
1-5 mol % AgOAc
N
MeO
R1
+
OSiMe3
R2
R1
NH
OMe
O
R2
Ph
4.4a
Scheme 4.2 Ag-Catalyzed Enantioselective Mannich Reactions with Ligand 4.4a
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(Scheme 4.3),18 and ester-substituted ketimines, which yield products such as 4.7 
(Scheme 4.3).19  
 
 Regarding the transformations shown in Schemes 4.2 and 4.3, further points that 
merit discussion are: (1) With the exception of the report involving ketimines,19 all other 
transformations are performed in undistilled solvent under an atmosphere of air. (2) The 
protic i-PrOH additive is required for high conversions; for example, the reaction to 
afford 4.5a in Scheme 4.3 only goes to 43% conversion without this additive versus 91% 
conversion with 1.1 equivalents of i-PrOH (4.5a obtained without the use of i-PrOH has 
                                                
(18) (a) Mandai, H.; Mandai, K.; Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2008, 130, 17961–
17969. For an example using the same conditions only with a siloxypyrrole as the nucleophile, see: (b) 
Ranieri, B.; Curti, C.; Battistini, L.; Sartori, A.; Pinna, L.; Casiraghi, G.; Zanardi, F. J. Org. Chem. 2011, 
76, 10291–10298. 
(19) Wieland, L. C.; Vieira, E. M.; Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 570–576. 
R1
N
G
+ O
PPh2
N
Z H
N
O
OMe
AgOAc, 1.1 equiv. i-PrOH,
 thf ,18 h
HN
R1
O
O
4.4c
R4
R3
OSiMe3
R3
R4
Scheme 4.3 Ag-Catalyzed Enantioselective Vinylogous Mannich Reactions
R2
G4.4a
4.4b
Z=(S)-s-Bu
Z=t-Bu
Z=(S)-CH(Me)Ot-Bu
HN
MeO
O
O
1 mol % 4.4a, 1 mol % AgOAc
82% yield, >99:1 d.r., 97.5:2.5 e.r.
HN
MeO
O
O
5 mol % 4.4a, 5 mol % AgOAc
85% yield, >99:1 d.r., 93.5:7.5 e.r.
Me HN
MeO
O
O
10 mol % 4.4b, 10 mol % AgOAc
70% yield, >99:1 d.r., 92.5:8.5 e.r.
Me
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MeS
O
O
5 mol % 4.4c, 5 mol % AgOAc
79% yield, >99:1 d.r., >99:1 e.r.
OMe
NH
OMe
O
O
11 mol % 4.4b, 10 mol % AgOAc
72% yield, 93:7 d.r., 95.5:4.5 e.r.
CO2Me
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an enantiomeric ratio of 96.5:3.5 e.r., which is very similar to the 97.5:2.5 e.r. observed 
for the reaction containing i-PrOH).17 We propose the alcohol eases catalytic turnover by 
facilitating removal of silyl-groups from the catalyst (II→III, Scheme 4.4). (3) As shown  
 
in I of Scheme 4.4, we propose the active catalyst is bifunctional.20 The bidentate 
phosphine-Schiff base acts as a binding site for the Lewis acidic silver, and the amide 
acts as a Lewis base to raise the nucleophilicity of the siloxyfuran. Catalysts containing a 
less Lewis basic methyl ester (versus an amide) are less efficient and enantioselective 
(though the transformation is still diastereoselective).17 (4) The modified protecting 
groups on products 4.6 and 4.7 facilitate their respective transformations in two different 
ways. Since the alkyl-substituted imines were formed in situ (due to their instability), the 
more electron- donating (versus ortho-anisidine) para-methoxy-ortho-thiomethyl aniline 
                                                
(20) We have proposed bifunctional catalysis for many other reactions involving amino acid derived-
ligands and catalysts. For representative examples, see: Reference 11e, (a) Fu, P.; Snapper, M. L.; 
Hoveyda, A. H. J. Am. Chem. Soc. 2008, 130, 5530–5541. (b) Friel, D. K.; Snapper, M. L.; Hoveyda, A. H. 
J. Am. Chem. Soc. 2008, 130, 9942–9951. (c) Manville, N.; Alite, H.; Haeffner, F.; Hoveyda, A. H.; 
Snapper, M. L. Nature Chem. 2013, 5, 768–774. For reviews, see: (d) Paull, D. H.; Abraham, C. J.; Scerba, 
M. T.; Alden-Danforth, E.; Lectka, T. Acc. Chem. Res. 2008, 41, 655–663. (e) Shibasaki, M.; Kanai, M.; 
Matsunaga, S.; Kumagai, N. Acc. Chem. Res. 2009, 42, 1117–1127. 
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Scheme 4.4 Proposed Mechanism for Ag-Catalyzed EVM of Siloxyfurans
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in 4.6 (Scheme 4.3) condensed with the aldehydes to form aldimines much faster than o-
anisidine (at 22 ºC in ten minutes, 90% versus 42% conversion).18a The exchange of a 
methoxy-group for a thiomethyl-group not only increases the nucleophilicity of this 
aniline, we propose sulfur binds to silver better than oxygen due to the more diffuse 
electron cloud on sulfur versus oxygen. Additionally, the lone pairs of electrons on the 
oxygen are more delocalized into the aryl-ring than those of sulfur due to the better 
orbital overlap between oxygen and carbon. The more electron-withdrawing (versus o-
anisidine) para-nitro-ortho-methoxy aniline in 4.7 (Scheme 4.3) is needed to enhance the 
electrophilicity of the ketimine. The nitro-group also serves as a handle for facile removal 
of the protecting group.19 (5) Unlike additions of unsubstituted and β-substituted 
siloxyfurans, addition of α-methyl substituted siloxyfuran affords the syn-diastereomer 
4.5c (>98:<2 d.r. versus >98:<2 d.r. anti for the products 4.5a and 4.5b and unsubstituted 
nucleophiles, Scheme 4.3). We propose this reversal comes from a steric interaction 
between the methyl group and the o-anisidine group (see IV) that causes the imine to 
bind in the anti-conformation in the reactive conformer (V). 
 
 To extend the scope of the Ag-catalyzed EVM reaction of siloxyfurans, our group 
began to investigate γ-substituted siloxyfurans as nucleophiles. As mentioned earlier, due 
to the increased sterics on the γ-position of the nucleophile, complications can arise 
N
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Figure 4.2 Proposal for Reversal of Diastereoselectivity with α-Methyl Siloxyfuran
 
Page 668
  
including competitive addition from the α-position of the nucleophile as well as overall 
decreased reactivity. Examples where complete γ-selectivity is observed with these 
nucleophiles have been reported, but they are almost exclusively additions to iminium or 
ammonium ions bearing minimal steric encumbrance.21 Indicative of the important role 
that sterics play in regioselectivity is the vinylogous Mannich reaction in Pilli's synthesis 
of (±)-homopumiliotoxin 223G (discussed earlier, Scheme 4.2). Changing the nitrogen-
protecting group from Cbz (4.2a, Scheme 4.5) to the more sterically bulky Boc (4.8a, 
Scheme 4.5) results in a change from complete γ-selectivity to obtaining a 64:36 ratio of 
γ- to α-addition products.10b Some additional reactions utilizing γ-substituted siloxyfurans 
show even lower amounts of γ-selectivity and sometimes 
 
                                                
(21) Many of these reports do not mention the possible regiochemical issues when using these 
nucleophiles, and we infer that they did not observe the α-addition product. It is possible that α-addition 
did occur in some of these reports, but was relegated to the status of an uncharacterized side product. For 
examples of vinylogous Mannich reactions, see: References contained in footnotes 9 and 10. For catalytic, 
enantioselective Michael additions that occur through a catalytically generated iminium intermediate, see: 
(a) Brown, S. P.; Goodwin, N. C.; MacMillan, D. W. C. J. Am. Chem. Soc. 2003, 125, 1192–1194. (b) 
Huang, Y.; Walji, A. M.; Larsen, C. H.; MacMillan, D. W. C. J. Am. Chem. Soc. 2005, 127, 15051–15053. 
(c) Quintard, A.; Lefranc, A.; Alexakis, A. Org. Lett. 2011, 13, 1540–1543. For a catalytic, enantioselective 
allylc alkylation occurring through a catalytically generated allylic ammonium, see: (d) Cui, H.-L. et al. 
Org. Lett. 2010, 12, 720–723. 
N
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OMe
OMe OTIPS
10 mol % TMSOTf,
thf/dcm, -78 ºC
80%, 6:1 d.r.
Scheme 4.5 Increase Substrate Sterics Increases α-Addition
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Me
O4.3
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N
Cbz
O
O
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N
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10 mol % TMSOTf,
thf/dcm, -78 ºC
67%, 19:1 d.r.
N
Boc
O
Me
O4.3 N
Boc
O
O
Me
+
No α-addition product detected
γ-addition product α-addition product
64:36 ratio of γ- to α-addition
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exclusively form the α-addition product.22  Of all reported methods for the catalytic EVM 
reaction with dienolfuran nucleophiles,23 only two involve γ-substituted nucleophiles. 
 The first is a Ti-catalyzed reaction of 2-aminophenol-derived aldimines with 
siloxyfurans (Scheme 4.6).24 Compared with α- (4.10), β- (4.11), and unsubstituted (4.9) 
siloxyfurans, all of which react to give the desired product in 50 to 80% yield, γ-
substituted siloxyfuran 4.3 does not add to the aldimine, even at -20 ºC. The authors note 
that at temperatures warmer than this, some product is formed, but it is in low yield and 
low selectivity (thy do not specify what type of selectivity is meant). 
 
 The second method, which came out while we were waiting to publish our report, 
is a Sc-catalyzed EVM reaction that proceeds in exclusive γ-selectivity to yield products 
in usually greater than 9:1 diastereomeric ratios and >95:5 enantiomeric ratios (Scheme 
                                                
(22) (a) Asaoka, M.; Sugimura, N.; Takei, H. Bull. Chem. Soc. Jpn. 1979, 52, 1953–1956. (b) Redero, E.; 
Sandoval, C.; Bermejo, F. Tetrahedron 2001, 57, 9597–9605. (c) Kong, K.; Romo, D. Org. Lett. 2006, 8, 
2909–2912. 
(23) For examples from outside of our laboratory that do not involve γ-substituted nucleophiles, see: (a) 
Akiyama, T.; Honma, Y.; Itoh, J.; Fuchibe, K. Adv. Synth. Catal. 2008, 350, 399–402.  (b) Yamaguchi, A.; 
Matsunaga, S.; Shibasaki, M. Org. Lett. 2008, 10, 2319–2322. (c) Yuan, Z.-L.; Jiang, J.-J.; Shi, M. 
Tetrahedron, 2009, 65, 6001–6007. (d) Deng, H.-P.; Wei, Y.; Shi, M. Adv. Synth. Catal. 2009, 351, 2897–
2902. 
(24) Martin, S. F.; Lopez, O. D. Tetrahedron Lett. 1999, 40, 8949–8953. 
O
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Scheme 4.6 Ti-Catalyzed EVM Reactions of Siloxyfurans
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4.7).25 Notably this method does not require a preformed siloxyfuran; the nucleophilic 
scandium dienolate is generated catalytically from α-angelica lactone 4.12 (the starting 
material used to synthesize γ-substituted siloxyfurans such as 4.3). Another strong point  
 
of this protocol is ligand 4.13 is accessed in four steps from readily available Boc-
pipecolic acid (<$1.50/mmol for either enantiomer). The main drawback of this 
transformation is that it uses the expensive precious metal salt Sc(OTf)3 ($16.9/mmol 
from Strem). 
4.3 Development and Scope of the Ag-Catalyzed EVM Reaction with γ-
Methylsiloxyfuran 
 Under conditions similar to those developed for the Ag-catalyzed EVM reaction 
of siloxyfurans, Dr. Emma Carswell discovered the transformation with γ-substituted 
siloxyfuran is quite stereoselective (Equation 5), but sluggish (no conversion observed at 
-78 ºC). However, the main drawback is that it affords a 64:36 mixture of regioisomeric 
γ-addition and α-addition products. The α-addition product 4.17, which is obtained in 
~55:45 e.r., eliminates to diene 4.18a upon standing. 
                                                
(25) Zhou, L.; Lin, L.; Ji, J.; Xie, M.; Liu, X.; Feng, X. Org. Lett. 2011, 13, 3056–3059. 
N N
O NH
O
OHN
O6 mol % 4.13
5 mol % Sc(OTf)3,
2-Me-thf, 3 Å MS, 0 ºC, 18 h
62–90%, 86:14–99:1 d.r.,
95:5–99:1 e.r. 4.13
R=Aryl,heteroaryl
O
OR
N
HO
HN
HO
O
MeR
O
+
Me
4.12
1.0 equiv.3.0 equiv.
Ar Ar
Ar=2,6-(i-Pr)2C6H3
Scheme 4.7 Sc-Catalyzed EVM Reaction of α-Angelica Lactone
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 Graduate student Peng Fu optimized this further by changing the protecting group 
of the imine to o-thiomethyl-containing 4.19a (Equation 6) and using more rigorously dry 
conditions. The conversion greatly improved under these conditions, but the γ:α ratio 
remained essentially the same. 
 
 Around this time, I began to work on this project with the task of finding a way to 
improve the regioselectivity. Screening various ligand modifications proved 
unsuccessful, as did screening metal salts (other silver salts behaved the same or worse 
than AgOAc; copper (I) and copper (II) salts not only gave about the same γ:α ratio, but 
also decreased the diastereomeric ratio to ~1:1 and afforded a substantial amount of 
unidentified side products). Changing silyl-groups of the nucleophile also did not lead to 
increased selectivity; the reaction with the triethylsilyl analog of 4.15 went to 51% 
conversion and with a γ:α ratio of 62:38; reactions with the TBS and TIPS analogs did 
not proceed at all. Spurred by a hypothesis that protic additives catalyze α-addition, basic 
additives were screened, but no improvement was discovered.  One parameter that did 
N
MeO
+
O
1.1 equiv. i-PrOH, 
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 -30 oC, 18 h
HN
MeO
O
O
OSiMe3
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Me
+
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MeO
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α
O
Meγ
Ph Ph Ph
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4.4c,
4.15 4.16 4.17
Upon 
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O
O
Me
diene
5 mol % AgOAc,
(5)
62% conv., 64:36 γ:α,
>99:1 d.r., 97:3 e.r.
4.18a
N
MeS
+
O
1.1 equiv. i-PrOH, 
distilled thf, N2,
 -30 oC, 3 h
HN
MeS
O
O
OSiMe3
Me
Me
+
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MeS
O
α
O
Meγ
Ph Ph Ph
5 mol %
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4.4c,
4.15 4.20a 4.21a
Upon 
Standing
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O
O
Me
diene
5 mol % AgOAc,
(6)
4.18a
96% conv., 68:32 γ:α, 40% yield γ,
>99:1 d.r., 98.5:1.5 e.r.
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prove impactful was temperature. By decreasing the temperature to -78 ºC, the γ:α ratio 
increased from 68:32 to 85:15 (Scheme 4.8). We next decided to examine N-activating 
groups to determine whether the selectivity and efficiency could be further improved 
(Table 4.1).  Although the enantioselectivity of the products with alternative N-activating 
groups is maintained, conversion and yield suffers (Table 4.1).   Therefore, o-
thiomethylaniline was retained as the N-activating group.  
 
 
 Before investigating the substrate scope, a few final modifications were made.  
tert-Leucine-derived ligand 4.4c was changed iso-leucine-derived 4.4a since they both 
N
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+
O
1.1 equiv. i-PrOH, 
thf, N2
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O
OSiMe3
Me
Me
+
HN
MeS
O
α
O
Meγ
Ph Ph Ph
5–10 mol %
1.1 equiv.
4.19a
4.4c,
4.15 4.20a 4.21a
5–10 mol % AgOAc,
Scheme 4.8 Decreasing Temperature Increases Regioselectivity
-30 ºC, 3 h,
95% conv., 68:32 γ:α,
40% yield γ,
>99:1 d.r., 98.5:1.5 e.r.
-50 ºC, 12 h,
95% conv., 75:25 γ:α,
61% yield γ,
>99:1 d.r., >99:1 e.r.
-78 ºC, 18 h,
81% conv., 85:15 γ:α,
64% yield γ,
>99:1 d.r., >99:1 e.r.
N
+ O
5 mol % ligand 4.4c,
5 mol % AgOAc,
1.1 equiv i-PrOH
dist. thf, N2, -78 oC, 18 h
HN
R
O
O
OTMS
Me
Me
Ph
Ph
1.2 equiv.
R
conv. (%)a γ:α additiona yield γ (%)b e.r (%)centry R
1 51 74:26 32 97
MeO
2 49 83:17 31 >98
MeS OMe
Diastereomeric ratio is >99:1 in both cases. a Determined by 400 MHz 1H NMR 
analysis of unpurified reaction mixture. b Yield of isolated product  c Determined by 
HPLC analysis.
Table 4.1 Different N-Protecting Groups
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lead to an identical EVM reaction and 4.4a is more easily accessible.26 The catalyst 
loading was also increased to 10 mol % in an effort to increase reproducibility of the 
reaction.  
 
 The Ag-catalyzed EVM reaction proceeds more efficiently, but with lower 
regioselectivity with an electron-poor aldimine (4.20b, Scheme 4.9). The reaction with 
electron rich para-methoxy aldimine is notably slower, requiring 48 hours to reach 75% 
                                                
(26) The identity of the amino-acid will not greatly impact the cost of these ligands since 2-
(diphenylphosphino)benzaldehyde, needed in the synthesis of these ligands, is $17.4/mmol (Aldrich). 
81% conv.,a 85:15 γ:α,b
64% yield γ,c 
>99:1 d.r.,d >99:1 e.r.e
97% conv.,a 79:21 γ:α,b
39% yield γ,c
 >99:1 d.r.,d >99:1 e.r.e
96% conv.,a 50:50 γ:αb,
38% yield γ,c 
 >99:1 d.r.,d >99:1 e.r.e
75% conv., 90:10 γ:α,
56% yield γ, 
 >99:1 d.r.,d >99:1 e.r.e
N
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+
O HN
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O
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Me
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1.2 equiv.
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80% yield γc,
 >99:1 d.r.,d >99:1 e.r.e
 2.2 equiv i-PrOH, thf,-78 ºC
PPh2
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H
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O
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O
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O4.20a
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O
Me
O4.20b
O2N
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O
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O4.20c
O
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O
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aConversion of starting material to products as determined by 400 MHz 1H analysis of the unpurified reaction 
mixture. b Determined by 400 MHz 1H analysis of the unpurified reaction mixture. cYield of isolated γ-addition 
product. dDetermined by 400 MHz 1H analysis of isolated γ-addition product. eDetermined by HPLC analysis.
Scheme 4.9 Additions to Aryl-Substituted Aldimines
Me
 
Page 674
  
conversion, although it more selective for γ-addition product 4.20e. Sterically unhindered 
2-furyl aldimine 4.19c undergoes addition more efficiently and with about the same 
levels of regioselectivity as benzaldehyde-derived aldimine 4.19a, affording 4.20c in 
80% yield. The decreased γ:α ratio (50:50) observed in the synthesis of 4.20d is likely 
due to the increased sterics of the ortho-Br benzaldehyde-derived aldimine. In all cases, 
the γ-addition products are obtained in >99:1 d.r. and e.r. 
 
Next, we examined reactions of alkynyl-substituted aldimines (Scheme 4.10).  We 
hypothesized that an unfavorable steric interaction is the cause of the undesired α-
addition in the EVM reaction with γ-substituted siloxyfuran 4.15, therefore, employing 
91% conv.,a 81:19 γ:α,b 58% yield γc 
>20:1 d.r.,d 97:3 e.r.e
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O
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O
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S
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O
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94% conv.,a 73:27 γ:α,b 54% yield γ,c
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>98% conv.,a 44:56 γ:α,b 30% yield γ,c 
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10 mol % AgOAc
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4.23a 4.23b
4.23d
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4.23e
Scheme 4.10 Additions to Alkynyl-Substituted Aldimines
aConversion of starting material to products as determined by 400 MHz 1H analysis of the unpurified reaction mixture. b 
Determined by 400 MHz 1H analysis of the unpurified reaction mixture. cYield of isolated γ-addition product. dDetermined 
by 400 MHz 1H analysis of isolated γ-addition product. eDetermined by HPLC analysis.
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the less sterically encumbered alkynyl-aldimine substrates should favor the formation of 
desired γ-addition product.  However, we obtain similar results to aryl-substituted 
aldimines in terms of γ-selectivity  (Scheme 4.10).  The smaller size of the aldimine 
substituent (and/or its increased electronegativity) did, however, lead to a more efficient 
reaction with 94 to 98% conversions being obtained in three hours (as opposed to 63 to 
97% conversions in 18 hours with aryl-substituted aldimines).  
 Another noteworthy difference in EVM reactions with alkynyl-substituted 
aldimines compared with that of aryl-substituted aldimines, is that in certain cases, lower 
levels of diastereoselectivity are observed with alkynyl-substituted aldimines. (Scheme 
4.10 versus Scheme 4.9).  Aldimines derived from aryl- and heterocycle-substituted 
alkynyl aldehydes afford high site-, diastereo-, and enantioselectivities (4.23a to 4.23c, 
Scheme 4.10).  Reaction with an imine substrate bearing a silyl-substituted alkyne yields 
high site- and diastereoselectivities but decreased enantioselectivities (4.23d, Scheme 
4.10).  EVM reactions with alkynylimines bearing an alkyl group result in a decrease 
both in diastereoselectivity and the ratio of γ- to α-addition product (4.23e, Scheme 4.10). 
 In order to increase the utility of the EVM reaction with γ-substituted 
siloxyfurans, an efficient method for the removal of the 2-thiomethylaniline N-protecting 
group must be developed. Employing PhI(OAc)2, which cleanly removes the o-anisidyl 
group from similar products (e.g. 4.5a in Scheme 4.3),17 only results in oxidation of the 
sulfur in 4.20a. Following extensive optimization, the best result is obtained with cerric 
ammonium nitrate (CAN) as an oxidant (Scheme 4.11). Following hydrolysis of 4.24, the 
free amine 4.25 is afforded in a modest 49% yield. 
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4.3 Conclusions 
 The EVM reaction with γ-substituted siloxyfuran 4.15 can be promoted by a Ag-
phosphine complex. Key to obtaining high yields of the desired  γ-addition product is 
performing the reaction at low temperature to minimize the formation of competing α-
addition product. In order to obtain acceptable conversions at such temperatures, use of a 
2-thiomethylaniline N-protecting group is employed. 
4.4 Experimental Section 
 ■  General. Infrared (IR) spectra were recorded on a Bruker alpha 
spectrophotometer, λmax in cm-1.  Bands are characterized as broad (br), strong (s), 
medium (m), and weak (w).  1H NMR spectra were recorded on a Varian Unity INOVA 
400 (400 MHz) or 500 (500 MHz) spectrometer.  Chemical shifts are reported in ppm 
from tetramethylsilane with the solvent resonance as the internal standard (CDCl3: δ 7.26 
ppm).  Data are reported as follows: chemical shift, integration, multiplicity (s = singlet, 
d = doublet, dd = doublet of doublets, t = triplet, q = quartet, br = broad, m = multiplet), 
and coupling constants (Hz). 13C NMR spectra were recorded on a Varian Unity INOVA 
400 (100 MHz) spectrometer with complete proton decoupling.  Chemical shifts are 
reported in ppm from tetramethylsilane with the solvent resonance as the internal 
standard (CDCl3: δ 77.16 ppm). Data are reported as follows: chemical shift, multiplicity 
Scheme 4.11 Removal of 2-Thiomethylaniline N-protecting Group
HN
MeS
O
O
Me
Ph
 4.4 equiv. CAN,
4:1 MeCN:H2O
0 ºC, 30 min
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N
MeS
O
O
Me
Ph
O
NH2
O
O
Me
Ph 1 N NaOH (pH=10)
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49% yield
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(singlet unless otherwise noted), and coupling constants (Hz). High-resolution mass 
spectrometry was performed on a JEOL AccuTOF-DART (positive mode) or an Advion 
Expression CMS (ESI+ or ESI-) or a Micromass LCT ESI-MS (positive mode) at the 
Mass Spectrometry Facility, Boston College and at the University of Illinois Mass 
Spectrometry Laboratories (Urbana, Illinois). Elemental microanalyses were performed at 
Robertson Microlit Laboratories (Madison, NJ). Enantiomer ratios (e.r.) values were 
determined by HPLC analysis using a SCL-10AVP chromatograph (Chiral Technologies 
Chiralcel OD (4.6 x 250 mm), Chiral Technologies Chiralcel OJ (4.6 x 250 mm), Chiral 
Technologies Chiralpak AD (4.6 x 250 mm). Specific rotations were measured using a 
Rudolph Research Analytical Autopol IV Polarimeter. Melting points were determined 
using a Thomas Hoover Uni-melt capillary melting point apparatus. Selected single 
crystals suitable for X-ray crystallographic analysis were used for structural 
determination. The X-ray intensity data were measured at 100(2) K (Oxford Cryostream 
700) on a Bruker Kappa APEX Duo diffractometer system equipped with a sealed Mo-
target X-ray tube (λ = 0.71073 Å) and a high brightness IµS copper source (λ = 1.54178 
Å). The crystals were mounted on agoniometer head with paratone oil. The detector was 
placed at a distance of 5.000 or 6.000 cm from the crystal. For each experiment, data 
collection strategy was determined by APEX software package and all frames were 
collected with a scan width of 0.5° in ω and φ with an exposure time of 10 or 20s/frame. 
The frames were integrated with the Bruker SAINT Software package using a narrow-
frame integration algorithm to a maximum 2θ angle of 56.54° (0.75 Å resolution) for Mo 
data and of 134° (0.84 Å resolution) for Cu data. The final cell constants are based upon 
the refinement of the XYZcentroids of several thousand reflections above 20 σ(I). 
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Analysis of the data showed negligible decay during data collection. Data were corrected 
for absorption effects using the empirical method (SADABS). The structures were solved 
and refined by full-matrix least squares procedures on ⎟⎟F2⎟⎟ using the Bruker 
SHELXTL (version 6.12) software package. All hydrogen atoms were included in 
idealized positions for structure factor calculations except for those forming hydrogen 
bonds or on a chiral center. Anisotropic displacement parameters were assigned to all 
non-hydrogen atoms, except those disordered. Unless otherwise noted, reactions were 
carried out under an atmosphere of dry N2 in oven-dried (135 ºC) glassware with the 
appropriate oven-dried (65 ºC) septa. 
■  Solvents: Unless otherwise noted, solvents were purged with Ar and purified under a 
positive pressure of dry Ar by a modified Innovative Technologies purification system.  
Toluene (Fisher, ACS Grade) was passed successively through activated copper and 
alumina columns.  Dichloromethane (Fisher, ACS Grade) and diethyl ether (Aldrich, 
Chromasolv®) were passed successively through two activated alumina columns. 
Tetrahydrofuran was purified by distillation from sodium benzophenone ketyl 
immediately prior to use. CDCl3 was purchased from Cambridge Isotope Laboratories 
and stored over activated 4Å molecular sieves prior to use. All work-up and purification 
procedures were carried out in air with reagent grade solvents (purchased from Fisher). 
Acetonitrile (HPLC grade) was purchased from Aldrich and used as received. 
■  Reagents: 
Aldehydes (for the Synthesis of Aldimines): The requisite aldehydes to access 
aldimines 4.19a–e and 4.22e were purchased from Aldrich and used as received. The 
alknyl-substituted aldehydes used in the synthesis of aldimines 4.22a to 4.22d were 
 
Page 679
  
synthesized from the corresponding alkynes in accordance to a procedure in the 
literature.27  
Cerric Ammonium Nitrate (CAN): Purchased from Aldrich (98.5%) and used as 
received. 
Isopropanol: Purchased from Fisher and distilled from CaH2 and stored over activated 
4Å MS prior to use. 
Magnesium Sulfate was purchased from Fisher and flame-dried under vacuum prior to 
use. 
Phosphine Ligands 4.4a–4.4c: Synthesized in accordance to a procedure in the 
literature.28 
2-(Methylthio)aniline: was purchased from Aldrich and used as received. 
Trimethyl((5-methylfuran-2-yl)oxy)silane (4.15): Synthesized in accordance to a 
procedure in the literature29 and purified by Kügel–Röhr distillation (~1 Torr, 50 ºC).  
Silver Acetate: was purchased from Aldrich (99.99% purity) and used as received. 
 
■  Representative Procedure for the Synthesis of o-Thiomethyl Aldimines (4.19a, 
Equation 6): 
A 200 mL round bottom flask equipped with a stirbar is charged with MgSO4 (11.6 g, 
96.5 mmol) then sealed with a rubber septum and connected to an atmosphere of N2 via a 
needle. Dichloromethane (30 mL), benzaldehyde (2.0 mL, 19.3 mmol), and 2-
(methylthio)aniline (2.4 mL, 19.5 mmol) are added sequentially and the reaction is 
allowed to stir at 22 ºC for 20 hours, during which time solution becomes bright yellow. 
The reaction mixture is passed through a fritted-glass funnel to remove the MgSO4 and 
                                                
(27) Journet, M.; Cai, D.; DiMichele, L. M.; Larsen, R. D. Tetrahedron Lett. 1998, 39, 6427–6428. 
(28) Carswell, E. L.; Snapper, M. L.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2006, 41, 6355–6359. 
(29) Simmons, B.; Walji, A. M.; ManMillan, D. W. C. 2009, 48, 4349–4353. 
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the resulting solution is concentrated to give a cloudy orange oil. The desired product is 
purified by trituration from ice-cold hexanes/diethyl ether to afford 4.19a (3.28g, 14.4 
mmol, 74.7% yield) as a bright yellow powder. If purification of the aldimine is not 
possible by recrystallization or trituration, then it can be purified by silica gel 
chromatography (columnmust be slurry-packed with ~95:5 hexanes:triethylamine or the 
substrate will decompose. 
Benzylidene-(2-methylsulfanyl-phenyl)-amine (4.19a, Scheme 4.9): M. p. = 44–46 °C. 
IR (neat): 3058 (m), 2918 (m), 1626 (s), 1575 (m), 1465 (m), 1437 (m), 1190 (s), 1072 
(m), 1042 (m), 761 (m) 690 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 8.42 (1H, s), 7.97-
7.95 (2H, m), 7.50–7.48 (3H, m), 7.23–7.22 (2H, m), 7.19–7.15 (1H, m), 7.00–6.98 (1H, 
m), 2.47 (3H, s); 13C NMR (100 MHz, CDCl3): δ 160.1, 149.2, 136.2, 134.1, 131.6, 
129.1, 128.9, 126.5, 125.3, 124.6, 117.6, 14.9. Elemental analysis for C14H13NS, Calcd: 
C, 73.97; H, 5.76; N, 6.16; found: C, 74.0; H, 5.94; N, 5.93. 
(2-Methylsulfanyl-phenyl)-(4-nitro-benzylidene)-amine  (4.19b, Scheme 4.9): Orange 
solid. M. p. = 134–136 °C. IR (neat): 1595 (m), 1514 (s), 1464 (m), 1434 (m), 1338 (s), 
851 (m), 756 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 8.52 (1H, s), 8.34–8.32 (2H, m), 
8.14–8.10 (2H, m), 7.30–7.23 (2H, m), 7.21–7.16 (1H, m), 7.05–7.02 (1H, m), 2.49 (3H, 
s); 13C NMR (100 MHz, CDCl3): δ 157.0, 149.5, 147.9, 141.6, 135.2, 129.7, 127.7, 125.3, 
124.8, 124.2, 117.2, 14.8; Elemental analysis for C14H12N2OS, calcd.: C, 61.75; H, 4.44; 
N, 10.29; found: C, 61.47; H, 4.36; N, 10.09. 
Furan-2-ylmethylene-(2-methylsulfanyl-phenyl)-amine (4.19c, Scheme 4.9): Yellow 
solid. M. p. = 69-71 °C. IR (neat): 3117 (m), 3055 (m), 2979 (m), 2918 (m), 1624 (s), 
1573 (s), 1482 (m), 1460 (s), 1438 (m), 1393 (m), 1346 (m), 1267 (m), 1199 (m), 1154 
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(m), 1077 (m), 1042 (m), 1018 (s), 934 (s), 883 (m), 782 (m), 745 (s) cm-1; 1H NMR (400 
MHz, CDCl3): δ 8.22 (1H, s), 7.62 (1H, d, J = 1.6 Hz), 7.21–7.20 (2H, m), 7.16–7.12 
(1H, m), 7.01 (1H, d, J = 3.6 Hz), 6.96–6.94 (1H, m), 6.55 (1H, dd, J = 3.2, 1.6 Hz), 2.46 
(3H, s); 13C NMR (100 MHz, CDCl3): δ 152.3, 149.1, 147.9, 145.9, 134.2, 126.6, 125.3, 
124.9, 117.5, 116.2, 112.3, 15.0; Elemental analysis for C12H11NOS, calcd.: C, 66.33; H, 
5.10; N, 6.45; found: C, 66.24; H, 5.03; N, 6.31. 
(2-Bromo-benzylidene)-(2-methylsulfanyl-phenyl)-amine (4.19d, Scheme 4.9): 
Yellow solid. M. p. = 72–74 °C. IR (neat): 3057 (m), 2982 (m), 2917 (m), 1616 (s), 1570 
(m), 1471 (s), 1437 (s), 1360 (m), 1271 (s), 1192 (m), 1069 (m), 1042 (s), 1024 (s), 967 
(m), 880 (s), 757 (s), 728 (s), 668 (s) cm-1. 1H NMR (400 MHz, CDCl3): δ 8.82 (1H, s), 
8.33 (1H, dd, J = 8.0, 1.6 Hz), 7.63–7.61 (1H, m), 7.44–7.40 (1H, m), 7.35–7.30 (1H, m), 
7.26–7.16 (3H, m), 7.05–7.02 (1H, m), 2.48 (3H, s); 13C NMR (100 MHz, CDCl3): δ 
158.9, 148.8, 134.7, 134.6, 133.3, 132.6, 129.6, 127.9, 127.0, 126.2, 125.4, 124.7, 117.8, 
14.9. Elemental analysis for C14H12BrNS, calcd.: C, 54.91; H, 3.95; N, 4.57; found: C, 
55.05; H, 3.88; N, 4.41. 
(4-Methoxy-benzylidene)-(2-methylsulfanyl-phenyl)-amine (4.19e, Scheme 4.9): 
Yellow solid. M. p. = 71–73 °C. IR (neat): 2917 (m), 2836 (m), 1622 (s), 1603 (m), 1573 
(m), 1511 (s), 1465 (m), 1438 (m), 1308 (m), 1252 (s), 1163 (m), 1069 (m), 1030 (m), 
833 (s), 826 (s), 748 (m) cm-1. 1H NMR (400 MHz, CDCl3): δ 8.34 (1H, s), 7.92–7.88 
(2H, m), 7.21–7.17 (2H, m), 7.16–7.13 (1H, m), 7.00–6.95 (3H, m), 3.88 (3H, s), 2.46 
(3H, s); 13C NMR (100 MHz, CDCl3): δ 162.5, 159.4, 149.5, 134.0, 130.8, 129.4, 126.1, 
125.3, 124.5, 117.6, 114.3, 55.6, 14.9. Elemental analysis for C15H15NOS, calcd.: C, 
70.01; H, 5.87; N, 5.44; found: C, 70.05; H, 5.74; N, 5.28. 
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(2-Methylsulfanyl-phenyl)-(3-phenyl-prop-2-ynylidene)-amine (4.22a, Scheme 4.10): 
Yellow solid. m. p. = 74–76 °C. IR (neat): 3054 (m), 2980 (m), 2918 (m), 2856 (m), 2197 
(s), 1597 (s), 1585 (s), 1572 (s), 1488 (m), 1462 (m), 1435 (s), 1351 (m), 1320 (m), 1265 
(m), 1200 (m), 1178 (m), 1160 (m), 1068 (m), 1017 (s), 949 (m), 848 (m), 754 (s), 742 
(s), 686 (s) cm-1. 1H NMR (400 MHz, CDCl3): δ 7.83 (1H, s), 7.57–7.55 (1H, m), 7.38–
7.32 (3H, m), 7.22-7.18 (2H, m), 7.12–7.08 (1H, m), 6.86 (1H, dd, J = 7.6; 0.8 Hz), 2.43 
(3H, s); 13C NMR (100 MHz, CDCl3): δ 149.0, 144.0, 134.4, 132.6, 130.0, 128.6, 127.5, 
125.4, 125.2, 121.6, 117.5, 95.5, 87.8, 15.2; Elemental analysis for C16H13NS, calcd.: C, 
76.46; H, 5.21; N, 5.57; found: C, 76.44; H,4.89; N, 5.43. 
[3-(4-Methoxy-phenyl)-prop-2-ynylidene]-(2-methylsulfanyl-phenyl)-amine (4.22b, 
Scheme 4.10): Yellow solid. M. p. = 102–104 °C. IR (neat): 2915 (w), 2837 (w), 2197 
(s), 1602 (s), 1584 (s), 1559 (s), 1505 (s), 1459 (s), 1439 (s), 1352 (m), 1267 (s), 1169 (s), 
1032 (s), 830 (s), 761 (s), 732 (m), 669 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.85 
(1H, s), 7.55 (1H, d, J = 9.2 Hz), 7.26–7.20 (2H, m), 7.17-7.12 (1H, m), 6.92–6.88 (3H, 
m), 3.84 (3H, s), 2.43 (3H, s); 13C NMR (100 MHz, CDCl3): δ 161.1, 149.2, 144.2, 134.4, 
134.3, 127.3, 125.4, 125.2, 117.5, 114.4, 113.5, 96.3, 87.3, 55.5, 15.2; HRMS Calcd for 
C17H16N1OS [M + H]+: 282.09526; Found: 282.09572. 
N-(2-(Methylthio)phenyl)-3-(thiophen-3-yl)prop-2-yn-1-imine (4.22c, Scheme 4.10): 
Yellow solid. ~95:5 E:Z M. p. = 91–93  °C. IR (neat): 3105 (w), 2201 (m), 1586 (m), 
1560 (w), 1070 (s), 798 (s), 754 (s), 694 (s), 626 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 
7.87 (1H,s), 7.73 (1H, m), 7.35 (1H, dd, J = 5.0, 3.0 Hz), 7.30–7.21 (m, 2H), 7.19–7.15 
(1H, m), 6.92 (1H, d, J = 8.0 Hz), 2.49 (3H, s). ; 13C NMR (100 MHz, CDCl3): δ 149.0, 
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143.6, 134.4, 132.1, 130.2, 127.5, 125.9, 125.4, 125.2, 120.8, 117.5, 90.7, 87.8, 15.2; 
HRMS Calcd for C14H12N1S2 [M + H]+: 258.04112; Found: 258.04106.  
 (2-Methylsulfanyl-phenyl)-(3-triisopropylsilanyl-prop-2-ynylidene)-amine (4.22d): 
Yellow oil. 2:1 mixture of E:Z isomers. IR (neat): 3057 (w), 2942 (s), 2890 (m), 2864 (s), 
2726 (w), 1590 (s), 1574 (m), 1461 (s), 1437 (m), 1384 (m), 1076 (m), 1057 (s), 1018 
(m), 996 (m), 920 (m), 881 (s), 752 (s), 734 (m), 703 (m), 664 (s), 597 (m), 583 (m), 532 
(m), 460 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.71 (0.5H, s), 7.67 (1H, s), 7.25-7.19 
(3H, m), 7.14–7.08 (1.5H, m), 7.03–7.01 (0.5H, m), 6.86–6.84 (1H, m), 2.45 (3H, s), 2.45 
(1.5H, s), 1.18–1.09 (21H, m), 1.01-0.93 (10.5H, m); 13C NMR (100 MHz, CDCl3): δ 
149.0, 148.8, 144.0, 143.3, 134.2, 130.9, 127.4, 126.1, 126.0, 125.3, 125.1, 125.1, 119.4, 
117.5, 104.2, 102.7, 99.9, 99.8, 18.7, 18.5, 15.7, 15.1, 11.3, 11.1; HRMS Calcd for 
C19H30N1SiS [M + H]+: 332.18682; Found: 332.18749. 
N-(2-(Methylthio)phenyl)oct-2-yn-1-imine (4.22e): Orange oil. ~85:15 mixture of E:Z 
(or Z:E) isomers.  IR (neat): 3056 (w), 2925 (m), 2890 (m), 2859 (w), 2213 (m), 1592 (s), 
1463 (m), 1437 (m), 1157 (m), 747 (s), cm-1; 1H NMR (400 MHz, CDCl3): δ 7.62 (1H, t, 
J = 1.7 Hz), 7.23–7.18 (2H, m), 7.14–7.07 (1H, m), 6.88 – 6.79 (1H, m), 2.44 (5H, d, J = 
4.4 Hz), 1.73–1.56 (2H, m), 1.50–1.29 (4H, m), 0.92 (3H, t, J = 7.2 Hz); 
 13C NMR (100 MHz, CDCl3): δ 149.1, 144.7, 133.9, 127.1, 125.3, 125.0, 117.5, 98.5, 
79.7, 31.2, 27.8, 22.3, 19.7, 15.1, 14.0; HRMS Calcd for C15H20NS [M + H]+: 246.13164; 
Found: 246.13116. 
■  Representative experimental procedure for the EVM reaction:   
To a 10 mL round-bottomed flask equipped with a stirbar, 3.4 mg (0.02 mmol, 0.1 
equivalents) AgOAc, 10.1 mg (0.02 mmol, 0.1 equivalents) of ligand 4.4a, and 45.5 mg 
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(0.2 mmol, 1.0 equivalents) of benzaldehyde-derived imine 4.19a is added and a septum 
is attached.  While covered in aluminum foil to prevent exposure to light, the vessel is 
purged with nitrogen for 15 minutes.  2.0 mL of a stock solution of distilled i-PrOH in 
distilled THF  (33.4 µL i-PrOH [2.2 equivalents]/ 2 mL THF) is added through a syringe. 
The solution is allowed to stir for 10 minutes.  The solution is allowed to cool to -78 ºC  
for 15 minutes after which time 45 µL (40.5, .24 mmol, 1.2 equivalents) of siloxyfuran 
4.15 is added to the reaction. After 18 hours, 1.0 mL of acetic acid in methanol (22 µL 
HOAc, 23.1 mg, 0.38 mmol) is added dropwise, and the mixture is allowed to stir at -78 
ºC for three hours before being allowed to warm to 23 ºC.  The solution is diluted with 
ethyl acetate, passed through a plug of silica, and concentrated in vacuo.  The resulting 
yellow oil is purified by silica gel chromatography (9 mm column, 10 mL 9:1 
hexanes:ethyl acetate, 48 mL 5:1 hexanes:ethyl acetate) to afford the desired product 
(41.4 mg 0.127 mmol, 64 % yield, >99:1 e.r)  as a pale yellow solid. 
 
5-Methyl-5-[(2-methylsulfanyl-phenylamino)-phenyl-methyl]-5H-furan-2-one 
(4.20a):  M.p. = 125–127 °C. IR (neat): 3368 (w), 3064 (w), 2986 (w), 2921 (w), 1760 
(s), 1587 (s), 1499 (s), 1451 (m), 1426 (w), 1319 (m), 1279 (m), 1235 (m), 1195 (m), 
1163 (m), 1140 (m), 1104 (m), 1072 (m), 1038 (s), 965 (m), 947 (m), 911 (m), 818 (m), 
778 (m), 748 (m), 702 (m) cm-1. 1H NMR (400 MHz, CDCl3): δ 7.41-7.38 (2H, m), 7.30-
7.24 (5H, m), 7.03-6.99 (1H, m), (6.64-6.60 (1H, m), 6.40 (1H, d, J = 8.0 Hz), 5.94 (1H, 
d, J = 5.6 Hz), 5.89 (1H, d, J = 8.4 Hz), 4.68 (1H, d, J = 8.4 Hz), 2.36 (3H, s), 1.64 (3H, 
s). 13C NMR (400 MHz, CDCl3): δ 171.8, 158.1, 146.8, 137.9, 134.4, 129.4, 128.8, 128.4, 
127.7, 121.9, 121.0, 118.0, 111.2, 90.2, 63.5, 22.5, 18.7. Elemental analysis for 
C19H19NO2S, calculated.: C, 70.12; H, 5.88; N, 4.30; found: C, 70.32; H, 5.77; N, 4.08. 
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Optical rotation: [α]D22 ºC 0.734 (c 1.18, CHCl3) for a 97:3 e.r. sample. The enantiomeric 
purity was determined by HPLC analysis (OD, 90:10 hexanes:i-PrOH, 1.0 mL/min, 220 
nm) tR 11 min (minor) and tR 16 min (major). 
 
Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 11.9 49.778 1 11.8 0.228 
2 17.4 50.222 2 16.9 99.772 
 
(5R)-5-Methyl-5-(((2-(methylthio)phenyl)amino)(4-nitrophenyl)methyl)furan-2(5H)-
one (4.20b, Scheme 4.9): Bright yellow oil. IR (neat): 3359 (br), 3107(w), 2923 (w), 
1758 (s), 1586 (m), 1519 (s), 1498 (s), 1344 (s), 1314 (m), 1139 (m), 1103 (m), 910 (m), 
818 (s), 729 (s), 697 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 8.15 (2H, dd, J = 9.0, 2.1 
Hz), 7.52–7.35 (4H, m), 7.07–6.95 (1H, m), 6.73–6.62 (1H, m), 6.29 (1H, d, J = 8.0), 
5.98 (1H, d, J = 8.5 Hz), 5.94 (1H, d, J = 5.7 Hz), 4.78 (1H, d, J = 8.5 Hz), 2.40 (3H, s), 
1.70 (3H, s); 13C NMR (100 MHz, CDCl3): δ 171.2, 157.7, 147.9, 145.9, 145.4, 134.4, 
129.4, 128.8, 124.0, 122.3, 121.5, 118.9, 111.1, 89.4, 63.1, 22.3, 18.8; HRMS calcd for 
C19H19N2O4S (M+H): 316.10655, Found: 316.10753. Optical rotation: [α]D20 –4.6 (c 
= 0.40, CHCl3) for a >99:1 e.r. sample. The enantiomeric purity was determined by chiral 
HPLC analysis (OD, 90:10 hexanes:i-PrOH, 1.0 mL/min, 254 nm) tR 41 min (minor) and 
tR 46 min (major). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 41.0 49.112 1 11.8 0.358 
2 45.9 50.888 2 16.9 99.642 
 
5-[Furan-2-yl-(2-methylsulfanyl-phenylamino)-methyl]-5-methyl-5H-furan-2-one 
(4.20c, Scheme 4.9): Pale yellow oil. IR (neat): 3350 (br), 3072 (m), 2984 (m), 2922 (m), 
2854 (m), 1752 (s), 1586 (s), 1497 (s), 1450 (m), 1426 (m), 1377 (m), 1314 (m), 1276 
(m), 1233 (m), 1147 (m), 1105 (m), 1069 (m), 1050 (m), 1038 (m), 1011 (m), 966 (m), 
950 (m), 916 (m), 900 (m), 884 (m), 861 (m), 815 (s), 739 (s), 684 (m), 597 (m) cm-1. 1H 
NMR (400 MHz, CDCl3): δ 7.53 (2H, d, J = 6.0 Hz), 7.39 (1H, dd, J = 7.6; 1.6 Hz), 7.35-
7.34 (1H, m), 7.14–7.10 (1H, m), 6.70–6.66 (1H, m), 6.57 (1H, d, J = 8.4 Hz), 6.29–6.26 
(2H, m), 6.08 (1H, d, J = 6.0 Hz), 5.54 (1H, d, J = 9.2 Hz), 4.81 (1H, d, J = 9.2 Hz), 2.28 
(3H, s), 1.59 (3H, s); 13C NMR (100 MHz, CDCl3): δ 171.8, 157.5, 151.2, 146.8, 142.4, 
134.6, 129.6, 122.3, 121.4, 118.6, 114.2, 111.3, 110.8, 108.8, 89.9, 57.8, 21.9, 18.6; 
HRMS calcd for C17H18NO3S (M+H): 316.10074, Found: 316.09947. Optical rotation: 
[α]D20 109.6 (c 0.62, CHCl3) for a 97:3 e.r. sample. The enantiomeric purity was 
determined by chiral HPLC analysis (OD, 95:5 hexanes:i-PrOH, 1.0 mL/min, 254 nm) tR 
18 min (minor) and tR 23 min (major). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 12.7 49.492 1 12.4 0.515 
2 15.4 50.508 2 14.9 99.485 
 
(5R)-5-((2-Bromophenyl)((2-(methylthio)phenyl)amino)methyl)-5-methylfuran-
2(5H)-one (4.20d, Scheme 4.9): Pale yellow solid. M. p. = 170–172 ºC. IR (neat): 3398 
(w), 2922 (w), 1763 (s), 1752 (s), 1500 (s), 1456 (s), 1321 (s), 1303 (m), 1109 (m), 924 
(s), 816 (s), 734 (s); 1H NMR (400 MHz, CDCl3): δ  7.64 (1H, d, J = 5.7 Hz), 7.48 (1H, 
dd, J = 8.0, 1.3 Hz), 7.39 (1H, dd, J = 7.6, 1.6 Hz), 7.35 (1H, dd, J = 7.8, 1.7 Hz), 7.23–
7.18 (1H, m), 7.16–7.01 (2H, m), 6.64 (1H, td, J = 7.5, 1.2 Hz), 6.42 (1H, dd, J = 8.3, 1.0 
Hz), 6.16 (1H, d, J = 9.4 Hz), 5.75 (1H, d, J = 5.7 Hz), 5.30 (1H, d, J = 9.4 Hz), 2.40 (3H, 
s), 1.79 (3H, s); 13C NMR (400 MHz, CDCl3): δ 171.8, 157.5, 146.5, 134.0, 134.5, 132.7, 
129.9, 129.7, 128.6, 128.4, 124.4, 121.8, 121.0, 118.3, 111.2, 90.4, 61.0, 22.8, 18.8; 
HRMS calcd for C19H19N81BrO2S (M+H): 406.02994, Found: 406.02972. Optical 
rotation: [α]D20 –144 (c = 0.88, CHCl3) for a >99:1 e.r. sample. The enantiomeric purity 
was determined by chiral HPLC analysis (OD, 90:10 hexanes:i-PrOH, 1.0 mL/min, 220 
nm) tR 8 min (minor) and tR 13 min (major).   
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 8.1 49.753 1 -n.d.- -n.d.- 
2 12.8 50.247 2 12.6 100.000 
 
5-[(4-Methoxy-phenyl)-(2-methylsulfanyl-phenylamino)-methyl]-5-methyl-5H-
furan-2-one (4.20e) White solid. M. p. = 134–136 °C. IR (neat): 3343 (w), 2958 (m), 
2923 (s), 2853 (m), 1755 (s), 1610 (m), 1586 (s), 1510 (s), 1500 (s), 1453 (m), 1305 (m), 
1278 (m), 1246 (s), 1177 (m), 1139 (m), 1101 (m), 1032 (m), 965 (m), 947 (m), 917 (m), 
841 (s), 818 (m), 747 (m), 723 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.39-7.37 (2H, 
m), 7.21-7.19 (2H, m), 7.04–6.99 (1H, m), 6.83-6.81 (2H, m), 6.64–6.60 (1H, m), 6.39 
(1H, d, J = 8.0 Hz), 5.95 (1H, d, J = 6.0 Hz), 5.83 (1H, d, J = 8.0 Hz), 4.63 (1H, d, J = 8.4 
Hz), 3.76 (3H, s), 2.36 (3H, s), 1.62 (3H, s); 13C NMR (400 MHz, CDCl3): δ 171.9, 
159.5, 158.2, 146.9, 134.4, 129.8, 129.5, 121.9, 121.0, 118.0, 114.2, 111.3, 90.5, 63.0, 
55.3, 22.5, 18.7; HRMS calcd for C20H22NO3S (M+H): 356.13204, Found: 356.13402. 
Optical rotation: [α]D20 13.54 (c 0.32, CHCl3) for a 99:1 e.r. sample. The enantiomeric 
purity was determined by chiral HPLC analysis (OD, 95:5 hexanes:i-PrOH, 1.0 mL/min, 
254 nm) tR 29 min (minor) and tR 35 min (major). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 17.0 50.579 1 -n.d.- -n.d.- 
2 20.7 49.421 2 20.6 100.000 
 
5-Methyl-5-[1-(2-methylsulfanyl-phenylamino)-3-phenyl-prop-2-ynyl]-5H-furan-2-
one (4.23a): Yellow oil; IR (neat): 3340 (br), 3064 (w), 2984 (w), 2922 (w), 1758 (s), 
1586 (m), 1491 (s), 1450 (m), 1425 (m), 1375 (m), 1313 (m), 1277 (m), 1234 (m), 1163 
(m), 1140 (m), 1107 (m), 1071 (s), 1038 (m), 990 (m), 960 (m), 910 (s), 816 (m), 729 (s), 
690 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.59 (1H, d, J = 6.0 Hz), 7.45–7.42 (1H, m), 
7.38–7.36 (2H, m), 7.33–7.29 (3H, m), 7.23–7.21 (1H, m), 6.82 (1H, d, J = 8.0 Hz), 6.79-
6.75 (1H, m), 6.26 (1H, d, J = 6.0 Hz), 5.20 (1H, d, J = 9.2 Hz), 4.64 (1H, d, J = 9.2 Hz), 
2.31 (3H, s), 1.79 (3H, s); 13C NMR (400 MHz, CDCl3): δ 171.7, 157.2, 146.7, 134.5, 
131.9, 129.6, 128.9, 128.5, 123.2, 122.1, 119.2, 112.1, 89.8, 86.2, 85.1, 53.3, 29.8, 21.4, 
18.7. HRMS calcd for C21H20NO2S (M+H): 350.12147, Found: 350.12270. [α]D20 = +194 
(c = 1.29, CHCl3) for a >20:1 d.r. and  96.5:3.5 e.r. sample. The enantiomeric purity of 
this compound was determined by HPLC analysis in comparison with authentic racemic 
material (Chiracel OD, 9:1 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 14 min (major) 
and 17 min (major). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 13.7 50.785 1 13.6 97.497 
2 17.4 49.215 2 17.5 2.504 
 
5-[3-(4-Methoxy-phenyl)-1-(2-methylsulfanyl-phenylamino)-prop-2-ynyl]-5-methyl-
5H-furan-2-one (4.23b):  Yellow oil; IR (neat): 2922 (w), 1763 (s), 1605 (m), 1587 (m), 
1509 (s), 1452 (m), 1291 (m), 1249 (s), 1173 (m), 1139 (m), 1108 (m), 1031 (m), 960 
(m), 917 (m), 834 (m), 818 (m), 748 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.59 (1H, 
d, J = 5.6 Hz), 7.42 (1H, dd, J = 7.6, 1.6 Hz), 7.31–7.29 (2H, m), 7.24–7.20 (1H, m), 
6.82–6.80 (3H, m), 6.77–6.73 (1H, m), 6.25 (1H, d, J = 5.6 Hz), 5.17 (1H, d, J = 9.2 Hz), 
4.62 (1H, d, J = 9.2 Hz), 3.80 (3H, s), 2.30 (3H, s), 1.78 (3H, s); 13C NMR (100 MHz, 
CDCl3): δ 171.8, 160.1, 157.3, 146.8, 134.5, 133.3, 129.6, 123.1, 122.0, 119.1, 114.1, 
112.1, 90.0, 86.2, 83.8, 55.4, 53.4, 29.8, 21.5, 18.7; HRMS calcd for C22H22NO3S (M+H): 
380.13204, Found: 380.13422; [α]D20 = +194 (c = 0.74, CHCl3) for a >20:1 d.r. and  
96.5:3.5 e.r. sample. The enantiomeric purity of this compound was determined by HPLC 
analysis in comparison with authentic racemic material (Chiracel OD, 95:5 hexanes:i-
PrOH, 0.5  mL/min, 220 nm): tR: 69 min (major) and 79 min (major). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 68.9 50.066 1 70.7 3.158 
2 78.6 49.934 2 78.5 96.842 
 
(R)-5-Methyl-5-((S)-1-((2-(methylthio)phenyl)amino)-3-(thiophen-3-yl)prop-2-yn-1-
yl)furan-2(5H)-one (4.23c, Scheme 4.10): Yellow oil; IR (neat): 3338 (w, br), 3105 (w), 
2920 (w), 2225 (w), 1755 (s), 1586 (m), 1494 (s), 1138 (m), 815 (m), 783 (m), 744 (s), 
625 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.58 (1H, d, J = 5.7 Hz), 7.47–7.37 (2H, 
m), 7.29–7.17 (2H, m), 7.05–7.03 (1H, m), 6.84–6.72 (2H, m), 6.25 (1H, d, J = 5.6 Hz), 
5.18 (1H, d, J = 9.3 Hz), 4.61 (1H, d, J = 9.2 Hz), 2.30 (3H, s), 1.77 (3H, s); 13C NMR 
(100 MHz, CDCl3): δ 171.7, 157.2, 146.7, 134.5, 129.9, 239.7, 129.6, 125.7, 123.2, 
122.0, 121.0, 119.2, 112.1, 89.8, 84.8, 81.379, 53.3, 21.5, 18.8; HRMS calcd for 
C19H18NO2S2 (M+H): 356.07789, Found: 356.07842; [α]D20 = +166 (c = 0.613, CHCl3) 
for a >20:1 d.r. and  97:3 e.r. sample. The enantiomeric purity of this compound was 
determined by HPLC analysis in comparison with authentic racemic material (Chiracel 
AD, 99:1 hexanes:i-PrOH, 0.4  mL/min, 220 nm): tR: 131 min (major) and 164 min 
(minor). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 131.8 50.335 1 127.9 96.796 
2 164.3 49.665 2 158.4 3.204 
 
(5R)-5-Methyl-5-(1-((2-(methylthio)phenyl)amino)-3-(triisopropylsilyl)prop-2-yn-1-
yl)furan-2(5H)-one (4.23d, Scheme 4.10): Yellow oil; IR (neat): 2941 (w), 2863 (m), 
1763 (s), 1588 (w), 1495 (m), 1452 (w), 1107 (m), 1019 (m), 882 (m), 816 (s), 745 (m), 
675 (s)  cm-1; 1H NMR (400 MHz, CDCl3): δ 7.52 (1H, d, J = 5.6 Hz), 7.41 (1H, dd, J = 
7.6, 1.6 Hz), 7.22–7.16 (1H, m), 6.78 (1H, d, J = 8.0 Hz), 6.76–6.70 (1H, m), 6.22 (1H, d, 
J = 5.6 Hz), 5.12 (1H, d, J = 9.2 Hz), 4.45 (1H, d, J = 9.2 Hz), 2.27 (3H, s), 1.75 (3H, s), 
1.01 (21H, s);   13C NMR (100 MHz, CDCl3): δ 171.6, 157.0, 146.9, 134.5, 129.6, 123.3, 
122.0, 119.2, 112.4, 103.3, 89.6, 88.0, 53.6, 21.6, 18.8, 18.6, 11.2; HRMS calcd for 
C24H36NO2SSi (M+H): 430.22360, Found: 430.22409; [α]D20 = +123 (c = 1.53, CHCl3) 
for a >20:1 d.r. and  88:12 e.r. sample. The enantiomeric purity of this compound was 
determined by HPLC analysis in comparison with authentic racemic material (Chiracel 
OD, 98:2 hexanes:i-PrOH, 0.3  mL/min, 220 nm): tR: 56 min (major) and 85 min (major). 
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 55.5 49.393 1 55.6 12.853 
2 86.6 50.607 2 85.2 87.168 
 
(5R)-5-Methyl-5-(1-((2-(methylthio)phenyl)amino)non-2-yn-1-yl)furan-2(5H)-one 
(4.23e, Scheme 4.10): Orange oil; IR (neat): 3353 (w, br), 2927 (w), 1761 (s), 1587 (m), 
1496 (s), 1107 (m), 816 (s), 744 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.51 (1H, d, J = 
5.6 Hz), 7.41 (1H, dd, J = 7.5, 1.6 Hz), 7.22–7.17 (1H, m), 6.75–6.71 (2H, m), 6.20 (1H, 
d, J = 5.6 Hz), 5.04 (1H, d, J = 9.1 Hz), 4.38 (1H, dt, J = 8.8, 2.1 Hz), 2.28 (3H, s), 2.15 
(2H, td, J = 7.1, 2.1 Hz), 1.71 (3H, s), 1.52–1.38 (2H, m), 1.37–1.20 (4H, m), 0.93–0.82 
(3H, m);   13C NMR (100 MHz, CDCl3): δ 171.8, 157.4, 147.0, 134.5, 129.6, 123.0, 
121.7, 118.9, 112.0, 90.0, 87.1, 76.3, 52.8, 31.1, 28.3, 22.2, 21.5, 18.7, 18.7, 14.1; HRMS 
calcd for C20H26NO2S (M+H): 344.16842, Found: 344.16827; [α]D20 = +101 (c = 1.07, 
CHCl3) for a >20:1 d.r. and  88:12 e.r. sample. The enantiomeric purity of this compound 
was determined by HPLC analysis in comparison with authentic racemic material 
(Chiracel OD, 98:2 hexanes:i-PrOH, 0.5  mL/min, 220 nm): tR: 38 min (minor) and 48 
min (major).  
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Peak # Ret. Time Area % Peak # Ret. Time Area % 
1 38.5 48.536 1 37.3 8.844 
2 48.1 51.464 2 48.4 91.156 
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